Citrus Sinensis ID: 015389

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSAPK
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccEEEHHHHcccccccEEEEccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEccccccHHHHHHHHHHHHHHHHccccccccEEEEEEccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccEEEEcccccccccccHHHcccccccccccccHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccHHHHHHcccccccHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEEEEEcccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEcccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEccccHHHEccccccccccEEEEEEcccccHHHHHccccccccHHHHHHEEEEEEHcccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHHccccHHHHHHHHccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mekkedscspvgvledyfrsedsetcsskepcsetkpesksnsrWHLFYDLFRNKSKKSLVTLYPlklsirrsssmregidmprnlfvnsydsqspqKIFSLYELqsatnnfsfenligkggyaeVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGimahvdhpntakLLGYGIEGGMHIVlelspngslASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIlltedfepqicdfglakwlpeqwthhtiskvegtfgylapeflmhgivdekTDVFAFGVLLLELVTgrraldysQQSLVLWARPMIKRNEIRELvdasladeydTRQMNLVLLAASLCiqqssirrpqMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSAPK
Flexible Loop (DISEMBL)
mekkedscspvgvledyfrsedsetcsskepcsetkpesksnsrWHLFYDLfrnkskkslvtlyplklsirrsssmregidMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTgrraldysqqslvlwarpmikrNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMtkcrspllrktlreelksapk
Low Complexity Region (SEG)
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSAPK
Disordered region (IsUnstruct)
*******************************************RWHLFYDLFRNKSKKSLVTLYPLKLSI**************NLFVNSY*****QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLL*************
Disordered Region (DISOPRED)
************************************************************************************************QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT**********FLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC**************************
Disordered Region (DISEMBL)
**********VGVLEDYF************************SRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLR********
Disordered Region (DISPRO)
*********PVGVLEDYFRSEDSETCSSKEPCS********NSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSS*********************PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC**************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSAPK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	408	2.2.26 [Sep-21-2011]
Q8RXC8	460	Receptor-like cytosolic s	no	no	0.892	0.791	0.588	1e-121
Q8H1D6	467	Receptor-like cytosolic s	no	no	0.686	0.599	0.586	4e-98
Q5XF57	579	Probable receptor-like se	no	no	0.688	0.485	0.545	4e-90
Q9LK03	717	Proline-rich receptor-lik	no	no	0.691	0.393	0.449	5e-65
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.693	0.551	0.447	6e-64
Q9LV48	652	Proline-rich receptor-lik	no	no	0.693	0.434	0.444	1e-63
Q8RWW0	744	Receptor-like serine/thre	no	no	0.678	0.372	0.445	7e-61
Q8GX23	670	Proline-rich receptor-lik	no	no	0.693	0.422	0.445	4e-60
Q9C821	509	Proline-rich receptor-lik	no	no	0.718	0.575	0.411	1e-59
C0LGG7	953	Probable LRR receptor-lik	no	no	0.681	0.291	0.420	2e-59

>sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1

 Score =  434 bits (1115), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 216/367 (58%), Positives = 274/367 (74%), Gaps = 3/367 (0%)

Query: 40  KSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFV--NSYDSQSPQ 97
           +++S W  F+ L++ +S K L +  PL  +        +  D   N  V  + YD QS  
Sbjct: 69  RASSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSL 128

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           + FS+ +++ AT+NFS EN+IG+GGYA+VY+G L  G+L+A+KRLT+GT DE  A+FLSE
Sbjct: 129 QNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSE 188

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGV 216
           LGI+AHVDHPNTAK +G  IEGGMH+V  LSP GSL SLL+G  K KL W  RY +ALG 
Sbjct: 189 LGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGT 248

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A+GL+YLHEGCQRRIIHRDIKA NILLTEDF+PQICDFGLAKWLP+Q THH +SK EGTF
Sbjct: 249 ADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTF 308

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
           GY APE+ MHGIVDEKTDVFAFGVLLLEL+TG  ALD SQQSLVLWA+P+++R  I+ELV
Sbjct: 309 GYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELV 368

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLR 396
           D SL DEY+  ++  +   ASLCI QSS+ RP+MSQVV+LL G+   +    + +  +++
Sbjct: 369 DPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAKIKMMQ 428

Query: 397 KTLREEL 403
           +T  EEL
Sbjct: 429 RTYSEEL 435

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1

 Score =  358 bits (919), Expect = 4e-98,   Method: Compositional matrix adjust.
 Identities = 166/283 (58%), Positives = 218/283 (77%), Gaps = 3/283 (1%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE--IIADFLSE 157
           F+  EL  AT+ F+ EN+IGKGG+AEVYKG L NG+ VAIK+L     +E   ++DFLSE
Sbjct: 141 FTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSDFLSE 200

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           LGI+AHV+HPN A+L G+  + G+H VLE +P GSLAS+L+G +E L+W IRYK+ALG+A
Sbjct: 201 LGIIAHVNHPNAARLRGFSSDRGLHFVLEYAPYGSLASMLFGSEECLEWKIRYKVALGIA 260

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +GL YLH  C RRIIHRDIKA+NILL  D+E QI DFGLAKWLPE W HH +  +EGTFG
Sbjct: 261 DGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVVFPIEGTFG 320

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY-SQQSLVLWARPMIKRNEIRELV 336
           YLAPE+ MHGIVDEK DVFAFGVLLLE++T RRA+D  S+QS+V WA+P +++N + ++V
Sbjct: 321 YLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTASRQSIVAWAKPFLEKNSMEDIV 380

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
           D  L + ++  +M  V+L AS+C+   +  RP M+++VQLLRG
Sbjct: 381 DPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRG 423

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  332 bits (850), Expect = 4e-90,   Method: Compositional matrix adjust.
 Identities = 155/284 (54%), Positives = 211/284 (74%), Gaps = 3/284 (1%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSEL 158
           F+  E+  ATN+F   N++G GGY+EVY+G L +G+ +A+KRL + + D     +FL+EL
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314

Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVA 217
           GI++HV HPNTA LLG  +E G+++V   S NG+L S L+  +   L W +RYKIA+GVA
Sbjct: 315 GIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGVA 374

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH+ C  RIIHRDIK++N+LL  D+EPQI DFGLAKWLP +WTHH +  VEGTFG
Sbjct: 375 RGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD 337
           YLAPE LM G +DEKTD++AFG+LLLE++TGRR ++ +Q+ ++LWA+P ++     ELVD
Sbjct: 435 YLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGNTSELVD 494

Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL-RGN 380
             L D+YD +QMN ++L AS C+QQS I RP M+QV++LL  GN
Sbjct: 495 PKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGN 538

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  248 bits (634), Expect = 5e-65,   Method: Compositional matrix adjust.
 Identities = 134/298 (44%), Positives = 195/298 (65%), Gaps = 16/298 (5%)

Query: 97  QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLS 156
           Q  F+  EL  ATN FS  NL+G+GG+  V+KG LRNG+ VA+K+L  G++ +   +F +
Sbjct: 339 QGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSS-QGEREFQA 397

Query: 157 ELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGM-KEKLKWGIRYKIAL 214
           E+GI++ V H +   L+GY I     + V E  PN +L   L+G  +  ++W  R KIA+
Sbjct: 398 EVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAV 457

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
           G A+GL YLHE C  +IIHRDIKA+NIL+   FE ++ DFGLAK   +  TH + ++V G
Sbjct: 458 GSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVMG 516

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD----YSQQSLVLWARPMIKRN 330
           TFGYLAPE+   G + EK+DVF+FGV+LLEL+TGRR +D    ++  SLV WARP++  N
Sbjct: 517 TFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLL--N 574

Query: 331 EIREL------VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC 382
           ++ EL      VD  L +EYD  +M  ++  A+ C++ ++ RRP+M QV ++L GN+ 
Sbjct: 575 QVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNIS 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  245 bits (625), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 132/295 (44%), Positives = 191/295 (64%), Gaps = 12/295 (4%)

Query: 97  QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLS 156
           Q  F+  EL  ATN FS  NL+G+GG+  VYKG L NG  VA+K+L  G+A +   +F +
Sbjct: 168 QSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSA-QGEKEFQA 226

Query: 157 ELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGM-KEKLKWGIRYKIAL 214
           E+ I++ + H N   L+GY I G   + V E  PN +L   L+G  +  ++W +R KIA+
Sbjct: 227 EVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAV 286

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
             ++GL YLHE C  +IIHRDIKAANIL+   FE ++ DFGLAK   +  TH + ++V G
Sbjct: 287 SSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVS-TRVMG 345

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD----YSQQSLVLWARPM---- 326
           TFGYLAPE+   G + EK+DV++FGV+LLEL+TGRR +D    Y+  SLV WARP+    
Sbjct: 346 TFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQA 405

Query: 327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           ++ +    L D  L +EYD  +M  ++  A+ C++ ++ RRP+M QVV++L GN+
Sbjct: 406 LEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNI 460

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  244 bits (622), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 131/295 (44%), Positives = 191/295 (64%), Gaps = 12/295 (4%)

Query: 97  QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLS 156
           +  F+  EL  ATN FS  NL+G+GG+  V+KG L +G+ VA+K+L  G+  +   +F +
Sbjct: 265 KSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQA 323

Query: 157 ELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGM-KEKLKWGIRYKIAL 214
           E+ I++ V H +   L+GY + G   + V E  PN +L   L+G  +  ++W  R KIAL
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIAL 383

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
           G A+GL YLHE C  +IIHRDIKA+NIL+   FE ++ DFGLAK   +  TH + ++V G
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVMG 442

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD----YSQQSLVLWARPMIKR- 329
           TFGYLAPE+   G + EK+DVF+FGV+LLEL+TGRR +D    Y   SLV WARP++ R 
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502

Query: 330 ---NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
               +   L D+ + +EYD  +M  ++  A+ C++ S+ RRP+MSQ+V+ L GN+
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNV 557

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  234 bits (598), Expect = 7e-61,   Method: Compositional matrix adjust.
 Identities = 128/287 (44%), Positives = 185/287 (64%), Gaps = 10/287 (3%)

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           K F+L EL+ AT+ FS + ++G+GG+  VY+G + +G  VA+K LTR   +    +F++E
Sbjct: 335 KTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD-REFIAE 393

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
           + +++ + H N  KL+G  IEG    ++ EL  NGS+ S L+  +  L W  R KIALG 
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--EGTLDWDARLKIALGA 451

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A GL YLHE    R+IHRD KA+N+LL +DF P++ DFGLA+   E  + H  ++V GTF
Sbjct: 452 ARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHISTRVMGTF 510

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS----LVLWARPMIKRNE- 331
           GY+APE+ M G +  K+DV+++GV+LLEL+TGRR +D SQ S    LV WARP++   E 
Sbjct: 511 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANREG 570

Query: 332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           + +LVD +LA  Y+   M  V   AS+C+ Q    RP M +VVQ L+
Sbjct: 571 LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617

Required during the differentiation of the protoderm into shoots epidermis and cuticle.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  232 bits (591), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 131/294 (44%), Positives = 183/294 (62%), Gaps = 11/294 (3%)

Query: 97  QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLS 156
           Q  F+  EL  AT  F+  NL+G+GG+  V+KG L +G+ VA+K L  G+  +   +F +
Sbjct: 297 QSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSG-QGEREFQA 355

Query: 157 ELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGM-KEKLKWGIRYKIAL 214
           E+ I++ V H +   L+GY I GG  + V E  PN +L   L+G  +  L W  R KIAL
Sbjct: 356 EVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIAL 415

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
           G A GL YLHE C  RIIHRDIKAANILL   FE ++ DFGLAK   + +T H  ++V G
Sbjct: 416 GSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYT-HVSTRVMG 474

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS---QQSLVLWARPM----I 327
           TFGYLAPE+   G + +K+DVF+FGV+LLEL+TGR  LD +   + SLV WARP+     
Sbjct: 475 TFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMEDSLVDWARPLCLKAA 534

Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           +  +  +L D  L   Y  ++M  +   A+  I+ S+ RRP+MSQ+V+ L G++
Sbjct: 535 QDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDM 588

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1

 Score =  230 bits (587), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 127/309 (41%), Positives = 195/309 (63%), Gaps = 16/309 (5%)

Query: 97  QKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLS 156
           Q +F+  +L  AT+NFS  NL+G+GG+  V++G L +G LVAIK+L  G+  +   +F +
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSG-QGEREFQA 186

Query: 157 ELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK--LKWGIRYKIA 213
           E+  ++ V H +   LLGY I G   + V E  PN +L   L+  KE+  ++W  R KIA
Sbjct: 187 EIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLH-EKERPVMEWSKRMKIA 245

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
           LG A+GL YLHE C  + IHRD+KAANIL+ + +E ++ DFGLA+   +  TH + +++ 
Sbjct: 246 LGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVS-TRIM 304

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ-----QSLVLWARPM-- 326
           GTFGYLAPE+   G + EK+DVF+ GV+LLEL+TGRR +D SQ      S+V WA+P+  
Sbjct: 305 GTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMI 364

Query: 327 --IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL 384
             +       LVD  L +++D  +M  ++  A+  ++ S+ RRP+MSQ+V+   GN+  +
Sbjct: 365 QALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNI-SI 423

Query: 385 KYMTKCRSP 393
             +T+  +P
Sbjct: 424 DDLTEGAAP 432

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2

 Score =  229 bits (585), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 121/288 (42%), Positives = 186/288 (64%), Gaps = 10/288 (3%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
           FSL +++ ATNNF   N IG+GG+  VYKG+L +G ++A+K+L+ G+  +   +FL+E+G
Sbjct: 612 FSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSK-QGNREFLNEIG 670

Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKE---KLKWGIRYKIALG 215
           +++ + HPN  KL G  +EGG + +V E   N SLA  L+G +E   +L W  R KI +G
Sbjct: 671 MISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIG 730

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA GL YLHE  + +I+HRDIKA N+LL +   P+I DFGLAK L E+ + H  +++ GT
Sbjct: 731 VARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK-LDEEDSTHISTRIAGT 789

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR-RALDYSQQS---LVLWARPMIKRNE 331
           FGY+APE+ M G + +K DV++FG++ LE+V GR   ++ S+ +   L+ W   + ++N 
Sbjct: 790 FGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNN 849

Query: 332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
           + ELVD  L  EY+  +   ++  A +C       RP MS+VV++L G
Sbjct: 850 LLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG 897

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
224131288	421	predicted protein [Populus trichocarpa]	0.977	0.947	0.773	1e-180
255567596	462	ATP binding protein, putative [Ricinus c	0.968	0.854	0.728	1e-166
356500232	423	PREDICTED: receptor-like cytosolic serin	0.977	0.943	0.694	1e-160
356535678	411	PREDICTED: receptor-like cytosolic serin	0.985	0.978	0.721	1e-157
226815616	413	Rop-interacting receptor-like cytoplasmi	0.977	0.966	0.704	1e-155
15239245	429	protein kinase-like protein [Arabidopsis	0.950	0.904	0.679	1e-154
356570544	405	PREDICTED: receptor-like cytosolic serin	0.968	0.975	0.695	1e-153
297805146	404	hypothetical protein ARALYDRAFT_355584 [	0.950	0.960	0.657	1e-152
449463832	414	PREDICTED: receptor-like cytosolic serin	0.975	0.961	0.662	1e-151
356504892	405	PREDICTED: receptor-like cytosolic serin	0.973	0.980	0.667	1e-148

>gi|224131288|ref|XP_002321047.1| predicted protein [Populus trichocarpa] gi|222861820|gb|EEE99362.1| predicted protein [Populus trichocarpa]

 Score =  637 bits (1644), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 315/407 (77%), Positives = 349/407 (85%), Gaps = 8/407 (1%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSL 60
           MEKKED+ SPVGVLEDYF+SEDSE+CSSK+P S+ +  SK  SRWH F  L R++SKKSL
Sbjct: 1   MEKKEDASSPVGVLEDYFKSEDSESCSSKDPSSDAEV-SKHASRWHGFVKLLRSRSKKSL 59

Query: 61  VTLYPL---KLSIRRSSSMREGIDMPRNLFVNSYDS--QSPQKIFSLYELQSATNNFSFE 115
            TL+PL   KLS+R+SSSMRE I    NLF NS  S  +SP+  F+L ELQ+ATNNFS E
Sbjct: 60  ATLHPLGVLKLSMRKSSSMRENIIT--NLFANSDSSNFKSPRINFTLSELQAATNNFSQE 117

Query: 116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           NLIGKGGYAEVYKG L+NG++VAIKRLTRGT DEII DFLSE+GIMAHV+HPNTAKL+GY
Sbjct: 118 NLIGKGGYAEVYKGCLQNGKIVAIKRLTRGTTDEIIGDFLSEMGIMAHVNHPNTAKLIGY 177

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           GIEGGMH+VLELSP+GSLAS+LYG KE+L W IRYKIALG A GLLYLHEGCQRRIIHRD
Sbjct: 178 GIEGGMHLVLELSPHGSLASVLYGSKERLTWHIRYKIALGTAHGLLYLHEGCQRRIIHRD 237

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           IKAANILLTEDFEPQICDFGLAKWLPE WTHHT+SK EGTFGYLAPE+LMHGIVDEKTDV
Sbjct: 238 IKAANILLTEDFEPQICDFGLAKWLPEHWTHHTVSKFEGTFGYLAPEYLMHGIVDEKTDV 297

Query: 296 FAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLA 355
           FAFGVLLLELVTGRRALDYSQQSLVLWA+P++K NEI ELVD +L D+Y+ RQMNLVLLA
Sbjct: 298 FAFGVLLLELVTGRRALDYSQQSLVLWAKPLLKNNEIGELVDPALVDDYNARQMNLVLLA 357

Query: 356 ASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREE 402
           ASLCIQQSSIRRP M QVVQ+L GNL CLK M K R P  RK    E
Sbjct: 358 ASLCIQQSSIRRPHMIQVVQILNGNLSCLKCMKKIRLPFFRKAFLNE 404

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567596|ref|XP_002524777.1| ATP binding protein, putative [Ricinus communis] gi|223535961|gb|EEF37620.1| ATP binding protein, putative [Ricinus communis]

 Score =  591 bits (1524), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 295/405 (72%), Positives = 344/405 (84%), Gaps = 10/405 (2%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSE--TKPESKSNSRWHLFYDLFRNKSKK 58
           MEKK D+ SPVGVLEDYFRSE+SE+ SSKEP S+  ++  SK  SRW  F+ L ++++KK
Sbjct: 36  MEKKGDTSSPVGVLEDYFRSEESESSSSKEPTSDFDSQKSSKPVSRWRGFFQLLKSRTKK 95

Query: 59  SLVTLYPL---KLSIRRSSSMREGIDMPRNLFVNS--YDSQSPQKIFSLYELQSATNNFS 113
            L TL+PL   KLS+RRSSSMRE   M  NLF +S  Y+   P+  F+L ELQ+ATN+FS
Sbjct: 96  PLATLHPLSVLKLSLRRSSSMRE---MVPNLFADSDSYNLNCPRMSFTLSELQAATNDFS 152

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
            ENLIGKGGYAEVYKG L+NG+LVAIKRL RGTADEI+ DFLSE+GIMAHV+HPNTA+L+
Sbjct: 153 QENLIGKGGYAEVYKGCLKNGKLVAIKRLIRGTADEIVGDFLSEMGIMAHVNHPNTARLI 212

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           GYGIEGGMH+VLELSP+GSLAS+L G KE LKW IRYKIA+G AEG+ YLHE CQRRIIH
Sbjct: 213 GYGIEGGMHLVLELSPHGSLASVLSGSKETLKWDIRYKIAVGTAEGIRYLHEDCQRRIIH 272

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIKAANILLTEDFEPQICDFGLAKWLP+QWTHH +SK EGTFGYLAPE+LMHGIVDEKT
Sbjct: 273 RDIKAANILLTEDFEPQICDFGLAKWLPQQWTHHVVSKFEGTFGYLAPEYLMHGIVDEKT 332

Query: 294 DVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL 353
           DVFAFGVLLLELVTGRRALDYSQQSLVLWA+P++K+NEIRELVD +L ++Y+ RQMNL+L
Sbjct: 333 DVFAFGVLLLELVTGRRALDYSQQSLVLWAKPLLKKNEIRELVDPALGNDYNARQMNLIL 392

Query: 354 LAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKT 398
           LAASLCIQQSS+RRP+++QVVQ+L  NL  L+ M K R    RK 
Sbjct: 393 LAASLCIQQSSLRRPKITQVVQILNDNLNSLRSMKKSRVAFFRKA 437

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500232|ref|XP_003518937.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  572 bits (1474), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 291/419 (69%), Positives = 330/419 (78%), Gaps = 20/419 (4%)

Query: 4   KEDSCSPVGVLEDYFR---------------SEDSETCSSKEPCSETKPESKSNSRWHLF 48
           KE   SPV VLEDYFR               SE  E   S     E++  SKS SRWH F
Sbjct: 2   KEKVDSPVTVLEDYFRSSDSESSSSKEPSADSESREFSKSASRWHESREFSKSASRWHAF 61

Query: 49  YDLFRNKSKKSLVTLYPL---KLSIRRSSSMREGIDMPRNLF-VNSYDSQSPQKIFSLYE 104
             L R+ SKK + TL+PL   KLS R S+SMRE I +P  L    +   +SP KIF+ +E
Sbjct: 62  LQLLRSGSKKQMNTLHPLSVLKLSKRMSTSMRESI-LPSCLLDATASPCRSPWKIFTHHE 120

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +Q ATN+FS ENLIGKGGYAEVYKG L N QLVA+KRLTRGTADEII DFLSELG+MAHV
Sbjct: 121 IQVATNSFSQENLIGKGGYAEVYKGCLPNRQLVAVKRLTRGTADEIIGDFLSELGVMAHV 180

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           +HPNTAKL+GYG++GGM++VLELS  GSLAS+LYG KEK  W IR+KIALG A+G+LYLH
Sbjct: 181 NHPNTAKLVGYGVDGGMYLVLELSEKGSLASVLYGSKEKPPWFIRHKIALGTAKGILYLH 240

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE WTHHT+SK EGTFGYLAPE+L
Sbjct: 241 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPENWTHHTVSKFEGTFGYLAPEYL 300

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY 344
           +HGIVDEKTDVFAFGVLLLELV+GRRALDYSQQSLVLWA+P++K+N+I ELVD SLA ++
Sbjct: 301 LHGIVDEKTDVFAFGVLLLELVSGRRALDYSQQSLVLWAKPLLKKNDIMELVDPSLAGDF 360

Query: 345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
           D+RQMNL+LLAASLCIQQSSIRRP   QVVQLL GNL C K M K R P  R+  REEL
Sbjct: 361 DSRQMNLMLLAASLCIQQSSIRRPSTRQVVQLLNGNLSCFKGMKKTRMPFFRRVFREEL 419

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356535678|ref|XP_003536371.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  561 bits (1446), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 296/410 (72%), Positives = 338/410 (82%), Gaps = 8/410 (1%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPC--SETKPESKSNSRWHLFYDLFRNKSKKSLV 61
           KE   SPV VLEDYFRS DSE+ SSKEP   SE++  SK  SRWH F  L R+ SKK + 
Sbjct: 2   KEKLDSPVTVLEDYFRSSDSESSSSKEPSADSESQELSKPASRWHSFIQLLRSGSKKQMN 61

Query: 62  -TLYPL---KLSIRRSSSMREGIDMPRNLF-VNSYDSQSPQKIFSLYELQSATNNFSFEN 116
            TL+PL   KLS R S+SMRE I +P  L    +   +SP KIF+ +E+Q ATN+FS EN
Sbjct: 62  NTLHPLSVLKLSKRMSTSMRESI-LPICLLDATASPCRSPWKIFTHHEIQVATNSFSQEN 120

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           LIGKGGYAEVYKG L N QLVAIKRLTRGTADEII DFLSELG+MAHV+H NTAKL+GYG
Sbjct: 121 LIGKGGYAEVYKGCLPNRQLVAIKRLTRGTADEIIGDFLSELGVMAHVNHTNTAKLVGYG 180

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           ++GGM++VLELS  GSLAS+LYG KEKL W IR+KIALG A+G+LYLHEGCQRRIIHRDI
Sbjct: 181 VDGGMYLVLELSEKGSLASVLYGSKEKLPWCIRHKIALGTAKGILYLHEGCQRRIIHRDI 240

Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVF 296
           KAANILLT+DFEPQICDFGLAKWLPE WTHHT+SK EGTFGYLAPE+L+HGIVDEKTDVF
Sbjct: 241 KAANILLTKDFEPQICDFGLAKWLPENWTHHTVSKFEGTFGYLAPEYLLHGIVDEKTDVF 300

Query: 297 AFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAA 356
           AFGVLLLELV+GRRALDYSQQSLVLWA+P++K+N+I ELVD SLA ++D+RQMNL+LLAA
Sbjct: 301 AFGVLLLELVSGRRALDYSQQSLVLWAKPLLKKNDIMELVDPSLAGDFDSRQMNLMLLAA 360

Query: 357 SLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSA 406
           SLCIQQSSIRRP + QVVQLL GNL C K M K R P  R+  REEL  +
Sbjct: 361 SLCIQQSSIRRPSIRQVVQLLNGNLSCFKGMKKTRMPFFRRVFREELHDS 410

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226815616|emb|CAT79821.1| Rop-interacting receptor-like cytoplasmic kinase 2 [Medicago truncatula]

 Score =  556 bits (1432), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 288/409 (70%), Positives = 332/409 (81%), Gaps = 10/409 (2%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPE---SKSNSRWHLFYDLFRNKSKKSL 60
           KE   SP+ VLEDYFRS DSE+ SSKEP  +++     SK  SRWH F  L +++SKK L
Sbjct: 2   KEKVDSPITVLEDYFRSSDSESSSSKEPTLDSESNDDISKPVSRWHSFLQLLKSRSKKQL 61

Query: 61  VTL-YPL--KLSIRRSSSMREGIDMPRNLFVNSYDS---QSPQKIFSLYELQSATNNFSF 114
             L +PL  + S R S SMRE I +P  L + +  S   +SP KIFS +++Q ATNNFS 
Sbjct: 62  PALNHPLNGQFSRRMSRSMRETI-LPSCLTLANATSTPCRSPWKIFSHHDIQVATNNFSQ 120

Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           ENLIGKGGYAEVYKG L N +LVAIKRLTRGT DEII DFLSELG+MAHV+HPNTAKL+G
Sbjct: 121 ENLIGKGGYAEVYKGCLPNHRLVAIKRLTRGTPDEIIGDFLSELGVMAHVNHPNTAKLVG 180

Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           YG++GGM++VLELS  GSLAS+LYG KEK++W IR KIALG A+G+LYLHEGCQ+R IHR
Sbjct: 181 YGVDGGMYLVLELSEKGSLASVLYGSKEKVQWCIRQKIALGTAKGILYLHEGCQKRFIHR 240

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAANILLTEDFEPQICDFGLAKWLPE WTHH +SK EGTFGYLAPE+L+HGIVDEKTD
Sbjct: 241 DIKAANILLTEDFEPQICDFGLAKWLPENWTHHNVSKFEGTFGYLAPEYLLHGIVDEKTD 300

Query: 295 VFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLL 354
           VFAFGVLLLELV+GRRALDYSQQSLVLWA+P++K+N+I +LVD SLA E+D RQMNL+LL
Sbjct: 301 VFAFGVLLLELVSGRRALDYSQQSLVLWAKPLLKKNDIMQLVDPSLAGEFDFRQMNLMLL 360

Query: 355 AASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
            ASLCIQQSSIRRP M QVVQLL GNL C K M K R P  RK  +EEL
Sbjct: 361 TASLCIQQSSIRRPSMRQVVQLLNGNLSCFKAMKKSRLPFFRKVFQEEL 409

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15239245|ref|NP_198445.1| protein kinase-like protein [Arabidopsis thaliana] gi|9758799|dbj|BAB09252.1| serine/threonine protein kinase-like [Arabidopsis thaliana] gi|332006650|gb|AED94033.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  550 bits (1416), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 280/412 (67%), Positives = 326/412 (79%), Gaps = 24/412 (5%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           K  DS SP GVLE++FR+E  E  SS E       ++ S+SR+     L R+KSKKSL  
Sbjct: 27  KVPDSSSPTGVLEEFFRTE--EFNSSSETV-----KNPSSSRFRKMVQLLRSKSKKSLEN 79

Query: 63  L-YP------LKLSIRRSSSMREGIDMPRNLFVNSYDSQ----SPQKIFSLYELQSATNN 111
           +  P      +K S RR SSMRE      NL  +S DS     SP++IF+  +L+SATNN
Sbjct: 80  VKIPFHNNGVIKSSFRRCSSMRE------NLRFSSNDSHFLLHSPRRIFTFSDLKSATNN 133

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           FS ENLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AK
Sbjct: 134 FSLENLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAK 193

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLGYG+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRI
Sbjct: 194 LLGYGVEGGMHLVLELSPHGSLASMLYSSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRI 253

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRDIKAANILLT DF PQICDFGLAKWLPE WTHH +SK EGTFGYLAPE+L HGIVDE
Sbjct: 254 IHRDIKAANILLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGTFGYLAPEYLTHGIVDE 313

Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL 351
           KTDVFA GVLLLELVTGRRALDYS+QSLVLWA+P++K+N+IREL+D SLA EY+ RQ+ L
Sbjct: 314 KTDVFALGVLLLELVTGRRALDYSKQSLVLWAKPLMKKNKIRELIDPSLAGEYEWRQIKL 373

Query: 352 VLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
           VLLAA+L IQQSSI RP+MSQVV++L+GNL  LK + KCR P  RK  R+E+
Sbjct: 374 VLLAAALSIQQSSIERPEMSQVVEILKGNLKDLKCIMKCRVPFYRKAFRDEV 425

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356570544|ref|XP_003553445.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  546 bits (1407), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 281/404 (69%), Positives = 325/404 (80%), Gaps = 9/404 (2%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPE-SKSNSRWHLFYDLFRNKSKKSLVT 62
           K++  SPVGVLEDYF+S +SET SSKEP +    + SK  SRW  F  L R+ SKK + T
Sbjct: 2   KDEVDSPVGVLEDYFKSSESETSSSKEPSTIVDSDKSKPGSRWLAFLQLLRDTSKKPIAT 61

Query: 63  LYPL---KLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIG 119
           L+PL   KLS R SSSMRE I     +  +S   + P KIF+ +E+Q ATN F+ EN IG
Sbjct: 62  LHPLSVLKLSRRMSSSMRETI-----IDADSSLHRPPWKIFTHHEIQIATNCFTQENFIG 116

Query: 120 KGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG 179
           KGGYAEVYKG L NGQLVAIKRLT GT +E I DFLSELGIMAHV+HPNTAKL+GYG+EG
Sbjct: 117 KGGYAEVYKGCLPNGQLVAIKRLTHGTENETIGDFLSELGIMAHVNHPNTAKLVGYGVEG 176

Query: 180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           GMH+VLELS  G LAS+L G KEKL W IR KIALG A+G++YLHEGCQRRIIHRDI AA
Sbjct: 177 GMHLVLELSEKGCLASVLNGFKEKLPWSIRQKIALGTAKGIMYLHEGCQRRIIHRDITAA 236

Query: 240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFG 299
           NILLTEDFEPQICDFGLAKWLPE WTHHT+SK+EGTFGYLAPE+L+HGIVDEKTDVFAFG
Sbjct: 237 NILLTEDFEPQICDFGLAKWLPENWTHHTVSKIEGTFGYLAPEYLLHGIVDEKTDVFAFG 296

Query: 300 VLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLC 359
           V+LLELVTGRRALD+SQQSLVLWA+P++K+N IREL+D SLAD++D RQ+ ++L AASLC
Sbjct: 297 VVLLELVTGRRALDHSQQSLVLWAKPLLKKNSIRELIDPSLADDFDCRQIKIMLWAASLC 356

Query: 360 IQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
           IQQSSI RP M QVVQLL GNL C K+  K + P  RK  +EEL
Sbjct: 357 IQQSSIHRPFMKQVVQLLNGNLSCFKFTKKSQHPFFRKVFQEEL 400

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805146|ref|XP_002870457.1| hypothetical protein ARALYDRAFT_355584 [Arabidopsis lyrata subsp. lyrata] gi|297316293|gb|EFH46716.1| hypothetical protein ARALYDRAFT_355584 [Arabidopsis lyrata subsp. lyrata]

 Score =  543 bits (1398), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 271/412 (65%), Positives = 326/412 (79%), Gaps = 24/412 (5%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
           K  DS SP GVLE++FR+E+  +       SET  E  S+SR+     L R++SKKS+  
Sbjct: 2   KAPDSSSPTGVLEEFFRTEEFGS-------SETVKEYPSSSRFRKMVQLLRSRSKKSIEN 54

Query: 63  L-YP------LKLSIRRSSSMREGIDMPRNLFVNSYDSQ----SPQKIFSLYELQSATNN 111
           L  P      ++ S+RR SSMR+      NL   S D+Q    SP++IF+  +L++ATNN
Sbjct: 55  LKIPFHNNGVIQSSLRRCSSMRD------NLRFGSSDAQFLLLSPRRIFTFSDLKTATNN 108

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           F+ ENLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AK
Sbjct: 109 FALENLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAK 168

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLGYG+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRI
Sbjct: 169 LLGYGVEGGMHLVLELSPHGSLASMLYNSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRI 228

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRD+KAANILLT DF PQICDFGL+KWLPE WTHH +SK EGTFGYLAPE+L HGIVDE
Sbjct: 229 IHRDVKAANILLTHDFSPQICDFGLSKWLPENWTHHIVSKFEGTFGYLAPEYLTHGIVDE 288

Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL 351
           KTDVFA GVLLLELVTGRRALDYS+QSLVLWA+P++K+N+IREL+D SL+ EY+ RQ+  
Sbjct: 289 KTDVFALGVLLLELVTGRRALDYSKQSLVLWAKPLMKKNKIRELIDPSLSGEYEWRQIKS 348

Query: 352 VLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
           VLLAA+L IQQSSI RP+MSQVV++L+GNL  LK + KCR P  RK  R+E+
Sbjct: 349 VLLAAALSIQQSSIERPEMSQVVEILKGNLKDLKCIMKCRVPFYRKAFRDEV 400

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463832|ref|XP_004149635.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus] gi|449515774|ref|XP_004164923.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Cucumis sativus]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 271/409 (66%), Positives = 326/409 (79%), Gaps = 11/409 (2%)

Query: 1   MEKKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSL 60
           M++K +S SP GVLEDYFRS   E+ SS+      KP   + S W   + +  +KS+K +
Sbjct: 1   MKEKVNSFSPTGVLEDYFRSSGPESTSSEL----AKP---AGSFWRGIFKILGSKSRKPV 53

Query: 61  VTLYP---LKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL 117
             L+P   LKLS R S+SMRE + +      +  +  SP K F+L EL++ATN FS EN+
Sbjct: 54  SKLHPQSVLKLSKRLSNSMRETLHLHFGFDSDVCNFNSPWKNFTLRELEAATNYFSPENV 113

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKGGYAEVY+G L++GQ+VAIKRLTRG+ DE + DFL ELGIMAH++HPNTAKL+GYGI
Sbjct: 114 IGKGGYAEVYRGCLKSGQVVAIKRLTRGSFDENVGDFLLELGIMAHLNHPNTAKLIGYGI 173

Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +GGMH+VLE  P+GSLAS L+G+KEKL+W IRYKIA+G+AEGL YLHEGCQRRIIHRDIK
Sbjct: 174 QGGMHLVLEFFPHGSLASTLHGLKEKLEWSIRYKIAIGIAEGLRYLHEGCQRRIIHRDIK 233

Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFA 297
           AANILLT+DFEPQICDFGLAKWLP+QWTHH +SK EGTFGYL PE+L HGIVDEKTDVFA
Sbjct: 234 AANILLTQDFEPQICDFGLAKWLPKQWTHHIVSKFEGTFGYLPPEYLSHGIVDEKTDVFA 293

Query: 298 FGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAAS 357
           FGVLLLELVTGRRALDYSQQSLVLWA+P++K+N +RELVD      Y++RQMNLVLLAAS
Sbjct: 294 FGVLLLELVTGRRALDYSQQSLVLWAKPLLKKNNVRELVDP-FTINYNSRQMNLVLLAAS 352

Query: 358 LCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSA 406
           LCIQQSSIRRP MSQVVQ+L G+L C++   K + P LR+  REEL  A
Sbjct: 353 LCIQQSSIRRPCMSQVVQILSGDLSCMRGTRKMQIPFLRRAFREELFRA 401

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504892|ref|XP_003521228.1| PREDICTED: receptor-like cytosolic serine/threonine-protein kinase RBK2-like [Glycine max]

 Score =  530 bits (1364), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 273/409 (66%), Positives = 319/409 (77%), Gaps = 12/409 (2%)

Query: 4   KEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPES---KSNSRWHLFYDLFRNKSKKSL 60
           K++  SP GVLEDYF  + SE+ +S      T  +S   K  SRW+ F  L R KSK  +
Sbjct: 2   KDEVDSPFGVLEDYFNFKSSESETSSSKEPSTIVDSDKLKPGSRWNAFLQLLRVKSK-PI 60

Query: 61  VTLYPL---KLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL 117
            TL+PL   KLS R SSSMRE +     +  +S   +SP KIF+ +E+Q ATN F  EN 
Sbjct: 61  ATLHPLSVLKLSRRMSSSMRETV-----IDADSSLHRSPWKIFTHHEIQIATNYFIQENC 115

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKGGYAEVYKG L NGQLVAIK LTRGT +E I DFLSELGIMAHV+H NTAKL+GYG+
Sbjct: 116 IGKGGYAEVYKGCLPNGQLVAIKMLTRGTENETIGDFLSELGIMAHVNHSNTAKLVGYGV 175

Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           EGGM++VLELS  G LAS+L G KEKL W  R KIALG A+G++YLHEGCQRRIIHRDI 
Sbjct: 176 EGGMYLVLELSEKGCLASMLNGSKEKLPWSFRQKIALGTAKGIMYLHEGCQRRIIHRDIT 235

Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFA 297
           AANILLTE+FEPQICDFGLAKWLPE WTHH +SK+EGTFGYL PE+L+HGIVDEKTDVFA
Sbjct: 236 AANILLTENFEPQICDFGLAKWLPENWTHHIVSKIEGTFGYLTPEYLLHGIVDEKTDVFA 295

Query: 298 FGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAAS 357
           FGV+LLELVTGRRALD+SQQSLVLWA+P++K+N IREL+D SLAD++D RQ+ ++LLAAS
Sbjct: 296 FGVVLLELVTGRRALDHSQQSLVLWAKPLLKKNCIRELIDPSLADDFDCRQIKIMLLAAS 355

Query: 358 LCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELKSA 406
           LCIQQSSIRRP M QVVQLL GNL C K+  K + PL RK  +EEL  A
Sbjct: 356 LCIQQSSIRRPSMKQVVQLLNGNLSCFKFTKKSQHPLFRKVFQEELLDA 404

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	408
TAIR|locus:2162848	429	AT5G35960 [Arabidopsis thalian	0.960	0.913	0.678	8e-140
TAIR|locus:2144970	511	AT5G18910 [Arabidopsis thalian	0.889	0.710	0.598	2.7e-116
TAIR|locus:2096209	460	RBK2 "ROP binding protein kina	0.892	0.791	0.588	1.4e-110
TAIR|locus:2155700	456	AT5G65530 [Arabidopsis thalian	0.911	0.815	0.507	4.7e-96
TAIR|locus:2142514	467	RBK1 "ROP binding protein kina	0.879	0.768	0.5	1.3e-94
TAIR|locus:2044420	392	AT2G18890 [Arabidopsis thalian	0.700	0.729	0.567	4.7e-87
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.688	0.485	0.545	7.4e-82
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.806	0.414	0.413	2e-63
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.747	0.403	0.430	3.3e-63
TAIR|locus:2059919	617	AT2G16750 [Arabidopsis thalian	0.678	0.448	0.440	2.4e-60

TAIR|locus:2162848 AT5G35960 [Arabidopsis thaliana (taxid:3702)]

 Score = 1368 (486.6 bits), Expect = 8.0e-140, P = 8.0e-140
 Identities = 277/408 (67%), Positives = 326/408 (79%)

Query:     3 KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVT 62
             K  DS SP GVLE++FR+E+    SS    SET  ++ S+SR+     L R+KSKKSL  
Sbjct:    27 KVPDSSSPTGVLEEFFRTEEFN--SS----SETV-KNPSSSRFRKMVQLLRSKSKKSLEN 79

Query:    63 L-YP------LKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFE 115
             +  P      +K S RR SSMRE +    N   + +   SP++IF+  +L+SATNNFS E
Sbjct:    80 VKIPFHNNGVIKSSFRRCSSMRENLRFSSN--DSHFLLHSPRRIFTFSDLKSATNNFSLE 137

Query:   116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
             NLIGKGGYAEVYKG L NGQ+VAIKRL RG ++EII DFLSE+GIMAHV+HPN AKLLGY
Sbjct:   138 NLIGKGGYAEVYKGMLPNGQMVAIKRLMRGNSEEIIVDFLSEMGIMAHVNHPNIAKLLGY 197

Query:   176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             G+EGGMH+VLELSP+GSLAS+LY  KEK+KW IRYKIALGVAEGL+YLH GC RRIIHRD
Sbjct:   198 GVEGGMHLVLELSPHGSLASMLYSSKEKMKWSIRYKIALGVAEGLVYLHRGCHRRIIHRD 257

Query:   236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
             IKAANILLT DF PQICDFGLAKWLPE WTHH +SK EGTFGYLAPE+L HGIVDEKTDV
Sbjct:   258 IKAANILLTHDFSPQICDFGLAKWLPENWTHHIVSKFEGTFGYLAPEYLTHGIVDEKTDV 317

Query:   296 FAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLA 355
             FA GVLLLELVTGRRALDYS+QSLVLWA+P++K+N+IREL+D SLA EY+ RQ+ LVLLA
Sbjct:   318 FALGVLLLELVTGRRALDYSKQSLVLWAKPLMKKNKIRELIDPSLAGEYEWRQIKLVLLA 377

Query:   356 ASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREEL 403
             A+L IQQSSI RP+MSQVV++L+GNL  LK + KCR P  RK  R+E+
Sbjct:   378 AALSIQQSSIERPEMSQVVEILKGNLKDLKCIMKCRVPFYRKAFRDEV 425

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2144970 AT5G18910 [Arabidopsis thaliana (taxid:3702)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 222/371 (59%), Positives = 288/371 (77%)

Query:    41 SNSRWHL-FYDLFRN-KSKKSLVTLYPLK----LSIRRSSSMREG-IDMPRNLFVNSYDS 93
             +N  W   F+ L +   S     T  PLK    L+ R+S  +R+  + +   L  +    
Sbjct:   113 NNGHWRRGFFRLLKKGSSAMPFNTFTPLKGVPKLTRRKSKRIRDNMVPVIPALDTDHLFY 172

Query:    94 QSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
               P  + FSL ++Q+ATN++S ENLIG+GGYAEVYKG++ +GQ+VAIK+LTRG+A+E+  
Sbjct:   173 FKPSWRNFSLRDIQTATNDYSRENLIGEGGYAEVYKGQMADGQIVAIKKLTRGSAEEMTM 232

Query:   153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
             D+LSELGI+ HVDHPN AKL+GY +EGGMH+VLELSPNGSLASLLY  KEKL W +RYK+
Sbjct:   233 DYLSELGIIVHVDHPNIAKLIGYCVEGGMHLVLELSPNGSLASLLYEAKEKLNWSMRYKV 292

Query:   213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
             A+G AEGL YLHEGCQRRIIH+DIKA+NILLT++FE QI DFGLAKWLP+QWTHHT+SKV
Sbjct:   293 AMGTAEGLYYLHEGCQRRIIHKDIKASNILLTQNFEAQISDFGLAKWLPDQWTHHTVSKV 352

Query:   273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI 332
             EGTFGYL PEF MHGIVDEKTDV+A+GVLLLEL+TGR+ALD SQ S+V+WA+P+IK N+I
Sbjct:   353 EGTFGYLPPEFFMHGIVDEKTDVYAYGVLLLELITGRQALDSSQHSIVMWAKPLIKENKI 412

Query:   333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRS 392
             ++LVD  L D+YD  +++ ++  ASLCI Q+S+ RPQMSQVV++LRG+ C L  + +  +
Sbjct:   413 KQLVDPILEDDYDVEELDRLVFIASLCIHQTSMNRPQMSQVVEILRGDKCSLDKLREREN 472

Query:   393 PLLRKTLREEL 403
               L++T  EEL
Sbjct:   473 SKLQRTYSEEL 483

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005777 "peroxisome" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2096209 RBK2 "ROP binding protein kinases 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
 Identities = 216/367 (58%), Positives = 274/367 (74%)

Query:    40 KSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFV--NSYDSQSPQ 97
             +++S W  F+ L++ +S K L +  PL  +        +  D   N  V  + YD QS  
Sbjct:    69 RASSNWGKFFKLWKRRSMKRLSSFPPLSGAAPPIIKQNKSADPNMNGMVLHDIYDFQSSL 128

Query:    98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
             + FS+ +++ AT+NFS EN+IG+GGYA+VY+G L  G+L+A+KRLT+GT DE  A+FLSE
Sbjct:   129 QNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQTAEFLSE 188

Query:   158 LGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGV 216
             LGI+AHVDHPNTAK +G  IEGGMH+V  LSP GSL SLL+G  K KL W  RY +ALG 
Sbjct:   189 LGIIAHVDHPNTAKFIGCCIEGGMHLVFRLSPLGSLGSLLHGPSKYKLTWSRRYNVALGT 248

Query:   217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
             A+GL+YLHEGCQRRIIHRDIKA NILLTEDF+PQICDFGLAKWLP+Q THH +SK EGTF
Sbjct:   249 ADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHHNVSKFEGTF 308

Query:   277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
             GY APE+ MHGIVDEKTDVFAFGVLLLEL+TG  ALD SQQSLVLWA+P+++R  I+ELV
Sbjct:   309 GYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALDESQQSLVLWAKPLLERKAIKELV 368

Query:   337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLR 396
             D SL DEY+  ++  +   ASLCI QSS+ RP+MSQVV+LL G+   +    + +  +++
Sbjct:   369 DPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDVVMTPREAKIKMMQ 428

Query:   397 KTLREEL 403
             +T  EEL
Sbjct:   429 RTYSEEL 435

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)]

 Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
 Identities = 200/394 (50%), Positives = 270/394 (68%)

Query:     5 EDSCSPVGVLEDYFRSEDSE---TCSS------KEPCSETKPESKSNSRWHLFYDLFRNK 55
             ED  SP  VLE    S DS+   +CSS        P S T P   S  +W+   +  + K
Sbjct:    26 EDP-SPRCVLEIPVMSSDSDNSSSCSSCSPDKSSSPLSTTPPNVSSFHQWNKMIESIKKK 84

Query:    56 SKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQS-----PQ-KIFSLYELQSAT 109
             S +   ++ PL  S   +   ++    P +   N +D        P  + F+  EL +AT
Sbjct:    85 SIRRF-SVIPLLASYELTRKKKQPKLSPCS--ENDFDCDQILVAKPSWRNFTFDELVAAT 141

Query:   110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
             +NF+ EN+IGKGG+AEVYKG L +G+ VAIK+LTR     +E ++DFLSELGI+AHV+HP
Sbjct:   142 DNFNPENMIGKGGHAEVYKGVLPDGETVAIKKLTRHAKEVEERVSDFLSELGIIAHVNHP 201

Query:   168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             N A+L G+  + G+H VLE S +GSLASLL+G +E L W  RYK+A+G+A+GL YLH  C
Sbjct:   202 NAARLRGFSCDRGLHFVLEYSSHGSLASLLFGSEECLDWKKRYKVAMGIADGLSYLHNDC 261

Query:   228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              RRIIHRDIKA+NILL++D+E QI DFGLAKWLPE W HH +  +EGTFGYLAPE+ MHG
Sbjct:   262 PRRIIHRDIKASNILLSQDYEAQISDFGLAKWLPEHWPHHIVFPIEGTFGYLAPEYFMHG 321

Query:   288 IVDEKTDVFAFGVLLLELVTGRRALDY-SQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
             IVDEKTDVFAFGVLLLE++TGRRA+D  S+QS+V+WA+P++++N + E+VD  L +++D 
Sbjct:   322 IVDEKTDVFAFGVLLLEIITGRRAVDTDSRQSIVMWAKPLLEKNNMEEIVDPQLGNDFDE 381

Query:   347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN 380
              +M  V+  AS+CI   S  RP M+++VQLLRG+
Sbjct:   382 TEMKRVMQTASMCIHHVSTMRPDMNRLVQLLRGD 415

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2142514 RBK1 "ROP binding protein kinases 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
 Identities = 186/372 (50%), Positives = 257/372 (69%)

Query:    20 SEDSETCSSKEPCSET-KPESKSNS--RWHLFYDLFRNKSKKSLVTLYPLKLS--IRRSS 74
             S D ++ S+  P S T K  S S+   +W+   +  + KS +   ++ PL  S  + R +
Sbjct:    53 SSDDKSSSTSSPFSNTTKTVSSSHHGLQWNKMIESIKKKSMRRF-SVIPLLASYELTRKN 111

Query:    75 SMREGIDM-P-RNLFV-NSYDSQSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
               R+   + P  + F   ++    P  + F+  EL  AT+ F+ EN+IGKGG+AEVYKG 
Sbjct:   112 LRRKQPKLTPSESAFTCEAFFMAKPSWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGV 171

Query:   131 LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS 188
             L NG+ VAIK+L     +E   ++DFLSELGI+AHV+HPN A+L G+  + G+H VLE +
Sbjct:   172 LINGETVAIKKLMSHAKEEEERVSDFLSELGIIAHVNHPNAARLRGFSSDRGLHFVLEYA 231

Query:   189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
             P GSLAS+L+G +E L+W IRYK+ALG+A+GL YLH  C RRIIHRDIKA+NILL  D+E
Sbjct:   232 PYGSLASMLFGSEECLEWKIRYKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYE 291

Query:   249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              QI DFGLAKWLPE W HH +  +EGTFGYLAPE+ MHGIVDEK DVFAFGVLLLE++T 
Sbjct:   292 AQISDFGLAKWLPENWPHHVVFPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITS 351

Query:   309 RRALDY-SQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRR 367
             RRA+D  S+QS+V WA+P +++N + ++VD  L + ++  +M  V+L AS+C+   +  R
Sbjct:   352 RRAVDTASRQSIVAWAKPFLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMR 411

Query:   368 PQMSQVVQLLRG 379
             P M+++VQLLRG
Sbjct:   412 PDMTRLVQLLRG 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009623 "response to parasitic fungus" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IEP

GO:0012505 "endomembrane system" evidence=IDA

GO:0051020 "GTPase binding" evidence=IPI

GO:0071369 "cellular response to ethylene stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)]

 Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
 Identities = 165/291 (56%), Positives = 222/291 (76%)

Query:    94 QSPQ-KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEII 151
             Q P+ K FS  E+  ATN FS ENL+G+GG+AEVYKG L +NG+ +A+KR+TRG  D+  
Sbjct:    49 QRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAVKRITRGGRDDER 108

Query:   152 AD--FLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGI 208
              +  FL E+G + HV HPN   LLG  I+ G+++V   S  GSLASLL+ + +  L+W  
Sbjct:   109 REKEFLMEIGTIGHVSHPNVLSLLGCCIDNGLYLVFIFSSRGSLASLLHDLNQAPLEWET 168

Query:   209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
             RYKIA+G A+GL YLH+GCQRRIIHRDIK++N+LL +DFEPQI DFGLAKWLP QW+HH+
Sbjct:   169 RYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISDFGLAKWLPSQWSHHS 228

Query:   269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK 328
             I+ +EGTFG+LAPE+  HGIVDEKTDVFAFGV LLEL++G++ +D S QSL  WA+ +IK
Sbjct:   229 IAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFLLELISGKKPVDASHQSLHSWAKLIIK 288

Query:   329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               EI +LVD  + +E+D +Q++ +  AASLCI+ SS+ RP M +V+++L+G
Sbjct:   289 DGEIEKLVDPRIGEEFDLQQLHRIAFAASLCIRSSSLCRPSMIEVLEVLQG 339

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
 Identities = 155/284 (54%), Positives = 211/284 (74%)

Query:   100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSEL 158
             F+  E+  ATN+F   N++G GGY+EVY+G L +G+ +A+KRL + + D     +FL+EL
Sbjct:   255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314

Query:   159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVA 217
             GI++HV HPNTA LLG  +E G+++V   S NG+L S L+  +   L W +RYKIA+GVA
Sbjct:   315 GIISHVSHPNTALLLGCCVEKGLYLVFRFSENGTLYSALHENENGSLDWPVRYKIAVGVA 374

Query:   218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
              GL YLH+ C  RIIHRDIK++N+LL  D+EPQI DFGLAKWLP +WTHH +  VEGTFG
Sbjct:   375 RGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434

Query:   278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD 337
             YLAPE LM G +DEKTD++AFG+LLLE++TGRR ++ +Q+ ++LWA+P ++     ELVD
Sbjct:   435 YLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPTQKHILLWAKPAMETGNTSELVD 494

Query:   338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL-RGN 380
               L D+YD +QMN ++L AS C+QQS I RP M+QV++LL  GN
Sbjct:   495 PKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGN 538

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 628 (226.1 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
 Identities = 144/348 (41%), Positives = 217/348 (62%)

Query:    47 LFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNL---FVNSYDS-QSPQKIFSL 102
             L YD   + +  +L  L P  ++   + S+ +  + PR L       Y+   S  + F  
Sbjct:   379 LGYDSSED-NLSTLNALVPFGINSITNKSIPD--NSPRKLPEELEGLYERFSSTCRFFKY 435

Query:   103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMA 162
              EL S T+NFS +N IGKGG + V++G L NG++VA+K L +   ++++ DF++E+ I+ 
Sbjct:   436 KELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQ--TEDVLNDFVAEIEIIT 493

Query:   163 HVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYG-MKEKLK--WGIRYKIALGVAE 218
              + H N   LLG+  E   + +V      GSL   L+G  K+ L   W  RYK+A+GVAE
Sbjct:   494 TLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKVAVGVAE 553

Query:   219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
              L YLH    + +IHRD+K++NILL++DFEPQ+ DFGLA+W     TH   S V GTFGY
Sbjct:   554 ALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDVAGTFGY 613

Query:   279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS----QQSLVLWARPMIKRNEIRE 334
             LAPE+ M+G V++K DV+AFGV+LLEL++GR+ +       Q+SLV+WA+P++   +  +
Sbjct:   614 LAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVMWAKPILDDGKYSQ 673

Query:   335 LVDASLADEYDTR--QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN 380
             L+D SL D  +    QM  + LAA+LCI++S   RP+MS V++LL+G+
Sbjct:   674 LLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLKGD 721

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 645 (232.1 bits), Expect = 3.3e-63, P = 3.3e-63
 Identities = 136/316 (43%), Positives = 206/316 (65%)

Query:    98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
             + F+  EL S T+NF  +N IGKGG + V++G L NG+ VA+K L R   + ++ DF++E
Sbjct:   395 QFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKR--TECVLKDFVAE 452

Query:   158 LGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKL---KWGIRYKIA 213
             + I+  + H N   LLGY  E   + +V      GSL   L+G K+ L   +W  RYK+A
Sbjct:   453 IDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVA 512

Query:   214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
             +G+AE L YLH    + +IHRD+K++NILL++DFEPQ+ DFGLAKW  E  T    S V 
Sbjct:   513 VGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVA 572

Query:   274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY----SQQSLVLWARPMIKR 329
             GTFGYLAPE+ M+G ++ K DV+A+GV+LLEL++GR+ ++     +Q SLV+WA+P++  
Sbjct:   573 GTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKPILDD 632

Query:   330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMT- 388
              E  +L+D+SL D+ ++ QM  + LAA+LCI+ +   RP M  V++LL+G++  LK+   
Sbjct:   633 KEYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEMLKWAKL 692

Query:   389 KCRSPLLRKTLREELK 404
             +  +PL    L ++ K
Sbjct:   693 QVSNPLEDSMLLKDEK 708

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)]

 Score = 618 (222.6 bits), Expect = 2.4e-60, P = 2.4e-60
 Identities = 126/286 (44%), Positives = 194/286 (67%)

Query:   100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
             FS   L++AT++FS ENLIGKGG  EVYKG L +G+ VA+K L + +  E + +F+ E+ 
Sbjct:   265 FSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKIL-KPSVKEAVKEFVHEVS 323

Query:   160 IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             I++ + H N + L+G  +    +  V  LS  GSL   L G K  L+W  R KIA+G+ E
Sbjct:   324 IVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQG-KHVLRWEERLKIAIGLGE 382

Query:   219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFG 277
              L YLH  C   +IHRD+K++N+LL+++FEPQ+ DFGL+ W  +    +TI + V GTFG
Sbjct:   383 ALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKS-CRYTIQRDVVGTFG 441

Query:   278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS----QQSLVLWARPMIKRNEIR 333
             YLAPE+ M+G V +K DV+AFGV+LLEL++GR ++       Q+SLV+WA+PMI++   +
Sbjct:   442 YLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKGNAK 501

Query:   334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
             EL+D ++A  +D  Q + ++LAA+ C+ +++  RP + ++++LLRG
Sbjct:   502 ELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRG 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00140825 hypothetical protein (422 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	408
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-48
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-45
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-30
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-28
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-27
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-27
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-27
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-24
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-21
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  168 bits (429), Expect = 7e-50
 Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 47/284 (16%)

Query: 113 SFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +    +G+G + EVYKG+L+         VA+K L    +++ I +FL E  IM  +DHP
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 168 NTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N  KLLG   E     IV+E    G L S L   + KL        AL +A G+ YL   
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGYLAPEF 283
             +  IHRD+ A N L+ E+   +I DFGL++            +  G      ++APE 
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174

Query: 284 LMHGIVDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIR 333
           L  G    K+DV++FGVLL E+          ++    L+Y +    L  +P     E+ 
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLP-QPPNCPPELY 233

Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
           +L                       C  +    RP  S++V++L
Sbjct: 234 DL--------------------MLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 5e-49
 Identities = 70/192 (36%), Positives = 107/192 (55%), Gaps = 9/192 (4%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+GG+  VY  R +  G+ VAIK + +  +  ++ + L E+ I+  ++HPN  KL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   +++V+E    GSL  LL   + KL      +I L + EGL YLH      IIHRD
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRD 117

Query: 236 IKAANILLTED-FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKT 293
           +K  NILL  D  + ++ DFGL+K L        +  + GT  Y+APE L+  G   EK+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 294 DVFAFGVLLLEL 305
           D+++ GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (416), Expect = 6e-48
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G+G + +VY  R +  G+LVAIK + +    +     L E+ I+  + HPN  
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           +L     +   +++V+E    G L  LL     + E      R+     +   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---ARF-YLRQILSALEYLH-- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + I+HRD+K  NILL ED   ++ DFGLA+ L       T     GT  Y+APE L+ 
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV---GTPEYMAPEVLLG 170

Query: 287 GIVDEKTDVFAFGVLLLELVTGR 309
               +  D+++ GV+L EL+TG+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  162 bits (413), Expect = 2e-47
 Identities = 83/283 (29%), Positives = 125/283 (44%), Gaps = 44/283 (15%)

Query: 113 SFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +    +G+G + EVYKG L+         VA+K L    +++ I +FL E  IM  +DHP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 168 NTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHE 225
           N  KLLG   E     IV+E  P G L   L   + K L        AL +A G+ YL  
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEFL 284
              +  IHRD+ A N L+ E+   +I DFGL++    + +      K+     ++APE L
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESL 176

Query: 285 MHGIVDEKTDVFAFGVLLLELVTG----------RRALDYSQQSLVLWARPMIKRNEIRE 334
             G    K+DV++FGVLL E+ T              L+Y ++   L  +P     E+ +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLP-KPPNCPPELYK 235

Query: 335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
           L                       C  +    RP  S++V++L
Sbjct: 236 L--------------------MLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  160 bits (407), Expect = 1e-46
 Identities = 85/277 (30%), Positives = 130/277 (46%), Gaps = 30/277 (10%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
                 +G+G + EVYKG L+         VA+K L  G ++E   +FL E  IM  + H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +LLG   +G    IV E  P G L   L    EKL      ++AL +A+G+ YL  
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEF 283
              +  +HRD+ A N L+TE+   +I DFGL++ + E    +   +  G     ++APE 
Sbjct: 121 ---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLPIKWMAPES 175

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--- 340
           L  G    K+DV++FGVLL E+ T        +Q       P +   E+ EL++      
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT------LGEQPY-----PGMSNEEVLELLEDGYRLP 224

Query: 341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
             E    ++  ++L    C       RP  S++V+ L
Sbjct: 225 RPENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (397), Expect = 4e-45
 Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 20/207 (9%)

Query: 116 NLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
             +G+G + EVYKG+L+        VA+K L    ++E   DFL E  +M  + HPN  +
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL--------YGMKEKLKWGIRYKIALGVAEGLLY 222
           LLG   E   +++VLE    G L   L           K  L        A+ +A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLA 280
           L     ++ +HRD+ A N L+ ED   +I DFGL++ + +    +   K  G     ++A
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD--DDYYRKKTGGKLPIRWMA 175

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVT 307
           PE L  GI   K+DV++FGVLL E+ T
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (394), Expect = 9e-45
 Identities = 68/203 (33%), Positives = 100/203 (49%), Gaps = 12/203 (5%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNT 169
           +     +G G +  VYK + +  G++VA+K L  R    +       E+ I+  + HPN 
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L+    +   +++V+E    G L   L      L      KIAL +  GL YLH    
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHS--- 116

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHG 287
             IIHRD+K  NILL E+   +I DFGLAK   +     +      GT  Y+APE L+ G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAK---KLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 288 I-VDEKTDVFAFGVLLLELVTGR 309
                K DV++ GV+L EL+TG+
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  150 bits (380), Expect = 1e-42
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 116 NLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            L+G+G +  VY    +  G+L+A+K   L+  + +E+      E+ I++ + HPN  + 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHPNIVRY 64

Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            G   +     ++I LE    GSL+SLL     + E +   IR K    + EGL YLH  
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLAYLHS- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
               I+HRDIK ANIL+  D   ++ DFG AK L +  T      V GT  ++APE +  
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 287 GIVDEKTDVFAFGVLLLELVTGRR 310
                  D+++ G  ++E+ TG+ 
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  147 bits (373), Expect = 8e-42
 Identities = 75/201 (37%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           FE L  IGKGG+ EVYK R  R G+ VAIK + +  + E     ++E+ I+    HPN  
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           K  G Y  +  + IV+E    GSL  LL    + L       +   + +GL YLH     
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---N 117

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAPEFLMHGI 288
            IIHRDIKAANILLT D E ++ DFGL+  L   +  +  +    GT  ++APE +    
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMAPEVINGKP 173

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
            D K D+++ G+  +EL  G+
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 4e-37
 Identities = 70/205 (34%), Positives = 113/205 (55%), Gaps = 15/205 (7%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTR-GTADEIIADFLSELGIMAHVDHPN 168
           N+   +LIG+G +  VYKG  L  G  VAIK+++     +E +   + E+ ++ ++ HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLH 224
             K +G       ++I+LE + NGSL  ++  +G   E L     Y +   V +GL YLH
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV--AVY-VY-QVLQGLAYLH 116

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           E   + +IHRDIKAANIL T+D   ++ DFG+A  L +       + V GT  ++APE +
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVI 171

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
                   +D+++ G  ++EL+TG 
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  127 bits (322), Expect = 3e-34
 Identities = 78/275 (28%), Positives = 129/275 (46%), Gaps = 39/275 (14%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
             IGKG + +VY  R   +G+L  +K   L+  +  E   D L+E+ I+  ++HPN  K 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHPNIIKY 64

Query: 173 LGYGIEGGM-HIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHE 225
                E G   IV+E +  G L+     +K++ K G  +         + +   L YLH 
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQK---IKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPE 282
              R+I+HRDIK  NI LT +   ++ DFG++K L       T+     V GT  YL+PE
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-----SSTVDLAKTVVGTPYYLSPE 173

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALD-YSQQSLVLWARPMIKRNEIRELVDASLA 341
              +   + K+D+++ G +L EL T +   +  +   L L     I + +        + 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL----KILKGQYPP-----IP 224

Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
            +Y +   NLV    S  +Q+    RP ++Q++Q 
Sbjct: 225 SQYSSELRNLV----SSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (298), Expect = 1e-30
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 13/221 (5%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +  F   +G+G + +V   R        G+ VA+K L     ++  +DF  E+ I+  +D
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 166 HPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           H N  K  G   + G   + +++E  P+GSL   L   ++++        +  + +G+ Y
Sbjct: 65  HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVEGTFGYLAP 281
           L     +R IHRD+ A NIL+  +   +I DFGLAK LPE   ++ +    E    + AP
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVL 321
           E L        +DV++FGV L EL T G  +     + L +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM 222

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 2e-30
 Identities = 72/204 (35%), Positives = 104/204 (50%), Gaps = 19/204 (9%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F+    IGKG + EVYK    R  Q+VAIK +    A++ I D   E+  ++    P   
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 171 KLLGYGIEG-GMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           K  G  ++G  + I++E    GS   LL    + E     I + I   V  GL YLHE  
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETY---IAF-ILREVLLGLEYLHEE- 117

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEFL 284
               IHRDIKAANILL+E+ + ++ DFG++  L       T+SK     GT  ++APE +
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFVGTPFWMAPEVI 170

Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                DEK D+++ G+  +EL  G
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 12/202 (5%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
             E L  +G G    V K   R  G+++A+K +     + I    L EL I+   + P  
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               G +   G + I +E    GSL  +L  ++ ++   I  KIA+ V +GL YLHE  +
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-GTFGYLAPEFLMHG 287
            +IIHRD+K +NIL+    + ++CDFG++  L       +++K   GT  Y+APE +   
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-----SLAKTFVGTSSYMAPERIQGN 174

Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               K+D+++ G+ L+EL TGR
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 36/217 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +  + E +IG G + EV +GRL+  G+    VAIK L  G++D+   DFL+E  IM   D
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  +L G   +   + I+ E   NGSL   L     K   G    +  G+A G+ YL 
Sbjct: 64  HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--------------PEQWTHHTIS 270
           E      +HRD+ A NIL+  +   ++ DFGL++ L              P +WT     
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----- 175

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                    APE + +      +DV++FG+++ E+++
Sbjct: 176 ---------APEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 8e-28
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 32/207 (15%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
            IGKG + +VYKG L+    VA+K        ++   FL E  I+   DHPN  KL+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           ++   ++IV+EL P GSL + L   K +L      +++L  A G+ YL     +  IHRD
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 236 IKAANILLTEDFEPQICDFGLA--------------KWLPEQWTHHTISKVEGTFGYLAP 281
           + A N L+ E+   +I DFG++              K +P +WT              AP
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT--------------AP 164

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTG 308
           E L +G    ++DV+++G+LL E  + 
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 9e-28
 Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GY 175
           +G G + +VYK + +  G   A K +   + +E+  DF+ E+ I++   HPN   L   Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSECKHPNIVGLYEAY 71

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
             E  + I++E    G+L S++  ++  L    IRY +   + E L +LH     ++IHR
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHS---HKVIHR 127

Query: 235 DIKAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGI 288
           D+KA NILLT D + ++ DFG+ AK         T     GT  ++APE +         
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDNP 184

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
            D K D+++ G+ L+EL    
Sbjct: 185 YDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  109 bits (275), Expect = 1e-27
 Identities = 71/211 (33%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++    +IG G  A VY    L N + VAIKR+        + +   E+  M+  +HPN
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIAL---GVAEGLLY 222
             K     + G  + +V+     GSL  +   MK     G      IA     V +GL Y
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDI---MKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTFGYLA 280
           LH   Q   IHRDIKA NILL ED   +I DFG++  L      T        GT  ++A
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174

Query: 281 PEFL--MHGIVDEKTDVFAFGVLLLELVTGR 309
           PE +  +HG  D K D+++FG+  +EL TG 
Sbjct: 175 PEVMEQVHG-YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (273), Expect = 2e-27
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 16/203 (7%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F     +G+G Y  VYK   +  GQ+VAIK +     +E + + + E+ I+   D P   
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL---GVAEGLLYLHEG 226
           K  G Y     + IV+E    GS++ ++    + L      +IA       +GL YLH  
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT---EEEIAAILYQTLKGLEYLH-- 116

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
              + IHRDIKA NILL E+ + ++ DFG++  L    T    + V GT  ++APE +  
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 287 GIVDEKTDVFAFGVLLLELVTGR 309
              + K D+++ G+  +E+  G+
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 2e-27
 Identities = 72/207 (34%), Positives = 102/207 (49%), Gaps = 36/207 (17%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTR--GTADEIIADFLSELGIMAHVDHPNTAKLLG 174
            IGKG + +V  G  R GQ VA+K L      A      FL+E  +M  + HPN  +LLG
Sbjct: 13  TIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA----FLAEASVMTTLRHPNLVQLLG 67

Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
             ++G  ++IV E    GSL   L    +  +    +   AL V EG+ YL E   +  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124

Query: 233 HRDIKAANILLTEDFEPQICDFGLAK---------WLPEQWTHHTISKVEGTFGYLAPEF 283
           HRD+ A N+L++ED   ++ DFGLAK          LP +WT              APE 
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------------APEA 170

Query: 284 LMHGIVDEKTDVFAFGVLLLELVT-GR 309
           L       K+DV++FG+LL E+ + GR
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 4e-27
 Identities = 72/216 (33%), Positives = 100/216 (46%), Gaps = 32/216 (14%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELG 159
             YEL            IG G Y +VYK R +  G+LVAIK + +    +       E+ 
Sbjct: 3   EDYELIQR---------IGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEIS 52

Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           ++    HPN     G Y     + IV+E    GSL  +    +  L      +IA    E
Sbjct: 53  MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---ELQIAYVCRE 109

Query: 219 ---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-- 273
              GL YLH   +   IHRDIK ANILLTED + ++ DFG++  L       TI+K +  
Sbjct: 110 TLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-----ATIAKRKSF 161

Query: 274 -GTFGYLAPEFL---MHGIVDEKTDVFAFGVLLLEL 305
            GT  ++APE       G  D K D++A G+  +EL
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (272), Expect = 4e-27
 Identities = 68/198 (34%), Positives = 99/198 (50%), Gaps = 15/198 (7%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G    VYK R +  G++ A+K++     +E     L EL  +   + P   K   YG
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC--YG 66

Query: 177 I---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHEGCQRRI 231
               EG + IVLE    GSLA LL   K+  K        IA  + +GL YLH   +R I
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHT--KRHI 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRDIK +N+L+    E +I DFG++K L E       + V GT  Y++PE +       
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFV-GTVTYMSPERIQGESYSY 179

Query: 292 KTDVFAFGVLLLELVTGR 309
             D+++ G+ LLE   G+
Sbjct: 180 AADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 6e-27
 Identities = 62/193 (32%), Positives = 93/193 (48%), Gaps = 9/193 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V+ G+ R    VAIK +  G   E   DF+ E  +M  + HPN  +L G   
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           +   + IV E   NG L + L   K KL       +   V E + YL        IHRD+
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
            A N L+ ED   ++ DFGLA++ L +Q+T    +K      +  PE   +     K+DV
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRFSSKSDV 184

Query: 296 FAFGVLLLELVTG 308
           ++FGVL+ E+ + 
Sbjct: 185 WSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  107 bits (270), Expect = 8e-27
 Identities = 82/278 (29%), Positives = 134/278 (48%), Gaps = 29/278 (10%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLT--RGTADEIIADFLSELGIMAHVD 165
             NF  E  IGKG ++ VYK   L +G++VA+K++        +   D L E+ ++  +D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 166 HPNTAKLLGYGIEGGM-HIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVA 217
           HPN  K L   IE    +IVLEL+  G L+ ++   K       E+  W    K  + + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLC 116

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
             L ++H    +RI+HRDIK AN+ +T     ++ D GL ++   + T    S V GT  
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLV-GTPY 171

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD 337
           Y++PE +     + K+D+++ G LL E+   +      + +L    +  I++ +   L  
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-IEKCDYPPLP- 229

Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
              AD Y     +LV    S CI     +RP +S V+Q
Sbjct: 230 ---ADHYSEELRDLV----SRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  107 bits (268), Expect = 8e-27
 Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 31/202 (15%)

Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           L+GKG + EV+KG L++   VA+K        E+   FLSE  I+   DHPN  KL+G  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 177 IE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL P G   S L   K++LK     K AL  A G+ YL     +  IHRD
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 236 IKAANILLTEDFEPQICDFGLA-------------KWLPEQWTHHTISKVEGTFGYLAPE 282
           + A N L+ E+   +I DFG++             K +P +WT              APE
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT--------------APE 164

Query: 283 FLMHGIVDEKTDVFAFGVLLLE 304
            L +G    ++DV+++G+LL E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (268), Expect = 8e-27
 Identities = 73/275 (26%), Positives = 131/275 (47%), Gaps = 31/275 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII-ADFLSELGIMAHVDHPN 168
           +F   N IGKG +  V+K   + + ++ A+K++     +     + + E  ++A +D   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLY 222
             +     ++ G ++IV+E + NG L  LL       + E   W    +I LG+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH    ++I+HRDIK+ N+ L      +I D G+AK L +    +  + + GT  YL+PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSPE 171

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDY-SQQSLVLWARPMIKRNEIRELVDASLA 341
                  +EK+DV+A GV+L E  TG+   D  +Q +L+L         +I   V   ++
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL---------KIIRGVFPPVS 222

Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
             Y  +   L+      C+ +   +RP   Q+++ 
Sbjct: 223 QMYSQQLAQLI----DQCLTKDYRQRPDTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (274), Expect = 8e-27
 Identities = 76/214 (35%), Positives = 110/214 (51%), Gaps = 19/214 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHP- 167
           ++     +G+G + EVY  R R  +LVA+K L +      + +  FL E+ I+A ++HP 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLH 224
           N  KL  +   EG +++V+E    GSL  LL   G K  L       I   +   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 225 EGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWTHHTI----SKVEGTFGYL 279
               + IIHRDIK  NILL  D    ++ DFGLAK LP+  +  +I    S   GT GY+
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 280 APEFLMHGI---VDEKTDVFAFGVLLLELVTGRR 310
           APE L+          +D+++ G+ L EL+TG  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 118 IGKGGYAEVYKG----RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G G +  VYKG         ++ VAIK L   T+ +   + L E  +MA VDHP+  +L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 173 LGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           LG  +   + ++ +L P G L   +       G +  L W ++      +A+G+ YL E 
Sbjct: 75  LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE- 127

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             +R++HRD+ A N+L+      +I DFGLAK L      +     +    ++A E ++H
Sbjct: 128 --KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 287 GIVDEKTDVFAFGVLLLELVT-GRR 310
            I   K+DV+++GV + EL+T G +
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  106 bits (267), Expect = 2e-26
 Identities = 70/201 (34%), Positives = 100/201 (49%), Gaps = 17/201 (8%)

Query: 117 LIGKGGYAEVYKGRLRN--GQL--VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            +G G +  V +G      G++  VA+K L      +I+ DFL E  IM  +DH N  +L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYLHEGCQR 229
            G  +   + +V EL+P GSL   L   K+ L           A+ +A G+ YL     +
Sbjct: 62  YGVVLTHPLMMVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE---SK 116

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS---KVEGTFGYLAPEFLMH 286
           R IHRD+ A NILL  D + +I DFGL + LP+   H+ +    KV   F + APE L  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 287 GIVDEKTDVFAFGVLLLELVT 307
                 +DV+ FGV L E+ T
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 15/206 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G G + EV+ G       VA+K L  GT       FL E  IM  + H   
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKL 63

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +L     E   ++IV E    GSL   L  G  +KL+      +A  +AEG+ YL    
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-- 121

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK--VEGTFGYLAPEFL 284
            R  IHRD+ A NIL+ E+   +I DFGLA+ + + ++T    +K  ++ T    APE  
Sbjct: 122 -RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176

Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GR 309
            +G    K+DV++FG+LL E+VT GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 4e-26
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +GKG + +V   R ++ G+L A+K L +      + +   L+E  I++ ++HP   KL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 175 YGI--EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           Y    E  +++VLE +P G L S L       E+     R+  A  +   L YLH     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER---ARFYAA-EIVLALEYLHS---L 112

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
            II+RD+K  NILL  D   ++ DFGLAK L         +   GT  YLAPE L+    
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 290 DEKTDVFAFGVLLLELVTGR 309
            +  D ++ GVLL E++TG+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  105 bits (264), Expect = 4e-26
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VAIK L +G+       FL+E  +M  + HP  
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRL 63

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYL 223
            +L     +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++
Sbjct: 64  VRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAPE 282
               ++  IHRD++AANIL++E    +I DFGLA+ +   ++T    +K      + APE
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPE 173

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT-GR 309
            + +G    K+DV++FG+LL E+VT GR
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  104 bits (262), Expect = 8e-26
 Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 10/199 (5%)

Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA-DFLSELGIMAHVDHPNTA 170
           F+ E  +G G + EV++G  +N   VAIK L     D +   DF  E+  +  + H +  
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            L      G  ++I+ EL   GSL + L   + + L       +A  VAEG+ YL E   
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           +  IHRD+ A NIL+ ED   ++ DFGLA+ + E     +  K+   + + APE   HG 
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGT 180

Query: 289 VDEKTDVFAFGVLLLELVT 307
              K+DV++FG+LL E+ T
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
                 + +G+G    V K RL+N  ++ A+K +T     ++    L EL I      P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 169 TAKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVA 217
             K   YG         + I +E    GSL S+    K+  K G R       KIA  V 
Sbjct: 61  IVKY--YGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVL 115

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +GL YLH    R+IIHRDIK +NILLT   + ++CDFG++  L        ++ + GTF 
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFT 164

Query: 278 ----YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
               Y+APE +        +DV++ G+ LLE+   R
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 82/270 (30%), Positives = 128/270 (47%), Gaps = 42/270 (15%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG+G +  V +G    GQ VA+K +     D     FL E  +M  + H N  +LLG  +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVKNIK---CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIALGVAEGLLYLHEGCQRRIIHRDI 236
             G++IV+EL   G+L + L      L   I+  + +L VAEG+ YL     ++++HRD+
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAK---------WLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
            A NIL++ED   ++ DFGLA+          LP +WT              APE L H 
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------------APEALKHK 172

Query: 288 IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR 347
               K+DV+++GVLL E+ +  RA  Y + SL           E++E V+     E    
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRA-PYPKMSL----------KEVKECVEKGYRMEPPEG 221

Query: 348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
               V +  + C +    +RP   ++ + L
Sbjct: 222 CPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 3e-25
 Identities = 71/198 (35%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV++G   N   VA+K L  GT D    DFL+E  IM  + HP   +L  Y +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQL--YAV 69

Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
              E  ++IV EL   GSL   L G   + LK      +A  VA G+ YL     +  IH
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+ A N+L+ E+   ++ DFGLA+ + E  +     +K      + APE  ++     K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 293 TDVFAFGVLLLELVT-GR 309
           +DV++FG+LL E+VT GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  103 bits (257), Expect = 4e-25
 Identities = 71/225 (31%), Positives = 106/225 (47%), Gaps = 50/225 (22%)

Query: 116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           N +G G + EVY+G   +          VA+K L +G  D+   +FL E  +M++ +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 169 TAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLL 221
             KLLG  +     +I++EL   G L S L   + +      L       I L VA+G +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 222 YLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAK--------------WLPE 262
           YL    Q   IHRD+ A N L++E     D   +I DFGLA+               LP 
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +W              +APE L+ G    ++DV++FGVL+ E++T
Sbjct: 178 RW--------------MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 1e-24
 Identities = 75/228 (32%), Positives = 111/228 (48%), Gaps = 38/228 (16%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMA- 162
           L   T  F    +IG+G Y +VYK R  + GQLVAIK +     DE   +   E  I+  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEE-EEIKEEYNILRK 58

Query: 163 HVDHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLLYG-------MKEKLKWGI 208
           + +HPN A   G        G +  + +V+EL   GS+  L+ G       +KE+    I
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW---I 115

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            Y I      GL YLHE    ++IHRDIK  NILLT++ E ++ DFG++  L       T
Sbjct: 116 AY-ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-----DST 166

Query: 269 ISK---VEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
           + +     GT  ++APE +          D ++DV++ G+  +EL  G
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.4 bits (248), Expect = 6e-24
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKR----LTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           L+G G +  VY+G  L +G   A+K         T  E +     E+ +++ + HPN  +
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEGC 227
            LG   E   ++I LEL P GSLA LL  YG   E +      +I LG+     YLH+  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLE----YLHD-- 120

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH- 286
            R  +HRDIK ANIL+  +   ++ DFG+AK + E          +G+  ++APE +   
Sbjct: 121 -RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIAQQ 176

Query: 287 GIVDEKTDVFAFGVLLLELVTGR 309
           G      D+++ G  +LE+ TG+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 26/210 (12%)

Query: 116 NLIGKGGYAEVYKG-RLRNGQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNT 169
           N IG G + +VY    L  G+L+A+K          T  EI      E+ ++  + HPN 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA----DEMKVLELLKHPNL 61

Query: 170 AKLLGYGIE---GGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K   YG+E     ++I +E    G+L  LL +G          Y + L   EGL YLH 
Sbjct: 62  VKY--YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHS 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT--HHTISKVEGTFGYLAPEF 283
                I+HRDIK ANI L  +   ++ DFG A  L    T     +  + GT  Y+APE 
Sbjct: 118 ---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 284 LMHGIVDEK---TDVFAFGVLLLELVTGRR 310
           +  G         D+++ G ++LE+ TG+R
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 99.2 bits (247), Expect = 9e-24
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +G G ++  Y+ R ++ G L+A+K     R T    +E++     E+ +MA ++HP+  
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           ++LG   E    ++ +E    GS++ LL  YG     K  +       +  GL YLHE  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHE-- 121

Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFL 284
             +IIHRD+K AN+L+ +     +I DFG A  L  + T     + +  GT  ++APE L
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
                    DV++ G +++E+ T +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.8 bits (246), Expect = 1e-23
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 113 SFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           + ++ +G G Y EVY+G   +    VA+K L   T +  + +FL E  +M  + HPN  +
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQ 66

Query: 172 LLGY-GIEGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    ++
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KK 123

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISKVEGTFGYLAPEFLMHGI 288
             IHRD+ A N L+ E+   ++ DFGL++ +    +T H  +K      + APE L +  
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNK 181

Query: 289 VDEKTDVFAFGVLLLELVT 307
              K+DV+AFGVLL E+ T
Sbjct: 182 FSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 55/237 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV---- 164
           ++F F  +IG+G ++ V   + +   +  AIK L +          L +   + +V    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--------RQLIKEKKVKYVKIEK 52

Query: 165 -------DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG------IRY 210
                   HP   KL   +  E  ++ VLE +PNG L   +       K+G       R+
Sbjct: 53  EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI------RKYGSLDEKCTRF 106

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-----PEQWT 265
             A  +   L YLH    + IIHRD+K  NILL +D   +I DFG AK L     PE   
Sbjct: 107 YAAE-ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 266 HHTISKVE-------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
               +                GT  Y++PE L      + +D++A G ++ +++TG+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.4 bits (246), Expect = 2e-23
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 16/219 (7%)

Query: 97  QKIFSLYELQSA---TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLT-RGTADEII 151
           +   +L ++ S       +     IG+G   EVYK   R  G+ VAIK++  R    E+I
Sbjct: 3   ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI 62

Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
              ++E+ IM    HPN       Y +   + +V+E    GSL  ++     ++      
Sbjct: 63  ---INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA 119

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTI 269
            +   V +GL YLH    + +IHRDIK+ NILL++D   ++ DFG A  L  E+   +++
Sbjct: 120 YVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV 176

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             V GT  ++APE +       K D+++ G++ +E+  G
Sbjct: 177 --V-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNT 169
           ++ L  IG+G Y  VYK R    G++VAIK++      E I    L E+ ++  ++HPN 
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLH 224
            KLL  +  +G +++V E   +  L  L+     G+ E L     Y++  G+A    + H
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----FCH 115

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAP 281
                 I+HRD+K  N+L+  +   ++ DFGLA+        +TH+ +     T  Y AP
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-----TRWYRAP 167

Query: 282 EFLMH-GIVDEKTDVFAFGVLLLELVTGR 309
           E L+         D+++ G +  EL++ R
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 8/193 (4%)

Query: 117 LIGKGGYAEVYKG---RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
            IG+G + +VY+G      N ++ VA+K     T+  +   FL E  IM   DHP+  KL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
           +G   E  + IV+EL+P G L S L   K  L        +  ++  L YL     +R +
Sbjct: 73  IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFV 129

Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           HRDI A N+L++     ++ DFGL+++L ++ +++  SK +    ++APE +        
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 293 TDVFAFGVLLLEL 305
           +DV+ FGV + E+
Sbjct: 189 SDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.7 bits (241), Expect = 6e-23
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)

Query: 111 NFSFENLIGKGGYAEVYK-GRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPN 168
           +F     +GKG Y  VYK  RL + Q  A+K +     + +   D ++E+ I+A V+HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLH 224
                   ++G  + IV+E +P G L+  +      ++ +     ++I + +  GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           E   ++I+HRD+K+ANILL  +   +I D G++K L +      I    GT  Y+APE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVW 173

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
                  K+D+++ G LL E+ T  
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 19/201 (9%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMA---HVDHPNTAKL 172
           LIG+G Y  VY+G+ +  G++VA+K +   T D+ ++D   E+ +++       PN  K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 173 LGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---YLHEGCQ 228
            G  ++G  + I++E +  GS+ +L+       K+     I++ + E L+   Y+H   +
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-----ISVIIREVLVALKYIH---K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             +IHRDIKAANIL+T     ++CDFG+A  L         S   GT  ++APE +  G 
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 289 V-DEKTDVFAFGVLLLELVTG 308
             D K D+++ G+ + E+ TG
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.7 bits (238), Expect = 2e-22
 Identities = 83/279 (29%), Positives = 131/279 (46%), Gaps = 38/279 (13%)

Query: 115 ENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           E +IG G + EV +GRL    +    VAIK L  G  ++   DFLSE  IM   DHPN  
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 171 KLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLYLH 224
            L G   +   + I+ E   NG+L S L     +   G    I L     G+A G+ YL 
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYLAP 281
           E      +HRD+ A NIL+  +   ++ DFGL+++L +  +  T +   G      + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVDAS 339
           E + +      +DV+++G+++ E+++ G R   D S Q ++         N I +  D  
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---------NAIEQ--DYR 229

Query: 340 LADEYD-TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
           L    D    ++ ++L    C Q+    RP+  Q+V  L
Sbjct: 230 LPPPMDCPTALHQLMLD---CWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 19/200 (9%)

Query: 118 IGKGGYAEVYKG--RLRNGQL--VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG   +++G+   VA+K L +        +FL E  +MA +DHP   +L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQR 229
           G      + +V+EL+P G L   L   +E     LK     ++A  VA G+ YL     +
Sbjct: 63  GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK-----ELAHQVAMGMAYLES---K 114

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHG 287
             +HRD+ A N+LL    + +I DFG+++ L     ++  +   G +   + APE + +G
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-ATTAGRWPLKWYAPECINYG 173

Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV+++GV L E  +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 74/236 (31%), Positives = 102/236 (43%), Gaps = 59/236 (25%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKG--RLRNG----QLVAIKRLTRGTADEIIADFLSELG 159
           +   ++ +    +G G + EVY+G  R R+G      VA+K L    +++  +DFL E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 160 IMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLL------------YGMKEKLKW 206
           IM+  +H N  +L+G   E     I+LEL   G L S L              MK+ L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF- 120

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK----- 258
                 A  VA+G  YL E      IHRDI A N LLT        +I DFG+A+     
Sbjct: 121 -----CARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172

Query: 259 ---------WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
                     LP +W                PE  + GI   KTDV++FGVLL E+
Sbjct: 173 SYYRKGGRAMLPIKWM--------------PPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 4e-22
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 18/206 (8%)

Query: 116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTA 170
            ++GKG Y  VY G    GQL+A+K++   T++ + A+        E+ ++  + H N  
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           + LG  ++   + I +E  P GS++S+L  +G    L   +  K    + +G+ YLH  C
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK---WLPEQWTHHTISK-VEGTFGYLAPEF 283
              ++HRDIK  N++L  +   ++ DFG A+   W+    TH  + K + GT  ++APE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGR 309
           +       K+D+++ G  + E+ TG+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 13/227 (5%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHP 167
           +F    +IGKG + +V   + R   ++ A+K + +    E   + + L+E  I+  ++HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 168 NTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               L  Y  +    M++V++L   G L   L   K K            +   L YLH 
Sbjct: 61  FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLHS 118

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              + IIHRDIK  NILL E     I DF +A  +       + S   GT GY+APE L 
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLC 172

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI 332
                   D ++ GV   E + G+R      +++    R   +  ++
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV 219

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.2 bits (231), Expect = 1e-21
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 33/203 (16%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +   VA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +LK     ++    A G+ YL        IHRD
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119

Query: 236 IKAANILLTEDFEPQICDFGLA--------------KWLPEQWTHHTISKVEGTFGYLAP 281
           + A N L+TE    +I DFG++              K +P +WT              AP
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT--------------AP 165

Query: 282 EFLMHGIVDEKTDVFAFGVLLLE 304
           E L +G    ++DV++FG+LL E
Sbjct: 166 EALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 67/210 (31%), Positives = 108/210 (51%), Gaps = 23/210 (10%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTADE-------IIADFLSELGIMAHVDH 166
           LIGKG Y  VY    +  G+++A+K+  L    A         ++    SE+  +  +DH
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 167 PNTAKLLGY-GIEGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLY 222
            N  + LG+   E  + I LE  P GS+ S L  YG  +E+L   +R+     V EGL Y
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH    + I+HRD+KA N+L+  D   +I DFG++K   + + +     ++G+  ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 283 F--LMHGIVDEKTDVFAFGVLLLELVTGRR 310
                      K D+++ G ++LE+  GRR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 74  LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 130

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           +HRD+ A N+L+      +I DFGLA+ L      +     +    ++A E + +     
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190

Query: 292 KTDVFAFGVLLLELVT 307
           ++DV+++GV + EL+T
Sbjct: 191 QSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 23/209 (11%)

Query: 114 FENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHP 167
           +E +  IG+G Y +VYK R  + G+LVA+K++      E   I A  + E+ ++  + HP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA--IREIKLLQKLRHP 58

Query: 168 NTAKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N  +L    I     +G +++V E   +  L  LL   + K            + EGL Y
Sbjct: 59  NIVRL--KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAP 281
           LH      I+HRDIK +NIL+  D   ++ DFGLA+         +T ++V  T  Y  P
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT-NRVI-TLWYRPP 170

Query: 282 EFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
           E L+       + D+++ G +L EL  G+
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 92.6 bits (230), Expect = 2e-21
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 29/217 (13%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG--QLVAIK---------RLTRGTADEIIADFLSELG 159
            ++    +G G +  VYK R +N    L+A+K            +   D+ I D +SE+ 
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 160 IM-AHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK-------WGIRY 210
           I+   + HPN  +     +E   ++IV++L     L      +KEK +       W I  
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
           ++ L     L YLH+  ++RI+HRD+   NI+L ED +  I DFGLAK   ++     ++
Sbjct: 121 QMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLT 171

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            V GT  Y  PE + +    EK DV+AFG +L ++ T
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 59/198 (29%), Positives = 108/198 (54%), Gaps = 19/198 (9%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  +HP   KLLG + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       I   + E L YLH     +IIHRD+
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136

Query: 237 KAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGIV--- 289
           KA N+LLT D + ++ DFG+ AK +       T+ + +   GT  ++APE +M   +   
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNV------KTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 290 --DEKTDVFAFGVLLLEL 305
             D K D+++ G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 114 FENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           F   +GKG +  V   R        G++VA+K+L   TA+ +  DF  E+ I+  + H N
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-RDFEREIEILKSLQHDN 66

Query: 169 TAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
             K  G     G   + +V+E  P GSL   L   +E+L        A  + +G+ YL  
Sbjct: 67  IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFL 284
              +R +HRD+   NIL+  +   +I DFGL K LP+   ++ + +  E    + APE L
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183

Query: 285 MHGIVDEKTDVFAFGVLLLELVT 307
                   +DV++FGV+L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 15/202 (7%)

Query: 116 NLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
            +IGKG +  VY G L          A+K L R T  E +  FL E  IM    HPN   
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 172 LLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG--VAEGLLYLHEGC 227
           LLG  +  EG   +VL    +G L + +    E     ++  I  G  VA+G+ YL    
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.2 bits (227), Expect = 6e-21
 Identities = 72/272 (26%), Positives = 121/272 (44%), Gaps = 30/272 (11%)

Query: 118 IGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFL-SELGIMAHVDHPNTAKLLGY 175
           IGKG +  V K  R  +G+++  K +  G   E     L SE+ I+  + HPN  +    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 176 GIEGG---MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ- 228
            I+     ++IV+E    G LA L+      ++ ++    ++I   +   L   H     
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127

Query: 229 -RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              ++HRD+K ANI L  +   ++ DFGLAK L    +    + V GT  Y++PE L H 
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKTYV-GTPYYMSPEQLNHM 185

Query: 288 IVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWARPMIKRNEIRELVDASLADEY 344
             DEK+D+++ G L+ EL        A   +Q  L       IK  + R +         
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTA--RNQLQL----ASKIKEGKFRRI------PYR 233

Query: 345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
            + ++N V+      +     +RP   +++QL
Sbjct: 234 YSSELNEVI---KSMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.8 bits (225), Expect = 7e-21
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 9/190 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  V+ G     + VAIK +  G   E   DF+ E  +M  + HP   +L G   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E   + +V E   +G L+  L   + K        + L V EG+ YL       +IHRD+
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126

Query: 237 KAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
            A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE         K+DV
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDV 184

Query: 296 FAFGVLLLEL 305
           ++FGVL+ E+
Sbjct: 185 WSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 117 LIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNT 169
            +G+G + +V K              VA+K L     ++ ++D +SE+ +M  +  H N 
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKIA 213
             LLG   + G +++V+E + +G+L   L      G            E L        A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
             VA G+ +L     ++ IHRD+ A N+L+TED   +I DFGLA+ +     +   +   
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
               ++APE L   +   ++DV++FGVLL E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 92.0 bits (228), Expect = 9e-21
 Identities = 69/205 (33%), Positives = 111/205 (54%), Gaps = 16/205 (7%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
           F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA VD+
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLH 224
           P+  +LLG  +   + ++ +L P G L  L Y  + K   G +Y +   + +A+G+ YL 
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTFGYLAPE 282
           E   RR++HRD+ A N+L+      +I DFGLAK L   E+  H    KV     ++A E
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALE 181

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT 307
            ++H I   ++DV+++GV + EL+T
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
           N +    ++G+G Y  V K R +  G++VAIK+      DE +    L E+ ++  + H 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 168 NTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   L   +  +G +++V E     +L  LL      L           + + + Y H  
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH-- 117

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL-- 284
               IIHRDIK  NIL++E    ++CDFG A+ L  +        V  T  Y APE L  
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVG 175

Query: 285 --MHGIVDEKTDVFAFGVLLLELVTGR 309
              +G   +  DV+A G ++ EL+ G 
Sbjct: 176 DTNYG---KPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLRNG----QLVAIK--RLTRGTADEIIADFLSELGIMAHVD 165
                ++G+G +  V +G+L         VA+K  +L   T  EI  +FLSE   M   D
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-EEFLSEAACMKDFD 59

Query: 166 HPNTAKLLGYGIEGGMH-------IVLELSPNGSLASLLYGMK-----EKLKWGIRYKIA 213
           HPN  KL+G   E           ++L    +G L S L   +     EKL      K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISK 271
           + +A G+ YL     R  IHRD+ A N +L ED    + DFGL+K  +  + +    I+K
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +     ++A E L   +   K+DV+AFGV + E+ T
Sbjct: 177 M--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EV+KG   R  Q+VAIK +    A++ I D   E+ +++  D P   K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 177 IEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           ++G  + I++E    GS   LL  G  ++ +     K  L   +GL YLH     + IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLH---SEKKIHR 125

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  + ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183

Query: 295 VFAFGVLLLELVTG 308
           +++ G+  +EL  G
Sbjct: 184 IWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNTA 170
           +G+G +  VY+G  +          VAIK +    +  E I  FL+E  +M   +  +  
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVV 72

Query: 171 KLLGYGIEGGMH--IVLELSPNGSLASLLYGMKEK---------LKWGIRYKIALGVAEG 219
           +LLG  +  G    +V+EL   G L S L   + +                ++A  +A+G
Sbjct: 73  RLLGV-VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           + YL     ++ +HRD+ A N ++ ED   +I DFG+ + + E   +    K      ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           APE L  G+   K+DV++FGV+L E+ T
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTAKL 172
           +GKGG+ EV   +++  G++ A K+L +        E +A  L+E  I+  V       L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58

Query: 173 LGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQR 229
             Y  E    +  V+ L   G L   +Y + E      R    A  +  GL +LH   QR
Sbjct: 59  -AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QR 114

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           RI++RD+K  N+LL +    +I D GLA  L        I    GT GY+APE L   + 
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVY 171

Query: 290 DEKTDVFAFGVLLLELVTGR 309
           D   D FA G  L E++ GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 17/197 (8%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     E L YLHE    +IIHRD+
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129

Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGI----- 288
           KA NIL T D + ++ DFG++          TI + +   GT  ++APE +M        
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 289 VDEKTDVFAFGVLLLEL 305
            D K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 4e-20
 Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY  R L     +AIK +        +     E+ + +++ H N  + LG 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWG--------IRYKIALGVAEGLLYLHEG 226
             E G   I +E  P GSL++LL     + KWG        I +     + EGL YLH+ 
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIIF-YTKQILEGLKYLHD- 126

Query: 227 CQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              +I+HRDIK  N+L+ T     +I DFG +K L     +       GT  Y+APE + 
Sbjct: 127 --NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVID 182

Query: 286 HGI--VDEKTDVFAFGVLLLELVTGR 309
            G        D+++ G  ++E+ TG+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 9/193 (4%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EVYKG   R  ++VAIK +    A++ I D   E+ +++  D P   +  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 177 IEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           ++G  + I++E    GS   LL      L+      I   + +GL YLH     R IHRD
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SERKIHRD 126

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           IKAAN+LL+E  + ++ DFG+A  L +  T    +   GT  ++APE +     D K D+
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 296 FAFGVLLLELVTG 308
           ++ G+  +EL  G
Sbjct: 185 WSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.8 bits (220), Expect = 7e-20
 Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 12/199 (6%)

Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 173 LGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E G   + +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS-KVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N+L+  + + +I DFGL K +     ++T+   ++    + APE L+   
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 289 VDEKTDVFAFGVLLLELVT 307
               +DV++FGV L EL+T
Sbjct: 189 FYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 88.3 bits (220), Expect = 9e-20
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNT 169
           +     +G+G Y  VYK R  + G++VA+K++     +E I +  L E+ ++  + HPN 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            KLL     E  +++V E      L   L      L   +   I   +  GL Y H    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---S 116

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-- 286
            RI+HRD+K  NIL+  D   ++ DFGLA+        +T  +V  T  Y APE L+   
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT-HEVV-TLWYRAPEILLGSK 174

Query: 287 ----GIVDEKTDVFAFGVLLLELVTGR 309
                +     D+++ G +  E++TG+
Sbjct: 175 HYSTAV-----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 26/211 (12%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADE--------IIADFLSELGIMAHVDHP 167
           LIG G +  VY G    +G+L+A+K++   +           ++     E+ ++  + H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEK--LKWGIRYKIALGVAEGLLY 222
           N  + LG  +    ++I LE  P GS+A+LL  YG  E+  ++  +R      + +GL Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-----ILKGLNY 121

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK----VEGTFGY 278
           LH    R IIHRDIK ANIL+      +I DFG++K L         +     ++G+  +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           +APE +       K D+++ G L++E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           IG+G +  V+K + R  G+ VA+K++     +  I +  L E+  +    HP   KLL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 176 GIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              G G  +V+E  P   L+ +L   +  L           + +G+ Y+H      I+HR
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHR 123

Query: 235 DIKAANILLTEDFEPQICDFGLAKWL----PEQWTHHTISKVEGTFGYLAPEFLMHGI-- 288
           D+K AN+L++ D   +I DFGLA+      P  ++H        T  Y APE L++G   
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-----ATRWYRAPE-LLYGARK 177

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
            D   D++A G +  EL+ G 
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 71/273 (26%), Positives = 133/273 (48%), Gaps = 21/273 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHP 167
           NF  E  IG+G ++EVY+   L + + VA+K++      +  A  D + E+ ++  ++HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYL 223
           N  K L   IE   ++IVLEL+  G L+ ++   K++ +       +K  + +   + ++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           H    RR++HRDIK AN+ +T     ++ D GL ++   + T      + GT  Y++PE 
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPER 177

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           +     + K+D+++ G LL E+   +    Y  +  +      I++ +   L      + 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLFSLCQKIEQCDYPPLP----TEH 232

Query: 344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
           Y  +   LV    S+CI     +RP +  V Q+
Sbjct: 233 YSEKLRELV----SMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 66/195 (33%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L  GT       FL E  IM  + H    +L     
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G    LK      +A  VA G+ Y+    +   IHRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128

Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           ++ANIL+ +    +I DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186

Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL ELVT  R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 9/195 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  IM  + H     L     
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP--EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G  + LK      +A  +A+G+ Y+    +   IHRD+
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128

Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ ++   +I DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 186

Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL ELVT  R
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 69/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
                  IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLV 62

Query: 171 KLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIALGVAEGLLYLHEGC 227
           +LLG  +E  GG++IV E    GSL   L      +  G    K +L V E + YL    
Sbjct: 63  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 119

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFGY 278
               +HRD+ A N+L++ED   ++ DFGL K          LP +WT             
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------------- 166

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT-GR 309
            APE L       K+DV++FG+LL E+ + GR
Sbjct: 167 -APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 11/194 (5%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA---TILREILKGLDYLH---SEKKIHR 125

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  E ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183

Query: 295 VFAFGVLLLELVTG 308
           +++ G+  +EL  G
Sbjct: 184 IWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 18/197 (9%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 69

Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 124

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHRD++AAN+L++E    +I DFGLA+ + + ++T    +K      + APE +  G   
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFT 182

Query: 291 EKTDVFAFGVLLLELVT 307
            K+DV++FG+LL E+VT
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 86.3 bits (213), Expect = 4e-19
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 9/202 (4%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 64

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 65  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 121

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 179

Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              K+DV++FG+LL EL T  R
Sbjct: 180 FTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 51/225 (22%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL---TRGTADEIIA-DFLSELGIMAHVD 165
            +     +G+G YA VYK R +  G++VAIK++    R  A + I    L E+ ++  + 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK-IALGVAE----- 218
           HPN   LL  +G +  +++V E      + + L    EK+   I+ K I L  A+     
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEF-----METDL----EKV---IKDKSIVLTPADIKSYM 108

Query: 219 -----GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTIS 270
                GL YLH      I+HRD+K  N+L+  D   ++ DFGLA+       + TH  + 
Sbjct: 109 LMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV- 164

Query: 271 KVEGTFGYLAPEFLM------HGIVDEKTDVFAFGVLLLELVTGR 309
               T  Y APE L        G+     D+++ G +  EL+   
Sbjct: 165 ----TRWYRAPELLFGARHYGVGV-----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 14/206 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPN 168
            F   N IG+G Y  VY+ R   +G++VA+K++      D I    L E+ ++ ++ HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 169 TAKLL----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             +L     G  ++  + +V+E      LASLL  M           + L +  GL YLH
Sbjct: 68  IVELKEVVVGKHLDS-IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           E     IIHRD+K +N+LLT+    +I DFGLA+         T   V  T  Y APE L
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELL 180

Query: 285 MHGIV-DEKTDVFAFGVLLLELVTGR 309
           +         D++A G +L EL+  +
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 79/313 (25%), Positives = 136/313 (43%), Gaps = 58/313 (18%)

Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTR 144
            F +S  S+S     ++ ++ S+      EN+I +G     YKG+ ++NG    +K +  
Sbjct: 673 QFFDSKVSKS----ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIND 725

Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEK 203
              + I +  ++++G    + HPN  KL+G    E G +++ E     +L+ +L      
Sbjct: 726 --VNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L W  R KIA+G+A+ L +LH  C   ++  ++    I++    EP +    L   L   
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS---QQSLV 320
                 S       Y+APE      + EK+D++ FG++L+EL+TG+   D       S+V
Sbjct: 836 TKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889

Query: 321 LWAR-------------PMIKRNEI---RELVDASLADEYDTRQMNLVLLAASLCIQQSS 364
            WAR             P I+ +      E+V+           MNL L     C     
Sbjct: 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEV----------MNLAL----HCTATDP 935

Query: 365 IRRPQMSQVVQLL 377
             RP  + V++ L
Sbjct: 936 TARPCANDVLKTL 948

Length = 968

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 26/218 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIA-------- 213
           HPN   LLG     G +++ +E +P+G+L   L     ++    + I    A        
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 214 ----LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
                 VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++   E +   T+
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM 182

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++     ++A E L + +    +DV+++GVLL E+V+
Sbjct: 183 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DH 166
           +  FE++IG+G + +V +  ++        AIK L    ++    DF  EL ++  +  H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRY 210
           PN   LLG     G ++I +E +P G+L   L               +G    L      
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
           + A  VA G+ YL E   ++ IHRD+ A N+L+ E+   +I DFGL++   E +   T+ 
Sbjct: 123 QFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRG-EEVYVKKTMG 178

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           ++     ++A E L + +   K+DV++FGVLL E+V+
Sbjct: 179 RL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 9/178 (5%)

Query: 134 GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSPN 190
           G++VA+K L R    +  + +  E+ I+  + H N  K  G   E G   + +++E  P 
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
           GSL    Y  K KL        A  + EG+ YLH    +  IHRD+ A N+LL  D   +
Sbjct: 93  GSL--RDYLPKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVK 147

Query: 251 ICDFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           I DFGLAK +PE   ++ + +  +    + A E L        +DV++FGV L EL+T
Sbjct: 148 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 71/221 (32%), Positives = 110/221 (49%), Gaps = 26/221 (11%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMA 162
           L+     F    L+G G Y +VYKGR ++ GQL AIK +   G  +E I   ++ L   +
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60

Query: 163 HVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKE---KLKWGIRYKI 212
           H  H N A   G        G++  + +V+E    GS+  L+   K    K +W I Y I
Sbjct: 61  H--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-I 116

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +  GL +LH   Q ++IHRDIK  N+LLTE+ E ++ DFG++  L    T    +  
Sbjct: 117 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTF 171

Query: 273 EGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
            GT  ++APE +          D K+D+++ G+  +E+  G
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +    E +IG G + EV  GRL+        VAIK L  G  ++   DFLSE  IM   D
Sbjct: 4   SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN   L G   +   + IV E   NGSL + L     +        +  G+A G+ YL 
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAP 281
           +      +HRD+ A NIL+  +   ++ DFGL++ L   PE    +T    +    + AP
Sbjct: 124 D---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTAP 178

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT 307
           E + +      +DV+++G+++ E+++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++ + + +IG G + EV++G L    R    VAIK L  G  ++   DFLSE  IM    
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 166 HPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N  +L G   +     I+ E   NG+L   L     +        +  G+A G+ YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAP 281
           +      +HRD+ A NIL+  + E ++ DFGL++ L   PE    +T S  +    + AP
Sbjct: 125 D---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE--GTYTTSGGKIPIRWTAP 179

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVDAS 339
           E + +      +DV++FG+++ E+++ G R   D S   +      M   N+   L  A 
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKAINDGFRL-PAP 232

Query: 340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
           +       Q+ L       C QQ   RRP+   +V LL
Sbjct: 233 MDCPSAVYQLML------QCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 30/214 (14%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVD---HPNTA 170
             IG+G Y  VYK R L  G+ VA+K++    + + I    L E+ ++  ++   HPN  
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 171 KLL----GYGIEGGMHI--VLELSPNGSLASLL-----YGM-KEKLKWGIRYKIALGVAE 218
           +LL    G   +  + +  V E   +  LA+ L      G+  E +K  +R      +  
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ-----LLR 118

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           G+ +LH     RI+HRD+K  NIL+T D + +I DFGLA+    +     ++ V  T  Y
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE---MALTSVVVTLWY 172

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+        D+++ G +  EL   RR L
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 21/215 (9%)

Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGI 177
           G GG     K  +  G ++A K +  G    +    L EL IM     P      G +  
Sbjct: 16  GNGGSVSKVK-HIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74

Query: 178 EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           E  + + +E    GSL  +    G    +   I  KIA+ V EGL YL+     RI+HRD
Sbjct: 75  ENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRD 129

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF----GYLAPEFLMHGIVDE 291
           IK +NIL+    + ++CDFG++  L        I+ +  TF     Y++PE +  G    
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGEL--------INSIADTFVGTSTYMSPERIQGGKYTV 181

Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM 326
           K+DV++ G+ ++EL  G+    +S         PM
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 65/238 (27%), Positives = 100/238 (42%), Gaps = 59/238 (24%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF  E  +MA 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSL------------ASLLYGMKEKLKWGIRY 210
            DHPN  KLLG    G  M ++ E    G L             SL +      K G+  
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 211 ---------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--- 258
                     IA  VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++   
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 259 -----------WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
                       +P +W              + PE + +     ++DV+A+GV+L E+
Sbjct: 182 SADYYKASENDAIPIRW--------------MPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 33/227 (14%)

Query: 111 NFSFENLIGKGGYAEVYKG-----RLRNG-QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N      +G+G + +V K      + R G   VA+K L    +   + D LSE  ++  V
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 165 DHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMK---------------------- 201
           +HP+  KL G    +G + +++E +  GSL S L   +                      
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 202 -EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
              L  G     A  ++ G+ YL E    +++HRD+ A N+L+ E  + +I DFGL++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            E+ ++   SK      ++A E L   I   ++DV++FGVLL E+VT
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 40/230 (17%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           +     IG G Y  V      R G+ VAIK+++    D I A   L E+ ++ H+ H N 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 170 AKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKL-----KWGIRYKIALGVAE 218
             LL             ++IV EL     L  ++    + L     ++   Y+I  G   
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK-SPQPLTDDHIQY-FLYQILRG--- 115

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK------WLPEQWTHHTISKV 272
            L YLH      +IHRD+K +NIL+  + + +ICDFGLA+            T + +   
Sbjct: 116 -LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV--- 168

Query: 273 EGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRAL----DYSQQ 317
             T  Y APE L+      +  D+++ G +  EL+T R+ L    DY  Q
Sbjct: 169 --TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQ 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 35/272 (12%)

Query: 118 IGKGGYAE--VYKGRLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           +GKG + E  +Y+ R  +  LV  K   LTR +  E   D L+E+ I++ + HPN     
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYY 65

Query: 174 GYGIEGG-MHIVLELSPNGSLASLLYGMKEKL------KWGIRYKIALGVAEGLLYLHEG 226
            + ++   + I +E +  G+L   +   K +L       W   ++I   V+    Y+H  
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS----YIH-- 118

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            +  I+HRDIK  NI LT+    ++ DFG++K L  +++      V GT  Y++PE    
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQG 175

Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
              + K+D++A G +L EL+T +R  D +    ++            ++V  +       
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV-----------KIVQGNYTPVVSV 224

Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
               L+ L  S  +QQ   +RP   +V+    
Sbjct: 225 YSSELISLVHS-LLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 26/209 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR-----LTRGTADEIIADFLSELGIMAHV 164
           NF  E  IG+G ++EVY+   L +G  VA+K+     L    A    AD + E+ ++  +
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR---ADCIKEIDLLKQL 59

Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGV 216
           +HPN  K     IE   ++IVLEL+  G L+ ++   K       EK  W  +Y + L  
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCS 117

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A  L ++H    RR++HRDIK AN+ +T     ++ D GL ++   + T      + GT 
Sbjct: 118 A--LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTP 170

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
            Y++PE +     + K+D+++ G LL E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 9/197 (4%)

Query: 113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +F   +G G +  V+ G+ R    VAIK +  G   E   DF+ E  +M  + HP   +L
Sbjct: 7   TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQL 64

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
            G   +   ++IV E   NG L + L   + KL   +   +   V EG+ YL    +   
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSF 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHRD+ A N L++     ++ DFG+ ++ L +++T  + +K      +  PE        
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYS 179

Query: 291 EKTDVFAFGVLLLELVT 307
            K+DV++FGVL+ E+ T
Sbjct: 180 SKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.5 bits (204), Expect = 8e-18
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 51/224 (22%)

Query: 118 IGKGGYAEVYKGRLRNGQ------LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+ G   + +      LVA+K L    +++   DF  E  ++ +  H N  K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 172 LLGYGIEGGMHI-VLELSPNGSL----------ASLLYGMKEK---LKWGIRYKIALGVA 217
             G   EG   I V E   +G L          A+ L         L      +IA+ +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------------WLPEQ 263
            G++YL     +  +HRD+   N L+  D   +I DFG+++               LP +
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           W              + PE +M+     ++DV++FGV+L E+ T
Sbjct: 190 W--------------MPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.9 bits (205), Expect = 9e-18
 Identities = 73/224 (32%), Positives = 110/224 (49%), Gaps = 33/224 (14%)

Query: 91  YDSQSPQKIFS-LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL--TRGT 146
           +    P+K+F+ L E             IG G +  VY  R +R  ++VAIK++  +   
Sbjct: 8   FSKDDPEKLFTDLRE-------------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ 54

Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
           ++E   D + E+  +  + HPNT +  G Y  E    +V+E    GS + +L   K+ L+
Sbjct: 55  SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQ 113

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQW 264
                 I  G  +GL YLH   +   IHRDIKA NILLTE    ++ DFG A  + P   
Sbjct: 114 EVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169

Query: 265 THHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLEL 305
                S V GT  ++APE ++    G  D K DV++ G+  +EL
Sbjct: 170 -----SFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.7 bits (207), Expect = 9e-18
 Identities = 86/306 (28%), Positives = 135/306 (44%), Gaps = 33/306 (10%)

Query: 82  MPRNLFVNSYDSQSPQKIFSLYELQSATNNFS-FE--NLIGKGGYAEVYKGRLR-NGQLV 137
           +P  L   S  S S     +     SA  + S  E  N IG G    VYK   R  G+L 
Sbjct: 43  VPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLY 102

Query: 138 AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASL 196
           A+K +     D +      E+ I+  V+HPN  K    +   G + ++LE    GSL   
Sbjct: 103 ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT 162

Query: 197 LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
               ++ L       +A  +  G+ YLH   +R I+HRDIK +N+L+      +I DFG+
Sbjct: 163 HIADEQFLA-----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGV 214

Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEF----LMHGIVDEKT-DVFAFGVLLLELVTGRRA 311
           ++ L +  T    +   GT  Y++PE     L HG  D    D+++ GV +LE   GR  
Sbjct: 215 SRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Query: 312 LDYSQQSLVLWARPM--IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ 369
               +Q    WA  M  I  ++  E   A+ + E+     + +    S C+Q+   +R  
Sbjct: 273 FGVGRQG--DWASLMCAICMSQPPE-APATASREF----RHFI----SCCLQREPAKRWS 321

Query: 370 MSQVVQ 375
             Q++Q
Sbjct: 322 AMQLLQ 327

Length = 353

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAK 171
           I KG Y  V+  + ++ G + AIK + +    ++I        L+E  I++    P   K
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKK---ADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 172 LLGYGIEG--GMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEG 226
           L  Y  +G   +++V+E  P G LASLL   G + E +    R  IA  +   L YLH  
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV---ARIYIA-EIVLALEYLH-- 110

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------WLPEQWTHHTISKVEGTFGY 278
               IIHRD+K  NIL+  +   ++ DFGL+K         L +        ++ GT  Y
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE--DKRIVGTPDY 167

Query: 279 LAPEFLM---HGIVDEKTDVFAFGVLLLELVTG 308
           +APE ++   H    +  D ++ G +L E + G
Sbjct: 168 IAPEVILGQGHS---KTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 13/204 (6%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G G + EV+         VA+K +  G+    +  FL+E  +M  + H    
Sbjct: 7   SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLV 64

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           KL     +  ++I+ E    GSL   L    G K+ L   I +  +  +AEG+ ++    
Sbjct: 65  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIE--- 119

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMH 286
           QR  IHRD++AANIL++     +I DFGLA+ + + ++T    +K      + APE +  
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINF 177

Query: 287 GIVDEKTDVFAFGVLLLELVTGRR 310
           G    K+DV++FG+LL+E+VT  R
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 19/200 (9%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGI-MAHVDHPNTAKLL 173
           I KG +  VY  + R  G   AIK L +        + +  +E  I M   + P  AKL 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 174 GYGIEGG--MHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            Y  +    +++V+E    G  ASL+  +      W  +Y     V  G+  LH   QR 
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLH---QRG 117

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IIHRDIK  N+L+ +    ++ DFGL++   E        K  GT  YLAPE ++    D
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGVGDD 171

Query: 291 EKTDVFAFGVLLLELVTGRR 310
           + +D ++ G ++ E + G  
Sbjct: 172 KMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 115 ENLIGKGGYAEVY---KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTA 170
           E   G+   AE Y   K R      VA+K L     D+ +AD +SE+ +M  +  H N  
Sbjct: 22  EGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNII 81

Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIAL 214
            LLG    EG +++++E +  G+L   L   +               E+L +      A 
Sbjct: 82  NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            VA G+ YL     RR IHRD+ A N+L+TED   +I DFGLA+ + +   +   S    
Sbjct: 142 QVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL 198

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++APE L   +   ++DV++FG+L+ E+ T
Sbjct: 199 PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 75/253 (29%), Positives = 117/253 (46%), Gaps = 26/253 (10%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPNT +  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH      +IH
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVD 290
           RD+KA NILL+E    ++ DFG A  +         +   GT  ++APE ++    G  D
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYD 192

Query: 291 EKTDVFAFGVLLLELVTGRRALDYSQQSLVLW-----ARPMIKRNE----IRELVDASLA 341
            K DV++ G+  +EL   +  L        L+       P ++        R  VD+ L 
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 342 DEYDTRQMNLVLL 354
                R  + VLL
Sbjct: 253 KIPQDRPTSEVLL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 80.7 bits (199), Expect = 2e-17
 Identities = 57/194 (29%), Positives = 99/194 (51%), Gaps = 13/194 (6%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M  + H    +L  YG+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLSHEKLVQL--YGV 67

Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  ++IV E   NG L + L    ++ +     ++   V EG+ YL     ++ IHR
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124

Query: 235 DIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           D+ A N L+ +    ++ DFGL+++ L +++T    SK      +  PE L++     K+
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKS 182

Query: 294 DVFAFGVLLLELVT 307
           DV+AFGVL+ E+ +
Sbjct: 183 DVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 32/210 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGY 175
           +G+G Y  V K R    G ++A+KR+      +     L +L I M  VD P T     Y
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTF--Y 66

Query: 176 GI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHEG 226
           G    EG + I +E+  + SL       K+    G+        KIA+ + + L YLH  
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKF---YKKVYDKGLTIPEDILGKIAVSIVKALEYLHS- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFL 284
            +  +IHRD+K +N+L+  + + ++CDFG++ +L +     +++K    G   Y+APE +
Sbjct: 122 -KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-----SVAKTIDAGCKPYMAPERI 175

Query: 285 -----MHGIVDEKTDVFAFGVLLLELVTGR 309
                  G  D K+DV++ G+ ++EL TGR
Sbjct: 176 NPELNQKGY-DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 22/201 (10%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLG- 174
           IG+G Y  V+K R R  GQ+VAIK+      D +I    L E+ ++  + HPN   L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 175 YGIEGGMHIVLELSPNGSLASL---LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +  +  +H+V E   +  L  L     G+ E L   I ++    V     + H   +   
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN----FCH---KHNC 121

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRD+K  NIL+T+  + ++CDFG A+ L      +T      T  Y APE L   + D 
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELL---VGDT 176

Query: 292 K----TDVFAFGVLLLELVTG 308
           +     DV+A G +  EL+TG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTR-GTADE---IIADFLSELGIMAHV 164
           N+      IG G   +VYK R +  G ++A+K++ R G  +E   I+ D   ++ + +H 
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL--DVVLKSH- 71

Query: 165 DHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           D P   K  GY I +  + I +EL     L  LL  ++  +   I  K+ + + + L YL
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
            E  +  +IHRD+K +NILL      ++CDFG++  L +       ++  G   Y+APE 
Sbjct: 131 KE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPER 185

Query: 284 L----MHGIVDEKTDVFAFGVLLLELVTGR 309
           +     +   D + DV++ G+ L+EL TG+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 12/198 (6%)

Query: 117 LIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  + +G+     VAIK L   T+ +   + L E  +MA V  P   +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQR 229
           LLG  +   + +V +L P G L  L Y  + K + G +  +   + +A+G+ YL E    
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R++HRD+ A N+L+      +I DFGLA+ L    T +     +    ++A E ++H   
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 290 DEKTDVFAFGVLLLELVT 307
             ++DV+++GV + EL+T
Sbjct: 189 THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 20/202 (9%)

Query: 117 LIGKGGYAEVYKG-RLRNGQL----VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           L+G G +  V+KG  +  G      VAIK +   +  +   +    +  M  +DH    +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHE 225
           LLG      + +V +LSP GSL   +   ++       L W ++      +A+G+ YL E
Sbjct: 74  LLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
               R++HR++ A NILL  D   QI DFG+A  L      +  S+ +    ++A E ++
Sbjct: 128 ---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
            G    ++DV+++GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.3 bits (199), Expect = 7e-17
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII-----ADFLSELGIMAH 163
           ++F F   +G G +  V   R + +G+  A+K L++    +I+        L+E  I+  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---AKIVKLKQVEHVLNEKRILQS 57

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGL 220
           + HP    L G +  +  +++V+E  P G L S L   G +        Y  A  V   L
Sbjct: 58  IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFY--AAQVVLAL 114

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISKVEGTFGYL 279
            YLH      I++RD+K  N+LL  D   +I DFG AK +  + +T      + GT  YL
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------LCGTPEYL 165

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           APE ++     +  D +A G+L+ E++ G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 50/229 (21%)

Query: 112 FSFENL-----IGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGI 160
           F   NL     +G+G + EV+  + +         LV +K L +   + + ++F  EL +
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 161 MAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEK--------LKWGIRYK 211
              + H N  +LLG   E   H ++LE +  G L   L   K K        L    +  
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK------------- 258
           +   +A G+ +L      R +HRD+ A N L++   E ++    L+K             
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            +P +W              LAPE +       K+DV++FGVL+ E+ T
Sbjct: 179 LIPLRW--------------LAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 70/228 (30%), Positives = 107/228 (46%), Gaps = 27/228 (11%)

Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYK-GRLRNGQLVAIKRL--TRGTADEIIADFL 155
           +  L  L   T+ +     IGKG Y +VYK    ++G L A+K L       +EI A++ 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY- 69

Query: 156 SELGIMAHV-DHPNTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM---KEKLK 205
               I+  + +HPN  K  G        + G + +VLEL   GS+  L+ G+    ++L 
Sbjct: 70  ---NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
             +   I  G   GL +LH     RIIHRD+K  NILLT +   ++ DFG++  L     
Sbjct: 127 EAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 266 HHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
               S   GT  ++APE +          D + DV++ G+  +EL  G
Sbjct: 184 RRNTSV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 116 NLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAK 171
           ++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  HPN   
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKIALG 215
           LLG     G +++ +E +P+G+L   L                     L        A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA G+ YL +   ++ IHRD+ A NIL+ E++  +I DFGL++   E +   T+ ++   
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRL--P 174

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             ++A E L + +    +DV+++GVLL E+V+
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 54/205 (26%), Positives = 101/205 (49%), Gaps = 15/205 (7%)

Query: 118 IGKGGYAEVYKG--RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G +  V KG  ++R  Q+ VAIK L       +  + + E  IM  +D+P   +++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
                 + +V+E++  G L   L G K+++      ++   V+ G+ YL     +  +HR
Sbjct: 63  VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHR 119

Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDEK 292
           D+ A N+LL      +I DFGL+K L    +++  ++  G +   + APE +       +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-ARSAGKWPLKWYAPECINFRKFSSR 178

Query: 293 TDVFAFGVLLLELVTGRRALDYSQQ 317
           +DV+++G+ + E      A  Y Q+
Sbjct: 179 SDVWSYGITMWE------AFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 17/195 (8%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY  R +R  ++VAIK+++     ++E   D + E+  +  + HPN+ +  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      I  G  +GL YLH      +IH
Sbjct: 93  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIH 148

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVD 290
           RDIKA NILLTE  + ++ DFG A            +   GT  ++APE ++    G  D
Sbjct: 149 RDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYD 202

Query: 291 EKTDVFAFGVLLLEL 305
            K DV++ G+  +EL
Sbjct: 203 GKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 78/263 (29%), Positives = 120/263 (45%), Gaps = 33/263 (12%)

Query: 118 IGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGY 175
           IGKG Y +V+K    +NG   A+K L      +I  +  +E  I+ A  DHPN  K  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 176 ----GIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYK---IALGVAEGLLYLHEG 226
                ++ G  + +VLEL   GS+  L+ G    LK G R +   IA  + E L+ L   
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGF---LKRGERMEEPIIAYILHEALMGLQHL 140

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL-- 284
              + IHRD+K  NILLT +   ++ DFG++  L    T    +   GT  ++APE +  
Sbjct: 141 HVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIAC 198

Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALD--YSQQSLVLWAR--------PMIKRNE 331
              +    D + DV++ G+  +EL  G   L   +  ++L    R        P +  NE
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNE 258

Query: 332 IRELVDASLADEYDTRQMNLVLL 354
             + +   L  +Y+ R     LL
Sbjct: 259 FNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 76/289 (26%), Positives = 132/289 (45%), Gaps = 40/289 (13%)

Query: 114 FENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           F   +G+  + ++YKG L      + QLVAIK L      +   +F  E  +MA + HPN
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 169 TAKLLG-------------YGIEGGMHIVLEL-SPN---GSLASLLYGMKEKLKWGIRYK 211
              LLG             Y  +G +H  L + SP+   G  +     +K  L  G    
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IA+ +A G+ YL        +H+D+ A NIL+ E    +I D GL++ +     +    K
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG--RRALDYSQQSLVLWARPMIKR 329
                 ++ PE +M+G     +D+++FGV+L E+ +   +    +S Q ++     M+++
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI----EMVRK 241

Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
              R+L+  S  ++   R  +L+    + C Q+   RRP+   +   LR
Sbjct: 242 ---RQLLPCS--EDCPPRMYSLM----TECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMA 162
           S   ++     +G+G + EVYK R ++ G++VA+K++      +   I A  L E+ I+ 
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILK 62

Query: 163 HVDHPNTAKLLGYGIE------GGMHIVLELSP--NGSLASLLYGMKEKLKWGIRYKIAL 214
            + HPN   L+   +E           V  ++P  +  L+ LL     KL         L
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTH----- 266
            + EG+ YLHE     I+HRDIKAANIL+      +I DFGLA+     P          
Sbjct: 123 QLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 267 -HTISKVEGTFGYLAPEFLMHGIVDEK-----TDVFAFGVLLLELVTGR 309
               + +  T  Y  PE L+     E+      D++  G +  E+ T R
Sbjct: 180 TRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 21/183 (11%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + EV+K R +   Q+VA+K++      E   I A  L E+ I+  + H N   L+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 77

Query: 174 ---------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
                        +G  ++V E   +  LA LL     K       K+   +  GL Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPE 282
              + +I+HRD+KAANIL+T+D   ++ DFGLA+   L +    +  +    T  Y  PE
Sbjct: 137 ---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 283 FLM 285
            L+
Sbjct: 194 LLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 58/188 (30%), Positives = 96/188 (51%), Gaps = 20/188 (10%)

Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     D+ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 195 SLLY-----GM----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L      GM          +E+L +      A  VA G+ YL     ++ IHRD+ A 
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163

Query: 240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFG 299
           N+L+TED   +I DFGLA+ +     +   +       ++APE L   +   ++DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Query: 300 VLLLELVT 307
           VLL E+ T
Sbjct: 224 VLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 81/255 (31%), Positives = 116/255 (45%), Gaps = 33/255 (12%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRL----TRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++GKGG+ EV   ++R  G++ A K+L     +    E +A  L+E  I+  V+      
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVS 64

Query: 172 L-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEG 226
           L   Y  +  + +VL L   G L   +Y M E    G     A+  A     GL  LH  
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLH-- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            Q RI++RD+K  NILL +    +I D GLA  +PE     TI    GT GY+APE + +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKN 175

Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
                  D +A G LL E++ G        QS     +  IKR E+  LV   + +EY  
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAG--------QSPFQQRKKKIKREEVERLVK-EVQEEYSE 226

Query: 347 RQMNLVLLAASLCIQ 361
           +       A SLC  
Sbjct: 227 K---FSPDARSLCKM 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 17/202 (8%)

Query: 118 IGKGGYAEVY-KGRLRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY        ++VA+K+++      +E   D + E+  +  + HPNT +  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      I  G  +GL YLH      +IH
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIH 144

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVD 290
           RDIKA NILLTE  + ++ DFG A            +   GT  ++APE ++    G  D
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 291 EKTDVFAFGVLLLELVTGRRAL 312
            K DV++ G+  +EL   +  L
Sbjct: 199 GKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 62/193 (32%), Positives = 99/193 (51%), Gaps = 30/193 (15%)

Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     ++ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 195 SLLY-----GMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L      GM+          E+L +      A  VA G+ YL     ++ IHRD+ A 
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169

Query: 240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG-----YLAPEFLMHGIVDEKTD 294
           N+L+TED   +I DFGLA+ +     HH     + T G     ++APE L   I   ++D
Sbjct: 170 NVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224

Query: 295 VFAFGVLLLELVT 307
           V++FGVLL E+ T
Sbjct: 225 VWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 41/276 (14%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           +GKG Y  VYK   R  G  +A+K +     +      + EL I+     P      G +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 176 GIEGGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            IEG +++ +E    GSL  L  G    E +   +  +I   V +GL +L E  +  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-GTFGYLAPEFLMHGIVDE- 291
           RD+K  N+L+  + + ++CDFG++  L       +++K   G   Y+APE +  G  ++ 
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVA-----SLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 292 -----KTDVFAFGVLLLELVTGR-------RALDYSQQSLVLWARPMIKRNEIRELVDAS 339
                ++DV++ G+ +LE+  GR        A  ++Q S ++   P             +
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------PT 229

Query: 340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           L   Y     + V    + C+ +   RRP  +Q+++
Sbjct: 230 LPSGYSDDAQDFV----AKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 69/228 (30%), Positives = 110/228 (48%), Gaps = 34/228 (14%)

Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSEL 158
           L  L+     F    ++G G Y +VYKGR ++ GQL AIK   +T    +EI  + ++ L
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INML 66

Query: 159 GIMAHVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKE---KLKWGI 208
              +H  H N A   G        G +  + +V+E    GS+  L+   K    K  W I
Sbjct: 67  KKYSH--HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            Y I   +  GL +LH     ++IHRDIK  N+LLTE+ E ++ DFG++  L       T
Sbjct: 124 AY-ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-----DRT 174

Query: 269 ISKVE---GTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
           + +     GT  ++APE +          D ++D+++ G+  +E+  G
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 48/225 (21%)

Query: 110 NNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL-TRGTADEIIADFLSELGIMA 162
           NN SF   +G G + +V +       +      VA+K L     + E  A  +SEL IM+
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREA-LMSELKIMS 93

Query: 163 HV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----V 216
           H+ +H N   LLG    GG + ++ E    G L + L   +E     +  +  L     V
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQV 150

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------------WLPE 262
           A+G+ +L     +  IHRD+ A N+LLT     +ICDFGLA+               LP 
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +W              +APE + + +   ++DV+++G+LL E+ +
Sbjct: 208 KW--------------MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 118 IGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +VYKG L       +   VAIK L      ++  +F  E  +M+ + HPN   
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 172 LLG-------------YGIEGGMH-IVLELSPNGSL--ASLLYGMKEKLKWGIRYKIALG 215
           LLG             Y   G +H  ++  SP+  +   S    +K  L       IA+ 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           +A G+ YL        +HRD+ A N L+ E    +I DFGL++ +     +   SK    
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
             ++ PE +++G    ++D+++FGV+L E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTAKL 172
           +GKGG+ EV   +++N G++ A K+L +      + E +A  L E  I+  V+ P    L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58

Query: 173 LGYGIEGGMHI--VLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGC 227
             Y  E   H+  V+ L   G L   +Y + E+   ++  I Y  +  +  G+L+LH   
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY--SAQITCGILHLHS-- 113

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              I++RD+K  N+LL +    ++ D GLA  L +     TI++  GT GY+APE L   
Sbjct: 114 -MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEE 169

Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
                 D FA G  + E+V GR
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 6e-15
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 17/208 (8%)

Query: 110 NNFSFENLIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N+    L+G+G +  VY       GR    + V     +  T  E+ A    E+ ++ +
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKN 60

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGL 220
           + H    +  G    +  + I +E  P GS+   L  YG    L   +  K    + EG+
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGV 117

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGYL 279
            YLH      I+HRDIK ANIL       ++ DFG +K L    +  T +  V GT  ++
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +PE +       K DV++ G  ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 116 NLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +L+ +G +  ++ G L +      + V +K +    ++  +   L E  ++  + H N  
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 171 KLLGYGIE-GGMHIVLELSPN-GSLASLLYGMKEKLKWGIR-------YKIALGVAEGLL 221
            +L   IE G    VL    N G+L   L   +       +         +A+ +A G+ 
Sbjct: 72  PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEG-TFGYL 279
           YLH   +R +IH+DI A N ++ E+ + +I D  L++ L P  +  H +   E     ++
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY--HCLGDNENRPVKWM 186

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           A E L++      +DV++FGVLL EL+T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 78/269 (28%), Positives = 134/269 (49%), Gaps = 35/269 (13%)

Query: 117 LIGKGGYAEVYKGRLRNGQ-LVAIKRLT--RGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           ++G+G +  V+  R +  Q LV IK++   + T DE +A   +E  ++  + HPN  +  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPNIIEYY 65

Query: 174 GYGIE-GGMHIVLELSPNGSLASLLYGMKEKL---KWGIRYKIALGVAEGLLYLHEGCQR 229
              +E   + IV+E +P G+LA  +      L      + + + +     LL LH    +
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHHVHTK 120

Query: 230 RIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
            I+HRD+K  NILL +     +I DFG++K L  +   +T   V GT  Y++PE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKP 177

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQ-QSLVLWARPMIKRNEIRELVDASLADEY--D 345
            ++K+D++A G +L EL + +RA + +   +LVL         +I     A ++D Y  D
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVL---------KIMSGTFAPISDRYSPD 228

Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVV 374
            RQ+ L +L           +RPQ+SQ++
Sbjct: 229 LRQLILSML------NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 16/196 (8%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    VY    +  GQ VAIK+  L +    E+I   ++E+ +M    HPN    L 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLD 83

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    GSL  ++   +  +  G    +     + L +LH     ++IH
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 138

Query: 234 RDIKAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RDIK+ NILL  D   ++ DFG  A+  PEQ    T+    GT  ++APE +       K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 195

Query: 293 TDVFAFGVLLLELVTG 308
            D+++ G++ +E+V G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           F+   ++GKG +  V + +L+    + Q VA+K L     +   I +FL E   M   DH
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 167 PNTAKLLGYGI----EGGMHIVLELSP---NGSLASLLYGMKE-----KLKWGIRYKIAL 214
           PN  KL+G  +    +G + I + + P   +G L + L   +       L      +  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKV 272
            +A G+ YL     +  IHRD+ A N +L E+    + DFGL+K  +  + +     SK+
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                +LA E L   +    +DV+AFGV + E++T
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 24/238 (10%)

Query: 84  RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRL 142
           +N  ++++ S+  +    + +L+    +F    +IG+G + EV   R ++ + V A+K L
Sbjct: 17  KNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLL 76

Query: 143 TRGTADEII-----ADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASL 196
           ++    E+I     A F  E  IMAH +     +L   +  +  +++V+E  P G L +L
Sbjct: 77  SK---FEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL 133

Query: 197 L--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
           +  Y + EK  W   Y      AE +L L        IHRD+K  N+LL +    ++ DF
Sbjct: 134 MSNYDIPEK--WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 186

Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLELVTG 308
           G    +         + V GT  Y++PE L      G    + D ++ GV L E++ G
Sbjct: 187 GTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 9/194 (4%)

Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLG-Y 175
           +G G    V K + +   L+  ++L        I +  + EL ++   + P      G +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             +G + I +E    GSL  +L   K ++   I  K+++ V  GL YL E  + +I+HRD
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRD 129

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L       ++D+
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDI 185

Query: 296 FAFGVLLLELVTGR 309
           ++ G+ L+EL  GR
Sbjct: 186 WSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 16/199 (8%)

Query: 114 FENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           ++ ++G G    VYK   L   +++A+K +      E+    +SEL I+   D P     
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
            G + +E  + I  E    GSL      +  K+   +  +IA+ V +GL YL      +I
Sbjct: 65  YGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYL---WSLKI 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-GTFGYLAPEFLMHGIVD 290
           +HRD+K +N+L+    + ++CDFG++  L      ++I+K   GT  Y+APE +      
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-----NSIAKTYVGTNAYMAPERISGEQYG 171

Query: 291 EKTDVFAFGVLLLELVTGR 309
             +DV++ G+  +EL  GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              VA G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 29/217 (13%)

Query: 112 FSFENL-----IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI-IADFLSEL-GIMAH 163
           F+ E+L     IG+G +  V K   +  G ++A+KR+ R T DE      L +L  +M  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRS 59

Query: 164 VDHPNTAKLLGYGI---EGGMHIVLEL--SPNGSLASLLYGMKEK-LKWGIRYKIALGVA 217
            D P   K   YG    EG   I +EL           +Y + +  +   I  KIA+   
Sbjct: 60  SDCPYIVKF--YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GT 275
           + L YL E  + +IIHRD+K +NILL  +   ++CDFG++  L +     +I+K    G 
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-----SIAKTRDAGC 170

Query: 276 FGYLAPEFLMHGIV---DEKTDVFAFGVLLLELVTGR 309
             Y+APE +        D ++DV++ G+ L E+ TG+
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 17/226 (7%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTADEIIADFLSELG 159
           EL + +     E ++G G + E+ +G L    +    VAI  L  G +D+    FL+E  
Sbjct: 1   ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58

Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            +   DH N  +L G    G  M IV E   NG+L S L   + +L  G    +  G+A 
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           G+ YL E      +H+ + A  +L+  D   +I  F     L E  +    + + G    
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPV 172

Query: 279 L--APEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLV 320
           L  APE + +      +DV++FG+++ E+++ G R   D S Q ++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI 218

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 69/240 (28%), Positives = 101/240 (42%), Gaps = 55/240 (22%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI----IADFLSELGIMAHV 164
           ++F    +IG+G + EV+  R +  GQ+ A+K L +  +D I    IA   +E  I+A  
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK--SDMIKRNQIAHVRAERDILADA 58

Query: 165 DHPNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGV 216
           D P   KL  Y  +   H+  V+E  P G L +LL          IR  +         +
Sbjct: 59  DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----------IRKDVFPEETARFYI 107

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK------------------ 258
           AE +L L    +   IHRDIK  NIL+  D   ++ DFGL K                  
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 259 ----------WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                        +Q      S V GT  Y+APE L       + D ++ GV+L E++ G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAK 171
           +G GG+  V   ++++  +  A+K + +     I+         SE  I+   +HP   K
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK---RHIVETGQQEHIFSEKEILEECNHPFIVK 57

Query: 172 LL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKL-KWGIRYKIALGVAEGLLYLHEGCQR 229
           L   +  +  +++++E    G L ++L   +    ++  R+ IA  V     YLH    R
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA-CVVLAFEYLHN---R 112

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
            II+RD+K  N+LL  +   ++ DFG AK L       T     GT  Y+APE +++   
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGY 169

Query: 290 DEKTDVFAFGVLLLELVTGR 309
           D   D ++ G+LL EL+TGR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 34/224 (15%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           +   + +G G Y +V        G+ VAIK+L+R     I A     EL ++ H+DH N 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 170 AKLL-----GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVAEG 219
             LL        +E    +++V  L     + + L  + +  K     I++ +   +  G
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHL-----MGADLNNIVKCQKLSDDHIQF-LVYQILRG 130

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           L Y+H      IIHRD+K +NI + ED E +I DFGLA+   ++ T +       T  Y 
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYR 182

Query: 280 APEFL---MHGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
           APE +   MH   ++  D+++ G ++ EL+TG+      D+  Q
Sbjct: 183 APEIMLNWMH--YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 42/212 (19%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSEL-GIMAHVDHPNTAKLL 173
           +G G +  VY  R +  G+LVAIK++ +     +E +   L E+  +    +HPN  KL 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64

Query: 174 GYGIEGG-MHIVLE-LSPNGSLASLLYGMKEKLKWG------IRYKIALGVAEGLLYLHE 225
               E   ++ V E +  N      LY + +  K        IR  I   + +GL ++H+
Sbjct: 65  EVFRENDELYFVFEYMEGN------LYQLMKDRKGKPFSESVIRS-IIYQILQGLAHIHK 117

Query: 226 -GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK------VEGTFGY 278
            G      HRD+K  N+L++     +I DFGLA+           S+      V  T  Y
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYV-STRWY 164

Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGR 309
            APE L+         D++A G ++ EL T R
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.4 bits (175), Expect = 6e-14
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R    G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
             KLL     E  +++V E   +  L     AS L G+   L     +++  G+A    +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYL 279
            H     R++HRD+K  N+L+  +   ++ DFGLA+   +P   +TH  +     T  Y 
Sbjct: 116 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYR 167

Query: 280 APEFLMHG-IVDEKTDVFAFGVLLLELVTGRRAL 312
           APE L+         D+++ G +  E+VT RRAL
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 64/277 (23%), Positives = 129/277 (46%), Gaps = 30/277 (10%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  +          VAIK +    +     +FL+E  +M   +  +  +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK---------WGIRYKIALGVAEGLL 221
           LLG   +G    +++EL   G L S L  ++ +++              ++A  +A+G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL+     + +HRD+ A N ++ EDF  +I DFG+ + + E   +    K      +++P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           E L  G+    +DV++FGV+L E+ T       ++Q      + M     +R +++  L 
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY----QGMSNEQVLRFVMEGGLL 240

Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           D+ D    +++     +C Q +   RP   +++  ++
Sbjct: 241 DKPDNCP-DMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           IG G Y  V      R+G+ VAIK++        +A   L EL I+ H  H N   +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                    +  +++V++L  +  L  +++  +   +  IRY     +  GL Y+H    
Sbjct: 73  LRPPGADFKD--VYVVMDLMES-DLHHIIHSDQPLTEEHIRY-FLYQLLRGLKYIHSAN- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAPE--F 283
             +IHRD+K +N+L+ ED E +I DFG+A+ L   P +  +     V  T  Y APE   
Sbjct: 128 --VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRAPELLL 184

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL----DYSQQ 317
            +        D+++ G +  E++ GRR L    +Y  Q
Sbjct: 185 SLPE-YTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQ 220

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 73/287 (25%), Positives = 136/287 (47%), Gaps = 44/287 (15%)

Query: 118 IGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  R+   G+    VA+K +    +     +FL+E  +M      +  +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK-----------LKWGIRYKIALGVAEG 219
           LLG   +G    +V+EL  +G L S L  ++ +           L+  I  ++A  +A+G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 131

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           + YL+    ++ +HRD+ A N ++  DF  +I DFG+ + + E   +    K      ++
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IRELVD 337
           APE L  G+    +D+++FGV+L E+ +     +   Q L          NE  ++ ++D
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS---LAEQPYQGL---------SNEQVLKFVMD 236

Query: 338 ASLADEYDT---RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
               D+ D    R  +L+     +C Q +   RP   ++V LL+ +L
Sbjct: 237 GGYLDQPDNCPERVTDLM----RMCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 118 IGKGGYAEVYKG---RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG     ++ + VA+K L     D  + D  L E  +M  +D+P   +++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+EL+  G L   L   K   +  I  ++   V+ G+ YL E      +H
Sbjct: 63  GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEE---TNFVH 118

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  +K  G +   + APE + +     
Sbjct: 119 RDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-AKTHGKWPVKWYAPECMNYYKFSS 177

Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 178 KSDVWSFGVLMWE------AFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 24/276 (8%)

Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ ++  + +  + +LQ    ++    +IG+G + EV   R ++ Q 
Sbjct: 10  LDFPALRKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQK 69

Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 70  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L       +IHRD+K  N+LL +    
Sbjct: 127 GGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181

Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH----GIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + E       + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 182 KLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240

Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           + G     Y+   +  +++ M  +N +    D  ++
Sbjct: 241 LVGDTPF-YADSLVGTYSKIMDHKNSLNFPEDVEIS 275

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 118 IGKGGYAEVYKGRLRNGQL---VAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G +  V +G+L        VA+K  ++   T  E+  DFLSE   M   DHPN  +L
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65

Query: 173 LGYGIEGGMH-------IVLELSPNGSLAS-LLYG----MKEKLKWGIRYKIALGVAEGL 220
           +G  ++           ++L    +G L S LLY       + L   +  K    +A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGY 278
            YL     +  IHRD+ A N +L E+    + DFGL+K  +  + +    I+K+     +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKW 180

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +A E L   +   K+DV++FGV + E+ T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------EIIADFLSELGIMAH 163
           + F  ++GKG Y EV   R R +G+   IK+L    A        E  A  LS+L     
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL----- 56

Query: 164 VDHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKL-------KWGIRYKIAL 214
             HPN    +    G +G ++IV+     G L   L   K KL       +W ++     
Sbjct: 57  -KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ----- 110

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            +A  L YLHE   + I+HRD+K  N+ LT     ++ D G+A+ L  Q      S + G
Sbjct: 111 -IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CDMASTLIG 164

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
           T  Y++PE   +   + K+DV+A G  + E+ T + A +
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHP 167
           +F     IG G Y +VYK R +  G+L AIK  +L  G    ++     E+ +M    H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKHS 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N     G Y     + I +E    GSL  + +      +  I Y ++    +GL YLH  
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLH-- 123

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEF 283
             +  +HRDIK ANILLT++   ++ DFG++  +       TI+K +   GT  ++APE 
Sbjct: 124 -SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEV 177

Query: 284 LM---HGIVDEKTDVFAFGVLLLEL 305
                 G  ++  D++A G+  +EL
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAIK+  L +    
Sbjct: 1   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK 60

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 61  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 115

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 116 QIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T+    GT  ++APE +       K D+++ G++ +E+V G
Sbjct: 173 STMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 26/210 (12%)

Query: 111 NFSFENLIGKGGYAEVY--KGRLRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDH 166
            +     IG+G + ++Y  K +  +   V IK   LT+    E  A    E+ ++A + H
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKH 58

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLAS-------LLYGMKEKLKWGIRYKIALGVAE 218
           PN       +   G + IV+E    G L         +L+   + L W ++      ++ 
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISL 112

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           GL ++H+   R+I+HRDIK+ NI L+++    ++ DFG+A+ L +  +        GT  
Sbjct: 113 GLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPY 167

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           YL+PE   +   + KTD+++ G +L EL T
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 21/213 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEIIAD-----FLSELGIMAHV 164
           +F+F  ++GKG + +V     +   +L AIK L +   D II D      + E  ++A  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK---DVIIQDDDVECTMVEKRVLALP 57

Query: 165 DHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGL 220
             P   T     +     ++ V+E    G L   +Y +++  K K       A  +A GL
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGL 114

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            +LH    + II+RD+K  N++L  +   +I DFG+ K     +   T     GT  Y+A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIA 169

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
           PE + +    +  D +AFGVLL E++ G+   D
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHPNTAK 171
           N I +G Y  VY+ R  + G++VA+K+L      E   I +  L E+ I+  + HPN   
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQHPNIVT 68

Query: 172 L----LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +    +G  ++  +++V+E   +  L SL+  MK+         + L +  G+ +LH   
Sbjct: 69  VKEVVVGSNLDK-IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--- 123

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-H 286
              I+HRD+K +N+LL      +ICDFGLA+        +T   V  T  Y APE L+  
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPELLLGA 181

Query: 287 GIVDEKTDVFAFGVLLLELVTGR 309
                  D+++ G +  EL+T +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 11/200 (5%)

Query: 114 FENL--IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTA 170
           FE +  +G G    V+K   +   L+  ++L        I +  + EL ++   + P   
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 123

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L     
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHY 179

Query: 290 DEKTDVFAFGVLLLELVTGR 309
             ++D+++ G+ L+E+  GR
Sbjct: 180 SVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVD 165
           F    ++G+G + +V     +  G+L AIK L +G   +IIA       + E  I    +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKG---DIIARDEVESLMCEKRIFETAN 57

Query: 166 ---HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
              HP    L   +  E  +  V+E +  G L   ++         + Y  A  V  GL 
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--AACVVLGLQ 115

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YLHE    +I++RD+K  N+LL  +   +I DFGL K           S   GT  +LAP
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAP 170

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTG 308
           E L         D +  GVL+ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 32/211 (15%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNT 169
           +ENL  +G+G Y  V K + +  GQ+VAIK+      D+++    + E+ ++  + H N 
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY----KIALGVAEGLLYLH 224
             L+  +  +  +++V E   +  L  L     EK   G+      K    +  G+ + H
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDL-----EKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP---EQWTHHTISKVEGTFGYLAP 281
                 IIHRDIK  NIL+++    ++CDFG A+ L    E +T +       T  Y AP
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAP 169

Query: 282 EFLMHGIVDEK----TDVFAFGVLLLELVTG 308
           E L   + D K     D++A G L+ E++TG
Sbjct: 170 ELL---VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 22/196 (11%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLA 194
           LVA+K L    +D    DFL E+ I++ +  PN A+LLG    +  + +++E   NG L 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 195 SLLY-------GMKEKLK---WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
             L        G+    K   +     +A  +A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164

Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGT----FGYLAPEFLMHGIVDEKTDVFAFGV 300
           +++  +I DFG+++ L          +V+G       ++A E ++ G    K+DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSS----DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 301 LLLELVTGRRALDYSQ 316
            L E++T  R   Y  
Sbjct: 221 TLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 117 LIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHV-DHPNT 169
           ++GKG + +V    L+   +L A+K L +   D I+ D      ++E  ++A    HP  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKK---DVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLHEG 226
            +L   +  +  +  V+E    G L   ++ ++   ++        A  +  GL +LHE 
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHE- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             R II+RD+K  N+LL  +   +I DFG+ K         T S   GT  Y+APE L +
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 287 GIVDEKTDVFAFGVLLLELVTGR 309
                  D +A GVLL E++ G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              S + GT  ++APE +       K D+++ G++ +E++ G
Sbjct: 174 ---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 45/228 (19%)

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRL-----------TRGTADEIIADF--LSELGIM 161
             +G+G Y +V K      G++VAIK++            R         F  L EL IM
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 162 AHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAE 218
             + H N   L+   +EG  +++V+++     L  ++     K++        I L +  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV---DRKIRLTESQVKCILLQILN 130

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---- 274
           GL  LH   +   +HRD+  ANI +      +I DFGLA+         T+SK E     
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 275 --------TFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGR 309
                   T  Y APE LM     H  V    D+++ G +  EL+TG+
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAV----DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 34/99 (34%), Positives = 59/99 (59%), Gaps = 6/99 (6%)

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
           KI++ V  GL YL E  + +I+HRD+K +NIL+    E ++CDFG++  L +   +  + 
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV- 159

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
              GT  Y++PE L       ++D+++ G+ L+E+  GR
Sbjct: 160 ---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 40/212 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYKGR  + GQ+VA+K++   + +E + +  + E+ ++  + HPN   L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 176 GI-EGGMHIVLE------------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            + E  ++++ E            L     + + L  +K  L     Y+I     +G+L+
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAEL--VKSYL-----YQI----LQGILF 116

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQ-WTHHTISKVEGTFGYL 279
            H    RR++HRD+K  N+L+      ++ DFGLA+   +P + +TH  +     T  Y 
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-----TLWYR 168

Query: 280 APEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
           APE L+ G     T  D+++ G +  E+ T +
Sbjct: 169 APEVLL-GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDH 166
           +++     +G G Y +VYK R L  G+L A+K  +L  G    +I     E+ ++    H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKH 65

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            N     G Y     + I +E    GSL  + +      +  I Y +     +GL YLH 
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLH- 123

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPE 282
              +  +HRDIK ANILLT++ + ++ DFG+A  +       TI+K +   GT  ++APE
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPE 176

Query: 283 FLM---HGIVDEKTDVFAFGVLLLEL 305
                 +G  ++  D++A G+  +EL
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 16/201 (7%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLT--RGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +GKGG+ EV   ++R  G+L A K+L   R    +     + E  I+A V H      L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59

Query: 175 YGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGCQ 228
           Y  +    + +V+ +   G L   +Y + E+   G     A      +  GL +LH   Q
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLH---Q 115

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           RRII+RD+K  N+LL  D   +I D GLA  L +  +        GT G++APE L    
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE 173

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
            D   D FA GV L E++  R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 40/236 (16%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +AT+  + E L G+G YA VYKG  R NGQLVA+K ++  T + +    + E  ++  + 
Sbjct: 3   AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKL-KWGIRYKIAL---------- 214
           H N   L         H ++      +L  +   M   L ++ I++   L          
Sbjct: 62  HANIVLL---------HDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMF 110

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA--KWLPEQWTHHTISKV 272
            +  GL Y+H    + I+HRD+K  N+L++   E ++ DFGLA  K +P Q    T S  
Sbjct: 111 QLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ----TYSSE 163

Query: 273 EGTFGYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGRRAL----DYSQQSLVLW 322
             T  Y  P+ L+ G  D  +  D++  G + +E++ G+ A     D  +Q   +W
Sbjct: 164 VVTLWYRPPDVLL-GATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 39/221 (17%)

Query: 117 LIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLG 174
            +G G Y  V      R G+ VAIK+L+R    EI A     EL ++ H+ H N   LL 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 175 --------------YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
                         Y +   M   L+      L+      ++K+++ + Y++      GL
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS------EDKVQYLV-YQML----CGL 130

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T + +++      Y A
Sbjct: 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRA 182

Query: 281 PEFLMHGIVDEKT-DVFAFGVLLLELVTGR---RALDYSQQ 317
           PE +++ +   +T D+++ G ++ E++TG+   +  DY  Q
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 49/177 (27%), Positives = 93/177 (52%), Gaps = 26/177 (14%)

Query: 157 ELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGI 208
           E+ +++++ HPN  +    +   G ++IV++    G L   +   +       + L W +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           +  +AL       ++H+   R+I+HRDIK+ NI LT+D   ++ DFG+A+ L     + T
Sbjct: 109 QICLALK------HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NST 154

Query: 269 ISKVE---GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY-SQQSLVL 321
           +       GT  YL+PE   +   + K+D++A G +L E+ T + A +  + ++LVL
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 29/235 (12%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDH 166
           F    ++GKGG+ EV   ++R  G++ A K+L +        E +A  L+E  I+  V+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59

Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLL 221
                L   Y  +  + +VL L   G L   +Y M      G   + A+  A     GL 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP---GFDEERAVFYAAEITCGLE 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            LH   + RI++RD+K  NILL +    +I D GLA  +PE     TI    GT GY+AP
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRGRVGTVGYMAP 170

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
           E + +       D +  G L+ E++ G        +S     +  +KR E+   V
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEG--------KSPFRQRKEKVKREEVERRV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 26/204 (12%)

Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK----IALGVAEGLL 221
           L           E  + +V E   +  L + L  + E    G+  +    +   +  GL 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLD 124

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           +LH     R++HRD+K  NIL+T   + ++ DFGLA+    Q     ++ V  T  Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAP 178

Query: 282 EFLMHGIVDEKTDVFAFGVLLLEL 305
           E L+        D+++ G +  E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 41/126 (32%), Positives = 60/126 (47%), Gaps = 15/126 (11%)

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           LL +H    + +IHRDIK+ANILL  +   ++ DFG +K      +        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS 339
           APE        +K D+F+ GVLL EL+T +R  D                  + E++  +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---------------NMEEVMHKT 257

Query: 340 LADEYD 345
           LA  YD
Sbjct: 258 LAGRYD 263

Length = 496

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 20/224 (8%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ ++  +      ++    IG+G    V+    +  GQ VAIK+  L +    
Sbjct: 1   DEEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK 60

Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYG--MKEKLK 205
           E+I   ++E+ +M  + +PN    L  + +   + +V+E    GSL  ++    M E   
Sbjct: 61  ELI---INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEA-- 115

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQW 264
                +IA    E L  L      ++IHRDIK+ N+LL  D   ++ DFG  A+  PEQ 
Sbjct: 116 -----QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170

Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              T+    GT  ++APE +       K D+++ G++ +E+V G
Sbjct: 171 KRSTMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 24/204 (11%)

Query: 117 LIGKGGYAEVYKGR----LRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNT 169
           ++G+G + +V+  R       GQL A+K L + T    D +      E  I+A V+HP  
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHPFI 60

Query: 170 AKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEG 226
            KL   +  EG ++++L+    G L + L   KE +  +  +++ +A  +A  L +LH  
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELALALDHLH-- 115

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFL 284
               II+RD+K  NILL E+   ++ DFGL+K    +   H        GT  Y+APE +
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++FGVL+ E++TG
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 59/191 (30%), Positives = 90/191 (47%), Gaps = 16/191 (8%)

Query: 134 GQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI--EGGMHIVLELSP 189
           G  VAIK  R      +   A F  E  + A + HPN   LL  G    G +  V E  P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFE 248
             +L  +L      L  G   ++ L V + L   H    + I+HRD+K  NI++++    
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVR 118

Query: 249 P--QICDFGLAKWLP--EQWTHHTISK---VEGTFGYLAPEFLMHGIVDEKTDVFAFGVL 301
           P  ++ DFG+   LP        T+++   V GT  Y APE L    V   +D++A+G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 302 LLELVTGRRAL 312
            LE +TG+R +
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 111 NFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+     G    G+L A+K L + T     +      +E  ++  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           V        L Y    +  +H++L+    G L + LY  +E        ++ + +AE +L
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIVL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            L    Q  II+RDIK  NILL  +    + DFGL+K    +      S   GT  Y+AP
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAP 175

Query: 282 EFLMHGIV--DEKTDVFAFGVLLLELVTG 308
           E +  G    D+  D ++ GVL  EL+TG
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 22/170 (12%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+ + +   +         
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P ++ NE   +
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIF-----------SLGASPYPGVQINEEFCQ 288

Query: 334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L D +   A E  T ++  ++LA   C Q     RP  S +V++L G+L
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLA---CWQGDPKERPTFSALVEIL-GDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 66/228 (28%), Positives = 102/228 (44%), Gaps = 25/228 (10%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD--FLSELGIMAHVDHPNTAKL- 172
           ++GKGG+ EV   ++R  G++ A KRL +    +   +   L+E  I+  V+      L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEGCQ 228
             Y  +  + +VL +   G L   +Y M      G   + AL  A     GL  LH   +
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLH---R 120

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
              ++RD+K  NILL +    +I D GLA  +PE     +I    GT GY+APE L +  
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNNQR 177

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
                D +  G L+ E++ G        QS     +  +KR E+   V
Sbjct: 178 YTLSPDYWGLGCLIYEMIEG--------QSPFRGRKEKVKREEVDRRV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F  ++L+G+G + EV   R +  G + A+K + +    A E ++ F  E  I++  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 167 PNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           P   +L  Y  +   ++  V+E  P G L SLL   +++    +       +AE +L +H
Sbjct: 61  PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIH 116

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              Q   +HRDIK  N+L+      ++ DFG A  L      ++   V GT  Y+APE L
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVL 175

Query: 285 ---------MHGIVDEKTDVFAFGVLLLELVTGR 309
                     +G+   + D ++ GV+  E++ GR
Sbjct: 176 TTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 16/209 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R      +G+L A+K L + T     +      +E  ++ H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           +        L Y    +  +H++L+    G L + L   +E+ K     ++ +   E +L
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK---EQEVQIYSGEIVL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            L    +  II+RDIK  NILL  +    + DFGL+K   E       S   GT  Y+AP
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYMAP 175

Query: 282 EFLMHGIV--DEKTDVFAFGVLLLELVTG 308
           + +  G    D+  D ++ GVL+ EL+TG
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 46/226 (20%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN---GQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           +  E  IG+G Y  VYK + +N   G+  AIK+    +     I      E+ ++  + H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI----RYKIALGVAE---- 218
            N   L+          V  L        LL+   E   W I    R    + +      
Sbjct: 62  ENVVSLVE---------VF-LEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 219 --------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAK--WLPEQW 264
                   G+ YLH      ++HRD+K ANIL+  +   +    I D GLA+    P + 
Sbjct: 112 SLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK- 167

Query: 265 THHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVT 307
               +  V  T  Y APE L+   H    +  D++A G +  EL+T
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F+F  ++GKG + +V     +   +L AIK L +     D+ +   + E  ++A  D P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 168 NTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYL 223
                L   +     ++ V+E    G L   +Y +++  K K       A  ++ GL +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPE 282
           H    R II+RD+K  N++L  +   +I DFG+ K  + +  T  T     GT  Y+APE
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC---GTPDYIAPE 171

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            + +    +  D +A+GVLL E++ G+   D
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 37/223 (16%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           LIGKGG  EVY        + VA+K++    ++   +   FL E  I A + HP    + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67

Query: 174 GYGIEGGMHIVLELSP---NGSLASLLYGM--KEKLKWGIRYKIALG--------VAEGL 220
            Y I      V    P     +L SLL  +  KE L   +  K ++G        +   +
Sbjct: 68  -YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------------PEQWTHH 267
            Y+H    + ++HRD+K  NILL    E  I D+G A +                   + 
Sbjct: 127 EYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 268 TIS---KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +++   K+ GT  Y+APE L+     E TD++A GV+L +++T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDH 166
           F    ++GKGG+ EV   ++R  G++ A K+L +        E +A  L+E  I+  V+ 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59

Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
                L   Y  +  + +VL +   G L   +Y M      G   + A+  A  L    E
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLE 116

Query: 226 GCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
             QR RI++RD+K  NILL +    +I D GLA  +PE     T+    GT GY+APE +
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVI 173

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
            +       D +  G L+ E++ G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 20/204 (9%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE +    L E+ ++  + H N  +L  Y
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--Y 65

Query: 176 GI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            +   +  + +V E   +  L          +   I       + +GL + H      ++
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVL 121

Query: 233 HRDIKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYLAPEFLMHG-I 288
           HRD+K  N+L+ ++ E ++ DFGLA+   +P   ++   +     T  Y  P+ L    +
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-----TLWYRPPDVLFGAKL 176

Query: 289 VDEKTDVFAFGVLLLELVTGRRAL 312
                D+++ G +  EL    R L
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 64/257 (24%), Positives = 116/257 (45%), Gaps = 29/257 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL--VAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           +F+F   +G G +  V     +N     VAIKR  +      + +    SE  I+ +++H
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV--AEGLLYL 223
           P    L G +  E  +++VLE    G   + L   K       R+   +G   A  ++ +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLI 143

Query: 224 HEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
            E  Q   I++RD+K  N+LL +D   ++ DFG AK +  +   +T+    GT  Y+APE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLC---GTPEYIAPE 198

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR--------PMIKRNEIRE 334
            L++    +  D +  G+ + E++ G     Y+ + L+++ +        P    N  + 
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPF-YANEPLLIYQKILEGIIYFPKFLDNNCKH 257

Query: 335 LVDASLADEYDTRQMNL 351
           L+   L+ +   R  NL
Sbjct: 258 LMKKLLSHDLTKRYGNL 274

Length = 340

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.6 bits (153), Expect = 8e-11
 Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 82/235 (34%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRL---------TRGTADEIIADFLSELGIMAHVDHP 167
           +GKG Y  V+K    R  ++VA+K++          + T  EI+  FL ELG     DHP
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM--FLQELG-----DHP 67

Query: 168 NTAKLLG---------------YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           N  KLL                Y +E  +H V+        A++L   ++  K  I Y++
Sbjct: 68  NIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-------ANIL---EDVHKRYIMYQL 116

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +     Y+H G    +IHRD+K +NILL  D   ++ DFGLA+         ++S++
Sbjct: 117 LKALK----YIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR---------SLSEL 160

Query: 273 EGTFG------------YLAPEFLM------HGIVDEKTDVFAFGVLLLELVTGR 309
           E                Y APE L+       G+     D+++ G +L E++ G+
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)

Query: 118 IGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H N   LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 176 -----GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
                 ++      L +   G+    L   ++  +  I++ +   + +GL Y+H      
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-LVYQMLKGLKYIHAA---G 138

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYLAPEFLMHG 287
           IIHRD+K  N+ + ED E +I DFGLA+         T S++ G   T  Y APE +++ 
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVVTRWYRAPEVILNW 190

Query: 288 IVDEKT-DVFAFGVLLLELVTGR 309
           +   +T D+++ G ++ E++TG+
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 62.1 bits (151), Expect = 8e-11
 Identities = 49/187 (26%), Positives = 95/187 (50%), Gaps = 27/187 (14%)

Query: 132 RNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELS 188
             G+ VA+K+  L +    E++    +E+ IM    HPN  ++   Y +   + +V+E  
Sbjct: 42  STGRQVAVKKMDLRKQQRRELL---FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98

Query: 189 PNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
             G+L  ++   +   E++       + L V + L +LH    + +IHRDIK+ +ILLT 
Sbjct: 99  EGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTS 150

Query: 246 DFEPQICDFG----LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVL 301
           D   ++ DFG    ++K +P +        + GT  ++APE +       + D+++ G++
Sbjct: 151 DGRVKLSDFGFCAQVSKEVPRR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204

Query: 302 LLELVTG 308
           ++E+V G
Sbjct: 205 VIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 21/208 (10%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F+ L  +G+G YA VYKGR R  G++VA+K +     +   +  + E+ +M  + H N 
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 170 AKLLGYGI---EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLH 224
            +L  + +   E  + +V E   +  L   +  +G++  L           + +G+ + H
Sbjct: 61  VRL--HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPE 282
           E    R++HRD+K  N+L+ +  E ++ DFGLA+   +P     +T S    T  Y AP+
Sbjct: 118 E---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTLWYRAPD 170

Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTGR 309
            L+         D+++ G ++ E++TGR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)

Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 137

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 138 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 189

Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 39/211 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYK R    G++VA+K++   T DE + +  + E+ ++  ++HPN  +LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 176 GIEGG-MHIVLEL-----------SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
                 +++V E            SP   L   L  +K  L     Y++  G+A    Y 
Sbjct: 67  VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSYL-----YQLLQGIA----YC 115

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+   +P   +TH  +     T  Y A
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 167

Query: 281 PEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
           PE L+ G     T  D+++ G +  E+V  R
Sbjct: 168 PEILL-GSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 16/200 (8%)

Query: 117 LIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++  D P   
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 171 KL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            +   +     +  +L+L   G L   L       +  +R+  A  +  GL ++H    R
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMH---NR 116

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
            +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE L  G  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTA 172

Query: 290 -DEKTDVFAFGVLLLELVTG 308
            D   D F+ G +L +L+ G
Sbjct: 173 YDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA-----DFLSELGIMAHV 164
           +F     +G G +  V   + +  G+  AIK L +    EI+          E  I+  +
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---REILKMKQVQHVAQEKSILMEL 75

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG---VAEGL 220
            HP    ++  +  E  ++ +LE    G L +        L+   R+   +     AE +
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFT-------HLRKAGRFPNDVAKFYHAELV 128

Query: 221 L---YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           L   YLH    + II+RD+K  N+LL      ++ DFG AK +P++    T+    GT  
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--TFTLC---GTPE 180

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           YLAPE +      +  D +  GVLL E + G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 39/210 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIM---AHVDHPNTAKL 172
           IG G Y  VYK R   +G  VA+K +   T ++ +    + E+ ++      DHPN  +L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 173 LGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           +                    ++  +   L+  P   L      +K+ ++  +R      
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLP--AETIKDLMRQFLR------ 119

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              GL +LH  C   I+HRD+K  NIL+T   + ++ DFGLA+          ++ V  T
Sbjct: 120 ---GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVT 170

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
             Y APE L+        D+++ G +  E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 117 LIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNT 169
           ++GKGGY +V++ R       G++ A+K L + T     +  A   +E  I+  V HP  
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 170 AKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L+  +   G ++++LE    G L   L    E+    +       ++E  L L    Q
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHL----EREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + II+RD+K  NILL      ++ DFGL K  + E    HT     GT  Y+APE LM  
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEILMRS 175

Query: 288 IVDEKTDVFAFGVLLLELVTG 308
              +  D ++ G L+ +++TG
Sbjct: 176 GHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRL-----TRGTADEIIADFLSELGIMAHV 164
           N+    L+G+G +  VY       G+ +A+K++     +  T+ E+ A    E+ ++ ++
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNL 61

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEG 219
            H    +  G     +E  + I +E  P GS+   L  YG    L   +  K    + EG
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEG 118

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
           + YLH      I+HRDIK ANIL       ++ DFG +K L       T +  V GT  +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           ++PE +       K D+++ G  ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 68/278 (24%), Positives = 127/278 (45%), Gaps = 24/278 (8%)

Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ ++    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 10  LDFPALRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 69

Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 70  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 126

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 127 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181

Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH----GIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + ++      + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240

Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           + G     Y+   +  +++ M  +N +    D  ++ E
Sbjct: 241 LVGDTPF-YADSLVGTYSKIMNHKNSLTFPDDNDISKE 277

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 16/206 (7%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
           TN +     +G G +  V   R    GQ VAIK++ +  +  ++A     EL ++ H+ H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 167 PNTAKLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
            N   L    I     ++ V EL     L  LL     + ++ I+Y     +  GL Y+H
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQF-IQY-FLYQILRGLKYVH 125

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE-F 283
                 ++HRD+K +NIL+ E+ + +ICDFGLA+    Q T +  ++      Y APE  
Sbjct: 126 SA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIM 177

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGR 309
           L     D + D+++ G +  E++ G+
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 25/201 (12%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNTAKLL 173
           +G+GGY +V+  + ++ G++VA+KR+ +      +E+    L+E  I+         KLL
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-RHVLTERDILTTTKSEWLVKLL 67

Query: 174 GYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE-GCQRR 230
            Y  +   ++ L  E  P G   +LL  +    +   R+ +A    E +  LHE G    
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF-EAVDALHELG---- 121

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG---YLAPEFLMHG 287
            IHRD+K  N L+      ++ DFGL+K          ++      G   Y+APE L   
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGK 173

Query: 288 IVDEKTDVFAFGVLLLELVTG 308
             D   D ++ G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           GL ++H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 161

Query: 279 LAPEFLMHGIV-DEKTDVFAFGVLLLELVTG 308
           +APE L  G+  D   D F+ G +L +L+ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 23/208 (11%)

Query: 114 FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHP 167
           ++NL  +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H 
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 168 NTAKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N   LL        IE    + L  +  G+  + +   ++     +++ I   +  GL Y
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV-----ATRWYRAPE 185

Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+ G+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 22/170 (12%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+ + +   +         
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCR 293

Query: 334 ELVDASL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 40/98 (40%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWTHHTISKVEGTFG 277
           GL YLH      I+HRDIK  N+L+  +   +ICDFGLA    P++  H T   V  T  
Sbjct: 115 GLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQY 169

Query: 278 YLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRAL 312
           Y APE LM   H       D+++ G +  EL+ GRR L
Sbjct: 170 YRAPEILMGSRH--YTSAVDIWSVGCIFAELL-GRRIL 204

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 39/241 (16%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQ-----------------LVAIKRLTRGTADEIIADFLS 156
           F+  +G+G + EV+   + N Q                 LVA+K L          DFL 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 157 ELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWG------ 207
           E+ I++ +  PN  +LLG  + E  + ++ E   NG L   L  + + +K + G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 208 ------IRYK----IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                 I Y     +AL +A G+ YL        +HRD+   N L+ E+   +I DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQ 317
           + L     +    +      ++A E ++ G     +DV+AFGV L E++   +   Y + 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 318 S 318
           +
Sbjct: 246 T 246

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 46/219 (21%)

Query: 118 IGKGGYAEVYKGRLRNGQLVA---IKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G + +V  G    G   A   +K L      +    FL E+     ++HPN  + LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALGVAEGLLYLHEGCQR 229
             IE     +VLE  P G L + L   +  +       +  ++A  VA GLL+LH   Q 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA--------------KWLPEQWTHHTISKVEGT 275
             IH D+   N  LT D   +I D+GLA                +P +W           
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL---------- 169

Query: 276 FGYLAPEF-------LMHGIVDEKTDVFAFGVLLLELVT 307
               APE        L+     +K+++++ GV + EL T
Sbjct: 170 ----APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 17/211 (8%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG--QLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
           +F+F  ++GKG + +V     R G  +L AIK L +     D+ +   + E  ++A    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLY 222
           P     L   +     ++ V+E    G L   +Y +++  ++   + +  A  +A GL +
Sbjct: 60  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFF 116

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH    + II+RD+K  N++L  +   +I DFG+ K     W   T     GT  Y+APE
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPE 171

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            + +    +  D +AFGVLL E++ G+   +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 31/218 (14%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHP 167
           F     IG+G Y +VYK R ++ G+LVA+K++      E   I A  + E+ I+  ++H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIKILRQLNHR 66

Query: 168 NTAKLLGYGIE-----------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
           N   L     +           G  ++V E   +  +  L  G+    +  I+      +
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-SFMKQL 125

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGT 275
            EGL Y H   ++  +HRDIK +NILL    + ++ DFGLA+ +  E+   +T +KV  T
Sbjct: 126 LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT-NKVI-T 180

Query: 276 FGYLAPEFLMHGIVDEK----TDVFAFGVLLLELVTGR 309
             Y  PE L+    +E+     DV++ G +L EL T +
Sbjct: 181 LWYRPPELLLG---EERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 12/135 (8%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTF 276
           GL Y+H      ++HRD+K AN+ + TED   +I DFGLA+ +   ++H   +S+   T 
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 277 GYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGRR----ALDYSQQSLVLWARPMIKRNE 331
            Y +P  L+      K  D++A G +  E++TG+     A +  Q  L+L + P+++  +
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 332 IREL--VDASLADEY 344
             EL  V  S     
Sbjct: 243 RNELLNVIPSFVRND 257

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 14/197 (7%)

Query: 118 IGKGGYAEVYKGRLRNGQLV-AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKL-L 173
           IGKG + +V + R R+ Q + A+K + +    +   +   L+E  ++A V+ P    L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++VL     G L    + ++ + ++ +  +     AE L  L    +  +I+
Sbjct: 61  SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDL-SRARFYTAELLCALENLHKFNVIY 116

Query: 234 RDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLM-HGIVDE 291
           RD+K  NILL       +CDFGL K  + +    +T     GT  YLAPE L+ HG   +
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHGYT-K 172

Query: 292 KTDVFAFGVLLLELVTG 308
             D +  GVLL E++TG
Sbjct: 173 AVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 42/220 (19%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
           N F    ++G+G Y  V K R +   ++VAIK+      +E + +  L EL ++  +   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 168 NTAKL-------------LGYGIEGGMHIVLELSPNGSLA----SLLYGMKEKLKWGIRY 210
           N  +L               Y +E  M  +LE  PNG       S +Y + + + W    
Sbjct: 61  NIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW---- 115

Query: 211 KIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
                           C +  I+HRDIK  N+L++ +   ++CDFG A+ L E  ++   
Sbjct: 116 ----------------CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANY 158

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           ++   T  Y +PE L+     +  D+++ G +L EL  G+
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 21/206 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +      +G G +  V+  R R        +++AI  + R   ++ +    +E  ++  V
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH---NEKRVLKEV 58

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HP   +L      +  +++++E  P G L S L     +         A  +   L YL
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYL 117

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISKVEGTFGYLAPE 282
           H    + I++RD+K  NILL ++   ++ DFG AK L ++ WT      + GT  YLAPE
Sbjct: 118 H---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT------LCGTPEYLAPE 168

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            +     ++  D +A G+L+ E++ G
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 52/173 (30%), Positives = 88/173 (50%), Gaps = 22/173 (12%)

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           +  VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+ + +   +      
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE- 331
                ++APE +   +   ++DV++FGVLL E+            SL     P ++ +E 
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF-----------SLGASPYPGVQIDEE 284

Query: 332 -IRELVDASL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
             R L + +   A EY T ++  ++L    C   +   RP  S++V++L G+L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLD---CWHNNPEDRPTFSELVEIL-GDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 19/181 (10%)

Query: 135 QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL 193
           Q  A+K +    +   + D   E  ++A + HPN       +  +G ++IV+E    G L
Sbjct: 26  QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85

Query: 194 ASLLYGMKEKL-------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
              +   + KL       +W +  ++ LGV     ++HE   +R++HRDIK+ NI LT++
Sbjct: 86  MQKIKLQRGKLFPEDTILQWFV--QMCLGVQ----HIHE---KRVLHRDIKSKNIFLTQN 136

Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            + ++ DFG A+ L     +       GT  Y+ PE   +   + K+D+++ G +L EL 
Sbjct: 137 GKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194

Query: 307 T 307
           T
Sbjct: 195 T 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 15/192 (7%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           LVA+K L          DFL E+ IM+ + +PN  +LLG  +    + ++ E   NG L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 195 SLLYGMKEKLKWGIRYKI-----------ALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
             L   + +  +     I           A+ +A G+ YL        +HRD+   N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
              +  +I DFG+++ L     +    +      ++A E ++ G     +DV+AFGV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 304 ELVTGRRALDYS 315
           E+ T  +   YS
Sbjct: 223 EMFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL- 172
           L+GKG + +V   R + +G+  A+K L +    A + +A  L+E  ++ +  HP    L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +  +  +  V+E    G L    +  +E++    R +     +   L YLH G   +I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMHGIVD 290
           ++RD+K  N++L +D   +I DFGL K   E  T   T+    GT  YLAPE L      
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 291 EKTDVFAFGVLLLELVTGR 309
              D +  GV++ E++ GR
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 113 SFENL--IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           S+E L  +G+G YA VYKG+ + NG+LVA+K +     +      + E  ++  + H N 
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLA-----SLLYGMKEKLKWGIR---YKIAL-GVAEGL 220
             L         H ++      +L      + L    +K   G+     K+ L  +  GL
Sbjct: 66  VLL---------HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            Y+H   QR I+HRD+K  N+L+++  E ++ DFGLA+   +    HT S    T  Y  
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRP 171

Query: 281 PEFLMHGIVDEKT--DVFAFGVLLLELVTGRRAL 312
           P+ L+ G  +  T  D++  G + +E++ G  A 
Sbjct: 172 PDVLL-GSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R   G    +L A+K L +       + +    +E  ++ H
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           V        L Y    E  +H++L+    G + + LY      +  +R+       E +L
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY----SGEIIL 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            L    +  I++RDIK  NILL  +    + DFGL+K    +    T S   GT  Y+AP
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC-GTIEYMAP 175

Query: 282 EFLM----HGIVDEKTDVFAFGVLLLELVTG 308
           E +     HG   +  D ++ G+L+ EL+TG
Sbjct: 176 EIIRGKGGHG---KAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 20/198 (10%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V    +++ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 84

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            Y +   + +V+E    G+L  ++   +   E++       + L V + L  LH    + 
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQG 136

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           +IHRDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +      
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYG 194

Query: 291 EKTDVFAFGVLLLELVTG 308
            + D+++ G++++E+V G
Sbjct: 195 PEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +N   +  +G+G + +V+     N        LVA+K L +  +D    DF  E  ++ +
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTN 63

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG-------MKE-----KLKWGIRY 210
           + H +  K  G  +EG  + +V E   +G L   L         M E     +L      
Sbjct: 64  LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
            IA  +A G++YL     +  +HRD+   N L+ E+   +I DFG+++ +     +    
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 180

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                  ++ PE +M+     ++DV++ GV+L E+ T
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 17/195 (8%)

Query: 143 TRGT--ADEIIADFL------------SELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL 187
           TRG+   ++++A F+            SEL  +A  DH    K    +  +  + +++E 
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 188 SPNGSL-ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
              G L   +   +KE L +   Y++ L   + +L L E   R+++HRD+K+ANI L   
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQ-EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205

Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
              ++ DFG +K   +  +    S   GT  YLAPE        +K D+++ GV+L EL+
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Query: 307 TGRRALDYSQQSLVL 321
           T  R      Q  ++
Sbjct: 266 TLHRPFKGPSQREIM 280

Length = 478

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)

Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IGKG + +VY+ R ++  ++ A+K L++    A + +A  + E  I+       +  ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 175 ----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
               +  +  +++V +    G L    + ++++ ++    +    +AE +L L    +  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFS-EDRAKFYIAELVLALEHLHKYD 116

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           I++RD+K  NILL       +CDFGL+K       + T +   GT  YLAPE L+    D
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL----D 170

Query: 291 EK-----TDVFAFGVLLLELVTG 308
           EK      D ++ GVL+ E+  G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIM-AHVDHPNTAKL 172
           +IG+G YA+V    L+   ++ A+K + +     DE I    +E  +     +HP    L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAEGLLYLHEGCQR 229
              +  E  +  V+E    G L   ++ M+ + K    +    +  ++  L +LHE   R
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHE---R 115

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
            II+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L     
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 290 DEKTDVFAFGVLLLELVTGRRALD 313
               D +A GVL+ E++ GR   D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 66/232 (28%), Positives = 96/232 (41%), Gaps = 39/232 (16%)

Query: 111 NFSFENLIGKGGYAEV----YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHV- 164
            +     +G+G Y  V            + VAIK++T   + +I+A   L EL ++ H  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAE---- 218
            H N   L        M IV   + N      LY   M+  L   IR    L  A     
Sbjct: 60  GHKNITCLYD------MDIVFPGNFNELY---LYEELMEADLHQIIRSGQPLTDAHFQSF 110

Query: 219 ------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTI 269
                 GL Y+H      ++HRD+K  N+L+  D E +ICDFGLA+     P +      
Sbjct: 111 IYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR---RALDYSQQ 317
             V  T  Y APE ++      K  DV++ G +L EL+  +   +  DY  Q
Sbjct: 168 EYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 19/206 (9%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL 173
           +IG+G YA+V   RL+ N Q+ A+K + +     DE I    +E  +       +   L+
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS--SNPFLV 59

Query: 174 G----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK--IALGVAEGLLYLHEGC 227
           G    +     + +V+E    G L   ++ M+ + K    +    A  +   L +LHE  
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE-- 114

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
            R II+RD+K  N+LL  D   ++ D+G+ K         T S   GT  Y+APE L   
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 288 IVDEKTDVFAFGVLLLELVTGRRALD 313
                 D +A GVL+ E++ GR   D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 21/201 (10%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMA-------HVDHPNT 169
           IGKG + +V   + + +G+  A+K L +    + I     +  IMA       +V HP  
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQK----KAILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 170 AKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L   +     ++ VL+    G L   L   +   +   R+  A  +A  L YLH    
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TISKVEGTFGYLAPEFLMHG 287
             II+RD+K  NILL       + DFGL K   E   H  T S   GT  YLAPE L   
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 288 IVDEKTDVFAFGVLLLELVTG 308
             D   D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKL 172
           ++GKG + +V+   L+   Q  AIK L +      D++    + +  +    +HP    L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYLHEGCQR 229
              +  +  +  V+E    G L   ++ ++   K+ +      A  +  GL +LH    +
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
            I++RD+K  NILL  D   +I DFG+ K   L +  T        GT  Y+APE L+  
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----CTFCGTPDYIAPEILLGQ 171

Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
             +   D ++FGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 19/205 (9%)

Query: 117 LIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           L+G+G +  VY       GR    + V     +  T+ E+ A    E+ ++ ++ H    
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERIV 67

Query: 171 KLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           +  G      E  + I +E  P GS+   L  YG    L   +  K    + EG+ YLH 
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH- 123

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGYLAPEFL 284
                I+HRDIK ANIL       ++ DFG +K L       T I  V GT  +++PE +
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
                  K DV++ G  ++E++T +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           GL +LH   ++ II+RD+K  N+LL +D   +I DFG+ K           S   GT  Y
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDY 162

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           +APE L     +E  D ++FGVLL E++ G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           L E  ++ +V+HP+  ++    + G +  ++    +  L + L      L       I  
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC--DFGLAKW---LPEQWTHHTI 269
            + EGL YLH    +RIIHRD+K  NI +  +   Q+C  D G A++    P        
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVAPAFL----- 214

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
             + GT    APE L     + K D+++ G++L E++
Sbjct: 215 -GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 11/202 (5%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKL 172
           +IG+G YA+V   RL+   ++ A+K + +     DE I    +E  +     +HP    L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 173 LG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE   R I
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGI 117

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           I+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L       
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175

Query: 292 KTDVFAFGVLLLELVTGRRALD 313
             D +A GVL+ E++ GR   D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 45/225 (20%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKL--- 172
           IG+G Y  V   +     + VAIK++     + I A   L E+ ++ H+DH N   +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 173 ---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----------VAEG 219
                      ++IV EL            M   L   IR    L           +  G
Sbjct: 73  MPPPHREAFNDVYIVYEL------------MDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           L Y+H      ++HRD+K +N+LL  + + +ICDFGLA+          +++   T  Y 
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYR 175

Query: 280 APEFLMHGIVDEKT---DVFAFGVLLLELVTGRRAL----DYSQQ 317
           APE L++    E T   DV++ G +  EL+ GR+ L    DY  Q
Sbjct: 176 APELLLN--CSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQ 217

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 33/207 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY- 175
           +G+G YA V+KGR +    LVA+K +     +      + E+ ++ ++ H N   L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 176 GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             E  + +V E         L   G+L S+ + +K  +   +R         GL Y H+ 
Sbjct: 73  HTERCLTLVFEYLDSDLKQYLDNCGNLMSM-HNVKIFMFQLLR---------GLSYCHK- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGL--AKWLPEQWTHHTISKVEGTFGYLAPEFL 284
             R+I+HRD+K  N+L+ E  E ++ DFGL  AK +P +    T S    T  Y  P+ L
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDVL 175

Query: 285 MHGIVDEKT--DVFAFGVLLLELVTGR 309
           + G  +  T  D++  G +L E+ TGR
Sbjct: 176 L-GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 20/158 (12%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           G+ Y+H   QRRI+HRD+KA NI L  +   +I DFG+++ L    +    +   GT  Y
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYY 171

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-YSQQSLVLWARPMIKRNEIRELVD 337
           ++PE L H   D K+D+++ G +L E+     A +  +  S+VL          I E   
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL---------RIVEGPT 222

Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
            SL + Y +RQ+N ++ +    + +    RP  +++++
Sbjct: 223 PSLPETY-SRQLNSIMQSM---LNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 17/223 (7%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN-TAKL 172
           L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  HP  TA  
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH    R +
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---SRDV 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TISKVEGTFGYLAPEFLMHGIVD 290
           ++RDIK  N++L +D   +I DFGL K   E  +   T+    GT  YLAPE L      
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 291 EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
              D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 19/209 (9%)

Query: 111 NFSFENLIGKGGYAEVY------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N+    L+G+G + EVY       GR    + V     ++ T+ E+ A    E+ ++ ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNL 61

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEG 219
            H    +  G      E  + I +E  P GS+   L  YG    L   +  +    + +G
Sbjct: 62  RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQG 118

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
           + YLH      I+HRDIK ANIL       ++ DFG +K +       T I  V GT  +
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           ++PE +       K DV++    ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKL 172
           ++GKG + +V    L+  G+  A+K L +      D++    + +  +    ++P    L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE---GLLYLHEGCQ 228
              +  +  +  V+E    G L   ++ +++K ++ + Y+     AE   GL +LH    
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDL-YRATFYAAEIVCGLQFLH---S 114

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + II+RD+K  N++L  D   +I DFG+ K     +  +  S   GT  Y+APE L    
Sbjct: 115 KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
                D ++FGVLL E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 65/234 (27%), Positives = 95/234 (40%), Gaps = 53/234 (22%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTA 170
           L+GKG    V+  RL+  G+L A+K L +    E+I        L+E  I+A +DHP   
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDK---KEMIKRNKVKRVLTEQEILATLDHPFLP 64

Query: 171 KLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLH-E 225
            L     +   ++  V++  P G L  LL     K   +   R+  A  +   L YLH  
Sbjct: 65  TLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLL 122

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------------------PEQWTH 266
           G    I++RD+K  NILL E     + DF L+K                           
Sbjct: 123 G----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 267 HTISKVE--------GTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGR 309
            T S+          GT  Y+APE +    HG      D +  G+LL E++ G 
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG---SAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 8e-09
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIM--AHVDHPN 168
           ++GKG + +V   RL+ +G+L A+K L +   D I+ D      ++E  I+  A  +HP 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKK---DVILQDDDVECTMTEKRILSLAR-NHPF 57

Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEG 226
             +L   +     +  V+E    G L  + +  K +     R +  A  +   L++LH+ 
Sbjct: 58  LTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHD- 114

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + II+RD+K  N+LL  +   ++ DFG+ K     +   T S   GT  Y+APE L  
Sbjct: 115 --KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
            +     D +A GVLL E++ G
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 47/203 (23%), Positives = 82/203 (40%), Gaps = 47/203 (23%)

Query: 133 NGQLVAIKRLTRGTADEIIADFL-SELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPN 190
              LVA+K++   +  +     L  E+     + HPN    +   I    +++V  L   
Sbjct: 24  TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83

Query: 191 GSLASLL-----YGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRDIKAANILLT 244
           GS   LL      G+ E     I + I   V   L Y+H +G     IHR +KA++ILL+
Sbjct: 84  GSCEDLLKTHFPEGLPELA---IAF-ILKDVLNALDYIHSKGF----IHRSVKASHILLS 135

Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTF----------------GYLAPEFL---M 285
            D +  +               +++S ++                    +L+PE L   +
Sbjct: 136 GDGKVVLSGL-----------RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 286 HGIVDEKTDVFAFGVLLLELVTG 308
            G  +EK+D+++ G+   EL  G
Sbjct: 185 QG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 28/203 (13%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTR--GTADEIIADFLSELGIMAHV-DHPNTAKLL 173
           IG+G ++EV K +  + G+  AIK + +   + +++    L E+  +  +  HPN  +L+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 174 GYGIE---GGMHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHE 225
               +   G + +V EL  + +L  L+ G K     +++K  + Y++       L ++H 
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYM-YQLLKS----LDHMH- 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE-FL 284
             +  I HRDIK  NIL+ +D   ++ DFG  + +   ++    ++   T  Y APE  L
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCRGI---YSKPPYTEYISTRWYRAPECLL 171

Query: 285 MHGIVDEKTDVFAFGVLLLELVT 307
             G    K D++A G +  E+++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 33/207 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY- 175
           +G+G YA VYKGR +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 176 GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             E  + +V E         L   G+  ++ + +K  L   +R         GL Y H  
Sbjct: 74  HTEKSLTLVFEYLDKDLKQYLDDCGNSINM-HNVKLFLFQLLR---------GLNYCH-- 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGL--AKWLPEQWTHHTISKVEGTFGYLAPEFL 284
            +R+++HRD+K  N+L+ E  E ++ DFGL  AK +P +    T S    T  Y  P+ L
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----TYSNEVVTLWYRPPDIL 176

Query: 285 MHGIVDEKT--DVFAFGVLLLELVTGR 309
           + G  D  T  D++  G +  E+ TGR
Sbjct: 177 L-GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 156 SELGIMAHV---DHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           + +  M H    D+PN  KL        G  ++++   +G L  LL   + KL      K
Sbjct: 55  NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKK 113

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTI 269
           I   + E L  LH   +  IIH DIK  N+L     + +I  CD+GL K         T 
Sbjct: 114 IIRQLVEALNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCK------IIGTP 163

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           S  +GT  Y +PE +     D   D +A GVL  EL+TG
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 17/223 (7%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL- 172
           L+GKG + +V   R    G+  A+K L +    A + +A  L+E  ++ +  HP    L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH      +
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDV 116

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMHGIVD 290
           ++RD+K  N++L +D   +I DFGL K   E  +   T+    GT  YLAPE L      
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 291 EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
              D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE--LILMEEIR 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 14/194 (7%)

Query: 136 LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           LVA+K L          DFL E+ IM+ +  PN  +LL   I    + ++ E   NG L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 195 SLLYGMKEK----------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
             L   + +          + +     +A  +A G+ YL        +HRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE 304
           +++  +I DFG+++ L     +    +      +++ E ++ G     +DV+AFGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224

Query: 305 LVTGRRALDYSQQS 318
           ++T  +   YSQ S
Sbjct: 225 ILTLCKEQPYSQLS 238

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 47/183 (25%), Positives = 91/183 (49%), Gaps = 21/183 (11%)

Query: 133 NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
            G+ VA+K+  L +    E++    +E+ IM    H N   +   Y +   + +V+E   
Sbjct: 46  TGKQVAVKKMDLRKQQRRELL---FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102

Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G+L  ++     ++       + L V   L YLH    + +IHRDIK+ +ILLT D   
Sbjct: 103 GGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 157

Query: 250 QICDFG----LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    ++K +P++        + GT  ++APE +       + D+++ G++++E+
Sbjct: 158 KLSDFGFCAQVSKEVPKR------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211

Query: 306 VTG 308
           + G
Sbjct: 212 IDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 13/166 (7%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA+ +     +         
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL 335
             ++APE + + +   ++DV+++G+LL E+ +   +  Y    +      MIK       
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS-PYPGMPVDSKFYKMIKEGYRMLS 338

Query: 336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            + + ++ YD  +          C     ++RP   Q+VQL+   L
Sbjct: 339 PECAPSEMYDIMKS---------CWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 25/216 (11%)

Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + + + HP
Sbjct: 9   FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68

Query: 168 NTAKLLGYGI-EGGMHIVLELSPNGSLASLLY---------------GMKEKLKWGIRYK 211
           N   LLG    E  + ++     +  L   L                 +K  L+      
Sbjct: 69  NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           I   +A G+ +L       ++H+D+   N+L+ +    +I D GL + +     +  +  
Sbjct: 129 IVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                 +++PE +M+G     +D++++GV+L E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 52/259 (20%), Positives = 96/259 (37%), Gaps = 42/259 (16%)

Query: 118 IGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +G+G +  +YKG LR          GQ V++     G+       F     +M+ + H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL G  +     +V E    G L   L+  K  +    +  +A  +A  L YL +   
Sbjct: 63  LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED--- 119

Query: 229 RRIIHRDIKAANILLTE---DFEPQIC----DFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           ++++H ++   NIL+     +          D G+        T  +  +      ++AP
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPWIAP 173

Query: 282 EFLMHGIV--DEKTDVFAFGVLLLELVTG-----------RRALDYSQQSLVLWARPMIK 328
           E + +G        D ++FG  LLE+ +             +   Y  Q  +    PM  
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRL----PMPD 229

Query: 329 RNEIRELVDASLADEYDTR 347
             E+  L++     +   R
Sbjct: 230 CAELANLINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 12/95 (12%)

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL--AKWLPEQWTHHTISKVEGTF 276
           GL Y H   QRR++HRD+K  N+L++E  E ++ DFGL  AK +P      T S    T 
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS----KTYSNEVVTL 167

Query: 277 GYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
            Y  P+ L+ G  +  T  D++  G +  E+ TGR
Sbjct: 168 WYRPPDVLL-GSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 19/201 (9%)

Query: 117 LIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMA-------HVDHPN 168
           +IGKG + +V    R  +G+  A+K L +    +I+ +   +  IMA       +V HP 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQK----KIVLNRKEQKHIMAERNVLLKNVKHPF 57

Query: 169 TAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   +     ++ VL+    G L   L   +   +   R+  A  +A  L YLH   
Sbjct: 58  LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              I++RD+K  NILL       + DFGL K    Q    T +   GT  YLAPE +   
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQ 171

Query: 288 IVDEKTDVFAFGVLLLELVTG 308
             D   D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71

Query: 172 LLGYGIEGG-MHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A +L G ++    +L  G    IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +     +    +     
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++ PE +++     ++D+++FGV+L E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN-TAKL 172
           L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  HP  TA  
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 173 LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEGCQRRI 231
             +     +  V+E +  G L    +  +E++    R +     +   L YLH   ++ +
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNV 117

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           ++RD+K  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE L      
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEVLEDNDYG 174

Query: 291 EKTDVFAFGVLLLELVTGR 309
              D +  GV++ E++ GR
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 9/95 (9%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA G+ +L     +  +HRD+ A N+L+ E    +ICDFGLA+ +     +  ISK   T
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISK-GST 301

Query: 276 F---GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           F    ++APE + + +    +DV++FG+LL E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 56/243 (23%)

Query: 113 SFENL--IGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV 164
            FE++  IG+G + EV   RL      G + A+K+L +      E +A   +E  I+A  
Sbjct: 2   DFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA 58

Query: 165 DHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLL 221
           D+P   KL   +  E  +++++E  P G + +LL  MK+    +   R+ IA    E +L
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFYIA----ETIL 112

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--------EQWTHHTISKVE 273
            +    +   IHRDIK  N+LL      ++ DFGL   L            +H   S   
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 274 ----------------------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
                                       GT  Y+APE  +    +++ D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232

Query: 306 VTG 308
           + G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.9 bits (127), Expect = 9e-08
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 39/215 (18%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDH-PNTAKLL 173
           IG+G Y +VYK R    G+LVA+K+ TR   DE  I    L E+ ++  +       +LL
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 174 GY------GIEGGMHIVLE---------LSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
                     +  +++V E         +  NG        +  K      Y++  GVA 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMYQLLKGVA- 124

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLP---EQWTHHTISKVEG 274
              + H   +  ++HRD+K  N+L+ +     +I D GL +      + +TH  +     
Sbjct: 125 ---HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----- 173

Query: 275 TFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTG 308
           T  Y APE L+         D+++ G +  E+   
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 61/247 (24%), Positives = 109/247 (44%), Gaps = 40/247 (16%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLT-RGTADEIIADFLSELGIMAH 163
           +S  N +     IG G + EV+  +  R  +    K ++ RG  +   +  + E+ +M  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68

Query: 164 VDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVA 217
           + H N  + +   +      ++I++E    G L+  +   Y M  K++      I   + 
Sbjct: 69  LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 218 EGLLYLH---EGCQ-RRIIHRDIKAANILLTEDFE-----------------PQICDFGL 256
             L Y H   +G    R++HRD+K  NI L+                      +I DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 257 AKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGR---- 309
           +K +  E   H  +    GT  Y +PE L+H     D+K+D++A G ++ EL +G+    
Sbjct: 189 SKNIGIESMAHSCV----GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244

Query: 310 RALDYSQ 316
           +A ++SQ
Sbjct: 245 KANNFSQ 251

Length = 1021

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 4/101 (3%)

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           I   V   + YLHE    RIIHRDIKA NI +    +  + DFG A + P     +    
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYG 242

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL 312
             GT    APE L         D+++ G++L E+ T   +L
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 48/179 (26%), Positives = 76/179 (42%), Gaps = 47/179 (26%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------------WLP 261
           VA+G+ +L     +  IHRD+ A N+LLT+    +ICDFGLA+               LP
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
            +W              +APE +   +   ++DV+++G+LL E+ +    L  S    +L
Sbjct: 278 VKW--------------MAPESIFDCVYTVQSDVWSYGILLWEIFS----LGKSPYPGIL 319

Query: 322 WAR---PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                  M+KR       D +  + Y   +M         C       RP  SQ+ QL+
Sbjct: 320 VNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM---------CWNLEPTERPTFSQISQLI 369

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 21/202 (10%)

Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMA-------HVDHPN 168
           +IGKG + +V   + + +G   A+K L + T    I     +  IMA       ++ HP 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT----ILKKKEQNHIMAERNVLLKNLKHPF 57

Query: 169 TAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLHEG 226
              L   +     ++ VL+    G L    +  +E+     R +  A  VA  + YLH  
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH-- 113

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
               II+RD+K  NILL       + DFGL K   E     T S   GT  YLAPE L  
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRK 170

Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
              D   D +  G +L E++ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 42/222 (18%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHP 167
           +  + +IGKG Y  V        G+ VAIK++      E ++D    L E+ ++  + HP
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRHP 59

Query: 168 NTAKLLGYGIEGGMHIVLELSPN--GSLASLLYGMKEKLKWGIR---------YKIAL-G 215
           +  ++         HI+L  S      +  +   M+  L   I+         ++  L  
Sbjct: 60  DIVEIK--------HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ 111

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL----PEQ--WTHHTI 269
           +   L Y+H      + HRD+K  NIL   D + +ICDFGLA+      P    WT +  
Sbjct: 112 LLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV- 167

Query: 270 SKVEGTFGYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGR 309
                T  Y APE             D+++ G +  E++TG+
Sbjct: 168 ----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 33/207 (15%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G YA V+KGR +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL---- 69

Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGI----------RYKIAL-GVAEGLLYLHE 225
                H ++    + SL  +   + + LK  +            KI L  +  GL Y H 
Sbjct: 70  -----HDIVH--TDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH- 121

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGL--AKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +R+++HRD+K  N+L+ E  E ++ DFGL  AK +P +    T S    T  Y  P+ 
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK----TYSNEVVTLWYRPPDV 175

Query: 284 LM-HGIVDEKTDVFAFGVLLLELVTGR 309
           L+       + D++  G +  E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 22/199 (11%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V   R + +G+ VA+K   L +    E++    +E+ IM    H N  ++  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHQNVVEMYK 85

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +++E    G+L  ++   + +L       +   V + L YLH    + +IH
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140

Query: 234 RDIKAANILLTEDFEPQICDFG----LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           RDIK+ +ILLT D   ++ DFG    ++K +P++        + GT  ++APE +     
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KSLVGTPYWMAPEVISRTPY 194

Query: 290 DEKTDVFAFGVLLLELVTG 308
             + D+++ G++++E+V G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 13/198 (6%)

Query: 117 LIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTADEIIAD--FLSELGIM-AHVDHPNTAKL 172
           +IGKG + +V   R +  +   A+K L +    +   +   +SE  ++  +V HP    L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 173 -LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              +     ++ VL+    G L   L   +  L+   R+  A  +A  L YLH      I
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TISKVEGTFGYLAPEFLMHGIVD 290
           ++RD+K  NILL       + DFGL K   E   H+ T S   GT  YLAPE L     D
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 291 EKTDVFAFGVLLLELVTG 308
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 19/211 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEII-----ADFLSELGIMAH 163
           ++F    +IG+G + EV   ++++ + + A+K L +    E++     A F  E  ++ +
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW---EMLKRAETACFREERNVLVN 57

Query: 164 VD-HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D    T     +  E  +++V++    G L +LL   +++L   +       +AE +L 
Sbjct: 58  GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYIAEMVLA 114

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H   Q   +HRDIK  N+LL  +   ++ DFG    + +  T  +   V GT  Y++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173

Query: 283 FLM-----HGIVDEKTDVFAFGVLLLELVTG 308
            L       G    + D ++ GV + E++ G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   + IG+G Y  V        G  VAIK+++           L E+ I+    H N 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 170 AKLLGYGIEGG------MHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGL 220
             +L             ++IV EL     L  L+       + +++ + Y+I      GL
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFL-YQIL----RGL 119

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGY 278
            Y+H      ++HRD+K +N+LL  + + +ICDFGLA+ + +    HT    E   T  Y
Sbjct: 120 KYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEYVATRWY 175

Query: 279 LAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
            APE +++     K  D+++ G +L E+++ R
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   T      DF  E  ++ ++ H +  K
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-KDFQREAELLTNLQHEHIVK 71

Query: 172 LLGYGIEGG-MHIVLELSPNGSLASLLYG---------------MKEKLKWGIRYKIALG 215
             G   +G  + +V E   +G L   L                  K +L       IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           +A G++YL     +  +HRD+   N L+  +   +I DFG+++ +     +         
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             ++ PE +M+     ++DV++FGV+L E+ T
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISK 271
           A  V   L++LH   +  +I+RD+K  NILL  +   ++ DFG+ K   E   +  T + 
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
             GT  Y+APE L         D +A GVL+ E++ G+
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 45/235 (19%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN 168
           FE+L  IG+G + EV   + ++ G + A+K L +      E +    +E  I+   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 169 TAKLLGYGIEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             K+  Y  +  +  ++++E  P G + +LL       +   ++ IA    E +L +   
Sbjct: 63  VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA----ETVLAIDSI 117

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL----------------PEQWTHHTIS 270
            Q   IHRDIK  N+LL      ++ DFGL   L                P  +T   ++
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 271 ---KVE--------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              K E              GT  Y+APE  M    ++  D ++ GV++ E++ G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 60/234 (25%), Positives = 100/234 (42%), Gaps = 43/234 (18%)

Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPN 168
           FE+L  IG+G + EV   + ++ G + A+K L +      E +A   +E  I+   D   
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             K+   +  +  +++++E  P G + +LL   K+ L           +AE +L +    
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-KKDTLS---EEATQFYIAETVLAIDAIH 118

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE--------QWTHHTIS--------- 270
           Q   IHRDIK  N+LL      ++ DFGL   L +          TH+  S         
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 271 --KVE--------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             K E              GT  Y+APE  M    ++  D ++ GV++ E++ G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
           +F    +IG+G + EV   +L+N  ++ A+K L +         A F  E  ++ + D+ 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHE 225
               L   +  E  +++V++    G L +LL   +++L   + R+ +A    E ++ +  
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA----EMVIAIDS 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
             Q   +HRDIK  NIL+  +   ++ DFG    L E  T  +   V GT  Y++PE L 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176

Query: 286 -----HGIVDEKTDVFAFGVLLLELVTG 308
                 G    + D ++ GV + E++ G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 22/182 (12%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLELS 188
           VA+K+L+R   ++  A     EL ++  V+H N   LL        +E    +++V+EL 
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 189 PNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
            + +L  +++     E++ + + Y++  G+     +LH      IIHRD+K +NI++  D
Sbjct: 109 -DANLCQVIHMELDHERMSY-LLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSD 159

Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
              +I DFGLA+      T+  ++    T  Y APE ++     E  D+++ G ++ ELV
Sbjct: 160 CTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Query: 307 TG 308
            G
Sbjct: 217 KG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 36/104 (34%), Positives = 47/104 (45%), Gaps = 9/104 (8%)

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           I   + E L YLH    R IIHRD+K  NI L E     + DFG A  L     H    +
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQ 243

Query: 272 VEGTFGYL---APEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL 312
             G  G L   +PE L       KTD+++ G++L E+      L
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 63/244 (25%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI----IADFLSELGIMAHVDHPNTAKL 172
           IG G + EV   R +    L A+K L +  AD +     A   +E  I+A  D+    KL
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRK--ADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 173 L-GYGIEGGMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
              +  +  ++ V++  P G + SLL  +   +E L    R+ IA  +   +  +H   +
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---K 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-------------------- 268
              IHRDIK  NIL+  D   ++ DFGL      +WTH +                    
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 269 --ISKVE---------------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
             I +                       GT  Y+APE L+     +  D ++ GV+L E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 306 VTGR 309
           + G+
Sbjct: 238 LVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 18/181 (9%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIE--GGMHIVLELS 188
           VAIK+L+R   ++  A     EL +M  V+H N   LL        +E    ++IV+EL 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
                  +   +  +    + Y++  G+     +LH      IIHRD+K +NI++  D  
Sbjct: 112 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCT 164

Query: 249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            +I DFGLA+      T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 165 LKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Query: 309 R 309
            
Sbjct: 222 G 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 46/217 (21%)

Query: 118 IGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G + +V  G + +G     V +K L    + +    FL E      + H N  + LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 175 YGIEGGMHI-VLELSPNGSLASLLYGMK--EKLKWGIR--YKIALGVAEGLLYLHEGCQR 229
              E   ++ V+E  P G L   L   +  E +        ++A  +A GLL+LH   + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLA--------------KWLPEQWTHHTISKVEGT 275
             IH D+   N LLT D   +I D+GL+               W+P +W           
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW----------- 168

Query: 276 FGYLAPEFL--MHG---IVDE--KTDVFAFGVLLLEL 305
              +APE +  +HG   +VD+  +++V++ GV + EL
Sbjct: 169 ---IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 27/92 (29%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA G+ +L     +  +HRD+ A N+LL +    +ICDFGLA+ +     + +       
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             ++APE +   +    +DV+++G+LL E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 59/217 (27%), Positives = 88/217 (40%), Gaps = 23/217 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F    LI  G Y  VY  R +   Q  A+K++ +        I     E  I+   ++
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 167 PNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           P    +     E   H+  V+E    G  A+LL  +        R   A  V   L YLH
Sbjct: 61  PFVVSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH 118

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----LPEQWTHHTISK--------- 271
                 I+HRD+K  N+L+T     ++ DFGL+K     L        I K         
Sbjct: 119 ---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           V GT  Y+APE ++     +  D +A G++L E + G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 44/214 (20%)

Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  VYK R R   + +A+K++     DE + +  + E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL--Q 67

Query: 176 GI---EGGMHIVLEL-----------SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +   E  +++V E            SP+       +    +L     Y+I  G+A    
Sbjct: 68  DVVHSEKRLYLVFEYLDLDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIA---- 116

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAK--WLP-EQWTHHTISKVEGTFG 277
           Y H     R++HRD+K  N+L+       ++ DFGLA+   +P   +TH  +     T  
Sbjct: 117 YCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-----TLW 168

Query: 278 YLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
           Y APE L+ G     T  D+++ G +  E+V  +
Sbjct: 169 YRAPEILL-GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 59/242 (24%), Positives = 92/242 (38%), Gaps = 54/242 (22%)

Query: 112 FSFENL-IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F +E   +G+G Y  VYK + ++G+      L +     I      E+ ++  + HPN  
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 171 KL---------------LGYGIEGGMHIV------------LELSPNGSLASLLYGMKEK 203
            L                 Y      HI+            ++L P G + SLLY     
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL-PRGMVKSLLYQ---- 116

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT----EDFEPQICDFGLAKW 259
                       + +G+ YLH      ++HRD+K ANIL+     E    +I D G A+ 
Sbjct: 117 ------------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 260 LPEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGRRALDYSQQ 317
                     +  V  TF Y APE L+      K  D++A G +  EL+T        Q+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Query: 318 SL 319
            +
Sbjct: 222 DI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 48/178 (26%), Positives = 82/178 (46%), Gaps = 18/178 (10%)

Query: 137 VAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELS 188
           VAIK+L+R   ++  A     EL +M  V+H N   LL              +++V+EL 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE 248
                  +   +  +    + Y++  G+     +LH      IIHRD+K +NI++  D  
Sbjct: 105 DANLCQVIQMELDHERMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCT 157

Query: 249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            +I DFGLA+      T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 158 LKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK------RLTRGTADEIIADFLSELGIMA 162
           ++F    +IG+G + EV   +++N GQ+ A+K       L R       A F  E  ++ 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE----TACFREERDVLV 56

Query: 163 HVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGL 220
           + D      L   +  E  +++V++    G L +LL   +++L   + R+ +A    E +
Sbjct: 57  NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA----EMV 112

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           L +    Q   +HRDIK  N+LL ++   ++ DFG    L    T  +   V GT  Y++
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYIS 171

Query: 281 PEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
           PE L       G    + D ++ GV + E++ G
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 22/159 (13%)

Query: 110 NNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
            +F    +IGKG + EV    +   G++ A+K L  +     + +A   +E  ++A  D 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 167 PNTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAE 218
           P    L  Y  +    +++++E  P G L ++L          I+Y           +AE
Sbjct: 61  PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----------IKYDTFSEDVTRFYMAE 109

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
            +L +    +   IHRDIK  NIL+      ++ DFGL+
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 57/243 (23%)

Query: 118 IGKGGYAEV-YKGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL- 173
           +G G + EV    ++    L A+K L +        +A   +E  I+A  D+    KL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +  +  ++ V++  P G + SLL  M+   +   R+ IA    E  L +    +   IH
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA----ELTLAIESVHKMGFIH 124

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT------------------------- 268
           RDIK  NIL+  D   ++ DFGL      +WTH++                         
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGF--RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 269 ------ISKVE----------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
                 +  +E                GT  Y+APE L+     +  D ++ GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 307 TGR 309
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 58/242 (23%), Positives = 91/242 (37%), Gaps = 54/242 (22%)

Query: 112 FSFENL-IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F +E   +G+G Y  VYK + ++G+      L +     I      E+ ++  + HPN  
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVI 61

Query: 171 KL---------------LGYGIEGGMHIV------------LELSPNGSLASLLYGMKEK 203
            L                 Y      HI+            ++L P   + SLLY     
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL-PRSMVKSLLYQ---- 116

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT----EDFEPQICDFGLAKW 259
                       + +G+ YLH      ++HRD+K ANIL+     E    +I D G A+ 
Sbjct: 117 ------------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Query: 260 LPEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGRRALDYSQQ 317
                     +  V  TF Y APE L+      K  D++A G +  EL+T        Q+
Sbjct: 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Query: 318 SL 319
            +
Sbjct: 222 DI 223

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/194 (22%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 126 VYKGRLRNGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG--- 180
           +YKG   N + V I+   +       +I    +E+  +  +D  N  K+ G+ I+     
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 181 --MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA 238
             + ++LE    G L  +L   ++ L +  +  +A+   +GL  L++   +   ++++ +
Sbjct: 95  PRLSLILEYCTRGYLREVLD-KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151

Query: 239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT---DV 295
            + L+TE+++ +I   GL K L          K      Y + + L   I  E T   D+
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSS-----PPFKNVNFMVYFSYKMLND-IFSEYTIKDDI 205

Query: 296 FAFGVLLLELVTGR 309
           ++ GV+L E+ TG+
Sbjct: 206 YSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 42/196 (21%)

Query: 134 GQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY-----GIEGGMH--IVL 185
           GQ VAIK+L+R   +   A     EL +M  V+H N   LL        +E      +V+
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100

Query: 186 ELSP------------NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           EL              +  ++ LLY M   +K                +LH      IIH
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQMLCGIK----------------HLHSA---GIIH 141

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RD+K +NI++  D   +I DFGLA+      T   ++    T  Y APE ++     E  
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 198

Query: 294 DVFAFGVLLLELVTGR 309
           D+++ G ++ E++ G 
Sbjct: 199 DIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 63/246 (25%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL- 173
           +G G + EV   R +    L A+K L +        +A   +E  I+A  D+    +L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
            +  +  ++ V++  P G + SLL  M    E L    R+ IA    E    +    +  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA---RFYIA----ELTCAVESVHKMG 121

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT---------------------- 268
            IHRDIK  NIL+  D   ++ DFGL      +WTH +                      
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQSGDHVRQDSMDFSNEWGD 179

Query: 269 ---------ISKVE----------------GTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
                    +  +E                GT  Y+APE L+     +  D ++ GV+L 
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239

Query: 304 ELVTGR 309
           E++ G+
Sbjct: 240 EMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 61/214 (28%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 118 IGKG--GYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLL 173
           IG+G      VY  R    G LV ++        E     L    +++H   HPN     
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 174 GYGIEGG-MHIVLELSPNGSLASLLY-----GMKEKLKWGIRYKIALGVAEGLLYLHE-G 226
                G  + ++      GS  SLL      GM E L   I +    G   GL YLH+ G
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILF----GALRGLNYLHQNG 121

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--------GY 278
                IHR+IKA++IL++ D    +   GL+  L     +   +KV   F         +
Sbjct: 122 Y----IHRNIKASHILISGDGLVSLS--GLSH-LYSLVRNGQKAKVVYDFPQFSTSVLPW 174

Query: 279 LAPEFL---MHGIVDEKTDVFAFGVLLLELVTGR 309
           L+PE L   ++G  + K+D+++ G+   EL TGR
Sbjct: 175 LSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 37/223 (16%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +S   ++   N+IG G +  VY+   +   + VAIK++ +    +       EL IM ++
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-----RELLIMKNL 116

Query: 165 DHPNTAKLLGYGIEGG---------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           +H N   L  Y              +++V+E  P          + + +K   R   AL 
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ--------TVHKYMKHYARNNHALP 168

Query: 216 VAEGLLYLHEGCQ-------RRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHH 267
           +    LY ++ C+       + I HRD+K  N+L+  +    ++CDFG AK L       
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA--GQR 226

Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTG 308
           ++S +   F Y APE LM G  +  T  D+++ G ++ E++ G
Sbjct: 227 SVSYICSRF-YRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 18/156 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI----IADFLSELGIMAHVDH 166
           F     I +G + +VY GR +N  +L A+K + +  AD I    +    +E   +A    
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK--ADMINKNMVHQVQAERDALALSKS 63

Query: 167 PNTAKLLGYGIEGG--MHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLY 222
           P    L  Y ++    +++V+E    G + SLL  YG  ++ +  ++Y I+  VA  L Y
Sbjct: 64  PFIVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE-EMAVKY-IS-EVALALDY 119

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
           LH   +  IIHRD+K  N+L++ +   ++ DFGL+K
Sbjct: 120 LH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 17/202 (8%)

Query: 118 IGKGGYAEVYKGRLRNGQLVA---IKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G + +V    +     VA   +K L    + +   +FL +      + HPN  + LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVAEGLLYLHEGCQRR 230
             +E     +V E    G L S L   +   +     +  ++A  +A G+ ++H   +  
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL--MHG- 287
            +H D+   N  LT D   ++ D+G+     ++    T         +LAPE +   HG 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 288 -IVDEKT---DVFAFGVLLLEL 305
            I  E+T   +V+A GV L EL
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 30/212 (14%)

Query: 117 LIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMAHVDHPNTAKL 172
           +IG+G      V   R +  G+ V ++R+        +  FL  EL +    +HPN    
Sbjct: 5   VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 173 LGYGI-EGGMHIVLELSPNGSLASLLY-----GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
               I +  + +V      GS   L+      GM E     I Y I  GV + L Y+H  
Sbjct: 65  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSE---LAIAY-ILQGVLKALDYIH-- 118

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--------GY 278
                +HR +KA++IL++ D   ++   GL   L     H    +V   F         +
Sbjct: 119 -HMGYVHRSVKASHILISVD--GKVYLSGLRSNL-SMINHGQRLRVVHDFPKYSVKVLPW 174

Query: 279 LAPEFLMHGI--VDEKTDVFAFGVLLLELVTG 308
           L+PE L   +   D K+D+++ G+   EL  G
Sbjct: 175 LSPEVLQQNLQGYDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 4/86 (4%)

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           Y+H+   +++IHRDIK  NI L  D +  + DFG A    ++        V GT    +P
Sbjct: 282 YIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSP 337

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT 307
           E L      E TD+++ G++LL++++
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 35/98 (35%), Positives = 47/98 (47%), Gaps = 17/98 (17%)

Query: 216 VAEGLL----YLH-EGCQRRIIHRDIKAANILLT--EDFEPQIC--DFGLAKWLPEQWTH 266
           VA  LL    Y+H EG    IIHRDIK  N+L+   ED    IC  DFG A +    W+ 
Sbjct: 265 VARQLLSAIDYIHGEG----IIHRDIKTENVLVNGPED----ICLGDFGAACFARGSWST 316

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE 304
                + GT    APE L         D+++ G+++ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	408
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
smart00090	237	RIO RIO-like kinase.	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.32
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.15
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.94
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.91
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.77
PRK09902	216	hypothetical protein; Provisional	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.36
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.36
PLN02876	822	acyl-CoA dehydrogenase	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.2
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.12
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.09
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.93
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.83
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.76
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.73
PRK10593	297	hypothetical protein; Provisional	97.68
PRK05231	319	homoserine kinase; Provisional	97.67
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.64
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.6
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.49
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.37
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.32
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.1
PLN02756	418	S-methyl-5-thioribose kinase	97.02
PLN02236	344	choline kinase	96.85
KOG2270	520	consensus Serine/threonine protein kinase involved	96.73
PRK12396	409	5-methylribose kinase; Reviewed	96.7
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.54
PRK06148	1013	hypothetical protein; Provisional	96.48
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.36
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.32
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.3
COG2334	331	Putative homoserine kinase type II (protein kinase	96.24
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.75
PRK11768	325	serine/threonine protein kinase; Provisional	95.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.69
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.55
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.07
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.77
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	94.58

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-57  Score=436.93  Aligned_cols=284  Identities=51%  Similarity=0.855  Sum_probs=254.5

Q ss_pred             CccccCHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeE
Q 015389           96 PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY  175 (408)
Q Consensus        96 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  175 (408)
                      +.+.|++.++..||++|.-.+.||+|+||.||+|...+|..||||++....... ..+|.+|+.++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            677899999999999999999999999999999999989999999888766543 4569999999999999999999999


Q ss_pred             EEeCC--eEEEEEecCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          176 GIEGG--MHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       176 ~~~~~--~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                      |.+.+  .++|+||+++|+|.++|+.... .++|..+++|+.++|.||+|||+.|...||||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99865  7999999999999999988766 89999999999999999999999888899999999999999999999999


Q ss_pred             ecCCcccCCCCCccceeccc-ccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc----ccchhhhhcccc
Q 015389          253 DFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS----QQSLVLWARPMI  327 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~----~~~~~~~~~~~~  327 (408)
                      |||+|+..+.....  .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+..    ....+.|+.+.+
T Consensus       220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999876652111  1122 7999999999999999999999999999999999999998853    334788999999


Q ss_pred             ccchHHHHhhhhcc-CcccH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          328 KRNEIRELVDASLA-DEYDT-RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       328 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+..+.+++|+.+. +.+.. .....+..++.+|++.+|..||+|.||++.|+.+..
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            89999999999987 66664 688899999999999999999999999999966543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-51  Score=376.35  Aligned_cols=248  Identities=29%  Similarity=0.433  Sum_probs=211.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE-eCC-eEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGG-MHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~-~~lv~e~  187 (408)
                      +.+.++.||+|..|+||++.++ +++.+|+|++.....+...+++.+|+++++..+||+||++|+.+. ++. ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455689999999999999987 689999999977777778899999999999999999999999554 553 8999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      |++|+|.+++.. .+.+++....+|+.++++||.|||+.  ++||||||||+|||++..|+|||||||.+..+-..    
T Consensus       160 MDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999999854 47799999999999999999999963  89999999999999999999999999999987554    


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc---Ccc
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA---DEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~---~~~  344 (408)
                      ...++.||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.          ...+.++++..+.   +..
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----------~~~~~~Ll~~Iv~~ppP~l  302 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----------YLDIFELLCAIVDEPPPRL  302 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----------CCCHHHHHHHHhcCCCCCC
Confidence            445688999999999999999999999999999999999999999865221          1122333333332   222


Q ss_pred             cH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DT-RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +. ....++..|+..||+.||.+||++.|+++
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            23 36778999999999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-50  Score=388.63  Aligned_cols=245  Identities=28%  Similarity=0.444  Sum_probs=211.5

Q ss_pred             CCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      .+|...+.||+|||+.||.++. ..|+.||+|++.+..  .....+.+.+|++|.++|+|||||++++|+.+ .++|+|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999997 679999999998743  23456778899999999999999999998776 4689999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+|.+++|..++. .++.+++.++..++.||+.||.|||+   ++|||||||..|+||+++.+|||+|||||..+...  
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~--  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD--  171 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc--
Confidence            9999999999995 77889999999999999999999999   99999999999999999999999999999988643  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc-
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY-  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-  344 (408)
                      .....+.||||.|+|||++.....+..+||||+|||||.|+.|++||+...               +.+..+.....++ 
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~---------------vkety~~Ik~~~Y~  236 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT---------------VKETYNKIKLNEYS  236 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch---------------HHHHHHHHHhcCcc
Confidence            234467899999999999999999999999999999999999999998532               2222222222222 


Q ss_pred             -cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 -DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 -~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       +........+||.++|+.||.+|||+++|+.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             2245566788999999999999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-49  Score=383.20  Aligned_cols=257  Identities=31%  Similarity=0.488  Sum_probs=217.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC--eEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG--MHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--~~lv~e~  187 (408)
                      ...+.+.||.|+||+||+|.+.+...||||++..... .+..+.|.+|+.+|..++|||||+++|++.+..  +++||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3344567999999999999997544499999986543 233789999999999999999999999999875  8999999


Q ss_pred             cCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeeCCCCCceEECCCC-ceEEeecCCcccCCCCC
Q 015389          188 SPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQW  264 (408)
Q Consensus       188 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~  264 (408)
                      +++|+|..+++. .+..+++..++.++.+|+.||.|||+   ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            999999999987 47889999999999999999999999   77 99999999999999998 99999999998765432


Q ss_pred             ccceecccccCCCcccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THHTISKVEGTFGYLAPEFLM--HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                        ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||.......           ....++....+.
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-----------~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-----------VASAVVVGGLRP  265 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-----------HHHHHHhcCCCC
Confidence              2333467999999999999  5699999999999999999999999998654321           122333444555


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ..+..+...+..++.+||+.||..||++.+++..|+.+...
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            55556788899999999999999999999999999876643

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-51  Score=362.36  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=211.0

Q ss_pred             CCCCccceecccCcEEEEEEE-EcCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEe--EEEeCC-eEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLG--YGIEGG-MHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~-~~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~--~~~~~~-~~lv  184 (408)
                      .+|+++++||+|.||+||++. ..+|..||.|.+.-+.. ....+.+..|+.+|++|+|||||++++  |-.++. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999996 45899999999985443 345778899999999999999999998  334455 7899


Q ss_pred             EEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ||+|.+|+|..++..   .+..+++..+|+++.|++.||.++|+..+++ |+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999854   5667999999999999999999999855454 779999999999999999999999999998


Q ss_pred             CCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ....+  ......|||+||+||.+.+..|+.|+||||+||++|||+.-++||.+.+               ..++-....
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---------------~~~L~~KI~  241 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---------------LLSLCKKIE  241 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---------------HHHHHHHHH
Confidence            76422  3456789999999999999999999999999999999999999998642               112222222


Q ss_pred             cCcc----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          341 ADEY----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       341 ~~~~----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+++    ...+...+..++..|+..||..||+...+++.+..
T Consensus       242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            2233    25678899999999999999999996666665544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=366.23  Aligned_cols=274  Identities=23%  Similarity=0.318  Sum_probs=220.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv  184 (408)
                      .++|++.++||+|+||+||.++.+ +++.||+|++++...-  ...+....|..||..++||+||+++- |...+++|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            478999999999999999999865 5999999999876432  34788899999999999999999975 7788889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+.||.|..+|. ..+.+++..+.-++..|+.||.|||+   ++||||||||+|||||.+|+++|+|||+++..... 
T Consensus       104 ld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-  178 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-  178 (357)
T ss_pred             EeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC-
Confidence            99999999999994 46778999888899999999999999   99999999999999999999999999999854332 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc-
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE-  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-  343 (408)
                       .....+++||+.|||||++.+..|+..+|+|||||++|||++|.+||...+..               .+.+..+.+. 
T Consensus       179 -~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---------------~~~~~I~~~k~  242 (357)
T KOG0598|consen  179 -GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---------------KMYDKILKGKL  242 (357)
T ss_pred             -CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---------------HHHHHHhcCcC
Confidence             23445689999999999999999999999999999999999999999865422               2222222221 


Q ss_pred             --ccHHHHHHHHHHHHhccccCCCCCC----CHHHHHH--HHhcccCccccccccCCchhhhhhhHhh
Q 015389          344 --YDTRQMNLVLLAASLCIQQSSIRRP----QMSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLREEL  403 (408)
Q Consensus       344 --~~~~~~~~l~~li~~cl~~~P~~RP----t~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (408)
                        ++.-......+++...|..||.+|.    .+.+|-+  +++++.+..-..++..+||.....+.++
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~  310 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLED  310 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCccc
Confidence              2222456677899999999999996    4454433  4455555444555566666655554443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=364.03  Aligned_cols=201  Identities=31%  Similarity=0.540  Sum_probs=180.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ..+|.+.+.||.|+||+||+|+++ ++..||||.+.+.. ..+..+.+..|+.+|+.++|||||.+++++... .+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            368889999999999999999976 58999999998765 455678889999999999999999999987764 579999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC------CceEEeecCCccc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED------FEPQICDFGLAKW  259 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~------~~~kl~DfGla~~  259 (408)
                      |||.||+|.++++. .+.+++.....++.||+.||++||+   ++||||||||+||||+..      -.+||+|||+|+.
T Consensus        89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            99999999999954 5589999999999999999999999   999999999999999765      3589999999999


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ  316 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~  316 (408)
                      +..+   ....+.+|++.|||||+++.+.|+.|+|+||+|+|||+|++|+.||+...
T Consensus       165 L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  165 LQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             CCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            8743   34567899999999999999999999999999999999999999998543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-49  Score=367.46  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch------HHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD------EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~------~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-  180 (408)
                      .+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+....      .......+|++||++|+|||||++++|+.... 
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            356888899999999999999865 6999999999864321      12344679999999999999999999888755 


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCc
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLA  257 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla  257 (408)
                      .|+||||+.||+|.+.+.. .+.+.+..-..++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchh
Confidence            6999999999999999854 5667788888899999999999999   999999999999999766   78999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCC---CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV---DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      +..++   ...+.++|||+.|.|||++.++.+   ..++|+||+|||||.+++|.+||...-+..           .+.+
T Consensus       327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----------sl~e  392 (475)
T KOG0615|consen  327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----------SLKE  392 (475)
T ss_pred             hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------cHHH
Confidence            98763   345678999999999999987653   358899999999999999999998654331           1112


Q ss_pred             Hhhh-hc--cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 LVDA-SL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ~~d~-~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+.. ..  ......+..++...+|.+||..||++||++.|+++
T Consensus       393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1211 11  22344567888999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=376.84  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=222.3

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~~  188 (408)
                      ..+.+++.||+|.||+||+|.+++...||+|.++.....  ...|.+|+++|++|+|+|||++++++..++ ++|||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            345677899999999999999987779999999876433  367889999999999999999999998855 99999999


Q ss_pred             CCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.|+|.++|.. .+..+...+.+.++.|||+|++||++   +++|||||.+.||||+++..+||+|||||+...++ ...
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYT  359 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC-cee
Confidence            99999999976 67789999999999999999999999   99999999999999999999999999999954432 222


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+....            ..++.+.++...+-..+.
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------------n~ev~~~le~GyRlp~P~  427 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------------NEEVLELLERGYRLPRPE  427 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------------HHHHHHHHhccCcCCCCC
Confidence            3333445678999999999999999999999999999999 888877543            335566778777878888


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .++..+.+++..||+.+|++|||+..+...|+....
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            899999999999999999999999999999877653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-46  Score=357.57  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=211.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEe-EEEeCCe
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGM  181 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~-~~~~~~~  181 (408)
                      ....+|.+++.||.|+|++|++|+.+ .++.||||++.+.-  .+...+.+..|-.+|.+| +||.|++||. |..+..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578999999999999999999865 69999999997643  233456677899999999 8999999997 7777889


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |+|+||+++|+|.++|.. -+.+++.-...++.+|+.||+|||+   +|||||||||+|||||+||+++|+|||.|+.++
T Consensus       150 YFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            999999999999999954 4789999999999999999999999   999999999999999999999999999999886


Q ss_pred             CCCcc-----------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc
Q 015389          262 EQWTH-----------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       262 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      .....           .....+.||..|.+||++..+..+..+|||+||||||+|+.|.+||...++-..          
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----------  295 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----------  295 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----------
Confidence            43221           112458899999999999999999999999999999999999999987654321          


Q ss_pred             hHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          331 EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       331 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ++.+++-  .-+++...++.+.+|+.+.|..||.+|+|..||-+.
T Consensus       296 -FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 -FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence             1222221  122334445678889999999999999999998874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-46  Score=359.89  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-  179 (408)
                      ..++|++.+.||+|+||.||+|.+      .++..||||++...........+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999974      235789999998665555567889999999999 899999999976643 


Q ss_pred             -CeEEEEEecCCCCHHHHHhccc---------------------------------------------------------
Q 015389          180 -GMHIVLELSPNGSLASLLYGMK---------------------------------------------------------  201 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  201 (408)
                       .+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             4789999999999999986421                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCC
Q 015389          202 ----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG  277 (408)
Q Consensus       202 ----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  277 (408)
                          ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                247778889999999999999999   9999999999999999999999999999986543322222233456788


Q ss_pred             ccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHH
Q 015389          278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAA  356 (408)
Q Consensus       278 y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li  356 (408)
                      |+|||++.+..++.++|||||||+||||++ |..||.........           ...+........+......+..++
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li  310 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----------CQRLKDGTRMRAPENATPEIYRIM  310 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----------HHHHhcCCCCCCCCCCCHHHHHHH
Confidence            999999999999999999999999999997 99999754322111           111111111111223455788999


Q ss_pred             HhccccCCCCCCCHHHHHHHHhccc
Q 015389          357 SLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       357 ~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+||+.||.+|||+.+|++.|+...
T Consensus       311 ~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         311 LACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=349.62  Aligned_cols=254  Identities=26%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEE-EeC--CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEG--GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~--~~~lv~  185 (408)
                      .+|...+.||+|+||.||++...+ |...|||.+....... .+.+.+|+.+|.+++|||||+++|.. ...  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            567888999999999999998764 9999999988764333 67788999999999999999999963 333  478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecCCcccCCC-C
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPE-Q  263 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~-~  263 (408)
                      ||+++|+|.+++...++.+++..+..++.||++||.|||+   +|||||||||+|||++. ++.+||+|||+++.... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999997766689999999999999999999999   99999999999999999 79999999999987653 1


Q ss_pred             CccceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ........+.||+.|||||++.++. ...++|||||||++.||+||++||... .....         .+..+......+
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~---------~~~~ig~~~~~P  242 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAE---------ALLLIGREDSLP  242 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHH---------HHHHHhccCCCC
Confidence            1222334578999999999999643 345999999999999999999999853 00000         011111111112


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      ..+...+....+++.+|+..+|..|||+.++++.-
T Consensus       243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            34445667788899999999999999999999865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=366.46  Aligned_cols=277  Identities=23%  Similarity=0.326  Sum_probs=228.0

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCC-CCceeEEEe-EEEeCC
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGG  180 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~-hpniv~l~~-~~~~~~  180 (408)
                      ....++|.++++||+|+||+|+++..+ +++.||||+++++..  .+.++..+.|..|+.... ||+++.++. |....+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345589999999999999999999876 588999999998752  345788889999988875 999999998 777888


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      +++||||+.||++..+  ...+.+++..+.-++..|+.||.|||+   ++|||||||.+|||||.+|.+||+|||+++..
T Consensus       444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999994333  356789999999999999999999999   99999999999999999999999999999964


Q ss_pred             CCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ..  .....++++||+.|+|||++.+..|+.++|+|||||+||||+.|..||.+.+.+               +++|..+
T Consensus       519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------e~FdsI~  581 (694)
T KOG0694|consen  519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------EVFDSIV  581 (694)
T ss_pred             CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHh
Confidence            42  334678899999999999999999999999999999999999999999865432               3444444


Q ss_pred             cC--cccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH--HHhcccCccccccccCCchhhhhhhHhhh
Q 015389          341 AD--EYDTRQMNLVLLAASLCIQQSSIRRPQM-----SQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLREELK  404 (408)
Q Consensus       341 ~~--~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (408)
                      .+  .|+.....+...++.++|..||++|.-+     .+|..  +++.+.+..-...+.++||..+.-+.+++
T Consensus       582 ~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~  654 (694)
T KOG0694|consen  582 NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDV  654 (694)
T ss_pred             cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhh
Confidence            33  3556677888999999999999999865     34443  45666655555566667666555444443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=344.00  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=212.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~  185 (408)
                      ..+.|.+.+.||.|..++||+|+.. .+++||||++.........+.+.+|+..|+.++||||++++. |..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            4478999999999999999999754 589999999997766666889999999999999999999998 55566799999


Q ss_pred             EecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      .|+.+|++.+++.. ....+++..+..|.+++++||.|||.   +|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999965 45569999999999999999999999   999999999999999999999999999887765543


Q ss_pred             cccee--cccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          265 THHTI--SKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       265 ~~~~~--~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .....  .++.||++|||||+++..  .|+.|+||||||++..||.+|..||....+..+....-.   +......-..+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq---n~pp~~~t~~~  257 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ---NDPPTLLTSGL  257 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CCCCCcccccC
Confidence            32221  467899999999997653  699999999999999999999999987554322211111   11110111112


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+........+.+++..||+.||.+|||+.+++.
T Consensus       258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            22223344557888999999999999999999876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-46  Score=336.11  Aligned_cols=260  Identities=23%  Similarity=0.340  Sum_probs=204.9

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +.|+.+.++|+|+||.||++++++ |+.||||++.....+ ...+-.++|+++|++++|||+|.+++++.. ..+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            467888999999999999999874 999999999876553 456667899999999999999999996654 56899999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      ||+..-|.++ ......++...+.+++.|++.|+.|+|+   +++|||||||+|||++.+|.+||||||+|+.+..  ..
T Consensus        82 ~~dhTvL~eL-e~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg  155 (396)
T KOG0593|consen   82 YCDHTVLHEL-ERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG  155 (396)
T ss_pred             ecchHHHHHH-HhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence            9988666554 4556678899999999999999999999   9999999999999999999999999999998874  33


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc---hHHHHhh-----
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN---EIRELVD-----  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~d-----  337 (408)
                      ...+....|.+|+|||.+.+ ..|...+||||+||++.||++|.+-|.+..+....+.......+   .-..++.     
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            45567789999999999988 68999999999999999999999988764432111111110000   0011111     


Q ss_pred             -----hhccC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 -----ASLAD-----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 -----~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                           |....     ...+.....+.+++..||+.||.+|++-+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 10000     011223457889999999999999999988764

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=357.69  Aligned_cols=271  Identities=26%  Similarity=0.384  Sum_probs=223.5

Q ss_pred             cCHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe
Q 015389          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus       100 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      .+..++++..+.+.+...||+|.||+||+|.|.+  .||||+++... ..+..+.|.+|+..+++.+|.||+-+.||+.+
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            3446666777788899999999999999999863  49999998654 44578999999999999999999999999999


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..+.||+.+|+|.+|..+++-.+..++....++|++||+.|+.|||.   ++|||||||..||||.+++.|||+|||++.
T Consensus       460 p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  460 PPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             CceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence            99999999999999999999888999999999999999999999999   999999999999999999999999999996


Q ss_pred             cCCCCCccceecccccCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHG---IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      .-..-..........|...|||||+++..   +|+..+|||||||++|||++|..||.....+...|+....-  -..+.
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~--l~pd~  614 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGY--LMPDL  614 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccc--cCccc
Confidence            43221112223345588899999999743   68999999999999999999999999655555555432110  00000


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      .      .....++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       615 s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  615 S------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             h------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            0      11234667889999999999999999999999988777653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=329.44  Aligned_cols=236  Identities=25%  Similarity=0.342  Sum_probs=199.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~  185 (408)
                      ++|++.+.||.|+||.|.+++.+ +|..+|+|++.+...  -...++..+|..+|+.+.||+++++++ +.....+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            67888999999999999999876 699999999987643  235678889999999999999999997 44556789999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||++||.|.++++ ..+++++..+.-++.||+.||+|||+   .+|++|||||+|||||.+|.+||+|||+|+.+..   
T Consensus       124 eyv~GGElFS~Lr-k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLR-KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHH-hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            9999999999995 45679999999999999999999999   9999999999999999999999999999997753   


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ..-+.|||+.|+|||.+....|+.++|+|||||++|||+.|.+||...+. ...+.+....+            -.++
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~------------v~fP  261 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGK------------VKFP  261 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCc------------ccCC
Confidence              24568999999999999999999999999999999999999999986544 22222211111            1233


Q ss_pred             HHHHHHHHHHHHhccccCCCCC
Q 015389          346 TRQMNLVLLAASLCIQQSSIRR  367 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~R  367 (408)
                      ......+..|+...|+.|-.+|
T Consensus       262 ~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  262 SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cccCHHHHHHHHHHHhhhhHhh
Confidence            3444566778888899988888

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=351.01  Aligned_cols=248  Identities=25%  Similarity=0.349  Sum_probs=205.8

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCC-CCceeEEEeEEE-eC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVD-HPNTAKLLGYGI-EG  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~-~~  179 (408)
                      ...++|.+.+.||+|+||.|+.|.+. +|..||+|++.+..    .....+.+.+|+.+++.+. ||||++++++.. ..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34578999999999999999999765 68999999877641    1134556668999999998 999999999655 45


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCcc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAK  258 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~  258 (408)
                      ..++||||+.+|+|.+++.. .+.+.+..+..+++|++.|++|+|+   +||+||||||+|||++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            68999999999999999976 7889999999999999999999999   999999999999999999 999999999999


Q ss_pred             cCCCCCccceecccccCCCccccccccCCC-CC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGI-VD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      ...  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+...               +.
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---------------l~  232 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---------------LY  232 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---------------HH
Confidence            774  1233456789999999999999977 86 78999999999999999999999633221               11


Q ss_pred             hhhccCc--ccHHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADE--YDTRQ-MNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~--~~~~~-~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.  ++... ...+..++.+||..||.+|+++.+|++
T Consensus       233 ~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  233 RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            1111111  11122 567788999999999999999999984

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=347.92  Aligned_cols=284  Identities=20%  Similarity=0.293  Sum_probs=219.0

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCe
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGM  181 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~  181 (408)
                      ....++|.++++||+|+||.||+|+-+ +|..+|+|++++...  ...++++..|-.+|...++|+||+||- |.....+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345689999999999999999999865 599999999998653  245788899999999999999999986 6666789


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ||||||++||++..+|. ..+.+++..+..++.+++.|+.-||.   .|+|||||||+|+|||..|++||+||||+.-+.
T Consensus       217 YLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence            99999999999999994 56789999999999999999999999   999999999999999999999999999986431


Q ss_pred             C-----------------------CCcc----c------------------eecccccCCCccccccccCCCCCcchhHH
Q 015389          262 E-----------------------QWTH----H------------------TISKVEGTFGYLAPEFLMHGIVDEKTDVF  296 (408)
Q Consensus       262 ~-----------------------~~~~----~------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dvw  296 (408)
                      .                       ....    .                  ..-...|||.|+|||++++..|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       0000    0                  00113599999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 015389          297 AFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ---MSQV  373 (408)
Q Consensus       297 SlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ev  373 (408)
                      |||||+|||+.|-+||........ |.+.       . -....+..........+..+||.+||. ||++|.-   +.||
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T-~rkI-------~-nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQET-YRKI-------V-NWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHH-HHHH-------H-HHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            999999999999999987654311 1100       0 011122333333445778889999999 9999986   4444


Q ss_pred             HH--HHhcccCccccccccCCchhhhhhhHhhhc
Q 015389          374 VQ--LLRGNLCCLKYMTKCRSPLLRKTLREELKS  405 (408)
Q Consensus       374 l~--~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~  405 (408)
                      -.  .+++..  ++..-...+||+..+-++++..
T Consensus       443 K~HPfF~~v~--W~~l~~~~apfvP~v~~~~DT~  474 (550)
T KOG0605|consen  443 KKHPFFKGVD--WDHLREMPAPFVPQVNSELDTQ  474 (550)
T ss_pred             hcCCccccCC--cchhhcCCCCCCCCCCCccccc
Confidence            33  233332  2333345677777776665543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.8e-44  Score=342.66  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=210.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .+|++.+.||+|+||.||+|.+. +|.    .||||.+...........+..|+.+++.++||||+++++++.....++|
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            57899999999999999999864 333    4899999866555566788899999999999999999999888888999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++|+|.+++......+++..++.++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            99999999999997766778999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........++..|+|||.+.+..++.++|||||||++|||++ |+.||.......            +...+.......
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~~  231 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------ISSILEKGERLP  231 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------------HHHHHhCCCCCC
Confidence            2222222335678999999999999999999999999999998 999997543221            111111111111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+..+...+..++.+||+.+|.+||++.+++..|....
T Consensus       232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            12234456788999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1e-43  Score=339.50  Aligned_cols=259  Identities=24%  Similarity=0.363  Sum_probs=203.2

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-----------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL  172 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  172 (408)
                      ++|++.+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            678899999999999999997532                 347999999876555567789999999999999999999


Q ss_pred             EeEEEe-CCeEEEEEecCCCCHHHHHhccc------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 015389          173 LGYGIE-GGMHIVLELSPNGSLASLLYGMK------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH  233 (408)
Q Consensus       173 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  233 (408)
                      ++++.+ +..++||||+.+|+|.+++....                  ..+++..++.++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            997765 45789999999999999985321                  246778899999999999999999   99999


Q ss_pred             eCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCC
Q 015389          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT--GRRA  311 (408)
Q Consensus       234 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--g~~p  311 (408)
                      |||||+|||++.++.+||+|||++..+.............++..|+|||++.++.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986644322222334456889999999999999999999999999999987  5567


Q ss_pred             CCccccchhhhhccccccchHHHHhhhh---ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          312 LDYSQQSLVLWARPMIKRNEIRELVDAS---LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       312 f~~~~~~~~~~~~~~~~~~~~~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      |..........        .........   .....+..++..+.+++.+||+.+|.+|||+.+|.+.|++
T Consensus       242 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDEQVIE--------NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHHHHHH--------HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            76432211110        000111100   0111122345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-45  Score=346.13  Aligned_cols=279  Identities=25%  Similarity=0.326  Sum_probs=213.5

Q ss_pred             cCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~l  183 (408)
                      .+.|+.+++||+|.||.||+|++ .+|+.||+|++..+.. ++...-..+|+.||++|+||||++|.+..++.   .+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35688889999999999999985 4799999999987653 34566678999999999999999999966553   6899


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+|||++ +|..++....-.+++.++..++.||+.||+|+|.   +||+|||||.+|||||.+|.+||+|||||+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999966 7888887777889999999999999999999999   99999999999999999999999999999977554


Q ss_pred             CccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc--------------hhhhhccccc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS--------------LVLWARPMIK  328 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~--------------~~~~~~~~~~  328 (408)
                      ... ..+...-|.+|+|||.+.|. .|+.++|+||.||||.||++|++.|.+....              ...|....+.
T Consensus       272 ~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 GSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            322 24556689999999999986 6999999999999999999999999875432              1123321111


Q ss_pred             cchHH---HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccccccccCCchhhh
Q 015389          329 RNEIR---ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRK  397 (408)
Q Consensus       329 ~~~~~---~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~~  397 (408)
                      .-...   .-....++.. -.......+.|+..+|..||.+|.|+.++++-    ....+.+..+.+..+.+
T Consensus       351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s----eyF~t~p~~~~p~~Lp~  417 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS----EYFTTEPLPCDPSSLPK  417 (560)
T ss_pred             cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC----cccccCCCCCCcccCCC
Confidence            00000   0000111111 11124557789999999999999999998752    12233444444444444

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-45  Score=345.87  Aligned_cols=262  Identities=22%  Similarity=0.276  Sum_probs=208.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC--CeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG--GMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~--~~~l  183 (408)
                      ..++|.++++||.|.||.||+|+.. .|..||||.+++....-...--++|+..|++++ ||||+++.+.+.+.  .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4578999999999999999999854 699999999987543322233368999999998 99999999976664  4899


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||| ..+|..++..++..+++..+..|+.||+.||+|+|.   +|+.|||+||+|||+..+..+||+|||+|+.+...
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC
Confidence            99999 559999998888899999999999999999999999   99999999999999998889999999999976543


Q ss_pred             CccceecccccCCCcccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh------ccccccchHHHHh
Q 015389          264 WTHHTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA------RPMIKRNEIRELV  336 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~------~~~~~~~~~~~~~  336 (408)
                         ...+....|.+|+|||++. .+.|+.+.|||++|||++|+.+-++.|.+.......|.      .+....-.....+
T Consensus       164 ---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  164 ---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence               3456678999999999886 46799999999999999999999999987543221111      1111111110111


Q ss_pred             hhhccCc-----------ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          337 DASLADE-----------YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       337 d~~l~~~-----------~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+.-.           .-.....+..+++.+|+.+||.+|||+.|.++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1111111           112356788999999999999999999999874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.9e-44  Score=349.94  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-G  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~  180 (408)
                      .++|++.+.||+|+||.||+|.+      .++..||||+++..........+.+|+.++..+ +||||+++++++..+ .
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35789999999999999999963      236689999997654444557788999999999 899999999977654 5


Q ss_pred             eEEEEEecCCCCHHHHHhccc-----------------------------------------------------------
Q 015389          181 MHIVLELSPNGSLASLLYGMK-----------------------------------------------------------  201 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  201 (408)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            789999999999999985421                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          202 ---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       202 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                                     ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           247888899999999999999999   99999999999999999999999999999876543222


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......           .+...+........+
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-----------KFYKMIKEGYRMLSP  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-----------HHHHHHHhCccCCCC
Confidence            22223345678999999999999999999999999999998 888987532211           111122222221122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            22345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-44  Score=347.97  Aligned_cols=244  Identities=27%  Similarity=0.456  Sum_probs=211.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeE-EEeCCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~-~~~~~~~lv~e  186 (408)
                      ++|.+.+.||+|+||.||+|+-+ +.+.||+|.+.+.. .+.....+.+|++|++.++||||+.++++ ....++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999865 68999999998654 44568889999999999999999999995 45677999999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.| +|..++ ...+.++++.+..|+.+++.||.|||+   .+|+|||+||.|||++.+|.+|+||||+|+.+..  ..
T Consensus        82 ~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT  154 (808)
T ss_pred             hhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence            9977 999999 457789999999999999999999999   9999999999999999999999999999997765  34


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc--c
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE--Y  344 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~  344 (408)
                      ...+.+.||+.|||||.+.++.|+..+|+||||||+|||.+|++||-..               .+..++...+.++  +
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------------si~~Lv~~I~~d~v~~  219 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---------------SITQLVKSILKDPVKP  219 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---------------HHHHHHHHHhcCCCCC
Confidence            4567788999999999999999999999999999999999999999732               3334444333322  3


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......+..++...|..||.+|.+..+++.
T Consensus       220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            3466778888999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=349.15  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             CCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~  187 (408)
                      ..|....+||+|+.|.||.|.. ..++.||||++...... ..+-+++|+.+|+..+|+|||++++ |...+++++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4578888999999999999975 46889999999866533 3566789999999999999999998 6666789999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++||+|.+.+  ....+++.++..|..+++.||+|||.   ++|+|||||.+|||++.+|.+||+|||++..+.....  
T Consensus       352 m~ggsLTDvV--t~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  352 MEGGSLTDVV--TKTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             cCCCchhhhh--hcccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            9999999998  44569999999999999999999999   9999999999999999999999999999988765433  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ...+..||++|||||++....|+.|+||||||++++||+-|.+||-..+.-...|.......          ..-.....
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~----------P~lk~~~k  494 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT----------PKLKNPEK  494 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC----------CCcCCccc
Confidence            34567899999999999999999999999999999999999999876443322222111110          11112334


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+.+|+.+||+.|+++||++.|+++
T Consensus       495 lS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 LSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            5567888999999999999999999997

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-45  Score=345.45  Aligned_cols=248  Identities=29%  Similarity=0.402  Sum_probs=211.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ..|+..+.||+|.||.||+|.+. .++.||+|++.....++.+..+.+|+.++.+++++||.++|+.+.. ..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45677789999999999999865 6999999999988877888999999999999999999999995554 568999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.||++.+.+. .+..+++..+.-|+++++.||.|||.   ++.+|||||+.|||+..+|.+||+|||++..+...... 
T Consensus        93 ~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-  167 (467)
T KOG0201|consen   93 CGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-  167 (467)
T ss_pred             hcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhc-
Confidence            99999999994 34445888888899999999999999   99999999999999999999999999999887664332 


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                       ..++.||+.|||||++++..|+.|+||||||++.+||.+|.+|+...++.-+.+..+...        -|.+.+    .
T Consensus       168 -r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~--------PP~L~~----~  234 (467)
T KOG0201|consen  168 -RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSA--------PPRLDG----D  234 (467)
T ss_pred             -cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCC--------CCcccc----c
Confidence             267889999999999998899999999999999999999999998877654444433322        222223    3


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+.+|+..||+.||+.||++.+++.
T Consensus       235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  235 FSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3456788999999999999999999886

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-43  Score=330.04  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++..........+.+|+.++.+++||||+++++++.. +..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            467899999999999999999753    3678999999876555556788999999999999999999997665 46899


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||+|||+   ++++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            999999999999997666678999999999999999999999   99999999999999999999999999987654221


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......++..|+|||.+.++.++.++|||||||++||+++ |..||.......            +...+......
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------------~~~~~~~~~~~  227 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------------VIKAVEDGFRL  227 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------------HHHHHHCCCCC
Confidence            11 11112335678999999999999999999999999999775 999997543211            11111111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|++.
T Consensus       228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            22334566788899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-43  Score=348.45  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~  180 (408)
                      .++|++.+.||+|+||.||+|.+.      ++..||||.+......+....+.+|+.+++.+ +||||+++++++.. +.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            367899999999999999998742      24579999998765555567788999999999 89999999997665 45


Q ss_pred             eEEEEEecCCCCHHHHHhccc-----------------------------------------------------------
Q 015389          181 MHIVLELSPNGSLASLLYGMK-----------------------------------------------------------  201 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  201 (408)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            789999999999999985321                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          202 ----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       202 ----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                                ..+++..+..++.||+.||.|||+   ++|+||||||+|||+++++.++|+|||++..+...........
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      247788899999999999999999   9999999999999999999999999999986644322222223


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......           .+............+...+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~  342 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-----------KFYKMVKRGYQMSRPDFAPP  342 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-----------HHHHHHHcccCccCCCCCCH
Confidence            345678999999999999999999999999999997 999997533211           11122222222212222346


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          351 LVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus       343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            7888999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.5e-43  Score=331.01  Aligned_cols=257  Identities=24%  Similarity=0.350  Sum_probs=208.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+. +|+    .|++|.+...........+..|+.++++++||||+++++++.....+++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            56788899999999999999864 344    4788887654444455678889999999999999999999887778999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++|+|.+++......+++..+..++.||+.||.|||+   ++++||||||+||+++.++.+||+|||+++.+....
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            99999999999997767789999999999999999999999   999999999999999999999999999998765433


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........++..|+|||.+.++.++.++|||||||++|||++ |+.||.......            +..++.......
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~~  231 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------------VPDLLEKGERLA  231 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------------HHHHHHCCCcCC
Confidence            2223344567889999999999999999999999999999998 999997543221            111111111111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+..+...+..++.+|+..+|.+||++.++++.|..+.
T Consensus       232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         232 QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11123456778999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-43  Score=330.94  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=208.3

Q ss_pred             CCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|++.+.||+|+||.||+|....      ...||+|.+...........+.+|+.++..++||||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999997642      2579999998665556677889999999999999999999977654 578


Q ss_pred             EEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          183 IVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +++||+++++|.+++....               ..+++..++.++.|++.||.|||+   ++++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            9999999999999985421               457888999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .++|+|||++................+++.|+|||.+.++.++.++|||||||++|||++ |..||......        
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999986543322222334457889999999999999999999999999999998 99998753321        


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                          .+...+........+..++..+..++.+||+.||.+||++.+|++.|++
T Consensus       234 ----~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 ----EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                1112222222222334566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-43  Score=329.81  Aligned_cols=249  Identities=32%  Similarity=0.518  Sum_probs=200.0

Q ss_pred             ccceecccCcEEEEEEEEc-----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          114 FENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.....+....+.+|+..+++++||||+++++++.. +..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4688999999999999876     3678999999776555668899999999999999999999998885 457899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++|+|.+++... ...+++..++.|+.||+.||.|||+   ++++|+||+++||+++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999775 6789999999999999999999999   99999999999999999999999999999876333222


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......+...|+|||.+.+..++.++||||||+++|||++ |+.||......            .+...+....+...+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------------~~~~~~~~~~~~~~~  227 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------------EIIEKLKQGQRLPIP  227 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------------HHHHHHHTTEETTSB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc------------cccccccccccceec
Confidence            23334457789999999999999999999999999999999 67887653221            222222333333344


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      ..++..+..++.+||+.+|.+||++.+|++.|
T Consensus       228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            45667788999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=325.49  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=209.0

Q ss_pred             CCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+..    ...||||.+...........+..|+.+++.++||||+++++++..+ ..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578999999999999999998742    4589999998766566677889999999999999999999976654 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++......+++..++.++.|++.||.|||+   ++|+|+||||+||++++++.++|+|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999999997766789999999999999999999999   999999999999999999999999999998775221


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||......            .+...+.......
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~~~  228 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------------DVIKAVEDGYRLP  228 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------------HHHHHHHcCCCCC
Confidence            2212222345678999999999999999999999999999998 99998643221            1111111111112


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .+...+..+.+++.+|++.+|++||++.+|++.|+.+
T Consensus       229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2234456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8e-43  Score=330.22  Aligned_cols=246  Identities=20%  Similarity=0.309  Sum_probs=200.5

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCeEEEEEec
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIVLELS  188 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~~lv~e~~  188 (408)
                      ..||+|++|.||+|.+ +|+.||||.+.....  ....+.+.+|+.++.+++||||+++++++.+     ...++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999998 588999999976432  2345778899999999999999999998766     2478999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++|+|.+++.. ...+++.....++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||+++.+....    
T Consensus       105 ~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----  177 (283)
T PHA02988        105 TRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----  177 (283)
T ss_pred             CCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----
Confidence            99999999964 45788999999999999999999972  488899999999999999999999999998654321    


Q ss_pred             ecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          269 ISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||........           ...+.....+...+.
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-----------~~~i~~~~~~~~~~~  245 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-----------YDLIINKNNSLKLPL  245 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----------HHHHHhcCCCCCCCC
Confidence             23458899999999976  6899999999999999999999999985432111           011111111222233


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .++..+.+++.+||+.||.+|||+.+|++.|+...
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            45667899999999999999999999999997653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-43  Score=312.45  Aligned_cols=260  Identities=25%  Similarity=0.346  Sum_probs=205.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCCceeEEEeE-EEeCCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~-~~~~~~~lv~e  186 (408)
                      .+|...++||+|.||.||+|++. +|+.||||+++.....+ .....++|+..|+.++|+||+.+++. ...+++.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46788899999999999999864 69999999998765443 35667899999999999999999995 45577999999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |++ .+|...+......+....+..++.+++.||+|||.   +.|+||||||.|+|++.+|.+||+|||+|+.++.....
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            994 58999998888889999999999999999999999   99999999999999999999999999999988754332


Q ss_pred             ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc--------------hhhhhcccc--cc
Q 015389          267 HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS--------------LVLWARPMI--KR  329 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~--------------~~~~~~~~~--~~  329 (408)
                      .  +...-|.+|+|||.+.|. .|+..+||||.|||+.||+.|.+-|.+..+-              ..+|.....  +-
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            2  223578999999999875 6999999999999999999998877654321              111211100  00


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ..+...-.+.+.. .-......+.+++..++..||.+|+++.|+++.
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1111111111111 223345667999999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.9e-44  Score=361.42  Aligned_cols=260  Identities=25%  Similarity=0.388  Sum_probs=218.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-  180 (408)
                      ...+..+.+.||+|.||+||+|...      +.+.||||.++.....+..++|.+|++++..++|||||+|+|.|.+++ 
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456677899999999999999743      357899999998887778999999999999999999999999998876 


Q ss_pred             eEEEEEecCCCCHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          181 MHIVLELSPNGSLASLLYGM-------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +++|+||+..|+|..+|...             ..+++..+.+.||.|||.|+.||-+   +.+|||||...|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceeccce
Confidence            68999999999999999531             2237888999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .|||+|||+++..-....++....-.-..+|||||.++.++|+.+||||||||+|||+++ |+.||.+..+..       
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------  713 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------  713 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------
Confidence            999999999987644434333333345689999999999999999999999999999999 899987543321       


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                          .+..+-+..+ -..+..++..+..|+..||+.+|.+||++.||-.+|+....
T Consensus       714 ----VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  714 ----VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ----HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                2222223333 45567889999999999999999999999999999977653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.9e-43  Score=330.81  Aligned_cols=250  Identities=26%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +|+..+.||+|+||.||+|... +|+.||||.+......  .....+.+|+.++++++|+||+++++++.+ +..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4778899999999999999864 6999999998754322  234567889999999999999999986655 45789999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||+++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999999887543 3468999999999999999999999   999999999999999999999999999998754321 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......||..|+|||++.+..++.++|||||||++|+|++|+.||.........        ..+...+. .....++
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--------~~~~~~~~-~~~~~~~  225 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--------EEVDRRVK-EDQEEYS  225 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--------HHHHHHhh-cccccCC
Confidence              223456999999999999999999999999999999999999999864321100        00111110 0111223


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ......+..|+.+||+.||.+||+     +.++++
T Consensus       226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            334567888999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-44  Score=348.00  Aligned_cols=245  Identities=25%  Similarity=0.346  Sum_probs=210.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEE-eCCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~  185 (408)
                      +-|++++.||.|+-|.|-+|++. +|+.+|||++.+..  .+.....+.+|+-||+.+.|||++++|+++. ..++|+|+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            56888999999999999999864 79999999998652  2334677789999999999999999999544 56789999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|.|.+++. .++++++..+.+++.||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|..-.   .
T Consensus        92 Eyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P  164 (786)
T ss_pred             EecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence            9999999999994 57788999999999999999999999   999999999999999999999999999997533   2


Q ss_pred             cceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .....+-||.+.|.|||+++|.+|+ .++||||.|||||.|++|+.||+.               ++++.++....++.|
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---------------dNir~LLlKV~~G~f  229 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---------------DNIRVLLLKVQRGVF  229 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---------------ccHHHHHHHHHcCcc
Confidence            3345678999999999999999986 799999999999999999999993               234445555445544


Q ss_pred             c--HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 D--TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~--~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .  .....+...|+.+|+..||.+|.|+.||+..
T Consensus       230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            4  3556778889999999999999999999983

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.3e-42  Score=327.45  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=209.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      ++|++.+.||+|+||+||+|.+. +|.    .||+|.+...........+.+|+.++..++||||+++++++.....+++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~   86 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV   86 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence            67888999999999999999854 444    4899999876555567788899999999999999999999888888999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            99999999999997666779999999999999999999999   999999999999999999999999999998765332


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........++..|+|||.+.+..++.++|||||||++|||++ |..||......            .+...+.......
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------~~~~~~~~~~~~~  231 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------------EIPDLLEKGERLP  231 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------HHHHHHHCCCcCC
Confidence            2211222335678999999999999999999999999999998 89998753321            1112222211222


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+......+.+++.+||+.||++||++.++++.|+...
T Consensus       232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            22334567888999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-42  Score=321.03  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      +.||+|+||.||+|.+. +++.||+|.+......+....+.+|+.+++.++||||+++++++.. ...++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999875 6899999998766555667789999999999999999999997665 457899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      .+++......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            99996656678999999999999999999998   999999999999999999999999999998654321111111122


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLV  352 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  352 (408)
                      ++..|+|||.+.++.++.++|||||||++|+|++ |..||......            .....+........+...+..+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~  225 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------------QTREAIEQGVRLPCPELCPDAV  225 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------------HHHHHHHcCCCCCCcccCCHHH
Confidence            3567999999999999999999999999999998 88888643221            1122222222223333446678


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          353 LLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       353 ~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      .+++.+||+.+|++||++.+|++.|+
T Consensus       226 ~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         226 YRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            89999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.9e-43  Score=338.81  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=207.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe--
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE--  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--  178 (408)
                      ..++|++.+.||.|+||.||+|...      .++.||+|++...........+..|+.++.++ +||||+++++++..  
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3468999999999999999999632      25789999997655445567788999999999 89999999997654  


Q ss_pred             CCeEEEEEecCCCCHHHHHhccc---------------------------------------------------------
Q 015389          179 GGMHIVLELSPNGSLASLLYGMK---------------------------------------------------------  201 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  201 (408)
                      ..+++++||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            34789999999999999985321                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCc
Q 015389          202 ---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY  278 (408)
Q Consensus       202 ---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  278 (408)
                         ..+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++..+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               257899999999999999999999   99999999999999999999999999999876433222222334567889


Q ss_pred             cccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHH
Q 015389          279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAAS  357 (408)
Q Consensus       279 ~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~  357 (408)
                      +|||++.+..++.++|||||||++|||++ |..||.......           .+...+........+......+.+++.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~  310 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----------EFCRRLKEGTRMRAPEYATPEIYSIML  310 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-----------HHHHHHhccCCCCCCccCCHHHHHHHH
Confidence            99999999999999999999999999998 999987532211           111111111111122234467889999


Q ss_pred             hccccCCCCCCCHHHHHHHHhcccC
Q 015389          358 LCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       358 ~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      +||+.+|++||++.+|++.|+.+..
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-42  Score=333.78  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||++.+. +|..||+|.+...........+.+|+.++++++||||+++++++.. +..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999876 5889999999876555567789999999999999999999996655 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.++|+|||++..+...   
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---  157 (331)
T cd06649          84 HMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (331)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence            9999999999854 45688999999999999999999971  36999999999999999999999999999865432   


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-h-hcccc-----------------
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-W-ARPMI-----------------  327 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~-~~~~~-----------------  327 (408)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... . ..+..                 
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             223456999999999999999999999999999999999999999754321110 0 00000                 


Q ss_pred             ------------ccchHHHHhhhhcc----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          328 ------------KRNEIRELVDASLA----DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       328 ------------~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                                  .......+.+....    ..........+.+|+.+||+.||++|||+.+|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        00001111111111    11112345678999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=367.80  Aligned_cols=261  Identities=29%  Similarity=0.448  Sum_probs=219.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC--Cc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-e
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN--GQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-M  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~  181 (408)
                      ..+..+...||+|.||.||.|...+  |.    .||||.+.+....+....|++|..+|+.++|||||+++|.+.+.. .
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4566788999999999999998643  43    499999999888888999999999999999999999999887754 6


Q ss_pred             EEEEEecCCCCHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          182 HIVLELSPNGSLASLLYGM------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      ++++|||++|+|..+|...      ...+.....+.++.+||+|+.||++   +++|||||.+.|+||+....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence            8899999999999999876      6679999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      +|+.+-............-...|||||.++.+.++.|+|||||||+|||++| |..||....+..+.           ..
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-----------~~  916 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-----------LD  916 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-----------HH
Confidence            9995543322222222234578999999999999999999999999999999 88899865443221           11


Q ss_pred             HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       335 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ..... +-+++..+++.+.+++.+||+.+|++||++..|++++..+.+..
T Consensus       917 ~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  917 VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            12222 55567788999999999999999999999999999887766443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-42  Score=328.71  Aligned_cols=259  Identities=23%  Similarity=0.322  Sum_probs=198.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            67999999999999999999875 68999999987554333345677899999999999999999976654 47899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+ +|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ..
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--TK  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--Cc
Confidence            975 8999886666678899999999999999999999   99999999999999999999999999999765332  11


Q ss_pred             eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--------------hhccccccchH
Q 015389          268 TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--------------WARPMIKRNEI  332 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--------------~~~~~~~~~~~  332 (408)
                      ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.........              |... ......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI-TSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc-ccchhh
Confidence            2233468999999999876 46899999999999999999999999764322110              0000 000011


Q ss_pred             HHHhhhhccCcc----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLADEY----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+......    .........+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            111111110000    0112356788999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-42  Score=341.24  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=206.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~  180 (408)
                      .++|.+.+.||+|+||.||+|.+.      .+..||||.+.........+.+.+|+.+++++. ||||+++++++.+ +.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            478899999999999999999753      234799999986655555678899999999996 9999999997765 45


Q ss_pred             eEEEEEecCCCCHHHHHhccc-----------------------------------------------------------
Q 015389          181 MHIVLELSPNGSLASLLYGMK-----------------------------------------------------------  201 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  201 (408)
                      .++||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            799999999999999885421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC
Q 015389          202 ------------------------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (408)
Q Consensus       202 ------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~  245 (408)
                                                          ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                                236778889999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhc
Q 015389          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWAR  324 (408)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  324 (408)
                      ++.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986643322222233457788999999999999999999999999999997 8999875322111    


Q ss_pred             cccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       325 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                             +...+........+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       349 -------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 -------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                   11111111122223345567889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=344.98  Aligned_cols=264  Identities=28%  Similarity=0.429  Sum_probs=219.3

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc--CC--cE-EEEEEecC--CCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR--NG--QL-VAIKRLTR--GTADEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~--~g--~~-vavK~~~~--~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  177 (408)
                      ++...++..+.++||+|+||+||+|.++  ++  .. ||||..+.  ....+.+.++++|.++|++++|||||++||+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            3444567777899999999999999865  23  23 89999885  345677899999999999999999999999887


Q ss_pred             eCC-eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       178 ~~~-~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ... +++|||++.||+|.++|......++..++..++.+.+.||+|||+   +++|||||.+.|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccc
Confidence            754 789999999999999998777789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceec-ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHH
Q 015389          257 AKWLPEQWTHHTIS-KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       257 a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      ++....   ..... .-.-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+....            .+..
T Consensus       309 s~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------------~v~~  373 (474)
T KOG0194|consen  309 SRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------------EVKA  373 (474)
T ss_pred             ccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------------HHHH
Confidence            875431   11111 1135678999999999999999999999999999999 88898865432            2333


Q ss_pred             Hh-hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccc
Q 015389          335 LV-DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKY  386 (408)
Q Consensus       335 ~~-d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~  386 (408)
                      .+ ....+-..+...+..+..++.+|+..+|++||+|.++.+.|+.+......
T Consensus       374 kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            33 44445555557778889999999999999999999999999888776664

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-42  Score=325.65  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  179 (408)
                      ...++|++.+.||+|+||.||+|.+.      .+..||||.+...........+.+|+.+++.++||||+++++++.++ 
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35578999999999999999999753      25679999987554444456788999999999999999999977654 


Q ss_pred             CeEEEEEecCCCCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceE
Q 015389          180 GMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~k  250 (408)
                      ..++||||+++++|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence            5789999999999999985422         235778889999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccccc
Q 015389          251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      |+|||++..+.............++..|+|||++.++.++.++|||||||++|||++ |..||........         
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---------  230 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---------  230 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---------
Confidence            999999986544322222223346788999999999999999999999999999999 7888865332110         


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                        ........ ....+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       231 --~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 --LRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --HHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              00111111 111222345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.2e-42  Score=325.62  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  181 (408)
                      .++|.+.+.||+|+||.||+|...      ++..||||.+......+....+.+|+.+++.++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888999999999999999763      2578999999876666567889999999999999999999997665 457


Q ss_pred             EEEEEecCCCCHHHHHhccc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          182 HIVLELSPNGSLASLLYGMK-------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      ++||||+++++|.+++...+             ..+++..+..++.|++.||.|||+   ++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence            89999999999999996432             347888999999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccc
Q 015389          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  327 (408)
                      ++|+|||++..+.............+++.|+|||++.++.++.++|||||||++|||++ |..||........       
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------  233 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------  233 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence            99999999976543222222233446788999999999999999999999999999998 9999865432211       


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                           ...+........+...+..+.+++.+||+.||.+||++.||++.|++
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 -----IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -----HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                 11111111112223445678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-42  Score=320.15  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+......  ...+.+|+.+++.++||||+++++++.+ ...++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457888999999999999999888889999988754332  3567889999999999999999997665 4578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++|+|.+++......+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++......... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~  157 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-S  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-c
Confidence            9999999997655678999999999999999999999   99999999999999999999999999999865432111 1


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.........           ..+.. ......+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~-----------~~i~~-~~~~~~~~~  225 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-----------EMISR-GFRLYRPKL  225 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-----------HHHHC-CCCCCCCCC
Confidence            122345678999999998899999999999999999999 89998754321110           00100 001111112


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      ....+..++.+||+.+|.+||++.++++.|
T Consensus       226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            345688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.1e-42  Score=319.38  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             eecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCCCH
Q 015389          117 LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSL  193 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L  193 (408)
                      .||+|+||.||+|.+.   .+..||+|++...........+.+|+.++++++||||+++++++.....++||||+++++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            3899999999999764   3567999999876555556788999999999999999999998877788999999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce-eccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKV  272 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~~  272 (408)
                      .+++......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++..+........ ....
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            99997666789999999999999999999999   9999999999999999999999999999986544322211 1112


Q ss_pred             ccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      .++..|+|||.+.+..++.++|||||||++|+|++ |..||......            .+...+........+..+...
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~  226 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------------EVMSFIEQGKRLDCPAECPPE  226 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------------HHHHHHHCCCCCCCCCCCCHH
Confidence            34678999999988889999999999999999996 99999754321            122222222233334445678


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          352 VLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       352 l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      +.+++.+||+.+|++||++.+|++.|+..
T Consensus       227 l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         227 MYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            88999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-42  Score=324.47  Aligned_cols=264  Identities=26%  Similarity=0.369  Sum_probs=207.5

Q ss_pred             CCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEE
Q 015389          112 FSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~l  183 (408)
                      |++.+.||+|+||+||++..     .++..||+|.+...........+.+|+.+++.++||||+++++++...   ..++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988653     357899999998665444567788999999999999999999976542   3789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+.+++|.+++..  ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++..+...
T Consensus        86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999999853  458999999999999999999999   99999999999999999999999999999876543


Q ss_pred             Cccce-ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh---ccccccchHHHHhhhh
Q 015389          264 WTHHT-ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA---RPMIKRNEIRELVDAS  339 (408)
Q Consensus       264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~d~~  339 (408)
                      ..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...........   .............+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            22111 1223456779999999988999999999999999999999999875433211111   1111112222233333


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .....+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            33223344567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-42  Score=329.92  Aligned_cols=261  Identities=22%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|.+.+.||.|+||.||+|... +|+.||||++...........+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999876 68999999997654333345667899999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+. ++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            995 68888886666778999999999999999999999   99999999999999999999999999998754322  1


Q ss_pred             ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc--cccc---chH------HH
Q 015389          267 HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP--MIKR---NEI------RE  334 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~--~~~~---~~~------~~  334 (408)
                      .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.............  ....   ...      ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            222345689999999998754 58899999999999999999999997643221110000  0000   000      00


Q ss_pred             Hhhhhcc--Cccc-------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 LVDASLA--DEYD-------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ~~d~~l~--~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.  ....       ......+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000  0000       011245778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-43  Score=337.73  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=212.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEE-EeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYG-IEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~-~~lv  184 (408)
                      .++|..++++|+|+||.+++.+++ ++..||+|.+...... .......+|+.+++++.|||||.+.+.+ .++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            368899999999999999999876 5889999999865432 3445778999999999999999999944 4555 7899


Q ss_pred             EEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+|++||+|.+.+...+ ..++++.+..++.|++.|+.|||+   +.|+|||||+.|||++.++.|+|+|||+|+.+...
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999997655 679999999999999999999998   99999999999999999999999999999988764


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .  ....++.||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|...+....            ..-+.......
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------------i~ki~~~~~~P  225 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------------ILKINRGLYSP  225 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------------HHHHhhccCCC
Confidence            3  244668899999999999999999999999999999999999999986543211            11111222334


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+..+...+..++..|++.+|..||++.+++..
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            455677889999999999999999999999875

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.2e-42  Score=324.08  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=211.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC-----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GG  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~  180 (408)
                      ..++|++.+.||+|+||.||+|.+.+     +..||+|.+...........+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45789999999999999999998765     788999998866555667888999999999999999999997765  45


Q ss_pred             eEEEEEecCCCCHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          181 MHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                      .+++++|+++++|.+++....       ..+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence            789999999999999985432       458899999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchH
Q 015389          254 FGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       254 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||......            .+
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~  228 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------------EM  228 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------------HH
Confidence            999986644322222233456788999999998899999999999999999999 99999754321            11


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ...+............+..+.+++.+|++.+|++|||+.+|++.|+.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         229 AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111111122334567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.8e-42  Score=326.44  Aligned_cols=261  Identities=22%  Similarity=0.318  Sum_probs=199.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.++ +++.||||++..... ......+.+|+.+++.++||||+++++++.. +..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47899999999999999999886 588999999876432 2345677899999999999999999986554 55789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |++++.+..+. .....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            99987776554 445678999999999999999999999   9999999999999999999999999999987643221 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh-c---cccccchHHH--------
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA-R---PMIKRNEIRE--------  334 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~---~~~~~~~~~~--------  334 (408)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .   ..........        
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            122345689999999999999999999999999999999999999976432111000 0   0000000000        


Q ss_pred             -Hhhhhcc------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 -LVDASLA------DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 -~~d~~l~------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ...+...      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000000      0001123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-42  Score=323.03  Aligned_cols=256  Identities=30%  Similarity=0.413  Sum_probs=203.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  180 (408)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||+|.+...........+..|+.+++.++|+||+++++++.+ +.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3478999999999999999999865      3578999988766555556778999999999999999999996655 45


Q ss_pred             eEEEEEecCCCCHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEE
Q 015389          181 MHIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQI  251 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl  251 (408)
                      .++||||+++++|.+++....      ..+++..+..++.||+.||.|||+   ++++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence            789999999999999986533      258899999999999999999999   8999999999999998765   5999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccc
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      +|||+++.+.............++..|+|||++.++.++.++|||||||++|||++ |..||......            
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------------  228 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------------  228 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------
Confidence            99999987633211111122234568999999999999999999999999999997 99999753321            


Q ss_pred             hHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          331 EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       331 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      .+...+........+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111122211122223344567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.9e-42  Score=323.22  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=204.5

Q ss_pred             CCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      .+|++.+.||+|+||.||+|.+     ..+..||+|.+......+....+.+|+.+++.++||||+++++++.. ...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5678889999999999999974     24678999999866555556788899999999999999999997665 45789


Q ss_pred             EEEecCCCCHHHHHhcc----------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          184 VLELSPNGSLASLLYGM----------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      ||||+++++|.+++...                ...+++.....++.|++.||.|||+   ++++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            99999999999998532                2347888899999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .+||+|||++................++..|+|||++.++.++.++|||||||++|||++ |..||......        
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--------  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--------  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999986643322222334456788999999998899999999999999999998 88898653221        


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                          .+.+.+........+......+..++.+|++.+|.+||++.+|.+.|++
T Consensus       234 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 ----EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                1111111111111222345678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-43  Score=319.03  Aligned_cols=261  Identities=24%  Similarity=0.324  Sum_probs=207.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~l  183 (408)
                      .+.|+.++.|++|.||.||+|+++ +++.||+|+++-....+ ..-.-++|+.+|.+++|||||.+-.+...   +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            367888999999999999999876 69999999998654322 33445799999999999999999986654   34899


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||++. +|..++...+.++...++..+..|++.||+|||.   +.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999965 8999999888999999999999999999999999   99999999999999999999999999999988764


Q ss_pred             CccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc--------------hhhhhccccc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS--------------LVLWARPMIK  328 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~--------------~~~~~~~~~~  328 (408)
                        ....+...-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....              ...|......
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence              3345567789999999999986 5999999999999999999999999764321              1112111110


Q ss_pred             c----chHHHHhhhhccCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          329 R----NEIRELVDASLADEYDTR-QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       329 ~----~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .    -.........++..+... ..+.-++|+...|..||.+|.|+.|.+.
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            0    011111112223333322 3466788999999999999999999876

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.6e-42  Score=326.69  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=208.7

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  179 (408)
                      ...++|++.+.||+|+||.||+|...      +...+|+|.+...........+.+|+.++..+ +||||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34467899999999999999999764      24689999998765555567788999999999 799999999976654


Q ss_pred             -CeEEEEEecCCCCHHHHHhc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          180 -GMHIVLELSPNGSLASLLYG---------------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                       ..+++|||+++|+|..++..               ....+++..++.++.|++.||.|||+   .+|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence             57899999999999999853               23468899999999999999999998   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||......    
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  241 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  241 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence            9999999999999987654322222223345678999999999999999999999999999997 88888643221    


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                              .+...+........+......+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus       242 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 --------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                    111122222222223344567889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-43  Score=325.85  Aligned_cols=246  Identities=22%  Similarity=0.361  Sum_probs=209.6

Q ss_pred             CCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.++++..  +...-++.+|++||+.|+||||+.+|+++.+ +...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            5788899999999999999975 6799999999987654  3456778899999999999999999996665 5688999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||..+|.|.+|+ ...+.+++.....+++||..|+.|+|.   ++++|||||.+|||||.|+++||+|||++..+..   
T Consensus       133 EYaS~GeLYDYi-Ser~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---  205 (668)
T KOG0611|consen  133 EYASGGELYDYI-SERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---  205 (668)
T ss_pred             EecCCccHHHHH-HHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc---
Confidence            999999999999 567789999999999999999999999   9999999999999999999999999999987754   


Q ss_pred             cceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .....++||++-|.+||++.+.+|. +.+|-|||||+||.|+.|..||++.+...               ++...-++.|
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---------------lvrQIs~GaY  270 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---------------LVRQISRGAY  270 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---------------HHHHhhcccc
Confidence            3456789999999999999999885 78999999999999999999999754321               1111112221


Q ss_pred             -cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          345 -DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       345 -~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                       .+..+....-||.|||-.||++|.|+.+|....
T Consensus       271 rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             123445566799999999999999999998865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=328.80  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....  ......+.+|+.+++.++||||+++++++.+ ...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999876 689999999875322  2345668899999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+...  
T Consensus        81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999999854 4568899999999999999999999   99999999999999999999999999999865432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+....  ..++
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-----------~~~i~~~~--~~~~  218 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-----------YEKILAGK--LEFP  218 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhCC--cCCC
Confidence               1235699999999999998999999999999999999999999975432111           01111111  1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQL  376 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~  376 (408)
                      ......+.+++.+||+.||.+||+     +.++++.
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            233456788999999999999995     7777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-42  Score=318.54  Aligned_cols=254  Identities=29%  Similarity=0.373  Sum_probs=205.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ..++|++.+.||+|++|.||+|.+.+++.||+|.+.....  ....+.+|+.++++++||||+++++++.. +..++|+|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3467899999999999999999987788899999876542  24567899999999999999999997665 45789999


Q ss_pred             ecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..+.....
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999996533 468999999999999999999999   9999999999999999999999999999987653211


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      . .......+..|+|||++.+..++.++||||||+++|||++ |+.||.......            +...++.......
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~~~  225 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------------VLQQVDQGYRMPC  225 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------------HHHHHHcCCCCCC
Confidence            1 1111223468999999998899999999999999999999 999997543211            1111111111122


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      +......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            33445678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.5e-42  Score=319.83  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=205.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .++|++.++||+|+||.||+|...++..||+|.+.....  ..+.+..|+.+++.++|+||+++++++.+ +..++++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            367899999999999999999988888999999875432  35678899999999999999999986655 457899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999998653 4568889999999999999999999   99999999999999999999999999999876442211


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                       ......++..|+|||++.++.++.++|||||||++|+|++ |..||........            ...+.........
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------------~~~~~~~~~~~~~  226 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV------------MSALQRGYRMPRM  226 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH------------HHHHHcCCCCCCC
Confidence             1223346778999999998899999999999999999998 9999975432211            1111111111112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2345678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.7e-42  Score=347.95  Aligned_cols=255  Identities=21%  Similarity=0.270  Sum_probs=205.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  179 (408)
                      ...++|.+.+.||+|+||+||+|... +|+.||||.+.... .......+.+|+.++..++|+|++++++.+...     
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999999864 69999999987543 334567788999999999999999998744321     


Q ss_pred             ----CeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          180 ----GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       180 ----~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                          .+++||||+++|+|.+++..   ....+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence                15789999999999999854   23568899999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      |||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.........           
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~-----------  254 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-----------  254 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-----------
Confidence            999998765433333344567999999999999999999999999999999999999999754321110           


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...... .....+......+..++.+||+.+|.+||++.++++.
T Consensus       255 ~~~~~~-~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTLAG-RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHhcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            011110 1111223345678889999999999999999998863

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.8e-42  Score=318.76  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=208.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~  187 (408)
                      ..++|++.++||+|+||.||+|..++++.||+|.+......  ...+.+|+.+++.++||||+++++++.++..++++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEc
Confidence            34689999999999999999999888999999998765433  3577899999999999999999998877889999999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +.+++|.+++... ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999998653 3568999999999999999999998   9999999999999999999999999999986653211 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......            ....+........+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~  225 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------------VIQNLERGYRMPRP  225 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------------HHHHHHcCCCCCCC
Confidence            11223346788999999998899999999999999999999 999997543221            11111111111222


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ...+..+.+++.+|++.+|++||++++++..|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            2345678999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-41  Score=323.38  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=205.7

Q ss_pred             CCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      +|++.+.||+|+||.||+|...      ....+|+|.+...........+.+|+.+++.++||||+++++++.. +..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999753      2357999998866555556788999999999999999999996655 45789


Q ss_pred             EEEecCCCCHHHHHhcc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCc
Q 015389          184 VLELSPNGSLASLLYGM-----------------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~N  240 (408)
                      |+||+.+++|.+++...                       ...+++..++.++.|++.||.|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            99999999999998532                       1347888999999999999999998   999999999999


Q ss_pred             eEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccch
Q 015389          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSL  319 (408)
Q Consensus       241 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~  319 (408)
                      ||+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999986543322222233446778999999988899999999999999999998 99998653321 


Q ss_pred             hhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                                 .+...+........+......+..++.+|++.+|.+||++.+++..|+++.
T Consensus       237 -----------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 -----------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             -----------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                       112222222222233344567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-42  Score=333.16  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=194.7

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542  22345677899999999999999999986655 4578999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      +|.+++.. ...+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~  154 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence            99999854 4578999999999999999999999   99999999999999999999999999998753221  122334


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+...  ...++......
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----------~~~~~~--~~~~p~~~~~~  221 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------ELILME--EIRFPRTLSPE  221 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-----------HHHHcC--CCCCCCCCCHH
Confidence            67999999999999999999999999999999999999999754322110           001100  11122334566


Q ss_pred             HHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       352 l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      +.+++.+||+.||.+||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            88899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=9.2e-42  Score=318.28  Aligned_cols=253  Identities=28%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEec
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~  188 (408)
                      .++|++.+.||+|+||.||+|...++..||+|.+......  ...+.+|+.+++.++|||++++++++.+...+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEec
Confidence            4678999999999999999999888888999999765432  35688999999999999999999988777889999999


Q ss_pred             CCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++++|.+++... ...+++..+..++.+++.||.|||+   ++++||||||+||++++++.++|+|||++..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence            999999998653 3458999999999999999999999   99999999999999999999999999999866432211 


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......            .....+........+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~~~~~~  226 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------------EVLEQVERGYRMPCPQ  226 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------------HHHHHHHcCCCCCCCC
Confidence            1122335678999999988899999999999999999999 88898653321            1111111111222233


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ..+..+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=335.39  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=201.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++.....  ......+..|+.++..++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 589999999975432  23456788999999999999999999866654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            99999999999953 4568899999999999999999999   9999999999999999999999999999986533   


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...............     .............
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~  226 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----KETLQRPVYDDPR  226 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----cccccCCCCCccc
Confidence              223456999999999999999999999999999999999999999764332110000000     0000000000001


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ......+.+++.+||..+|.+||++.+++..
T Consensus       227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1335678889999999999999999999874

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-41  Score=329.91  Aligned_cols=260  Identities=23%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||.|+||.||+|.+. +|..+|+|.+...........+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999876 5889999998876555566788999999999999999999997665 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+.  .+|+|+||||+|||++.++.+||+|||++..+...   
T Consensus        84 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---  157 (333)
T cd06650          84 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  157 (333)
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence            9999999999854 45688999999999999999999971  47999999999999999999999999999765332   


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc-c------------------
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-I------------------  327 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-~------------------  327 (408)
                       ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.............. .                  
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR  236 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence             12335689999999999988999999999999999999999999975432211100000 0                  


Q ss_pred             ----------ccchHHHHhhhhccCccc----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          328 ----------KRNEIRELVDASLADEYD----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       328 ----------~~~~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                .......+.+.......+    ......+.+++.+||+.||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                      000011111111111100    113456889999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.8e-42  Score=327.35  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|.+...........+.+|+.+++.++||||+++++++.....++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~   85 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL   85 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence            357788899999999999999864 343    579998876655455567889999999999999999999888777889


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ++||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+|+||||+||+++.++.+||+|||++..+...
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence            999999999999997666678999999999999999999999   99999999999999999999999999999876533


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ..........++..|+|||.+.+..++.++|||||||++|||++ |+.||.......            ...++......
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------------IPDLLEKGERL  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------------HHHHHHCCCCC
Confidence            22222223346778999999998999999999999999999997 899987532211            11111111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+..+...+..++..|+..+|++||++.++++.|+.+.
T Consensus       231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111223456788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.9e-42  Score=317.71  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=202.2

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~  188 (408)
                      ++|.+.+.||+|+||.||+|.+.++..||||.+......  ...+.+|+.++..++||||+++++++.+. ..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc--HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            467888999999999999998877777999998754332  35688999999999999999999977654 478999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      .+|+|.+++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            9999999997655578999999999999999999999   9999999999999999999999999999886543211 11


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||........            ...+...........
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~~  225 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------------VEKVSQGLRLYRPHL  225 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------------HHHHhcCCCCCCCCC
Confidence            122335678999999998889999999999999999998 9999875432211            111111111111222


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ....+.+++.+||+.+|.+||++.+|+..|+
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            3567889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-42  Score=334.42  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|.+.+.||+|+||.||+|.+. +|+.||||.+.....  ......+.+|+.++++++||||+++++++.+ +..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67899999999999999999876 589999999875421  2345678899999999999999999996655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        98 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             cCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            99999999999854 4568889999999999999999999   99999999999999999999999999999866432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+....  ..++
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----------~~~i~~~~--~~~p  235 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-----------YEKILAGR--LKFP  235 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-----------HHHHhcCC--cCCC
Confidence               1235699999999999999999999999999999999999999975432110           01111111  1112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ......+.+++.+||+.||.+||+     +.+++.
T Consensus       236 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            223456778999999999999996     677664

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=327.46  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-------------HHHHHHHHHHHHhcCCCCceeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-------------IIADFLSELGIMAHVDHPNTAKLL  173 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~E~~il~~l~hpniv~l~  173 (408)
                      -.++|++.+.||+|.||.|-+|+.. +++.||||++.+.....             ..+...+|+.||+++.|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3488999999999999999999875 69999999997643210             235788999999999999999999


Q ss_pred             eEEEe---CCeEEEEEecCCCCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          174 GYGIE---GGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       174 ~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      ++..+   ..+|+|+|||..|.+...=  .... +.+.++++++.+++.||+|||.   +|||||||||+|+||+++|.+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence            98765   4589999999999875532  3334 8999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCc---cceecccccCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccchhhh
Q 015389          250 QICDFGLAKWLPEQWT---HHTISKVEGTFGYLAPEFLMHGI----VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW  322 (408)
Q Consensus       250 kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~  322 (408)
                      ||+|||.+...+.+..   ........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||-....-    
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----  325 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----  325 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence            9999999987644321   12233467999999999988743    357899999999999999999999743211    


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                             .-...++...+...-..+..+.+.+||.++|+.||++|.++.+|....
T Consensus       326 -------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 -------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                   011223333333333345677888999999999999999999987654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=337.37  Aligned_cols=240  Identities=28%  Similarity=0.445  Sum_probs=207.0

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEecCCCCH
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSL  193 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~~~~g~L  193 (408)
                      ++-||.|+.|.||+|+++ ++.||||+++..+        ..++.-|++|+||||+.+.|+|.... +|||||||..|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            467999999999999996 6789999775332        25788899999999999999999987 5799999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      ...|. .+..+.......+..+||.|+.|||.   +.|||||||.-||||..+..|||+|||-++.+...   .+.-.++
T Consensus       200 ~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa  272 (904)
T KOG4721|consen  200 YEVLK-AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA  272 (904)
T ss_pred             HHHHh-ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence            99994 56778888889999999999999999   99999999999999999999999999999876543   2233578


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      ||..|||||++.+.+.++|+||||||||||||+||..||..-+...+.|.-.           ...|.-..+..+++.+.
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG-----------sNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG-----------SNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc-----------CCcccccCcccCchHHH
Confidence            9999999999999999999999999999999999999998877766665432           22344455667888899


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          354 LAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .|+++||+..|.+||+++|++..|+-..
T Consensus       342 lL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  342 LLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            9999999999999999999999996543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-41  Score=329.78  Aligned_cols=267  Identities=20%  Similarity=0.302  Sum_probs=198.8

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~  182 (408)
                      +|++.+.||+|+||.||+|... +|+.||||.+.... .......+.+|+.+++.++||||+++++++...      ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999865 68999999987532 223345788999999999999999999976532      368


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+. ++|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68988884 34568999999999999999999999   9999999999999999999999999999986532


Q ss_pred             CCcc-ceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccchh-hhhccc-----------c
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV-LWARPM-----------I  327 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~-----------~  327 (408)
                      .... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ ......           .
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2111 12234569999999999876  6789999999999999999999999976432110 000000           0


Q ss_pred             ccchHHHHhhhhccC---ccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccC
Q 015389          328 KRNEIRELVDASLAD---EYD---TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNLC  382 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~---~~~---~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~  382 (408)
                      ........+......   ...   ......+.+++.+||+.+|++||++.++++.  +++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            000111111111000   000   0123457889999999999999999999963  444433

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-41  Score=316.00  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=201.5

Q ss_pred             eecccCcEEEEEEEEc---CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCCC
Q 015389          117 LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGS  192 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~  192 (408)
                      .||+|+||.||+|.+.   ++..||+|+++.... ......+..|+.+++.++||||+++++++.....++||||+++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            5899999999999653   578999999875543 335677889999999999999999999888788899999999999


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce-ecc
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISK  271 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~  271 (408)
                      |.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||.||+++.++.++|+|||++..+........ ...
T Consensus        82 L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          82 LNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence            9999853 4568999999999999999999999   9999999999999999999999999999987654322211 122


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ..++..|+|||.+.+..++.++|||||||++|||++ |+.||......            .+...+........+...+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------~~~~~i~~~~~~~~~~~~~~  225 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------------EVTQMIESGERMECPQRCPP  225 (257)
T ss_pred             CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHCCCCCCCCCCCCH
Confidence            234678999999988889999999999999999998 99999754322            12222222222233334566


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          351 LVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+.+++.+||+.||++||++.+|++.|++
T Consensus       226 ~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         226 EMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            78899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.3e-42  Score=319.26  Aligned_cols=254  Identities=29%  Similarity=0.412  Sum_probs=208.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ...+|++.++||.|+||.||+|.+.++..+|+|.+...... ....+..|+.+++.++||||+++++++... ..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34578999999999999999999888999999998765432 355688999999999999999999976654 4789999


Q ss_pred             ecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++++|.+++.. ....+++..++.++.||+.||.|||+   ++++|+||+|+||+++.++.+||+|||++..+.....
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999965 34568999999999999999999999   9999999999999999999999999999987643221


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .  .....++..|+|||.+.++.++.++||||||+++|+|++ |+.||......            .....+........
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~~~~  225 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------------EVYDQITAGYRMPC  225 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------------HHHHHHHhCCcCCC
Confidence            1  123346778999999998899999999999999999998 89999754321            11111222222223


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      +...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            34456778899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-42  Score=322.31  Aligned_cols=255  Identities=22%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  182 (408)
                      .+|++.+.||.|+||.||+|...      .+..||||++...........+..|+.++..++||||+++++++.. ...+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            45778899999999999999753      2578999999866555556778899999999999999999997665 4578


Q ss_pred             EEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          183 IVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +++||+.+++|.+++...               ...+++..+..++.|++.||.|||+   ++|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence            999999999999998421               2347888899999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .+||+|||+++.+.............+++.|+|||.+.++.++.++|||||||++|||++ |..||......        
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------  233 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------  233 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999886643322222233456789999999998999999999999999999998 88888653221        


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                          .+...+........+..++..+..++.+||+.+|.+||++.+|+..|+.
T Consensus       234 ----~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         234 ----DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                1111111111112233456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-41  Score=317.72  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=206.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEec
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~  188 (408)
                      .++|++.++||+|+||.||+|.+.++..||+|.+......  ...+.+|+.+++.++||||+++++++.+...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence            4679999999999999999998877678999999864332  35678999999999999999999987777889999999


Q ss_pred             CCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||.+..+...... 
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            999999999653 3458899999999999999999999   99999999999999999999999999999866433211 


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......++..|+|||+..++.++.++|||||||++|+|++ |..||........            ..............
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~  226 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------------LDQVERGYRMPCPP  226 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------------HHHHhcCCCCCCcc
Confidence            1122346778999999988999999999999999999999 8888875432111            11111111112233


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus       227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            4566788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-43  Score=304.88  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=208.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|.+++.||+|.||.||+|+.+ ++-.||+|++.+....  ....++.+|++|-++|+||||+++|+++.+. ..|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            78899999999999999999865 6889999999765432  3457788999999999999999999987775 589999


Q ss_pred             EecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||..+|+|...|.. ....+++.....++.|++.||.|+|.   +++|||||||+|+|++.++.+||+|||-+..-+   
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  175 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence            99999999999964 34568999999999999999999999   999999999999999999999999999887544   


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .....+.+||..|.|||...+..++..+|+|++|++.||++.|.+||......           ....++..-.  -.+
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----------etYkrI~k~~--~~~  241 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----------ETYKRIRKVD--LKF  241 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----------HHHHHHHHcc--ccC
Confidence             22345789999999999999999999999999999999999999999864321           1112222211  222


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +........++|.+|+..+|.+|....||++.
T Consensus       242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            34556778889999999999999999999864

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=316.19  Aligned_cols=250  Identities=27%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~  188 (408)
                      .+|++.+.||+|+||.||+|.++++..+|+|.+......  ...+.+|+.+++.++||||+++++++... ..++|+||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            457888999999999999999877788999998754332  34677899999999999999999976654 478999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++++|.+++......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++........ .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~  157 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S  157 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence            9999999997656678999999999999999999999   99999999999999999999999999999865432111 1


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......            ....+........+..
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~  225 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------------VVESVSAGYRLYRPKL  225 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------------HHHHHHcCCcCCCCCC
Confidence            111224568999999999999999999999999999999 889987533211            1111111112222233


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .+..+.+++.+||+.+|++|||+.++++.|
T Consensus       226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            566789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=307.78  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             hhhcCCCCccceecccCcEEEEEEE-EcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----  179 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  179 (408)
                      .+..++|++.+.||.|||+-||++. ..++..||+|++..... +..+..++|++..++++|||++++++++..+     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~-~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ-EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccch-HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            4566899999999999999999997 45789999999987763 4578889999999999999999999865432     


Q ss_pred             -CeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECCCCceEEee
Q 015389          180 -GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                       ..|++++|...|+|.+.+..   .+..+++.+++.|+.+|++||++||+   ..  ++||||||.|||+.+.+.++|.|
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~---~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE---KEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc---cCCcccccCCCcceeEecCCCceEEEe
Confidence             37899999999999999865   34579999999999999999999998   55  99999999999999999999999


Q ss_pred             cCCcccCCCCCccc-------eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh
Q 015389          254 FGLAKWLPEQWTHH-------TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA  323 (408)
Q Consensus       254 fGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~  323 (408)
                      ||.+...+-.....       .......|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-+.     
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----  247 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----  247 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----
Confidence            99998664322211       112234789999999985   456789999999999999999999999752211     


Q ss_pred             ccccccchHH-HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          324 RPMIKRNEIR-ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       324 ~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                           .+.+. .+....+...-..++++.+.+++.+|++.||.+||++.+++..++.+
T Consensus       248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                 01111 01111222222334788999999999999999999999999998765

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7e-42  Score=324.18  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=192.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc--CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcC---CCCceeEEEeEEE------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGI------  177 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l---~hpniv~l~~~~~------  177 (408)
                      ++|++.+.||+|+||.||+|.+.  +|+.||||.+...... .....+.+|+.+++.+   +||||+++++++.      
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47899999999999999999863  4788999998754322 2234455677666655   6999999999764      


Q ss_pred             eCCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          178 EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       178 ~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ....++|+||+. ++|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            234789999996 6899888643 3458999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccc---cccchH
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPM---IKRNEI  332 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~---~~~~~~  332 (408)
                      +......   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....   ......
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9865432   2233456899999999999999999999999999999999999999864332110 00000   000000


Q ss_pred             HH---Hhhhhcc--C-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RE---LVDASLA--D-----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~---~~d~~l~--~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..   +....+.  .     .........+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00   0000000  0     000123456778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-41  Score=321.00  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=204.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-C
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-G  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  179 (408)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+...........+.+|+.+++.++||||+++++++.+ .
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999753      2558999998765444445567899999999999999999997655 4


Q ss_pred             CeEEEEEecCCCCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceE
Q 015389          180 GMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~k  250 (408)
                      ..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            5789999999999999996422         234667788999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccccc
Q 015389          251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      |+|||+++.+.............++..|+|||.+.++.++.++|||||||++|||++ |..||........         
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---------  230 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---------  230 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---------
Confidence            999999986543322222223345778999999999999999999999999999998 7888865322111         


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                        ...+.+.. ....+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus       231 --~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 --LKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --HHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence              01111111 11112233467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-41  Score=319.64  Aligned_cols=268  Identities=24%  Similarity=0.351  Sum_probs=208.2

Q ss_pred             CCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---Ce
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~  181 (408)
                      ..|++.+.||+|+||.||++..     .++..||+|.+...........+.+|+.+++.++|||++++++++...   ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999974     247899999998665555667889999999999999999999977653   47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            89999999999999996655578999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH---HHhh
Q 015389          262 EQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR---ELVD  337 (408)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~d  337 (408)
                      ..... .......++..|+|||++.+..++.++|||||||++|+|++++.|.............+........   ..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            43221 1223455778899999999889999999999999999999988765432111110000000011111   1111


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...........+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111122233567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=328.99  Aligned_cols=239  Identities=23%  Similarity=0.286  Sum_probs=191.5

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||+|+||.||+|... +++.||+|.+....  .......+..|+.++.+++||||+++++++.+ +..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 58899999987532  22345678899999999999999999986655 457899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      .+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||+++......  .......
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            999854 4568999999999999999999999   999999999999999999999999999998543221  2233467


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      ||+.|+|||.+.+..++.++|||||||++|+|++|+.||........           ...+...  ...++......+.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-----------~~~~~~~--~~~~~~~~~~~~~  221 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-----------YRKILQE--PLRFPDGFDRDAK  221 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-----------HHHHHcC--CCCCCCcCCHHHH
Confidence            99999999999999999999999999999999999999975432110           0111111  1112233456678


Q ss_pred             HHHHhccccCCCCCCC---HHHHHH
Q 015389          354 LAASLCIQQSSIRRPQ---MSQVVQ  375 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt---~~evl~  375 (408)
                      +++.+||+.||.+||+   +.+++.
T Consensus       222 ~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         222 DLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            8999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=318.29  Aligned_cols=257  Identities=27%  Similarity=0.421  Sum_probs=210.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .+|++.+.||+|+||.||+|.+. +|.    .||+|.+...........+.+|+.+++.++||||+++++++.....++|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            57888899999999999999864 233    6899998877655566788899999999999999999998888889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++|+|.+++......+++..++.++.|++.||+|||+   ++++|+||||+||+++.++.++|+|||++..+....
T Consensus        87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            99999999999997767779999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||......            .+...+.......
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~~~~  231 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------------EIPDLLEKGERLP  231 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------------HHHHHHhCCCCCC
Confidence            2222222234678999999988899999999999999999998 99999754321            1111221111111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+..+...+..++.+||..+|..||++.++++.|+...
T Consensus       232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         232 QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            22223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-41  Score=315.96  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=199.0

Q ss_pred             CCccceecccCcEEEEEEEEcC-Cc--EEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------C
Q 015389          112 FSFENLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------G  180 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------~  180 (408)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.++... .......+..|+.+++.++||||+++++++...       .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998754 33  69999987643 334467888999999999999999999965421       3


Q ss_pred             eEEEEEecCCCCHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          181 MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      .++++||+.+|+|.+++..     ....+++.....++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            5799999999999988732     23458899999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      ++..+.............+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......            +..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------------~~~  225 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------------IYD  225 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------------HHH
Confidence            9987654322222223346778999999999999999999999999999999 788987532211            111


Q ss_pred             HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       335 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .+...............+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111111111223456688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.5e-41  Score=317.06  Aligned_cols=257  Identities=26%  Similarity=0.388  Sum_probs=209.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      .+|.+.+.||+|+||.||+|.+.+    ...||||........+..+.+.+|+.+++.++||||+++++++.+...++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~   85 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM   85 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence            568889999999999999998643    3469999987665555667889999999999999999999988888889999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++......+++..++.++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            9999999999997656678999999999999999999999   9999999999999999999999999999986644311


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .......++..|+|||.+....++.++|||||||++|||++ |..||..........            .+........
T Consensus       163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------------~~~~~~~~~~  229 (270)
T cd05056         163 -YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG------------RIENGERLPM  229 (270)
T ss_pred             -eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------------HHHcCCcCCC
Confidence             11223335578999999988889999999999999999986 999997543221110            0011111112


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      +...+..+.+++.+|+..+|.+|||+.+++..|+.+.+
T Consensus       230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         230 PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            23345678889999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-41  Score=332.67  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=194.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .+|+..+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++|+||+++++++.. +..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            56777899999999999999875 6899999999766555567788999999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+|+|.+.     ...++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....  
T Consensus       154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  223 (353)
T PLN00034        154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--  223 (353)
T ss_pred             CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence            999998653     235677788899999999999999   9999999999999999999999999999987643211  


Q ss_pred             eecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          268 TISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ......||..|+|||.+..     ...+.++|||||||++|||++|+.||.......  |..       ....+......
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~-------~~~~~~~~~~~  294 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WAS-------LMCAICMSQPP  294 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHH-------HHHHHhccCCC
Confidence            2234569999999998743     234568999999999999999999997432210  000       00000000111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .........+.+++.+||+.||++||++.||++.
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223345678899999999999999999999974

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-41  Score=311.72  Aligned_cols=247  Identities=31%  Similarity=0.454  Sum_probs=201.3

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEecCCCCHH
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLA  194 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~  194 (408)
                      ++||+|+||.||+|...++..||+|.+......+....+.+|+.+++.++||||+++++++... ..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998889999999988766555566789999999999999999999976654 578999999999999


Q ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceeccccc
Q 015389          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (408)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  274 (408)
                      +++......+++..+..++.+++.||.|||+   ++++||||||+||+++.++.++|+|||++......... ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence            9987666678999999999999999999998   99999999999999999999999999998754332111 1122335


Q ss_pred             CCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       275 t~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      +..|+|||++.++.++.++||||||+++|+|++ |..||........            ...+........+...+..+.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~  224 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------------REQVEKGYRMSCPQKCPDDVY  224 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------------HHHHHcCCCCCCCCCCCHHHH
Confidence            678999999998899999999999999999998 9999975432211            111111111222233456788


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHh
Q 015389          354 LAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +++.+|++.+|++||++.++++.|.
T Consensus       225 ~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         225 KVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHcccCcccCCCHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.3e-41  Score=313.90  Aligned_cols=252  Identities=29%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP  189 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~  189 (408)
                      ++|.+.+.||+|+||.||+|.+.++..||+|.+.....  ....+.+|+.+++.++|||++++++++..+..++||||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCC
Confidence            56888999999999999999987777899998875432  2356788999999999999999999887778899999999


Q ss_pred             CCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          190 NGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       190 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      +++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            99999999653 3458899999999999999999999   9999999999999999999999999999986643211 11


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....++..|+|||...+..++.++|||||||++|+|++ |..||.......            ....+........+..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~  227 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------------VLEQVERGYRMPCPQG  227 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------------HHHHHHcCCCCCCCcc
Confidence            122346778999999988899999999999999999999 899987543211            1111111111122234


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            45678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-41  Score=323.01  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~  180 (408)
                      .++|.+.+.||+|+||.||+|...      .+..||||.+...........+.+|+.+++++ +||||+++++++.. +.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            367899999999999999999741      35689999988665555567889999999999 79999999997665 45


Q ss_pred             eEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          181 MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      .++|+||+.+|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            789999999999999996533 348999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      +.............++..|+|||.+.++.++.++|||||||++|||++ |..||......           ......+..
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----------~~~~~~~~~  259 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----------SKFYKLIKE  259 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----------HHHHHHHHc
Confidence            654322222223446788999999999999999999999999999998 99998753321           111122222


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ......+......+.+++.+|++.+|++||++.+|++.|+..
T Consensus       260 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            222222223346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-41  Score=320.44  Aligned_cols=257  Identities=23%  Similarity=0.344  Sum_probs=204.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  181 (408)
                      .++|.+.+.||.|+||.||++...      ++..+|+|.+.... ......+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            367889999999999999999742      35678999887654 3346778899999999999999999997765 457


Q ss_pred             EEEEEecCCCCHHHHHhccc------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          182 HIVLELSPNGSLASLLYGMK------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      ++|+||+++++|.+++....            ..+++..++.++.|++.||.|||+   ++++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence            89999999999999986432            248999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  328 (408)
                      +|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........        
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~--------  231 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV--------  231 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------
Confidence            9999999986643322222233446788999999998899999999999999999998 8999875432211        


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                         +..+ ........+......+.+++.+||+.+|.+|||+.+|+..|+.+.
T Consensus       232 ---~~~i-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         232 ---IECI-TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             ---HHHH-HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence               0011 110001111223456899999999999999999999999997765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.1e-41  Score=316.54  Aligned_cols=253  Identities=27%  Similarity=0.409  Sum_probs=204.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .+|.+.+.||.|+||.||+|.+. .++.||+|.+....  .....+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            56888899999999999999865 58899999987543  235678899999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++... ...+++..++.++.|++.||.|||+   ++++||||||+||++++++.+||+|||++.........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999998653 3468999999999999999999999   99999999999999999999999999999876443211


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |..||......            .....+........+
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------------~~~~~~~~~~~~~~~  227 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYELLEKGYRMERP  227 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------HHHHHHHCCCCCCCC
Confidence             1122334678999999999999999999999999999998 89998753221            111112222222333


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            34556788999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=312.95  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=202.0

Q ss_pred             ceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||+|.+..    +..||+|.+...........+..|+.+++.++||||+++++++.....++|+||++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            469999999999997532    3689999998766545567889999999999999999999988877889999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce-ec
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-IS  270 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~  270 (408)
                      +|.+++... ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+........ ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~  156 (257)
T cd05060          81 PLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT  156 (257)
T ss_pred             cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence            999999643 378999999999999999999999   9999999999999999999999999999987644322211 11


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.......            +...+........+...+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~  224 (257)
T cd05060         157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE------------VIAMLESGERLPRPEECP  224 (257)
T ss_pred             CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH------------HHHHHHcCCcCCCCCCCC
Confidence            2224568999999999999999999999999999998 999997543221            111111111112223345


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          350 NLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+.+++.+|++.+|.+||++.+|++.|+++-
T Consensus       225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         225 QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            67889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.3e-41  Score=313.53  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=206.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +++.||||.+....  ..+....+.+|+.+++.++||||+++++++.. +..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999865 68999999876422  23456678899999999999999999996654 5678999


Q ss_pred             EecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998853   23457889999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-hcc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-SLA  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~  341 (408)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........+.          ..+.. ...
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~----------~~~~~~~~~  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC----------QKIEQCDYP  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH----------HHHhcCCCC
Confidence            221  12234688999999999988899999999999999999999999865432211111          11111 111


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111234456789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.5e-41  Score=315.70  Aligned_cols=256  Identities=28%  Similarity=0.394  Sum_probs=205.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      .+|++.+.||+|+||.||+|.+.    .+..+|+|.+...........+.+|+.++++++||||+++++++.. +..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999764    2347999999766555567788999999999999999999997665 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++......+++..++.++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++..+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999997666678999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccce-ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THHT-ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .... .....++..|+|||.+.+..++.++|||||||++||+++ |..||........           ...+. .....
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~-----------~~~~~-~~~~~  228 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV-----------IKAIE-EGYRL  228 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH-----------HHHHh-CCCcC
Confidence            2111 112234568999999999899999999999999999887 9999875332110           00111 11111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ......+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            11223456788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.6e-41  Score=315.51  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=206.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CC---cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NG---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.+...........+..|+.+++.++|||++++++++.. +..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357888899999999999999865 23   37999998766545556788899999999999999999997665 45789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            999999999999997666779999999999999999999999   99999999999999999999999999999866443


Q ss_pred             Ccccee-cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          264 WTHHTI-SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       264 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...... .....+..|+|||++.++.++.++|||||||++|||++ |+.||......            .+...+.....
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------------~~~~~i~~~~~  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------------EVMKAINDGFR  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------------HHHHHHhcCCC
Confidence            221111 11223567999999998899999999999999999997 99999653321            11111111112


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .......+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       229 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222233456788999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-41  Score=323.42  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=207.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-  178 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-  178 (408)
                      .++|.+.+.||+|+||.||+|...        ++..||+|.+...........+.+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999641        24579999987654445567889999999999 89999999997665 


Q ss_pred             CCeEEEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          179 GGMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      ...++||||+.+|+|.+++...               ...+++..+..++.||+.||.|||+   ++++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            4578999999999999999642               1347888899999999999999999   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.+||+|||++..+.............++..|+|||++.+..++.++||||||+++|+|++ |..||......    
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----  246 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----  246 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence            9999999999999987654332222233446778999999999899999999999999999998 78888643211    


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                              .+...+........+...+..+..++.+||+.+|.+||++.+|++.|+++...
T Consensus       247 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 --------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                    11111111111122234556788899999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-41  Score=323.27  Aligned_cols=259  Identities=27%  Similarity=0.409  Sum_probs=206.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-  178 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-  178 (408)
                      .++|.+.+.||+|+||.||+|...        .+..||+|.+...........+..|+.+++.+ +||||+++++++.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999999752        23579999998665445567788999999999 79999999997665 


Q ss_pred             CCeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          179 GGMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      +..++|+||+++|+|.+++....               ..+++..++.++.|++.||+|||+   ++++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            45789999999999999996432               348889999999999999999998   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            9999999999999986643211111122334578999999999999999999999999999998 88888643221    


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                              .+...+........+......+.+++.+|++.+|.+||++.+|++.|+.+..
T Consensus       250 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         250 --------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             --------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                    1111122222222233445678889999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-41  Score=318.06  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|++.+.||+|+||.||+|...+      +..||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4688999999999999999997642      4689999987665445567788999999999999999999976654 57


Q ss_pred             EEEEEecCCCCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          182 HIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                      ++||||+++|+|.+++....         ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence            89999999999999985422         246888999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccch
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      |||+++.+.............++..|+|||.+.++.++.++|||||||++|||++ |..||........           
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----------  230 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-----------  230 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-----------
Confidence            9999986543322222233457889999999998899999999999999999998 8999864332211           


Q ss_pred             HHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       332 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                       ...+........+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       231 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 -LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             1111111111122234667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.3e-41  Score=316.10  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=204.9

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-C---cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..|++.+.||+|+||.||+|.+.. +   ..||||.+.....+.....+..|+.+++.++||||+++++++.++ ..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999998653 3   369999998765555678899999999999999999999977654 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++++|.+++......+++..++.++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            99999999999997666778999999999999999999999   999999999999999999999999999998664432


Q ss_pred             ccceecc-cc--cCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          265 THHTISK-VE--GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       265 ~~~~~~~-~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ....... ..  .+..|+|||++.++.++.++|||||||++|||++ |..||.......            +...+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------------~~~~i~~~~  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------------VINAIEQDY  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------------HHHHHHcCC
Confidence            2211111 11  2457999999999999999999999999999886 999986532211            111111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ....+...+..+.+++.+||+.+|++||++.+|+..|+..
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1122233456688899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.4e-41  Score=316.66  Aligned_cols=267  Identities=26%  Similarity=0.366  Sum_probs=205.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~  181 (408)
                      .+|++.+.||+|+||.||+|..+     ++..||+|.+..... .....+.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            57889999999999999999742     588999999876543 345778899999999999999999996543   347


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++..+.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            89999999999999997666678999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcccee-cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc----ccchHHHHh
Q 015389          262 EQWTHHTI-SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI----KRNEIRELV  336 (408)
Q Consensus       262 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~  336 (408)
                      ........ ....++..|+|||.+.+..++.++|||||||++|||++|..++...............    ....+.+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            43222111 1223445699999999889999999999999999999998776543221111000000    001111222


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ............+..+.+++.+||+.+|++|||+.+|+..|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            22212122233456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-41  Score=328.23  Aligned_cols=241  Identities=23%  Similarity=0.302  Sum_probs=193.6

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||++... +|..||+|.+....  .......+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542  22345677889999999999999999986554 5578999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      +|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~  154 (323)
T cd05595          81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence            99988843 4578999999999999999999999   99999999999999999999999999998753221  112234


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      ..||+.|+|||++.++.++.++|||||||++|||++|+.||.........           ..+....  ..++......
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-----------~~~~~~~--~~~p~~~~~~  221 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----------ELILMEE--IRFPRTLSPE  221 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-----------HHHhcCC--CCCCCCCCHH
Confidence            67999999999999999999999999999999999999999754322110           1111111  1122234556


Q ss_pred             HHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       352 l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      +.+++.+||+.||.+||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            78899999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=346.96  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=211.5

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEcCC-cEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEe-EEEe----
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLG-YGIE----  178 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~g-~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~-~~~~----  178 (408)
                      .+...++++.++|.+|||+.||+|.+..+ ..||+|++... .+.....+.+|+.+|+.|. |+|||.+++ ....    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            45567889999999999999999997765 99999999877 5567888999999999996 999999999 3221    


Q ss_pred             C---CeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          179 G---GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       179 ~---~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                      +   ++.|+||||.||.|.+++.. ....|++.++++|+.++++|+.+||. ++.+|||||||-+||||..+|..|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            1   25689999999999999964 23449999999999999999999996 5567999999999999999999999999


Q ss_pred             CCcccCCCCC-ccceec------ccccCCCccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc
Q 015389          255 GLAKWLPEQW-THHTIS------KVEGTFGYLAPEFL---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR  324 (408)
Q Consensus       255 Gla~~~~~~~-~~~~~~------~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  324 (408)
                      |.|.-..... ......      ...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+..+.-.     
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----  265 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----  265 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence            9986432221 111100      11368999999976   46789999999999999999999999999764431     


Q ss_pred             cccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       325 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                                +++..........+...+..||..||+.||.+||++-||++.+-.+...
T Consensus       266 ----------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  266 ----------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             ----------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                      2222233333467889999999999999999999999999988766543

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.3e-41  Score=340.83  Aligned_cols=250  Identities=21%  Similarity=0.256  Sum_probs=200.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-C-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-N-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ..|.+.+.||+|+||.||+|... + ++.||+|.+..... .....+.+|+.+++.++||||+++++++.. +..++|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            34889999999999999999754 3 67889997755432 344667789999999999999999996665 55789999


Q ss_pred             ecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+++|+|.+++..   ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999998853   24468899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|+.||........           +..+.... ...
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-----------~~~~~~~~-~~~  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-----------MQQVLYGK-YDP  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhCC-CCC
Confidence            332334456799999999999999999999999999999999999999975432111           11111110 111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+......+..++.+||+.+|.+||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            22234567888999999999999999999864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-41  Score=328.86  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             cCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe--C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE--G  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--~  179 (408)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.+...........+.+|+.++.++ +||||+++++++..  .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            36899999999999999999973      247899999998655555567788999999999 68999999997654  3


Q ss_pred             CeEEEEEecCCCCHHHHHhccc----------------------------------------------------------
Q 015389          180 GMHIVLELSPNGSLASLLYGMK----------------------------------------------------------  201 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  201 (408)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            4689999999999999985421                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          202 --------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       202 --------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                              ..+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    236778888999999999999999   999999999999999999999999999998654322222222344


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLV  352 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  352 (408)
                      ++..|+|||.+.+..++.++||||||+++|+|++ |..||.......           .+...+........+......+
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~  311 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----------EFCRRLKEGTRMRAPDYTTPEM  311 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----------HHHHHHhccCCCCCCCCCCHHH
Confidence            6778999999999999999999999999999997 888986532211           0111111111111111123468


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          353 LLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       353 ~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+++..||+.+|.+||++.+|++.|+.+.+
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            889999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.7e-41  Score=319.31  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-----------------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-----------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK  171 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  171 (408)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|.+...........+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4688999999999999999987542                 24689999987665566788899999999999999999


Q ss_pred             EEeEEEe-CCeEEEEEecCCCCHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCc
Q 015389          172 LLGYGIE-GGMHIVLELSPNGSLASLLYGMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (408)
Q Consensus       172 l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~N  240 (408)
                      +++++.. ...++|+|++++++|.+++....          ..+++..++.++.|++.||.|||+   .+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9997766 55789999999999999986533          268999999999999999999999   999999999999


Q ss_pred             eEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccc
Q 015389          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT--GRRALDYSQQS  318 (408)
Q Consensus       241 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--g~~pf~~~~~~  318 (408)
                      |+++.++.++|+|||++..+.............++..|+|||.+.++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986544322223334557789999999998899999999999999999998  66777643221


Q ss_pred             hhh-hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          319 LVL-WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       319 ~~~-~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ... .........      ........+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            110 000000000      000001112233467899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-41  Score=319.10  Aligned_cols=257  Identities=23%  Similarity=0.332  Sum_probs=205.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            56888899999999999999742      356789998875543 3346788999999999999999999977664 478


Q ss_pred             EEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          183 IVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +||||+++++|.+++...               ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCC
Confidence            999999999999999642               2348899999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||........      
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------  234 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------  234 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence            999999999986544322222233457889999999999999999999999999999999 9999865432211      


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                            .+.+............+..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       235 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 ------IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ------HHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                  11111111111222345678899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-41  Score=327.73  Aligned_cols=242  Identities=23%  Similarity=0.293  Sum_probs=194.5

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||++... +|+.||||++....  .......+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542  23345678899999999999999999986655 4578999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      +|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ......
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            99988853 4578999999999999999999999   99999999999999999999999999998754321  122234


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+...  ...++......
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~-----------~~~~~~--~~~~p~~~~~~  221 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------ELILME--DIKFPRTLSAD  221 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH-----------HHhccC--CccCCCCCCHH
Confidence            67999999999999999999999999999999999999999754322110           000000  01122233456


Q ss_pred             HHHHHHhccccCCCCCC-----CHHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRP-----QMSQVVQL  376 (408)
Q Consensus       352 l~~li~~cl~~~P~~RP-----t~~evl~~  376 (408)
                      +..++.+||+.||.+||     ++.++++.
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            78899999999999997     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-42  Score=333.88  Aligned_cols=251  Identities=25%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|.+.+.||+|+||+||+|... +|+.||||++.....  ......+..|+.++..++||||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999876 699999999975421  2345678899999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC-
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW-  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-  264 (408)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999654 678999999999999999999999   999999999999999999999999999998765432 


Q ss_pred             --------------------------ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 015389          265 --------------------------THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS  318 (408)
Q Consensus       265 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~  318 (408)
                                                .........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001223456999999999999999999999999999999999999999764422


Q ss_pred             hhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 015389          319 LVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ-MSQVVQL  376 (408)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~~  376 (408)
                      ..           ...+..  ..+...........+..++.+|+. +|.+||+ +.++++.
T Consensus       237 ~~-----------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ET-----------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-----------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11           111111  111111111135667889999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-41  Score=313.69  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=201.2

Q ss_pred             CCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC------
Q 015389          112 FSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------  180 (408)
                      |.+.+.||+|+||.||+|....    +..||||.+..... ......+.+|+..++.++||||+++++++....      
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999998642    47899999876432 334677899999999999999999999765432      


Q ss_pred             -eEEEEEecCCCCHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          181 -MHIVLELSPNGSLASLLYGM-----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                       .++++||+++|+|..++...     ...+++..+..++.|++.||.|||+   ++++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             58999999999999988432     2468899999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......            +.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~------------~~  225 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------------IY  225 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH------------HH
Confidence            99987644322222222345678999999988899999999999999999999 888886533211            11


Q ss_pred             HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       334 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+........+......+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111111122234556789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.2e-42  Score=331.60  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=200.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|.+.+.||+|+||+||+|... +|+.||+|++.....  .+....+..|+.+++.++||||+++++++.+ ...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999875 689999999986432  2345677889999999999999999986665 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            9999999999997666789999999999999999999999   9999999999999999999999999999987654322


Q ss_pred             cceecccccCCCcccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-
Q 015389          266 HHTISKVEGTFGYLAPEFLM------HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-  338 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-  338 (408)
                      . ......||+.|+|||++.      +..++.++|||||||++|||++|+.||........           ...+... 
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------~~~i~~~~  225 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----------YNNIMNFQ  225 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----------HHHHHcCC
Confidence            1 223356999999999987      45678999999999999999999999975432211           1111110 


Q ss_pred             -hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 -SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 -~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       .+...........+..++..|++ +|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         226 RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence             01111112345567889999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=309.03  Aligned_cols=248  Identities=28%  Similarity=0.423  Sum_probs=201.0

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCHH
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLA  194 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~  194 (408)
                      ++||.|+||.||+|.+.+++.||+|.+......+....+.+|+.++++++||||+++++++.+ ...++|+||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998876555556788999999999999999999997665 4578999999999999


Q ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceeccccc
Q 015389          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (408)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  274 (408)
                      +++......+++..+..++.+++.||.|||+   ++++||||+|+||+++.++.++|+|||++................+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            9997666678899999999999999999999   9999999999999999999999999999986543211111112234


Q ss_pred             CCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       275 t~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      +..|+|||.+.++.++.++|||||||++|+|++ |..||......            .....+........+...+..+.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~  225 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------------QTRERIESGYRMPAPQLCPEEIY  225 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------------HHHHHHhcCCCCCCCccCCHHHH
Confidence            667999999998999999999999999999999 88888654321            11111111111222334456788


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHh
Q 015389          354 LAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +++.+|++.+|.+||++.+|++.|+
T Consensus       226 ~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         226 RLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHhccChhhCcCHHHHHHHhh
Confidence            9999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=320.85  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             CCCCccceecccCcEEEEEEEEcC---------------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN---------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      ++|++.+.||+|+||.||++...+               ...||+|.+...........+.+|+++++.++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            689999999999999999987532               23589999987655556678899999999999999999999


Q ss_pred             EEEe-CCeEEEEEecCCCCHHHHHhccc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          175 YGIE-GGMHIVLELSPNGSLASLLYGMK-----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       175 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                      ++.. ...++||||+++++|.+++....           ..+++..++.++.|++.||.|||+   .+++|+||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            7665 45789999999999999985421           236788899999999999999999   99999999999999


Q ss_pred             ECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccchh
Q 015389          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT--GRRALDYSQQSLV  320 (408)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--g~~pf~~~~~~~~  320 (408)
                      ++.++.+||+|||++..+.............++..|+|||.+.++.++.++|||||||++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222233446788999999999999999999999999999998  5567764322111


Q ss_pred             hhhccccccchHHHHhhh---hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          321 LWARPMIKRNEIRELVDA---SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      .-        ........   ......+...+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus       242 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IE--------NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HH--------HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            00        00000110   0011112223467999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-41  Score=329.79  Aligned_cols=246  Identities=22%  Similarity=0.331  Sum_probs=199.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC--CcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~--g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|.+.+.||+|+||.||+|.+.+  +..||+|.+....  .......+.+|+.+++.++||||+++++++.++ ..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3689999999999999999998643  4689999986532  223456788999999999999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...
T Consensus       109 v~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999954 4568999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+.....  .
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-----------~~i~~~~~--~  246 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-----------QKILEGII--Y  246 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-----------HHHhcCCC--C
Confidence                 23456999999999999989999999999999999999999999764332110           11111111  1


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~  376 (408)
                      ++......+..++.+||+.+|.+|+     ++.++++.
T Consensus       247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1222344577899999999999995     88888764

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-41  Score=333.78  Aligned_cols=261  Identities=25%  Similarity=0.371  Sum_probs=206.5

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-  178 (408)
                      ...++|.+.+.||+|+||.||+|.+.      .+..||||++...........+.+|+.++..+. ||||+++++++.. 
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34467888999999999999999853      246899999987655555567889999999997 9999999997665 


Q ss_pred             CCeEEEEEecCCCCHHHHHhccc---------------------------------------------------------
Q 015389          179 GGMHIVLELSPNGSLASLLYGMK---------------------------------------------------------  201 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  201 (408)
                      +..++|+||+.+|+|.++++..+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            55799999999999999996422                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCce
Q 015389          202 ----------------------------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (408)
Q Consensus       202 ----------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NI  241 (408)
                                                              ..+++..+..++.||+.||.|||+   ++++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceE
Confidence                                                    135667788899999999999998   9999999999999


Q ss_pred             EECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchh
Q 015389          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLV  320 (408)
Q Consensus       242 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~  320 (408)
                      |+++++.++|+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |+.||....... 
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-  349 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-  349 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence            999999999999999986543222112223457889999999998899999999999999999998 888986432211 


Q ss_pred             hhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          321 LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                                .....+....+...+......+.+++.+||+.+|.+||++++|++.|+...
T Consensus       350 ----------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 ----------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                      111222222222223334567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5e-41  Score=319.89  Aligned_cols=258  Identities=28%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-C--cEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-G--QLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g--~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++..........+.+|+.++.++ +||||+++++++... ..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999998753 3  347888887554445567789999999999 799999999977654 47899


Q ss_pred             EEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          185 LELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      +||+++++|.+++....               ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999995422               358889999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  328 (408)
                      ||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......         
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---------  226 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------  226 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            999999986432111   1111223567999999988899999999999999999997 999997543221         


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                         ....+........+......+.+++.+||+.+|.+||++.++++.|+.+....+
T Consensus       227 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         227 ---LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             ---HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence               111111111222223345678889999999999999999999999988775543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.3e-41  Score=325.28  Aligned_cols=244  Identities=25%  Similarity=0.353  Sum_probs=192.7

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHH---hcCCCCceeEEEeEEEe-CCeEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIM---AHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il---~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      |++.+.||+|+||.||+|.+. +|+.||||++....  .......+..|..++   ..++||||+++++++.. +..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999875 58999999997542  122345566666554   56789999999997665 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|..++.  ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05589          81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-  154 (324)
T ss_pred             EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence            99999999998884  4578999999999999999999999   99999999999999999999999999998753221 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       ........|++.|+|||.+.+..++.++|||||||++|+|++|+.||........           ...+....  ..+
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-----------~~~i~~~~--~~~  220 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-----------FDSIVNDE--VRY  220 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhCC--CCC
Confidence             1223456799999999999999999999999999999999999999975432211           11111111  112


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      +......+.+++.+||+.||.+||     ++.++++
T Consensus       221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            223456678899999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.5e-41  Score=330.18  Aligned_cols=203  Identities=24%  Similarity=0.361  Sum_probs=173.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|... +++.||||++.....  .+....+..|+.++.+++||||+++++.+.+ ...++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999875 589999999975422  2345677889999999999999999986665 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999999954 4678999999999999999999999   9999999999999999999999999999976532110


Q ss_pred             c---------------------------------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015389          266 H---------------------------------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL  312 (408)
Q Consensus       266 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf  312 (408)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012357999999999999999999999999999999999999999


Q ss_pred             Cccc
Q 015389          313 DYSQ  316 (408)
Q Consensus       313 ~~~~  316 (408)
                      ....
T Consensus       237 ~~~~  240 (363)
T cd05628         237 CSET  240 (363)
T ss_pred             CCCC
Confidence            7543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6.2e-41  Score=317.50  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+...........+.+|+.+++.++||||+++++++.++ ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46789999998665555567788999999999999999999976654 57


Q ss_pred             EEEEEecCCCCHHHHHhccc---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCc
Q 015389          182 HIVLELSPNGSLASLLYGMK---------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~N  240 (408)
                      ++|+||+++|+|.+++....                     ..+++..++.++.|++.||.|||+   ++++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            89999999999999996321                     247788899999999999999999   999999999999


Q ss_pred             eEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccch
Q 015389          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSL  319 (408)
Q Consensus       241 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~  319 (408)
                      |+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543222222222335678999999998999999999999999999998 888886432211


Q ss_pred             hhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                                  ....+........+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus       241 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ------------VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                        111111110111122345678889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.6e-41  Score=332.23  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=194.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +|.+++.||+|+||+||+|... +++.||||++....  .......+..|+.++..++||||+++++++.+ +..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999865 58999999997543  23346778899999999999999999997665 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc-
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT-  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-  265 (408)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999999854 4568888999999999999999999   9999999999999999999999999999764311000 


Q ss_pred             --------------------------------------------cceecccccCCCccccccccCCCCCcchhHHHHHHH
Q 015389          266 --------------------------------------------HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVL  301 (408)
Q Consensus       266 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvi  301 (408)
                                                                  ........||+.|+|||.+.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123569999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccccchhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHh--ccccCCCCCCCHHHHHHH
Q 015389          302 LLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASL--CIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       302 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~--cl~~~P~~RPt~~evl~~  376 (408)
                      +|||++|+.||.........           ..+..  ..+...........+.+++.+  |+..+|..||++.+++..
T Consensus       238 l~elltG~~Pf~~~~~~~~~-----------~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ-----------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH-----------HHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999999764332111           01111  001111111223455567766  556667779999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-41  Score=326.82  Aligned_cols=251  Identities=22%  Similarity=0.309  Sum_probs=195.5

Q ss_pred             CCCccceecccCcEEEEEEEE----cCCcEEEEEEecCCC---chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCe
Q 015389          111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~---~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~  181 (408)
                      +|++.+.||+|+||.||++..    .+|+.||+|++.+..   .......+..|+.++..+ +||||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588899999999999999975    258899999987532   223456678899999999 59999999986654 457


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            899999999999999854 4568999999999999999999999   999999999999999999999999999998653


Q ss_pred             CCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........        ..+...+.. .
T Consensus       157 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------~~~~~~~~~-~  226 (332)
T cd05614         157 SEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------SEVSRRILK-C  226 (332)
T ss_pred             ccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--------HHHHHHHhc-C
Confidence            32221 22345799999999999865 4789999999999999999999999743221000        001000000 1


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ....+......+.+++.+||+.||++||     ++.++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1122223455678899999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=309.71  Aligned_cols=248  Identities=31%  Similarity=0.463  Sum_probs=204.8

Q ss_pred             ceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|....    +..||+|.+...........+.+|+.++..++|+|++++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998753    889999999876655457888999999999999999999997666 457899999999


Q ss_pred             CCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          191 GSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       191 g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ++|.+++...        ...+++..++.++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999765        4779999999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...........++..|+|||.+.+..++.++|||||||++|+|++ |..||......            .+...+.....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------------EVLEYLRKGYR  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------------HHHHHHHcCCC
Confidence            332222344567899999999988899999999999999999999 69999764221            11111111112


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ...+...+..+.+++.+|++.+|.+||++.+++..|+
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            2223344678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.7e-41  Score=318.33  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=201.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-----------------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-----------------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL  172 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l  172 (408)
                      ++|++.+.||+|+||.||++...                 ++..||+|.+...........+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999998532                 2457999999866555566788999999999999999999


Q ss_pred             EeEEEe-CCeEEEEEecCCCCHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCce
Q 015389          173 LGYGIE-GGMHIVLELSPNGSLASLLYGMK----------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (408)
Q Consensus       173 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NI  241 (408)
                      ++++.. ...++||||+++++|.+++....          ..+++..++.++.|++.||.|||+   .+++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            997665 45789999999999999986432          236778899999999999999999   9999999999999


Q ss_pred             EECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccch
Q 015389          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT--GRRALDYSQQSL  319 (408)
Q Consensus       242 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--g~~pf~~~~~~~  319 (408)
                      +++.++.++|+|||++..+.............++..|+|||...++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222223345678999999888899999999999999999998  677876432211


Q ss_pred             hhhhccccccchHHHHhhhh---ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          320 VLWARPMIKRNEIRELVDAS---LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ...        .........   .....+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       242 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIE--------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH--------HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            110        000111100   011112234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-40  Score=308.68  Aligned_cols=249  Identities=26%  Similarity=0.387  Sum_probs=204.0

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||+|++|.||+|... +|+.|++|.+.... .......+.+|+.+++.++||||+++++++.+. ..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999875 68999999987532 234567788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++... ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999664 4678999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                       ......|++.|+|||++.++.++.++|||||||++|+|++|+.||........           .... ..........
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~-~~~~~~~~~~  223 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-----------ILKI-IRGVFPPVSQ  223 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHH-HcCCCCCCcc
Confidence             12345688999999999999999999999999999999999999975442211           1111 1111122223


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .....+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            456678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=332.71  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|... +|+.||||++....  .......+.+|+.++..++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999876 58999999997542  223456678899999999999999999966654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999999854 4568999999999999999999999   9999999999999999999999999999876532111


Q ss_pred             cc------------------------------------eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 015389          266 HH------------------------------------TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR  309 (408)
Q Consensus       266 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~  309 (408)
                      ..                                    ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011246999999999999999999999999999999999999


Q ss_pred             CCCCccccchhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 015389          310 RALDYSQQSLVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ---MSQVVQ  375 (408)
Q Consensus       310 ~pf~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~  375 (408)
                      .||.........           ..+..  ..+...........+.+++.+|+. +|.+|++   +.++++
T Consensus       237 ~Pf~~~~~~~~~-----------~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQETY-----------RKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHHH-----------HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999764332111           01110  001111111234567778888996 9999997   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.4e-41  Score=320.91  Aligned_cols=258  Identities=27%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-  179 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-  179 (408)
                      ++|.+.+.||+|+||.||+|...        .+..||+|.+...........+..|+.+++++ +||||+++++++... 
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            67889999999999999999742        24579999988655555577888999999999 699999999977654 


Q ss_pred             CeEEEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC
Q 015389          180 GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT  244 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~  244 (408)
                      ..++|+||+++|+|.+++...               ...+++..+..++.||+.||.|||+   ++++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            478999999999999999542               1358888999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhh
Q 015389          245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWA  323 (408)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~  323 (408)
                      .++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|+|++ |..||.......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----  244 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE----  244 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986643222111122334568999999999999999999999999999999 888886532211    


Q ss_pred             ccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          324 RPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       324 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                              +...+........+......+.+++.+||+.+|.+||++.++++.|.+...
T Consensus       245 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 --------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             --------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                    111111111112223345578889999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-40  Score=309.10  Aligned_cols=256  Identities=27%  Similarity=0.411  Sum_probs=206.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||.|+||.||+|... +|+.||+|.++...  .......+.+|+.++++++|+|++++++++.+ +..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999876 79999999886422  22346778899999999999999999996665 4578999


Q ss_pred             EecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+++++|.+++..   ....+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998853   34558899999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........          ...+......
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------~~~~~~~~~~  226 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL----------CKKIEKCDYP  226 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH----------HhhhhcCCCC
Confidence            221  1223458899999999998899999999999999999999999986543221111          0011111111


Q ss_pred             ccc-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          343 EYD-TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       343 ~~~-~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+ ......+.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            111 24556788999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.6e-41  Score=315.48  Aligned_cols=254  Identities=21%  Similarity=0.348  Sum_probs=201.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+.... ......+.+|+.+++.++|+||+++++++..+ ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            57788899999999999999632      36689999887544 33467889999999999999999999977664 478


Q ss_pred             EEEEecCCCCHHHHHhccc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          183 IVLELSPNGSLASLLYGMK--------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      +++||+++++|.+++....              ..+++..++.++.|++.||.|||+   ++++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCC
Confidence            9999999999999986532              347889999999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccc
Q 015389          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  327 (408)
                      ++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||........       
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence            99999999976543222222223345788999999999999999999999999999998 8999864322111       


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                           ...+........+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 -----IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -----HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                 11111111111222345668899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.2e-41  Score=321.58  Aligned_cols=260  Identities=21%  Similarity=0.305  Sum_probs=198.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999875 5889999998765443334567789999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+ +|.+++......+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            975 8888886666678999999999999999999999   999999999999999999999999999997543321  1


Q ss_pred             eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-ccc---ccchHHHH------h
Q 015389          268 TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PMI---KRNEIREL------V  336 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~---~~~~~~~~------~  336 (408)
                      ......+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............ ...   .......+      .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2233458899999999865 46899999999999999999999999764432111000 000   00000000      0


Q ss_pred             hhhccCc-------ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADE-------YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~-------~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......       ........+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000       00123456788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.9e-41  Score=331.42  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=199.1

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~  180 (408)
                      +....++|++.+.||+|+||.||+|.+. +++.||+|.+.+..  .......+..|+.+++.++||||+++++++.++ .
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445578999999999999999999876 58899999986532  122345677899999999999999999966654 5


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++|+|.+++..  ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            7899999999999999843  458888999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccceecccccCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHG----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      .... ........||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.......           ....+.
T Consensus       193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----------~~~~i~  260 (370)
T cd05621         193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----------TYSKIM  260 (370)
T ss_pred             ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----------HHHHHH
Confidence            4321 1122356799999999998754    37899999999999999999999997543211           111222


Q ss_pred             hhh--ccCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015389          337 DAS--LADEYDTRQMNLVLLAASLCIQQSSIR--RPQMSQVVQL  376 (408)
Q Consensus       337 d~~--l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~  376 (408)
                      +..  +...........+..++..|+..++.+  ||++.++++.
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            211  111111233556777888999865544  8899999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-40  Score=313.46  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=197.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+......+....+.+|+.++++++||||+++++++.. +..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999999864 6899999998766545556778999999999999999999996655 557899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|..+.     .+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++..+...    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997543     46788889999999999999999   99999999999999999999999999999765432    


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......||..|+|||++.+..++.++|||||||++|+|++|+.||..........    ........+.+..........
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  224 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL----MPLQLLQCIVDEDPPVLPVGQ  224 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc----chHHHHHHHhccCCCCCCCCc
Confidence            2234568999999999999999999999999999999999999997532211000    000011111111111111112


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+.+++.+|++.+|.+||++.++++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            34567889999999999999999998874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=308.38  Aligned_cols=248  Identities=30%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .++|++.+.||.|+||.||+|... |+.||||.+.....  ...++.+|+.+++.++|+||+++++++.+ ...++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            467889999999999999999875 78899999976643  46778899999999999999999997764 567899999


Q ss_pred             cCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999996533 368999999999999999999999   9999999999999999999999999999987633211 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                          ...++..|+|||++.++.++.++||||||+++|+|++ |..||.......            +...+........+
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~  221 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------VVPHVEKGYRMEAP  221 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH------------HHHHHhcCCCCCCc
Confidence                2335678999999998899999999999999999997 999986532211            11111111111122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ...+..+.+++.+||..+|++||++.+|++.|+.
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            2345678899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-41  Score=332.19  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=195.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....  ..+....+.+|+.++++++||||+++++++.+. ..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999865 68999999986532  223456788999999999999999999976664 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999999854 4568899999999999999999999   9999999999999999999999999999964321100


Q ss_pred             c------------c---------------------------------eecccccCCCccccccccCCCCCcchhHHHHHH
Q 015389          266 H------------H---------------------------------TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGV  300 (408)
Q Consensus       266 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGv  300 (408)
                      .            .                                 ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCccccchhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 015389          301 LLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRR---PQMSQVVQ  375 (408)
Q Consensus       301 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~~evl~  375 (408)
                      ++|||++|..||.........           ..+..  ..+.-.........+.+++.+||. +|.+|   +++.+++.
T Consensus       237 il~elltG~~Pf~~~~~~~~~-----------~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETY-----------RKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHH-----------HHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            999999999999754322110           00100  000000011234567789999997 66665   59999887


Q ss_pred             H
Q 015389          376 L  376 (408)
Q Consensus       376 ~  376 (408)
                      .
T Consensus       305 h  305 (377)
T cd05629         305 H  305 (377)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-40  Score=309.82  Aligned_cols=254  Identities=29%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ..++|.+.+.||.|+||.||+|..++++.||||.+......  ...+.+|+.+++.++||||+++++++.. ...++|+|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            44789999999999999999999888888999998865432  3568899999999999999999997766 56889999


Q ss_pred             ecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++++|.+++.... ..+++..+..++.+++.||.|||+   ++++|+||||+||+++.++.++|+|||++..+.....
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            999999999996543 468999999999999999999999   9999999999999999999999999999987653211


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.........           .. +........
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-----------~~-~~~~~~~~~  225 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-----------EQ-VERGYRMPR  225 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------HH-HHcCCCCCC
Confidence             11122235678999999998899999999999999999998 99998653321110           01 111111111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      +...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            22235678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-41  Score=324.02  Aligned_cols=241  Identities=24%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             ceecccCcEEEEEEEE----cCCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +.||+|+||.||++..    .+++.||||++.....   ......+..|+.+++.++||||+++++++.. +..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999975    2588999999875321   2234567789999999999999999986554 557899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+++|.+++.. ...+.+..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            999999999854 4567888888999999999999999   999999999999999999999999999987532221  1


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........           +..+.....  ..+..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-----------~~~~~~~~~--~~~~~  222 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-----------IDKILKGKL--NLPPY  222 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----------HHHHHcCCC--CCCCC
Confidence            22345699999999999998999999999999999999999999975432211           111111111  11223


Q ss_pred             HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ....+.+++.+||+.+|++||     ++.++++
T Consensus       223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            345678899999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-40  Score=313.78  Aligned_cols=268  Identities=25%  Similarity=0.363  Sum_probs=211.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~  181 (408)
                      +.|++.+.||+|+||.||+|.+.     ++..||||.+...........+.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46778899999999999999853     3789999999876554456788999999999999999999997765   247


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            89999999999999997766679999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc---cchHHHHhh
Q 015389          262 EQWTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK---RNEIRELVD  337 (408)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~d  337 (408)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........+......   ...+...+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            322211 1112345667999999988899999999999999999999999986533222111111111   111222222


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .......+..++..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            2222222334457799999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.1e-41  Score=323.94  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=192.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCC-ceeEEEeEEEe-CCeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP-NTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hp-niv~l~~~~~~-~~~~lv~  185 (408)
                      +|++.+.||+|+||.||+|... +++.||||++....  .......+..|..++..++|+ +|+++++++.. +..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999876 57899999997542  233456778899999999765 57888876554 5588999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~--  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--  154 (324)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence            99999999999853 4568899999999999999999999   99999999999999999999999999998743221  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+...  ...++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-----------~~i~~~--~~~~~  221 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-----------QSIMEH--NVSYP  221 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHcC--CCCCC
Confidence            12233467999999999999999999999999999999999999999754322111           111111  11122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ......+.+++.+||+.||.+|++.
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2344567889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-41  Score=313.65  Aligned_cols=276  Identities=23%  Similarity=0.306  Sum_probs=220.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeE-EEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~-~~~~~~~lv  184 (408)
                      .+.|++++.||.|.-|+||++.+++ +..+|+|++.+...  .+...+...|-+||+.++||.+..||+. ..+...|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            3678888999999999999999874 69999999987643  2456778899999999999999999985 455567999


Q ss_pred             EEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+||+|..+++. ..+.+++..+.-++..++.||+|||.   .|||+|||||+||||.++|++.|+||.|+......
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999976 45569999999999999999999999   99999999999999999999999999987654210


Q ss_pred             ---------------------------------Ccc---------------------ceecccccCCCccccccccCCCC
Q 015389          264 ---------------------------------WTH---------------------HTISKVEGTFGYLAPEFLMHGIV  289 (408)
Q Consensus       264 ---------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~  289 (408)
                                                       ...                     .....+.||-.|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                             000                     00112469999999999999999


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCC
Q 015389          290 DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       290 ~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                      +.++|+|+|||+||||+.|..||.+.+..           ..+..++...+.....+.....+.+||++.|..||.+|..
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-----------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-----------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch-----------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            99999999999999999999999876543           2334444444443333456678889999999999999997


Q ss_pred             ----HHHHHH--HHhcccCccccccccCCchhhhhhh
Q 015389          370 ----MSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLR  400 (408)
Q Consensus       370 ----~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~  400 (408)
                          +.||-+  ++++..+.  ......+|++.++..
T Consensus       382 ~~rGA~eIK~HpFF~gVnWa--Lir~~~PP~iP~~~d  416 (459)
T KOG0610|consen  382 SKRGAAEIKRHPFFEGVNWA--LIRCARPPEIPKPVD  416 (459)
T ss_pred             cccchHHhhcCccccCCChh--heeccCCCcCCCccc
Confidence                777766  55666544  444555665555543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.1e-40  Score=309.17  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~  187 (408)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+....  .....+.+|+.+++.++|+||+++++++.+...++++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEe
Confidence            347899999999999999999988778889999887543  235678899999999999999999998777778999999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+..... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999999653 4557888999999999999999998   9999999999999999999999999999986643211 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......++..|+|||++.++.++.++|+|||||++|+|++ |+.||........            ...+.........
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------------~~~~~~~~~~~~~  225 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV------------IRALERGYRMPRP  225 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH------------HHHHhCCCCCCCc
Confidence            11122346678999999998899999999999999999999 8999875432211            1111111111122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ...+..+.+++.+|++.+|++||++.++...|+.
T Consensus       226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            3345678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-40  Score=308.83  Aligned_cols=249  Identities=30%  Similarity=0.437  Sum_probs=201.4

Q ss_pred             ceecccCcEEEEEEEEcC--C--cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLRN--G--QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  191 (408)
                      +.||+|++|.||+|.+.+  +  ..||||.+.........+.+.+|+.++++++||||+++++++.+...++|+||++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            468999999999998643  3  369999998776545678899999999999999999999977777788999999999


Q ss_pred             CHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce-e
Q 015389          192 SLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-I  269 (408)
Q Consensus       192 ~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~  269 (408)
                      +|.+++.... ..+++..++.++.|++.||+|||+   ++++|+||+|+||+++.++.+||+|||++..+........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999996644 578999999999999999999999   9999999999999999999999999999987754322211 1


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.........           ..+.........+...
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~~~  226 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL-----------KKIDKEGERLERPEAC  226 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------HHHHhcCCcCCCCccC
Confidence            23457889999999998899999999999999999999 99998643222110           0000001111112234


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +..+.+++.+|++.+|.+||++.+|++.|.
T Consensus       227 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         227 PQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=315.29  Aligned_cols=251  Identities=26%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +|++.++||+|+||+||++... +++.||||.+.....  ......+.+|+.+++.++||||+++++.+.. ...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            5788899999999999999865 689999999875432  2234567789999999999999999986655 55889999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++|+|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999988553 3468999999999999999999999   999999999999999999999999999998654321 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........        ..+...+.. ....++
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--------~~~~~~~~~-~~~~~~  225 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--------EEVERRVKE-DQEEYS  225 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--------HHHHHHhhh-cccccC
Confidence              122346899999999999999999999999999999999999999754321100        011111111 112233


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQL  376 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~  376 (408)
                      ......+.+++.+||+.||.+||     ++.++++.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            34566788999999999999999     78887653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=343.61  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=228.2

Q ss_pred             CCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv  184 (408)
                      ....+.++||.|.||+|++|+++-    ...||||.++....+....+|+.|..||-+++||||++|.|+..... +.||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            456788999999999999998762    45799999999999989999999999999999999999999888765 6799


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +|||++|+|..+|....+.+.+.++.-++++|+.|+.||-+   .++|||||.+.|||++.+..+|++|||+++.+.++.
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999999888999999999999999999999999   999999999999999999999999999999886654


Q ss_pred             ccceeccccc--CCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          265 THHTISKVEG--TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       265 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                       ....++.-|  +..|.|||.+...+++.++|||||||+|||.++ |.+||....+            .++-.-++...+
T Consensus       786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------------QdVIkaIe~gyR  852 (996)
T KOG0196|consen  786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------QDVIKAIEQGYR  852 (996)
T ss_pred             -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------------HHHHHHHHhccC
Confidence             222233323  578999999999999999999999999999887 9999875433            244455666777


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      -..+++++..|.+|+.+||+.|-.+||.+.||+..|+++....
T Consensus       853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            7888999999999999999999999999999999998876443

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.9e-41  Score=323.77  Aligned_cols=249  Identities=23%  Similarity=0.278  Sum_probs=193.1

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      ++||+|+||.||+|.+. +++.||||+++...  ..+....+..|..++..+ +||||+++++++.. ...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 58999999998643  223456678899999888 79999999997665 457999999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (329)
T cd05588          81 GDLMFHMQ-RQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS  154 (329)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence            99998884 34679999999999999999999999   99999999999999999999999999998743211  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH-HHhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR-ELVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~~~~~~~  349 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||+.........  . .....+. .+.....  ..+....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~--~~p~~~~  229 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD--Q-NTEDYLFQVILEKQI--RIPRSLS  229 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc--c-cchHHHHHHHHcCCC--CCCCCCC
Confidence            5679999999999999999999999999999999999999997432110000  0 0000011 1111111  1222344


Q ss_pred             HHHHHHHHhccccCCCCCCC------HHHHHH
Q 015389          350 NLVLLAASLCIQQSSIRRPQ------MSQVVQ  375 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt------~~evl~  375 (408)
                      ..+..++.+||+.||.+||+      +.++++
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            56788999999999999997      667664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-40  Score=307.72  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc----hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      ++|.+.+.||.|++|.||+|... +++.||+|.+.....    ......+.+|+.++++++||||+++++++.+ +..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999864 689999999875432    1234678899999999999999999997665 45789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            9999999999999854 4568889999999999999999999   99999999999999999999999999999765432


Q ss_pred             Cccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........           ..........
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----------~~~~~~~~~~  226 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-----------FKIATQPTNP  226 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-----------HHHhccCCCC
Confidence            1111 112355888999999999989999999999999999999999999754322111           1111111122


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ..+......+..++.+||..+|.+|||+.++++.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            2333455678889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.5e-41  Score=330.90  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=199.9

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+....  .......+..|+.+++.++||||+++++++.++ ..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34578999999999999999999876 58999999997532  122345577899999999999999999876654 478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++|+|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+..
T Consensus       120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999999843  457888888999999999999999   9999999999999999999999999999986543


Q ss_pred             CCccceecccccCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHG----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.......           ....+...
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----------~~~~i~~~  262 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----------TYSKIMDH  262 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----------HHHHHHcC
Confidence            211 122346799999999998653    47899999999999999999999997543211           11111111


Q ss_pred             h--ccCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015389          339 S--LADEYDTRQMNLVLLAASLCIQQSSIR--RPQMSQVVQL  376 (408)
Q Consensus       339 ~--l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~  376 (408)
                      .  +...........+.+++.+||+.+|.+  ||++.++++.
T Consensus       263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1  111111234567888999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-40  Score=328.57  Aligned_cols=254  Identities=22%  Similarity=0.222  Sum_probs=192.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|....       ..+.+|+.++++++||||+++++++..+ ..++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            467999999999999999999875 689999996532       3457899999999999999999966654 4688999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      ++. ++|..++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...... ..
T Consensus       164 ~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~  237 (391)
T PHA03212        164 RYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA  237 (391)
T ss_pred             cCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence            984 688888743 4568899999999999999999999   99999999999999999999999999999754321 11


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc------hhh---hhc---------cccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS------LVL---WAR---------PMIK  328 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~------~~~---~~~---------~~~~  328 (408)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||-.....      ...   ...         +...
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            2233467999999999999999999999999999999999999886432110      000   000         0000


Q ss_pred             cchHHHHhhhhc---------cCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          329 RNEIRELVDASL---------ADEY--DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       329 ~~~~~~~~d~~l---------~~~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+........         +...  ....+..+..++.+||+.||.+|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            001111110000         0000  0123457888999999999999999999985

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.7e-40  Score=310.57  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=205.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +|..||||.+....  .......+.+|+.+++.++||||+++++++.+ +..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57888999999999999999864 78999999886532  22345678899999999999999999996655 4578999


Q ss_pred             EecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+++++|.+++..   ....+++..++.++.||+.||.|||+   ++++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853   34568999999999999999999999   9999999999999999999999999999886643


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|..||.........+..         .+.......
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~  227 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDYPP  227 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------hhhcCCCCC
Confidence            321  123356899999999999889999999999999999999999998653322111110         011111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .........+..++.+|++.+|++|||+.+|++.+++.
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11223556788999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.2e-41  Score=322.30  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=189.3

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|.+. +++.||||.++....  +.....+..|..++.. .+||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 588999999975421  2234455667777664 489999999986655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            999998854 4568999999999999999999999   999999999999999999999999999997543221  2233


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.........           ..+..  ....++.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~-----------~~i~~--~~~~~~~~~~~  221 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF-----------DSILN--DRPHFPRWISK  221 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHc--CCCCCCCCCCH
Confidence            467999999999999999999999999999999999999999764332111           00110  01122233455


Q ss_pred             HHHHHHHhccccCCCCCCCHH-HHHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMS-QVVQ  375 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~-evl~  375 (408)
                      .+.+++.+||+.+|.+||++. ++++
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHHc
Confidence            678899999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=309.13  Aligned_cols=281  Identities=22%  Similarity=0.301  Sum_probs=213.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe------C
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------G  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~  179 (408)
                      ....|...+.||.|+||.|+.|.++ +|+.||||++.... ..-..++..+|+.++++++|+||+.+++....      .
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            4456777799999999999999875 69999999987432 33357888999999999999999999996543      3


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ++|+|+|++ +.+|...+. .+..++......++.||+.||.|+|+   .+|+||||||+|+|++.+..+||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceee
Confidence            489999999 778888884 34458999999999999999999999   9999999999999999999999999999998


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccc----hhhhhccccccchHHH
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQS----LVLWARPMIKRNEIRE  334 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~  334 (408)
                      ..........+....|.+|.|||.+.. ..|+...||||+||||.||++|++-|.+.+..    ......+...+..+..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            765422233466778999999998865 57999999999999999999999999875432    1111111111212221


Q ss_pred             Hh--------hhhc-cCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccCccccccccCCc
Q 015389          335 LV--------DASL-ADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCCLKYMTKCRSP  393 (408)
Q Consensus       335 ~~--------d~~l-~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~~~~~~~~~~~~  393 (408)
                      +-        ...- ....+     +.......+|+.+||..||.+|+|+.|.++  -|...-...+.|.....+
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~  329 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIF  329 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCC
Confidence            11        1110 01111     123455788999999999999999999988  456665555555544443

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.5e-41  Score=322.81  Aligned_cols=245  Identities=24%  Similarity=0.279  Sum_probs=188.8

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|... +++.||+|++.+..  .......+..|+.++.++ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 58899999998642  223456677898888776 89999999996655 557899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (329)
T cd05618          81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTS  154 (329)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccc
Confidence            999988843 4578999999999999999999999   99999999999999999999999999998753221  11223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.........   .......+...+.. .....+.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~---~~~~~~~~~~~i~~-~~~~~p~~~~~  230 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP---DQNTEDYLFQVILE-KQIRIPRSLSV  230 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc---ccccHHHHHHHHhc-CCCCCCCCCCH
Confidence            467999999999999999999999999999999999999999642211000   00000001111110 01122333456


Q ss_pred             HHHHHHHhccccCCCCCCCH
Q 015389          351 LVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~  370 (408)
                      .+..++.+||+.||.+||++
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCC
Confidence            67889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-40  Score=309.18  Aligned_cols=250  Identities=30%  Similarity=0.475  Sum_probs=199.4

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHH-HHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      |++.+.||+|+||+||++... +++.||+|.+........ ......|+.++++++||||+++++++.+ ...++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999986 477899999988765443 2344569999999999999999997765 4578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      .+++|.+++. ....+++..+..++.|++.||.+||+   .+|+|+||||+||+++.++.++|+|||.+.....  ....
T Consensus        81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNEN  154 (260)
T ss_dssp             TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSE
T ss_pred             cccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999996 56778999999999999999999999   9999999999999999999999999999976421  2223


Q ss_pred             ecccccCCCcccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc--c
Q 015389          269 ISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY--D  345 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~  345 (408)
                      .....++..|+|||++. +..++.++||||||+++|+|++|..||..........        .+............  .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~  226 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE--------IIEKILKRPLPSSSQQS  226 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH--------HHHHHHHTHHHHHTTSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhh--------hhhhccccccccccccc
Confidence            34567899999999998 7889999999999999999999999998652110000        00011110000000  0


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+||+.||++||++.++++
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            011278899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-40  Score=318.14  Aligned_cols=258  Identities=28%  Similarity=0.420  Sum_probs=202.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc--EEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.+...........+.+|+.++.++ +||||+++++++.. +..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            68899999999999999999865 344  46888877655455567888999999999 89999999997665 457899


Q ss_pred             EEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          185 LELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      +||+++++|.+++....               ..+++..++.++.|++.||.|||+   ++++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999999996432               357899999999999999999998   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  328 (408)
                      +|+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||........        
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------  232 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------  232 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--------
Confidence            99999998632211   11111234668999999988889999999999999999998 9999865332210        


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                          ...+........+......+.+++.+|++.+|++||++.++++.|+.+....+
T Consensus       233 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         233 ----YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ----HHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                11111111111122234567889999999999999999999999987654443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6e-41  Score=330.73  Aligned_cols=249  Identities=21%  Similarity=0.243  Sum_probs=192.0

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +|+++++||+|+||+||+|... +++.||||.+....  .......+.+|+.++++++||||+++++.+.+ +..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999865 58899999987542  22346678899999999999999999996655 45799999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc-
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT-  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-  265 (408)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            9999999999854 3568889999999999999999999   9999999999999999999999999999753311000 


Q ss_pred             --------------------------------------------cceecccccCCCccccccccCCCCCcchhHHHHHHH
Q 015389          266 --------------------------------------------HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVL  301 (408)
Q Consensus       266 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvi  301 (408)
                                                                  ........||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123569999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCccccchhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 015389          302 LLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ---MSQVVQ  375 (408)
Q Consensus       302 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~  375 (408)
                      +|||++|+.||.........           ..+..  ..+...........+.+++.+++ .+|.+|++   +.++++
T Consensus       238 l~elltG~~Pf~~~~~~~~~-----------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQ-----------MKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHH-----------HHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999999764332111           01110  01111111122344556666665 59999997   777765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.8e-40  Score=307.50  Aligned_cols=247  Identities=29%  Similarity=0.421  Sum_probs=200.3

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~e~  187 (408)
                      .+|.+.+.||+|+||.||+|... |..||+|.+....   ..+.+.+|+.+++.++|+|++++++++..  ...++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            57889999999999999999875 7889999986543   24568899999999999999999986543  357899999


Q ss_pred             cCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++..... .+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~---  155 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  155 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence            999999999865433 48899999999999999999998   99999999999999999999999999998754322   


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......            +...+.........
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~  221 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------VVPRVEKGYKMDAP  221 (256)
T ss_pred             --CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------------HHHHHhcCCCCCCC
Confidence              122345678999999998899999999999999999997 999986432211            11111111122222


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            34456788899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-40  Score=314.53  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=192.8

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||+|+||+||++... +|+.||+|.+......  .....+..|+.+++.++||||+++++++.. ...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 6899999998754322  234667889999999999999999986655 458899999999999


Q ss_pred             HHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          194 ASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       194 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      .+++..   ....+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988743   34568999999999999999999999   9999999999999999999999999999986644221  223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........       ..........  ...++.....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-------~~~~~~~~~~--~~~~~~~~~~  226 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------KELKQRILND--SVTYPDKFSP  226 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-------HHHHHhhccc--CCCCcccCCH
Confidence            456999999999999999999999999999999999999999754321100       0000011111  0112234556


Q ss_pred             HHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          351 LVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      .+.+++.+||+.||++||     ++.++++
T Consensus       227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            788899999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-40  Score=307.50  Aligned_cols=249  Identities=20%  Similarity=0.286  Sum_probs=201.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      +|++.+.||.|+||.||++... +++.||+|.+.........+.+..|+.+++.++||||+++++.+.. +..++|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5788899999999999999876 5899999998755444456778899999999999999999986655 4578999999


Q ss_pred             CCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++++|.+++.. ....+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||++..+.....  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            99999998854 33458899999999999999999999   9999999999999999999999999999986643211  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..........           .+. .......+..
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~-----------~~~-~~~~~~~~~~  223 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL-----------KVC-QGSYKPLPSH  223 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-----------HHh-cCCCCCCCcc
Confidence            1234568999999999998889999999999999999999999997543211110           000 0111112223


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+.+++.+||+.||.+||++.+|+..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            44568889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-40  Score=321.53  Aligned_cols=259  Identities=26%  Similarity=0.385  Sum_probs=205.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  179 (408)
                      ..+|.+.+.||+|+||.||+|...        .+..||+|.+...........+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            357899999999999999999742        12368999888665555677889999999999 799999999977654


Q ss_pred             -CeEEEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          180 -GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                       ..++++||+++|+|.+++...               ...+++..+..++.|++.||.|||+   ++++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence             478999999999999998542               2347888899999999999999999   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999986643222112222335678999999999999999999999999999998 888886532211   


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                               ....+........+......+..++.+|++.+|.+||++.++++.|+.+..
T Consensus       245 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         245 ---------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ---------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                     111111111222223445678899999999999999999999999987763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.5e-40  Score=307.66  Aligned_cols=251  Identities=28%  Similarity=0.364  Sum_probs=195.2

Q ss_pred             ceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEEEEEecC
Q 015389          116 NLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLELSP  189 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~e~~~  189 (408)
                      +.||+|+||.||+|.+.    ++..||+|.+...........+.+|+.+++.++||||+++++++..  +..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    2467999998755444456788899999999999999999996653  34789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc--c
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH--H  267 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~  267 (408)
                      +|+|.+++......+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++..+......  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            999999997655667888888999999999999998   99999999999999999999999999999755332111  1


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG-RRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......++..|+|||.+.+..++.++|||||||++|||++| ..||......            .+...+........+.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~  225 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------------DITVYLLQGRRLLQPE  225 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------------HHHHHHhcCCCCCCCC
Confidence            11233467789999999888999999999999999999995 5556532211            0111111111111122


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+..+.+++.+||+.+|++||++.+|+..|+.+.
T Consensus       226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            23457889999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.7e-41  Score=321.65  Aligned_cols=241  Identities=24%  Similarity=0.327  Sum_probs=189.6

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||+||+|.+. +++.||||.+.....  +.....+..|..++.. ++||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 588999999976421  2234556677888775 489999999996655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05619          81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence            999999853 4568899999999999999999999   99999999999999999999999999998753221  11223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.........            ..+.. ....++.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------------~~i~~-~~~~~~~~~~~  221 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRM-DNPCYPRWLTR  221 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH------------HHHHh-CCCCCCccCCH
Confidence            456999999999999999999999999999999999999999754322110            00000 01112222345


Q ss_pred             HHHHHHHhccccCCCCCCCHH-HHHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMS-QVVQ  375 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~-evl~  375 (408)
                      .+.+++.+||+.+|.+||++. ++.+
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCChHHHHc
Confidence            678899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-41  Score=332.14  Aligned_cols=253  Identities=21%  Similarity=0.222  Sum_probs=193.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      .+|++.+.||+|+||.||+|... +++.||||.+.....  ......+.+|+.++.+++||||+++++.+.+ +..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37899999999999999999865 589999999865321  2235667899999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC-
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW-  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-  264 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||+|..+.... 
T Consensus        81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999954 4568888899999999999999999   999999999999999999999999999975321000 


Q ss_pred             ----------------------------------------ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHH
Q 015389          265 ----------------------------------------THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE  304 (408)
Q Consensus       265 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~e  304 (408)
                                                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123569999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCC---CHHHHHHH
Q 015389          305 LVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRP---QMSQVVQL  376 (408)
Q Consensus       305 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP---t~~evl~~  376 (408)
                      |++|+.||..............         ....+...........+.+++.+|+ .+|.+|+   ++.+++..
T Consensus       237 ll~G~~Pf~~~~~~~~~~~i~~---------~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLKVIN---------WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHHHhc---------cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999976543211100000         0000111111122344566777765 5999999   88888864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3e-40  Score=307.04  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=201.6

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      .+|++.+.||.|+||.||+|.+.++..+|+|.+......  ...+..|++++++++|||++++++++.. ...++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            467888999999999999998877889999998755432  3467889999999999999999997655 4578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      .+++|.+++......+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++......... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~  157 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-S  157 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-c
Confidence            9999999997666678999999999999999999999   99999999999999999999999999998765432111 1


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....++..|+|||.+.++.++.++||||||+++|||++ |..||.........            ..+........+..
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~~  225 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------------ETINAGFRLYKPRL  225 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH------------HHHhCCCCCCCCCC
Confidence            122335678999999998899999999999999999998 99998753322111            01111111111112


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      .+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            3467889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.7e-41  Score=321.49  Aligned_cols=236  Identities=24%  Similarity=0.363  Sum_probs=188.9

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|..+ +++.||||++....  .+.....+..|..++..+ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 58999999987542  223456677888888776 79999999997665 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||++......  .....
T Consensus        81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (320)
T cd05590          81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS  154 (320)
T ss_pred             chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence            999998854 4568999999999999999999999   99999999999999999999999999998754221  12233


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+....  ...+.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-----------~~i~~~~--~~~~~~~~~  221 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF-----------EAILNDE--VVYPTWLSQ  221 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-----------HHHhcCC--CCCCCCCCH
Confidence            467999999999999999999999999999999999999999754332110           0111100  111222445


Q ss_pred             HHHHHHHhccccCCCCCCCH
Q 015389          351 LVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~  370 (408)
                      .+.+++.+||+.||.+||++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCC
Confidence            67889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-40  Score=319.77  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=192.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      +|.+.+.||+|+||.||+|... +++.||||++.+...  ......+..|..++..+ +|++|+++++++.. +..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999876 578999999976432  23345567788888777 58999999986655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus        81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~--  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--  154 (323)
T ss_pred             cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence            99999999998854 4568999999999999999999999   99999999999999999999999999999754321  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+...  ...++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~-----------~~i~~~--~~~~p  221 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-----------QSIMEH--NVAYP  221 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhC--CCCCC
Confidence            11233467999999999999999999999999999999999999999764332111           111111  11122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ......+..++.+||+.+|.+|++.
T Consensus       222 ~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            3345667889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=333.90  Aligned_cols=256  Identities=20%  Similarity=0.293  Sum_probs=191.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      ...+|++.+.||+|+||.||+|... +++.||||++.....     ...+|+.+++.++||||+++++++...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            4578999999999999999999875 589999998865432     224799999999999999998865321       


Q ss_pred             --CeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEee
Q 015389          180 --GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICD  253 (408)
Q Consensus       180 --~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~D  253 (408)
                        .+++||||+++ +|.+++..   ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeec
Confidence              25689999975 67666532   45678999999999999999999999   9999999999999998665 799999


Q ss_pred             cCCcccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccccccch
Q 015389          254 FGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIKRNE  331 (408)
Q Consensus       254 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~  331 (408)
                      ||+|+.+....   ......||+.|+|||++.+. .++.++|||||||++|||++|..||......... ..........
T Consensus       215 FGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        215 FGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             cccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99998664321   12235689999999998764 6899999999999999999999999764321110 0000000000


Q ss_pred             HHH--Hhh-------------hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 IRE--LVD-------------ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ~~~--~~d-------------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...  ...             ..+...++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000  000             00111111223457889999999999999999999885

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=9e-41  Score=321.82  Aligned_cols=242  Identities=23%  Similarity=0.310  Sum_probs=192.5

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|... +|+.||||++....  ..+....+..|..++..+ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 58899999987542  223456677888888766 79999999997665 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05591          81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT  154 (321)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence            999998854 4568899999999999999999999   99999999999999999999999999998754321  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+....  ..++.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~-----------~~i~~~~--~~~p~~~~~  221 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF-----------ESILHDD--VLYPVWLSK  221 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-----------HHHHcCC--CCCCCCCCH
Confidence            467999999999999999999999999999999999999999864332111           1111110  011222345


Q ss_pred             HHHHHHHhccccCCCCCC-------CHHHHHHH
Q 015389          351 LVLLAASLCIQQSSIRRP-------QMSQVVQL  376 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RP-------t~~evl~~  376 (408)
                      .+.+++..||+.||.+||       ++.++++.
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            678899999999999999       77777753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.8e-41  Score=324.26  Aligned_cols=243  Identities=23%  Similarity=0.298  Sum_probs=193.3

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||++... +|+.||+|.+....  .......+..|+.++..++||||+++++++.. +..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999865 68999999997542  22345677889999999999999999986655 4578999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      +|..++.. ...+++..+..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||++......  ......
T Consensus        81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~  155 (325)
T cd05594          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKT  155 (325)
T ss_pred             cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccccc
Confidence            99998843 4578999999999999999999996  169999999999999999999999999998754321  112234


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+...  ...++......
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-----------~~i~~~--~~~~p~~~~~~  222 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------ELILME--EIRFPRTLSPE  222 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-----------HHHhcC--CCCCCCCCCHH
Confidence            56999999999999999999999999999999999999999754322110           000000  01122233456


Q ss_pred             HHHHHHhccccCCCCCC-----CHHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRP-----QMSQVVQL  376 (408)
Q Consensus       352 l~~li~~cl~~~P~~RP-----t~~evl~~  376 (408)
                      +.+++.+||+.||.+|+     ++.++++.
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            78899999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6e-40  Score=314.18  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||++.+. +|..||+|.+......+....+.+|++++.+++||||+++++++.. +..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999865 5888999998766555566778899999999999999999996655 557899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.++|+|||++..+...    
T Consensus        81 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  153 (308)
T cd06615          81 MDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----  153 (308)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence            999999999954 36688999999999999999999972  58999999999999999999999999998765332    


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccccc------------------
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIK------------------  328 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~------------------  328 (408)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......... +......                  
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            123456899999999998888999999999999999999999999653321111 0000000                  


Q ss_pred             --cchHHHHhhhhccCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          329 --RNEIRELVDASLADE----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       329 --~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        .....+..+......    ........+.+++.+||+.+|++||++.+|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000111111111100    001134568899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3e-40  Score=323.10  Aligned_cols=258  Identities=23%  Similarity=0.281  Sum_probs=196.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------  179 (408)
                      ..++|++.+.||+|+||.||+|... +|..||||.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999875 58999999997543 233456778999999999999999999976532      


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             36899999965 5666552   347888899999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc--ccc-------
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM--IKR-------  329 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~--~~~-------  329 (408)
                      .....   .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ..|....  ...       
T Consensus       172 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHHHH
Confidence            54322   1223456899999999999999999999999999999999999999864321 1110000  000       


Q ss_pred             ---chHHHHhhhh--cc----------------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          330 ---NEIRELVDAS--LA----------------DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       330 ---~~~~~~~d~~--l~----------------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                         ..+.......  ..                ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence               0000000000  00                00011123567899999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-40  Score=307.62  Aligned_cols=246  Identities=29%  Similarity=0.476  Sum_probs=202.4

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP  189 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~  189 (408)
                      ++|++.+.||+|+||.||+|.. .++.||+|.+....   ....+.+|+.+++.++|||++++++++..+..++||||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCC
Confidence            5688999999999999999975 57889999986543   2356789999999999999999999888888999999999


Q ss_pred             CCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          190 NGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       190 ~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      +++|.+++... ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            99999999654 3458899999999999999999999   99999999999999999999999999998754322     


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......+..|+|||.+.++.++.++|+|||||++|+|++ |+.||.......            ....+...........
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~~  221 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------------VKECVEKGYRMEPPEG  221 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------------HHHHHhCCCCCCCCCc
Confidence            122334678999999998999999999999999999998 999987533211            1111222222222334


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+..+..++.+||+.+|..||++.+|++.|+.
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            45678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.4e-41  Score=309.26  Aligned_cols=256  Identities=20%  Similarity=0.291  Sum_probs=199.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCc-eeEEEeEEEeC-------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPN-TAKLLGYGIEG-------  179 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~-------  179 (408)
                      ..|..+++||+|.||+||+|+.. +|+.||+|++.....+ .......+|+.+++.++|+| |+.+++++...       
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45777788999999999999865 6899999999866542 34455689999999999999 99999976653       


Q ss_pred             CeEEEEEecCCCCHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          180 GMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      .+++|+||+ .-+|..++....   ..++...+..++.||+.||+|||+   ++|+||||||+|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            467999999 558999997655   467888999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc--------------hhh
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS--------------LVL  321 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~--------------~~~  321 (408)
                      |+....  .....+...+|.+|+|||++.+. .|+...||||+|||++||++++.-|.+....              ...
T Consensus       167 Ara~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            996542  22334566799999999999987 7999999999999999999999999764321              111


Q ss_pred             hhccccccchHHHHhhhhccCcc-----cHH---HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          322 WARPMIKRNEIRELVDASLADEY-----DTR---QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~-----~~~---~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      |.....     ..-.+.......     ...   ......+++.+||+.+|.+|.|+...++.
T Consensus       245 Wp~v~~-----~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSS-----LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccc-----cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111100     000000111100     000   11367889999999999999999999885

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3e-40  Score=311.48  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=194.1

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||+|+||.||++..+ +|+.||+|.+.....  ......+..|+.++++++||||+++++++.. ...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 599999999875322  1223445679999999999999999986654 457899999999999


Q ss_pred             HHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceeccc
Q 015389          194 ASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV  272 (408)
Q Consensus       194 ~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  272 (408)
                      .+++... ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            9888543 3458899999999999999999999   999999999999999999999999999998664321   22335


Q ss_pred             ccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHH
Q 015389          273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLV  352 (408)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  352 (408)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||.........       .............. ........+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~  226 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-------EELKRRTLEDEVKF-EHQNFTEES  226 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-------HHHHHHhhcccccc-ccccCCHHH
Confidence            6899999999999999999999999999999999999999753221000       00011111111110 011345568


Q ss_pred             HHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          353 LLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       353 ~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+++.+||+.||.+||++.|+++.+....
T Consensus       227 ~~li~~~L~~~P~~R~~~~~~~~~~~~h~  255 (277)
T cd05607         227 KDICRLFLAKKPEDRLGSREKNDDPRKHE  255 (277)
T ss_pred             HHHHHHHhccCHhhCCCCccchhhhhcCh
Confidence            89999999999999999988776554443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-40  Score=308.82  Aligned_cols=247  Identities=31%  Similarity=0.438  Sum_probs=202.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++.++ ..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999875 58999999997665444567788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++..  ..+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..+....  .
T Consensus        81 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            999999999854  378999999999999999999999   999999999999999999999999999998775432  1


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.....            ..+...........
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------------~~~~~~~~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------------FLIPKNNPPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------------HHhhhcCCCCCccc
Confidence            223456889999999999988999999999999999999999999754322111            01111111111111


Q ss_pred             -HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 -QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 -~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ....+.+++.+||+.+|++||++++++.
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             4556888999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-40  Score=307.07  Aligned_cols=248  Identities=27%  Similarity=0.411  Sum_probs=194.7

Q ss_pred             ceecccCcEEEEEEEEcC-Cc--EEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLRN-GQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|.+.+ +.  .+|+|.+...........+..|+.++.++ +||||+++++++... ..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998753 43  57889887655445567888999999999 899999999977654 47899999999


Q ss_pred             CCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          191 GSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       191 g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      |+|.+++....               ..+++..+..++.|++.||+|||+   ++++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999985422               247889999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      ++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||.......            ...
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------------~~~  222 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------LYE  222 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------------HHH
Confidence            98632211   11112234667999999988899999999999999999997 999996532211            111


Q ss_pred             HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       335 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+........+......+.+++.+|++.+|.+||++.+++..|+.+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11111111122234456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4e-40  Score=308.44  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=197.4

Q ss_pred             ceecccCcEEEEEEEEcC-------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +.||+|+||.||+|...+       +..||+|.+...........+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       368999998765544556778899999999999999999997655 457899999


Q ss_pred             cCCCCHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-----ceEEeecCC
Q 015389          188 SPNGSLASLLYGM------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-----EPQICDFGL  256 (408)
Q Consensus       188 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DfGl  256 (408)
                      +++++|.+++...      ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999642      2347889999999999999999998   9999999999999999887     899999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHH
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      +..+.............++..|+|||++.++.++.++|||||||++|+|++ |+.||.......            ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------------~~~~  225 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------------VLQH  225 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------------HHHH
Confidence            986643322222223346788999999999999999999999999999998 999987533211            1111


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1111111223345677889999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.7e-40  Score=304.79  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||.|+||.||+|...+ ++.||+|.+.....   ...+.+|+.+++.++||||+++++++.. ...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            688999999999999999998764 88999999875432   6788899999999999999999996655 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            99999999997667789999999999999999999999   9999999999999999999999999999987654321  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..............        ....  ....+..
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~--~~~~~~~  224 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--------KPPP--TLSDPEK  224 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------CCCC--CCCchhh
Confidence            22334588999999999988999999999999999999999999975432211100000        0000  0111223


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+.+++.+|++.+|.+||++.||++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            4456888999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-40  Score=325.01  Aligned_cols=260  Identities=20%  Similarity=0.264  Sum_probs=196.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~  182 (408)
                      +|++.+.||+|+||.||+|... +|+.||||.+..... ......+.+|+.+++.++||||+++++++...      ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999864 699999999875422 23456788999999999999999999976654      478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +|+||+. ++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999986 57877774 34578999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccccccchHH-------
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIKRNEIR-------  333 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~-------  333 (408)
                      ... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ............       
T Consensus       156 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Ccc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            211 122334588999999998874 4799999999999999999999999764432110 000000000000       


Q ss_pred             ---HHhhhh-ccC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          334 ---ELVDAS-LAD-------EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       334 ---~~~d~~-l~~-------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                         ..+... ...       .........+.+++.+||+.||.+|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               000000 000       0011124567889999999999999999999873

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-40  Score=321.05  Aligned_cols=237  Identities=25%  Similarity=0.302  Sum_probs=186.5

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHH-HHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||+||+|... +|+.||||++.....  ......+..|.. +++.++||||+++++++.+ +..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999875 699999999875321  122345555555 4678999999999986655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS  154 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence            999998854 4578899999999999999999999   99999999999999999999999999998753221  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+.....  ........
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----------~~~i~~~~~--~~~~~~~~  221 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-----------YDNILNKPL--RLKPNISV  221 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-----------HHHHHcCCC--CCCCCCCH
Confidence            46799999999999999999999999999999999999999975432110           011111111  11122355


Q ss_pred             HHHHHHHhccccCCCCCCCHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMS  371 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~  371 (408)
                      .+.+++.+||+.+|.+||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         222 SARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHhhcCHHhCCCCC
Confidence            678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-41  Score=323.43  Aligned_cols=238  Identities=25%  Similarity=0.277  Sum_probs=190.5

Q ss_pred             ceecccCcEEEEEEEE----cCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          116 NLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      +.||+|+||.||++..    .+|+.||+|++...... .....+..|+.++++++||||+++++++.. +..++||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    35899999999754322 234566789999999999999999986655 45789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.++|+|||++.......  ...
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            9999999843 4568999999999999999999999   999999999999999999999999999998653321  122


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........           ..+....  ...+....
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----------~~i~~~~--~~~p~~~~  222 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM-----------TMILKAK--LGMPQFLS  222 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH-----------HHHHcCC--CCCCCCCC
Confidence            3467999999999999888999999999999999999999999754322111           1111111  11122234


Q ss_pred             HHHHHHHHhccccCCCCCCCHHH
Q 015389          350 NLVLLAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~~e  372 (408)
                      ..+..++.+||+.||.+||++.+
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCC
Confidence            56788999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.9e-40  Score=309.03  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe------
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE------  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~------  178 (408)
                      .+++.|++.+.||+|+||.||+|... +++.||+|.+......  ...+..|+.++..+ +||||+++++++..      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45678999999999999999999875 5889999998755322  35677899999988 79999999997654      


Q ss_pred             -CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          179 -GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                       ...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+   ++|+|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             2368999999999999998653 3468999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      +..+....  .......|+..|+|||++.     +..++.++|||||||++|||++|+.||...........        
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--------  227 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------  227 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--------
Confidence            98654321  1223466899999999986     34588899999999999999999999964332211100        


Q ss_pred             HHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                         ..............+..+.+++.+||+.+|.+|||+.+++.
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 ---IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ---HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence               00000011111223456888999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=328.18  Aligned_cols=260  Identities=21%  Similarity=0.258  Sum_probs=189.7

Q ss_pred             HHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC------CCceeEEEeEE
Q 015389          104 ELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD------HPNTAKLLGYG  176 (408)
Q Consensus       104 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~------hpniv~l~~~~  176 (408)
                      ++....++|++.++||+|+||+||+|.+. .++.||||+++....  ....+..|+.++..+.      |++++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34456789999999999999999999865 588999999965321  2233445666655554      55688998876


Q ss_pred             EeC--CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-------
Q 015389          177 IEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-------  247 (408)
Q Consensus       177 ~~~--~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-------  247 (408)
                      ...  ..++||+++ +++|.+++.. ...+++..+..|+.||+.||.|||+.  .+||||||||+|||++.++       
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence            653  467888877 7888888854 45789999999999999999999971  4999999999999998765       


Q ss_pred             ---------ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 015389          248 ---------EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS  318 (408)
Q Consensus       248 ---------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~  318 (408)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998864321     223567999999999999999999999999999999999999999864432


Q ss_pred             hhh-------------hhccccccchHHHHhhhh--ccCcc---------------cHHHHHHHHHHHHhccccCCCCCC
Q 015389          319 LVL-------------WARPMIKRNEIRELVDAS--LADEY---------------DTRQMNLVLLAASLCIQQSSIRRP  368 (408)
Q Consensus       319 ~~~-------------~~~~~~~~~~~~~~~d~~--l~~~~---------------~~~~~~~l~~li~~cl~~~P~~RP  368 (408)
                      ...             |.... .......+++..  +....               .......+.+|+.+||+.||.+||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            110             00000 000000111100  00000               001234577999999999999999


Q ss_pred             CHHHHHH
Q 015389          369 QMSQVVQ  375 (408)
Q Consensus       369 t~~evl~  375 (408)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999997

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.9e-40  Score=307.30  Aligned_cols=252  Identities=25%  Similarity=0.309  Sum_probs=189.9

Q ss_pred             ceecccCcEEEEEEEEcC---CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||+|...+   +..+|+|.+...........+.+|+.++++++||||+++++++.+ ...++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999997643   467999998766544455678899999999999999999997665 4578999999999


Q ss_pred             CHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          192 SLASLLYGMK----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       192 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +|.+++....    ...++..+..++.|++.||.|||+   ++++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986422    245677788899999999999999   999999999999999999999999999997544322222


Q ss_pred             eecccccCCCccccccccCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          268 TISKVEGTFGYLAPEFLMHG-------IVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ......|+..|+|||++.+.       .++.++|||||||++|||++ |+.||............   .........++.
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQLKLPKPR  234 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhcccCCCCCCc
Confidence            22334578899999998642       35789999999999999996 99999754322111000   000000111111


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +.    ......+.+++..|+ .+|++|||+.+|+..|+
T Consensus       235 ~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11    123345677889998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-40  Score=311.28  Aligned_cols=258  Identities=25%  Similarity=0.352  Sum_probs=205.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||+|+||+||+|... +|+.||+|++...........+.+|+++++.++||||+++++++.. ...++|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            367888999999999999999865 5899999998766555567788999999999999999999996665 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++.. .+.+++..+..++.+++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++......   
T Consensus        84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999998854 45689999999999999999999962  58999999999999999999999999998754322   


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc---Cc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA---DE  343 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~---~~  343 (408)
                       ......|+..|+|||++.++.++.++|||||||++|+|++|+.||..........    .....+...+.....   ..
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ----DDPMGILDLLQQIVQEPPPR  232 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh----hhhhHHHHHHHHHhhccCCC
Confidence             1123568999999999988899999999999999999999999998543211000    000111112221111   11


Q ss_pred             c-cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          344 Y-DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       344 ~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      . ....+..+.+++.+|++.||.+||++.||+...
T Consensus       233 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1 122456788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-41  Score=312.38  Aligned_cols=253  Identities=27%  Similarity=0.370  Sum_probs=194.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---C-C--eEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---G-G--MHI  183 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~-~--~~l  183 (408)
                      .|.-.+++|.|+||.||.|... +++.||||+.-.+....     .+|+.+|+.++|||||++.-++..   . .  +.+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4666789999999999999865 57999999987665432     379999999999999999886543   2 2  348


Q ss_pred             EEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCccc
Q 015389          184 VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKW  259 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~  259 (408)
                      ||||++. +|.+.++.   .+..++...+.-+..||++||.|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999976 78887753   35678888888899999999999999   999999999999999977 8999999999998


Q ss_pred             CCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc--hhhhhcccc--ccchHHH
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS--LVLWARPMI--KRNEIRE  334 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~--~~~~~~~~~--~~~~~~~  334 (408)
                      +..+...   .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....  ++...+.+.  ...++..
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            8654333   335578899999999885 6999999999999999999999999874321  221111111  1111111


Q ss_pred             ------------HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 ------------LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ------------~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                  +....+..-+......+..+|+.++|..+|.+|.++.|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                        11111111122345667889999999999999999999875

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-40  Score=325.59  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEE
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  177 (408)
                      .+.++....++|++.+.||+|+||.||+|.+. +++.||+|++....  .......+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34555666789999999999999999999876 58899999986432  1223456778999999999999999998766


Q ss_pred             eC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          178 EG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       178 ~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ++ ..++||||+++|+|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            54 47899999999999999843  457888889999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHG----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      +..+..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........           .
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------~  256 (371)
T cd05622         189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----------Y  256 (371)
T ss_pred             eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----------H
Confidence            987643211 122346799999999998754    378999999999999999999999975432110           1


Q ss_pred             HHHhhh--hccCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 015389          333 RELVDA--SLADEYDTRQMNLVLLAASLCIQQSSIR--RPQMSQVVQLL  377 (408)
Q Consensus       333 ~~~~d~--~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~L  377 (408)
                      ..+...  .+...........+..++..||..++.+  ||++.++++..
T Consensus       257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111110  0111111234566778999999844443  78899888743

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.8e-40  Score=321.82  Aligned_cols=258  Identities=22%  Similarity=0.265  Sum_probs=197.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------  179 (408)
                      ..++|++.+.||+|+||.||+|... .++.||||.+..... ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4579999999999999999999865 588999999976432 33456778999999999999999999965432      


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence             36899999965 5666653   357888899999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc---cc--------
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP---MI--------  327 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~---~~--------  327 (408)
                      ......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ +...   ..        
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            654321   22345689999999999999999999999999999999999999976432110 0000   00        


Q ss_pred             -ccchHHHHhhhh----------------cc--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          328 -KRNEIRELVDAS----------------LA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       328 -~~~~~~~~~d~~----------------l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ....+...++..                ..  ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             000011111000                00  00111124567899999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.9e-40  Score=317.94  Aligned_cols=241  Identities=24%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|.+. +++.||||++.+..  ..+....+..|..++..+ +||||+++++++.. +..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 58899999997642  223456677888988877 79999999996655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (318)
T cd05570          81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTS  154 (318)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCccc
Confidence            999998853 4578999999999999999999999   99999999999999999999999999998753221  11223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+...  ...++.....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~-----------~~i~~~--~~~~~~~~~~  221 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF-----------QSILED--EVRYPRWLSK  221 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-----------HHHHcC--CCCCCCcCCH
Confidence            456999999999999999999999999999999999999999754322110           011111  1112223456


Q ss_pred             HHHHHHHhccccCCCCCCCH-----HHHHH
Q 015389          351 LVLLAASLCIQQSSIRRPQM-----SQVVQ  375 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~-----~evl~  375 (408)
                      .+.+++.+||+.||.+||++     .+++.
T Consensus       222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            78889999999999999999     77765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=327.06  Aligned_cols=258  Identities=27%  Similarity=0.430  Sum_probs=224.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      .....+.++||.|.||.||+|.+.+     .-.||||.-+.+...+..+.|+.|..+|+.++||||++++|.+.+...++
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wi  467 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWI  467 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeE
Confidence            3455667899999999999997532     34589999998777777899999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||.++-|.|..+|...+..++......++.||+.||.|||+   .++|||||...|||+....-|||+|||+++++..+
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999999888999999999999999999999999   99999999999999999999999999999998765


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ... ..+...-+..|||||-+.-..++.++|||-|||.+||++. |..||.+-.++.+.            ..+...-+.
T Consensus       545 ~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------------~~iEnGeRl  611 (974)
T KOG4257|consen  545 AYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------------GHIENGERL  611 (974)
T ss_pred             chh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------------EEecCCCCC
Confidence            433 3345556788999999999999999999999999999987 99999875544332            122333355


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ..++.++..+..++.+||.++|.+||++.++...|.....
T Consensus       612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            5677888899999999999999999999999999877665

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-40  Score=318.09  Aligned_cols=240  Identities=24%  Similarity=0.320  Sum_probs=189.0

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|.+. +|+.||+|.+.....  +.....+..|..++.. ++||||+++++++.+ +..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 588999999975421  2234556678887765 489999999996655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.++|+|||++......  .....
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS  154 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence            999998854 4568899999999999999999999   99999999999999999999999999998743211  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........            ...+... ...++.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------------~~~~~~~-~~~~~~~~~~  221 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------------FESIRVD-TPHYPRWITK  221 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhC-CCCCCCCCCH
Confidence            56799999999999999999999999999999999999999975432211            0000000 1111222345


Q ss_pred             HHHHHHHhccccCCCCCCCHH-HHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMS-QVV  374 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~-evl  374 (408)
                      .+.+++.+||+.||.+||++. ++.
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            677899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.8e-39  Score=301.77  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=201.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-C-CeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-G-GMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-~~~lv~e  186 (408)
                      +|++.+.||+|++|.||++... +++.||+|.+..... ......+.+|+.++++++|||++++++.+.. + ..++|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999865 578999999875432 3345678899999999999999999986543 3 3689999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++++|.+++... ...+++..+..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999998653 3458999999999999999999999   999999999999999999999999999998664322 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                       .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+.. ......+
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-----------~~~~~-~~~~~~~  223 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-----------YRIIE-GKLPPMP  223 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-----------HHHHh-cCCCCCc
Confidence             1223456899999999999999999999999999999999999999753321110           01111 1111223


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ......+.+++.+|++.+|.+||++.++++.
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            3455678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.5e-40  Score=309.87  Aligned_cols=247  Identities=28%  Similarity=0.415  Sum_probs=201.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      .|+..+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++.. ...++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667789999999999999865 5889999998866555566788999999999999999999996655 4578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++++|.+++.  ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++..+....  ..
T Consensus        85 ~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLK--PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999999884  4568899999999999999999998   999999999999999999999999999998664321  11


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||.........+            .+............
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------~~~~~~~~~~~~~~  225 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------------LIPKNSPPTLEGQY  225 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------------hhhcCCCCCCCccc
Confidence            223468899999999999899999999999999999999999987433221111            11111111122234


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+.+++.+||+.+|.+||++.+|+..
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         226 SKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            5668889999999999999999999983

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=318.99  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=210.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCch--HHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CCeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD--EIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~  182 (408)
                      ....|.+.+.||+|.||.||++..+. |+.+|+|.+.+....  .....+.+|+.+|+++. |||||.+++++.. ..++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34678999999999999999998774 999999999875432  23567889999999998 9999999996554 5689


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC----CceEEeecCCcc
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQICDFGLAK  258 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~  258 (408)
                      +|||++.||.|.+.+...  .+++..+..++.|++.|+.|||+   .||+||||||+|+|+...    +.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999655  49999999999999999999999   999999999999999543    479999999999


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ....   .......+||++|+|||++....|+..+||||+||++|.|++|..||..........           .+...
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----------~i~~~  253 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----------AILRG  253 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----------HHHcC
Confidence            8765   334567889999999999999999999999999999999999999998765432221           11111


Q ss_pred             --hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          339 --SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       339 --~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        .....+.....+.+.+++..|+..||..|+|+.++++.
T Consensus       254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence              22334445567888999999999999999999999994

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5e-40  Score=317.52  Aligned_cols=242  Identities=25%  Similarity=0.297  Sum_probs=189.5

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|... +++.||+|++.....  .+....+..|+.++.++ +||||+++++++.. ...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 588999999986432  23456788899999888 69999999997655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (327)
T cd05617          81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS  154 (327)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence            999988843 4578999999999999999999999   99999999999999999999999999998753221  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH-HhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE-LVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~~~~~~  349 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.........     .....+.. +...  ....+....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-----~~~~~~~~~~~~~--~~~~p~~~~  227 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-----NTEDYLFQVILEK--PIRIPRFLS  227 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-----ccHHHHHHHHHhC--CCCCCCCCC
Confidence            567999999999999999999999999999999999999999643211000     00000111 1111  111222344


Q ss_pred             HHHHHHHHhccccCCCCCCCH
Q 015389          350 NLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ..+..++.+||+.||.+||++
T Consensus       228 ~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         228 VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHHHhccCHHHcCCC
Confidence            567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.1e-40  Score=314.10  Aligned_cols=260  Identities=22%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|.+.+.||.|+||.||+|... +++.||+|.+...........+.+|+.+++.++||||+++++++.. +..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            67899999999999999999875 5889999998755433334567789999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +. ++|.+++......+++..+..++.||+.||.|||+   ++|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence            97 58999887666778999999999999999999999   999999999999999999999999999997543221  1


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcccc---ccchHHHHhh-----
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMI---KRNEIRELVD-----  337 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~---~~~~~~~~~d-----  337 (408)
                      ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||......... ......   .......+..     
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            12234578999999998764 5788999999999999999999999764321100 000000   0000000000     


Q ss_pred             ----hhccCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ----ASLADE----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ----~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                          +....+    ........+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                000000    01123456788999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=311.02  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=211.2

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~~  188 (408)
                      -|.++++||+|+||.||+|.++ .|+.+|||.+....   ..+++.+|+.||.+++.|++|++|| |+...++++|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            3567789999999999999876 69999999987653   3677889999999999999999999 66677899999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      -.|+..+.+...+..+.+..+..+++..+.||+|||.   ..-||||||+.||||+.+|..||+|||.|-.+.....  .
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K  185 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K  185 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence            9999999998899999999999999999999999999   8899999999999999999999999999987654322  2


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      ..++.||+.|||||++..-.|+.++||||||++..||..|++||..-++....+..+.-...          ....+...
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP----------TF~KPE~W  255 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP----------TFKKPEEW  255 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC----------CCCChHhh
Confidence            34678999999999999999999999999999999999999999865554333333321111          11223455


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+.+++++||-.+|++|-|+-++++.
T Consensus       256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  256 SSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            6778889999999999999999998873

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=302.19  Aligned_cols=252  Identities=27%  Similarity=0.369  Sum_probs=203.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+.+++.++||||+++++++.++ ..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            67899999999999999999875 5788999999865443 467788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+....  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            99999999987665789999999999999999999998   999999999999999999999999999998654321  1


Q ss_pred             eecccccCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLMHG---IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ......++..|+|||.+.+.   .++.++|||||||++|+|++|+.||..............   .   .....  ....
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~---~---~~~~~--~~~~  228 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK---S---NFPPP--KLKD  228 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---c---cCCCc--cccc
Confidence            22345688999999999877   889999999999999999999999975432211100000   0   00000  0111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......+.+++.+||+.+|.+||++.+|+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2334567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-39  Score=304.89  Aligned_cols=248  Identities=28%  Similarity=0.401  Sum_probs=204.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~  187 (408)
                      ..|+..+.||.|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++.++. .++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777899999999999999875 588999999886655556778899999999999999999999776654 7899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....  
T Consensus        84 ~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            99999999984  3568889999999999999999998   9999999999999999999999999999976543211  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......++..|+|||.+.+..++.++|+|||||++|||++|..||.........            ..............
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------~~~~~~~~~~~~~~  224 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------FLIPKNNPPTLTGE  224 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------------hhhhcCCCCCCchh
Confidence            122345888999999999889999999999999999999999998754322111            11111112233345


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+..+.+++.+||+.+|++||++.+++..
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         225 FSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            66778899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.2e-40  Score=306.31  Aligned_cols=251  Identities=26%  Similarity=0.333  Sum_probs=187.3

Q ss_pred             eecccCcEEEEEEEEcC---CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCC
Q 015389          117 LIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGS  192 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~  192 (408)
                      .||+|+||.||+|...+   ...+|+|.+...........+.+|+.+++.++||||+++++++.. ...++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   457899988765555556778899999999999999999997665 45789999999999


Q ss_pred             HHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          193 LASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       193 L~~~l~~~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      |.+++.....    ..++.....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999965332    24677888999999999999999   9999999999999999999999999999875433211111


Q ss_pred             ecccccCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          269 ISKVEGTFGYLAPEFLMH-------GIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||.............  ... ...+..+  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~-~~~~~~~--  233 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV--REQ-DIKLPKP--  233 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh--hcc-CccCCCC--
Confidence            223346778999998743       356889999999999999999 778886543221110000  000 0000111  


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                        .........+..++..|+ .+|++||++.+|++.|.
T Consensus       234 --~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         234 --QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             --cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence              112234455666888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.1e-40  Score=320.60  Aligned_cols=258  Identities=24%  Similarity=0.284  Sum_probs=196.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-------  178 (408)
                      ..++|++.+.||+|+||.||+|... .++.||||++..... ......+.+|+.+++.++||||+++++++..       
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3478999999999999999999865 588999999975432 3345677899999999999999999986543       


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ...++||||+.+ +|...+.   ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            236899999965 6777663   347888899999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc--cc--cchH--
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM--IK--RNEI--  332 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~--~~--~~~~--  332 (408)
                      ......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ +....  ..  ....  
T Consensus       175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            654321   22345689999999999999999999999999999999999999976432111 00000  00  0000  


Q ss_pred             ------HHHhhhh---------------c---cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          333 ------RELVDAS---------------L---ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       333 ------~~~~d~~---------------l---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                            .......               .   ...........+.+++.+||+.||.+|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000000               0   000011123467899999999999999999999883

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-39  Score=304.75  Aligned_cols=250  Identities=24%  Similarity=0.415  Sum_probs=199.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-----hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      +|.+.+.||+|+||+||+|...+|+.+|||.+.....     ......+.+|+.++++++|+||+++++++.+. ..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999887899999998874321     23456788999999999999999999977665 46899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999999954 3568899999999999999999999   999999999999999999999999999987653211


Q ss_pred             c----cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-h
Q 015389          265 T----HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-S  339 (408)
Q Consensus       265 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-~  339 (408)
                      .    ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.........           ...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~  225 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----------FYIGAHRG  225 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----------HHhhhccC
Confidence            1    11123356899999999999889999999999999999999999999753321110           000000 0


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+......+..++.+||+.+|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111122234566888999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-41  Score=298.07  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-------chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-------ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  179 (408)
                      ..+|.-.+.||.|..+.|-++.++ +|..+|+|++....       ..+..+.-.+|+.||+++ .||+|+++.+++..+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            367788899999999999998765 68889999886432       223456667899999998 799999999966654


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       -+++|+|.++.|.|.++| ...-.++++...+|++|+++|++|||.   ++||||||||+|||++++.+++|+|||+++
T Consensus        96 sF~FlVFdl~prGELFDyL-ts~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYL-TSKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHh-hhheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceee
Confidence             468899999999999999 456779999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCccceecccccCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMH------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      .++.+   ......|||++|+|||.+..      ..|+..+|+|++|||+|.|+.|.+||....+.+.            
T Consensus       172 ~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM------------  236 (411)
T KOG0599|consen  172 QLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM------------  236 (411)
T ss_pred             ccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH------------
Confidence            88764   34466899999999999863      3578899999999999999999999986554321            


Q ss_pred             HHHhhhh---ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDAS---LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..++...   .+.....+......+|+.+||+.||.+|.|++|++.
T Consensus       237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            1111111   122233456677889999999999999999999876

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=315.46  Aligned_cols=247  Identities=22%  Similarity=0.385  Sum_probs=211.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCCceeEEEeEE-EeCCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~~lv~e  186 (408)
                      +-|.+.+.||+|.|+.|-+|++- .|..||||++.+...++ ...++.+|++.|+.++|||||++|++. .+..+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            56888899999999999999754 69999999999877654 467788999999999999999999964 4567999999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE-CCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      .-++|+|.+|+..+...+.+....+++.||+.|+.|+|.   ..+|||||||+||.+ ..-|.|||+|||++..+..+  
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--  172 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence            999999999998888999999999999999999999998   999999999999877 45689999999999876543  


Q ss_pred             cceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       ....+.+|...|-|||++.+..|+ +++||||||||||.|++|+.||+..+++           +.+..++|-..  ..
T Consensus       173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------ETLTmImDCKY--tv  238 (864)
T KOG4717|consen  173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------ETLTMIMDCKY--TV  238 (864)
T ss_pred             -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------hhhhhhhcccc--cC
Confidence             345678999999999999999997 5789999999999999999999875543           22333444322  23


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +.....+..+||..||..||.+|.+.++|+.
T Consensus       239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            4456677788999999999999999999886

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-40  Score=320.12  Aligned_cols=243  Identities=23%  Similarity=0.276  Sum_probs=189.1

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHH-HHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||+||+|... +|+.||+|++.....  ......+..|.. +++.++||||+++++++.. +..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999865 689999999875421  223445556655 4677899999999986554 568899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQ-RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            99998885 35678999999999999999999999   99999999999999999999999999998753221  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+....+  ........
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-----------~~~~~~~~~--~~~~~~~~  221 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-----------YDNILHKPL--VLRPGASL  221 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-----------HHHHHcCCc--cCCCCCCH
Confidence            56799999999999999999999999999999999999999975432111           011111111  01112345


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .+.+++.+|++.+|.+||++++.++.+
T Consensus       222 ~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         222 TAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             HHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            677899999999999999986544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.3e-40  Score=342.60  Aligned_cols=259  Identities=25%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.++||+|+||.||+|.+. +|+.||||++....  .+....++.+|+.+++.++||||+++++++.++ ..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            68999999999999999999876 58999999997542  234567889999999999999999999977665 478999


Q ss_pred             EecCCCCHHHHHhcc----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          186 ELSPNGSLASLLYGM----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       186 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      ||++||+|.+++...          ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998531          1235667788999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCc----------------cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccch
Q 015389          256 LAKWLPEQWT----------------HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL  319 (408)
Q Consensus       256 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~  319 (408)
                      ++........                ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621100                001123569999999999999999999999999999999999999997533221


Q ss_pred             hhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhccc
Q 015389          320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRP-QMSQVVQLLRGNL  381 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~  381 (408)
                      ..+...         +.++. ........+..+.+++.+|++.||.+|| ++.++++.|+...
T Consensus       239 i~~~~~---------i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        239 ISYRDV---------ILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhh---------ccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            111100         00000 0001123345678899999999999996 5677777776654

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-40  Score=319.41  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=189.3

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHH-HHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||+|+||.||+|.+. +++.||+|++.....  ......+..|.. +++.++||||+++++++.. +..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 578999999875321  122334445544 5678899999999986655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|.+++.. ...+.+..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~  154 (325)
T cd05602          81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS  154 (325)
T ss_pred             CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence            999999854 4567888888899999999999999   99999999999999999999999999999754221  11234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+.....  ........
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~~~i~~~~~--~~~~~~~~  221 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----------YDNILNKPL--QLKPNITN  221 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-----------HHHHHhCCc--CCCCCCCH
Confidence            56799999999999999999999999999999999999999975432211           111111111  11223455


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          351 LVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+.+++.+||+.+|.+||++.+.+..+..
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~~~~~i~~  250 (325)
T cd05602         222 SARHLLEGLLQKDRTKRLGAKDDFMEIKN  250 (325)
T ss_pred             HHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence            67889999999999999998754444333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.5e-39  Score=302.00  Aligned_cols=250  Identities=32%  Similarity=0.479  Sum_probs=201.7

Q ss_pred             CCccceecccCcEEEEEEEEcC-----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      +++.+.||.|+||.||++.+.+     +..||+|.+......+....+..|+.++..++|+||+++++++.+ +..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998753     388999999876655467788999999999999999999997665 5578999


Q ss_pred             EecCCCCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |++++++|.+++...... +++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999654444 8999999999999999999999   999999999999999999999999999998765431


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......            .+...+.......
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------------~~~~~~~~~~~~~  224 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------------EVLEYLKKGYRLP  224 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHhcCCCCC
Confidence            2111 12337789999999988889999999999999999998 78888653221            1111111111112


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .....+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            2223566788899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-40  Score=325.21  Aligned_cols=250  Identities=22%  Similarity=0.304  Sum_probs=193.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +++.||||++....  ..+....+..|+.++.+++||||+++++.+.+ +..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999875 58999999997532  22345678889999999999999999986655 4579999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999999999853 4568999999999999999999999   9999999999999999999999999999875532110


Q ss_pred             c---------------------------------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015389          266 H---------------------------------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL  312 (408)
Q Consensus       266 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf  312 (408)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012356999999999999999999999999999999999999999


Q ss_pred             CccccchhhhhccccccchHHHHhh--hhccCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 015389          313 DYSQQSLVLWARPMIKRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ---MSQVVQ  375 (408)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~  375 (408)
                      .........           ..+..  ..+...........+.+++.+++ .+|.+|++   +.++++
T Consensus       237 ~~~~~~~~~-----------~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQETY-----------RKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHHHHH-----------HHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            764332111           11111  00000001112345666777766 49999985   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2e-39  Score=307.98  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=199.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE-eCCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~e  186 (408)
                      .++|++.+.||.|+||.||+|... ++..||+|.+..... +....+..|+.+++.++||||+++++++. ++..++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            367999999999999999999876 489999999876543 34677889999999999999999999554 456899999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......  
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            999999999886666779999999999999999999998   999999999999999999999999999987543221  


Q ss_pred             ceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc-
Q 015389          267 HTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-  340 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l-  340 (408)
                      .......+++.|+|||++.     ...++.++|||||||++|+|++|+.||.........           ..+..... 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----------~~~~~~~~~  233 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----------LKIAKSEPP  233 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH-----------HHHhcCCCc
Confidence            1123456889999999985     345788999999999999999999998753321110           00100000 


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00111233456788999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-39  Score=301.89  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=203.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~  185 (408)
                      +|++.+.||.|+||.||+|... +|+.||+|.+.... .......+..|+.+++.++||||+++++++..   ...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999864 68899999987543 33456778899999999999999999996653   2368999


Q ss_pred             EecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          186 ELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGC--QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       186 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ||+++++|.+++...   ...+++..++.++.||+.||.|||..+  ..+++|+||+|+||+++.++.++|+|||++..+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998643   567899999999999999999999211  289999999999999999999999999999876


Q ss_pred             CCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......            .+...+....
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~~~~~~~~~~  226 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------------QLASKIKEGK  226 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------------HHHHHHhcCC
Confidence            54321  123356899999999999989999999999999999999999999854321            1111112222


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+......+.+++.+|++.+|.+||++.+|++.
T Consensus       227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            223334556788999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.8e-40  Score=327.33  Aligned_cols=257  Identities=21%  Similarity=0.251  Sum_probs=193.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ..+|.+.+.||+|+||.||+|.+. .++.||||....       ..+.+|+.++++++||||+++++++..+ ..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999876 488999996432       2346899999999999999999976655 4688999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      ++ .++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||+++.+......
T Consensus       241 ~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            98 478888886656679999999999999999999999   99999999999999999999999999999876443222


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc---------h---hhhhcccc---c---
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS---------L---VLWARPMI---K---  328 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~---------~---~~~~~~~~---~---  328 (408)
                      .......||+.|+|||++.+..++.++|||||||+||||++|..|+-.....         .   ........   .   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2223467999999999999999999999999999999999987654321110         0   00000000   0   


Q ss_pred             cchHHHHhhhh----ccCcc----cH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          329 RNEIRELVDAS----LADEY----DT---RQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       329 ~~~~~~~~d~~----l~~~~----~~---~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+.......    .....    ..   .....+.+|+.+||+.||.+|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000000000    00000    00   122357789999999999999999999874

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-39  Score=308.57  Aligned_cols=250  Identities=28%  Similarity=0.391  Sum_probs=198.0

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .|++.+.||+|+||.||++... +++.||||.+.....  ......+.+|+.+++.++|+|++.+++.+.. +..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677789999999999999875 689999999875432  2234567789999999999999999986554 55789999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999999988543 3458999999999999999999999   9999999999999999999999999999976543221


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........        .......+. ....+.
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--------~~~~~~~~~-~~~~~~  225 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--------EEVERLVKE-VQEEYS  225 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--------HHHHhhhhh-hhhhcC
Confidence               12346899999999999999999999999999999999999999754321100        011111111 111122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ......+.+++.+||+.||.+|||     +.|+++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            234456788999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-39  Score=307.60  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=200.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE-eCCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||+|.+. +|..||+|.+.....+.....+.+|+.++++++||||+++++++. ++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999876 689999999876544455678899999999999999999999554 4568899999


Q ss_pred             cCCCCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      +++++|..++...  ...+++..+..++.|++.||.|||+.  .+|+|+||||+||+++.++.++|+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            9999999988543  34789999999999999999999962  59999999999999999999999999999765332  


Q ss_pred             cceecccccCCCccccccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGI------VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                        ......|+..|+|||.+.+..      ++.++|||||||++|+|++|+.||.........        ..+..+.+. 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--------~~~~~~~~~-  225 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF--------AQLSAIVDG-  225 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH--------HHHHHHhhc-
Confidence              123345888999999985543      588999999999999999999999753221110        001111111 


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+......+..++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         226 DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            112223345677888999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-39  Score=309.61  Aligned_cols=249  Identities=21%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ..+|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++|||++++++++.. ...++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            368999999999999999999864 6889999998765443 34667899999999999999999986655 55789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.......  
T Consensus        98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--  170 (296)
T cd06654          98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (296)
T ss_pred             ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence            999999999984  3457899999999999999999999   999999999999999999999999999987653321  


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||............          ..........+.
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~----------~~~~~~~~~~~~  240 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI----------ATNGTPELQNPE  240 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH----------hcCCCCCCCCcc
Confidence            1123346889999999999888999999999999999999999999754321110000          000000001122


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+++.+||..+|++||++.+|++
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            34456888999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.9e-40  Score=311.06  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=190.4

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcC---CCCceeEEEeEEEe------C
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGIE------G  179 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l---~hpniv~l~~~~~~------~  179 (408)
                      +|++.+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+.+++.+   +||||+++++++..      .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999876 5899999998754321 1223345666666554   79999999997653      2


Q ss_pred             CeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..++|+|++.+ +|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            36899999974 888888553 3458999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhccc--cccchHHH
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WARPM--IKRNEIRE  334 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~--~~~~~~~~  334 (408)
                      ......   ......||..|+|||.+.+..++.++|||||||++|+|++|++||.........  .....  ........
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            664321   123356899999999999999999999999999999999999999754322110  00000  00000000


Q ss_pred             H-------hhhhcc---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 L-------VDASLA---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ~-------~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .       ..+...   ..........+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       000000   0011123456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-40  Score=317.81  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=195.1

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe------
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE------  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~------  178 (408)
                      ...++|++.+.||.|+||.||+|... +++.||||.+...... .....+.+|+.++++++||||+++++++..      
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999864 6889999998764322 234567789999999999999999986542      


Q ss_pred             -CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          179 -GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                       ...+++++++ +++|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence             2357888876 889988873  4568999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhccc--------
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WARPM--------  326 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~--------  326 (408)
                      ......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.....  +....        
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL  240 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865432     234568999999999877 56899999999999999999999999754321100  00000        


Q ss_pred             --cccchHHHHhhhhccCccc-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          327 --IKRNEIRELVDASLADEYD-------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       327 --~~~~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        ........... .+.....       ......+.+++.+||+.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         241 KKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00000000000 0000000       0112346789999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.1e-40  Score=315.88  Aligned_cols=241  Identities=24%  Similarity=0.348  Sum_probs=191.6

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CCeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv~  185 (408)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  .......+..|..++..+. |++|+++++++.. +..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999875 68999999997542  2234566778888888885 5678888886554 4588999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++......  
T Consensus        81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~--  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--  154 (323)
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC--
Confidence            99999999999843 4568999999999999999999999   99999999999999999999999999998754321  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||........           ...+....  ..++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-----------~~~i~~~~--~~~p  221 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-----------FQSIMEHN--VSYP  221 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhCC--CCCC
Confidence            1122345699999999999999999999999999999999999999976432211           11111111  1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ......+.+++.+||+.+|.+|++.
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ccCCHHHHHHHHHHcccCHhhCCCC
Confidence            2344567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.8e-40  Score=305.96  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++.. +..++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            67999999999999999999864 6889999998754332 34567789999999999999999996655 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||+|+||+++.++.++|+|||++..+.....  
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd06646          88 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--  161 (267)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence            999999998853 4578999999999999999999999   9999999999999999999999999999986643211  


Q ss_pred             eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||...........   .....   ...+....  
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~---~~~~~---~~~~~~~~--  233 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---MSKSN---FQPPKLKD--  233 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee---eecCC---CCCCCCcc--
Confidence            122356889999999884   34578899999999999999999999864332111000   00000   00000000  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .......+.+++.+||+.+|++||++.+|++.|
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            112345788899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-39  Score=306.39  Aligned_cols=249  Identities=27%  Similarity=0.376  Sum_probs=197.4

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      |++.+.||.|+||.||+|... ++..+|+|.+..... .....+.+|+.+++.++|||++++++++.. +..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            677889999999999999876 478899999865543 346678899999999999999999996655 45789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +++|..++......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......  ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            999999886656779999999999999999999999   999999999999999999999999999987654321  122


Q ss_pred             cccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          270 SKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ....|+..|+|||++.     +..++.++|||||||++|+|++|+.||.............        ....+.  ...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~--~~~  230 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA--------KSEPPT--LAQ  230 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh--------hcCCCC--CCC
Confidence            3456899999999984     4557889999999999999999999987543211110000        000000  011


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +......+.+++.+||+.+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22345678889999999999999999988753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.3e-39  Score=302.41  Aligned_cols=253  Identities=24%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      ..+++++.....||+|+||.||+|.+. ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..+ ..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566666689999999999999865 5788999988765433 356788999999999999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhcccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecCCcccC
Q 015389          184 VLELSPNGSLASLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWL  260 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~  260 (408)
                      |+||+++++|.+++......+  ++..+..++.||+.||.|||+   ++|+||||||+||+++. ++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999999997654555  788888999999999999999   99999999999999976 679999999998765


Q ss_pred             CCCCccceecccccCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccch-hhhhccccccchHHHHhh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPMIKRNEIRELVD  337 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d  337 (408)
                      .....  ......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||....... ..+...           .
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-----------~  226 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-----------M  226 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-----------h
Confidence            43211  122345889999999987654  7899999999999999999999997533211 111100           0


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......+......+..++.+||+.+|.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            01112223344567888999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.3e-39  Score=302.14  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=196.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~  181 (408)
                      .+|+..+.||+|+||.||+|... +|..||+|.+....    .......+.+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47899999999999999999875 58999999886432    12345678899999999999999999997654   346


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++..+.
T Consensus        82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            789999999999999854 3458899999999999999999998   999999999999999999999999999997654


Q ss_pred             CCCc-cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWT-HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... ........++..|+|||.+.+..++.++|||||||++|+|++|+.||........           +........
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----------~~~~~~~~~  226 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----------IFKIATQPT  226 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----------HHHHhcCCC
Confidence            3211 1112235588999999999988899999999999999999999999975432111           111111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......+..++ .||..+|++||++++|++
T Consensus       227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1222333344556666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-39  Score=301.71  Aligned_cols=249  Identities=26%  Similarity=0.444  Sum_probs=200.1

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  180 (408)
                      +|.+...||.|+||.||+|... +++.||+|.+.....        .+..+.+.+|+.++++++||||+++++++.+ +.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778899999999999999864 588999998865322        1234678899999999999999999997665 45


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            7899999999999999954 3568889999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          261 PEQWTH----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       261 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      ......    .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........           +....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~~  225 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----------IFKIG  225 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----------HHHHh
Confidence            532111    111234588999999999998999999999999999999999999975432111           11111


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      . ......+......+..++.+||+.+|.+||++.+|++
T Consensus       226 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 E-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             c-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1 1122233345567888999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.9e-40  Score=317.34  Aligned_cols=237  Identities=25%  Similarity=0.278  Sum_probs=186.0

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHH-HHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELG-IMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      ++||+|+||.||+|... +|+.||+|++.+...  ......+..|.. +++.++||||+++++++.+ +..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999875 589999999875422  223445555654 5788999999999986655 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      ++|...+.. ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS  154 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence            999988843 4568888899999999999999999   99999999999999999999999999998753221  12234


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMN  350 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  350 (408)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+....           ...+....  ...+.....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~~~i~~~~--~~~~~~~~~  221 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-----------YDNILHKP--LQLPGGKTV  221 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-----------HHHHhcCC--CCCCCCCCH
Confidence            46799999999999999999999999999999999999999975432111           01111111  112223445


Q ss_pred             HHHHHHHhccccCCCCCCCHH
Q 015389          351 LVLLAASLCIQQSSIRRPQMS  371 (408)
Q Consensus       351 ~l~~li~~cl~~~P~~RPt~~  371 (408)
                      .+.+++.+||+.+|.+||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         222 AACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHccCCHhhcCCCC
Confidence            688899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-40  Score=315.95  Aligned_cols=252  Identities=20%  Similarity=0.262  Sum_probs=193.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||++... +++.||||++.+..  .......+..|+.++..++|+||+++++++.+ +..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999875 58999999987532  12235667889999999999999999996655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            9999999999996656778999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             cceecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh--
Q 015389          266 HHTISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA--  338 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~--  338 (408)
                      . ......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||.........           ..+...  
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-----------~~i~~~~~  225 (331)
T cd05597         158 V-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-----------GKIMNHKE  225 (331)
T ss_pred             c-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-----------HHHHcCCC
Confidence            1 1223469999999999863     45788999999999999999999999754321110           001100  


Q ss_pred             hcc-CcccHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 015389          339 SLA-DEYDTRQMNLVLLAASLCIQQSS--IRRPQMSQVVQL  376 (408)
Q Consensus       339 ~l~-~~~~~~~~~~l~~li~~cl~~~P--~~RPt~~evl~~  376 (408)
                      ... ..........+..++.+|++..+  ..||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         226 HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000 00011234556777877775433  347899888875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8e-40  Score=316.60  Aligned_cols=252  Identities=19%  Similarity=0.249  Sum_probs=195.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|.+.+.||+|+||.||++... +++.||+|.+.+..  .......+..|..++..++|+||+++++++.+ +..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999876 58899999987532  12234567789999999999999999997665 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            9999999999997656778999999999999999999999   9999999999999999999999999999986643322


Q ss_pred             cceecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          266 HHTISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      . ......||+.|+|||++.+     +.++.++|||||||+||+|++|+.||........           ...+.....
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----------~~~i~~~~~  225 (331)
T cd05624         158 V-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----------YGKIMNHEE  225 (331)
T ss_pred             e-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----------HHHHHcCCC
Confidence            1 2234569999999999875     5688999999999999999999999975432111           111111110


Q ss_pred             cCccc---HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015389          341 ADEYD---TRQMNLVLLAASLCIQQSSIR--RPQMSQVVQL  376 (408)
Q Consensus       341 ~~~~~---~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~  376 (408)
                      +..++   ......+.+++.+|++..+.+  |+++.+++..
T Consensus       226 ~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         226 RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            00111   123456778888988866544  4678877653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-39  Score=322.67  Aligned_cols=257  Identities=22%  Similarity=0.227  Sum_probs=196.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ..+|.+.+.||.|+||.||++...   .+..||||.+....      ...+|+.+++.++||||+++++++.. ...++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            468999999999999999999753   36789999886542      23479999999999999999986654 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||++. ++|.+++ .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++..+....
T Consensus       165 ~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        165 MPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             ehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            99985 6888888 445679999999999999999999999   999999999999999999999999999998765443


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh-----hhhc---------cccccc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV-----LWAR---------PMIKRN  330 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~-----~~~~---------~~~~~~  330 (408)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||........     ....         +.....
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            33333456799999999999999999999999999999999999999965432100     0000         000000


Q ss_pred             hHHHHhh---hhccCccc-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          331 EIRELVD---ASLADEYD-------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       331 ~~~~~~d---~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+...+.   ...+..+.       ......+..++.+||..+|++||++.+++..
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0101000   00111111       0123467789999999999999999999874

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-39  Score=306.43  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .|+..+.||+|+||+||+|.+. +++.||+|.+.....  ......+.+|+.+++.++|+||+.+++++.. +..++|+|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            3677789999999999999875 689999999875432  2234557789999999999999999986554 45789999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+.+++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999999888653 3469999999999999999999999   999999999999999999999999999997654321 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.........        ..+...+... ...+.
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--------~~~~~~~~~~-~~~~~  225 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--------EEVDRRVLET-EEVYS  225 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHHHhhhcc-ccccC
Confidence              123356899999999999999999999999999999999999999754321110        0000000000 11122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ......+.+++..|++.||++||+     +.+++.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            334456788999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-39  Score=299.30  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=202.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||.|+||.||.+... +++.+++|.+.... .......+.+|+.++++++|+||+++++++.+. ..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999764 58899999987543 334567788999999999999999999977665 46889999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999654 4568999999999999999999998   8999999999999999999999999999986644321 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                       ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........           ...+..... .....
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----------~~~~~~~~~-~~~~~  223 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-----------VVKIVQGNY-TPVVS  223 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-----------HHHHHcCCC-CCCcc
Confidence             22345689999999999888899999999999999999999999975332211           111111111 11123


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .....+..++.+||+.+|.+||++.++++.+
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            3456688899999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=321.26  Aligned_cols=261  Identities=23%  Similarity=0.357  Sum_probs=217.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      .....+.++||+|.||+|.++...++..||||.++.........+|.+|+.+|.+|+||||+.+++.|..+ .+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            35567889999999999999999888999999999888777789999999999999999999999987764 57899999


Q ss_pred             cCCCCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++|+|..++..+.-+ ..-.....|+.||+.|++||.+   .++|||||.+.|+|++.++++||+|||+++-+-.+..+
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999654323 3455567799999999999999   99999999999999999999999999999987777677


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCccccchhhhhccccccchHHHHhhh---hcc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT--GRRALDYSQQSLVLWARPMIKRNEIRELVDA---SLA  341 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~---~l~  341 (408)
                      +......-+..|||||.+..++++.++|||+||+++||+++  ...||....++.+.        .+...+++.   ...
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv--------en~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV--------ENAGEFFRDQGRQVV  765 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH--------HhhhhhcCCCCccee
Confidence            77777778899999999999999999999999999999976  66788765443221        011111111   111


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...+.-++..+.+++..||..+..+||++++|...|...
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            223445778899999999999999999999999988654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-39  Score=302.32  Aligned_cols=255  Identities=28%  Similarity=0.391  Sum_probs=203.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+.+++.++|+|++++++.+.. ...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999865 6889999999765544467788999999999999999999986555 457899999


Q ss_pred             cCCCCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            9999999999653  2568999999999999999999998   9999999999999999999999999999987654322


Q ss_pred             cc--eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          266 HH--TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       266 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ..  ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||.............. .       ..+.+..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~-~-------~~~~~~~  229 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-N-------DPPSLET  229 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc-C-------CCCCcCC
Confidence            21  22345689999999998877 789999999999999999999999975432211100000 0       0011111


Q ss_pred             cc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EY-DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .. .......+.+++.+|++.||++||++.+|++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11 1234567889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-39  Score=301.79  Aligned_cols=238  Identities=22%  Similarity=0.344  Sum_probs=190.2

Q ss_pred             ceecccCcEEEEEEEEcC-C----------cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          116 NLIGKGGYAEVYKGRLRN-G----------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      +.||+|+||.||+|.+.+ +          ..|++|.+......  ...+.+|+.+++.++||||+++++++.....++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEE
Confidence            468999999999998764 3          25788877654332  5778899999999999999999997776778999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-------ceEEeecCCc
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-------EPQICDFGLA  257 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-------~~kl~DfGla  257 (408)
                      +||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+||+++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999997655578999999999999999999998   9999999999999999887       7999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHH
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      ..+..      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.........  .         .
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--~---------~  218 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--R---------F  218 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--H---------H
Confidence            86543      1223467889999999876  78999999999999999999 57777653211100  0         0


Q ss_pred             HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       335 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      .....   ..+......+.+++.+||..+|.+||++.+|++.|+
T Consensus       219 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00000   001111267888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.7e-39  Score=303.94  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|++...||.|+||.||+|..+      +...||+|.+...........+.+|+.++++++||||+++++++.+. ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999854      25679999987665555677889999999999999999999987664 478


Q ss_pred             EEEEecCCCCHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          183 IVLELSPNGSLASLLYGMK--------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999996433        158999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      |++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.........           .
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~-----------~  229 (275)
T cd05046         162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL-----------N  229 (275)
T ss_pred             ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH-----------H
Confidence            998754322 1112223346778999999988889999999999999999999 78888643221110           0


Q ss_pred             HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       334 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ......+........+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            011111111112234467888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-39  Score=317.34  Aligned_cols=191  Identities=26%  Similarity=0.374  Sum_probs=163.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~  185 (408)
                      ...+|.+.+.||+|+||.||+|... +++.||+|......       ...|+.++++++||||+++++++..+. .++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            4468999999999999999999876 47889999754432       246899999999999999999776654 67899


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |++ .++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++......  
T Consensus       137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            998 468888887667789999999999999999999999   99999999999999999999999999999753321  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL  312 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf  312 (408)
                       .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             1223456999999999999999999999999999999999865554

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=327.26  Aligned_cols=250  Identities=26%  Similarity=0.405  Sum_probs=203.9

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~  187 (408)
                      +-|.++.-||.|+||.||+|..++ +-.-|.|++.... ++...+++-|++||..++||+||+|++ |+.++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            346677889999999999998875 4445666665443 456889999999999999999999998 8889999999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      |.||-...++...+..+++.++.-+..|++.||.|||+   ++|||||||+.|||++-+|.++|+|||.+.....  +..
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQ  185 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHh
Confidence            99999999988888899999999999999999999999   9999999999999999999999999998865432  233


Q ss_pred             eecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          268 TISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ....+.||++|||||+.+     ..+|+.++||||||++|.||..+.+|-...+..-+........        -|.+  
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--------PPTL--  255 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------PPTL--  255 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--------CCcc--
Confidence            345688999999999876     4679999999999999999999999976544332221111100        0111  


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+......+.+++..||..||..||++.|+++
T Consensus       256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            112345567888999999999999999998876

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-39  Score=315.23  Aligned_cols=252  Identities=21%  Similarity=0.255  Sum_probs=195.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||++..+ +++.||+|.+.+..  .......+..|+.++..++|+||+++++++.+ ...++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999876 48889999986432  12234557789999999999999999986655 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++..+.....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            9999999999997666778999999999999999999999   9999999999999999999999999999976533221


Q ss_pred             cceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          266 HHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                       .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||.........           ..+.....
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-----------~~i~~~~~  225 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-----------GKIMNHKE  225 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-----------HHHhCCCc
Confidence             1223356999999999986     346889999999999999999999999754321111           11111100


Q ss_pred             cCcc---cHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 015389          341 ADEY---DTRQMNLVLLAASLCIQQSSIR--RPQMSQVVQL  376 (408)
Q Consensus       341 ~~~~---~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~  376 (408)
                      ...+   .......+.+++.+|+..++.+  |+++.++++.
T Consensus       226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0001   1123456777888888655444  6889988775

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.8e-39  Score=302.50  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             CCccceecccCcEEEEEEEEc----CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC------
Q 015389          112 FSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------  180 (408)
                      |.+.+.||+|+||.||+|.+.    .++.||||.+.... .....+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999753    37899999987643 2345677889999999999999999999765421      


Q ss_pred             -eEEEEEecCCCCHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          181 -MHIVLELSPNGSLASLLYGM-----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                       .+++++|+.+|+|.+++...     ...+++.....++.|++.||.|||+   ++|+||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence             36788999999999887432     2247888999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      |++..+.............++..|++||.+.+..++.++|||||||++|+|++ |+.||........            .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~------------~  225 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------------Y  225 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH------------H
Confidence            99987643322222223345678999999998899999999999999999999 8888875432111            0


Q ss_pred             HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       334 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+........+......+.+++.+|++.+|.+||++.++++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         226 NYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00000000111123446788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=325.66  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=218.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc--CCc--EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--NGQ--LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      +...+.++||+|.||.|++|.|+  +|.  .||||.+..+.......+|++|+.+|.+|+|||+++|||...+....+|+
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~  189 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVF  189 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHh
Confidence            44566789999999999999886  343  58999999887776889999999999999999999999999988889999


Q ss_pred             EecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |+++.|+|.+.|+. .+..+.......++.||+.|+.||..   +++|||||...|+||..-..|||+||||.+-++.+.
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999987 56668888899999999999999999   999999999999999999999999999999998776


Q ss_pred             ccceecc-cccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~~~~-~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ..+.... ..-.+.|+|||.+.+..++.++|||+|||++|||++ |..||-+-..            -.+.+.+|..-+-
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------IQILKNIDAGERL  334 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------HHHHHhccccccC
Confidence            6654432 235678999999999999999999999999999999 6778875432            2345566655555


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+..+.+++++++..||..+|++|||+..|.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            667789999999999999999999999999974

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.3e-39  Score=308.06  Aligned_cols=195  Identities=25%  Similarity=0.421  Sum_probs=158.9

Q ss_pred             cceecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEEEEEec
Q 015389          115 ENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVLELS  188 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~e~~  188 (408)
                      .++||+|+||+||+|...   +++.||+|.+.....   ...+.+|+.++++++||||+++++++..   ...++|+||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            368999999999999864   468899999875432   2345689999999999999999997643   3367899998


Q ss_pred             CCCCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE----CCCCceEEeecCC
Q 015389          189 PNGSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGL  256 (408)
Q Consensus       189 ~~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGl  256 (408)
                      . ++|.+++...        ...+++..+..++.||+.||.|||+   ++|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            5 5788876421        2358889999999999999999999   999999999999999    4567899999999


Q ss_pred             cccCCCCCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 015389          257 AKWLPEQWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQ  316 (408)
Q Consensus       257 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~  316 (408)
                      +......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9876543221 122346789999999999874 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-39  Score=304.33  Aligned_cols=249  Identities=26%  Similarity=0.434  Sum_probs=193.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHH-HhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|.+......+....+..|+.+ ++.++||||+++++++.. +..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999876 5999999999865443334556667665 566799999999996654 56899999


Q ss_pred             ecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          187 LSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       187 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      |++ |+|.+++..   ....+++..++.++.||+.||.|||+   + +++||||||+||+++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 678777643   34568999999999999999999998   6 999999999999999999999999999986543


Q ss_pred             CCccceecccccCCCccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMH----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ..   ......|+..|+|||.+.+    ..++.++|+|||||++|+|++|+.||........          .+......
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------~~~~~~~~  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----------QLKQVVEE  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH----------HHHHHHhc
Confidence            21   1223458899999998865    4568899999999999999999999964322111          11111111


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..........+..+..++.+||..+|.+||++.+|++
T Consensus       224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111234567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.5e-39  Score=304.60  Aligned_cols=259  Identities=20%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|++.+.||.|++|.||+|... +++.||||.+...... .....+.+|+.+++.++||||+++++++.+ ...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5788899999999999999875 6899999998754322 234667789999999999999999997665 557899999


Q ss_pred             cCCCCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      +. ++|.+++...  ...+++..+..++.||+.||.|||+   ++++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 6888887543  2568999999999999999999999   999999999999999999999999999997654321 


Q ss_pred             cceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc------cc---cc----cch
Q 015389          266 HHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR------PM---IK----RNE  331 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~------~~---~~----~~~  331 (408)
                       .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.........+..      +.   +.    ...
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             122234578999999988754 5789999999999999999999999754332111100      00   00    000


Q ss_pred             HHHHhhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 IRELVDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......   .........+.+++.+||+.||.+|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000000   001113456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-39  Score=306.24  Aligned_cols=259  Identities=29%  Similarity=0.398  Sum_probs=200.6

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      .+..+..+.++|++.+.||+|+||.||+|... +++.||+|.+.....  ....+..|+.+++.+ +||||+++++++..
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34455667799999999999999999999875 588999998865332  235567899999998 79999999997642


Q ss_pred             ------CCeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          179 ------GGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       179 ------~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                            +..++||||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                  347899999999999998753   34568889999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR  324 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~  324 (408)
                      +|+|||++..+.....  ......|++.|+|||++..     ..++.++|||||||++|+|++|+.||............
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            9999999986543211  1233468999999999853     45788999999999999999999998754321111000


Q ss_pred             cccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       325 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .   ..     ..+.+  ..+......+..++.+||+.+|++||++.+|++.
T Consensus       242 ~---~~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 P---RN-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c---cc-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0   00     00000  0011123468889999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.4e-39  Score=304.70  Aligned_cols=260  Identities=29%  Similarity=0.434  Sum_probs=202.4

Q ss_pred             ccCHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEE
Q 015389           99 IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYG  176 (408)
Q Consensus        99 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~  176 (408)
                      .+.+.++..++++|.+.+.||+|+||.||+|... +++.+|+|.+.....  ....+.+|+.++..+ +|||++++++++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            3455566667899999999999999999999875 688999999875432  235567889999988 899999999976


Q ss_pred             EeC------CeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          177 IEG------GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       177 ~~~------~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      ...      ..++|+||+++++|.+++..   ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence            532      37899999999999998853   34568999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW  322 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~  322 (408)
                      .++|+|||++..+.....  ......|+..|+|||.+...     .++.++|||||||++|+|++|+.||..........
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~  243 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF  243 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence            999999999886543211  11234588999999998643     36889999999999999999999997543211110


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...   ..     ..+.+  .........+..++.+|++.+|++||++.++++
T Consensus       244 ~~~---~~-----~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KIP---RN-----PPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHh---cC-----CCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000   00     00000  011223456888999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-39  Score=302.77  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=203.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.+......+....+.+|+.+++.++||||+++++++.. ...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999876 5899999999877655667788999999999999999999986654 557899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+++|.+++......+++..+..++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+|||.+..+.....  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            99999999997655788999999999999999999997  37999999999999999999999999999876533211  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........      ....+....... .......
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~  227 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------IFELLQYIVNEP-PPRLPSG  227 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc------HHHHHHHHhcCC-CCCCChh
Confidence              1266889999999999999999999999999999999999999754221000      000111111111 1111111


Q ss_pred             -HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 -QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 -~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ....+.+++.+||..+|.+|||+.+++.
T Consensus       228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence             5567889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4e-39  Score=304.25  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||+|++..... ....+.+.+|+.++++++|||++++++++... ..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999876 589999999875432 22345678999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |++++.|..++. ....+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+..... 
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887764 34568999999999999999999999   9999999999999999999999999999987654321 


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc---hHHHHhh-----
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN---EIRELVD-----  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~---~~~~~~d-----  337 (408)
                       ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........+........   ......+     
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457889999999876 45789999999999999999999999764332111100000000   0000000     


Q ss_pred             -----hhccCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 -----ASLADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 -----~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                           +......     .......+.+++.+||+.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                 0000000     0122466889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.6e-39  Score=300.94  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=201.1

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~  188 (408)
                      -|++.+.||.|+||.||+|.+. ++..||||.+...........+.+|+.+++.++||||+++++++..+ ..++|+||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667889999999999999865 68999999987655445567888999999999999999999976665 478999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++++|.+++.  ...+++..+..++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++..+....  ..
T Consensus        85 ~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            9999999984  4568999999999999999999998   999999999999999999999999999987664321  11


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.........            ..+............
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~~~  225 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------------FLIPKNNPPTLEGNY  225 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------------HHHhcCCCCCCCccc
Confidence            23356889999999999888999999999999999999999998753321111            111111111222334


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+.+++.+||+.+|.+||++.++++.
T Consensus       226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         226 SKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            5668889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-39  Score=302.92  Aligned_cols=252  Identities=29%  Similarity=0.409  Sum_probs=201.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~  185 (408)
                      ++|...+.||.|++|.||+|.+. +++.||+|.+...........+.+|+++++.++||||+++++++.+.   ..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999875 58999999998665545667889999999999999999999976542   478999


Q ss_pred             EecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+++++|.+++..   ....+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988743   34568889999999999999999999   9999999999999999999999999999875533


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH-Hhh---h
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE-LVD---A  338 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~d---~  338 (408)
                      ..    .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........       ...+... +..   +
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~  226 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-------GPIELLSYIVNMPNP  226 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-------ChHHHHHHHhcCCch
Confidence            21    1234578899999999999999999999999999999999999986532100       0000111 111   1


Q ss_pred             hccCccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLADEYD--TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~~~~--~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+.....  ......+.+++.+||+.+|.+|||+.||++
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1111111  123567889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.6e-39  Score=300.33  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=200.3

Q ss_pred             CCCccceecccCcEEEEEEEEcC--CcEEEEEEecCC---------CchHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRLTRG---------TADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE  178 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~--g~~vavK~~~~~---------~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~  178 (408)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+...         ........+..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998764  788999987532         123345667889988865 799999999996665


Q ss_pred             -CCeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          179 -GGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                       +..++||||+++++|.+++..   ....+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence             457899999999999998743   34568999999999999999999995  168999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      |++.......   ......|+..|+|||.+.++.++.++||||||+++|+|++|+.||........           ...
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-----------~~~  224 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-----------ATK  224 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-----------HHH
Confidence            9998654432   23445689999999999998899999999999999999999999875432111           111


Q ss_pred             HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       335 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      +................+.+++.+||+.||++||++.||.+.++
T Consensus       225 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11111111111133466888999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-39  Score=305.25  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||.|+||.||+|.+. ++..||+|.+..... .....+..|+.+++.++||||+++++++.. ...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            367899999999999999999875 589999999876543 345778899999999999999999996665 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++......+++..+..++.|++.||.|||+   ++|+|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            999999999997666779999999999999999999999   9999999999999999999999999999876543211 


Q ss_pred             ceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc-
Q 015389          267 HTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-  340 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l-  340 (408)
                       ......|++.|+|||.+.     +..++.++|||||||++|+|++|+.||.........           ..+..... 
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~  226 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL-----------LKILKSEPP  226 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH-----------HHHhcCCCC
Confidence             223356899999999975     345788999999999999999999999754322110           00110000 


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+......+.+++..||+.+|.+||++.+|++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            001122344567889999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=320.80  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=218.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ...+....++||.|.||.||.|.|+. ...||||.++.+..+  ..+|+.|..+|+.++|||+|+|+|+|..+ .+|||+
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            34566777899999999999999875 677999999876543  68899999999999999999999987754 589999


Q ss_pred             EecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||..|+|.+||... +..++.-..+.++.||..|++||..   +++|||||...|+|+.++..||++|||+++++..+ 
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-  418 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-  418 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCC-
Confidence            999999999999764 4457777888999999999999999   99999999999999999999999999999987543 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      +..........+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+-+            -..+-.++....+-+
T Consensus       419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------lSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYGLLEKGYRMD  486 (1157)
T ss_pred             ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------HHHHHHHHhcccccc
Confidence            2212222334678999999999999999999999999999998 777876533            234456667777777


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+..|+..+++|+..||+++|.+||++.++-+.++.+..
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            788899999999999999999999999999998877653

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4e-39  Score=311.09  Aligned_cols=259  Identities=21%  Similarity=0.302  Sum_probs=192.3

Q ss_pred             ccceeccc--CcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          114 FENLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       114 ~~~~lg~G--~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      +.++||+|  +|++||++... +|+.||||.+.... ..+....+.+|+.+++.++||||+++++++.. +..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999865 69999999997653 23445667789999999999999999997665 4578999999


Q ss_pred             CCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc-
Q 015389          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-  266 (408)
Q Consensus       189 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-  266 (408)
                      ++|+|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.++++|||.+..+...... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999998543 3458999999999999999999999   99999999999999999999999999875443211110 


Q ss_pred             ----ceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc------ccchH--
Q 015389          267 ----HTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI------KRNEI--  332 (408)
Q Consensus       267 ----~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~------~~~~~--  332 (408)
                          .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...............      ....+  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                01122346788999999976  45899999999999999999999999753321111000000      00000  


Q ss_pred             HHH--------hhh-----------------hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 REL--------VDA-----------------SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~--------~d~-----------------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+        .+.                 .............+.+++.+||+.||++|||+.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000        000                 0000112233457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.7e-39  Score=299.06  Aligned_cols=239  Identities=20%  Similarity=0.304  Sum_probs=187.4

Q ss_pred             ceecccCcEEEEEEEEcC-------------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          116 NLIGKGGYAEVYKGRLRN-------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      +.||+|+||.||+|....             ...||+|.+.... .+....+..|+.++..++||||+++++++... ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            468999999999997432             2358999876543 33456788899999999999999999977654 57


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc-------eEEeec
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-------PQICDF  254 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~-------~kl~Df  254 (408)
                      ++||||+++|+|..++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            89999999999999987666779999999999999999999999   99999999999999987664       899999


Q ss_pred             CCcccCCCCCccceecccccCCCcccccccc-CCCCCcchhHHHHHHHHHHHH-hCCCCCCccccchhhhhccccccchH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELV-TGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      |++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|..||........            
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------------  218 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------------  218 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------------
Confidence            998754321      2245788999999887 466899999999999999998 58888764321110            


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ..........  .......+..++.+||+.||.+||++.+|++.|+
T Consensus       219 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFYEGQCML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHhcCccC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1111111110  1112356788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-39  Score=304.23  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ++.++..+.+.|++.+.||.|+||.||+|.+. +++.||+|.+....  .....+..|+.+++.+ +||||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            44455566789999999999999999999875 58999999986543  2345677899999888 79999999997642


Q ss_pred             -------CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceE
Q 015389          179 -------GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (408)
Q Consensus       179 -------~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~k  250 (408)
                             ...+++|||+.+|+|.+++... ...+++..+..++.||+.||.|||+   .+|+|+||+|+||+++.++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence                   3468999999999999998653 3458888899999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccCCCCCccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc
Q 015389          251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP  325 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  325 (408)
                      |+|||++........  ......|+..|+|||.+.     +..++.++|||||||++|+|++|..||..........   
T Consensus       162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---  236 (282)
T cd06636         162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---  236 (282)
T ss_pred             EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence            999999876532211  223456899999999886     3468889999999999999999999996533211110   


Q ss_pred             ccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                              ...............+..+.+++.+||+.||.+||++.|+++
T Consensus       237 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 --------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    000000011111234567889999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=340.34  Aligned_cols=260  Identities=22%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CC
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GG  180 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~  180 (408)
                      ....++|.+.+.||+|+||+||+|.+. .+..||+|.+.... .......+..|+.++.+++||||+++++++..   ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445589999999999999999999876 58899999987543 33456778899999999999999999996654   23


Q ss_pred             eEEEEEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeeCCCCCceEECC--------
Q 015389          181 MHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGC----QRRIIHRDIKAANILLTE--------  245 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~iiH~Dikp~NIll~~--------  245 (408)
                      +++||||+++|+|.++|...   ...+++..++.|+.||+.||.|||+..    ..+||||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            78999999999999998642   356999999999999999999999832    145999999999999964        


Q ss_pred             ---------CCceEEeecCCcccCCCCCccceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          246 ---------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       246 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                               .+.+||+|||++..+....   ......||+.|+|||++.+  ..++.++||||||||||+|++|+.||..
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     2358999999998664321   2234569999999999864  4588999999999999999999999975


Q ss_pred             cccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          315 SQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      .......           ...+.... ..........+..|+..||+.+|.+||++.|++.  .+...
T Consensus       246 ~~~~~ql-----------i~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        246 ANNFSQL-----------ISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcHHHH-----------HHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            3321110           00010000 0001123456888999999999999999999984  45433

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-38  Score=297.84  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---Ce
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~  181 (408)
                      .+|++.+.||+|+||.||+|... +|..||||.+....    .......+.+|+.+++.++||||+++++++.+.   .+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999875 58999999886422    123456788999999999999999999976542   36


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+++++|.+++... ..+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            7899999999999998543 457888899999999999999999   999999999999999999999999999998653


Q ss_pred             CCCc-cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWT-HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||........           +........
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----------~~~~~~~~~  226 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----------IFKIATQPT  226 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----------HHHHhcCCC
Confidence            2111 1122335689999999999988899999999999999999999999974322111           111111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......+..++.+|+. +|.+||++.+|++
T Consensus       227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            222334455667788899985 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.5e-39  Score=305.87  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .+|++.+.||.|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++|||++++++++.. ...++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            57999999999999999999864 6899999998754433 35677899999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|..++.  ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+.....  
T Consensus        98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          98 LAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             cCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            99999999884  3468999999999999999999999   9999999999999999999999999999886543211  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-hccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-SLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~  346 (408)
                      ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........           .+... ......+.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----------~~~~~~~~~~~~~~  239 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------LIATNGTPELQNPE  239 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------HHHhcCCcccCCcc
Confidence            1233568899999999998889999999999999999999999997644321110           00000 00001122


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+++.+||..+|.+||++.+|+.
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            33456778999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-39  Score=301.71  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=196.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+.+++.++||||+++++++.. +..++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            57888999999999999999865 5899999998765433 34567789999999999999999996655 557899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.. .+.+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++..+....  .
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06645          88 CGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A  161 (267)
T ss_pred             cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence            999999999853 4578999999999999999999999   999999999999999999999999999987654321  1


Q ss_pred             eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ......|+..|+|||++.   .+.++.++|||||||++|+|++|..||.........+....  .    ....+....  
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~----~~~~~~~~~--  233 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--S----NFQPPKLKD--  233 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--c----CCCCCcccc--
Confidence            223456899999999874   45688999999999999999999999864332211110000  0    000000000  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......+.+++.+||+.+|++||++.+|++
T Consensus       234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0122346788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.9e-39  Score=299.49  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=186.6

Q ss_pred             eecccCcEEEEEEEEcC---CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          117 LIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      .||+|+||.||+|...+   ...+++|.+...........+.+|+.+++.++||||+++++++.+. ..++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            59999999999997543   3456777777655445577899999999999999999999977654 5789999999999


Q ss_pred             HHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          193 LASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       193 L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      |.+++...   ....++..+..++.||+.||.|||+   .+++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999653   2346667788999999999999999   99999999999999999999999999998643221111122


Q ss_pred             cccccCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          270 SKVEGTFGYLAPEFLMH-------GIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......... . ... ......+.++.+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~-~~~-~~~~~~~~~~~~~  235 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL-N-HVI-KDQQVKLFKPQLE  235 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH-H-HHH-hhcccccCCCccC
Confidence            34568899999998753       245789999999999999997 56687643321110 0 000 0111112222222


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ..    ....+.+++..|+ .+|.+||++.+|++.|.
T Consensus       236 ~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 LP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22    3455677888899 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=301.04  Aligned_cols=251  Identities=30%  Similarity=0.441  Sum_probs=199.9

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC----
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG----  180 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~----  180 (408)
                      .++++|++.+.||.|+||.||+|..+ +++.|++|.+.....  ....+.+|+.+++.+ +|+||+++++++....    
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            35689999999999999999999875 588999999876543  346788999999998 7999999999776533    


Q ss_pred             ---eEEEEEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          181 ---MHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       181 ---~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                         .++||||+++++|.+++...   ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCC
Confidence               68999999999999998643   4678999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccccc
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      |++........  ......|+..|+|||.+..     ..++.++|||||||++|+|++|+.||.........        
T Consensus       158 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--------  227 (275)
T cd06608         158 GVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--------  227 (275)
T ss_pred             ccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--------
Confidence            99876543221  2233568999999998753     34678999999999999999999999743221110        


Q ss_pred             chHHHHhhhhc-cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          330 NEIRELVDASL-ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       330 ~~~~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                         ..+..... ...........+.+++.+||..||++|||+.+|++
T Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 ---FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               01111000 01111234567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=304.62  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=195.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||.|++|.||+|..+ +++.||||.+...........+.+|+.+++.++||||+++++++.++ ..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            68999999999999999999876 68999999987544333334567899999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+ +|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++......  ..
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence            975 8999887666678999999999999999999999   99999999999999999999999999998754321  11


Q ss_pred             eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc--ccc---ccchHHHHhh----
Q 015389          268 TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR--PMI---KRNEIRELVD----  337 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~--~~~---~~~~~~~~~d----  337 (408)
                      ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........+..  ...   ..........    
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346889999999876 45889999999999999999999999754321110000  000   0000000000    


Q ss_pred             ----------hhccCcc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ----------ASLADEY-DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ----------~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                ..+.... .......+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                      0000000 0011256778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-38  Score=296.76  Aligned_cols=245  Identities=22%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.+++.++||||+++++++.+. ..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999865 68999999987532 233456788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +.+++|.+++... ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999998653 3357899999999999999999999   9999999999999999999999999999986543221 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc---Cc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA---DE  343 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~---~~  343 (408)
                       ......|++.|+|||++.++.++.++|+|||||++|+|++|+.||......               ..++..+.   ..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---------------~~~~~~~~~~~~~  220 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---------------NLVLKIIRGSYPP  220 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---------------HHHHHHhcCCCCC
Confidence             122345889999999999989999999999999999999999998743221               11111111   11


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+......+.+++.+||+.+|.+||++.+|++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            22344567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.6e-39  Score=299.72  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=198.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc---------hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  179 (408)
                      +|.+.+.||.|+||.||+|... +|+.||||.+.....         ....+.+..|+.+++.++|||++++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5778899999999999999865 689999998864211         11345678899999999999999999977654 


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++|+||+++++|.+++... ..+++..+..++.||+.||.|||+   ++++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            578999999999999999654 578999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccceecccccCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ..............|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||.........+...   ..    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~----~~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG---NK----RSA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh---cc----ccC
Confidence            54332222233456899999999987655  7899999999999999999999996433221111000   00    000


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ..+...........+.+++.+||+.+|.+||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            001111112345678889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-40  Score=316.29  Aligned_cols=240  Identities=22%  Similarity=0.275  Sum_probs=183.8

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcC---CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV---DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      ||+|+||+||+|... +|+.||||++.....  ......+..|..++..+   +||||+++++++.. ...++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 589999999864321  22344556677777655   69999999986654 558999999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|..++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||++......  .....
T Consensus        81 g~L~~~l~-~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~  154 (330)
T cd05586          81 GELFWHLQ-KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTN  154 (330)
T ss_pred             ChHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCcc
Confidence            99999885 35678999999999999999999999   99999999999999999999999999998754321  11223


Q ss_pred             ccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ...||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.........           ..+....... ......
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-----------~~i~~~~~~~-~~~~~~  222 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-----------RNIAFGKVRF-PKNVLS  222 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-----------HHHHcCCCCC-CCccCC
Confidence            46799999999998765 4899999999999999999999999754321110           0011000000 011234


Q ss_pred             HHHHHHHHhccccCCCCCCC----HHHHHH
Q 015389          350 NLVLLAASLCIQQSSIRRPQ----MSQVVQ  375 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt----~~evl~  375 (408)
                      ..+.+++.+||+.||.+||+    +.++++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            56778999999999999995    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-39  Score=300.86  Aligned_cols=238  Identities=23%  Similarity=0.336  Sum_probs=186.2

Q ss_pred             eecccCcEEEEEEEEcC-------------------------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeE
Q 015389          117 LIGKGGYAEVYKGRLRN-------------------------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK  171 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  171 (408)
                      .||+|+||.||+|.+..                         ...||+|.+..... +....+..|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999997421                         23589998865432 34567788999999999999999


Q ss_pred             EEeEEEeC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---
Q 015389          172 LLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---  247 (408)
Q Consensus       172 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---  247 (408)
                      +++++.+. ..++||||+++|+|..++......+++..+..++.||+.||+|||+   ++|+||||||+||+++..+   
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            99987765 4789999999999999997666788999999999999999999998   9999999999999997654   


Q ss_pred             ----ceEEeecCCcccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHH-hCCCCCCccccchhh
Q 015389          248 ----EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELV-TGRRALDYSQQSLVL  321 (408)
Q Consensus       248 ----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~ell-tg~~pf~~~~~~~~~  321 (408)
                          .++++|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........ 
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-  230 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence                3799999988643221      12347788999998876 56899999999999999994 68999875432211 


Q ss_pred             hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          322 WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                                 .........  .+......+..++.+||+.+|++||++.+|++.|.
T Consensus       231 -----------~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 -----------ERFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -----------HHHHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                       111111111  11112245788999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-39  Score=305.65  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=199.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ..+|++.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+.+++.++||||+++++++.. +..++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            378999999999999999999864 6999999998754433 34667889999999999999999996665 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++.  ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            999999999984  3567889999999999999999999   9999999999999999999999999999876543211 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                       ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.............  ..+      .+  ....+.
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--~~~------~~--~~~~~~  239 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNG------TP--ELQNPE  239 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--cCC------CC--CCCCcc
Confidence             1233468899999999999899999999999999999999999997543321110000  000      00  001122


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+++.+||+.+|.+||++.+|++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            33455778999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=305.88  Aligned_cols=252  Identities=25%  Similarity=0.297  Sum_probs=200.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......  .....+..|+.+++.++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999876 4899999999865433  3567788999999999999999999976654 478999


Q ss_pred             EecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||+.+++|.+++... ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999998643 3568999999999999999999999   999999999999999999999999999987653221


Q ss_pred             cc---------------------------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 015389          265 TH---------------------------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQ  317 (408)
Q Consensus       265 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~  317 (408)
                      ..                           .......||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011134588999999999998999999999999999999999999975433


Q ss_pred             chhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 015389          318 SLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ----MSQVVQ  375 (408)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~evl~  375 (408)
                      ...           ...+................+.+++.+||+.+|++||+    +.+++.
T Consensus       238 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DET-----------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHH-----------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            211           11111111111111124677899999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.7e-39  Score=302.92  Aligned_cols=262  Identities=23%  Similarity=0.272  Sum_probs=195.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++++|.+.+.||+|+||.||+|... +|+.||+|.+.....+.....+.+|+.+++.++|+||+++++++..+ ..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578999999999999999999865 58899999987654333344667899999999999999999976664 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+. ++|.+++......+++..+..++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++....... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence            9995 67777775555667888889999999999999999   899999999999999999999999999997543321 


Q ss_pred             cceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh----hhccccccchH-------H
Q 015389          266 HHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL----WARPMIKRNEI-------R  333 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~----~~~~~~~~~~~-------~  333 (408)
                       .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.........    |..........       .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence             112234578999999998764 5789999999999999999999999754322111    00000000000       0


Q ss_pred             HHhhhhccCccc---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVDASLADEYD---------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ............         ......+.+++.+|+..||.+|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000         011356778999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-39  Score=301.64  Aligned_cols=239  Identities=18%  Similarity=0.310  Sum_probs=187.8

Q ss_pred             ceecccCcEEEEEEEEcC-C-------cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          116 NLIGKGGYAEVYKGRLRN-G-------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +.||.|+||.||+|.... +       ..||+|.+.... ....+.+..|+.+++.++|||++++++++.. ...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            469999999999997642 2       348888876443 2345677889999999999999999997665 56789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc--------eEEeecCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--------PQICDFGLAK  258 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~kl~DfGla~  258 (408)
                      |+.+|+|.+++...+..+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.        ++++|||++.
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            999999999997766678999999999999999999999   99999999999999987765        6999999887


Q ss_pred             cCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCC-CCCCccccchhhhhccccccchHHHHh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGR-RALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      ....      .....++..|+|||++.+. .++.++|||||||++|+|++|. .||........            ....
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------------~~~~  218 (258)
T cd05078         157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------------LQFY  218 (258)
T ss_pred             ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------------HHHH
Confidence            5432      1235588899999999874 5799999999999999999995 55543222110            0011


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ..  ....+......+.+++.+||+.+|++|||++++++.|+
T Consensus       219 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11  11122223356888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.6e-39  Score=305.52  Aligned_cols=259  Identities=20%  Similarity=0.298  Sum_probs=194.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|++.+.||+|+||.||+|.+. +|+.||+|.+..... +.....+.+|+.+++.++||||+++++++.+ ...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999875 689999999875432 2234567789999999999999999996554 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +. ++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++..+.....  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            96 57888876656779999999999999999999999   9999999999999999999999999999986543211  


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc--cc---ccc---hHHHHhhh
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP--MI---KRN---EIRELVDA  338 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~--~~---~~~---~~~~~~d~  338 (408)
                      ......++..|+|||.+.+. .++.++|||||||++|+|++|+.|+.........+...  ..   ...   .+....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            22334578999999998775 47899999999999999999999864322211110000  00   000   00000000


Q ss_pred             h----ccC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 S----LAD-----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~----l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .    ...     .........+.+++.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0    000     001123466788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=311.24  Aligned_cols=269  Identities=21%  Similarity=0.290  Sum_probs=201.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~  181 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||.+...........+..|+.+++.++||||+++++++...      ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            478999999999999999999865 68999999987544444567788999999999999999999865543      36


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+. ++|..++  ....+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~--~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLI--KTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            89999986 4788777  34568999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCccc-eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcccc---ccchHHHH
Q 015389          262 EQWTHH-TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMI---KRNEIREL  335 (408)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~---~~~~~~~~  335 (408)
                      ...... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..... ......   .......+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            322211 1123568999999998765 46899999999999999999999999754321100 000000   00111111


Q ss_pred             hhhhc-------cC--cc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccCc
Q 015389          336 VDASL-------AD--EY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNLCC  383 (408)
Q Consensus       336 ~d~~l-------~~--~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~  383 (408)
                      .+...       ..  ..     .......+.+++.+||+.+|.+|||+.++++.  ++....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            11100       00  00     01224568899999999999999999999986  6655443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-38  Score=295.51  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=199.5

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      +|+..+.||+|+||.||+|... +++.|++|.+....    ..+....+..|+.+++.++||||+++++++.++ ..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999876 78999999986533    134567788999999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999999854 3468899999999999999999999   999999999999999999999999999988654322


Q ss_pred             ccceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                         ......|+..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.........+..           ....-...
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~-----------~~~~~~~~  222 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-----------GRSKELPP  222 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH-----------HhcccCCC
Confidence               223456899999999987776 899999999999999999999999754321111110           00000112


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+......+.+++.+||+.+|.+||++.+++.
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            22234566788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-38  Score=306.16  Aligned_cols=193  Identities=24%  Similarity=0.415  Sum_probs=157.4

Q ss_pred             ceecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEEEEEecC
Q 015389          116 NLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIVLELSP  189 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~e~~~  189 (408)
                      .+||+|+||.||+|...   ++..||+|.+.....   ...+.+|+.+++.++||||+++++++..   ...++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            58999999999999865   357899999875432   2346789999999999999999997643   34689999986


Q ss_pred             CCCHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE----CCCCceEEeecCCc
Q 015389          190 NGSLASLLYG--------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLA  257 (408)
Q Consensus       190 ~g~L~~~l~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla  257 (408)
                      + +|.+++..        ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 77777632        12347888999999999999999999   999999999999999    56678999999999


Q ss_pred             ccCCCCCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 015389          258 KWLPEQWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYS  315 (408)
Q Consensus       258 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~  315 (408)
                      +........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221 122345689999999998764 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-38  Score=294.87  Aligned_cols=247  Identities=24%  Similarity=0.359  Sum_probs=198.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|++.+.||+|+||.||++... +++.+|||.+.... ..+....+.+|+.+++.++|||++++++.+.. +..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888999999999999999865 68899999987543 23446788899999999999999999986554 457899999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~  265 (408)
                      +++++|.+++... ...+++..+..++.+++.||.|||+   ++++|+||+|+||+++.++ .++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999999654 3458999999999999999999999   9999999999999998654 689999999987654321


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........           ...... ......
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~~~  222 (256)
T cd08220         158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV-----------LKIMSG-TFAPIS  222 (256)
T ss_pred             ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH-----------HHHHhc-CCCCCC
Confidence               12345889999999999888999999999999999999999999754321110           011111 111122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+..++.+||+.+|.+|||+.|+++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            234556888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=299.22  Aligned_cols=273  Identities=25%  Similarity=0.342  Sum_probs=220.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEE-EeEEEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l-~~~~~~~~~~lv  184 (408)
                      .++|..+++||+|.||.|-+++-+ .|+.||+|++++..  ..+...+-+.|-++|...+||++..+ |.|...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            478999999999999999999866 69999999998753  34557788899999999999999888 568888999999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||..||.|..+|. ....+++....-+-..|+.||.|||+   ++||+||||.+|+|||.+|++||+|||+++.-..  
T Consensus       247 MeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--  320 (516)
T ss_pred             EEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence            99999999999884 45667888888888999999999999   9999999999999999999999999999985322  


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh-hhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV-DASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-d~~l~~~  343 (408)
                      ......+++||+.|+|||++....|+.++|+|.+||++|||++|+.||...+..            .+.+++ -..  -.
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------------kLFeLIl~ed--~k  386 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------------KLFELILMED--LK  386 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh------------HHHHHHHhhh--cc
Confidence            334667899999999999999999999999999999999999999999864432            122211 111  12


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH--HHhcccCccccccccCCchhhhhhhH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLRE  401 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~  401 (408)
                      ++.....+...|+.-.|..||.+|.     .+.||.+  ++.++.+.-...++..+||-..+.++
T Consensus       387 FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSe  451 (516)
T KOG0690|consen  387 FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSE  451 (516)
T ss_pred             CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccc
Confidence            3444455667788899999999996     4666654  45666666566666666665555444

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-38  Score=299.15  Aligned_cols=260  Identities=24%  Similarity=0.301  Sum_probs=200.2

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||.|+||.||+|.+. +|..||||++..... ......+.+|+.++++++||||+++++++..+ ..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5788999999999999999875 689999999876543 33457788999999999999999999976654 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      + +++|.+++......+++..++.++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 999999997666779999999999999999999999   9999999999999999999999999999987654321 1


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc--cccccc---hHH--------
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR--PMIKRN---EIR--------  333 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~--~~~~~~---~~~--------  333 (408)
                      ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||....... .+..  ......   ...        
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcchh
Confidence            22345689999999998754 46899999999999999999988886543211 0000  000000   000        


Q ss_pred             -HHhhhhcc----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          334 -ELVDASLA----DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       334 -~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       .+..+...    ..........+.+++.+||+.+|.+||+++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             00000000    00001234778999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-38  Score=303.87  Aligned_cols=255  Identities=23%  Similarity=0.296  Sum_probs=199.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||++... .++.||+|.+.....  ......+.+|+.+++.++||||+++++.+..+ ..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47889999999999999999876 488999999876532  23456788999999999999999999966554 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||+++.......
T Consensus        81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999999954 3568999999999999999999999   9999999999999999999999999999864211100


Q ss_pred             -------------cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          266 -------------HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       266 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                                   ........|+..|+|||.+.+..++.++|||||||++|||++|..||........           .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~-----------~  225 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-----------F  225 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------H
Confidence                         0011234578899999999998999999999999999999999999975332111           0


Q ss_pred             HHHhhhhcc-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          333 RELVDASLA-DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       333 ~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ......... .......+..+..++.+||+.+|++||+..++.+.|+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111000 00111345568899999999999999998777777755

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.3e-39  Score=317.08  Aligned_cols=195  Identities=28%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-C-----CceeEEEeEE-EeCCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-H-----PNTAKLLGYG-IEGGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-h-----pniv~l~~~~-~~~~~  181 (408)
                      -+|.+.+.||+|.||.|.+|.+. +++.||||+++...  ....+...|+.+|..|+ |     -|+|++++++ ..+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            37899999999999999999754 69999999998764  34566678999999986 3     4899999954 56789


Q ss_pred             EEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC--ceEEeecCCcc
Q 015389          182 HIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF--EPQICDFGLAK  258 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~--~~kl~DfGla~  258 (408)
                      |||+|.+ ..+|.+++... -..++...+..|+.||+.||.+||+   .+|||+||||+||||..-+  .+||+|||.+.
T Consensus       264 ciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            9999998 66999999653 3458999999999999999999999   9999999999999996543  79999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS  315 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~  315 (408)
                      .......     +...+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.
T Consensus       340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            7654322     556788999999999999999999999999999999998888764

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=298.44  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=198.0

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CCceeEEEeEEEeC-CeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~-~~~lv~  185 (408)
                      .|++.+.||.|+||.||+|.+. +++.||+|.+...........+.+|+.+++.+.   |||++++++++.++ ..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5778899999999999999864 689999999876554455677888999999886   99999999976654 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++..  ..+++..++.++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999999999843  478999999999999999999999   9999999999999999999999999999987654321


Q ss_pred             cceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                        ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||...........   ....     ..+.+..  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~-----~~~~~~~--  224 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML---IPKS-----KPPRLED--  224 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc---cccC-----CCCCCCc--
Confidence              22334689999999998754 468999999999999999999999975432211100   0000     0011111  


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ......+.+++.+||+.||.+||++.+++.
T Consensus       225 -~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 -NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             -ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence             113456888999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-38  Score=348.03  Aligned_cols=259  Identities=27%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ..|...+.||+|+||.||+|... +|..||||.+.......     ..|+.++++++||||+++++++.+. ..++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45777889999999999999874 78999999987543221     2468889999999999999987764 47899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++|+|.++++    .++|..+..++.|++.||+|||..+..+|+||||||+||+++.++.+++. ||.+......    
T Consensus       765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----  835 (968)
T PLN00113        765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----  835 (968)
T ss_pred             CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence            99999999994    38899999999999999999997666899999999999999999888876 6665432211    


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc---ccchhhhhccccccchHHHHhhhhccCc-
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS---QQSLVLWARPMIKRNEIRELVDASLADE-  343 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~~-  343 (408)
                        ....||+.|+|||++.+..++.++|||||||++|||++|+.||+..   ......|+............+++.+... 
T Consensus       836 --~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        836 --TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             --CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence              2235889999999999999999999999999999999999999643   2234455554444444555666666432 


Q ss_pred             -ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          344 -YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       344 -~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                       .+..+...+.+++.+|++.+|++||+|.||++.|+.+....
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence             34566778899999999999999999999999998876533

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4e-38  Score=293.53  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=205.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||.|++|.||+|... +++.||||.+...........+.+|+.++..++|||++++++++.. +..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999876 4999999999876554557788999999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++... ..+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            9999999999543 6789999999999999999999962  79999999999999999999999999999876443221 


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......  +      ......+... .....+..
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~------~~~~~~~~~~-~~~~~~~~  226 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--F------FELMQAICDG-PPPSLPAE  226 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--H------HHHHHHHhcC-CCCCCCcc
Confidence             124458899999999999999999999999999999999999997654200  0      0001111111 11122223


Q ss_pred             -HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 -QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 -~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       .+..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         227 EFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence             5678899999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.3e-38  Score=301.11  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=198.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      ....|++.+.||+|+||.||+|... +|+.||+|.+....  ..+....+.+|+.+++.++||||+++++++.+ +..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3467888999999999999999875 68999999986432  23445678899999999999999999997765 45789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+||+. |+|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999996 67777776556679999999999999999999999   99999999999999999999999999998755322


Q ss_pred             CccceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                            ....|+..|+|||.+.   .+.++.++||||||+++|||++|+.||...+........           .....
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-----------~~~~~  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----------AQNDS  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-----------hcCCC
Confidence                  2345888999999874   456889999999999999999999998754332111100           00000


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...........+..++.+||+.+|.+||++.+|+..
T Consensus       232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            011122345678899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=292.43  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEE-eCCeEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv~  185 (408)
                      +++|++.+.||+|.|+.|+++.+. +|+.+|+|.+..... ....+.+.+|+.|-+.|+||||+++.+-.. ++-.|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            478889999999999999999765 699999998864322 224677889999999999999999998444 45578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~~  262 (408)
                      |++.|++|..-+.. +..+++..+-..++||++||.|+|.   ++|||||+||.|++|...   --+||+|||+|..+..
T Consensus        90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            99999999887743 3567777788899999999999999   999999999999999543   3599999999998863


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh--hc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA--SL  340 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~--~l  340 (408)
                         ......+.|||+|+|||++....|+..+|||+.|||||-|+.|..||....+....           ..+...  ..
T Consensus       166 ---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-----------e~I~~g~yd~  231 (355)
T KOG0033|consen  166 ---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----------EQIKAGAYDY  231 (355)
T ss_pred             ---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-----------HHHhccccCC
Confidence               22334567999999999999999999999999999999999999999874433110           011111  01


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+.+.....+....|+.+||..||.+|.|+.|.+.
T Consensus       232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            12233445667888999999999999999877553

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=301.90  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=198.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||++.+. +++.||+|.+.....  ......+.+|+.++++++||||+++++++.++ ..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999875 589999999875432  23457788999999999999999999976654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|.||+++.++.++|+|||++......  
T Consensus        81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            99999999999854 3678999999999999999999999   99999999999999999999999999999876443  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .          .......  ....+
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~----------~~~~~~~--~~~~~  218 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-I----------YEKILEG--KVRFP  218 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-H----------HHHHhcC--CccCC
Confidence               234568999999999988889999999999999999999999997543210 0          0011111  11112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ......+..++.+||+.+|.+||     ++.++++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            22356778899999999999999     6666654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-39  Score=312.73  Aligned_cols=254  Identities=20%  Similarity=0.326  Sum_probs=205.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecC-CCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTR-GTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~-~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~l  183 (408)
                      +....|+++++||+||.+.||++...+.+.||+|++.. ...+.....+.+|+..|.+| .|.+|++||+|...+ .+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34567999999999999999999988878888887764 34456788999999999999 599999999998765 4788


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+= ..+|..+|......++.-.+..+..|++.|+.++|.   .||||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            99875 568999997766655544788899999999999999   99999999999998864 58999999999998887


Q ss_pred             CccceecccccCCCccccccccCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGI-----------VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      .+.-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||......          -..+
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------~aKl  582 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------IAKL  582 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH----------HHHH
Confidence            6666666788999999999986432           567899999999999999999999853211          1234


Q ss_pred             HHHhhhhccCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLADEYDTR-QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+.++.-...|+.- ....+..+++.||..||.+||+..+|++
T Consensus       583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  583 HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            455555443333321 1223889999999999999999999987

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8e-39  Score=302.34  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=197.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...... .....+.+|+.+++.++||||+++++++..+ ..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47889999999999999999876 5899999998754332 3456678899999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|..+... ...+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++..+....  
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            9999988887643 4458999999999999999999999   999999999999999999999999999998654322  


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchh-----hhhccccc-------cch-H
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV-----LWARPMIK-------RNE-I  332 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~-----~~~~~~~~-------~~~-~  332 (408)
                      .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........     .+......       ... +
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22233558899999999876 4578899999999999999999999865332100     00000000       000 0


Q ss_pred             HHHhhhhccCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLADE-----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.....     ........+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000000     01123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.7e-38  Score=294.81  Aligned_cols=253  Identities=26%  Similarity=0.424  Sum_probs=200.5

Q ss_pred             CCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCc-----hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+.....     ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            578889999999999999986 4689999999875331     2346788899999999999999999997665 45789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~  262 (408)
                      |+||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++ .++|+|||++..+..
T Consensus        81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999999854 4578899999999999999999999   9999999999999998776 599999999987654


Q ss_pred             CCcc--ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          263 QWTH--HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       263 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ....  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.........        ..+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--------ALIFKIASATT  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH--------HHHHHHhccCC
Confidence            3111  1112345889999999998888999999999999999999999999643211000        00111111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......+.+++.+|++.+|.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            23334445677888999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=300.00  Aligned_cols=261  Identities=24%  Similarity=0.349  Sum_probs=200.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +++.||||.+..... ......+.+|+.+++.++|+||+++++++..+ ..++|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46889999999999999999876 588999999875432 33457788999999999999999999976654 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |++++.+..+. .....+++..+..++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99987776655 344568999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc-------------cccchH
Q 015389          267 HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-------------IKRNEI  332 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-------------~~~~~~  332 (408)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........+....             ......
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122345688999999999888 889999999999999999999999975432211110000             000000


Q ss_pred             HH--Hhhh----hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RE--LVDA----SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~--~~d~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..  ..+.    .+...++...+..+.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00  0000    0000111223577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.5e-38  Score=297.63  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ..+++|+..+.||+|+||.||+|.+. ++..||+|++.....  ....+.+|+.+++.++|+|++++++++.. ...++|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            35578888999999999999999876 688999999976543  45678899999999999999999996655 557899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++++|.+++......+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999997655589999999999999999999999   999999999999999999999999999987654321


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC-c
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD-E  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-~  343 (408)
                      .  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+....... .
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~~  237 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL-----------FLITTKGIPPLK  237 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhcCCCCCc
Confidence            1  123345888999999999888999999999999999999999998754322111           0011111111 1


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ........+..++.+|++.+|..||++.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11224567888999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.9e-38  Score=288.22  Aligned_cols=246  Identities=31%  Similarity=0.467  Sum_probs=201.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      +|++.+.||+|++|.||++... ++..|++|++..... .....+.+|+.+++.++|||++++++++.. ...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            4778899999999999999876 689999999987654 346788899999999999999999997665 4578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++++|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            9999999996655689999999999999999999999   9999999999999999999999999999987654321   


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc--H
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD--T  346 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~  346 (408)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........            ..........  .
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~  221 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK------------IATNGPPGLRNPE  221 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH------------HHhcCCCCcCccc
Confidence            2345688999999999888899999999999999999999999975422111100            0001011111  1


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+++.+||+.||.+|||+.++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            12567888999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=318.56  Aligned_cols=242  Identities=28%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             eecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEecCCCCHH
Q 015389          117 LIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLA  194 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~~~~g~L~  194 (408)
                      +||+|.||+||-|++.+ ...+|||.+...... ..+-+..|+.+-++|.|.|||+++|.+.+++ +-|.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            69999999999998764 667999998755433 3567789999999999999999999877766 45889999999999


Q ss_pred             HHHhcccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-CCCceEEeecCCcccCCCCCccceecc
Q 015389          195 SLLYGMKEKL--KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       195 ~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      ++|...-+++  ++..+-.+.+||++||.|||+   +.|||||||-+|||++ -.|.+||+|||-++.+..  -.....+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence            9998887887  778888899999999999999   9999999999999996 468999999999998753  2334467


Q ss_pred             cccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccch-hhhhccccccchHHHHhhhhccCcccHHH
Q 015389          272 VEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      +.||..|||||++-.|  .|..++|||||||++.||.||++||...+... .++.-.+           -...+..+...
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm-----------yKvHP~iPeel  804 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM-----------YKVHPPIPEEL  804 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc-----------eecCCCCcHHH
Confidence            8899999999999876  48899999999999999999999997654321 1111111           11234556677


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......++.+|+..+|.+||++.++++
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            788888999999999999999999987

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.5e-38  Score=300.41  Aligned_cols=260  Identities=23%  Similarity=0.360  Sum_probs=198.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv  184 (408)
                      ++|++.+.||.|+||.||+|.+. +++.||+|.++..... .....+.+|+.++.+++||||+++++++..   ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57899999999999999999876 5889999999754332 234456789999999999999999997654   458899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+. ++|.+++......+++..+..++.||+.||.|||+   .+++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 48999886655679999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhh--------------hhc----c
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--------------WAR----P  325 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--------------~~~----~  325 (408)
                        .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.........              |..    +
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              1223345788999999987654 689999999999999999999999754321110              000    0


Q ss_pred             ccccchHHHHhhhhccCcccHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 MIKRNEIRELVDASLADEYDTR-QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 ~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..............+...+... ....+.+++.+||+.+|++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000000000011111112111 3566788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=286.47  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=202.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ++.+++..||.|..|.||++... .|..+|||.+.+....+..++++..+.++..- +.|+||+.+||+.- .++++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44556688999999999999876 58999999999887777889999999987665 59999999997665 45777788


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      .+ ..-+..++.....++++..+-++...++.||.||.+  .++|||||+||+|||+|+.|++||||||++-++-+... 
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-  247 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-  247 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence            76 445666666677889999999999999999999998  48999999999999999999999999999987755333 


Q ss_pred             ceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          267 HTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        .+.-.|.+.|||||.+.-   ..|+.++||||||++|+||.||+.||...+.+.....+....+       -+.+...
T Consensus       248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-------PP~L~~~  318 (391)
T KOG0983|consen  248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-------PPLLPGH  318 (391)
T ss_pred             --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-------CCCCCcc
Confidence              344569999999999853   4689999999999999999999999987655543322221111       1222221


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        ......+.+++..||..|+.+||.+.++++.
T Consensus       319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence              1245567889999999999999999998863

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.9e-38  Score=289.09  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=204.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVL  185 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~  185 (408)
                      +|++.+.||+|++|.||+|... ++..|++|++..... ......+.+|+.++++++||||+++++++.+.   ..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999876 689999999876543 34567888999999999999999999977665   478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |++.+++|.+++.... .+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999996543 88999999999999999999999   9999999999999999999999999999987655432


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      ........++..|+|||.+.+..++.++||||||+++|+|++|..||.........          ...+.........+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~  226 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----------LYKIGSSGEPPEIP  226 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH----------HHhccccCCCcCCC
Confidence            11123456889999999998888999999999999999999999999865411111          00111111112223


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+|++.+|.+||++.+++.
T Consensus       227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            334677889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.7e-38  Score=291.47  Aligned_cols=250  Identities=28%  Similarity=0.423  Sum_probs=199.6

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||+|+||.||+|... +++.||+|.+...... .....+..|+.+++.++|+||+++++++... ..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999865 6899999998765442 4578889999999999999999999976654 47899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.. ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999999854 3457889999999999999999999   999999999999999999999999999998765432221


Q ss_pred             e--ecccccCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          268 T--ISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       268 ~--~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||...........           .+......
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~-----------~~~~~~~~  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-----------HVGAGHKP  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH-----------HHhcCCCC
Confidence            1  12356889999999998766   88999999999999999999999975432211100           00000011


Q ss_pred             ccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYD--TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~--~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+  ......+.+++.+||+.+|.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111  122556778999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=315.16  Aligned_cols=244  Identities=31%  Similarity=0.441  Sum_probs=201.1

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEe
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~  187 (408)
                      |+-++-||.|+||.||-|++. +.+.||||++.-...  .+...++++|+..|.++.|||++.+-||+..+. .++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            444578999999999999864 789999999975432  356788999999999999999999999887665 6899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      | -|+-.+++.-.+.++-+..+..|..+.+.||.|||+   .+.||||||+.||||++.|.|||+|||.|.....     
T Consensus       108 C-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----  178 (948)
T ss_pred             H-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence            9 567888887788899999999999999999999999   9999999999999999999999999999986533     


Q ss_pred             eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       ...+.|||+|||||++.   .|.|+-++|||||||+..||.-.++|+-..+.....+-   +..++     .|.+.   
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH---IAQNe-----sPtLq---  246 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE-----SPTLQ---  246 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH---HHhcC-----CCCCC---
Confidence             24578999999999986   47899999999999999999999999765543222211   11111     12221   


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ..+....+..|+..||+.-|.+|||..+++..
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            24556778889999999999999999887753

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.2e-38  Score=295.05  Aligned_cols=256  Identities=22%  Similarity=0.268  Sum_probs=192.7

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe---CCeEEEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE---GGMHIVLE  186 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~~~lv~e  186 (408)
                      |++.+.||+|+||.||+|... +++.||+|.++.............|+.++.++. |||++++++++.+   +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            677899999999999999865 689999999876533322334457888898885 9999999997665   45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+. ++|.+.+......+++..+..++.|++.||.|||+   .+++||||+|+||+++. +.++|+|||++..+..... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 58888886656679999999999999999999999   99999999999999999 9999999999987643222 


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccch-hhhhccccc--cchHHHHhhhhccC
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPMIK--RNEIRELVDASLAD  342 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~--~~~~~~~~d~~l~~  342 (408)
                        .....++..|+|||.+.. +.++.++|||||||++|||++|..||...+... .........  ...........-..
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence              123458899999997654 557899999999999999999999997643211 111100000  00000000000000


Q ss_pred             --c-----------ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 --E-----------YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 --~-----------~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        .           .....+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              0           01134578999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2e-38  Score=301.44  Aligned_cols=248  Identities=21%  Similarity=0.337  Sum_probs=195.8

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      .|.....||.|+||.||++... ++..||||.+.... ......+.+|+.+++.++||||+++++.+.. +..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3344467999999999999865 58899999986543 2345678899999999999999999985554 5578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++++|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++........  .
T Consensus       102 ~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         102 EGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            9999999884  3468899999999999999999999   9999999999999999999999999999876543221  1


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..........        .+.....+.+..  ....
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--------~~~~~~~~~~~~--~~~~  244 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR--------RIRDNLPPRVKD--SHKV  244 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhcCCCcccc--cccc
Confidence            223458999999999988899999999999999999999999997543211100        001111111111  1123


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+..++.+|+..+|.+|||+.++++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            4567789999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.7e-38  Score=296.76  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      +|++.+.||.|++|.||+|.+. +|..||||.+...........+.+|+.++++++||||+++++++.+ +..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999976 5899999999866544445667789999999999999999997665 5579999999


Q ss_pred             CCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          189 PNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       189 ~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      .+ +|.+++....  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888875433  568999999999999999999998   9999999999999999999999999999976543211 


Q ss_pred             ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh------hhccccccchHHHHhh-h
Q 015389          267 HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL------WARPMIKRNEIRELVD-A  338 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~------~~~~~~~~~~~~~~~d-~  338 (408)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.........      +..+  .......+.+ +
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  232 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTP--TESTWPGISQLP  232 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC--ChhhHHHHhcCc
Confidence             12234578899999998664 5789999999999999999999999754321100      0000  0000000000 0


Q ss_pred             hcc-----------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLA-----------DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~-----------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+.           ..........+.+++.+|++.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000           0111223566889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-37  Score=298.39  Aligned_cols=249  Identities=27%  Similarity=0.395  Sum_probs=198.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ..|...+.||+|+||.||+|... +|..||+|.+....  ..+....+.+|+.+++.++|||++++++++.++ ..++|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34677889999999999999865 68999999987532  234566788999999999999999999977665 468999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+. |+|.+.+......+++..+..++.|++.||.|||+   ++|+||||+|+||+++.++.++|+|||++......  
T Consensus       105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9996 57888876667779999999999999999999999   99999999999999999999999999998754321  


Q ss_pred             cceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          266 HHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                          ....|+..|+|||++.   ++.++.++|||||||++|+|++|+.||........           ...+.......
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----------~~~~~~~~~~~  243 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LYHIAQNESPT  243 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----------HHHHHhccCCC
Confidence                2345889999999974   45689999999999999999999999865322111           11111111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .........+..++.+||+.+|.+||++.+|++.+-.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            1122345568889999999999999999999986533

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.6e-38  Score=298.10  Aligned_cols=259  Identities=23%  Similarity=0.282  Sum_probs=197.4

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      +|.+.+.||.|+||.||+|... +|+.||||.+......    .....+..|+.+++.++|+||+++++++.+. ..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999875 5899999999765432    2345667899999999999999999976664 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+ +++|.+++......+++..+..++.||++||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 999999996544479999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc--ccc---cchHH-----
Q 015389          265 THHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP--MIK---RNEIR-----  333 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~--~~~---~~~~~-----  333 (408)
                      .  ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... .....  ...   .....     
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence            1  2223456888999998865 457899999999999999999988876543211 00000  000   00000     


Q ss_pred             -HHhhhhccCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          334 -ELVDASLADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       334 -~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ...........     .......+.+++.+||+.+|.+||++.+|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000000001     12235678899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-38  Score=300.50  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=193.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ++|...+.||+|+||.||++.+. +|+.||+|.+...........+.+|+.++.++. ||||+++++++.. +..++++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666789999999999999875 589999999886554455677889999999996 9999999996554 45788999


Q ss_pred             ecCCCCHHHHH---hc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          187 LSPNGSLASLL---YG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       187 ~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      |+.. ++.++.   .. ....+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.++|+|||++..+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9754 554433   22 346789999999999999999999972  4999999999999999999999999999976543


Q ss_pred             CCccceecccccCCCccccccccCC---CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh---
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHG---IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV---  336 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---  336 (408)
                      ...   .....|+..|+|||.+.+.   .++.++|||||||++|+|++|+.||.........          +....   
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~~~~  227 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ----------LTQVVKGD  227 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH----------HhhhcCCC
Confidence            221   1234588999999998776   6899999999999999999999999754311000          00100   


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+.+...........+.+++.+||+.+|.+|||+.+|+..
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111122222355678899999999999999999998873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=304.57  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEE-EeEEEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l-~~~~~~~~~~lv  184 (408)
                      .+.|+.-++||+||||+||-+... +|+.||.|.+.+....  ......++|-.|+..++.++||.+ |+|...+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999999755 6999999998754332  234556889999999999999998 568888899999


Q ss_pred             EEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      +..|.||+|..+|.+.+ ..+++..+.-++.+|+.||++||+   ++||+||+||+|||||+.|+++|+|+|+|..++.+
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999997754 458999999999999999999999   99999999999999999999999999999988765


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      ...   ....||.+|||||++.++.|+...|+|||||+||||+.|+.||.....        ..+..++...+.. ....
T Consensus       341 ~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke--------Kvk~eEvdrr~~~-~~~e  408 (591)
T KOG0986|consen  341 KPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE--------KVKREEVDRRTLE-DPEE  408 (591)
T ss_pred             Ccc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh--------hhhHHHHHHHHhc-chhh
Confidence            333   234699999999999999999999999999999999999999975322        1122233322211 1233


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCC
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                      ++....++...+....|+.||.+|.-
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhcc
Confidence            45566777888999999999999974

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-37  Score=304.37  Aligned_cols=257  Identities=24%  Similarity=0.294  Sum_probs=197.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------  179 (408)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+.... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3478999999999999999999875 68999999987532 233456677899999999999999999965432      


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++|+||+. ++|.+.+..   .++...+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence             3689999995 588887743   28889999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc--c--ccchH--
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM--I--KRNEI--  332 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~--~--~~~~~--  332 (408)
                      .......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ..|....  .  ....+  
T Consensus       167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         167 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            6643221   23345889999999999999999999999999999999999999754321 1110000  0  00000  


Q ss_pred             ---------------------HHHhhhhc----cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 ---------------------RELVDASL----ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ---------------------~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                           ..+....+    ...........+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                                 00000000    00001134566889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.3e-38  Score=294.82  Aligned_cols=247  Identities=25%  Similarity=0.316  Sum_probs=200.9

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      +|++.+.||.|+||.||+|... ++..||+|.+.....  ....+.+.+|+.++++++||||+++++++.+ ...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999876 589999999975432  2356788999999999999999999986555 45889999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+++|.+++... ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999998543 578999999999999999999999   999999999999999999999999999998765432  


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.........         .+...... .....+.
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---------~~~~~~~~-~~~~~~~  223 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---------QIRAKQET-ADVLYPA  223 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---------HHHHHhcc-ccccCcc
Confidence             123456889999999999888999999999999999999999999865432111         11111110 1122333


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQM--SQVV  374 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~--~evl  374 (408)
                      ..+..+.+++.+||+.+|.+||++  .+++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            445778899999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=289.87  Aligned_cols=250  Identities=21%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---Ce
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~  181 (408)
                      .+|++.+.||+|+||.||+|.+. +|..||+|.+....    .......+.+|+.++++++||||+++++++.+.   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999999865 58999999875321    233457788999999999999999999977653   36


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++++||+++++|.+++.. ...+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            789999999999999854 3458889999999999999999999   999999999999999999999999999998653


Q ss_pred             CCCc-cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWT-HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... ........|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......           .+........
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~  226 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----------AIFKIATQPT  226 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----------HHHHHHcCCC
Confidence            2111 112234568999999999998889999999999999999999999997532211           1111111112


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+......+.+++.+|+. +|..||++.+++.
T Consensus       227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            233344556778899999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.5e-38  Score=297.02  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=193.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|+..+.||.|+||.||+|... +|+.||||.+..... ......+.+|+.++++++||||+++++++.+ +..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999875 689999999875432 2334678899999999999999999996655 457899999


Q ss_pred             cCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +. ++|.+++.. ....+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+....  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            95 688888854 34568999999999999999999999   999999999999999999999999999987654321  


Q ss_pred             ceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--ccc-cccch-------HHHH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RPM-IKRNE-------IREL  335 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~~-~~~~~-------~~~~  335 (408)
                      .......++..|+|||.+.+.. ++.++|||||||++|+|++|+.||...........  ... .....       +...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            1223345788999999887654 68899999999999999999999975432111000  000 00000       0000


Q ss_pred             hhh--hcc-Cc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          336 VDA--SLA-DE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       336 ~d~--~l~-~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...  ... ..   ........+.+++.+||+.||.+|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000  000 00   00112345678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8e-38  Score=297.59  Aligned_cols=261  Identities=18%  Similarity=0.208  Sum_probs=186.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCch---HH-------HHHHHHHHHHHhcCCCCceeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTAD---EI-------IADFLSELGIMAHVDHPNTAKLL  173 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~---~~-------~~~~~~E~~il~~l~hpniv~l~  173 (408)
                      ..++|.+.++||+|+||.||+|.+.+    +..+|+|........   +.       ......++..+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34689999999999999999998654    456677754332211   10       11223444556778999999999


Q ss_pred             eEEEeCC-----eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          174 GYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       174 ~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      +++....     .+++++++. .++.+.+.. ....++..+..++.|++.||.|||+   ++|+||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCc
Confidence            8655432     245666653 356666532 3346788889999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccCCCCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh
Q 015389          249 PQICDFGLAKWLPEQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA  323 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~  323 (408)
                      ++|+|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999999876432111     112235699999999999999999999999999999999999999986532211100


Q ss_pred             ccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          324 RPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       324 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ..  ...-+..+....+   .....+..+.+++..|+..+|++||++.++++.|+
T Consensus       245 ~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AA--KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             Hh--HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            00  0000111111111   01123567889999999999999999999999873

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.1e-38  Score=299.98  Aligned_cols=245  Identities=20%  Similarity=0.293  Sum_probs=194.1

Q ss_pred             ccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          114 FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      ....||.|+||.||+|... +++.||+|.+...... ....+.+|+.++..++|||++++++++.. +..++|+||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence            3457999999999999865 6899999998654332 34667899999999999999999996554 5678999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK  271 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  271 (408)
                      +|..++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....  ....
T Consensus       104 ~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~  176 (297)
T cd06659         104 ALTDIVS--QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS  176 (297)
T ss_pred             CHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence            9999873  3568899999999999999999999   9999999999999999999999999999876543322  1233


Q ss_pred             cccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHH
Q 015389          272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNL  351 (408)
Q Consensus       272 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  351 (408)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||.............        ........  ........
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~  246 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--------DSPPPKLK--NAHKISPV  246 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------ccCCCCcc--ccCCCCHH
Confidence            568999999999998899999999999999999999999997543221110000        00000000  01123456


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       352 l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +.+++.+||+.+|.+||++.+|++.
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhC
Confidence            7889999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-37  Score=288.19  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|.+.+.||.|+||.||++.+. ++..||+|++..... ......+..|+++++.++|||++++++.+.. ...++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999875 589999999986543 2456778899999999999999999986555 457899999


Q ss_pred             cCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          188 SPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       188 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +++++|.+++...   ...+++..+..++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            9999999999654   3779999999999999999999999   899999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.........           ..... ......
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----------~~~~~-~~~~~~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA-----------LKILK-GQYPPI  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH-----------HHHhc-CCCCCC
Confidence              1233456899999999998888999999999999999999999999754321110           01111 111122


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......+..++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2234567888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-37  Score=288.89  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=202.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|++.+.||.|+||.||++... +++.+|+|.+.... .......+..|+.+++.++||||+++++++.+ ...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788899999999999999765 68899999987643 23446677899999999999999999986554 557899999


Q ss_pred             cCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          188 SPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       188 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +++++|.+++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999854   23568999999999999999999999   99999999999999999999999999999876543 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......            .+...+........
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------------~~~~~~~~~~~~~~  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------------DLRYKVQRGKYPPI  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHhcCCCCCC
Confidence               122345889999999999999999999999999999999999999754321            11111122222223


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +......+..++.+|++.+|.+||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            34556778999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-37  Score=296.18  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.+++.++|||++++++++.. +..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            68899999999999999999864 688999999865432 234677899999999999999999996655 458899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            99999999984  3457888999999999999999999   9999999999999999999999999999876543221  


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......|++.|+|||.+.++.++.++|||||||++|+|++|+.||..............          ...........
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~----------~~~~~~~~~~~  240 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT----------NGTPELQNPEK  240 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc----------CCCCCCCCccc
Confidence            22334688999999999888899999999999999999999999976433211100000          00000111222


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+.+++.+||+.+|++||++.+++..
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            34567789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.1e-38  Score=299.39  Aligned_cols=261  Identities=28%  Similarity=0.374  Sum_probs=195.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~l  183 (408)
                      .++|++.+.||.|+||.||+|.+. +|+.||+|.+..... ......+.+|+.++++++|+||+++++++.+.   ..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            478999999999999999999875 589999999875432 22234456899999999999999999977643   4789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+||+. ++|.+++......+++..+..++.||+.||.|||+   .+++||||||+||+++.++.++|+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 48888886656779999999999999999999999   99999999999999999999999999999876532


Q ss_pred             CccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh-hccccc--cchHH-HHhhh
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW-ARPMIK--RNEIR-ELVDA  338 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~--~~~~~-~~~d~  338 (408)
                      ..  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........- ......  ..... ...+.
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            21  1222345788999999876 457899999999999999999999997543221100 000000  00000 00000


Q ss_pred             ------hccCc-c------cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 ------SLADE-Y------DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ------~l~~~-~------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                            .+... .      .......+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                  00000 0      0012455778999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-37  Score=297.28  Aligned_cols=263  Identities=23%  Similarity=0.313  Sum_probs=194.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|++.+.||+|+||.||+|... +++.||||.+..... +.....+.+|+.++++++||||+++++++...       
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            368999999999999999999875 589999998865432 22334556899999999999999999976542       


Q ss_pred             --CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          180 --GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       180 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                        ..++|+||+. ++|.+++......+++..+..++.||+.||.|||+   ++++|+||||+||+++.++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              2489999986 48888886655678999999999999999999999   89999999999999999999999999999


Q ss_pred             ccCCCCCcc--ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchh-hhhccc---cc--
Q 015389          258 KWLPEQWTH--HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV-LWARPM---IK--  328 (408)
Q Consensus       258 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~-~~~~~~---~~--  328 (408)
                      ..+......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ......   ..  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866432221  112234578899999988765 478899999999999999999999976432110 000000   00  


Q ss_pred             ---cchHHHHhhhh-ccCccc---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          329 ---RNEIRELVDAS-LADEYD---------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       329 ---~~~~~~~~d~~-l~~~~~---------~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                         ...-....+.. ......         ......+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence               00000000000 000000         001245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=292.50  Aligned_cols=259  Identities=24%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIVLE  186 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv~e  186 (408)
                      |++.+.||.|+||.||+|... +|+.||+|.+.... .......+.+|+.+++.++|||++++++++.+.   ..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667899999999999999876 48999999998664 233456778999999999999999999977654   5889999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++ +|.+++......+++..++.++.||+.||.|||+   .+++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9974 8988886655689999999999999999999999   9999999999999999999999999999987654321 


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcccc---ccchHHH-------
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMI---KRNEIRE-------  334 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~---~~~~~~~-------  334 (408)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......   .......       
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            11223457889999998765 45789999999999999999999999764321100 000000   0000000       


Q ss_pred             -------HhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 -------LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 -------~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                             .....+...+...+...+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   00000000111112567889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.5e-38  Score=296.46  Aligned_cols=260  Identities=18%  Similarity=0.245  Sum_probs=191.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-C-----
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-G-----  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~-----  180 (408)
                      ++|++.+.||.|+||.||+|.+. +|+.||||.+...... .....+.+|+.+++.+. ||||+++++++... .     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47889999999999999999875 6899999988754322 23456788999999995 69999999966543 3     


Q ss_pred             eEEEEEecCCCCHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecC
Q 015389          181 MHIVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFG  255 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfG  255 (408)
                      .++||||+.+ +|.+++...    ...+++..++.++.||+.||.|||+   ++|+||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            6899999985 788887542    2458999999999999999999999   99999999999999998 8899999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-cccccch--
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PMIKRNE--  331 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~--  331 (408)
                      ++..+.....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........+.. ..+....  
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9876533211  1122346889999998865 45799999999999999999999999754321110000 0000000  


Q ss_pred             ----HHHHhh----hhccC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 ----IRELVD----ASLAD----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ----~~~~~d----~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                          .....+    +....    .........+.+++.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                000000    00000    001123456888999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.8e-38  Score=290.27  Aligned_cols=248  Identities=21%  Similarity=0.345  Sum_probs=197.8

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||.|+||.||+|... +|..||+|.+..... ......+.+|+.+++.++|+||+++++.+..+ ..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999876 588999999875422 12345678999999999999999999966554 57899999


Q ss_pred             cCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~  265 (408)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++ .++|+|||.+..+.....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999986533 357899999999999999999999   9999999999999999886 469999999987654321


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........           +........ ....
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~-~~~~  223 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL-----------VLKICQGYF-APIS  223 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----------HHHHhcccC-CCCC
Confidence              22234589999999999888899999999999999999999999875332111           111111111 1112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+|++.+|++|||+.+|+.
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            234457888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-37  Score=289.02  Aligned_cols=242  Identities=22%  Similarity=0.295  Sum_probs=195.2

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L  193 (408)
                      ||.|+||.||+|... +++.||+|.+.....  ......+.+|+.+++.++||||+++++++.++ ..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999876 489999999976432  24457788999999999999999999976554 57899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      .+++.. ...+++..+..++.||+.||.|||+   ++++|+||+|+||+++.++.++|+|||++.......   ......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            999954 3458899999999999999999999   999999999999999999999999999998765432   122346


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..||.........         ....+........++......+.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---------IYNDILKGNGKLEFPNYIDKAAK  224 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---------HHHHHhccCCCCCCCcccCHHHH
Confidence            889999999998888999999999999999999999999765421111         11112211112223333367789


Q ss_pred             HHHHhccccCCCCCCC-----HHHHHH
Q 015389          354 LAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      .++.+||+.+|.+||+     +.|+++
T Consensus       225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         225 DLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHccCChhhCcCCcccCHHHHhc
Confidence            9999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.2e-37  Score=292.05  Aligned_cols=246  Identities=21%  Similarity=0.330  Sum_probs=195.5

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      |...+.||.|++|.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.. +..++|+||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            444579999999999999864 688999998865433 234667899999999999999999996554 55789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +++|.+++..  ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++........  ..
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            9999999854  568999999999999999999999   9999999999999999999999999998876543221  12


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.....  .      .+.....+.+.  ......
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~--~------~~~~~~~~~~~--~~~~~~  242 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--K------RIRDNLPPKLK--NLHKVS  242 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH--H------HHHhcCCCCCc--ccccCC
Confidence            2355899999999998888999999999999999999999998753321110  0      00000000011  011234


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          350 NLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         243 PRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHcc
Confidence            57889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.3e-38  Score=304.13  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~  181 (408)
                      .++|++.+.||.|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++..     ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999865 599999999875432 2345677889999999999999999986532     347


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            89999995 689888854 4558999999999999999999999   999999999999999999999999999997654


Q ss_pred             CCCcc--ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh--hccc----------
Q 015389          262 EQWTH--HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW--ARPM----------  326 (408)
Q Consensus       262 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~--~~~~----------  326 (408)
                      .....  .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........  ....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11234568999999999866 468999999999999999999999997643221100  0000          


Q ss_pred             cccchHHHHhhhhc-cCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 IKRNEIRELVDASL-ADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 ~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+....+..- ....     .......+.+++.+||+.+|.+||++.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00011111111100 0001     1223567899999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=297.54  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=193.1

Q ss_pred             CCCccceecccCcEEEEEEEEc---CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~  182 (408)
                      .|++.+.||+|+||.||+|...   +++.||+|.+....  .......+.+|+.+++.++||||+++++++.+.   ..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999865   47899999998643  122345667899999999999999999977654   378


Q ss_pred             EEEEecCCCCHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC----CCceEEeec
Q 015389          183 IVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE----DFEPQICDF  254 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~----~~~~kl~Df  254 (408)
                      +||||+.+ +|.+++...    ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999875 676666321    2368899999999999999999999   99999999999999999    899999999


Q ss_pred             CCcccCCCCCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-----------
Q 015389          255 GLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-----------  321 (408)
Q Consensus       255 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-----------  321 (408)
                      |++..+...... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.........           
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876443221 112234688999999988764 5889999999999999999999999764432100           


Q ss_pred             hhcccc-----------ccchHHHHhhhhccCccc---------H--HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          322 WARPMI-----------KRNEIRELVDASLADEYD---------T--RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       322 ~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......           .........+......++         .  .....+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000           000000000000000011         0  23356888999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-37  Score=295.81  Aligned_cols=252  Identities=26%  Similarity=0.432  Sum_probs=195.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      .++|++.+.||+|+||.||+|.+.+ ++.||||.+...........+..|+.++... +||||+++++++.+. ..++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4788999999999999999999864 8999999998655444556667788766666 599999999976654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+. ++|.+++......+++..+..++.|++.||.|||+.  .+|+||||+|+||++++++.++|+|||++..+.....
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            9984 577777765566899999999999999999999962  5899999999999999999999999999976543221


Q ss_pred             cceecccccCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGI----VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                         .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.........          +.........
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~~~~~~  237 (296)
T cd06618         171 ---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV----------LTKILQEEPP  237 (296)
T ss_pred             ---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH----------HHHHhcCCCC
Confidence               12235788999999987553    789999999999999999999999753222110          1111111100


Q ss_pred             -CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          342 -DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       342 -~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ..........+.+++.+||+.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00011235568889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-38  Score=307.88  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCCceeEEEeEEE-eCCeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~~~-~~~~~lv  184 (408)
                      ....|.+...||+|.|+.|.+|++. .+..||||.+.+...+. ....+.+|+++|+.++|||||+++.+.. +..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4478999999999999999999865 69999999998876543 3455889999999999999999999655 6789999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+.+|.+.+++...+. +.+..+..++.|++.|++|||.   ++|+|||||++||||+.+.++||+|||++..+..  
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--  207 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--
Confidence            999999999999976544 4458888899999999999999   9999999999999999999999999999998753  


Q ss_pred             ccceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                       .....+++|++.|.|||++.+..|+ +.+|+||+|++||.|+.|..||++..               +..+-.+.+++.
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------lk~Lr~rvl~gk  271 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------LKELRPRVLRGK  271 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------cccccchheeee
Confidence             3345678999999999999998874 79999999999999999999998532               222222223222


Q ss_pred             cc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YD--TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~--~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +-  .-.....-.+++++|-.+|.+|++++++..
T Consensus       272 ~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            11  112334556899999999999999999876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.8e-37  Score=294.22  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  179 (408)
                      ...++|++.+.||.|+||.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+.     
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45578999999999999999999876 589999999975432 22345667899999999999999999876543     


Q ss_pred             ------CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          180 ------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       180 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                            ..++|+||+++ ++...+......+++..+..++.||+.||.|||+   .+|+|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence                  47899999976 7777776555678999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhccccc--
Q 015389          254 FGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WARPMIK--  328 (408)
Q Consensus       254 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~--  328 (408)
                      ||++..+..... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||.........  .......  
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987654322 111223467889999988654 5789999999999999999999999754321100  0000000  


Q ss_pred             cchHHHHh--------h------hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          329 RNEIRELV--------D------ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       329 ~~~~~~~~--------d------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.        +      ..+.... ...+..+.+++.+||+.+|.+||++.+|++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000000        0      0000000 112456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=286.08  Aligned_cols=247  Identities=29%  Similarity=0.434  Sum_probs=202.1

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +|++.+.||+|++|.||+|... +++.||+|.+..... +.....+.+|++++.+++|||++++++++.++ ..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5788899999999999999865 588999999986543 23567889999999999999999999976654 47899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++......... 
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999998543 678999999999999999999998   99999999999999999999999999999876543221 


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                       .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........+...            .......+..
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~  222 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV------------QDDHPPLPEG  222 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh------------ccCCCCCCCC
Confidence             234568899999999988888999999999999999999999997543322211111            0111122233


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+..++.+||..+|++||++.+++.
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         223 ISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            4567888999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.9e-37  Score=291.50  Aligned_cols=247  Identities=25%  Similarity=0.299  Sum_probs=187.4

Q ss_pred             eecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHH---HHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELG---IMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~---il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      .||+|+||.||++... +|+.||+|.+......  .....+..|..   ++...+||||+.+++++.. +..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 5899999988754321  11223334443   3344579999999986654 56789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +++|.+++.. ...+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.++|+|||++......    ..
T Consensus        81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            9999998853 4569999999999999999999999   99999999999999999999999999998755332    11


Q ss_pred             cccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          270 SKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.........         .+... ........+...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---------~~~~~-~~~~~~~~~~~~  222 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------EIDRM-TLTVNVELPDSF  222 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---------HHHHH-hhcCCcCCcccc
Confidence            23468999999999864 56899999999999999999999999754321110         01111 011112223344


Q ss_pred             HHHHHHHHHhccccCCCCCC-----CHHHHHHH--Hhccc
Q 015389          349 MNLVLLAASLCIQQSSIRRP-----QMSQVVQL--LRGNL  381 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RP-----t~~evl~~--L~~~~  381 (408)
                      ...+.+++.+||+.||.+||     ++.++++.  ++++.
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            56788899999999999999     69998884  44443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=293.88  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~  188 (408)
                      |++.+.||.|++|.||+|.+. +|..||+|++...... .....+.+|+.+++.++|||++++++++.++ ..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567899999999999999865 6999999998754322 2345678899999999999999999976664 478999999


Q ss_pred             CCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      . ++|.+++.... ..+++..+..++.|++.||.|||+   ++++||||+|+||+++.++.++|+|||++..+.....  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999885533 468999999999999999999999   9999999999999999999999999999976543211  


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--cc-ccccch-------HHHHh
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RP-MIKRNE-------IRELV  336 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~-~~~~~~-------~~~~~  336 (408)
                      ......++..|+|||++.+. .++.++||||||+++|+|++|+.||.........+.  .. ....+.       +....
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            11223468899999988764 578999999999999999999999975433211100  00 000000       00000


Q ss_pred             hhh--cc----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DAS--LA----DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~--l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...  ..    ..........+.+++.+|++.+|.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000  00    0011123356888999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=291.43  Aligned_cols=258  Identities=23%  Similarity=0.314  Sum_probs=198.2

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      |++.+.||.|++|.||+|... +|+.+|+|.+...... .....+..|+.+++.++||||+++++++.. ...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999875 6899999998765433 345677889999999999999999996554 5578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      .+ +|.+++......+++..+..++.|++.||.|||+   .+|+|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 8888886655789999999999999999999999   999999999999999999999999999998765432  12


Q ss_pred             ecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccccc---cchHHHHhh---h--
Q 015389          269 ISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIK---RNEIRELVD---A--  338 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~---~~~~~~~~d---~--  338 (408)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......... .......   ........+   .  
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2234578899999998877 7899999999999999999999999754321100 0000000   000000000   0  


Q ss_pred             -hc-------cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 -SL-------ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 -~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ..       ...........+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             00       00111234577889999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-37  Score=294.18  Aligned_cols=260  Identities=18%  Similarity=0.275  Sum_probs=192.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      ++|++.+.||.|++|.||+|... +|+.||+|.+..... ......+.+|+.+++.++||||+++++++.+ ...++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999876 689999999875432 2344667889999999999999999997665 45789999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~  264 (408)
                      |+. ++|.+++... ...+++..+..++.||+.||.|||+   ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 5777777442 3336788888999999999999999   99999999999999985 5579999999997654321


Q ss_pred             ccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh------ccccc----cchHH
Q 015389          265 THHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA------RPMIK----RNEIR  333 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~------~~~~~----~~~~~  333 (408)
                        .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...........      .+...    -..+.
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              112234578899999998764 578999999999999999999999975432211100      00000    00000


Q ss_pred             HHhh--hhccCc----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVD--ASLADE----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....  +.....    ........+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  000000    01123455788999999999999999999986

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-37  Score=299.16  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC---Ce
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~---~~  181 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++++ +||||+++++++...   ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3478999999999999999999875 58899999886432 223345677899999999 999999999976532   36


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+. ++|..++..  ..+++..+..++.||+.||.|||+   .+|+|+||||+||+++.++.++|+|||++..+.
T Consensus        85 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            89999997 589888844  378899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCcc---ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh----hhccccccchHH
Q 015389          262 EQWTH---HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL----WARPMIKRNEIR  333 (408)
Q Consensus       262 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~----~~~~~~~~~~~~  333 (408)
                      .....   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........    ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            43221   22234568999999998765 45789999999999999999999999754322110    000000000000


Q ss_pred             --------HHhhhhccC------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          334 --------ELVDASLAD------EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       334 --------~~~d~~l~~------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                              .+++.....      .........+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    111100000      0001135678899999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-37  Score=288.76  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=195.0

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||.|+||.||++... +|+.||+|.+.....  ......+.+|+.+++.++||||+++++.+.. ...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 499999999876533  2456778899999999999999999986554 457899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc------cc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT------HH  267 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~------~~  267 (408)
                      .+++... ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            9999653 378999999999999999999999   9999999999999999999999999999876533211      11


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|..||........           ...+............
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----------~~~~~~~~~~~~~~~~  225 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----------FQNILNGKIEWPEDVE  225 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHhcCCcCCCcccc
Confidence            22345688899999999888899999999999999999999999975432211           0111110111101111


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ....+..++.+|++.+|.+|||+..+.+.|+
T Consensus       226 ~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            2567889999999999999999977776664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.5e-37  Score=296.30  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=191.2

Q ss_pred             ceeccc--CcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G--~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      ..||+|  +||+||+|.+. +|+.||+|.+.... ..+..+.+.+|+.+++.++||||+++++++.. +..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457776  99999999875 69999999987543 33456788899999999999999999997665 457899999999


Q ss_pred             CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc--
Q 015389          191 GSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH--  267 (408)
Q Consensus       191 g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~--  267 (408)
                      ++|.+++... ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++++|||.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999998653 3458899999999999999999998   999999999999999999999999998654332211110  


Q ss_pred             ---eecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc---ccc-------ccchH
Q 015389          268 ---TISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR---PMI-------KRNEI  332 (408)
Q Consensus       268 ---~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~---~~~-------~~~~~  332 (408)
                         ......++..|+|||++.+.  .++.++|||||||++|+|++|+.||............   ...       .....
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112356679999999764  4789999999999999999999999764322111000   000       00000


Q ss_pred             ------------------------HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 ------------------------RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ------------------------~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                              ..+.+..+...........+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                    0001111122223345677899999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-37  Score=289.71  Aligned_cols=243  Identities=27%  Similarity=0.359  Sum_probs=189.8

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||+|+||+||+|... +|+.||+|.+.....  ......+..|+.+++.++||||+++++.+.. +..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999765 689999999875432  2234566789999999999999999986554 558899999999999


Q ss_pred             HHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceeccc
Q 015389          194 ASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV  272 (408)
Q Consensus       194 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  272 (408)
                      .+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            99986543 368999999999999999999999   99999999999999999999999999998765432   112234


Q ss_pred             ccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHH
Q 015389          273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLV  352 (408)
Q Consensus       273 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  352 (408)
                      .++..|+|||.+.++.++.++|||||||++|+|++|+.||........        ...+...... .....+......+
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~~  225 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--------KEELKRRTLE-MAVEYPDKFSPEA  225 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--------HHHHHhcccc-ccccCCccCCHHH
Confidence            578899999999888899999999999999999999999975432100        0000000000 0111222335667


Q ss_pred             HHHHHhccccCCCCCC-----CHHHHHH
Q 015389          353 LLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       353 ~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      .+++.+||+.+|.+||     ++.+++.
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         226 KDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHccCChhHccCCCcccHHHHHh
Confidence            8899999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-37  Score=286.11  Aligned_cols=241  Identities=25%  Similarity=0.310  Sum_probs=188.5

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHH-HhcCCCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGI-MAHVDHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.||.|+||.||+|... +|+.||||.+.....  ......+..|..+ ....+|||++++++++.. +..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999875 589999999875432  1223344455544 445689999999997665 457899999999


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      ++|.+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....      ..
T Consensus        82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            999999853 4568899999999999999999999   9999999999999999999999999999875432      22


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh--ccCcccHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS--LADEYDTRQ  348 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~~~~~~~~  348 (408)
                      ...|+..|+|||.+.+..++.++||||||+++|+|++|..||........ +          ..+....  .........
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~----------~~~~~~~~~~~~~~~~~~  220 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-F----------DNILSRRINWPEEVKEFC  220 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-H----------HHHHhcccCCCCcccccC
Confidence            34588999999999888899999999999999999999999975432211 0          0011100  111112234


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      ...+.+++.+||+.+|++||++.++.+.|
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            56788999999999999999887776665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=336.60  Aligned_cols=257  Identities=27%  Similarity=0.352  Sum_probs=208.1

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ...+-+|+-...||.|.||.||-|.+ ++|...|+|.+..... ......+..|+.++..++|||+|++||+.... .++
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34456788889999999999999985 4699999998874332 33456677899999999999999999987764 578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      |.||||.+|+|.+++. .++-.++.....+..|++.|+.|||+   .|||||||||.||+|+.+|.+|++|||.|..+..
T Consensus      1311 IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            9999999999999994 45566777777788999999999999   9999999999999999999999999999988765


Q ss_pred             CCcc--ceecccccCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          263 QWTH--HTISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       263 ~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ....  .......||+.|||||++.+..   -..+.||||||||+.||+||++||...+.+.           .+...+.
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----------aIMy~V~ 1455 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----------AIMYHVA 1455 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----------HHHhHHh
Confidence            4211  1223456999999999998654   4568999999999999999999998655441           1222333


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .+-.+..+.+....-.+++..||+.||.+|.++.|+++.=
T Consensus      1456 ~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1456 AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            3334555666777788899999999999999999888764

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-36  Score=291.31  Aligned_cols=244  Identities=28%  Similarity=0.409  Sum_probs=193.2

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEEe
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLEL  187 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e~  187 (408)
                      |...+.||+|+||.||+|... +|..||+|.+....  .......+..|+.+++.++|||++++++++.+.. .++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566688999999999999875 58999999987532  2234567889999999999999999999776654 7899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +. |+|.+++......+++..+..++.||+.||.|||+   .+++|+||+|+||+++.++.++|+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 57888876666779999999999999999999999   9999999999999999999999999999864322     


Q ss_pred             eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .....|+..|+|||++.   ++.++.++|||||||++|+|++|..||...+.......           ..........
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~-----------~~~~~~~~~~  241 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----------IAQNDSPTLQ  241 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-----------HHhcCCCCCC
Confidence             12456899999999984   45688999999999999999999999875432211100           0000001111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .......+..++.+||+.+|.+||++.+++..
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            12233457889999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=312.45  Aligned_cols=265  Identities=23%  Similarity=0.322  Sum_probs=201.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-------e
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-------M  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-------~  181 (408)
                      ..|...+.||+||||.||+|+++ .|+.||||..+........+...+|++++++++|||||++++......       .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            34556689999999999999965 699999999987544444677789999999999999999998654432       4


Q ss_pred             EEEEEecCCCCHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC--CCC--ceEEeecC
Q 015389          182 HIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDF--EPQICDFG  255 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~--~~~--~~kl~DfG  255 (408)
                      .+|||||.+|+|...|..  ....+++.+.+.+...++.||.|||+   +||+||||||.||++-  .+|  .-||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            689999999999999965  33459999999999999999999999   9999999999999993  333  57999999


Q ss_pred             CcccCCCCCccceecccccCCCcccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCccccc----hhhhhccccccc
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS----LVLWARPMIKRN  330 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~----~~~~~~~~~~~~  330 (408)
                      .|+.+.++.   ....+.||..|++||.+. .+.|+..+|.|||||++|+.+||..||......    ..+|....-+..
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            999887643   456688999999999998 488999999999999999999999999764433    133332221111


Q ss_pred             hHHHHhhhhc------------cCcccHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHhcc
Q 015389          331 EIRELVDASL------------ADEYDTRQMNLVLLAASLCIQQSSIRRP--QMSQVVQLLRGN  380 (408)
Q Consensus       331 ~~~~~~d~~l------------~~~~~~~~~~~l~~li~~cl~~~P~~RP--t~~evl~~L~~~  380 (408)
                      .+.....+..            ...........+-..+..+|..+|.+|-  ...+....+..+
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            1111111111            1112233455666778888899999998  444444444333

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.1e-38  Score=325.76  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=193.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EE---------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG---------  176 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~---------  176 (408)
                      -..+|+..+.||+||||.||+++++ ||+.||||++.....+.....+.+|+..+++|+|||||++|. |.         
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467888899999999999999987 899999999987666667888999999999999999999985 21         


Q ss_pred             -----------------------------------------------E--------------------------------
Q 015389          177 -----------------------------------------------I--------------------------------  177 (408)
Q Consensus       177 -----------------------------------------------~--------------------------------  177 (408)
                                                                     .                                
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                           0                                


Q ss_pred             -----------------------e--------CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015389          178 -----------------------E--------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG  226 (408)
Q Consensus       178 -----------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  226 (408)
                                             +        --+||=||||+...|.+++......-.....|+++++|++||.|+|+ 
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-  715 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-  715 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-
Confidence                                   0        01356789998888888885432222467789999999999999999 


Q ss_pred             CCCCeEeeCCCCCceEECCCCceEEeecCCcccCC----------C-----CCccc-eecccccCCCccccccccCCC--
Q 015389          227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP----------E-----QWTHH-TISKVEGTFGYLAPEFLMHGI--  288 (408)
Q Consensus       227 ~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~----------~-----~~~~~-~~~~~~gt~~y~aPE~~~~~~--  288 (408)
                        +|||||||||.||||++++.|||+|||+|..+.          .     ..... ..+...||.-|+|||.+.+..  
T Consensus       716 --~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 --QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             --CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence              999999999999999999999999999998721          0     00111 335567999999999997654  


Q ss_pred             -CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC--cccHHHHHHHHHHHHhccccCCC
Q 015389          289 -VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD--EYDTRQMNLVLLAASLCIQQSSI  365 (408)
Q Consensus       289 -~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~~P~  365 (408)
                       |+.|+|+|||||||+||+.   ||+..-..          ...+..+-+..+..  ++.......-..+|.+++++||.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~  860 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMER----------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS  860 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHH----------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence             9999999999999999985   56643221          11222222222222  22333445566799999999999


Q ss_pred             CCCCHHHHHH
Q 015389          366 RRPQMSQVVQ  375 (408)
Q Consensus       366 ~RPt~~evl~  375 (408)
                      +|||+.|++.
T Consensus       861 kRPtA~eLL~  870 (1351)
T KOG1035|consen  861 KRPTATELLN  870 (1351)
T ss_pred             cCCCHHHHhh
Confidence            9999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-37  Score=298.55  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=196.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+..... +.....+.+|+.+++.++||||+++++++...       
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999865 689999999875432 23346678999999999999999999976542       


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++|+||+. .+|..++   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            3589999986 4676665   3468899999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc---cccchHHH-
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM---IKRNEIRE-  334 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~---~~~~~~~~-  334 (408)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............   ........ 
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            5332     123457889999999876 4689999999999999999999999986432111100000   00000000 


Q ss_pred             --------Hhhhh---ccCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccC
Q 015389          335 --------LVDAS---LADEYD---TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNLC  382 (408)
Q Consensus       335 --------~~d~~---l~~~~~---~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~  382 (408)
                              .....   ......   ......+.+++.+||+.||.+||++.+++..  +++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                    00000   000000   1123457899999999999999999999953  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-37  Score=299.60  Aligned_cols=269  Identities=21%  Similarity=0.281  Sum_probs=201.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------G  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~  180 (408)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+.... .......+..|+.+++.++||||+++++++...      .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            367999999999999999999865 68999999987532 222345677899999999999999999865432      3


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+   ++++||||||+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            789999995 688888843 4678999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hh---c-------ccc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WA---R-------PMI  327 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~---~-------~~~  327 (408)
                      ....  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  ..   .       ...
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            4321  12233458899999998865 46899999999999999999999999754321000  00   0       000


Q ss_pred             ccchHHHHhhhhcc---C---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccCcc
Q 015389          328 KRNEIRELVDASLA---D---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNLCCL  384 (408)
Q Consensus       328 ~~~~~~~~~d~~l~---~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~~  384 (408)
                      ........+...-.   .   .........+.+++.+||+.+|.+||++.++++.  ++......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence            01111111110000   0   0011245668899999999999999999999986  66554333

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-38  Score=308.90  Aligned_cols=247  Identities=24%  Similarity=0.408  Sum_probs=193.5

Q ss_pred             ccceecccCcEEEEEEEEc-CCcEEEEEEec---CCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC--eEEEEE
Q 015389          114 FENLIGKGGYAEVYKGRLR-NGQLVAIKRLT---RGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG--MHIVLE  186 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~---~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~--~~lv~e  186 (408)
                      +..+||+|+|-+||+|.+. +|..||--.++   .....+..++|..|+.+|+.|+||||+++|++..+ .+  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4478999999999999875 47777644333   33344567899999999999999999999995554 33  678999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~~  265 (408)
                      .+..|+|..|+.. -+.++...+..|++||+.||.|||++ ..+|||||||.+||||+.+ |.|||+|+|||..+.... 
T Consensus       124 L~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  124 LFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             cccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            9999999999954 45678889999999999999999985 4689999999999999765 899999999999875432 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc--cccchHHHHhhhhccCc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM--IKRNEIRELVDASLADE  343 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~d~~l~~~  343 (408)
                         ...+.|||.|||||.+. ..|++.+||||||+.++||+|+..||..-....-.+.+..  .+...+..+-       
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~-------  269 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK-------  269 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC-------
Confidence               23377999999999986 8899999999999999999999999986433322221111  1111111111       


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                           ...+.+||.+||.. ...|||+.|++.  +|...
T Consensus       270 -----dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 -----DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             -----CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                 23467799999999 889999999987  45443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=296.54  Aligned_cols=265  Identities=23%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      ...++....++|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++.+++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566678899999999999999999999864 689999999976432 2235667889999999999999999986643


Q ss_pred             C-------CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEE
Q 015389          179 G-------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (408)
Q Consensus       179 ~-------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl  251 (408)
                      .       ..+++++++ +++|.+++.  ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence            2       245666665 889988874  3468999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhc----
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WAR----  324 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~----  324 (408)
                      +|||++......     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  ...    
T Consensus       162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998864322     223468899999999876 56889999999999999999999999654321100  000    


Q ss_pred             ------cccccchHHHHhhhh--c-cCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          325 ------PMIKRNEIRELVDAS--L-ADEYD---TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       325 ------~~~~~~~~~~~~d~~--l-~~~~~---~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                            ...........+...  . ...+.   ......+.+++.+|++.+|.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                  000000000110000  0 00000   0124467899999999999999999998873

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.1e-37  Score=292.78  Aligned_cols=263  Identities=24%  Similarity=0.305  Sum_probs=194.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|++.+.||.|+||.||+|.+. +++.||||.+...... .....+.+|+.+++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            579999999999999999999875 5899999998654322 2234567899999999999999999865332       


Q ss_pred             --CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          180 --GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       180 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                        .+++|+||+.+ +|...+......+++..+..++.|+++||.|||+   ++|+|+||||+||++++++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              25889999865 6777776666689999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCcc---------ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchh---hhhc
Q 015389          258 KWLPEQWTH---------HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV---LWAR  324 (408)
Q Consensus       258 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~---~~~~  324 (408)
                      .........         ...+...|++.|+|||.+.+. .++.++|||||||++|||++|+.||........   .+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            865432211         111234578899999988654 588999999999999999999999975432110   0000


Q ss_pred             cc-cccch------HHHHh----hhhccCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          325 PM-IKRNE------IRELV----DASLADEY---DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       325 ~~-~~~~~------~~~~~----d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .. .....      +....    ........   .......+.+++.+||+.+|.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            00 00000      00000    00000000   0112256888999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.4e-37  Score=292.07  Aligned_cols=247  Identities=28%  Similarity=0.398  Sum_probs=196.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ..|...+.||.|+||.||+|... ++..||+|.+...  .......++.+|+.+++.++|+|++++++++... ..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            44777789999999999999875 5889999998643  2334456788999999999999999999976665 468999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+. |+|.+++......+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 68888776556678999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          266 HHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                          ....|+..|+|||.+.   .+.++.++|||||||++|+|++|+.||..........           .........
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----------~~~~~~~~~  233 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----------HIAQNESPA  233 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-----------HHhhcCCCC
Confidence                2345889999999975   3568889999999999999999999986533211110           111111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      .........+..++.+||+.+|.+||++.+|+..-
T Consensus       234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            11223456688899999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=288.57  Aligned_cols=257  Identities=24%  Similarity=0.317  Sum_probs=192.9

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CCeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      |++.+.||.|+||+||+|... +++.||||.+.............+|+..++.++ |||++++++++.+ +..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567899999999999999976 488999999876543222334457899999998 9999999996554 5678999999


Q ss_pred             CCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                       +|+|.+++.... ..+++..+..++.|++.||.|||+   ++++|+||+|+||+++.++.++|+|||++........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             889999886543 578999999999999999999999   9999999999999999999999999999986543211  


Q ss_pred             eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--------------hhccccccchH
Q 015389          268 TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--------------WARPMIKRNEI  332 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--------------~~~~~~~~~~~  332 (408)
                       .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........              |.........+
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence             223458889999998854 45789999999999999999999999654322111              00000000000


Q ss_pred             HHHhhhhcc---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLA---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+.....   ..........+..++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000   0000112466889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-37  Score=310.51  Aligned_cols=265  Identities=17%  Similarity=0.204  Sum_probs=184.4

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc--CCcEEEEEEec--------------C--CCchHHHHHHHHHHHHHhcCCCC
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLT--------------R--GTADEIIADFLSELGIMAHVDHP  167 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~--~g~~vavK~~~--------------~--~~~~~~~~~~~~E~~il~~l~hp  167 (408)
                      ....++|++.+.||+|+||+||++..+  .+..+++|.+.              +  .........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            334578999999999999999998654  23333333111              0  01122356678999999999999


Q ss_pred             ceeEEEeEEEeC-CeEEEEEecCCCCHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          168 NTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGM----KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       168 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                      ||+++++++... ..++|++++. ++|.+++...    ........+..++.||+.||.|||+   ++|+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            999999977664 4678888884 5677766432    1223455677899999999999999   99999999999999


Q ss_pred             ECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCccccch-h
Q 015389          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR-ALDYSQQSL-V  320 (408)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~-pf~~~~~~~-~  320 (408)
                      ++.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|.. |+....... .
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999999876543221 2234569999999999999999999999999999999999875 443322110 0


Q ss_pred             hhhc---cc-ccc-------chHHHHhhhhccCc----cc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          321 LWAR---PM-IKR-------NEIRELVDASLADE----YD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       321 ~~~~---~~-~~~-------~~~~~~~d~~l~~~----~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....   .. ...       ..+...++......    ..     ......+.+++.+||+.||.+|||+.|++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000   00 000       01111111100000    00     012245667899999999999999999986

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.7e-36  Score=292.93  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=196.7

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCe
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGM  181 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~  181 (408)
                      ...+++|++.+.||.|+||.||+|... +|+.||||.+.... .......+..|+.+++.++||||+++++++..  ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346689999999999999999999865 69999999886532 22345667789999999999999999997654  357


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+ +++|..++.  ...+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++....
T Consensus        86 ~lv~e~~-~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             EEEeehh-ccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            8999998 568988884  3457888888999999999999999   999999999999999999999999999987543


Q ss_pred             CCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchh--hh-----------hcccc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV--LW-----------ARPMI  327 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~--~~-----------~~~~~  327 (408)
                      ..     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........  .+           .....
T Consensus       160 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         160 PQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            21     123457889999998866 5689999999999999999999999975432110  00           00000


Q ss_pred             ccchHHHHhhhh-ccCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          328 KRNEIRELVDAS-LADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       328 ~~~~~~~~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .. .....+... .....+     ......+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00 001111110 011111     1134678899999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=285.69  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=191.6

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcC---CCCceeEEEeEEEeC-C-----
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGIEG-G-----  180 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l---~hpniv~l~~~~~~~-~-----  180 (408)
                      |++.+.||+|+||.||+|.++ +++.||+|.+...... .....+.+|+.++.++   +|||++++++++... .     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567899999999999999986 4899999999754322 2334566777776655   699999999976653 3     


Q ss_pred             eEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          181 MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      .++++|++.+ +|.+++.... ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            7899999974 7888886533 368999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhccccccchH-----
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WARPMIKRNEI-----  332 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~~~~~~~-----  332 (408)
                      +.....   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........  +..........     
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            643211   12334788999999999999999999999999999999999998754321100  00000000000     


Q ss_pred             ----HHHhhhhcc---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 ----RELVDASLA---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ----~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                          .........   ..........+.+++.+||+.||.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                000000000   0111233466788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-36  Score=284.13  Aligned_cols=247  Identities=23%  Similarity=0.257  Sum_probs=189.2

Q ss_pred             HHhhhcCCCCcccee--cccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe-
Q 015389          104 ELQSATNNFSFENLI--GKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-  178 (408)
Q Consensus       104 ~~~~~~~~y~~~~~l--g~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-  178 (408)
                      +.....++|.+.+.+  |+|+||.||++..+ ++..+|+|.+.......      .|+..... .+||||+++++++.. 
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence            334445677777776  99999999999865 68899999987543221      12222221 279999999996654 


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCc
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLA  257 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla  257 (408)
                      +..++||||+++++|.+++... ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            5578999999999999999543 488999999999999999999999   9999999999999999998 9999999998


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ......      ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........+       ..+.....
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~  224 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL-------ESLLKRQQ  224 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH-------HHHHHhhc
Confidence            865432      22458999999999999899999999999999999999999997543321110       01111111


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ-MSQVVQ  375 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~  375 (408)
                      .  ...........+..++.+||+.+|.+||+ +.++++
T Consensus       225 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1  11112245567888999999999999996 588774

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=295.65  Aligned_cols=262  Identities=23%  Similarity=0.323  Sum_probs=197.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------  179 (408)
                      ..++|++.+.||+|+||.||+|... +|..||||.+..... ......+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4578999999999999999999865 699999999865332 33456778999999999999999999966543      


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++|++++ +++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~  166 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence             247899998 789988884  3568999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--c-c---------
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--R-P---------  325 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~-~---------  325 (408)
                      .....     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........  . .         
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         167 QTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             ccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            65432     123457899999999876 4588999999999999999999999975432110000  0 0         


Q ss_pred             ccccchHHHHhhhh--cc-C---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          326 MIKRNEIRELVDAS--LA-D---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       326 ~~~~~~~~~~~d~~--l~-~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      .+............  .. .   .........+.+++.+|++.||.+|||+.+++.  .++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            00000000110000  00 0   001122345788999999999999999999984  44443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.1e-36  Score=285.46  Aligned_cols=241  Identities=27%  Similarity=0.334  Sum_probs=184.4

Q ss_pred             eecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHH---HHHHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSE---LGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E---~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      .||+|+||.||+|... +++.||+|.+......  .....+..|   +.+++..+||||+++++++.+ +..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 5899999998754321  111222333   344555689999999986655 55789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +++|..++.. ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++..+...    ..
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            9999998853 4579999999999999999999999   99999999999999999999999999998765332    11


Q ss_pred             cccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH
Q 015389          270 SKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ  348 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  348 (408)
                      ....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||.........         ....... ......+...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~  222 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------EIDRMTL-TMAVELPDSF  222 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---------HHHHHhh-ccCCCCCCcC
Confidence            234689999999998755 6899999999999999999999999764321110         0111000 0111122223


Q ss_pred             HHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          349 MNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ...+.+++.+|+..+|.+||     ++.++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            56788899999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-36  Score=291.05  Aligned_cols=258  Identities=21%  Similarity=0.262  Sum_probs=189.8

Q ss_pred             ccceecccCcEEEEEEEEcCCcEEEEEEecCC-CchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCC
Q 015389          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG-TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNG  191 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g  191 (408)
                      +.+.+|.|+++.|+++.. +|+.||||++... ...+....+..|+.+++.++||||+++++++.+ +..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344555555555555544 6899999999765 334456789999999999999999999996665 4578999999999


Q ss_pred             CHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc-----
Q 015389          192 SLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT-----  265 (408)
Q Consensus       192 ~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-----  265 (408)
                      +|.+++... ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||.+..+.....     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999653 3468899999999999999999999   9999999999999999999999999998875532211     


Q ss_pred             cceecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc------ccccchHHH---
Q 015389          266 HHTISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP------MIKRNEIRE---  334 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~------~~~~~~~~~---  334 (408)
                      ........++..|+|||++.+.  .++.++|||||||++|||++|+.||.............      .........   
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            1112334578899999998763  58899999999999999999999997543221110000      000000000   


Q ss_pred             --------Hhhh----hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 --------LVDA----SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 --------~~d~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                              ..++    .............+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                    0000    0011122234567888999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.3e-37  Score=287.52  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=200.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv  184 (408)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++....  .......+..|+.++.+++ ||||+++++++.. +..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47889999999999999999875 69999999987532  2334567889999999998 9999999996554 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||++.+++|.+++.. ...+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            999999999999954 3479999999999999999999999   999999999999999999999999999998765432


Q ss_pred             cc------------------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc
Q 015389          265 TH------------------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       265 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  326 (408)
                      ..                  .......|+..|+|||.+.+..++.++||||||++++++++|+.||........      
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------  230 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT------  230 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH------
Confidence            21                  122335688999999999888899999999999999999999999985432110      


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQM----SQVVQ  375 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~----~evl~  375 (408)
                           ......  .....+......+..++.+||+.+|.+||++    .+++.
T Consensus       231 -----~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -----FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -----HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                 111111  1112223335678889999999999999999    66553

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-37  Score=296.30  Aligned_cols=267  Identities=22%  Similarity=0.279  Sum_probs=203.4

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~  182 (408)
                      +|++.+.||.|+||.||+|... +|+.||||.+..... ....+.+..|+.+++.++||||+++++++...      ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999875 489999999876542 34467788999999999999999999976654      478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +|++|+. ++|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 578888854 4489999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh------hccc------cc
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW------ARPM------IK  328 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~------~~~~------~~  328 (408)
                      .... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..........      ..+.      ..
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            3210 112334588999999999888 78999999999999999999999997644211000      0000      00


Q ss_pred             cchHHHHhhhhc-cCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccC
Q 015389          329 RNEIRELVDASL-ADE-----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLC  382 (408)
Q Consensus       329 ~~~~~~~~d~~l-~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~  382 (408)
                      .......+...- ...     ........+.+++.+||+.+|.+||++.+++.  .+++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            001111111000 000     01123466889999999999999999999998  3655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-36  Score=287.87  Aligned_cols=240  Identities=20%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      .+||+|+||.||+|... +|+.||||.+.... ......+.+|+.+++.++|+|++++++++.. +..++||||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            67999999999999875 68999999886543 2345678899999999999999999996665 557899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      .+++.  ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++..+.....  ......
T Consensus       105 ~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVT--HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            99873  3468899999999999999999999   9999999999999999999999999999876543221  123355


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc--cHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY--DTRQMNL  351 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~  351 (408)
                      |++.|+|||.+.+..++.++|+|||||++|+|++|..||........            ...+...+....  .......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------------MKMIRDNLPPKLKNLHKVSPS  245 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------------HHHHHhhCCcccCCcccCCHH
Confidence            88999999999888899999999999999999999999875322110            011111111110  1123445


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       352 l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +..++.+||+.+|.+||++.+|++
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc
Confidence            778999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=311.54  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=223.4

Q ss_pred             CccceecccCcEEEEEEEEc-C----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEe
Q 015389          113 SFENLIGKGGYAEVYKGRLR-N----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~  187 (408)
                      ...++||+|+||+||+|.+- .    ..+||+|++......+.-.+++.|+.+|..++|||++++++++....+.||++|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~  778 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL  778 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence            44589999999999999753 2    346899999877766677889999999999999999999999998889999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++.|.|.++++.++..+-.+..+.|..||++|+.|||+   +.++||||-..|||+..-..+||.|||+++.+..+....
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            99999999999999999999999999999999999999   999999999999999999999999999999988765555


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......-.+.|+|=|.+....|+.++|||||||++||++| |..|++..            ...++..++....+-..++
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi------------~~~eI~dlle~geRLsqPp  923 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI------------PAEEIPDLLEKGERLSQPP  923 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC------------CHHHhhHHHhccccCCCCC
Confidence            5544555778999999999999999999999999999999 88888753            2346667777666667778


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .+.-++..++.+||..|+..||+++++...+...
T Consensus       924 iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  924 ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             CccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            8889999999999999999999999998877543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-36  Score=287.30  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=197.5

Q ss_pred             CCCccceecccCcEEEEEEEE----cCCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCe
Q 015389          111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~  181 (408)
                      +|++.+.||+|+||.||++..    .++..||||.+.....   ......+..|+.++.++ +||||+++++.+.. ...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478889999999999999974    2578899999875422   23456778999999999 69999999985554 457


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++..+.
T Consensus        81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            899999999999999854 3568899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCccceecccccCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH-HHhhh
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR-ELVDA  338 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~d~  338 (408)
                      ..... ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.........        ..+. .....
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------~~~~~~~~~~  227 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--------SEISRRILKS  227 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--------HHHHHHHHcc
Confidence            32211 122356899999999987765  788999999999999999999999643211000        0011 11111


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                        ....+......+.+++.+||+.+|++|||+.++.+.|+-
T Consensus       228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              111222344567889999999999999999988887754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-36  Score=286.30  Aligned_cols=249  Identities=25%  Similarity=0.340  Sum_probs=193.5

Q ss_pred             CCCccceecccCcEEEEEEEE----cCCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-Ce
Q 015389          111 NFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~  181 (408)
                      +|++.+.||.|+||.||+|..    .+|..||+|++.....   ......+..|+.++.++ +|+||+++++++..+ ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            578889999999999999975    3689999999875432   22356678899999999 699999999866554 57


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+   .+++||||+|+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            899999999999999854 4568889999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCccceecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      .... .......|+..|+|||.+.+.  .++.++||||||+++|+|++|+.||.......           ....+....
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----------~~~~~~~~~  224 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-----------SQAEISRRI  224 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-----------cHHHHHHHh
Confidence            3211 122235689999999998753  46889999999999999999999996432110           011111111


Q ss_pred             c--cCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          340 L--ADEYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       340 l--~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      .  ...++......+..++.+||+.+|.+||     ++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1  1112233456678899999999999997     6666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=290.59  Aligned_cols=270  Identities=25%  Similarity=0.376  Sum_probs=206.3

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC--CCCceeEEEeEEEe-----CCeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV--DHPNTAKLLGYGIE-----GGMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l--~hpniv~l~~~~~~-----~~~~  182 (408)
                      ...++.++||+|.||.||+|.+. ++.||||++..    +..+.|.+|-+|++..  +|+||+++++....     .+++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            45567789999999999999995 69999999964    4467788888887764  79999999986543     2578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC------QRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ||++|.+.|+|.++|  ....++|....+|+..+++||+|||+..      ..+|+|||||.+||||.+|+...|+|||+
T Consensus       285 LVt~fh~kGsL~dyL--~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL--KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHH--HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999999  4567899999999999999999999843      45799999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCC-CC-----cchhHHHHHHHHHHHHhCCCCCCc--cccchhhhhccccc
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI-VD-----EKTDVFAFGVLLLELVTGRRALDY--SQQSLVLWARPMIK  328 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DvwSlGvil~elltg~~pf~~--~~~~~~~~~~~~~~  328 (408)
                      |..+..+..........||.+|||||++.+.. +.     .+.||||+|.|||||++....++.  ...-...+......
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99887654444444467999999999997643 22     368999999999999998766542  11111111111112


Q ss_pred             cchHHHHhh----hhccCcccH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccc
Q 015389          329 RNEIRELVD----ASLADEYDT-----RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKY  386 (408)
Q Consensus       329 ~~~~~~~~d----~~l~~~~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~  386 (408)
                      .+.+.++.+    ...++.++.     ..+.-+.+.+..||.+||+.|.|+.=|.+++..+....+.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            222222222    222232222     2467789999999999999999999999998777765553

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-36  Score=295.08  Aligned_cols=260  Identities=21%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC--------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--------  179 (408)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|.+..... +..+.+.+|+.+++.++||||+++++++...        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            378999999999999999999875 589999999876543 3456778999999999999999999754432        


Q ss_pred             -------CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEE
Q 015389          180 -------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQI  251 (408)
Q Consensus       180 -------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl  251 (408)
                             ..++|+||+. ++|.+++.  ...+++..+..++.||+.||.|||+   .+|+||||||+||+++. ++.++|
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                   3689999997 58888873  3468899999999999999999999   99999999999999974 557899


Q ss_pred             eecCCcccCCCCCccc-eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh----hcc
Q 015389          252 CDFGLAKWLPEQWTHH-TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW----ARP  325 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~----~~~  325 (408)
                      +|||++..+....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........    ..+
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999998654322211 1122357889999998755 468899999999999999999999997543321110    000


Q ss_pred             ccccchHHHHh---hh-----hccCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 MIKRNEIRELV---DA-----SLADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 ~~~~~~~~~~~---d~-----~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...........   ..     ......+     ......+.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00000000000   00     0000000     123356788999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=321.97  Aligned_cols=285  Identities=21%  Similarity=0.270  Sum_probs=222.1

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEE-eEE
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLL-GYG  176 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~-~~~  176 (408)
                      .+.++....++|.++++||+|+||.|.+++.+ .++.||+|++.+-..  .....-|..|-.+|..-+.+.|+.++ +|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34566667789999999999999999999986 589999999987321  12356788999999999999999996 588


Q ss_pred             EeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       177 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      .+.++|+||||++||+|..++.... .+++..+..++..|+.||.-||+   .|+|||||||+|||||..|++||+|||.
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence            8889999999999999999996655 89999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCcccccccc----C-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLM----H-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      +-.+..++.- ......|||.|++||++.    + +.|+..+|+||+||++|||+.|..||....-. ..+         
T Consensus       222 Clkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-eTY---------  290 (1317)
T KOG0612|consen  222 CLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-ETY---------  290 (1317)
T ss_pred             HHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-HHH---------
Confidence            9888755443 334567999999999986    2 57899999999999999999999999743211 111         


Q ss_pred             HHHHhhh--hccCcccHHHHHHHHHHHHhccccCCCCCCC---HHHHHH--HHhcccCccccccccCCchhhhhhhHhhh
Q 015389          332 IRELVDA--SLADEYDTRQMNLVLLAASLCIQQSSIRRPQ---MSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLREELK  404 (408)
Q Consensus       332 ~~~~~d~--~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~~~~~  404 (408)
                       ..+++-  .+..+.....++...+||...+. +|+.|..   +.++-.  +++++.+  .....+.+|++..+.+.++.
T Consensus       291 -~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W--~~iR~~~pP~vPevssd~DT  366 (1317)
T KOG0612|consen  291 -GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW--DNIRESVPPVVPEVSSDDDT  366 (1317)
T ss_pred             -HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh--hhhhhcCCCCCCcCCCCCcc
Confidence             111111  22222123345566667776665 5667776   888776  4566654  55556777777776665544

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=285.03  Aligned_cols=258  Identities=24%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      |++.+.||+|+||.||+|... +++.||+|.+..... +.....+..|+.+++.++|+|++++++++.+ +..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566789999999999999876 599999999986542 2345677889999999999999999996655 5688999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      . ++|.+++......+++..+..++.|++.||.|||+   ++|+||||+|+||++++++.++|+|||++........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 58999997655679999999999999999999999   9999999999999999999999999999986643221  2


Q ss_pred             ecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcccc---ccchHHHH-----hhh
Q 015389          269 ISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMI---KRNEIREL-----VDA  338 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~---~~~~~~~~-----~d~  338 (408)
                      .....++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ......   .+.....+     .+.
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2234467889999998776 7899999999999999999999999764321100 000000   00000000     000


Q ss_pred             hccC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLAD-------EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~-------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....       .........+.+++.+||+.+|.+||++.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000       000112457899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=287.03  Aligned_cols=242  Identities=24%  Similarity=0.363  Sum_probs=198.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCC-CCceeEEEe-EEEeCCeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGGMH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~-hpniv~l~~-~~~~~~~~  182 (408)
                      ...+|.++.+||+|+||.|.+|..+ +.+.||||+++++..  ++..+--+.|-++|+... -|.+++++. |..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3468899999999999999999765 478999999987642  223444567888887774 678888887 55668899


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+.||+|.-.+. .-+.+.+..+.-++..|+-||-+||+   +|||+||||.+||||+.+|++||+|||+++.-- 
T Consensus       427 FVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-  501 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-  501 (683)
T ss_pred             eEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc-
Confidence            9999999999999985 45667888888899999999999999   999999999999999999999999999998432 


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                       ....+..+++||+.|+|||++...+|+.++|+|||||+||||+.|+.||++.+....           ...+.+.  .-
T Consensus       502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-----------F~aI~eh--nv  567 (683)
T KOG0696|consen  502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-----------FQAIMEH--NV  567 (683)
T ss_pred             -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHHc--cC
Confidence             233455689999999999999999999999999999999999999999997654321           1122222  12


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRP  368 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RP  368 (408)
                      .++.....+.+.++...|...|.+|.
T Consensus       568 syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             cCcccccHHHHHHHHHHhhcCCcccc
Confidence            34556667778888889999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.5e-36  Score=280.45  Aligned_cols=247  Identities=22%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             CCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      +|.+.+.||+|+||.||++.+.. +..+++|.++...    .......+..|+.+++.++||||+++++++.+ ...++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 4556666655322    12233456689999999999999999986554 457899


Q ss_pred             EEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      +||+++++|.+++..   ....+++..++.++.|++.||.|||+   .+++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998853   34568999999999999999999999   99999999999999975 569999999987654


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ....  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........           ..... ....
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----------~~~~~-~~~~  222 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-----------VLRIV-EGPT  222 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----------HHHHH-cCCC
Confidence            3211  22345688999999999888899999999999999999999999864321100           00111 1111


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+......+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1223455667888999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-36  Score=295.43  Aligned_cols=257  Identities=24%  Similarity=0.351  Sum_probs=195.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC----
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG----  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~----  180 (408)
                      ..++|++.+.||.|+||.||+|.+. +++.||||++.... .......+.+|+.+++.++|||++++++++.. +.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999876 58899999987542 22345667789999999999999999885443 22    


Q ss_pred             --eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          181 --MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       181 --~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                        .++|+||+ +++|.+++..  ..+++..+..++.|++.||.|||+   .+|+||||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              78899988 6799998843  568999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh--hc--cc-------
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW--AR--PM-------  326 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~--~~--~~-------  326 (408)
                      .....     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........  ..  ..       
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ  241 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence            65432     233457889999999865 367899999999999999999999997543211000  00  00       


Q ss_pred             -cccchHHHHhhhhc---cCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 -IKRNEIRELVDASL---ADEYD---TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 -~~~~~~~~~~d~~l---~~~~~---~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       .........+....   ...+.   ......+.+++.+||+.+|.+|||+.+|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             00000111111100   00010   112567889999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=312.12  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=216.6

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc----C----CcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR----N----GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGY  175 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  175 (408)
                      ++...++..+.+.||.|.||.|++|...    .    ...||||.++........+.+..|+.+|+.+ .||||+.++++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3444456667789999999999999743    1    4579999999877667788999999999999 59999999998


Q ss_pred             EEe-CCeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 015389          176 GIE-GGMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (408)
Q Consensus       176 ~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~  239 (408)
                      +.+ +.+++|+||+..|+|..++...+               ..+.....+.++.||+.|++||++   .++|||||.+.
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence            887 55889999999999999997665               348888999999999999999999   99999999999


Q ss_pred             ceEECCCCceEEeecCCcccCCCCCccceecccc--cCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 015389          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQ  316 (408)
Q Consensus       240 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~  316 (408)
                      |||+..+..+||+|||+|+.......... ..-.  -...|||||.+....|+.++|||||||+||||++ |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999996554323221 1112  2456999999999999999999999999999999 788886421


Q ss_pred             cchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          317 QSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .           ..++-+.+.++.+-..+..+...+..+++.||+.+|++||++.++++.|+...
T Consensus       527 ~-----------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  527 P-----------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             c-----------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1           12233355555566677778899999999999999999999999999998853

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9e-36  Score=288.29  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=191.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-C--CcEEEEEEecCCC-chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-----CC
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-N--GQLVAIKRLTRGT-ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-----GG  180 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~--g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-----~~  180 (408)
                      +|++.+.||+|+||.||++... .  +..||+|.+.... .......+.+|+.++.++ +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999865 3  7899999987532 223456778899999999 59999999985432     23


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .+++++++. ++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++..+
T Consensus        81 ~~~~~e~~~-~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            567777775 68988884 35678999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCcc--ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcc---ccccchHH
Q 015389          261 PEQWTH--HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARP---MIKRNEIR  333 (408)
Q Consensus       261 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~---~~~~~~~~  333 (408)
                      ......  .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..... ....   ........
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432211  11233568999999998766 46899999999999999999999999764321100 0000   00000000


Q ss_pred             HHhhhh-------c----cCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVDAS-------L----ADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d~~-------l----~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+..+.       .    ...   ........+..++.+|++.+|.+|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000       0    000   00112456889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=288.06  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=191.5

Q ss_pred             CCCC-ccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-------------HHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          110 NNFS-FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-------------IIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       110 ~~y~-~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      ++|. +.+.||.|+||+||+|.+. +++.||||.+.......             ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 4577999999999999865 68999999986543211             0124678999999999999999999


Q ss_pred             EEEe-CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          175 YGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       175 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                      ++.. +..++||||+. |+|.+++. ....+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence            7665 45789999996 68988884 34568999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCC------------ccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchh
Q 015389          254 FGLAKWLPEQW------------THHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV  320 (408)
Q Consensus       254 fGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~  320 (408)
                      ||++.......            .........++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99998664111            01111223468899999998764 468999999999999999999999976543211


Q ss_pred             h-hhccccccch---HHHHh--------hhhccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          321 L-WARPMIKRNE---IRELV--------DASLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       321 ~-~~~~~~~~~~---~~~~~--------d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      . ..........   .....        .......   ........+.+++.+||+.+|++||++.+++.
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            0 0000000000   00000        0000000   00112456788999999999999999999987

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-35  Score=272.46  Aligned_cols=236  Identities=28%  Similarity=0.349  Sum_probs=190.9

Q ss_pred             ecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCH
Q 015389          118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSL  193 (408)
Q Consensus       118 lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L  193 (408)
                      ||.|+||.||++... +++.||+|.+.....  ......+..|+.+++.++||||+++++.+.. ...++|||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 589999999876532  2356778899999999999999999985544 557899999999999


Q ss_pred             HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc
Q 015389          194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE  273 (408)
Q Consensus       194 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  273 (408)
                      .+++.. ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  .......
T Consensus        81 ~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSK-EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            999954 3468999999999999999999999   999999999999999999999999999998654321  1223456


Q ss_pred             cCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       274 gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|+.||........           ...+...  ....+......+.
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-----------~~~~~~~--~~~~~~~~~~~l~  221 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-----------YEKILKD--PLRFPEFLSPEAR  221 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----------HHHHhcC--CCCCCCCCCHHHH
Confidence            88999999999888899999999999999999999999975432110           1111111  1122223356778


Q ss_pred             HHHHhccccCCCCCCCHHH
Q 015389          354 LAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt~~e  372 (408)
                      +++.+|+..+|++||++.+
T Consensus       222 ~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         222 DLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHhcCCHhhCCCccc
Confidence            8999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=272.82  Aligned_cols=255  Identities=21%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             ceecccCcEEEEEEE-EcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      +.||+|+||.|--+. ..+|..||||++.+.. .....++.+|++++.+. .|+||+++++|+.++ .+|+|||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            789999999999986 5579999999998773 35678889999999999 599999999977765 5899999999999


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecCCcccCCCCC-----
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPEQW-----  264 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~-----  264 (408)
                      |...++ ....+++..+.++..+|+.||.|||.   +||.||||||+|||...-.   -+|||||.+..-...+.     
T Consensus       163 lLshI~-~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  163 LLSHIQ-KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             HHHHHH-HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            999995 45678999999999999999999999   9999999999999997654   48999998875432211     


Q ss_pred             ccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          265 THHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ......+.+|+..|||||+..     ...|+.+.|.||||||||-|++|-.||.+.......|...-....=...++...
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            112234567999999999763     246899999999999999999999999987777677765544332222233322


Q ss_pred             ccCcc--c----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 LADEY--D----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l~~~~--~----~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      -.+.|  +    ........++++..+..++.+|.++.++++
T Consensus       319 QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  319 QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            22222  2    335677888999999999999999999887

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.2e-35  Score=306.79  Aligned_cols=145  Identities=28%  Similarity=0.411  Sum_probs=128.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++....  .......+..|+.++..++||||+++++++.. ...++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            68999999999999999999876 68999999997543  23445778899999999999999999986655 4579999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ||+.+++|.+++.. ...+++..++.++.||+.||.|||.   .+|+||||||+|||++.++.++|+|||+++
T Consensus        84 Ey~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999854 4568889999999999999999999   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=276.61  Aligned_cols=251  Identities=26%  Similarity=0.366  Sum_probs=194.3

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHH-hcCCCCceeEEEe-EEEeCCeEEEEEec
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLG-YGIEGGMHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~-~~~~~~~~lv~e~~  188 (408)
                      .+-+..||.|+||+|++-.++ .|+..|||++.....+...++++.|.+.. +.-+.||||++|| .+.++..++.||.+
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            334578999999999999876 69999999999877777788899998764 4557999999999 55667788999998


Q ss_pred             CCCCHHHHH---hc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          189 PNGSLASLL---YG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       189 ~~g~L~~~l---~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      + .+|..+.   +. .+..++++.+-.|...++.||.||.+.  ..|||||+||+||||+..|.+||||||++-.+....
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            4 4554433   22 456799999999999999999999984  899999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .   .+.-.|...|||||.+..  ..|+.++||||||++|||+.||+.|+........+.......+.       +.+..
T Consensus       223 A---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp-------p~l~~  292 (361)
T KOG1006|consen  223 A---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP-------PILLF  292 (361)
T ss_pred             H---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC-------CeecC
Confidence            2   234568899999999864  35999999999999999999999999864432211111110110       11111


Q ss_pred             cc-cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EY-DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +. ..+....+..++..|+-.|-..||.+.++..
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11 1335667888999999999999999998765

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-36  Score=272.84  Aligned_cols=201  Identities=25%  Similarity=0.401  Sum_probs=167.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc---C--CcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEE--eCCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR---N--GQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGI--EGGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~---~--g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~--~~~~  181 (408)
                      ..|+....||+|.||.||+|.-+   +  ...+|||.++..... ..-....+|+.+++.++|||++.+..++.  +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            56888999999999999999543   2  236999999865432 23456679999999999999999998554  4568


Q ss_pred             EEEEEecCCCCHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC----CceEEee
Q 015389          182 HIVLELSPNGSLASLLYG----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQICD  253 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~D  253 (408)
                      ++++||.+. +|+..++.    ....++...+..|+.||+.|+.|||+   +-|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999966 78887754    33568899999999999999999999   999999999999999888    8999999


Q ss_pred             cCCcccCCCCCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          254 FGLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       254 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                      ||+++.+...... .....+.-|.+|+|||.+.|. -||.+.|||+.|||+.||+|-.+-|..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999987654332 233456789999999999986 589999999999999999999888765

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=273.78  Aligned_cols=248  Identities=25%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEe-EEEeCCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~-~~~~~~~~l  183 (408)
                      .++|.++++||+|+|+.|.+++++ +.+.||+|++++.-  .++.+.-...|..+..+. +||++|.++. |..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            478999999999999999999875 58899999998643  233456667788888776 7999999998 566778999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |.||++||+|...+. ...+++++.+..+...|+.||.|||+   +|||+||||.+|+|+|..|++||+|+|+++..-. 
T Consensus       329 vieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~-  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-  403 (593)
T ss_pred             EEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence            999999999998884 45678999999899999999999999   9999999999999999999999999999985322 


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch-HHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE-IRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~  342 (408)
                       .....++++||+.|+|||++.+..|...+|+|+|||+++||+.|+.||+..+.....    ...+.- .+-++...++.
T Consensus       404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d----~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD----MNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----cchhHHHHHHHhhhcccc
Confidence             335667899999999999999999999999999999999999999999863321000    000011 11122222222


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRP  368 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RP  368 (408)
                        +....-....+++.-|+.||.+|.
T Consensus       479 --prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  479 --PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --cceeehhhHHHHHHhhcCCcHHhc
Confidence              222333455578888999999985

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=284.88  Aligned_cols=257  Identities=26%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCc------hHHHHHHHHHHHHHhcCCCCceeEEEeEEE-e-C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTA------DEIIADFLSELGIMAHVDHPNTAKLLGYGI-E-G  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~hpniv~l~~~~~-~-~  179 (408)
                      .++|-++++||+|||++||+|.+ ...++||||+-.....      +...+...+|..|-+.|+||.||++|+++. + +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35688889999999999999975 4689999998654332      224567789999999999999999999665 3 3


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCC
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGL  256 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGl  256 (408)
                      .+|-|+|||+|.+|..+|. ....+++..+..|+.||+.||.||.+. ..+|||-||||.||||-+   -|.+||+|||+
T Consensus       542 sFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            4788999999999999994 456789999999999999999999873 468999999999999944   47899999999


Q ss_pred             cccCCCCCccc-----eecccccCCCccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc
Q 015389          257 AKWLPEQWTHH-----TISKVEGTFGYLAPEFLMHG----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       257 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  327 (408)
                      ++.+..+....     ..+-..||.+|++||.+.-+    +++.|+||||+|||+|+.+.|+.||...........    
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq----  695 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ----  695 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh----
Confidence            99986543332     23456799999999988644    578999999999999999999999986433211111    


Q ss_pred             ccchHHHHhhh-hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          328 KRNEIRELVDA-SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       328 ~~~~~~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ++.+   +.. .+.....+....+...+|++||++--++|....++..
T Consensus       696 -eNTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 -ENTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -hhch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence             1111   111 1111122334456777999999999999988777653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=266.20  Aligned_cols=248  Identities=20%  Similarity=0.230  Sum_probs=195.4

Q ss_pred             hcCCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-----
Q 015389          108 ATNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-----  179 (408)
Q Consensus       108 ~~~~y~~~-~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-----  179 (408)
                      .+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++....      ...+|+++--.. .|||||.+++++.+.     
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            45677665 57999999999999876 69999999986542      224677765554 699999999965532     


Q ss_pred             CeEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecC
Q 015389          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFG  255 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfG  255 (408)
                      -+.+|||.++||.|.+.+...+ ..+++.++..|+.||+.|+.|||+   .+|.||||||+|+|.+.+   -.+||+|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence            2568999999999999997643 459999999999999999999999   999999999999999654   469999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      +|+.-..   .....+.+-|++|.|||++...+|+...|+||+||++|-|++|-+||-..+...        ....+..-
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------ispgMk~r  278 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------ISPGMKRR  278 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--------CChhHHhH
Confidence            9985432   344567889999999999999999999999999999999999999997654321        11222222


Q ss_pred             hhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          336 VDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       336 ~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +...-..   .-.....+...++|+.+|..+|.+|.|+.+++.
T Consensus       279 I~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  279 IRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             hhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2222111   112345677888999999999999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=290.52  Aligned_cols=243  Identities=21%  Similarity=0.258  Sum_probs=202.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCc-EEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~-~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv  184 (408)
                      ..++..+..||-||||.|-++..++.. .+|+|.+++...  ....+++..|-.||..+..|+||++|- |-.+..+|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            456777788999999999999876433 489999986432  345678889999999999999999997 5455668999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||-|-||.|+..|. .++.++......++..+++|++|||.   ++||+|||||+|++|+.+|-+||.|||+|+.+..+ 
T Consensus       499 mEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  499 MEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             HHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            99999999999994 56778888888899999999999999   99999999999999999999999999999988754 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                        ...-+++||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++....           ..++...-.-.+
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-----------n~ILkGid~i~~  640 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-----------NLILKGIDKIEF  640 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----------HHHHhhhhhhhc
Confidence              2345789999999999999999999999999999999999999999986654211           011111112345


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCC
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                      +.........++.+.+..+|.+|.-
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhc
Confidence            5666777888999999999999985

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=293.94  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEE-----
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI-----  177 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~-----  177 (408)
                      +...++.|.+.+.||.|.+|.||+++.. +|+..|||++......+  +++..|.+|++.+ +|||++.+|+++.     
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            3345578899999999999999999854 69999999988765443  4556788888877 7999999999654     


Q ss_pred             -eCCeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          178 -EGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       178 -~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                       .+.++||||||.+|+..+++.+ .+..+.|..+..|++.++.||.+||+   +.++|||||=.|||++.++.|||+|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeee
Confidence             2458999999999999999976 45679999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      ++..+...  .....+..||+.|||||++...     .|+..+|+||||++..||--|.+|+-...+....+..+.-.. 
T Consensus       169 vSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-  245 (953)
T KOG0587|consen  169 VSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-  245 (953)
T ss_pred             eeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-
Confidence            99876542  3334467899999999999643     478899999999999999999999987766544444332111 


Q ss_pred             hHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          331 EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       331 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                               ..-..+..-...+.++|..||..|-.+||++.++++
T Consensus       246 ---------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  246 ---------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     111223455677888999999999999999988776

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=286.52  Aligned_cols=238  Identities=23%  Similarity=0.356  Sum_probs=192.4

Q ss_pred             cceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEecCCC
Q 015389          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNG  191 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~~~~g  191 (408)
                      .++||+|.||+||-|.++ +|+.||||++.+..-. .....+.+|+.||.++.||.||.+.. |...+.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            378999999999999865 7999999999875432 23467789999999999999999987 55667789999999777


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCcccCCCCCccce
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      -|.-.|...++.+++.....++.||+.||.|||.   ++|+|+||||+||||.+.   -.+||||||+|+++++..-   
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence            7777777788999999999999999999999999   999999999999999654   3799999999999886433   


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh---hccCccc
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA---SLADEYD  345 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~---~l~~~~~  345 (408)
                      ...+.||+.|+|||++.++.|+..-|+||.|||+|.-++|.-||....+.              .+.+..   +......
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--------------ndQIQNAaFMyPp~PW  788 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--------------NDQIQNAAFMYPPNPW  788 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--------------hHHhhccccccCCCch
Confidence            24577999999999999999999999999999999999999999854322              111111   1122333


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~e  372 (408)
                      .+......++|...|+..-.+|-+...
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk  815 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDK  815 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence            445555666777777777777776554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=289.38  Aligned_cols=239  Identities=24%  Similarity=0.289  Sum_probs=193.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv  184 (408)
                      .+..|.+...+|.|+|+.|-.+... +++..+||++.+...+.     .+|+.++... +||||+++.+.+.+ .+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~-----~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN-----QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccccc-----ccccchhhhhcCCCcceeecceecCCceeeee
Confidence            4577889999999999999999765 58889999998763221     2566555444 79999999996665 568999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE-CCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll-~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||.+.|+.|.+.+....  .....+..|+.+|+.|+.|||+   +|+|||||||+|||+ ++.++++|+|||.++.+...
T Consensus       395 ~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             ehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999999999885432  2226677899999999999999   999999999999999 68899999999999977654


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                           ..+.+-|..|.|||++....||+++||||||++||+|++|+.||......              .++......+.
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------------~ei~~~i~~~~  530 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------------IEIHTRIQMPK  530 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------------HHHHHhhcCCc
Confidence                 33456789999999999999999999999999999999999999753322              12222233344


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +.........+|+.+||+.||.+||+|.++..
T Consensus       531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            44566777888999999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=272.55  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=199.8

Q ss_pred             HHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCCceeEEEeEEEeC
Q 015389          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIEG  179 (408)
Q Consensus       102 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~  179 (408)
                      +--.....++..+.+.||+|.||+||+|.+. |+.||||++....    ...+.+|.+|+..  |+|+||+.+++.-..+
T Consensus       203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            3334455678899999999999999999996 8899999997543    2445567777655  5999999999854332


Q ss_pred             -----CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEeeCCCCCceEECCCCce
Q 015389          180 -----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE-----GCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       180 -----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                           +++||++|.+.|+|.|+|  ....++-...++++..+|.||+|||.     +-...|.|||||..|||+..++.+
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL--~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYL--NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHH--hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence                 378999999999999999  44778999999999999999999997     223569999999999999999999


Q ss_pred             EEeecCCcccCCCCCcc-c-eecccccCCCccccccccCCC----C--CcchhHHHHHHHHHHHHhC----------CCC
Q 015389          250 QICDFGLAKWLPEQWTH-H-TISKVEGTFGYLAPEFLMHGI----V--DEKTDVFAFGVLLLELVTG----------RRA  311 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~-~-~~~~~~gt~~y~aPE~~~~~~----~--~~k~DvwSlGvil~elltg----------~~p  311 (408)
                      .|+|+|||-........ . ......||..|||||++-...    +  -..+||||||.|+||+...          +.|
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P  435 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP  435 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence            99999999876543211 1 112346999999999986432    1  1368999999999999753          244


Q ss_pred             CCccccchhhhhccccccchHHHHhh----hhccCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          312 LDYSQQSLVLWARPMIKRNEIRELVD----ASLADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       312 f~~~~~~~~~~~~~~~~~~~~~~~~d----~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      |...-+          .++.+.++.+    ..+++..+     ......+.++++.||..||.-|-|+--|-..|.++.+
T Consensus       436 yyd~Vp----------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  436 YYDVVP----------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cccCCC----------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            433211          1222222222    22233222     3567889999999999999999999998888877764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.1e-35  Score=267.81  Aligned_cols=219  Identities=19%  Similarity=0.147  Sum_probs=173.0

Q ss_pred             cCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCHHHHHh
Q 015389          121 GGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLY  198 (408)
Q Consensus       121 G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~  198 (408)
                      |.||.||++.+. +|+.||+|.+.....      +..|...+....||||+++++++.+ ...++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999875 689999999976532      1234445555679999999996655 45789999999999999985


Q ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCc
Q 015389          199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY  278 (408)
Q Consensus       199 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  278 (408)
                      . ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||.+..+....     ....++..|
T Consensus        78 ~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y  148 (237)
T cd05576          78 K-FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMY  148 (237)
T ss_pred             H-hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccc
Confidence            4 3468999999999999999999999   999999999999999999999999999887554321     223467789


Q ss_pred             cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHh
Q 015389          279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASL  358 (408)
Q Consensus       279 ~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~  358 (408)
                      +|||.+.+..++.++||||+||++|||++|+.|+........                 .......+......+..++.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~  211 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIPEWVSEEARSLLQQ  211 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCcccCCHHHHHHHHH
Confidence            999999888899999999999999999999988753221100                 000001122234567889999


Q ss_pred             ccccCCCCCCCHH
Q 015389          359 CIQQSSIRRPQMS  371 (408)
Q Consensus       359 cl~~~P~~RPt~~  371 (408)
                      |++.||++||++.
T Consensus       212 ~l~~dp~~R~~~~  224 (237)
T cd05576         212 LLQFNPTERLGAG  224 (237)
T ss_pred             HccCCHHHhcCCC
Confidence            9999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=246.89  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchH-HHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +|...++||+|.||+||+|+.. .++.||+|.+..+..++ .....++|+-+++.++|.|||++++.... ..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5666789999999999999865 58999999998665443 56778899999999999999999996554 568899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      |. .+|..+....++.++.+....++.|+++||.|+|+   +++.|||+||.|+|++.+|++||+|||+++-++-..  .
T Consensus        83 cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv--r  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--R  156 (292)
T ss_pred             hh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce--E
Confidence            94 57888888888999999999999999999999999   999999999999999999999999999999765432  2


Q ss_pred             eecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHh-CCCCCCccccch----hhhhccccccc---hHHHHhhh
Q 015389          268 TISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVT-GRRALDYSQQSL----VLWARPMIKRN---EIRELVDA  338 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~----~~~~~~~~~~~---~~~~~~d~  338 (408)
                      -.+...-|.+|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|.+.+-..    +.|......+.   .+..+-|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            233445789999999998865 8999999999999999987 555565533210    11111111111   11111121


Q ss_pred             hccCccc---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLADEYD---------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~~~~---------~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+-++         ++....=.++++..+.-+|.+|.+++..++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1111111         112223345777788889999999988775

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-33  Score=258.73  Aligned_cols=236  Identities=28%  Similarity=0.371  Sum_probs=190.9

Q ss_pred             CcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCHHHHHhc
Q 015389          122 GYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYG  199 (408)
Q Consensus       122 ~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~  199 (408)
                      +||.||+|... +|+.+|+|++...........+.+|+..+++++|+|++++++++.. ...++++|++.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999986 4899999999876544336788899999999999999999997766 457899999999999999854


Q ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCcc
Q 015389          200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL  279 (408)
Q Consensus       200 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  279 (408)
                      .. .+++..++.++.+++.++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            33 38899999999999999999999   899999999999999999999999999998765432   223456889999


Q ss_pred             ccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH--HHHHHHHHHH
Q 015389          280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR--QMNLVLLAAS  357 (408)
Q Consensus       280 aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~--~~~~l~~li~  357 (408)
                      |||.+.+..++.++||||||+++|+|++|..||......           ..+...............  ....+..++.
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  222 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----------LELFKKIGKPKPPFPPPEWKISPEAKDLIR  222 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----------HHHHHHHhccCCCCccccccCCHHHHHHHH
Confidence            999998888999999999999999999999998752111           011111111111111111  4567888999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 015389          358 LCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       358 ~cl~~~P~~RPt~~evl~  375 (408)
                      +|+..+|++||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-34  Score=280.85  Aligned_cols=203  Identities=26%  Similarity=0.362  Sum_probs=170.1

Q ss_pred             CCCCccceecccCcEEEEEEE-EcCCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~  185 (408)
                      .-|..++.||-|+||+|.+++ .++...||.|.+.+...  .....+...|-.||...+.+.||+||- |..++.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            346777889999999999996 44578899999976532  234677889999999999999999986 77778899999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC--
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ--  263 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~--  263 (408)
                      +|++||++..+|.. -+-+.+..+..++..+..|+++.|+   .|+|||||||+|||||.+|++||+||||+.-+...  
T Consensus       709 dYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             eccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999999999854 3557788888888999999999999   99999999999999999999999999998643100  


Q ss_pred             ------Cccc--------------------------------eecccccCCCccccccccCCCCCcchhHHHHHHHHHHH
Q 015389          264 ------WTHH--------------------------------TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL  305 (408)
Q Consensus       264 ------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~el  305 (408)
                            ..+.                                ......||+.|+|||++....|+..+|+||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                  0000                                01124599999999999999999999999999999999


Q ss_pred             HhCCCCCCccc
Q 015389          306 VTGRRALDYSQ  316 (408)
Q Consensus       306 ltg~~pf~~~~  316 (408)
                      +.|+.||....
T Consensus       865 ~~g~~pf~~~t  875 (1034)
T KOG0608|consen  865 LVGQPPFLADT  875 (1034)
T ss_pred             hhCCCCccCCC
Confidence            99999997643

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.8e-34  Score=291.82  Aligned_cols=260  Identities=19%  Similarity=0.211  Sum_probs=168.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-C----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-E------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-N----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y------  175 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~------  175 (408)
                      ..++|.+.+.||+|+||.||+|.+. +    +..||||++......+.   ...+  .+....+.++..++. +      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~---~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI---WMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH---HHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            5679999999999999999999875 4    68999998865332211   1111  111122222222221 1      


Q ss_pred             EEeCCeEEEEEecCCCCHHHHHhcccCC-------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 015389          176 GIEGGMHIVLELSPNGSLASLLYGMKEK-------------------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (408)
Q Consensus       176 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  236 (408)
                      ..+...++|+||+.+++|.+++......                   .....+..++.||+.||.|||+   ++|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence            2334588999999999999998643211                   1123456799999999999999   99999999


Q ss_pred             CCCceEECC-CCceEEeecCCcccCCCCCccceecccccCCCccccccccCC----------------------CCCcch
Q 015389          237 KAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG----------------------IVDEKT  293 (408)
Q Consensus       237 kp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~  293 (408)
                      ||+|||++. ++.+||+|||+|+.+..... .......+|+.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 57899999999986643322 233456789999999965422                      234567


Q ss_pred             hHHHHHHHHHHHHhCCCCCCccccchhh-hhccccccchHHHHhhhhccCc----cc--HHHHHHHHHHHHhccccCCCC
Q 015389          294 DVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIKRNEIRELVDASLADE----YD--TRQMNLVLLAASLCIQQSSIR  366 (408)
Q Consensus       294 DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~d~~l~~~----~~--~~~~~~l~~li~~cl~~~P~~  366 (408)
                      |||||||+||||+++..+++........ +.............+.+....+    +.  ........+|+.+||+.||.+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            9999999999999987665432111000 0000000000111111110000    00  001223457999999999999


Q ss_pred             CCCHHHHHHH
Q 015389          367 RPQMSQVVQL  376 (408)
Q Consensus       367 RPt~~evl~~  376 (408)
                      |||+.|+++.
T Consensus       441 R~ta~e~L~H  450 (566)
T PLN03225        441 RISAKAALAH  450 (566)
T ss_pred             CCCHHHHhCC
Confidence            9999999983

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=247.70  Aligned_cols=205  Identities=28%  Similarity=0.421  Sum_probs=171.8

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEe-EEEeCCeEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHI  183 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~-~~~~~~~~l  183 (408)
                      ...+...-+..||+|++|.|-+-++. +|+..|+|.+......+..+++++|+.+..+. .+|++|.+|| ++.+++.++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            34455556678999999999888765 79999999998776677788999999986555 7999999999 677788999


Q ss_pred             EEEecCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          184 VLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       184 v~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .||.+ ..+|..+..   ..+..+++..+-+|+..++.||.|||+  +..+||||+||+|||++.+|.+|+||||++-.+
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            99998 446665543   367789999999999999999999999  479999999999999999999999999999877


Q ss_pred             CCCCccceecccccCCCccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMH----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQ  317 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvil~elltg~~pf~~~~~  317 (408)
                      .+...   .+...|...|+|||.+..    ..|+.++||||||+++.||.+++.||+....
T Consensus       200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            54322   223458899999998853    3689999999999999999999999986443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-35  Score=260.97  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecC-CCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTR-GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---------  178 (408)
                      +.|.-..+||+|.||+||+|+.+ .|+.||+|++-- ...+..-...++|+.+|..+.|+|++.+++.|..         
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999999866 488899986543 2222334556799999999999999999985431         


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..+|+||.+|+. +|..+|......++...+.+++.++.+||.|+|.   ..|+|||+||.|+|++.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            237899999955 7889997777889999999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCC--CccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccc-hhh--------hhccc
Q 015389          259 WLPEQ--WTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQS-LVL--------WARPM  326 (408)
Q Consensus       259 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~-~~~--------~~~~~  326 (408)
                      .+...  ......+...-|.+|++||.+.|. .|+.+.|||.-|||+.||.||.+-+++.... ...        .....
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            66432  122233445569999999999875 6999999999999999999999988764321 000        00111


Q ss_pred             cc---cchHHHHhh-hhcc-Cccc--HHH------HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          327 IK---RNEIRELVD-ASLA-DEYD--TRQ------MNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       327 ~~---~~~~~~~~d-~~l~-~~~~--~~~------~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +.   +-++-+.+. +-+. +.+.  .+.      ....++++.+++..||.+|+++++++..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            11   111111110 0011 0000  011      1256789999999999999999998764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.1e-33  Score=278.63  Aligned_cols=260  Identities=21%  Similarity=0.241  Sum_probs=178.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-----------------cCCcEEEEEEecCCCchHHHH--------------HHHH
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-----------------RNGQLVAIKRLTRGTADEIIA--------------DFLS  156 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~  156 (408)
                      ..++|.+.++||+|+||.||+|..                 ..++.||||++...... ...              ....
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhHH
Confidence            457999999999999999999964                 23568999998754321 112              2334


Q ss_pred             HHHHHhcCCCCce-----eEEEeEEE---------eCCeEEEEEecCCCCHHHHHhccc---------------------
Q 015389          157 ELGIMAHVDHPNT-----AKLLGYGI---------EGGMHIVLELSPNGSLASLLYGMK---------------------  201 (408)
Q Consensus       157 E~~il~~l~hpni-----v~l~~~~~---------~~~~~lv~e~~~~g~L~~~l~~~~---------------------  201 (408)
                      |+.++.+++|.++     +++++++.         ++..++|+||+.+++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777766554     56666543         345789999999999999986421                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCcc
Q 015389          202 --EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL  279 (408)
Q Consensus       202 --~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  279 (408)
                        ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+...... ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence              124567788999999999999999   99999999999999999999999999999765432211 111233578999


Q ss_pred             ccccccCCC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCCccccchhhhhccccccchHHHH-
Q 015389          280 APEFLMHGI--------------------V--DEKTDVFAFGVLLLELVTGRR-ALDYSQQSLVLWARPMIKRNEIREL-  335 (408)
Q Consensus       280 aPE~~~~~~--------------------~--~~k~DvwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~-  335 (408)
                      |||.+....                    +  ..+.||||+|||+|+|++|.. ||.....-......   .......+ 
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~---~~~~~~~~r  454 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ---YDNDLNRWR  454 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh---ccchHHHHH
Confidence            999886432                    1  134799999999999999875 66532111000000   00111100 


Q ss_pred             --hhhhccCcccHHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 015389          336 --VDASLADEYDTRQMNLVLLAASLCIQQSS---IRRPQMSQVVQ  375 (408)
Q Consensus       336 --~d~~l~~~~~~~~~~~l~~li~~cl~~~P---~~RPt~~evl~  375 (408)
                        ......-...........+++.++|..+|   .+|+|+.|+++
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence              00011111122345667889999999766   68999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=262.41  Aligned_cols=258  Identities=21%  Similarity=0.299  Sum_probs=194.8

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--C----ceeEEEeEE-Ee
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--P----NTAKLLGYG-IE  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h--p----niv~l~~~~-~~  178 (408)
                      ..+++|.+...+|+|.||.|-.+.+. .+..||||+++.-.  ...+..+-|++++.++.+  |    -+|.+.+|+ ..
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            34689999999999999999999754 47899999997643  234455679999999832  2    356666754 45


Q ss_pred             CCeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-------------
Q 015389          179 GGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-------------  244 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-------------  244 (408)
                      ++.|+|+|.+ |-++.++|.. .-.+++..++..++.|+++++.|||+   .+++|.||||+|||+.             
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCc
Confidence            7789999998 6689999955 34568899999999999999999999   9999999999999993             


Q ss_pred             -------CCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 015389          245 -------EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQ  317 (408)
Q Consensus       245 -------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~  317 (408)
                             .+..++|+|||.|..-.+.     .+.+..|..|+|||++++-.|+.++||||+||||+|+.+|...|+..++
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                   1345899999999864332     2567789999999999999999999999999999999999999987542


Q ss_pred             c--hhhhhcccc-------ccc--------------------hHHHHhhhhcc----CcccHHHHHHHHHHHHhccccCC
Q 015389          318 S--LVLWARPMI-------KRN--------------------EIRELVDASLA----DEYDTRQMNLVLLAASLCIQQSS  364 (408)
Q Consensus       318 ~--~~~~~~~~~-------~~~--------------------~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P  364 (408)
                      .  +.+....+.       ...                    +.....++...    -.....+...+.+|+..||..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            2  111111000       000                    00111111100    01123456679999999999999


Q ss_pred             CCCCCHHHHHH
Q 015389          365 IRRPQMSQVVQ  375 (408)
Q Consensus       365 ~~RPt~~evl~  375 (408)
                      .+|+|++|++.
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=258.83  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=223.0

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      ...++.....++++..++-+|.||.||.|.+.      +.+.|-||.++....+-....++.|-.++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34566666788999999999999999999654      355688898887776667888999999999999999999999


Q ss_pred             EEEeCC--eEEEEEecCCCCHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC
Q 015389          175 YGIEGG--MHIVLELSPNGSLASLLYG-------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (408)
Q Consensus       175 ~~~~~~--~~lv~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~  245 (408)
                      .+.+..  .++++.+..-|+|..+|..       ....+.-.+.-.++.|++.|++|||+   +++||.||...|.++++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence            776643  5678889999999999962       12336666777899999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhc
Q 015389          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWAR  324 (408)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~  324 (408)
                      .-.+||+|=.+++.+-....+.-......+..||+||.+.+..|+.++|||||||+||||+| |+.|+-.          
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae----------  501 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE----------  501 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc----------
Confidence            99999999999998766555554444556788999999999999999999999999999998 8888763          


Q ss_pred             cccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       325 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                        ++..++...+....+-..+.+++++++.++.-||...|++||+..|++.-|.+
T Consensus       502 --IDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  502 --IDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             --cCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence              23446667777777778888999999999999999999999999999988753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-33  Score=277.63  Aligned_cols=243  Identities=26%  Similarity=0.360  Sum_probs=183.2

Q ss_pred             CCccceecccCcE-EEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEEEEec
Q 015389          112 FSFENLIGKGGYA-EVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELS  188 (408)
Q Consensus       112 y~~~~~lg~G~fg-~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv~e~~  188 (408)
                      |.-.+++|.|+-| .||+|... |+.||||++-.    +......+|+..+..- +|||||++|+...+.+ .|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            4455789999988 56999994 88999998854    3344567899999887 6999999999776655 67888888


Q ss_pred             CCCCHHHHHhcccCC--CCH-HHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---C--CceEEeecCCcccC
Q 015389          189 PNGSLASLLYGMKEK--LKW-GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---D--FEPQICDFGLAKWL  260 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~--l~~-~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~--~~~kl~DfGla~~~  260 (408)
                       ..+|.+++......  ... ...+.+..|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             66999999663111  111 3346788999999999999   99999999999999976   3  36899999999998


Q ss_pred             CCCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccchhhhhccccccchHHHHhhh
Q 015389          261 PEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG-RRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      +.+... .......||-+|+|||.+....-+.++||||||||+|+.++| .+||...-.........   ...+.     
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~---~~~L~-----  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG---NYTLV-----  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC---cccee-----
Confidence            765333 234567799999999999998888899999999999999996 88998642221110000   00000     


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+..  ..++  ...+||.+|++.+|..||++.+|+.
T Consensus       734 ~L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 HLEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0011  1111  6778999999999999999999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.8e-30  Score=231.70  Aligned_cols=210  Identities=34%  Similarity=0.571  Sum_probs=182.5

Q ss_pred             ecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecCCCCHHH
Q 015389          118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLAS  195 (408)
Q Consensus       118 lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~  195 (408)
                      ||.|++|.||++...+ |+.+++|.+...........+.+|+..++.+.|++++++++++.. ...++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998764 899999999876554345778899999999999999999997766 55789999999999999


Q ss_pred             HHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecCCcccCCCCCccceeccccc
Q 015389          196 LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTISKVEG  274 (408)
Q Consensus       196 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~g  274 (408)
                      ++......+++..+..++.+++.+|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            996544578999999999999999999999   89999999999999999 89999999999986654321  1233557


Q ss_pred             CCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHH
Q 015389          275 TFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVL  353 (408)
Q Consensus       275 t~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  353 (408)
                      ...|++||.+... .++.++|+|+||+++++|                                            ..+.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~~  191 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PELK  191 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHHH
Confidence            8899999999877 888999999999999999                                            4577


Q ss_pred             HHHHhccccCCCCCCCHHHHHHH
Q 015389          354 LAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       354 ~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      +++.+|++.+|.+||++.+++..
T Consensus       192 ~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         192 DLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHhhCCcccCcCHHHHhhC
Confidence            79999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=249.72  Aligned_cols=256  Identities=22%  Similarity=0.319  Sum_probs=193.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-----C---CceeEEEeEEEeC-
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----H---PNTAKLLGYGIEG-  179 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----h---pniv~l~~~~~~~-  179 (408)
                      .+|.+.++||.|.|++||++.+. +.+.||+|+.+...  ...+..+.|+.+|+++.     |   ..||+|++++... 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            78999999999999999999765 57899999997653  34556678999999882     3   4799999965532 


Q ss_pred             ----CeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC----------
Q 015389          180 ----GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT----------  244 (408)
Q Consensus       180 ----~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~----------  244 (408)
                          ++|+|+|++ |.+|..+|.. .-+.++...+.+|++||+.||.|||..  -||||.||||+|||+.          
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~~  232 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKDA  232 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhhh
Confidence                378899998 7788888754 456699999999999999999999995  5999999999999993          


Q ss_pred             --------------------------------------------------------------------------------
Q 015389          245 --------------------------------------------------------------------------------  244 (408)
Q Consensus       245 --------------------------------------------------------------------------------  244 (408)
                                                                                                      
T Consensus       233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~  312 (590)
T KOG1290|consen  233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN  312 (590)
T ss_pred             hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence                                                                                            


Q ss_pred             ------------------------CC----------------------------------------------------Cc
Q 015389          245 ------------------------ED----------------------------------------------------FE  248 (408)
Q Consensus       245 ------------------------~~----------------------------------------------------~~  248 (408)
                                              .+                                                    -.
T Consensus       313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~  392 (590)
T KOG1290|consen  313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR  392 (590)
T ss_pred             ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence                                    00                                                    02


Q ss_pred             eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc--------hh
Q 015389          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS--------LV  320 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~--------~~  320 (408)
                      +||+|||-|+|.....     +.-..|..|+|||++.+..|+..+||||++|++|||+||...|+.....        +.
T Consensus       393 vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  393 VKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             EEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            5788888888654433     3344788999999999999999999999999999999999988642111        00


Q ss_pred             hh-------hcccc-ccchHHHHhh-----------------hhcc--CcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 015389          321 LW-------ARPMI-KRNEIRELVD-----------------ASLA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQV  373 (408)
Q Consensus       321 ~~-------~~~~~-~~~~~~~~~d-----------------~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev  373 (408)
                      ..       ..... ...--+++++                 ..|.  -.++.++...+.+|+.-||+.+|++|||+.+.
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            00       00000 0001111111                 1111  13456778889999999999999999999999


Q ss_pred             HH
Q 015389          374 VQ  375 (408)
Q Consensus       374 l~  375 (408)
                      ++
T Consensus       548 l~  549 (590)
T KOG1290|consen  548 LK  549 (590)
T ss_pred             hc
Confidence            86

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4.7e-31  Score=229.33  Aligned_cols=253  Identities=18%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC---CeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG---GMH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~---~~~  182 (408)
                      ..++|++.+++|+|.+++||.|.. .+++.++||+++.-.    .+.+.+|+.||..|. ||||+++++...+.   ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            457899999999999999999974 578899999998653    455679999999996 99999999976653   357


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCcccCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLP  261 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~~~  261 (408)
                      +|+|++.+.+...+.    ..++...+...+.+++.||.|+|+   .||+|||+||.|+++|.. ..++|+|||+|.+..
T Consensus       112 LiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999999998877765    346666778899999999999999   999999999999999865 479999999999887


Q ss_pred             CCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccc---hhhhhccccccchHH----
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQS---LVLWARPMIKRNEIR----  333 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~----  333 (408)
                      .+...+.   ...+..|.-||.+.. ..|+.+-|+|||||+|..|+..+.||-....+   ++..++. +...++.    
T Consensus       185 p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV-LGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV-LGTDELYAYLN  260 (338)
T ss_pred             CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH-hChHHHHHHHH
Confidence            6544332   335678999999875 46899999999999999999999998654332   2222221 1111221    


Q ss_pred             -----------HHhhhhccCcc-------cHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 -----------ELVDASLADEY-------DTR-QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 -----------~~~d~~l~~~~-------~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                 .++...-+...       +.. ...+..+++...|..|-++|||++|.+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                       11111111100       000 1256788999999999999999999765

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=243.64  Aligned_cols=263  Identities=20%  Similarity=0.267  Sum_probs=190.7

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~  182 (408)
                      +.+..+.||.|+||.||.+.+. +|+.||+|++..-... -..+++.+|+.++..++|.|++..++.....      ++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3445688999999999999864 7999999988754322 2357788999999999999999988754332      245


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +|+|.+ ..+|...+. ....++...+.-+..||++||.|||+   .+|.||||||.|+|++.|..+||||||+|+.-..
T Consensus       134 V~TELm-QSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHH-Hhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence            667766 446666553 35568888888899999999999999   9999999999999999999999999999986543


Q ss_pred             CCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccch-hhhhccccccchHHHHhh---
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPMIKRNEIRELVD---  337 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~d---  337 (408)
                      +.. ...+...-|.+|+|||.++|. .|+.+.||||.|||+.||+..+..|+..++.. ......++....+..+-.   
T Consensus       209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            322 223334568899999999986 58999999999999999999988887644321 111111222222222111   


Q ss_pred             --------hhcc-Cccc--------HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          338 --------ASLA-DEYD--------TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       338 --------~~l~-~~~~--------~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                              ...+ ...+        ..-....+.+...++..||..|.+..+.+..+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence                    1110 0000        1122345667888999999999999888876643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=2.1e-31  Score=254.67  Aligned_cols=268  Identities=21%  Similarity=0.284  Sum_probs=203.7

Q ss_pred             cccCHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC------CCcee
Q 015389           98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD------HPNTA  170 (408)
Q Consensus        98 ~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~------hpniv  170 (408)
                      -+|.+..++..-.+|.+....|+|-|++|..|.+. -|+.||||++..+..  ..+.=+.|++||+.|+      .-|++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            35556666667789999999999999999999865 488999999987643  3455578999999995      34788


Q ss_pred             EEEe-EEEeCCeEEEEEecCCCCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       171 ~l~~-~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +++. |...+++|+|+|.+ ..+|.++|...  +..+....+..++.|++.||..|..   -+|+|.||||+|||+++..
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence            8885 77889999999998 66899999653  4457778899999999999999998   8999999999999998764


Q ss_pred             -ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh--hhh-
Q 015389          248 -EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV--LWA-  323 (408)
Q Consensus       248 -~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~--~~~-  323 (408)
                       .+||||||.|.....+    ..+...-+..|.|||++.|-.|+...|+||+||+||||.||+..|.+..++..  .+. 
T Consensus       574 ~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence             6899999999876543    23334455679999999999999999999999999999999999976433211  000 


Q ss_pred             ------cccccc----------------------------------chHHHHhhhhcc----CcccHHHHHHHHHHHHhc
Q 015389          324 ------RPMIKR----------------------------------NEIRELVDASLA----DEYDTRQMNLVLLAASLC  359 (408)
Q Consensus       324 ------~~~~~~----------------------------------~~~~~~~d~~l~----~~~~~~~~~~l~~li~~c  359 (408)
                            ..++..                                  .+...+-...+.    .+-.......+..|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence                  000000                                  000111111111    112234567788899999


Q ss_pred             cccCCCCCCCHHHHHH
Q 015389          360 IQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       360 l~~~P~~RPt~~evl~  375 (408)
                      +..||++|.|..|.+.
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=257.41  Aligned_cols=196  Identities=25%  Similarity=0.357  Sum_probs=165.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-------HHHHHHHHHHHHHhcCC---CCceeEEEeEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVD---HPNTAKLLGYGIE  178 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~il~~l~---hpniv~l~~~~~~  178 (408)
                      .+|...+.+|.|+||.|++|.++ +...|+||.+.+.+.-       ...-.+-.|+.||..++   |+||+++++|+.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46899999999999999999987 4667999988765321       11222446999999997   9999999998887


Q ss_pred             CC-eEEEEEec-CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          179 GG-MHIVLELS-PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       179 ~~-~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ++ +|++||.- ++.+|.+++ ..+..+++.....|+.|++.|+++||+   .+|||||||-+|+.++.+|-+||+|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~I-E~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI-EFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh-hccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            65 56788864 567999999 456779999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCC
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~  313 (408)
                      |.....+    ....+.||..|.|||++.|.+| ...-|||+||++||.++....||-
T Consensus       717 aa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9765433    3456789999999999998887 467899999999999999888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.1e-29  Score=227.42  Aligned_cols=199  Identities=33%  Similarity=0.498  Sum_probs=170.8

Q ss_pred             CCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEecC
Q 015389          112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSP  189 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~~  189 (408)
                      |.+.+.||.|++|.||+|...+ ++.+|+|.+...........+.+|+..+..++|+|++++++++.. ...++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999998764 899999999876543346788899999999999999999997665 45789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +++|.+++......+++..+..++.+++.++.+||+   .+++|+||+|.||+++.++.++|+|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            999999996544338899999999999999999999   8999999999999999999999999999987654321 122


Q ss_pred             cccccCCCccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          270 SKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                      ....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=234.76  Aligned_cols=255  Identities=24%  Similarity=0.283  Sum_probs=191.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------C
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------G  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------~  180 (408)
                      .+|.-+..+|.|.- .|-.|.+. .++.||+|.+..... ....++..+|+..+..++|+||++++.++.-.       +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56777788999987 66666543 588999998865422 22356677999999999999999999976632       4


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .|+|||++ ..+|...++   ..++-..+..|+.|++.|+.|||+   .+|+||||||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence            78999999 557888774   456777888999999999999999   99999999999999999999999999999853


Q ss_pred             CCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc-----c------
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK-----R------  329 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~-----~------  329 (408)
                      ..   .-..+....|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.. ..-+|.+....     .      
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-HIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-HHHHHHHHHHHhcCCCHHHHHHh
Confidence            32   234566778999999999999899999999999999999999999887532 22222211100     0      


Q ss_pred             ----------------chHHHHh-hhhccCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          330 ----------------NEIRELV-DASLADE--YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       330 ----------------~~~~~~~-d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                                      ....+.+ |..+...  .+......+..++.+||-.||++|.+++++++.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                            0000100 1111110  111234557789999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.4e-31  Score=257.49  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=199.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~  187 (408)
                      ++|.+...+|.|.+|.||+++++ .++..|||+++....+ ...-+..|+.+++..+||||+.+++ |-....+++.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            68899999999999999999876 6999999999876543 3566678999999999999999999 5556789999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      |.+|+|.+.- ...+.+++.++..+.+..+.||+|||+   .+-+|||||=.||++++.|.+|++|||.+..+....  .
T Consensus        94 cgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~  167 (829)
T KOG0576|consen   94 CGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A  167 (829)
T ss_pred             cCCCccccee-eecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh--h
Confidence            9999999976 457889999999999999999999999   999999999999999999999999999987664322  2


Q ss_pred             eecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          268 TISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ....+.||++|||||+..   .+.|..++|||++|++..|+---+.|.-...+....+.-.+       ..+++--..+ 
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-------S~~qpp~lkD-  239 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-------SGFQPPTLKD-  239 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-------cCCCCCcccC-
Confidence            334578999999999863   56799999999999999999877777443222211111000       0011110000 


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...-.+.+..|++.|+..+|.+||++.-++.
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1234566888999999999999999876554

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-29  Score=222.14  Aligned_cols=246  Identities=20%  Similarity=0.347  Sum_probs=181.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEe--EEEeCCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG--YGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~--~~~~~~~~lv  184 (408)
                      .+.|.+.+.||+|.||.+.++.++ +.+.+++|.+....  -..++|.+|..---.| .|.||+.-|+  |...+...++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            367899999999999999999987 47889999887653  3468888998876666 4899999997  5566667789


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-C-CCceEEeecCCcccCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-E-DFEPQICDFGLAKWLPE  262 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~-~~~~kl~DfGla~~~~~  262 (408)
                      +||++.|+|.+-+.  ...+-+....+++.|++.||.|+|+   +++||||||.+|||+- . ...+||||||+....+.
T Consensus       101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999999883  3557778888999999999999999   9999999999999993 3 34799999999885433


Q ss_pred             CCccceecccccCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccc-hhhhhccccccchHHHHh
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHG-----IVDEKTDVFAFGVLLLELVTGRRALDYSQQS-LVLWARPMIKRNEIRELV  336 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  336 (408)
                           ......-+..|.|||.....     ..++.+|||.||+|+|.++||+.||+..... ...|....+.....    
T Consensus       176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~----  246 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN----  246 (378)
T ss_pred             -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC----
Confidence                 22334467789999976432     2467899999999999999999999842211 11111111111110    


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e  372 (408)
                       +.+...+ ....+.++.+.++-+..+|.+|=-..+
T Consensus       247 -~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~  280 (378)
T KOG1345|consen  247 -PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWT  280 (378)
T ss_pred             -ccCchhh-cccCHHHHHHHHHhcCCcccccchhHH
Confidence             1111111 123455677888889999988843333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=8.1e-28  Score=210.97  Aligned_cols=162  Identities=20%  Similarity=0.187  Sum_probs=126.9

Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceec
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |+|.+++...+..+++..++.++.||+.||.|||+   ++      ||+|||++.++.+++  ||++......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            78999997667779999999999999999999998   55      999999999999999  9999865432       


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC-----ccc
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD-----EYD  345 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~-----~~~  345 (408)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......          ..+..+.......     ...
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~  132 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS----------AILEILLNGMPADDPRDRSNL  132 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc----------HHHHHHHHHhccCCccccccH
Confidence            1258999999999999999999999999999999999999997533211          0111111111111     011


Q ss_pred             HHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          346 TRQMN--LVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       346 ~~~~~--~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .....  .+.+++.+||+.+|.+||++.++++.+...
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22223  589999999999999999999999988544

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.5e-28  Score=263.47  Aligned_cols=194  Identities=16%  Similarity=0.133  Sum_probs=135.7

Q ss_pred             CCC-CceeEEEeEE-------Ee-CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 015389          164 VDH-PNTAKLLGYG-------IE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR  234 (408)
Q Consensus       164 l~h-pniv~l~~~~-------~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  234 (408)
                      ++| +||+++++++       .+ ..+++++|++ +++|.+++......+++..+..++.||+.||.|||+   ++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeec
Confidence            344 5777777754       11 2345667766 779999997656679999999999999999999999   999999


Q ss_pred             CCCCCceEECCCC-------------------ceEEeecCCcccCCCCCc--------------cceecccccCCCcccc
Q 015389          235 DIKAANILLTEDF-------------------EPQICDFGLAKWLPEQWT--------------HHTISKVEGTFGYLAP  281 (408)
Q Consensus       235 Dikp~NIll~~~~-------------------~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~aP  281 (408)
                      ||||+||||+..+                   .+||+|||+++.......              ........||+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            9999999996544                   455566666543211000              0001124588999999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccc
Q 015389          282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQ  361 (408)
Q Consensus       282 E~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~  361 (408)
                      |++.+..++.++|||||||+||||++|..|+.........             +....+... ..........++.+||+
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~-------------~~~~~~~~~-~~~~~~~~~~~~~~~L~  250 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSS-------------LRHRVLPPQ-ILLNWPKEASFCLWLLH  250 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHH-------------HHHhhcChh-hhhcCHHHHHHHHHhCC
Confidence            9999999999999999999999999998886532211100             000001110 01112334578889999


Q ss_pred             cCCCCCCCHHHHHH
Q 015389          362 QSSIRRPQMSQVVQ  375 (408)
Q Consensus       362 ~~P~~RPt~~evl~  375 (408)
                      .+|.+||++.||++
T Consensus       251 ~~P~~Rps~~eil~  264 (793)
T PLN00181        251 PEPSCRPSMSELLQ  264 (793)
T ss_pred             CChhhCcChHHHhh
Confidence            99999999999986

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.4e-27  Score=224.37  Aligned_cols=260  Identities=25%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-C
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-G  179 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~  179 (408)
                      ....+.|..+++||.|.|++||++.+.    .++.||+|.+......   .++.+|+++|..+ .+.||+++.++... +
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            334578999999999999999999743    4789999999876544   4578999999998 59999999997665 5


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCcc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAK  258 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~  258 (408)
                      ...+|+||+++....++...    ++...+..+++.++.||.++|.   +|||||||||+|+|.+.. +.-.|.|||+|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence            57899999999999998843    5677888899999999999999   999999999999999754 567899999998


Q ss_pred             cCCCC-------------Cc----------------------c-------ceecccccCCCccccccccCC-CCCcchhH
Q 015389          259 WLPEQ-------------WT----------------------H-------HTISKVEGTFGYLAPEFLMHG-IVDEKTDV  295 (408)
Q Consensus       259 ~~~~~-------------~~----------------------~-------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv  295 (408)
                      .....             .+                      .       .......||++|.|||++..- .-+.++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            32100             00                      0       000123599999999998754 56889999


Q ss_pred             HHHHHHHHHHHhCCCCCCccccchhhh---------------hc---c--ccc-cc--hHHHHhh-------hhc-cCcc
Q 015389          296 FAFGVLLLELVTGRRALDYSQQSLVLW---------------AR---P--MIK-RN--EIRELVD-------ASL-ADEY  344 (408)
Q Consensus       296 wSlGvil~elltg~~pf~~~~~~~~~~---------------~~---~--~~~-~~--~~~~~~d-------~~l-~~~~  344 (408)
                      ||.|||++.+++++.||-....+....               +.   .  .+. .+  .+.+...       ..+ ..+.
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            999999999999999986533221000               00   0  000 00  1111110       011 1111


Q ss_pred             --------cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 --------DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 --------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                              ....+..+++++.+|++.||.+|.|+++.+.
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                    1123446889999999999999999998775

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=5.8e-26  Score=219.30  Aligned_cols=167  Identities=19%  Similarity=0.150  Sum_probs=132.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc--CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeE-EEeEEEeC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAK-LLGYGIEG  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~--~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~-l~~~~~~~  179 (408)
                      ...++|.+.+.||+|+||+||+|.+.  +++.||||++....    .......+.+|+.++++++|+|++. ++++   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            45588999999999999999999864  57888999875331    2334567899999999999999985 5443   5


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC-CCCceEECCCCceEEeecCCcc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI-KAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..++||||++|++|.. +...    .   ...++.+++.||.|||+   +||+|||| ||+|||++.++.++|+|||+|+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            6799999999999963 2111    1   14678899999999999   99999999 9999999999999999999999


Q ss_pred             cCCCCCccce------ecccccCCCccccccccCC
Q 015389          259 WLPEQWTHHT------ISKVEGTFGYLAPEFLMHG  287 (408)
Q Consensus       259 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  287 (408)
                      .+........      .+...+++.|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            7755432211      2456789999999998643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-24  Score=208.99  Aligned_cols=260  Identities=19%  Similarity=0.233  Sum_probs=190.4

Q ss_pred             CCCccceecccCcEEEEEEEEcC--CcEEEEEEecCCCchHHHHHHHHHHHHHhcCC----CCceeEEEeEEE-eCC-eE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRN--GQLVAIKRLTRGTADEIIADFLSELGIMAHVD----HPNTAKLLGYGI-EGG-MH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~----hpniv~l~~~~~-~~~-~~  182 (408)
                      +|.+.++||+|+||.||+|....  ...+|+|........... .+..|..++..+.    .+++..+++.+. .+. .+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            89999999999999999998765  357999988765332211 5567888887776    268899998873 444 56


Q ss_pred             EEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-----CceEEeecCC
Q 015389          183 IVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-----FEPQICDFGL  256 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-----~~~kl~DfGl  256 (408)
                      +||+.+ |.+|.++..... +.++....+.|+.|++.+|.+||+   .|++||||||+|+++...     ..+.|.|||+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            777666 889999885444 789999999999999999999999   999999999999999765     3699999999


Q ss_pred             cc--cCCCCCc----cc-e-ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc
Q 015389          257 AK--WLPEQWT----HH-T-ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       257 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  328 (408)
                      ++  .......    .. . ...+.||..|+++....+...+.+.|+||++.++.+++.|..||........        
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--------  245 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--------  245 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--------
Confidence            98  3322111    11 1 2345699999999999999999999999999999999999999965432211        


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ...+................+..+..+...+-..+...+|....+...|+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            0111111111111101112234455555556668999999999999998665433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=7.4e-24  Score=200.83  Aligned_cols=252  Identities=30%  Similarity=0.437  Sum_probs=196.6

Q ss_pred             CCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchH--HHHHHHHHHHHHhcCCCC-ceeEEEeEEEeCC-eEEEEEe
Q 015389          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP-NTAKLLGYGIEGG-MHIVLEL  187 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~E~~il~~l~hp-niv~l~~~~~~~~-~~lv~e~  187 (408)
                      |.+...||.|+||.||++...  ..+++|.+.......  ....+.+|+.++..+.|+ +++++++++.... .++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999886  789999998665433  478889999999999988 7999999776555 5899999


Q ss_pred             cCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCCCC
Q 015389          188 SPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQW  264 (408)
Q Consensus       188 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~  264 (408)
                      +.++++.+++....  ..+.......++.|++.++.|+|.   .+++|||+||+||+++..+ .++++|||++..+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997774433  278899999999999999999999   8999999999999999998 79999999998665433


Q ss_pred             ccc----eecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          265 THH----TISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       265 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ...    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......        .........+.
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--------~~~~~~~~~~~  228 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--------SATSQTLKIIL  228 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------ccHHHHHHHHH
Confidence            221    2356779999999999987   57889999999999999999999997654421        00001111111


Q ss_pred             hhc----cCccc----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          338 ASL----ADEYD----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       338 ~~l----~~~~~----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...    .....    ......+..++..|+..+|..|.++.+....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111    01111    1123567889999999999999998877664

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-24  Score=190.74  Aligned_cols=257  Identities=20%  Similarity=0.244  Sum_probs=190.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC-CceeEEEeEEEeCC-eEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~-~~lv  184 (408)
                      ..++|.++++||.|+||.+|.|.. .+|..||||+-......   ..+..|..+...|++ ..|..+..|..+.. ..+|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            447899999999999999999974 57999999988765432   345678888888864 56666677776655 4688


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~  261 (408)
                      |+.+ |.+|.+++.-....++....+-++-|++.-++|+|.   +++|||||||+|+|..-+   ..+.|+|||+|+..-
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            8887 889999998788899999999999999999999999   999999999999999644   468999999999764


Q ss_pred             CCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          262 EQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       262 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      +..+.     .......||..|.+--...+...+...|+-|+|.+|..+..|..||++............+.+..+.-.+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i  245 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI  245 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence            43222     2234567999999998888888899999999999999999999999985543222222222221111111


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .....+     .+.++...+.-|-..--++-|...-+-+.
T Consensus       246 e~LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  246 EVLCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             HHHhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            111111     23445556667777777777775444333

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=2.4e-25  Score=228.43  Aligned_cols=263  Identities=24%  Similarity=0.313  Sum_probs=192.0

Q ss_pred             CccceecccCcEEEEEEEEc-CCcEEEEEEec----CCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          113 SFENLIGKGGYAEVYKGRLR-NGQLVAIKRLT----RGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~----~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ....++|.|++|.|+.+... ....++.|...    ....+ +....+..|+.+-..+.|||++..+....+ .....+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45688999999988877532 34444444332    22222 223337788888999999999887764333 2333459


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++ +|..++.. ...+....+..++.|++.|+.|+|.   .||.|||+|++|++++.+|.+||+|||.+......+.
T Consensus       401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 99999843 3478888899999999999999999   9999999999999999999999999999987766555


Q ss_pred             c--ceecccccCCCccccccccCCCCCc-chhHHHHHHHHHHHHhCCCCCCccccchhhh-hccccccchHHHHhhhhcc
Q 015389          266 H--HTISKVEGTFGYLAPEFLMHGIVDE-KTDVFAFGVLLLELVTGRRALDYSQQSLVLW-ARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       266 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-k~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~  341 (408)
                      .  .....++|+..|+|||.+.+..|+. ..||||.|++++.|++|+.||.........+ .........     ...-.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~-----~~~~~  550 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN-----IFEGP  550 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc-----cccCh
Confidence            5  4556788999999999999999985 6899999999999999999998755443221 000000000     00000


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccCccc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCCLK  385 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~~~~  385 (408)
                      .......+.....++.++|+.+|.+|.|+.+|++  .++.+..|.-
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v  596 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV  596 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence            1112234556677999999999999999999987  5555554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=5.9e-23  Score=187.82  Aligned_cols=256  Identities=19%  Similarity=0.225  Sum_probs=190.7

Q ss_pred             CCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCCe-EEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGM-HIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~-~lv~e  186 (408)
                      -+|++.++||.|+||.++.|.+ -+++.||||.-...+.-   -++..|....+.| ..++|...|-|.-++.. .+|+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A---PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA---PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCc---chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            5799999999999999999974 47999999987654322   3345677777777 47899998888777654 47888


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-----ceEEeecCCcccCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-----EPQICDFGLAKWLP  261 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-----~~kl~DfGla~~~~  261 (408)
                      .+ |-+|.|+..-.+..++.+.+..+|.|++.-++|+|+   +.+|+|||||+|+||..-+     .+.|+|||+|+...
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            77 889999998889999999999999999999999999   9999999999999996443     58999999999875


Q ss_pred             CCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          262 EQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       262 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      +..+.     .......||..||+=-...+.+-+.+.|+-|||=+++..+.|..||++.......-....+.+..-..-+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            43332     2234567999999999999999999999999999999999999999985543222122222221111111


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      +....+     .++++..-+.-.-..+-.+-|..+-+...+
T Consensus       261 ~~Lc~g-----~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf  296 (449)
T KOG1165|consen  261 EVLCEG-----FPEEFATYLRYVRRLDFFETPDYDYLRKLF  296 (449)
T ss_pred             HHHHhc-----CHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            111111     233444444445556777778766554444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=4.5e-23  Score=186.03  Aligned_cols=173  Identities=10%  Similarity=0.085  Sum_probs=134.9

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc--hHHHHH------HHHHHHHHhcCCCCceeEEEeEEEe
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DEIIAD------FLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~--~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      ...++|+..++||.|+||.||++.. ++..+|||.+.....  +.....      +.+|+..+.++.||+|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3468999999999999999999766 577899999975432  223333      5789999999999999999886442


Q ss_pred             ---------CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          179 ---------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       179 ---------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                               +..++||||++|.+|.++..     ++.    ....+++.+|..+|.   .|++|||+||+||+++.+| +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence                     24789999999999988741     222    245699999999999   9999999999999999998 9


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT  307 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt  307 (408)
                      +|+|||...........              ..+++...|+.++|+||||+++..+..
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999988754321111              114455567789999999999877643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=7.9e-23  Score=181.63  Aligned_cols=140  Identities=19%  Similarity=0.125  Sum_probs=109.7

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchH-------------------------HHHHHHHHHHHHhcCCCCce
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-------------------------IIADFLSELGIMAHVDHPNT  169 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~-------------------------~~~~~~~E~~il~~l~hpni  169 (408)
                      ...||+|+||.||+|...+|+.||||+++......                         .......|+.++..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46899999999999998789999999997643210                         01223459999999987776


Q ss_pred             eEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeeCCCCCceEECCCCc
Q 015389          170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL-HEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      .....+.. ...++||||++++++..... ....++......++.|++.+|.|+ |+   .+|+||||||+|||++ ++.
T Consensus        82 ~~p~~~~~-~~~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          82 PCPEPILL-KSHVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCCcEEEe-cCCEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCc
Confidence            44333322 23489999999987765532 245788899999999999999999 67   8999999999999998 478


Q ss_pred             eEEeecCCcccC
Q 015389          249 PQICDFGLAKWL  260 (408)
Q Consensus       249 ~kl~DfGla~~~  260 (408)
                      ++|+|||+|...
T Consensus       156 v~LiDFG~a~~~  167 (190)
T cd05147         156 LYIIDVSQSVEH  167 (190)
T ss_pred             EEEEEccccccC
Confidence            999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1e-23  Score=217.40  Aligned_cols=252  Identities=21%  Similarity=0.228  Sum_probs=179.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchH---HHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~---~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      +|...+.||++.|=+|.+|+++.|. |+||++-+....-   ...+.+.|+. ....+|||++.+.-+..... .|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777899999999999999998887 8899987654321   2233344555 56678999999877544433 456666


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc--CCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~--~~~~~  264 (408)
                      |. ..+|.|.+ ..+..+...+...|+.|++.||.-+|+   .||+|||||.+|||++.-+-+.|+||..-+.  ++++.
T Consensus       102 yv-khnLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YV-KHNLYDRL-STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HH-hhhhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            66 55888888 445567777888899999999999999   9999999999999999999999999986653  33332


Q ss_pred             ccce---ecccccCCCccccccccCC-----------CCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccccc
Q 015389          265 THHT---ISKVEGTFGYLAPEFLMHG-----------IVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       265 ~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      ....   ..+-..-..|+|||.+...           ..+++.||||+||+++||++ |++||...+-     ....-.+
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----LAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----HhHhccC
Confidence            2211   1222334579999988542           15678999999999999998 6888874321     1111010


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ....+.+-..+.+       ..+..++..|++.||.+|.+++++++.-.+..
T Consensus       252 ~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  252 ADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             ccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence            1111111111111       14566999999999999999999999876654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.5e-23  Score=183.30  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=190.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      ...+..+|.....|+.|+|++. |..+++|++..... .....+|..|.-.++-+.||||+.+++.|.. .++.++..|+
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3455678999999999999996 45567788764432 2345678889999999999999999997765 5678999999


Q ss_pred             CCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE-eeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          189 PNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRII-HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       189 ~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii-H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +.|+|...++.... ..+-.++.+++.++++|++|||+-  ..++ ---|....+++|++...+|+ .+-+++.-.    
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris-mad~kfsfq----  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ----  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee-cccceeeee----
Confidence            99999999987443 477788999999999999999983  3444 44688899999999887775 221111000    


Q ss_pred             ceecccccCCCccccccccCCCCC---cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVD---EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~---~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                       . ....-.+.|++||.++..+-+   .++|+|||+++||||.|...||....+...           ...+.-..++..
T Consensus       343 -e-~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-----------gmkialeglrv~  409 (448)
T KOG0195|consen  343 -E-VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-----------GMKIALEGLRVH  409 (448)
T ss_pred             -c-cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----------hhhhhhcccccc
Confidence             0 011245789999999877644   579999999999999999999975433211           112334556667


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .++....-+.+++.-|+..||.+||.+.+|+-+|++..
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            77777788899999999999999999999999998753

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=3e-21  Score=171.74  Aligned_cols=143  Identities=20%  Similarity=0.168  Sum_probs=112.5

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCch-------------------------HHHHHHHHHHHHHhcCCCCce
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-------------------------EIIADFLSELGIMAHVDHPNT  169 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-------------------------~~~~~~~~E~~il~~l~hpni  169 (408)
                      ...||+|+||.||+|.+.+|+.||||++......                         .....+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4789999999999999878999999998865211                         012234578999999999987


Q ss_pred             eEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      .....+... ..++||||++++++..... ....++......++.|++.++.+||+.  .||+||||||+||+++ ++.+
T Consensus        82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          82 PVPEPILLK-KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCceEEEec-CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCE
Confidence            554444333 3489999999886544321 234677888999999999999999972  7999999999999999 7899


Q ss_pred             EEeecCCcccCCC
Q 015389          250 QICDFGLAKWLPE  262 (408)
Q Consensus       250 kl~DfGla~~~~~  262 (408)
                      +|+|||++..+..
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=7.5e-21  Score=168.25  Aligned_cols=186  Identities=19%  Similarity=0.076  Sum_probs=140.9

Q ss_pred             ccceecccCcEEEEEEEEcCCcEEEEEEecCCCch--H-HHHHHHHHHHHHhcCC-CCceeEEEeEEEeCCeEEEEEecC
Q 015389          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--E-IIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLELSP  189 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~--~-~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~lv~e~~~  189 (408)
                      +...|++|+||+||.+.. ++..++.+.+.....-  . ....+.+|+.+|++|. |+++.+++++   +..+++|+|+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence            457899999999998766 6788888877655431  1 1235789999999995 5889999886   45799999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC-CCCceEECCCCceEEeecCCcccCCCCCcc--
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI-KAANILLTEDFEPQICDFGLAKWLPEQWTH--  266 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di-kp~NIll~~~~~~kl~DfGla~~~~~~~~~--  266 (408)
                      |.+|...+..        ....++.|++.+|.++|.   +||+|||| ||+|||++.++.++|+|||+|.........  
T Consensus        82 G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         82 GAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             CccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9998754311        113578899999999999   99999999 799999999999999999999865543210  


Q ss_pred             ----ce-----ecccccCCCccccccccCC-CCC-cchhHHHHHHHHHHHHhCCCCCCc
Q 015389          267 ----HT-----ISKVEGTFGYLAPEFLMHG-IVD-EKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       267 ----~~-----~~~~~gt~~y~aPE~~~~~-~~~-~k~DvwSlGvil~elltg~~pf~~  314 (408)
                          ..     ......++.|++|+...-- ..+ ...++++.|.-+|.++|++.+.-.
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                00     0112367888888754322 223 567999999999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=7.8e-23  Score=201.55  Aligned_cols=225  Identities=25%  Similarity=0.283  Sum_probs=176.3

Q ss_pred             eecccCcEEEEEEE----EcCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCC-CCceeEEEe-EEEeCCeEEEEEecC
Q 015389          117 LIGKGGYAEVYKGR----LRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSP  189 (408)
Q Consensus       117 ~lg~G~fg~V~~~~----~~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~-hpniv~l~~-~~~~~~~~lv~e~~~  189 (408)
                      .+|+|.||.|+++.    .+.|..+|+|++.+.... ........|..++...+ ||.++++.- +..++.+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999864    345889999998765321 11225556888888886 999999975 778889999999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      +|.|...+. ....+++.....+...++.|++++|+   .+|+|||+|++||+++.+|++++.|||+++..-..      
T Consensus        81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------  150 (612)
T KOG0603|consen   81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------  150 (612)
T ss_pred             cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhh------
Confidence            999998884 34456666667778889999999999   99999999999999999999999999999865322      


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ...+||..|||||++.  .....+|+||||++++||+||-.||..               ..+..+...  ....+....
T Consensus       151 ~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------~~~~~Il~~--~~~~p~~l~  211 (612)
T KOG0603|consen  151 KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------DTMKRILKA--ELEMPRELS  211 (612)
T ss_pred             hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------HHHHHHhhh--ccCCchhhh
Confidence            1128999999999987  567789999999999999999999985               111112221  122344555


Q ss_pred             HHHHHHHHhccccCCCCCCCH
Q 015389          350 NLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ..+..++..++..+|.+|.-.
T Consensus       212 ~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  212 AEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHHhhCHHHHhcc
Confidence            666778888999999999765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=2.6e-20  Score=173.06  Aligned_cols=231  Identities=19%  Similarity=0.215  Sum_probs=148.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCC----------CceeEEEe---
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH----------PNTAKLLG---  174 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~h----------pniv~l~~---  174 (408)
                      ++...+.||.|+++.||.+.+. +|+.+|||+.....  .....+.+.+|.-....+.+          -.++..++   
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4456789999999999999986 49999999876433  22356666666655544322          12222222   


Q ss_pred             ------EEEeC---------CeEEEEEecCCCCHHHHHhc---ccC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 015389          175 ------YGIEG---------GMHIVLELSPNGSLASLLYG---MKE---KLKWGIRYKIALGVAEGLLYLHEGCQRRIIH  233 (408)
Q Consensus       175 ------~~~~~---------~~~lv~e~~~~g~L~~~l~~---~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  233 (408)
                            +....         +.+++|+-+ .++|.+++..   ...   .+....++.+..|++..+++||.   .|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                  11111         234566555 7788887632   111   23445566777999999999999   99999


Q ss_pred             eCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccC--------CCCCcchhHHHHHHHHHHH
Q 015389          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH--------GIVDEKTDVFAFGVLLLEL  305 (408)
Q Consensus       234 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvil~el  305 (408)
                      +||+|+|++++.+|.+.|+||+.....+....     ....+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999998775443211     1335678999997643        2478899999999999999


Q ss_pred             HhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCC
Q 015389          306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRR  367 (408)
Q Consensus       306 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R  367 (408)
                      .+|+.||+........        ..       .+ ..+. +.++.+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~--------~~-------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADP--------EW-------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTS--------GG-------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccc--------cc-------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999864332111        00       11 1233 678889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=8.2e-21  Score=199.22  Aligned_cols=200  Identities=23%  Similarity=0.230  Sum_probs=159.5

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CCceeEEEe-EEEe
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLG-YGIE  178 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~-~~~~  178 (408)
                      .+.+.....|.|.+.||.|+||.||+|...+|+.||||+-+.....+.+    --.+++.+|+   -+-|..+.. +...
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY----I~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY----ICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee----ehHHHHHhhchhhhcchHHHHHHHccC
Confidence            3444556789999999999999999999888999999998876654321    1223333333   122333332 3445


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-------CCceEE
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-------DFEPQI  251 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-------~~~~kl  251 (408)
                      +.-++|+||.+.|+|.+++. ..+.++|.....++.|++..+++||.   .+||||||||+|+||..       +..++|
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             CcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence            66789999999999999995 66779999999999999999999999   99999999999999942       345899


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR  310 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~  310 (408)
                      +|||.+-.+............++|-.+--+|...|..|+..+|.|.|+.+++.|+.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999976644333345566788999999999999999999999999999999999974

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=5.2e-21  Score=188.45  Aligned_cols=212  Identities=23%  Similarity=0.380  Sum_probs=160.1

Q ss_pred             HhcCCCCceeEEEeEEEeCC-eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EeeCCCC
Q 015389          161 MAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI-IHRDIKA  238 (408)
Q Consensus       161 l~~l~hpniv~l~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-iH~Dikp  238 (408)
                      |+++.|.|+.+++|.+.++. .+.|.+|+..|+|.+.+......+++.....++++|+.||.|||+   ..| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeecc
Confidence            46788999999999777754 678999999999999998888889999999999999999999998   444 8999999


Q ss_pred             CceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCC-------CCcchhHHHHHHHHHHHHhCCCC
Q 015389          239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI-------VDEKTDVFAFGVLLLELVTGRRA  311 (408)
Q Consensus       239 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~k~DvwSlGvil~elltg~~p  311 (408)
                      .|.+++....+||+|||+.................-..-|.|||.+.+..       .+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999998775311111111222345799999987642       46679999999999999999999


Q ss_pred             CCccccchhhhhccccccchHHHHh---hhhccCccc-H-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          312 LDYSQQSLVLWARPMIKRNEIRELV---DASLADEYD-T-RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       312 f~~~~~~~~~~~~~~~~~~~~~~~~---d~~l~~~~~-~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      |+........       ..-+..+.   .+..++... . .....+..++.+||..+|.+||++.+|-..++.+..
T Consensus       158 ~~~~~~~~~~-------~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDP-------DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCCh-------HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9863322110       00000011   111122111 1 233468889999999999999999999999876654

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.3e-19  Score=166.44  Aligned_cols=147  Identities=18%  Similarity=0.146  Sum_probs=114.2

Q ss_pred             hhcCCCCccceecccCcEEEEEEE--EcCCcEEEEEEecCCCch-----------------------HHHHHHHHHHHHH
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGR--LRNGQLVAIKRLTRGTAD-----------------------EIIADFLSELGIM  161 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~--~~~g~~vavK~~~~~~~~-----------------------~~~~~~~~E~~il  161 (408)
                      ....-|.+.+.||+|+||.||+|.  ..+|+.||||++.....+                       .....+..|+.++
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333458899999999999999998  457999999998754210                       0123456899999


Q ss_pred             hcCCCC--ceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeeCCCC
Q 015389          162 AHVDHP--NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIHRDIKA  238 (408)
Q Consensus       162 ~~l~hp--niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dikp  238 (408)
                      .++.+.  .+.+++++   ...++||||+.+++|...... ...+.......++.||+.+|.+||.   .+ |+||||||
T Consensus       105 ~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp  177 (237)
T smart00090      105 QRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSE  177 (237)
T ss_pred             HHHHhcCCCCCeeeEe---cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCCh
Confidence            999753  34444543   345899999999888765422 3345566678899999999999999   88 99999999


Q ss_pred             CceEECCCCceEEeecCCcccCC
Q 015389          239 ANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       239 ~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 7899999999987543

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=3.7e-19  Score=159.80  Aligned_cols=134  Identities=20%  Similarity=0.275  Sum_probs=102.4

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-----CCCceeEEEeEEEeCC----eE-EE
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-----DHPNTAKLLGYGIEGG----MH-IV  184 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~~~----~~-lv  184 (408)
                      .+.||+|+||.||. ...++.. +||++...... ....+.+|+.+++.+     +||||+++++++..+.    ++ +|
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            47899999999996 2224444 69988764322 346788999999999     6799999999766542    33 68


Q ss_pred             EEe--cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeeCCCCCceEECCC----CceEEeec-CC
Q 015389          185 LEL--SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL-LYLHEGCQRRIIHRDIKAANILLTED----FEPQICDF-GL  256 (408)
Q Consensus       185 ~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~Df-Gl  256 (408)
                      +||  +.+++|.+++..  ..+++.  ..++.+++.++ .|||+   ++|+||||||+|||++.+    +.++|+|| |.
T Consensus        84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  567999999954  345555  35577888777 99999   999999999999999743    37999995 54


Q ss_pred             cc
Q 015389          257 AK  258 (408)
Q Consensus       257 a~  258 (408)
                      ..
T Consensus       157 ~~  158 (210)
T PRK10345        157 ST  158 (210)
T ss_pred             cc
Confidence            43

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=6e-20  Score=189.64  Aligned_cols=209  Identities=26%  Similarity=0.334  Sum_probs=146.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~  187 (408)
                      ..+|..++.|..|++|.||.++++. .+.+|+|+ ++...  .    ++-  |+.....|++|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--i----lRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--I----LRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--h----hhc--cccccCCccee-----------------
Confidence            3688999999999999999998874 77888853 32211  1    111  44444455554                 


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc--
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT--  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~--  265 (408)
                         |+-...+.. -+.++..        ++.+++|||+   .+|+|||+||+|++|+.-|.+|++|||+.+..-....  
T Consensus       136 ---gDc~tllk~-~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKN-IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhccc-CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               444555532 2333332        2789999999   9999999999999999999999999999876422111  


Q ss_pred             ----------cce-ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH
Q 015389          266 ----------HHT-ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       266 ----------~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                                +.. ...++||+.|+|||++....|...+|+|++|+|+||.+.|..||.+...+...           ..
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf-----------g~  269 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-----------GQ  269 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----------hh
Confidence                      111 12358999999999999999999999999999999999999999876433111           11


Q ss_pred             Hhhh-hccCcccHHHHHHHHHHHHhccccCCCCCCC
Q 015389          335 LVDA-SLADEYDTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       335 ~~d~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                      ++.. ..-.+-+.....++.+++.+.|+++|..|--
T Consensus       270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            1110 0011112233456777899999999999963

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.1e-18  Score=156.34  Aligned_cols=146  Identities=20%  Similarity=0.127  Sum_probs=113.9

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch---------------------HHHHHHHHHHHHH
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---------------------EIIADFLSELGIM  161 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~E~~il  161 (408)
                      .++......|.+.+.||.|+||.||+|...+|+.||||++......                     .....+..|+.++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3444444568889999999999999999888999999987643210                     0112356788889


Q ss_pred             hcCCCCc--eeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 015389          162 AHVDHPN--TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (408)
Q Consensus       162 ~~l~hpn--iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~  239 (408)
                      ..+.|++  +...++   ....++||||+++++|......       .....++.+++.++.++|+   .+|+||||+|+
T Consensus        88 ~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~  154 (198)
T cd05144          88 KALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEF  154 (198)
T ss_pred             HHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcc
Confidence            8887774  444443   3456899999999998775421       3456788999999999999   99999999999


Q ss_pred             ceEECCCCceEEeecCCcccCC
Q 015389          240 NILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       240 NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ||++++++.++|+|||++..+.
T Consensus       155 Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=1.5e-19  Score=175.39  Aligned_cols=240  Identities=21%  Similarity=0.285  Sum_probs=157.7

Q ss_pred             CCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-----E--EE---
Q 015389          112 FSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-----Y--GI---  177 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-----~--~~---  177 (408)
                      ..+.+..+..+++.++.....+    ...++-+....+.... .....+++..+....|-+..-+.+     +  ..   
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~-~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCA-CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK  324 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhh-hhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence            3445666777777776654322    2334444444333221 223334454444444433333322     1  11   


Q ss_pred             ---eCCeEEEEEecCCCCHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          178 ---EGGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       178 ---~~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                         ...+||.|++|...+|.++|..  .....++.....++.|++.|+.|      ++.+|+|+||.||+...+..+||+
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhh
Confidence               1236789999999999999953  44567888899999999999999      689999999999999999999999


Q ss_pred             ecCCcccCCCCC----ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccc
Q 015389          253 DFGLAKWLPEQW----THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       253 DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  327 (408)
                      |||+........    .....+...||..||+||.+.+..|+.|+||||||+||+|++. -..++..             
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------  465 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------  465 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------
Confidence            999998765443    1223355679999999999999999999999999999999998 2222221             


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQV  373 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev  373 (408)
                       ...+..+-|..+...+..+.+ .-..|+.+++...|.+||++.++
T Consensus       466 -~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 -IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence             111122222222211111111 12358899999999999954443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.2e-18  Score=153.25  Aligned_cols=134  Identities=25%  Similarity=0.277  Sum_probs=109.8

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCc--hH-----HHHHHHHHHHHHhcCCCCceeEEEeEE-EeCCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--DE-----IIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~--~~-----~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~~lv~e~  187 (408)
                      +.||+|++|.||+|.+ .|..|+||+......  .+     ....+.+|+.++..+.|+++.....++ .....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 577899998654321  11     234677899999999999887665543 44567899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ++|++|.+++....    . .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999985322    1 778899999999999999   9999999999999999 78999999998874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=1e-17  Score=149.98  Aligned_cols=130  Identities=22%  Similarity=0.289  Sum_probs=103.6

Q ss_pred             eecccCcEEEEEEEEcCCcEEEEEEecCCCc--h-----HHHHHHHHHHHHHhcCCCCceeEEEeE-EEeCCeEEEEEec
Q 015389          117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--D-----EIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELS  188 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~--~-----~~~~~~~~E~~il~~l~hpniv~l~~~-~~~~~~~lv~e~~  188 (408)
                      .||+|+||.||+|.+ +|..|++|.......  +     -...++.+|+.++..+.|+++.....+ ..+...++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 577899998654321  1     124667789999999988765443332 2345578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      +|++|.+++.....        .++.+++.+|.+||+   .+++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998743211        789999999999999   9999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.5e-17  Score=170.87  Aligned_cols=138  Identities=23%  Similarity=0.323  Sum_probs=109.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEe-cCC-Cch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-C
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL-TRG-TAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIE-G  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~-~~~-~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  179 (408)
                      ....|...+.||+|+||+||+|.+.++. +++|+. .+. ...     ....++.+|+.++..++|++++....+... .
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455677899999999999999876443 444432 221 111     124668899999999999999887765544 4


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++||||+++++|.+++.         ....++.+++.+|.|||+   .+++||||||+|||+ .++.++|+|||+++.
T Consensus       410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            5789999999999999884         356789999999999999   999999999999999 577999999999974

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.2e-17  Score=153.61  Aligned_cols=196  Identities=20%  Similarity=0.248  Sum_probs=133.5

Q ss_pred             CCCceeEEEeEEEe----------------------------CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHH
Q 015389          165 DHPNTAKLLGYGIE----------------------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV  216 (408)
Q Consensus       165 ~hpniv~l~~~~~~----------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i  216 (408)
                      .|||||++.+++.+                            ..+|+||.-+ ..+|..++..  ...+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence            59999999975421                            1267788766 4478888843  344555666688999


Q ss_pred             HHHHHHHHhcCCCCeEeeCCCCCceEE--CCCC--ceEEeecCCcccCCC---CCccc-eecccccCCCccccccccCCC
Q 015389          217 AEGLLYLHEGCQRRIIHRDIKAANILL--TEDF--EPQICDFGLAKWLPE---QWTHH-TISKVEGTFGYLAPEFLMHGI  288 (408)
Q Consensus       217 ~~~L~~LH~~~~~~iiH~Dikp~NIll--~~~~--~~kl~DfGla~~~~~---~~~~~-~~~~~~gt~~y~aPE~~~~~~  288 (408)
                      ++|+.|||.   +||.|||+|.+|||+  ++|+  .+.|+|||++---..   +.... ..-..-|...-||||+....+
T Consensus       351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999   999999999999999  4444  478999998742211   10110 111234788899999986432


Q ss_pred             -----C-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhcccc
Q 015389          289 -----V-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQ  362 (408)
Q Consensus       289 -----~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~  362 (408)
                           . -.|+|.|+.|.+.||+++...||-..+..       .+.....++---+.    .+..++..+.+++...|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-------~L~~r~Yqe~qLPa----lp~~vpp~~rqlV~~lL~r  496 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-------LLDTRTYQESQLPA----LPSRVPPVARQLVFDLLKR  496 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-------eechhhhhhhhCCC----CcccCChHHHHHHHHHhcC
Confidence                 1 35899999999999999999999763322       11111122222222    2334455677788889999


Q ss_pred             CCCCCCCHHHHHHHH
Q 015389          363 SSIRRPQMSQVVQLL  377 (408)
Q Consensus       363 ~P~~RPt~~evl~~L  377 (408)
                      ||.+|++.+-....|
T Consensus       497 ~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  497 DPSKRVSPNIAANVL  511 (598)
T ss_pred             CccccCCccHHHhHH
Confidence            999999866544443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.2e-18  Score=179.03  Aligned_cols=255  Identities=21%  Similarity=0.249  Sum_probs=191.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc--CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeCC-eEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~-~~lv  184 (408)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+.... ......+...|..+-+.+. |+|++.+++...+.+ .+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45677788999999999988653  35667777776543 2334555667888888887 999999999766654 5688


Q ss_pred             EEecCCCCHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~  261 (408)
                      +++..++++.+.+ +......+....-.++.|+..++.|+| .   .++.|+||||+|.+++..+ .++++|||+|..+.
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999988 444435566667778999999999999 7   9999999999999999999 99999999999887


Q ss_pred             C-CCccceeccccc-CCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          262 E-QWTHHTISKVEG-TFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       262 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      . +.........+| ++.|.|||...+. ......|+||.|+++.-+++|..|++........+....  +..      .
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~--~~~------~  248 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK--SNK------G  248 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec--ccc------c
Confidence            6 545555556778 9999999999885 456789999999999999999999986544321111110  000      0


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ................++.+++..+|..|.+.+++..
T Consensus       249 ~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            0011222334455667888899999999999887643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.8e-16  Score=140.36  Aligned_cols=137  Identities=20%  Similarity=0.182  Sum_probs=97.6

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCch--HHHH---------------------HHHHHHHHHhcCCCC--ce
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--EIIA---------------------DFLSELGIMAHVDHP--NT  169 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~--~~~~---------------------~~~~E~~il~~l~hp--ni  169 (408)
                      .+.||+|+||.||+|...+|+.||||++......  ....                     ....|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4789999999999999878999999998754321  1111                     113455556555433  24


Q ss_pred             eEEEeEEEeCCeEEEEEecCCCCHHHH-HhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          170 AKLLGYGIEGGMHIVLELSPNGSLASL-LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       170 v~l~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      .+.+++   ...++||||++++.+... +....  .. .....++.+++.++.++|..  .+|+|+||||+||+++ ++.
T Consensus        82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEec---CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCc
Confidence            444443   346899999999543221 11111  11 56778999999999999973  7999999999999999 889


Q ss_pred             eEEeecCCcccC
Q 015389          249 PQICDFGLAKWL  260 (408)
Q Consensus       249 ~kl~DfGla~~~  260 (408)
                      ++|+|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999999744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=3.1e-16  Score=132.73  Aligned_cols=135  Identities=22%  Similarity=0.167  Sum_probs=110.5

Q ss_pred             ccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--CceeEEEeEEEe-CCeEEEEEecCC
Q 015389          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--PNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      +.+.||.|.++.||++...+ ..+++|.......   ...+..|+.++..+.|  .++.+++.+... +..++++||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35789999999999999854 7899999876543   4567789999999876  588888876554 457899999988


Q ss_pred             CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       191 g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      +.+..+        +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.+...
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            877543        45566778999999999999854458999999999999999899999999998743

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=1.4e-15  Score=139.93  Aligned_cols=134  Identities=19%  Similarity=0.248  Sum_probs=104.0

Q ss_pred             ceec-ccCcEEEEEEEEcCCcEEEEEEecCCCc------------hHHHHHHHHHHHHHhcCCCCce--eEEEeEEEe-C
Q 015389          116 NLIG-KGGYAEVYKGRLRNGQLVAIKRLTRGTA------------DEIIADFLSELGIMAHVDHPNT--AKLLGYGIE-G  179 (408)
Q Consensus       116 ~~lg-~G~fg~V~~~~~~~g~~vavK~~~~~~~------------~~~~~~~~~E~~il~~l~hpni--v~l~~~~~~-~  179 (408)
                      ..|| .||.|+||.+... +..++||.+.....            ......+.+|+.++.++.|+++  +..+++... .
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999875 67899998854211            1224567889999999988775  666665332 2


Q ss_pred             C----eEEEEEecCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          180 G----MHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       180 ~----~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                      .    .++|+|++++ .+|.+++..  ..++..    .+.+|+.+|.+||.   .||+||||||.|||++.++.++|+||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEEC
Confidence            2    2499999997 689888743  344443    36789999999999   99999999999999999889999999


Q ss_pred             CCccc
Q 015389          255 GLAKW  259 (408)
Q Consensus       255 Gla~~  259 (408)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=3.7e-14  Score=141.58  Aligned_cols=142  Identities=22%  Similarity=0.216  Sum_probs=100.4

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHH---------------------------------------HHHH
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII---------------------------------------ADFL  155 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~---------------------------------------~~~~  155 (408)
                      .+.||.|++|.||+|++.+|+.||||+.+.+..+...                                       -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998765322110                                       1233


Q ss_pred             HHHHHHhcC----CCCceeEEEeEE--EeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHH-HHHHHHhcCC
Q 015389          156 SELGIMAHV----DHPNTAKLLGYG--IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE-GLLYLHEGCQ  228 (408)
Q Consensus       156 ~E~~il~~l----~hpniv~l~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~  228 (408)
                      +|...+.++    .|.+-+.+-..+  .....++||||++|++|.++........   ....++..++. .+..+|.   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~---  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR---  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh---
Confidence            455444444    233333333322  2345789999999999988764322222   23456666665 4678888   


Q ss_pred             CCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       229 ~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      .|++|+|++|.||+++.++.++|+|||++..+..
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=2.5e-14  Score=131.50  Aligned_cols=199  Identities=19%  Similarity=0.237  Sum_probs=138.8

Q ss_pred             HHHHhcCCCCceeEEEeEEEeC------CeEEEEEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 015389          158 LGIMAHVDHPNTAKLLGYGIEG------GMHIVLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQ  228 (408)
Q Consensus       158 ~~il~~l~hpniv~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~  228 (408)
                      +.-+.++.|-|||+++.|..+.      ...+++||+..|+|..+|...   ...+......++..||+.||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            3445566799999999876553      357899999999999999653   3457777888999999999999997 67


Q ss_pred             CCeEeeCCCCCceEECCCCceEEeecCCcccCC--CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHH
Q 015389          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV  306 (408)
Q Consensus       229 ~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ell  306 (408)
                      ..|+|+++..+.|++..+|-+||+----....+  ............+-++|.|||+-.....+.++|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            899999999999999999988875211111000  000011122334778999999876677788999999999999998


Q ss_pred             hCCCCCCccccchhhhhccccccchHH----HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          307 TGRRALDYSQQSLVLWARPMIKRNEIR----ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       307 tg~~pf~~~~~~~~~~~~~~~~~~~~~----~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .|..--......       ...+..+.    .+-+..-++            ++..|++..|..||+|++++..
T Consensus       277 ilEiq~tnseS~-------~~~ee~ia~~i~~len~lqr~------------~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESK-------VEVEENIANVIIGLENGLQRG------------SITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcce-------eehhhhhhhheeeccCccccC------------cCcccccCCCCCCcchhhhhcC
Confidence            876432211111       11111111    112222223            6778999999999999987653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.50  E-value=4.5e-14  Score=139.80  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=178.2

Q ss_pred             CCCCccceecc--cCcEEEEEEEE---cCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-e
Q 015389          110 NNFSFENLIGK--GGYAEVYKGRL---RNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-M  181 (408)
Q Consensus       110 ~~y~~~~~lg~--G~fg~V~~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~  181 (408)
                      ..|.+...+|.  |.+|.||.+..   .++..+|+|.-+.-.. .....+=++|+.....+ .|+|.++.+......+ +
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45667788999  99999999976   3688999998543221 11122234666666666 4999999777555554 5


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE----GLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGL  256 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGl  256 (408)
                      ++-+|.+ +.+|..+.+.....++....+..+.+...    ||.++|.   .+++|-|+||.||++..+ ...+++|||+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence            5555555 68999998776667888889999999998    9999999   999999999999999999 8899999999


Q ss_pred             cccCCCCCccce---ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH
Q 015389          257 AKWLPEQWTHHT---ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       257 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      ...+....-...   .....|...|++||.. ++.++...|||++|.++.+-.+|..+.......  .|...  ..    
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~--r~----  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQL--RQ----  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--Ccccc--cc----
Confidence            988866532221   1223578889999986 567889999999999999999987665432111  11100  00    


Q ss_pred             HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ..   +..++-......+...+.++++.+|-.|++.+.+..
T Consensus       341 -~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 -GY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -cc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             00   112222222334455888999999999998877654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=5.4e-13  Score=115.95  Aligned_cols=129  Identities=16%  Similarity=0.080  Sum_probs=94.3

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCcee-EEEeEEEeCCeEEEEEecCCCCHH
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA-KLLGYGIEGGMHIVLELSPNGSLA  194 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv-~l~~~~~~~~~~lv~e~~~~g~L~  194 (408)
                      +.|+.|.++.||++... |..|+||........  ...+..|+.++..+.+.+++ +++.+. ....++|||+++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCCccc
Confidence            67899999999999875 778999987654321  22346788888887654443 444443 33457999999998876


Q ss_pred             HHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC--QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       195 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ...         .....++.+++.+|..||...  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            430         111245678999999999822  12359999999999999 6689999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.42  E-value=4.6e-13  Score=135.53  Aligned_cols=142  Identities=16%  Similarity=0.146  Sum_probs=93.9

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCch---------------------------------HHHHH--
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTAD---------------------------------EIIAD--  153 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~---------------------------------~~~~~--  153 (408)
                      ..|.. +.||+|++|.||+|++++ |+.||||+...+..+                                 +..+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999887 999999999765211                                 11122  


Q ss_pred             ----HHHHHHHHhcC----CCCceeEEEeEEE--eCCeEEEEEecCCCCHHHHHhcccCCCC-----HHHHHHHHHHHHH
Q 015389          154 ----FLSELGIMAHV----DHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLK-----WGIRYKIALGVAE  218 (408)
Q Consensus       154 ----~~~E~~il~~l----~hpniv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~-----~~~~~~i~~~i~~  218 (408)
                          +.+|...+.++    .+.+.+.+-..+.  ....++||||+.|+.+.++-.-.....+     ......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                33344333333    2333344333222  3456899999999999875321122222     22222233333  


Q ss_pred             HHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCcccCCC
Q 015389          219 GLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAKWLPE  262 (408)
Q Consensus       219 ~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla~~~~~  262 (408)
                           ..   .|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 34   8999999999999999888    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.33  E-value=4.3e-11  Score=120.06  Aligned_cols=230  Identities=16%  Similarity=0.140  Sum_probs=147.4

Q ss_pred             EcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHH
Q 015389          131 LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR  209 (408)
Q Consensus       131 ~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~  209 (408)
                      ..++.+|.|...+.... +......+-+..++.++||||+++++ +..++..|+|+|-+.  .|..++...+    ....
T Consensus        34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            33688888888877665 44555677888899999999999998 555677999999863  4555663322    4455


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCC
Q 015389          210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV  289 (408)
Q Consensus       210 ~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  289 (408)
                      ...+.||+.||.|||+  ..+++|++|..+.|+++..|+.||++|.++........  ......---.|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            6678899999999997  37899999999999999999999999988764332111  000111122356666442222 


Q ss_pred             CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCC
Q 015389          290 DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       290 ~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                       -..|.|-|||+++|++.|..+  ........   ..+. .......-..+ +......+. ...++..|....+--|=.
T Consensus       182 -~s~D~~~Lg~li~el~ng~~~--~~~~~~~~---~~ip-k~~~~~~~k~~-~~~~~~r~n-~~~~~~~~~~~~gff~n~  252 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGSLL--TKTDLSNT---GKIP-KALIELYCKKL-GATELKRPN-KLRFILECRLLGGFFRND  252 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcccC--cchhhhcc---Cccc-hhHHHHHHHHh-ccccccccc-hhhHHHHHHhccccccch
Confidence             346999999999999999322  11100000   0000 00111111111 001111112 556777777777777778


Q ss_pred             HHHHHHHHhccc
Q 015389          370 MSQVVQLLRGNL  381 (408)
Q Consensus       370 ~~evl~~L~~~~  381 (408)
                      .-+++.+|+++.
T Consensus       253 fvd~~~fLeel~  264 (690)
T KOG1243|consen  253 FVDTLLFLEELR  264 (690)
T ss_pred             HHHHHHHHHhcc
Confidence            888888887765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.32  E-value=3.1e-11  Score=106.84  Aligned_cols=137  Identities=15%  Similarity=0.070  Sum_probs=98.3

Q ss_pred             cceecccCcEEEEEEEEcC-------CcEEEEEEecCCCc-----------h----------HHHHH----HHHHHHHHh
Q 015389          115 ENLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTA-----------D----------EIIAD----FLSELGIMA  162 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~-------g~~vavK~~~~~~~-----------~----------~~~~~----~~~E~~il~  162 (408)
                      ...||.|.=+.||.|...+       +..+|||+.+....           +          .....    ..+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999997543       47899998753211           0          00112    237999998


Q ss_pred             cCCC--CceeEEEeEEEeCCeEEEEEecCCCCHHH-HHhcccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeeCCCC
Q 015389          163 HVDH--PNTAKLLGYGIEGGMHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYL-HEGCQRRIIHRDIKA  238 (408)
Q Consensus       163 ~l~h--pniv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~Dikp  238 (408)
                      ++..  -++.+++++   ...++||||+.++.+.. .+.  ...++......+..+++.+|..| |.   .++|||||++
T Consensus        82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence            8843  456666654   56789999997754422 221  22344556677889999999998 77   8999999999


Q ss_pred             CceEECCCCceEEeecCCcccC
Q 015389          239 ANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       239 ~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .||++++ +.+.|+|||.+-..
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 68999999988644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.3e-12  Score=129.42  Aligned_cols=259  Identities=20%  Similarity=0.205  Sum_probs=177.2

Q ss_pred             CCccccCHHH-HhhhcCCCCccceecccCcEEEEEEEE--cCCcEEEEEEecCCCchHHH-HHHHHHHHHHhcC-CCCce
Q 015389           95 SPQKIFSLYE-LQSATNNFSFENLIGKGGYAEVYKGRL--RNGQLVAIKRLTRGTADEII-ADFLSELGIMAHV-DHPNT  169 (408)
Q Consensus        95 ~~~~~~~~~~-~~~~~~~y~~~~~lg~G~fg~V~~~~~--~~g~~vavK~~~~~~~~~~~-~~~~~E~~il~~l-~hpni  169 (408)
                      ++.++|.-.+ ......+|..+..||.|.|+.|+....  .++..|++|.+.+......- ..-+.|+-+...+ .|.++
T Consensus       249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence            3445555555 445567899999999999999998853  36889999988776433211 1123455555554 47778


Q ss_pred             eEEEe-EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-C
Q 015389          170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-F  247 (408)
Q Consensus       170 v~l~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~  247 (408)
                      +..+. |....+.++=-||+.++++...+ .....+++..++.+..|++.++.++|+   ..++|+|+||+||++..+ +
T Consensus       329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~  404 (524)
T KOG0601|consen  329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGF  404 (524)
T ss_pred             CCCCCCccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchh
Confidence            88765 66666777888999999888776 445567888889999999999999998   999999999999999886 7


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCc-cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGY-LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  326 (408)
                      ..+++|||+...+.-    .......++..| .+|+......+-.+.|++|||..+.+.++|..--....+    |....
T Consensus       405 ~~~~~~~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~  476 (524)
T KOG0601|consen  405 FSKLGDFGCWTRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIR  476 (524)
T ss_pred             hhhccccccccccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeee
Confidence            889999998864321    111112233334 355555566778899999999999999998753221111    11110


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                        .+.        + ...+ .....+..++..++..++..||.+.++....
T Consensus       477 --~~~--------~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  477 --SGD--------T-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             --ccc--------c-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence              000        0 0000 1114455577778899999999888776544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.29  E-value=2.4e-11  Score=110.11  Aligned_cols=142  Identities=19%  Similarity=0.199  Sum_probs=109.5

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--CceeEEEeEEEeC----CeEEEEEecC
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--PNTAKLLGYGIEG----GMHIVLELSP  189 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~----~~~lv~e~~~  189 (408)
                      +.|+.|..+.||++...+|..++||.............+..|..++..+.+  .++.+++.+..+.    ..++|||+++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            578999999999998876788999998654332234567789999999865  4456677765542    4689999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-------------------------------------------  226 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------  226 (408)
                      |.++.+.+..  ..++......++.+++.+|..||+.                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9988775521  4567777778888888888888852                                           


Q ss_pred             ----------CCCCeEeeCCCCCceEECC--CCceEEeecCCccc
Q 015389          227 ----------CQRRIIHRDIKAANILLTE--DFEPQICDFGLAKW  259 (408)
Q Consensus       227 ----------~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~  259 (408)
                                ....++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      1356899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=3.2e-10  Score=97.13  Aligned_cols=142  Identities=23%  Similarity=0.238  Sum_probs=101.9

Q ss_pred             ccceecccCcEEEEEEEEcCCcEEEEEEec-CCCc------hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeEEEE
Q 015389          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTA------DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVL  185 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~~g~~vavK~~~-~~~~------~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~lv~  185 (408)
                      ....|-+|+-+.|+++.+. |+.++||.-. +.-.      .-...+..+|..++.++.--.|.-..= |+....-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999985 7777777533 2211      113567788999998875433322222 33334567999


Q ss_pred             EecCC-CCHHHHHhcccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecCCccc
Q 015389          186 ELSPN-GSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKW  259 (408)
Q Consensus       186 e~~~~-g~L~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~  259 (408)
                      ||++| .++.+++...-.. ........++..|-+.+.-||.   ++||||||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 4777777553333 2333336789999999999999   9999999999999997665   458999999863

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=5.3e-10  Score=96.17  Aligned_cols=131  Identities=24%  Similarity=0.300  Sum_probs=96.2

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEec-CCCc----hH--HHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTA----DE--IIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~-~~~~----~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ..+++|+=+.+|.+.+. |..+++|.-. +.-.    ++  ...+-.+|..++..+.--.|...+=|..+ ....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999775 4446667433 2211    11  24556789999988854444333323333 445799999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ++|-.|.+.+...        ...++..+-.-+.-||.   .||+|+||.++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999988443        35677888888999999   9999999999999998774 99999999973

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.15  E-value=7.7e-12  Score=130.40  Aligned_cols=250  Identities=18%  Similarity=0.183  Sum_probs=167.9

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEe-EEEeCCeE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMH  182 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~-~~~~~~~~  182 (408)
                      +..+.+.+.+-+-+|.++.++.+.-. .|...+.|+......  ....+....+-.+.-...+|.++...- +-.....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            44577888888999999999988643 354455554433211  111233334444444445677766554 23345688


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ++++|+.+++|...|+... ..+.......+..+..+++|||.   ..++|+|++|.|++...+|..+++|||.....+.
T Consensus       881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999999999999997644 45555556667778899999998   7799999999999999999999999984433210


Q ss_pred             C---------------------Cc--------cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015389          263 Q---------------------WT--------HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       263 ~---------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~  313 (408)
                      -                     ..        ........||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                     00        011223568999999999999999999999999999999999999998


Q ss_pred             ccccchhhhhccccccchHHHHhhhhcc-CcccHHHHHHHHHHHHhccccCCCCCCCHH
Q 015389          314 YSQQSLVLWARPMIKRNEIRELVDASLA-DEYDTRQMNLVLLAASLCIQQSSIRRPQMS  371 (408)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~  371 (408)
                      ......+.           ..+...... ..-+.........++...+..+|.+|-.+.
T Consensus      1037 a~tpq~~f-----------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF-----------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh-----------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            65433111           000000000 001122234455567777788888887665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=2.1e-09  Score=94.81  Aligned_cols=126  Identities=25%  Similarity=0.227  Sum_probs=84.5

Q ss_pred             EEEEEEEcCCcEEEEEEecCCCc-------------------------hHHHHHHHHHHHHHhcCCCC--ceeEEEeEEE
Q 015389          125 EVYKGRLRNGQLVAIKRLTRGTA-------------------------DEIIADFLSELGIMAHVDHP--NTAKLLGYGI  177 (408)
Q Consensus       125 ~V~~~~~~~g~~vavK~~~~~~~-------------------------~~~~~~~~~E~~il~~l~hp--niv~l~~~~~  177 (408)
                      .||.|...+|..+|||+.+....                         .-......+|...|..+..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988899999998754211                         11235567899999999765  45666654  


Q ss_pred             eCCeEEEEEecC--CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          178 EGGMHIVLELSP--NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY-LHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       178 ~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                       ....+||||+.  |..+..+....   ++......++.+++..+.. +|.   .||+||||.+.||+++++ .+.|+||
T Consensus        79 -~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf  150 (188)
T PF01163_consen   79 -NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDF  150 (188)
T ss_dssp             -ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--G
T ss_pred             -eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEec
Confidence             24579999998  65555544221   1134456677888886655 567   899999999999999988 9999999


Q ss_pred             CCcccC
Q 015389          255 GLAKWL  260 (408)
Q Consensus       255 Gla~~~  260 (408)
                      |.+...
T Consensus       151 ~qav~~  156 (188)
T PF01163_consen  151 GQAVDS  156 (188)
T ss_dssp             TTEEET
T ss_pred             Ccceec
Confidence            988744

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.07  E-value=5.2e-09  Score=97.62  Aligned_cols=139  Identities=17%  Similarity=0.115  Sum_probs=99.1

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHH----------HHHHHHHHHhcCCCC--ceeEEEeEEEe-----
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA----------DFLSELGIMAHVDHP--NTAKLLGYGIE-----  178 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~----------~~~~E~~il~~l~hp--niv~l~~~~~~-----  178 (408)
                      +.+-......|+++.. +|+.|.||........+..+          .+.+|+..+..+..-  ....++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777766 57889999875544222222          367888888777432  23344444432     


Q ss_pred             -CCeEEEEEecCCC-CHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-------CCc
Q 015389          179 -GGMHIVLELSPNG-SLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-------DFE  248 (408)
Q Consensus       179 -~~~~lv~e~~~~g-~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-------~~~  248 (408)
                       ...++|+|++++. +|.+++.. .....+......++.+++..+.-||.   .||+|+|+++.|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence             2367999999886 89888743 13445666777899999999999999   99999999999999975       467


Q ss_pred             eEEeecCCcc
Q 015389          249 PQICDFGLAK  258 (408)
Q Consensus       249 ~kl~DfGla~  258 (408)
                      +.|+||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999885

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=5.5e-09  Score=102.19  Aligned_cols=165  Identities=21%  Similarity=0.275  Sum_probs=123.2

Q ss_pred             cEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE-----eCCeEEEEEecCC-CCHHH
Q 015389          123 YAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI-----EGGMHIVLELSPN-GSLAS  195 (408)
Q Consensus       123 fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~-----~~~~~lv~e~~~~-g~L~~  195 (408)
                      -.+.|++... +|..|++|++...... .......-+++++++.|+|+|++.+++.     +..+++|++|+++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3578999754 7999999999433221 1112235678899999999999988443     3457899999875 46776


Q ss_pred             HHhc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          196 LLYG--------------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       196 ~l~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      +-..              .+...++..+|.++.|+..||.++|+   .|+.-+-|.|.+|+++.+..++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5532              12347788999999999999999999   999999999999999999899998888776554


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR  310 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~  310 (408)
                      .+..                |-+.+   -.+-|.=-||.+++.|.||..
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            3320                11111   135689999999999999964

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=1.4e-08  Score=97.23  Aligned_cols=265  Identities=17%  Similarity=0.161  Sum_probs=161.4

Q ss_pred             CccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEe------EEEeCC--eEE
Q 015389          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG------YGIEGG--MHI  183 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~------~~~~~~--~~l  183 (408)
                      ....-||+|+-+.+|-.-.-.+  .+.|++..-.... ..   ..+..|... .||-+-.=+.      +.-+..  ..+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhhc--hhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3457899999999997532112  2447766543221 11   122233333 5664433122      122222  456


Q ss_pred             EEEecCCCCHHHHHhc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          184 VLELSPNGSLASLLYG------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                      +|..+.+..-...+.+      .-...+|...+++++.++.+.+.||+   .|.+-+|+.++|+|+.+++.|.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence            7777666532222222      11237899999999999999999999   99999999999999999999999986544


Q ss_pred             ccCCCCCccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCccccchhhhhcccc---c
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG-RRALDYSQQSLVLWARPMI---K  328 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~---~  328 (408)
                      ....+   ........|...|.+||.-.     +-.-+...|.|.|||++++++.| ++||.+-...... ..+..   .
T Consensus       165 qi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a-p~p~E~~Ia  240 (637)
T COG4248         165 QINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA-PNPLETDIA  240 (637)
T ss_pred             eeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC-CCcchhhhh
Confidence            33211   22233456899999999754     33457789999999999999886 9999863221000 00000   0


Q ss_pred             cchHHHHhh--hhcc---Cccc-HHHHHHHHHHHHhccccC--CCCCCCHHHHHHHHhcccCcccccccc
Q 015389          329 RNEIRELVD--ASLA---DEYD-TRQMNLVLLAASLCIQQS--SIRRPQMSQVVQLLRGNLCCLKYMTKC  390 (408)
Q Consensus       329 ~~~~~~~~d--~~l~---~~~~-~~~~~~l~~li~~cl~~~--P~~RPt~~evl~~L~~~~~~~~~~~~~  390 (408)
                      .+.....-+  ..+.   ...+ .-.+..+..+..+|+...  +.-|||++..+..|..+...++.+..+
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~  310 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS  310 (637)
T ss_pred             cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence            000000001  0010   0111 123445666777888654  567999999999998887776655543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.94  E-value=8.1e-09  Score=94.04  Aligned_cols=135  Identities=23%  Similarity=0.196  Sum_probs=97.7

Q ss_pred             CCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc---------------------hHHHHHHHHHHHHHhcCCCC--c
Q 015389          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA---------------------DEIIADFLSELGIMAHVDHP--N  168 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~---------------------~~~~~~~~~E~~il~~l~hp--n  168 (408)
                      +.+.+.||-|.=+.||.|....|..+|||.-..+..                     .-......+|.++|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            566789999999999999998999999996543321                     01234466899999988544  5


Q ss_pred             eeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       169 iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      +.+.+++   +...+|||+++|-.|...-      ++....-.++..|++-+.-+-.   .||||+|+.+-||+++++|.
T Consensus       173 VP~P~~~---nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         173 VPKPIAW---NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             CCCcccc---ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence            5555554   4467999999997765532      1233333445555555544445   89999999999999999999


Q ss_pred             eEEeecCCcc
Q 015389          249 PQICDFGLAK  258 (408)
Q Consensus       249 ~kl~DfGla~  258 (408)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999996554

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.91  E-value=3.4e-10  Score=114.08  Aligned_cols=150  Identities=19%  Similarity=0.307  Sum_probs=104.1

Q ss_pred             HHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc--cc-----eecccccCCCccccccccCC
Q 015389          215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT--HH-----TISKVEGTFGYLAPEFLMHG  287 (408)
Q Consensus       215 ~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~--~~-----~~~~~~gt~~y~aPE~~~~~  287 (408)
                      +++.|+.|+|.  ..++||++|.|++|.++.++..||+.|+.+........  ..     ......-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            45599999998  48999999999999999999999999998765433111  11     11112345689999999998


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCC-CCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCC
Q 015389          288 IVDEKTDVFAFGVLLLELVTGRRA-LDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIR  366 (408)
Q Consensus       288 ~~~~k~DvwSlGvil~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~  366 (408)
                      ..+.++|+||+||++|-+..|..+ +...+....         .......+..-...+....+.++.+=+.+++..++.-
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~  255 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAV  255 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch---------hhhhhcccccccccccccCcHHHHHHHHHHhcCCccc
Confidence            888999999999999999955444 433322211         1111111222222233455677778888899999999


Q ss_pred             CCCHHHHHH
Q 015389          367 RPQMSQVVQ  375 (408)
Q Consensus       367 RPt~~evl~  375 (408)
                      ||++.++..
T Consensus       256 rp~~~~l~~  264 (700)
T KOG2137|consen  256 RPTLDLLLS  264 (700)
T ss_pred             Ccchhhhhc
Confidence            998776543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.77  E-value=4.2e-08  Score=99.08  Aligned_cols=142  Identities=18%  Similarity=0.175  Sum_probs=94.9

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCch---------------------------------HHHH------HHHH
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---------------------------------EIIA------DFLS  156 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~---------------------------------~~~~------~~~~  156 (408)
                      +-|+.++-|.||+|++++|+.||||+...+-.+                                 +..+      ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999999999999998654321                                 1111      1233


Q ss_pred             HHHHHhcC----CCCceeEEEe--EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHH-HHHHHhcCCC
Q 015389          157 ELGIMAHV----DHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG-LLYLHEGCQR  229 (408)
Q Consensus       157 E~~il~~l----~hpniv~l~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~  229 (408)
                      |..-+.++    ....-+++-.  +...+...++|||++|..+.+........++...+.   ..++.+ +.-+-.   .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~---d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLR---D  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHh---c
Confidence            44444333    1222222223  223466789999999999999854344555543333   222222 222222   7


Q ss_pred             CeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       230 ~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |++|+|.+|.||+++.+|.+.+.|||+...+...
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999999877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=7.1e-08  Score=86.82  Aligned_cols=124  Identities=21%  Similarity=0.204  Sum_probs=88.5

Q ss_pred             CCcEEEEEEecCCCch------HHHHHHHHHHHHHhcCC--CCceeEEEeEEEeC-----CeEEEEEecCCC-CHHHHHh
Q 015389          133 NGQLVAIKRLTRGTAD------EIIADFLSELGIMAHVD--HPNTAKLLGYGIEG-----GMHIVLELSPNG-SLASLLY  198 (408)
Q Consensus       133 ~g~~vavK~~~~~~~~------~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~-----~~~lv~e~~~~g-~L~~~l~  198 (408)
                      .++.+.+|.+......      -......+|...+..|.  .-.+.+.+++....     ..++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3556666654322111      12345667887777764  23345555554432     247999999885 7998885


Q ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecCCcccC
Q 015389          199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWL  260 (408)
Q Consensus       199 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~  260 (408)
                      .... .+......++.+++..+.-||.   .||+|+|+++.|||++.++   .+.++||+-+...
T Consensus       111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWEQ-LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhcc-cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            4222 6666778899999999999999   9999999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=1.1e-06  Score=78.24  Aligned_cols=138  Identities=14%  Similarity=0.064  Sum_probs=99.8

Q ss_pred             ecccCcEEEEEEEEcCCcEEEEEEecCCCc-----hHHHHHHHHHHHHHhcCCC--CceeEEEeEEE--eC---CeEEEE
Q 015389          118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDH--PNTAKLLGYGI--EG---GMHIVL  185 (408)
Q Consensus       118 lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~h--pniv~l~~~~~--~~---~~~lv~  185 (408)
                      -|+||.+.|+..... |..+-||.-.....     .-....|.+|+..+.++..  -.+.+...+..  .+   ...||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467999999998775 55788897652211     1134678889998888843  22444442221  12   146899


Q ss_pred             EecCC-CCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc--eEEeecCCccc
Q 015389          186 ELSPN-GSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGLAKW  259 (408)
Q Consensus       186 e~~~~-g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGla~~  259 (408)
                      |.+.+ -+|.+++... ..+.+...+..++.+++..+.-||.   .|+.|+|+-+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 4888887432 3356777788999999999999999   99999999999999986666  99999986653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=2.4e-06  Score=76.46  Aligned_cols=139  Identities=13%  Similarity=0.155  Sum_probs=90.0

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch--HHH---------HHHHHHHHHHhcCCCCceeEEEe-
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD--EII---------ADFLSELGIMAHVDHPNTAKLLG-  174 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~--~~~---------~~~~~E~~il~~l~hpniv~l~~-  174 (408)
                      ...++|...+++-......|.+... +|..+++|........  ...         .++......+....--..+.++. 
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3457888888888888777777666 5788999987653321  111         11222222222222222223222 


Q ss_pred             -----EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          175 -----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       175 -----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                           +.......++|||++|..|.++..     +++    .++..+.+++.-||.   .|+.|+|..|.|++++++ .+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cE
Confidence                 112223458999999988876541     222    245667788999999   999999999999999866 59


Q ss_pred             EEeecCCccc
Q 015389          250 QICDFGLAKW  259 (408)
Q Consensus       250 kl~DfGla~~  259 (408)
                      +++||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=2.4e-06  Score=77.66  Aligned_cols=140  Identities=17%  Similarity=0.167  Sum_probs=82.5

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC--ceeEEEeEEEeC----CeEEEEEec
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGYGIEG----GMHIVLELS  188 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~~~~~----~~~lv~e~~  188 (408)
                      ++.|+.|..+.||+....+ ..+++|.....   .....+..|..++..+...  .+.+++.+....    ..+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            3678999999999999876 58999987654   3455666788888777422  355666644332    257899999


Q ss_pred             CCCCHHH----------------HHh---ccc---CCCCHHHH--H----HH---------------HHHHHH-HHHHHH
Q 015389          189 PNGSLAS----------------LLY---GMK---EKLKWGIR--Y----KI---------------ALGVAE-GLLYLH  224 (408)
Q Consensus       189 ~~g~L~~----------------~l~---~~~---~~l~~~~~--~----~i---------------~~~i~~-~L~~LH  224 (408)
                      ++..+..                .+.   ...   ........  .    .+               ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9998888                111   110   01111000  0    00               111222 233333


Q ss_pred             h----cCCCCeEeeCCCCCceEEC-CCCceEEeecCCcc
Q 015389          225 E----GCQRRIIHRDIKAANILLT-EDFEPQICDFGLAK  258 (408)
Q Consensus       225 ~----~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~  258 (408)
                      .    .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    2347799999999999999 56666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=1.7e-06  Score=87.36  Aligned_cols=142  Identities=21%  Similarity=0.191  Sum_probs=92.3

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCch------------------------------HHHHH------HHHHHH
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD------------------------------EIIAD------FLSELG  159 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~------------------------------~~~~~------~~~E~~  159 (408)
                      +-||.-+.|.||+|++++|+.||||+-+.+-..                              +..+.      |.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            679999999999999999999999988654321                              11122      233333


Q ss_pred             HHhc----CCCCce---eEEEe--EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 015389          160 IMAH----VDHPNT---AKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR  230 (408)
Q Consensus       160 il~~----l~hpni---v~l~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  230 (408)
                      -..+    +.|-+.   |.+-.  +.......++|||++|..+.+.-.-....++...+   +..+.++.  ++.-...|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~--~~qIf~~G  321 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAY--LEQIFKTG  321 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHH--HHHHHhcC
Confidence            2222    234441   11222  22334678999999999888775445555665533   33333332  22222268


Q ss_pred             eEeeCCCCCceEECC----CCceEEeecCCcccCCC
Q 015389          231 IIHRDIKAANILLTE----DFEPQICDFGLAKWLPE  262 (408)
Q Consensus       231 iiH~Dikp~NIll~~----~~~~kl~DfGla~~~~~  262 (408)
                      ++|+|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999983    66899999999987654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=5.6e-06  Score=75.54  Aligned_cols=137  Identities=17%  Similarity=0.191  Sum_probs=80.9

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc--eeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      ..||.|..+.||+.   .|..+++|........   ....+|.+++..+..-.  +.+.+++.... ...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   2445788988754422   34568898888875332  45666665543 3578999999963


Q ss_pred             -HHHHH---------------------hccc-CCCCHHHHH-HHHHH----------HHH-HHHHHHhc-CCCCeEeeCC
Q 015389          193 -LASLL---------------------YGMK-EKLKWGIRY-KIALG----------VAE-GLLYLHEG-CQRRIIHRDI  236 (408)
Q Consensus       193 -L~~~l---------------------~~~~-~~l~~~~~~-~i~~~----------i~~-~L~~LH~~-~~~~iiH~Di  236 (408)
                       +...+                     |... ......... .+..+          +.. ...+|... ....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     1100 011111100 01000          111 11222211 1345789999


Q ss_pred             CCCceEECCCCceEEeecCCccc
Q 015389          237 KAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       237 kp~NIll~~~~~~kl~DfGla~~  259 (408)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.36  E-value=3.8e-08  Score=98.63  Aligned_cols=190  Identities=22%  Similarity=0.193  Sum_probs=134.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc-eeEEEe-EEEeCCeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLG-YGIEGGMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~-~~~~~~~~lv~  185 (408)
                      .+.-+...+-+++|+++.+++.+....+...++.+...      ....-++++|.+++||| .+..++ +..+....+++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            34455566778999999999998654444556665543      23346889999999999 444444 34445567899


Q ss_pred             EecCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +++.++ +-..........+..-+...+.+.-.+++++||+   ..-+|+|    ||+..+ +..+..||+....+....
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            998777 2222111111223333344455566678999997   5568888    777765 589999999998776644


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                         ...++.+|+.++|||+...+.++.+.|+|++|+-..+|--|-+|-..
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence               34567799999999999999999999999999987788777777544

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.36  E-value=4.3e-06  Score=75.69  Aligned_cols=149  Identities=21%  Similarity=0.217  Sum_probs=94.9

Q ss_pred             HHhhhcCCCCccc---eecccCcEEEEEEEEcCCcEEEEEEecCCCch-----------------------HHHHHHHHH
Q 015389          104 ELQSATNNFSFEN---LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-----------------------EIIADFLSE  157 (408)
Q Consensus       104 ~~~~~~~~y~~~~---~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-----------------------~~~~~~~~E  157 (408)
                      .+.....+..+..   .|..|.-+.||+|...++..+|||++......                       ....-..+|
T Consensus        39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE  118 (268)
T COG1718          39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE  118 (268)
T ss_pred             HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence            3334444444444   56678888999999888999999998643221                       011223456


Q ss_pred             HHHHhcCC--CCceeEEEeEEEeCCeEEEEEecCCCC-HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEee
Q 015389          158 LGIMAHVD--HPNTAKLLGYGIEGGMHIVLELSPNGS-LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR  234 (408)
Q Consensus       158 ~~il~~l~--hpniv~l~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~  234 (408)
                      +.-|+++.  +-.+.+.+++.   +..+||||+.... -.-.|  ..-.+.......+..++++.+.-|-.  ..++||+
T Consensus       119 f~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHg  191 (268)
T COG1718         119 FRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHG  191 (268)
T ss_pred             HHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccc
Confidence            76666663  33334444432   3468999985541 11111  11122232566677788888776654  2799999


Q ss_pred             CCCCCceEECCCCceEEeecCCcccC
Q 015389          235 DIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       235 Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ||..-|||+. ++.+.|+|||-|...
T Consensus       192 DLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         192 DLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             cchhhheEEE-CCeEEEEECcccccc
Confidence            9999999999 779999999988654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.1e-05  Score=87.29  Aligned_cols=146  Identities=15%  Similarity=0.199  Sum_probs=90.9

Q ss_pred             cceecccCcEEEEEEEEcCC---cEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCce--eEEEeEEEe----CCeEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNT--AKLLGYGIE----GGMHIV  184 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpni--v~l~~~~~~----~~~~lv  184 (408)
                      .+.|+.|.+..+|+....++   ..+++|+............+.+|+.+++.+. |.++  .+++.++.+    +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876553   4678887655432222345678999999885 6654  777777665    347899


Q ss_pred             EEecCCCCHHH--------------------H---HhcccC----------CCCH--HHHHHHHH---------------
Q 015389          185 LELSPNGSLAS--------------------L---LYGMKE----------KLKW--GIRYKIAL---------------  214 (408)
Q Consensus       185 ~e~~~~g~L~~--------------------~---l~~~~~----------~l~~--~~~~~i~~---------------  214 (408)
                      ||+++|..+.+                    .   ||....          ...+  .++..+..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998865321                    1   111000          0000  11111111               


Q ss_pred             HHHHHHHHHHhcCC--------CCeEeeCCCCCceEECCC-C-ceEEeecCCcccC
Q 015389          215 GVAEGLLYLHEGCQ--------RRIIHRDIKAANILLTED-F-EPQICDFGLAKWL  260 (408)
Q Consensus       215 ~i~~~L~~LH~~~~--------~~iiH~Dikp~NIll~~~-~-~~kl~DfGla~~~  260 (408)
                      .+...+.+|..+.+        ..+||+|+++.||+++.+ + .+-|.||+++...
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            12234566754332        359999999999999753 3 3579999998754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.20  E-value=2.5e-05  Score=72.05  Aligned_cols=137  Identities=16%  Similarity=0.144  Sum_probs=81.5

Q ss_pred             eecccCc-EEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-CeEEEEEecCCCCH
Q 015389          117 LIGKGGY-AEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGSL  193 (408)
Q Consensus       117 ~lg~G~f-g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~~~lv~e~~~~g~L  193 (408)
                      .|..|.. +.||+.... +..++||+.....    ...+.+|+.+++.+. +--+.+++++...+ ..++||++++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455555 789999764 4678889876543    233457888877773 34455667665543 46899999999887


Q ss_pred             HHHH-------------------hccc---CCCCHH--HHHHHHH--------------------HHHHHHHHHHh----
Q 015389          194 ASLL-------------------YGMK---EKLKWG--IRYKIAL--------------------GVAEGLLYLHE----  225 (408)
Q Consensus       194 ~~~l-------------------~~~~---~~l~~~--~~~~i~~--------------------~i~~~L~~LH~----  225 (408)
                      ....                   +...   ..+...  .......                    .+...+..|-.    
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6442                   1100   011100  0000000                    01111122211    


Q ss_pred             cCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       226 ~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      .....++|+|+.|.||++++++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            112558999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=8.2e-06  Score=72.18  Aligned_cols=101  Identities=25%  Similarity=0.206  Sum_probs=82.4

Q ss_pred             HHHHHHhcCCC-CceeEEEeEEEeCCeEEEEEecCCCCHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 015389          156 SELGIMAHVDH-PNTAKLLGYGIEGGMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII  232 (408)
Q Consensus       156 ~E~~il~~l~h-pniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  232 (408)
                      .|.-++..+++ +++.+++|+|   +..+|+|+...+++...-.  ..-...+|..+.+|+.++++.+.+|++.....+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~   84 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY   84 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence            57888888865 6999999987   4568999998876653210  0123468999999999999999999987767788


Q ss_pred             eeCCCCCceEECCCCceEEeecCCccc
Q 015389          233 HRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       233 H~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      -.|++++|+-++++|.+|++|...+..
T Consensus        85 lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   85 LCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EeecchHHeEEeCCCcEEEEechhcch
Confidence            999999999999999999999987754

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.12  E-value=8.4e-05  Score=66.16  Aligned_cols=134  Identities=20%  Similarity=0.308  Sum_probs=88.3

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCC---------------chHHHHHHHHHHHHHhcCC------CCceeEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT---------------ADEIIADFLSELGIMAHVD------HPNTAKLLG  174 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~---------------~~~~~~~~~~E~~il~~l~------hpniv~l~~  174 (408)
                      ..||+|+.-.||.--  +.....||+.....               .........+|+.-..++.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            679999999999743  33446788887655               0112344555665555544      889999999


Q ss_pred             EE-EeCCeEEEEEecCC------CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          175 YG-IEGGMHIVLELSPN------GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       175 ~~-~~~~~~lv~e~~~~------g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +. ++.+..+|+|.+..      -+|.+++.  .+.++. .   +...+-+-..||-.   ..|+.+|++|.||++..+.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-H---HHHHHHHHHHHHHH---cCCeecCCCcccEEEEecC
Confidence            54 55678889888643      26777773  334444 2   23333444567777   8999999999999995432


Q ss_pred             ----ceEEee-cCCcccC
Q 015389          248 ----EPQICD-FGLAKWL  260 (408)
Q Consensus       248 ----~~kl~D-fGla~~~  260 (408)
                          .+.|+| ||....+
T Consensus       156 ~~~~~lvlIDG~G~~~~i  173 (199)
T PF10707_consen  156 SGEFRLVLIDGLGEKELI  173 (199)
T ss_pred             CCceEEEEEeCCCCcccc
Confidence                467777 6655543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.09  E-value=2.8e-05  Score=66.80  Aligned_cols=129  Identities=26%  Similarity=0.276  Sum_probs=89.9

Q ss_pred             CccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeE-EEeEEEeCCeEEEEEecCCC
Q 015389          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK-LLGYGIEGGMHIVLELSPNG  191 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~-l~~~~~~~~~~lv~e~~~~g  191 (408)
                      +..+.||+|.+|.||+|.+. |..+|+|+-..+..   ...+..|.+++..++-.++.+ +|.|.   ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCc
Confidence            34578999999999999996 55889998766543   456678999988887655543 33332   233559999998


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC-CCceEECCCCceEEeecCCccc
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK-AANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik-p~NIll~~~~~~kl~DfGla~~  259 (408)
                      +|.+.-...    +..    -...++++---|..   .||-|+.|. |...+|..++.+.|+||..|..
T Consensus        98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG----DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc----cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888765321    222    23455566445555   899999987 5555555555999999998873

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.98  E-value=5.9e-05  Score=69.21  Aligned_cols=72  Identities=11%  Similarity=0.117  Sum_probs=44.2

Q ss_pred             ceecccCcE-EEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC---ceeEEEeEEEe----CCeEEEEEe
Q 015389          116 NLIGKGGYA-EVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP---NTAKLLGYGIE----GGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg-~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~~~~~~----~~~~lv~e~  187 (408)
                      +.|+.||.. .||+.    +..+++|......   ....+..|..++..+...   .+.++++....    +..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            567877777 58875    2347778755422   234677888888777421   23344443322    124789999


Q ss_pred             cCCCCHH
Q 015389          188 SPNGSLA  194 (408)
Q Consensus       188 ~~~g~L~  194 (408)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.93  E-value=0.00017  Score=63.93  Aligned_cols=125  Identities=22%  Similarity=0.332  Sum_probs=88.6

Q ss_pred             CCCCccceecccCc-EEEEEEEEcCCcEEEEEEecC---CCc-------h----------HHHHHHHHHHHHHhcC---C
Q 015389          110 NNFSFENLIGKGGY-AEVYKGRLRNGQLVAIKRLTR---GTA-------D----------EIIADFLSELGIMAHV---D  165 (408)
Q Consensus       110 ~~y~~~~~lg~G~f-g~V~~~~~~~g~~vavK~~~~---~~~-------~----------~~~~~~~~E~~il~~l---~  165 (408)
                      .+++.++.||.|.. |.||++.. +|+.||||....   ...       .          .....|..|.+...+|   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68889999999999 99999998 478999999321   000       0          1234577888877666   4


Q ss_pred             CCce--eEEEeEEEeC-------------------CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Q 015389          166 HPNT--AKLLGYGIEG-------------------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH  224 (408)
Q Consensus       166 hpni--v~l~~~~~~~-------------------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH  224 (408)
                      +.++  |+++||..=.                   -..||.||.+...          .+    ...-+.+|.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------cc----chhHHHHHHHHHHHHH
Confidence            5556  9999975211                   0247778765543          11    2223567778888899


Q ss_pred             hcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       225 ~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                      .   .||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 K---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---CCeeeccCcccccc-----CCEEEecccC
Confidence            8   99999999999955     3579999865

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.83  E-value=8.3e-05  Score=79.91  Aligned_cols=197  Identities=23%  Similarity=0.224  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHhcCCCCceeEEEeEEEeCC-----eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc
Q 015389          152 ADFLSELGIMAHVDHPNTAKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG  226 (408)
Q Consensus       152 ~~~~~E~~il~~l~hpniv~l~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  226 (408)
                      .....|+..+..+.|+|++.++.|..+..     ..+..+++...++...+. ....++....+.+..++.+||.|+|+ 
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            33445777788889999999999877542     234557888888888884 45678888888899999999999998 


Q ss_pred             CCCCeEeeCCCCC---ceEECCCCceEEe--ecCCcccCCCCCccceecccccCCCccccccccCCCCCc--chhHHHHH
Q 015389          227 CQRRIIHRDIKAA---NILLTEDFEPQIC--DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE--KTDVFAFG  299 (408)
Q Consensus       227 ~~~~iiH~Dikp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--k~DvwSlG  299 (408)
                        ....|.-+..+   +-..+..+.+.++  ||+....++.....   ....-+..+.|||......++.  ..|+|.+|
T Consensus       305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             --hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence              54444444444   4444556667777  99988876543222   1223456788888887766554  47999999


Q ss_pred             HHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 015389          300 VLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL  377 (408)
Q Consensus       300 vil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L  377 (408)
                      ..+..+..|..+-.....              ...+.+    ....    ..+......|+..++++|+++.+++...
T Consensus       380 ll~~~~~~~~~i~~~~~~--------------~~~~l~----~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAV--------------PVSLLD----VLST----SELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHhhhhhcCcccccccc--------------hhhhhc----cccc----hhhhhhhhhhcchhhhhccchhhhhhch
Confidence            999999998765321110              011111    1111    1355577889999999999999999865

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.76  E-value=0.0003  Score=64.33  Aligned_cols=139  Identities=18%  Similarity=0.199  Sum_probs=79.6

Q ss_pred             ceecccCcEEEEEEEEcC--CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc-eeEEEeEEEeCCeEEEEEecCCCC
Q 015389          116 NLIGKGGYAEVYKGRLRN--GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVLELSPNGS  192 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~lv~e~~~~g~  192 (408)
                      +.|..|-...+|+....+  +..|++|+.......  .....+|+.++..+...+ ..+++++.. +  .+|+||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ-N--GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--cEEEEeeCCCc
Confidence            567788888999998664  678999977543211  112236777777774322 344444322 2  47999999876


Q ss_pred             HHHH----------H-------hcccCCC----------C-HHHHHHHHH----------------------HHHHHHHH
Q 015389          193 LASL----------L-------YGMKEKL----------K-WGIRYKIAL----------------------GVAEGLLY  222 (408)
Q Consensus       193 L~~~----------l-------~~~~~~l----------~-~~~~~~i~~----------------------~i~~~L~~  222 (408)
                      +...          +       |......          . +..+..+..                      .+...+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321          1       1111111          1 111111111                      11111111


Q ss_pred             H----Hh-cCCCCeEeeCCCCCceEECC-CCceEEeecCCccc
Q 015389          223 L----HE-GCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKW  259 (408)
Q Consensus       223 L----H~-~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~  259 (408)
                      |    -. .....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1    11 12357999999999999998 57899999988763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.73  E-value=0.001  Score=65.62  Aligned_cols=76  Identities=17%  Similarity=0.091  Sum_probs=53.0

Q ss_pred             ceecccCcEEEEEEEEcCC-cEEEEEEecCC-----C-chHHHHHHHHHHHHHhcCC---CCceeEEEeEEEeCCeEEEE
Q 015389          116 NLIGKGGYAEVYKGRLRNG-QLVAIKRLTRG-----T-ADEIIADFLSELGIMAHVD---HPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g-~~vavK~~~~~-----~-~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~lv~  185 (408)
                      +.||.|.+..||++...+| +.|+||.-...     . ..-...+...|.+.|..+.   ..++.+++.+. .+..++||
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-~~~~~lVM  110 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-EELAVTVM  110 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-CCCCEEEE
Confidence            5799999999999998776 58999975421     1 0113456667887777752   34567777763 34467999


Q ss_pred             EecCCCC
Q 015389          186 ELSPNGS  192 (408)
Q Consensus       186 e~~~~g~  192 (408)
                      |++++..
T Consensus       111 E~L~~~~  117 (401)
T PRK09550        111 EDLSDHK  117 (401)
T ss_pred             ecCCCcc
Confidence            9998754

>PRK10593 hypothetical protein; Provisional

Probab=97.68  E-value=0.0012  Score=62.77  Aligned_cols=75  Identities=13%  Similarity=-0.003  Sum_probs=52.7

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC---CceeEEEeEEEe----CCeEEEEEe
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH---PNTAKLLGYGIE----GGMHIVLEL  187 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~----~~~~lv~e~  187 (408)
                      .+.||.|..+.||.....++ .+++|..+....   ...+..|...++.+..   ..+.++++++..    +..++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQG-NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCC-CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            46799999999999976555 466777543211   2456688888877742   357777776542    447999999


Q ss_pred             cCCCCH
Q 015389          188 SPNGSL  193 (408)
Q Consensus       188 ~~~g~L  193 (408)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998764

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.0014  Score=63.06  Aligned_cols=32  Identities=31%  Similarity=0.388  Sum_probs=27.6

Q ss_pred             CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       227 ~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      .+.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            35789999999999999977556899999886

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.67  E-value=0.00027  Score=65.68  Aligned_cols=137  Identities=13%  Similarity=0.053  Sum_probs=76.4

Q ss_pred             eecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCce-eEEEeEEEeCCeEEEEEecCCCCHHH
Q 015389          117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPNGSLAS  195 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~lv~e~~~~g~L~~  195 (408)
                      .+..|-...+|+... +|..+++|........ ......+|..+++.+..-.+ .+++.+.   .-.+|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCccccc
Confidence            355677789998874 5677888876543211 10123578888887753323 2333332   2368999999876532


Q ss_pred             H-----------------Hhccc---CCCCHHHH-HHHHHHH---------HHHHHHHHhc-----CCCCeEeeCCCCCc
Q 015389          196 L-----------------LYGMK---EKLKWGIR-YKIALGV---------AEGLLYLHEG-----CQRRIIHRDIKAAN  240 (408)
Q Consensus       196 ~-----------------l~~~~---~~l~~~~~-~~i~~~i---------~~~L~~LH~~-----~~~~iiH~Dikp~N  240 (408)
                      .                 +|...   ..++.... .....++         ...+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111   11121111 1111111         1112222111     12468999999999


Q ss_pred             eEECCCCceEEeecCCccc
Q 015389          241 ILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       241 Ill~~~~~~kl~DfGla~~  259 (408)
                      |++++++ +.|+||+.|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999887 78999998863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.64  E-value=0.00053  Score=65.11  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=81.2

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC--ceeEEEeE-------EEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGY-------GIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~-------~~~~~~~lv~  185 (408)
                      .+.|..|....+|+....+ ..+++|+.....    ...+..|+.++..+.+-  .+.+++..       ...+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKVS----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCCC----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4567778778999987654 468889876522    23345566666666322  24444321       2234567899


Q ss_pred             EecCCCCHHH----H----------HhcccC----------CCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 015389          186 ELSPNGSLAS----L----------LYGMKE----------KLKWGIRY----------KIALGVAEGLLYLHE----GC  227 (408)
Q Consensus       186 e~~~~g~L~~----~----------l~~~~~----------~l~~~~~~----------~i~~~i~~~L~~LH~----~~  227 (408)
                      ++++|..+..    .          +|....          ...|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998876422    1          111000          01111110          011112334444442    23


Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      +.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            4679999999999999998777899999876

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.60  E-value=0.00082  Score=64.27  Aligned_cols=140  Identities=19%  Similarity=0.214  Sum_probs=79.4

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC--ceeEEEeE-------EEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP--NTAKLLGY-------GIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp--niv~l~~~-------~~~~~~~lv~  185 (408)
                      .+.++.|....+|+....+| .+++|+.......+   .+..|..++..|...  .+.+++..       ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777789999876555 57789876543222   233455666555321  23333321       1234567899


Q ss_pred             EecCCCCHH-----------HH---HhcccCCC-----------CHHHHH------------HHHHHHHHHHHHHHh---
Q 015389          186 ELSPNGSLA-----------SL---LYGMKEKL-----------KWGIRY------------KIALGVAEGLLYLHE---  225 (408)
Q Consensus       186 e~~~~g~L~-----------~~---l~~~~~~l-----------~~~~~~------------~i~~~i~~~L~~LH~---  225 (408)
                      +|++|..+.           ..   +|.....+           .|....            .....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885431           11   11110110           111100            001112334444432   


Q ss_pred             -cCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          226 -GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       226 -~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             345789999999999999998877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.49  E-value=0.00064  Score=64.78  Aligned_cols=138  Identities=25%  Similarity=0.268  Sum_probs=79.7

Q ss_pred             ceecccCcEEEEEEEEcC-------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc-eeEEEeEEEeCCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRN-------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~lv~e~  187 (408)
                      +.|..|-...+|+....+       ++.|++|+......  ......+|..++..+...+ ..+++++.. +  ..|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~--~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N--GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C--Cchhhe
Confidence            456666667999987654       57899999765432  1233457777777774322 234444433 2  357899


Q ss_pred             cCCCCHHHH-----------------HhcccCCC------CHHHHH----H--------------------------HHH
Q 015389          188 SPNGSLASL-----------------LYGMKEKL------KWGIRY----K--------------------------IAL  214 (408)
Q Consensus       188 ~~~g~L~~~-----------------l~~~~~~l------~~~~~~----~--------------------------i~~  214 (408)
                      ++|..+...                 +|......      ......    .                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            888766431                 11111110      000010    0                          011


Q ss_pred             HHHHHHHHHHh------cCCCCeEeeCCCCCceEECCC----CceEEeecCCcc
Q 015389          215 GVAEGLLYLHE------GCQRRIIHRDIKAANILLTED----FEPQICDFGLAK  258 (408)
Q Consensus       215 ~i~~~L~~LH~------~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~  258 (408)
                      .+...+..|-.      ..+..++|+|+.+.||+++.+    +.+.++||..|.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            11222333331      245678999999999999985    789999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.37  E-value=0.00012  Score=68.85  Aligned_cols=133  Identities=20%  Similarity=0.178  Sum_probs=90.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch-------------------H--HHHHHHHHHHHHhcCC-CC-
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-------------------E--IIADFLSELGIMAHVD-HP-  167 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-------------------~--~~~~~~~E~~il~~l~-hp-  167 (408)
                      -+.+.++||-|.-+.||.+-+.+|+..++|.-..+...                   -  ..-...+|+..|+.|. |- 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            47788999999999999999999999999964332110                   0  1122346777777763 21 


Q ss_pred             ceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       168 niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      -+.+.++   .+..++|||++.+..|...-+    -.+...++   ..+..-+--|.+   +|+||||..-=||++++++
T Consensus       173 pVPkpiD---~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~  239 (465)
T KOG2268|consen  173 PVPKPID---HNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDD  239 (465)
T ss_pred             CCCCccc---ccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHH---cCceecccchheeEEecCC
Confidence            1223333   234678999999988866432    22333333   333334455666   8999999999999999999


Q ss_pred             ceEEeecCC
Q 015389          248 EPQICDFGL  256 (408)
Q Consensus       248 ~~kl~DfGl  256 (408)
                      .++++||--
T Consensus       240 ~i~vIDFPQ  248 (465)
T KOG2268|consen  240 KIVVIDFPQ  248 (465)
T ss_pred             CEEEeechH
Confidence            999999953

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.32  E-value=0.0023  Score=60.26  Aligned_cols=31  Identities=29%  Similarity=0.476  Sum_probs=25.8

Q ss_pred             CCeEeeCCCCCceEECCCCc-eEEeecCCccc
Q 015389          229 RRIIHRDIKAANILLTEDFE-PQICDFGLAKW  259 (408)
Q Consensus       229 ~~iiH~Dikp~NIll~~~~~-~kl~DfGla~~  259 (408)
                      ..++|+|++|.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.30  E-value=0.0027  Score=61.48  Aligned_cols=80  Identities=13%  Similarity=0.064  Sum_probs=48.6

Q ss_pred             eecccCcEEEEEEEEcCC-cEEEEEEecCC------CchHHHHHHHHHHHHHhcCC--CC-ceeEEEeEEEeCCeEEEEE
Q 015389          117 LIGKGGYAEVYKGRLRNG-QLVAIKRLTRG------TADEIIADFLSELGIMAHVD--HP-NTAKLLGYGIEGGMHIVLE  186 (408)
Q Consensus       117 ~lg~G~fg~V~~~~~~~g-~~vavK~~~~~------~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~lv~e  186 (408)
                      .||.|...-||++...+| +.|+||.-..-      ...-...+..-|...|+...  -| .+.++|.| ..+...+|||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME   80 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME   80 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence            479999999999997654 68999964311      11112445556777776653  34 34445443 4444568999


Q ss_pred             ecCCC-CHHHHH
Q 015389          187 LSPNG-SLASLL  197 (408)
Q Consensus       187 ~~~~g-~L~~~l  197 (408)
                      +++.. .|...|
T Consensus        81 dL~~~~ilR~~L   92 (370)
T TIGR01767        81 DLSHHKIARKGL   92 (370)
T ss_pred             hCccchHHHHHH
Confidence            98554 343433

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.0058  Score=58.30  Aligned_cols=138  Identities=22%  Similarity=0.219  Sum_probs=80.6

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecC-CCchHHHHHHHHHHHHHhcCCC--CceeEEEeEEEeC---CeEEEEEec
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTR-GTADEIIADFLSELGIMAHVDH--PNTAKLLGYGIEG---GMHIVLELS  188 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~---~~~lv~e~~  188 (408)
                      .+.+..|.--.+|..... ++.++|. ... ...-+......+|+.+++.+.-  .-+...++.|.++   ..++||+++
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344433333345555443 7778888 332 2223345556678888887743  2233344544443   358999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHH-HHHHHHHHHHh------------------------------------------
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIAL-GVAEGLLYLHE------------------------------------------  225 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~-~i~~~L~~LH~------------------------------------------  225 (408)
                      +|..+.+.+..  ....    .+++. .+++.|.-||+                                          
T Consensus       108 eGe~~~~~~~~--~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~  181 (321)
T COG3173         108 EGEVVWSALPP--ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD  181 (321)
T ss_pred             cceeccCcCCc--ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence            88543332211  0000    11122 44444444444                                          


Q ss_pred             -------------cCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          226 -------------GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       226 -------------~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                                   .....++|+|+.+.||+++.++-+-+.||+++...
T Consensus       182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                         12356999999999999999988999999998753

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.10  E-value=9.6e-05  Score=81.30  Aligned_cols=161  Identities=12%  Similarity=-0.072  Sum_probs=115.7

Q ss_pred             HHHHHHHHHHHhcCCCCceeEEEeEEE---eCCeEEEEEecCCCCHHHHHhcccC---CCCHHHHHHHHHHHHHHHHHHH
Q 015389          151 IADFLSELGIMAHVDHPNTAKLLGYGI---EGGMHIVLELSPNGSLASLLYGMKE---KLKWGIRYKIALGVAEGLLYLH  224 (408)
Q Consensus       151 ~~~~~~E~~il~~l~hpniv~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH  224 (408)
                      .+-.+.|...++...|+++...+.-..   +...+.+++++.+|.+.+.+-+...   .++.........+.+.+..-.|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            444556666677778999888776322   2346889999999999998854222   2333333333333345554444


Q ss_pred             hc--CCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHH
Q 015389          225 EG--CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL  302 (408)
Q Consensus       225 ~~--~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil  302 (408)
                      ..  .+.-.+|+++|+-|.+|..+..++++++|+.+.....  ........+++.|++|+....-.++.++|+|..|+-+
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence            42  2344789999999999999999999999999843321  2233445688899999999888999999999999999


Q ss_pred             HHHHhCCCCCC
Q 015389          303 LELVTGRRALD  313 (408)
Q Consensus       303 ~elltg~~pf~  313 (408)
                      |+...|..+|-
T Consensus      1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred             HHHhcccHHHH
Confidence            99998887764

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.02  E-value=0.02  Score=56.54  Aligned_cols=81  Identities=12%  Similarity=-0.031  Sum_probs=52.0

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCc------hHHHHHHHHHHHHHhcCC---CCceeEEEeEEEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA------DEIIADFLSELGIMAHVD---HPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~------~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~~~~~lv~  185 (408)
                      .+.||.|....||+.... +..|+||.-.....      .....+...|...|..+.   ..++.+++.++. +..+++|
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-d~~vlvM  114 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-TMALIGM  114 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-CCCEEEE
Confidence            467899999999998874 55688997652111      012333345566665553   347778888766 3456789


Q ss_pred             EecCC--CCHHHHH
Q 015389          186 ELSPN--GSLASLL  197 (408)
Q Consensus       186 e~~~~--g~L~~~l  197 (408)
                      |++++  ..+.+.+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99977  3455444

>PLN02236 choline kinase

Probab=96.85  E-value=0.0076  Score=58.62  Aligned_cols=139  Identities=17%  Similarity=0.223  Sum_probs=78.7

Q ss_pred             ceecccCcEEEEEEEEcC-----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCce-eEEEeEEEeCCeEEEEEecC
Q 015389          116 NLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSP  189 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~lv~e~~~  189 (408)
                      ..|-.|-.-.+|+....+     ++.|++|+..... +..+. ..+|..+++.+..-++ .++++++..+   .|.+|++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc---eEEEeeC
Confidence            455557777899987532     3678999876543 22222 2578888887753333 3445544333   5788887


Q ss_pred             CCCHHHH-----------------HhcccC-----CCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 015389          190 NGSLASL-----------------LYGMKE-----KLKWGIRYKIALG-----------------VAEGLLYL----HE-  225 (408)
Q Consensus       190 ~g~L~~~-----------------l~~~~~-----~l~~~~~~~i~~~-----------------i~~~L~~L----H~-  225 (408)
                      +.+|...                 +|....     ...+..+.++..+                 +...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665421                 111110     1112222222211                 11112222    21 


Q ss_pred             cCCCCeEeeCCCCCceEECC-CCceEEeecCCccc
Q 015389          226 GCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKW  259 (408)
Q Consensus       226 ~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~  259 (408)
                      ..+..++|+|+++.||++++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22357899999999999976 46899999988863

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.73  E-value=0.014  Score=56.26  Aligned_cols=141  Identities=17%  Similarity=0.136  Sum_probs=92.8

Q ss_pred             CccceecccCcEEEEEEEEcCCcEEEEEEecCCCc------------------------hH-HHHHHHHHHHHHhcCCCC
Q 015389          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA------------------------DE-IIADFLSELGIMAHVDHP  167 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~------------------------~~-~~~~~~~E~~il~~l~hp  167 (408)
                      .+..+|..|.-+.||.|...+|..+|||+++....                        .. ...-...|++-|++++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            34467889999999999998999999998753210                        01 112234677777777654


Q ss_pred             ceeEEEeEEEeCCeEEEEEecCCCCHHH-HHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC
Q 015389          168 NTAKLLGYGIEGGMHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED  246 (408)
Q Consensus       168 niv~l~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~  246 (408)
                      .|. +-.-..-....|||+|+.+..... .|  ..-.++...+..+-.+++.-+.-|...  -++||.||.--|+|+. +
T Consensus       227 GIP-~PePIlLk~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d  300 (520)
T KOG2270|consen  227 GIP-CPEPILLKNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D  300 (520)
T ss_pred             CCC-CCCceeeecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence            422 211111123468999985432211 11  223455556677777888888777764  5899999999999886 4


Q ss_pred             CceEEeecCCccc
Q 015389          247 FEPQICDFGLAKW  259 (408)
Q Consensus       247 ~~~kl~DfGla~~  259 (408)
                      |.+.|+|-+-+..
T Consensus       301 G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 GKLYIIDVSQSVE  313 (520)
T ss_pred             CEEEEEEcccccc
Confidence            5899999987653

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.70  E-value=0.0072  Score=59.29  Aligned_cols=82  Identities=16%  Similarity=0.080  Sum_probs=50.4

Q ss_pred             cceecccCcEEEEEEEEcC-CcEEEEEEecC----C-CchHHHHHHHHHHHHHhcCC--CC-ceeEEEeEEEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRN-GQLVAIKRLTR----G-TADEIIADFLSELGIMAHVD--HP-NTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~----~-~~~~~~~~~~~E~~il~~l~--hp-niv~l~~~~~~~~~~lv~  185 (408)
                      .+.||.|.-.-||++.+.+ +..|+||.-..    . ...-...+..-|...|+.+.  -| .+.++|.| ......+||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM  112 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM  112 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence            4678999999999999753 56799996431    1 11113455566777777653  34 34455544 444456889


Q ss_pred             EecCCC-CHHHHH
Q 015389          186 ELSPNG-SLASLL  197 (408)
Q Consensus       186 e~~~~g-~L~~~l  197 (408)
                      |+++.. .|...|
T Consensus       113 EdL~~~~ilR~~L  125 (409)
T PRK12396        113 EDLSDHTILRTAL  125 (409)
T ss_pred             HhCcccHHHHHHH
Confidence            988543 344443

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.54  E-value=0.0084  Score=59.94  Aligned_cols=182  Identities=18%  Similarity=0.179  Sum_probs=96.2

Q ss_pred             EEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC--CeEEEEEecCCCCHHHHHhcccCC
Q 015389          126 VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--GMHIVLELSPNGSLASLLYGMKEK  203 (408)
Q Consensus       126 V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~  203 (408)
                      .+.|....|..+ ..-+....   ....++--..+++.+.|+|....+++....  ...+|+|++ +.+|.+.+....  
T Consensus         5 ~~~a~~~~~~~c-~nglplt~---~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--   77 (725)
T KOG1093|consen    5 TFFAQEKPGDVC-SNGLPLTP---NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--   77 (725)
T ss_pred             EEehhcCCCccc-cCCCcCCC---cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--
Confidence            455555555544 22222221   234456678889999999999999875543  355677777 778988874322  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCcccccc
Q 015389          204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF  283 (408)
Q Consensus       204 l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  283 (408)
                      +..      +...      .     +++.|-.            ..+++| -++    ..   .  ....|         
T Consensus        78 l~~------~s~~------~-----~~~~~~~------------~~~~td-~~~----t~---~--~~~~~---------  109 (725)
T KOG1093|consen   78 LKD------ESLL------A-----HGVLHLN------------IIYITD-HFL----TK---Y--PSPIG---------  109 (725)
T ss_pred             cch------hhhc------c-----cccceeh------------hhhccc-ccc----cc---C--CCCCC---------
Confidence            111      1111      1     2333321            122333 000    00   0  00111         


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh--hhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccc
Q 015389          284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV--LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQ  361 (408)
Q Consensus       284 ~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~  361 (408)
                             +|+||||+|.|+.|+..|..-+........  ...+....+.....+...   ..+.-.+.+.+..+...|+-
T Consensus       110 -------pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~  179 (725)
T KOG1093|consen  110 -------PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLW  179 (725)
T ss_pred             -------cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCc
Confidence                   399999999999999998765443221111  111111111111111111   02333456678889999999


Q ss_pred             cCCCCCCCHHH
Q 015389          362 QSSIRRPQMSQ  372 (408)
Q Consensus       362 ~~P~~RPt~~e  372 (408)
                      ..|..||...+
T Consensus       180 ~~~~ir~l~~~  190 (725)
T KOG1093|consen  180 LEPIIRPLPME  190 (725)
T ss_pred             cccccccchhH
Confidence            99999996544

>PRK06148 hypothetical protein; Provisional

Probab=96.48  E-value=0.057  Score=60.06  Aligned_cols=140  Identities=18%  Similarity=0.193  Sum_probs=78.1

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-------CCCceeEEEe--EE--E---eC--
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-------DHPNTAKLLG--YG--I---EG--  179 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-------~hpniv~l~~--~~--~---~~--  179 (408)
                      +.|+ |..-.+|+....+|..+++|+........   .+..|...+..|       .-|.+++-.+  +.  .   ++  
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~~---~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPRV---ESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccchh---HHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            3453 34577898887778889999998653322   222333444333       2344444332  11  1   12  


Q ss_pred             CeEEEEEecCCCCHHHH-------H----------hc------c---cCCCCHHH-----------------HHHHHHHH
Q 015389          180 GMHIVLELSPNGSLASL-------L----------YG------M---KEKLKWGI-----------------RYKIALGV  216 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~-------l----------~~------~---~~~l~~~~-----------------~~~i~~~i  216 (408)
                      ..+.+++|++|..+.+.       +          +.      .   ...+.|..                 ...++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            24568999999877651       1          10      0   01122221                 11222233


Q ss_pred             HHHHH----HHHhcCCCCeEeeCCCCCceEECCCC--ceE-EeecCCccc
Q 015389          217 AEGLL----YLHEGCQRRIIHRDIKAANILLTEDF--EPQ-ICDFGLAKW  259 (408)
Q Consensus       217 ~~~L~----~LH~~~~~~iiH~Dikp~NIll~~~~--~~k-l~DfGla~~  259 (408)
                      ++...    -.....+.++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            32221    11123467899999999999999875  454 999998864

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.36  E-value=0.029  Score=52.99  Aligned_cols=72  Identities=17%  Similarity=0.213  Sum_probs=42.9

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC---CCCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV---DHPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      .+.|+.|....+|+.. .+++.+.||.-....    ...|..|..-|+.|   .--.+.+++++... +..++|+||++.
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            4678889999999987 568889999876322    23445676666666   34467778886654 456899999887


Q ss_pred             C
Q 015389          191 G  191 (408)
Q Consensus       191 g  191 (408)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            7

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.32  E-value=0.057  Score=51.63  Aligned_cols=32  Identities=16%  Similarity=0.296  Sum_probs=28.8

Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      +.+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            46899999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.30  E-value=0.11  Score=49.43  Aligned_cols=30  Identities=33%  Similarity=0.443  Sum_probs=26.2

Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999987 578999998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.24  E-value=0.11  Score=50.17  Aligned_cols=136  Identities=23%  Similarity=0.342  Sum_probs=78.5

Q ss_pred             ecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CCceeE---EEe---EEEeC--CeEEEEE
Q 015389          118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAK---LLG---YGIEG--GMHIVLE  186 (408)
Q Consensus       118 lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~---l~~---~~~~~--~~~lv~e  186 (408)
                      |.+ .-..||+....+|+. +||+.......   ..+.-|+..+..|.   .+=.+.   +=|   ....+  ...-|++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPGWTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCCCCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 456789988877776 99998876222   33445666666652   222222   222   12234  4567899


Q ss_pred             ecCCCCHHH------------H---Hhc--cc---------CCCCHHH----H---------HHHHHHHHHHHHHHHh--
Q 015389          187 LSPNGSLAS------------L---LYG--MK---------EKLKWGI----R---------YKIALGVAEGLLYLHE--  225 (408)
Q Consensus       187 ~~~~g~L~~------------~---l~~--~~---------~~l~~~~----~---------~~i~~~i~~~L~~LH~--  225 (408)
                      |++|..+..            +   ||.  .+         ....|..    .         .....++...+..+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872            1   111  00         0122321    0         0122233333333333  


Q ss_pred             --cCCCC---eEeeCCCCCceEECCCCc-eEEeecCCcc
Q 015389          226 --GCQRR---IIHRDIKAANILLTEDFE-PQICDFGLAK  258 (408)
Q Consensus       226 --~~~~~---iiH~Dikp~NIll~~~~~-~kl~DfGla~  258 (408)
                        ..+.+   +||+|+.|.||+++.+.. +.++|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              22344   999999999999999885 8899999775

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.75  E-value=0.026  Score=50.69  Aligned_cols=30  Identities=33%  Similarity=0.491  Sum_probs=21.2

Q ss_pred             CCeEeeCCCCCceEE-CCCCceEEeecCCcc
Q 015389          229 RRIIHRDIKAANILL-TEDFEPQICDFGLAK  258 (408)
Q Consensus       229 ~~iiH~Dikp~NIll-~~~~~~kl~DfGla~  258 (408)
                      ..+.|.|+.|.||++ +.++.++|+||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            457799999999999 888899999998876

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.73  E-value=0.21  Score=48.22  Aligned_cols=29  Identities=31%  Similarity=0.461  Sum_probs=25.0

Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..+++|+|+.+.|||++ + .+.|+||+.+.
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            46799999999999995 4 57899999876

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.69  E-value=0.058  Score=52.14  Aligned_cols=139  Identities=19%  Similarity=0.234  Sum_probs=75.7

Q ss_pred             ceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCce-eEEEeEEEeCCeEEEEEecCC
Q 015389          116 NLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPN  190 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~lv~e~~~~  190 (408)
                      +.|..|=.-.+|+....+    +..|++|+...... . .-.-.+|..+++.+..-++ .+++++. .++  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-Y-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-e-EechHHHHHHHHHHHhcCCCCceeEEe-CCc--EeehhhcC
Confidence            445556667888886543    23788998765432 1 1222468888877754444 3455554 333  48888876


Q ss_pred             CCHHH----------H-------HhcccCC----C-CHHHHHHHHHHH----------------------HHHHHHHHh-
Q 015389          191 GSLAS----------L-------LYGMKEK----L-KWGIRYKIALGV----------------------AEGLLYLHE-  225 (408)
Q Consensus       191 g~L~~----------~-------l~~~~~~----l-~~~~~~~i~~~i----------------------~~~L~~LH~-  225 (408)
                      -.|..          .       +|....+    . -+..+.++..++                      ..-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65421          0       1111100    1 122222222111                      111112111 


Q ss_pred             ----cCCCCeEeeCCCCCceEECC-CCceEEeecCCccc
Q 015389          226 ----GCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKW  259 (408)
Q Consensus       226 ----~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~  259 (408)
                          ..+.-+.|.|+.+.||++++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11234789999999999975 46899999998863

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.55  E-value=0.068  Score=48.06  Aligned_cols=137  Identities=14%  Similarity=0.103  Sum_probs=80.2

Q ss_pred             EEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHH
Q 015389          137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG  215 (408)
Q Consensus       137 vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~  215 (408)
                      ..+|++......-...-+..+..+++++.  .|+++..=  ++ ++.++.|.|......          .    ..++.-
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~----------~----~N~i~a  149 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN----------F----SNFITA  149 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc----------h----hHHHHH
Confidence            44555543322212344567888888764  47777621  22 245888887442111          1    111111


Q ss_pred             HHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhH
Q 015389          216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV  295 (408)
Q Consensus       216 i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv  295 (408)
                      =+.+|.-.|+. ..+.+|||-.|+||+-|..|.+||.|=+..-.              .+..|.--|   ....+.++.+
T Consensus       150 gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~~aE~  211 (308)
T PF07387_consen  150 GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQEAEV  211 (308)
T ss_pred             hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccChHHHH
Confidence            14667788853 37899999999999999999999999875421              111122211   1223556667


Q ss_pred             HHHHHHHHHHHhCC
Q 015389          296 FAFGVLLLELVTGR  309 (408)
Q Consensus       296 wSlGvil~elltg~  309 (408)
                      -+|=.-++++....
T Consensus       212 ~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  212 KVFVKSCLKLVEKQ  225 (308)
T ss_pred             HHHHHHHHHHHHHH
Confidence            67766667776643

The function of this family is unknown.

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.07  E-value=0.19  Score=47.56  Aligned_cols=31  Identities=32%  Similarity=0.466  Sum_probs=25.6

Q ss_pred             CCeEeeCCCCCceEECCC--C---ceEEeecCCccc
Q 015389          229 RRIIHRDIKAANILLTED--F---EPQICDFGLAKW  259 (408)
Q Consensus       229 ~~iiH~Dikp~NIll~~~--~---~~kl~DfGla~~  259 (408)
                      .-++|||+++.|||+..+  |   .+++.||-+++.
T Consensus       215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence            558999999999999655  3   589999987763

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.77  E-value=0.098  Score=50.49  Aligned_cols=86  Identities=15%  Similarity=0.160  Sum_probs=59.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccc
Q 015389          203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE  282 (408)
Q Consensus       203 ~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE  282 (408)
                      ...+.+...|+.+-+..+.-+..  .-..-|||+.-.||||+ +|+|-|+||-+++.-..   ...    ......--|-
T Consensus       317 ~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~---q~~----isy~rldhp~  386 (488)
T COG5072         317 ADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS---QGI----ISYNRLDHPD  386 (488)
T ss_pred             cccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecccC---Cce----eeccccCchh
Confidence            45678888898888887777776  25688999999999999 89999999999983211   111    1112233444


Q ss_pred             cccCCCCCcchhHHHHH
Q 015389          283 FLMHGIVDEKTDVFAFG  299 (408)
Q Consensus       283 ~~~~~~~~~k~DvwSlG  299 (408)
                      .+. |.-+..-+||-+-
T Consensus       387 lF~-G~dd~QFeIYrlM  402 (488)
T COG5072         387 LFN-GVDDYQFEIYRLM  402 (488)
T ss_pred             hhc-CccceeeeHHHHH
Confidence            444 3336667777643

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.67  E-value=0.086  Score=51.61  Aligned_cols=62  Identities=16%  Similarity=0.147  Sum_probs=42.7

Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED  246 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~  246 (408)
                      ..++-+|..|-++..++..  ...++....+++.--++|+.-+--  -.+++|.|+.|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence            3456678888899888843  334455666666666666543332  1789999999999999533

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=94.58  E-value=0.0084  Score=59.67  Aligned_cols=72  Identities=22%  Similarity=0.417  Sum_probs=61.3

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~  176 (408)
                      +....++|.....+|.||||+|+.+..+ ++..+|||++.....+....+.++|..-+..+.|+++++++..+
T Consensus        44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~  116 (516)
T KOG1033|consen   44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAW  116 (516)
T ss_pred             hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheece
Confidence            4455688999999999999999999876 45689999998877777778888999999999999999988643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	408
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-58
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-57
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-37
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-19
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-19
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-19
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-19
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-19
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-19
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-19
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-19
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-19
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		7e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-19
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-19
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-18
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-18
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		7e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-18
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		9e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-17
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-17
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-17
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-17
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-17
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-14
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		8e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		7e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-05
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 129/314 (41%), Positives = 187/314 (59%), Gaps = 17/314 (5%)
Query: 83  PRNLFVNSYDSQSPQ------KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           P++ F +    + P+      K FSL ELQ A++NFS +N++G+GG+ +VYKGRL +G L
Sbjct: 5   PQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL 64
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLAS 195
           VA+KRL           F +E+ +++   H N  +L G+ +     + V     NGS+AS
Sbjct: 65  VAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 124
Query: 196 LLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
            L    E    L W  R +IALG A GL YLH+ C  +IIHRD+KAANILL E+FE  + 
Sbjct: 125 CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 184
Query: 253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL 312
           DFGLAK L +    H    V GT G++APE+L  G   EKTDVF +GV+LLEL+TG+RA 
Sbjct: 185 DFGLAK-LMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 243
Query: 313 DYSQQS------LVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIR 366
           D ++ +      L+ W + ++K  ++  LVD  L   Y   ++  ++  A LC Q S + 
Sbjct: 244 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPME 303
Query: 367 RPQMSQVVQLLRGN 380
           RP+MS+VV++L G+
Sbjct: 304 RPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  218 bits (555), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 124/293 (42%), Positives = 177/293 (60%), Gaps = 11/293 (3%)
Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           K FSL ELQ A++NF  +N++G+GG+ +VYKGRL +G LVA+KRL           F +E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK---LKWGIRYKIA 213
           + +++   H N  +L G+ +     + V     NGS+AS L    E    L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
           LG A GL YLH+ C  +IIHRD+KAANILL E+FE  + DFGLAK L +    H    V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAVR 196
Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS------LVLWARPMI 327
           G  G++APE+L  G   EKTDVF +GV+LLEL+TG+RA D ++ +      L+ W + ++
Sbjct: 197 GXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN 380
           K  ++  LVD  L   Y   ++  ++  A LC Q S + RP+MS+VV++L G+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 158/281 (56%), Gaps = 12/281 (4%)
Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIM 161
           L +L+ ATNNF  + LIG G + +VYKG LR+G  VA+KR T  ++ + I +F +E+  +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETL 89
Query: 162 AHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVA 217
           +   HP+   L+G+  E   M ++ +   NG+L   LYG       + W  R +I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH    R IIHRD+K+ NILL E+F P+I DFG++K   E    H    V+GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS----QQSLVLWARPMIKRNEIR 333
           Y+ PE+ + G + EK+DV++FGV+L E++  R A+  S      +L  WA       ++ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVV 374
           ++VD +LAD+     +      A  C+  SS  RP M  V+
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/281 (37%), Positives = 158/281 (56%), Gaps = 12/281 (4%)
Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIM 161
           L +L+ ATNNF  + LIG G + +VYKG LR+G  VA+KR T  ++ + I +F +E+  +
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETL 89
Query: 162 AHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVA 217
           +   HP+   L+G+  E   M ++ +   NG+L   LYG       + W  R +I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL YLH    R IIHRD+K+ NILL E+F P+I DFG++K   E    H    V+GT G
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS----QQSLVLWARPMIKRNEIR 333
           Y+ PE+ + G + EK+DV++FGV+L E++  R A+  S      +L  WA       ++ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVV 374
           ++VD +LAD+     +      A  C+  SS  RP M  V+
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (398), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 107/294 (36%), Positives = 160/294 (54%), Gaps = 21/294 (7%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW---AR 324
             S++ GT  Y+APE L  G +  K+D+++FGV+LLE++TG  A+D  ++  +L      
Sbjct: 191 MXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
              +   I + +D  + D  D+  +  +   AS C+ +   +RP + +V QLL+
Sbjct: 250 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 21/294 (7%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW---AR 324
              ++ GT  Y+APE L  G +  K+D+++FGV+LLE++TG  A+D  ++  +L      
Sbjct: 191 MXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
              +   I + +D  + D  D+  +  +   AS C+ +   +RP + +V QLL+
Sbjct: 250 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 106/294 (36%), Positives = 159/294 (54%), Gaps = 21/294 (7%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ +MA   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
           +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW---AR 324
              ++ GT  Y+APE L  G +  K+D+++FGV+LLE++TG  A+D  ++  +L      
Sbjct: 185 MXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 243
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
              +   I + +D  + D  D+  +  +   AS C+ +   +RP + +V QLL+
Sbjct: 244 IEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 105/293 (35%), Positives = 155/293 (52%), Gaps = 19/293 (6%)
Query: 100 FSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEI 150
           FS YEL++ TNNF         N  G+GG+  VYKG + N   VA+K+L      T +E+
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK--EKLKWG 207
              F  E+ + A   H N  +LLG+  +G  + +V    PNGSL   L  +     L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +     
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
             S++ GT  Y APE L  G +  K+D+++FGV+LLE++TG  A+D  ++  +L      
Sbjct: 182 XXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 240
Query: 328 KRNEIRELVD--ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
             +E + + D      ++ D+  +      AS C+ +   +RP + +V QLL+
Sbjct: 241 IEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 141/284 (49%), Gaps = 30/284 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DFGL+     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGN 189
Query: 276 FGYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           F ++APE +        EK D ++F ++L  ++TG    D      + +   MI+   +R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-MIREEGLR 248
Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                ++ ++   R  N++     LC      +RP  S +V+ L
Sbjct: 249 ----PTIPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 140/284 (49%), Gaps = 30/284 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DFG +     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGN 189
Query: 276 FGYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           F ++APE +        EK D ++F ++L  ++TG    D      + +   MI+   +R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-MIREEGLR 248
Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                ++ ++   R  N++     LC      +RP  S +V+ L
Sbjct: 249 ----PTIPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 140/284 (49%), Gaps = 30/284 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTAD------EIIADFLSELGI 160
           A N   +E  IGKGG+  V+KGRL ++  +VAIK L  G ++      E   +F  E+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           M++++HPN  KL G  +     +V+E  P G L   L      +KW ++ ++ L +A G+
Sbjct: 77  MSNLNHPNIVKLYGL-MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTE-DFEPQIC----DFGLAKWLPEQWTHHTISKVEGT 275
            Y+ +     I+HRD+++ NI L   D    +C    DF L+     Q + H++S + G 
Sbjct: 136 EYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGN 189
Query: 276 FGYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           F ++APE +        EK D ++F ++L  ++TG    D      + +   MI+   +R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-MIREEGLR 248
Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                ++ ++   R  N++     LC      +RP  S +V+ L
Sbjct: 249 ----PTIPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKEL 284

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 135/273 (49%), Gaps = 21/273 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNT 169
           + + +  IG G +  V++    +G  VA+K L  +    E + +FL E+ IM  + HPN 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 170 AKLLGYGIEG-GMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
               I+HR++K+ N+L+ + +  ++CDFGL++   +  T  +     GT  ++APE L  
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-IKRNEIRELVDASLADEYD 345
              +EK+DV++FGV+L EL T ++       + V+ A     KR EI   ++  +A   +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                        C      +RP  + ++ LLR
Sbjct: 274 G------------CWTNEPWKRPSFATIMDLLR 294

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 58
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 113
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ L E   +
Sbjct: 114 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEY 169
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
                 +    + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 170 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 134/273 (49%), Gaps = 21/273 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNT 169
           + + +  IG G +  V++    +G  VA+K L  +    E + +FL E+ IM  + HPN 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 170 AKLLGYGIEG-GMHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
               I+HRD+K+ N+L+ + +  ++CDFGL++     +     +   GT  ++APE L  
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMAPEVLRD 213
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-IKRNEIRELVDASLADEYD 345
              +EK+DV++FGV+L EL T ++       + V+ A     KR EI   ++  +A   +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                        C      +RP  + ++ LLR
Sbjct: 274 G------------CWTNEPWKRPSFATIMDLLR 294

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 59
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 114
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ L E   +
Sbjct: 115 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEY 170
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
                 +    + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 171 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 6   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 63
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 64  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 118
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ L E   +
Sbjct: 119 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEY 174
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
                 +    + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 175 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 101
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 158
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLMHGIVDE---KT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +     +    ++
Sbjct: 159 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 218 DVYAFGIVLYELMTGQ--LPYS 237

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 76
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 133
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +          ++
Sbjct: 134 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 193 DVYAFGIVLYELMTGQ--LPYS 212

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 135
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLMHGIVDE---KT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +     +    ++
Sbjct: 136 SNNIFLHEDNTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 195 DVYAFGIVLYELMTGQ--LPYS 214

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 110/204 (53%), Gaps = 15/204 (7%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 159
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLMHGIVDE----- 291
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +   + D+     
Sbjct: 160 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIR--MQDKNPYSF 216
Query: 292 KTDVFAFGVLLLELVTGRRALDYS 315
           ++DV+AFG++L EL+TG+  L YS
Sbjct: 217 QSDVYAFGIVLYELMTGQ--LPYS 238

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 136
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +          ++
Sbjct: 137 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 196 DVYAFGIVLYELMTGQ--LPYS 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +          ++
Sbjct: 132 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 191 DVYAFGIVLYELMTGQ--LPYS 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 136
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +          ++
Sbjct: 137 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 196 DVYAFGIVLYELMTGQ--LPYS 215

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 59
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 114
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ + +    
Sbjct: 115 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED---- 167
Query: 267 HTISKVEGT---FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           +  +  EG      + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 168 NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 23/227 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           +Q PQK +   E +           +G G + EV+ G       VA+K L +G+      
Sbjct: 4   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--D 61
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            FL+E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I
Sbjct: 62  AFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTI 116
Query: 213 ------ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                 A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ + +    
Sbjct: 117 NKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED---- 169
Query: 267 HTISKVEGT---FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           +  +  EG      + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 170 NEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
              + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L ED   +I DFGLA  +  +W+  H   ++ G+  ++APE +          ++
Sbjct: 132 SNNIFLHEDLTVKIGDFGLAT-VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 294 DVFAFGVLLLELVTGRRALDYS 315
           DV+AFG++L EL+TG+  L YS
Sbjct: 191 DVYAFGIVLYELMTGQ--LPYS 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 94
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 151
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVDEKTD 294
           + NI L ED   +I DFGLA         H   ++ G+  ++APE +          ++D
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 295 VFAFGVLLLELVTGRRALDYS 315
           V+AFG++L EL+TG+  L YS
Sbjct: 212 VYAFGIVLYELMTGQ--LPYS 230

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 159
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE-----K 292
           + NI L ED   +I DFGLA         H   ++ G+  ++APE +   + D+     +
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR--MQDKNPYSFQ 217
Query: 293 TDVFAFGVLLLELVTGRRALDYS 315
           +DV+AFG++L EL+TG+  L YS
Sbjct: 218 SDVYAFGIVLYELMTGQ--LPYS 238

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 9/201 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 90
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 147
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE---KTD 294
           + NI L ED   +I DFGLA         H   ++ G+  ++APE +     +    ++D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 295 VFAFGVLLLELVTGRRALDYS 315
           V+AFG++L EL+TG+  L YS
Sbjct: 208 VYAFGIVLYELMTGQ--LPYS 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 9/201 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+ ++ K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVDEKTD 294
           + NI L ED   +I DFGLA         H   ++ G+  ++APE +          ++D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 295 VFAFGVLLLELVTGRRALDYS 315
           V+AFG++L EL+TG+  L YS
Sbjct: 192 VYAFGIVLYELMTGQ--LPYS 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 19/209 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI---IADFLSELGIMAHVDHPN 168
            + E +IG GG+ +VY+     G  VA+K       ++I   I +   E  + A + HPN
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L G  + E  + +V+E +  G L  +L G  +++   I    A+ +A G+ YLH+  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 228 QRRIIHRDIKAANILLTEDFEP--------QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
              IIHRD+K++NIL+ +  E         +I DFGLA+    +W   T     G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWM 181
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           APE +   +  + +DV+++GVLL EL+TG
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V +  +T  T  ++ A F +E+G++    H N    +GY  
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFMGYST 90
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
              + IV +     SL   L+  + K +      IA   A G+ YLH    + IIHRD+K
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLK 147
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE---KTD 294
           + NI L ED   +I DFGLA         H   ++ G+  ++APE +     +    ++D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 295 VFAFGVLLLELVTGRRALDYS 315
           V+AFG++L EL+TG+  L YS
Sbjct: 208 VYAFGIVLYELMTGQ--LPYS 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 138/273 (50%), Gaps = 37/273 (13%)
Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           E ++G+G +  V K + R  + VAIK++   +  +    F+ EL  ++ V+HPN  KL G
Sbjct: 14  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 69
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQRRII 232
             +   + +V+E +  GSL ++L+G +    +   + ++  L  ++G+ YLH    + +I
Sbjct: 70  ACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 233 HRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           HRD+K  N+LL       +ICDFG A    +  TH T +K  G+  ++APE        E
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK--GSAAWMAPEVFEGSNYSE 183
Query: 292 KTDVFAFGVLLLELVTGRRALDY--SQQSLVLWA-----RPMIKRNEIRELVDASLADEY 344
           K DVF++G++L E++T R+  D        ++WA     RP + +N  + +      +  
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI------ESL 237
Query: 345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
            TR           C  +   +RP M ++V+++
Sbjct: 238 MTR-----------CWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 136/268 (50%), Gaps = 27/268 (10%)
Query: 115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           E ++G+G +  V K + R  + VAIK++   +  +    F+ EL  ++ V+HPN  KL G
Sbjct: 13  EEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYG 68
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--LGVAEGLLYLHEGCQRRII 232
             +   + +V+E +  GSL ++L+G +    +   + ++  L  ++G+ YLH    + +I
Sbjct: 69  ACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 233 HRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           HRD+K  N+LL       +ICDFG A    +  TH T +K  G+  ++APE        E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNNK--GSAAWMAPEVFEGSNYSE 182
Query: 292 KTDVFAFGVLLLELVTGRRALDY--SQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM 349
           K DVF++G++L E++T R+  D        ++WA      N  R  +  +L    ++   
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA----VHNGTRPPLIKNLPKPIESLM- 237
Query: 350 NLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                  + C  +   +RP M ++V+++
Sbjct: 238 -------TRCWSKDPSQRPSMEEIVKIM 258

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFL 155
           PQK +   E +           +G G + EV+ G       VA+K L +G+       FL
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFL 65
Query: 156 SELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--- 212
           +E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I   
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKL 120
Query: 213 ---ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ + +    +  
Sbjct: 121 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEX 173
Query: 270 SKVEGT---FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           +  EG      + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 174 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFL 155
           PQK +   E +           +G G + EV+ G       VA+K L +G+       FL
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFL 58
Query: 156 SELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--- 212
           +E  +M  + H    +L     +  ++I+ E   NGSL   L     K   GI+  I   
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKL 113
Query: 213 ---ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  +AEG+ ++ E   R  IHRD++AANIL+++    +I DFGLA+ + +    +  
Sbjct: 114 LDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED----NEX 166
Query: 270 SKVEGT---FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           +  EG      + APE + +G    K+DV++FG+LL E+VT  R
Sbjct: 167 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 82  LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 138
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           +HRD+ A N+L+      +I DFGLA+ L      +     +    ++A E + +     
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 198
Query: 292 KTDVFAFGVLLLELVT 307
           ++DV+++GV + EL+T
Sbjct: 199 QSDVWSYGVTIWELMT 214

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 105/196 (53%), Gaps = 8/196 (4%)
Query: 117 LIGKGGYAEVYKG-RLRNGQLV----AIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  +  G+ V    AIK L   T  +   +F+ E  IMA +DHP+  +
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           LLG  +   + +V +L P+G L   ++  K+ +   +     + +A+G++YL E   RR+
Sbjct: 105 LLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRL 161
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           +HRD+ A N+L+      +I DFGLA+ L      +     +    ++A E + +     
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 221
Query: 292 KTDVFAFGVLLLELVT 307
           ++DV+++GV + EL+T
Sbjct: 222 QSDVWSYGVTIWELMT 237

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 28/303 (9%)
Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQ---LVAIKR 141
           +F++ +  + P +    +  +   +    E +IG G + EV  G L+  G+    VAIK 
Sbjct: 9   IFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 68
Query: 142 LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM 200
           L  G  ++   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL S L   
Sbjct: 69  LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 128
Query: 201 KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
             +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL+++L
Sbjct: 129 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 261 PEQWTHHTISKVEG---TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYS 315
            +  +  T +   G      + APE + +      +DV+++G+++ E+++ G R   D +
Sbjct: 186 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 245
Query: 316 QQSLVLWARPMIKRNEIRELVDASLADEYD-TRQMNLVLLAASLCIQQSSIRRPQMSQVV 374
            Q ++         N I +  D  L    D    ++ ++L    C Q+    RP+  Q+V
Sbjct: 246 NQDVI---------NAIEQ--DYRLPPPMDCPSALHQLMLD---CWQKDRNHRPKFGQIV 291
Query: 375 QLL 377
             L
Sbjct: 292 NTL 294

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRD++AANIL+++    +I DFGLA+ L E   +      +    + APE + +G    
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 292 KTDVFAFGVLLLELVTGRR 310
           K+DV++FG+LL E+VT  R
Sbjct: 190 KSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 74  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 125
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHRD++AANIL+++    +I DFGLA+ + + ++T    +K      + APE + +G   
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFT 183
Query: 291 EKTDVFAFGVLLLELVTGRR 310
            K+DV++FG+LL E+VT  R
Sbjct: 184 IKSDVWSFGILLTEIVTHGR 203

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +AEG+ YL 
Sbjct: 72  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 132 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 189 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 136 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 139 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 76  DNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 136 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 193 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 80  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGYLAPEFLMHGI 288
           IHRD++AANIL+++    +I DFGLA+ + +    +  +  EG      + APE + +G 
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINYGT 187
Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              K+DV++FG+LL E+VT  R
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGR 209

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGYLAPEFLMHGI 288
           IHRD++AANIL+++    +I DFGLA+ + +    +  +  EG      + APE + +G 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINYGT 186
Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              K+DV++FG+LL E+VT  R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 118/234 (50%), Gaps = 23/234 (9%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL- 136
           G+D+   NL+  S D    ++            + + ++ +G G Y EVY G  +   L 
Sbjct: 11  GVDLGTENLYFQSMDKWEMER-----------TDITMKHKLGGGQYGEVYVGVWKKYSLT 59
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L   T +  + +FL E  +M  + HPN  +LLG   +E   +IV E  P G+L  
Sbjct: 60  VAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLD 117
Query: 196 LLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
            L    +E++   +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DF
Sbjct: 118 YLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADF 174
Query: 255 GLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           GL++ +  + +T H  +K      + APE L +     K+DV+AFGVLL E+ T
Sbjct: 175 GLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 23/202 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGYLAPEFLMHGI 288
           IHRD++AANIL+++    +I DFGLA+ + +    +  +  EG      + APE + +G 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED----NEXTAREGAKFPIKWTAPEAINYGT 186
Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              K+DV++FG+LL E+VT  R
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 85  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 145 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 202 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 69  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 81  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 141 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 198 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 100 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 160 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 217 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 19/200 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 75  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 126
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHR+++AANIL+++    +I DFGLA+ + + ++T    +K      + APE + +G   
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINYGTFT 184
Query: 291 EKTDVFAFGVLLLELVTGRR 310
            K+DV++FG+LL E+VT  R
Sbjct: 185 IKSDVWSFGILLTEIVTHGR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 78  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 138 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 195 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 26/232 (11%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF 154
           P +IF   +L           ++GKG + +  K   R  G+++ +K L R   +E    F
Sbjct: 3   PHRIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIR-FDEETQRTF 54
Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L E+ +M  ++HPN  K +G   +   ++ + E    G+L  ++  M  +  W  R   A
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH----HTI 269
             +A G+ YLH      IIHRD+ + N L+ E+    + DFGLA+ + ++ T      ++
Sbjct: 115 KDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 270 SK--------VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            K        V G   ++APE +     DEK DVF+FG++L E++ GR   D
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           S  PQK +     +    +   E  +G G + EV+         VA+K +  G+    + 
Sbjct: 165 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VE 222
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIR 209
            FL+E  +M  + H    KL     +  ++I+ E    GSL   L    G K+ L   I 
Sbjct: 223 AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 282
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW---LPEQWTH 266
           +  +  +AEG+ ++    QR  IHRD++AANIL++     +I DFGLA+     P +WT 
Sbjct: 283 F--SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT- 336
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
                        APE +  G    K+DV++FG+LL+E+VT  R
Sbjct: 337 -------------APEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G   EV+ G       VA+K L +G+       FL+E  +M  + H    +L     
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI------ALGVAEGLLYLHEGCQRRI 231
           +  ++I+ E   NGSL   L     K   GI+  I      A  +AEG+ ++ E   R  
Sbjct: 79  QEPIYIITEYMENGSLVDFL-----KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRD++AANIL+++    +I DFGLA+ L E          +    + APE + +G    
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 292 KTDVFAFGVLLLELVTGRR 310
           K+DV++FG+LL E+VT  R
Sbjct: 190 KSDVWSFGILLTEIVTHGR 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 13/222 (5%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIA 152
           S  PQK +     +    +   E  +G G + EV+         VA+K +  G+    + 
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VE 228
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIR 209
            FL+E  +M  + H    KL     +  ++I+ E    GSL   L    G K+ L   I 
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 288
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHT 268
           +  +  +AEG+ ++    QR  IHRD++AANIL++     +I DFGLA+ + + ++T   
Sbjct: 289 F--SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
            +K      + APE +  G    K+DV++FG+LL+E+VT  R
Sbjct: 344 GAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 5/189 (2%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 177 IEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +L+     ++    A G+ YL   C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           + A N L+TE    +I DFG+++   +     +    +    + APE L +G    ++DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 296 FAFGVLLLE 304
           ++FG+LL E
Sbjct: 299 WSFGILLWE 307

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 79  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 139 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 196 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++++L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGI----- 288
           KA NIL T D + ++ DFG++          TI + +   GT  ++APE +M        
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 289 VDEKTDVFAFGVLLLEL 305
            D K DV++ G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 5/189 (2%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN  +L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 177 IEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            +   ++IV+EL   G   + L     +L+     ++    A G+ YL   C    IHRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238
Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           + A N L+TE    +I DFG+++   +     +    +    + APE L +G    ++DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 296 FAFGVLLLE 304
           ++FG+LL E
Sbjct: 299 WSFGILLWE 307

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGLA+ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 141/301 (46%), Gaps = 28/301 (9%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQ---LVAIKRL 142
           FV+ +  + P +    +  +   +    E +IG G + EV  GRL+  G+    VAIK L
Sbjct: 6   FVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL 65
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMK 201
             G  D+   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL + L    
Sbjct: 66  KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKND 125
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL- 260
            +        +  G+  G+ YL +      +HRD+ A NIL+  +   ++ DFG+++ L 
Sbjct: 126 GRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLE 182
Query: 261 --PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQ 316
             PE    +T    +    + APE + +      +DV+++G+++ E+++ G R   D S 
Sbjct: 183 DDPE--AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 240
Query: 317 QSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
           Q ++   + + +   +   +D  +A       ++ ++L    C Q+    RP+  Q+V +
Sbjct: 241 QDVI---KAIEEGYRLPPPMDCPIA-------LHQLMLD---CWQKERSDRPKFGQIVNM 287
Query: 377 L 377
           L
Sbjct: 288 L 288

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 26/302 (8%)
Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQL---VAIK 140
             +   +  + P +    +  +   +    E +IG G   EV  GRLR  GQ    VAIK
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYG 199
            L  G  +    DFLSE  IM   DHPN  +L G    G +  IV E   NGSL + L  
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ 
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ 316
           L   P+     T  K+     + APE +        +DV++FGV++ E+      L Y +
Sbjct: 201 LEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEV------LAYGE 252
Query: 317 QSLV-LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +    +  R +I   E    + A +   +   Q+ L       C  +   +RP+ SQ+V 
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD------CWHKDRAQRPRFSQIVS 306
Query: 376 LL 377
           +L
Sbjct: 307 VL 308

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAI  L   T+ +   + L E  +MA V
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 109 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 169 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 116/223 (52%), Gaps = 15/223 (6%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
            S D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 1   TSMDPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I++E    G+L   L    ++++ 
Sbjct: 57  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           T H  +K      + APE L +     K+DV+AFGVLL E+ T
Sbjct: 172 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 109/198 (55%), Gaps = 19/198 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  DHP   KLLG Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       +   + E L +LH    +RIIHRD+
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143
Query: 237 KAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGIV--- 289
           KA N+L+T + + ++ DFG+ AK L       T+ K +   GT  ++APE +M   +   
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNL------KTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 290 --DEKTDVFAFGVLLLEL 305
             D K D+++ G+ L+E+
Sbjct: 198 PYDYKADIWSLGITLIEM 215

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 13/229 (5%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL- 260
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 261 --PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 199 DDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 2   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 77  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 137 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 194 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 26/302 (8%)
Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQL---VAIK 140
             +   +  + P +    +  +   +    E +IG G   EV  GRLR  GQ    VAIK
Sbjct: 24  QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYG 199
            L  G  +    DFLSE  IM   DHPN  +L G    G +  IV E   NGSL + L  
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ 
Sbjct: 144 HDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ 316
           L   P+     T  K+     + APE +        +DV++FGV++ E+      L Y +
Sbjct: 201 LEDDPDAAYTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEV------LAYGE 252
Query: 317 QSLV-LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +    +  R +I   E    + A +   +   Q+ L       C  +   +RP+ SQ+V 
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD------CWHKDRAQRPRFSQIVS 306
Query: 376 LL 377
           +L
Sbjct: 307 VL 308

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 7   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 65  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 125 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 180
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++  G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E +
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 13/229 (5%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD 141
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL- 260
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 261 --PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 199 DDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 8   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 66  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 126 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 181
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 109/198 (55%), Gaps = 19/198 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YG 176
           +G G + +VYK + +    +A  ++    ++E + D++ E+ I+A  DHP   KLLG Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +G + I++E  P G++ +++  +   L       +   + E L +LH    +RIIHRD+
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 135
Query: 237 KAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGIV--- 289
           KA N+L+T + + ++ DFG+ AK L       T+ K +   GT  ++APE +M   +   
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNL------KTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 290 --DEKTDVFAFGVLLLEL 305
             D K D+++ G+ L+E+
Sbjct: 190 PYDYKADIWSLGITLIEM 207

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 73
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      ++  +A G+ Y+    + 
Sbjct: 74  QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RM 130
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + +WT    +K      + APE  ++G 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF--PIKWTAPEAALYGR 188
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRV 211

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG  +  G+     VAIK L   T+ +   + L E  +MA V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 82  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +   RR++HRD+ A N+L+      +I DFG AK L  +   +     +    ++A E +
Sbjct: 142 D---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 285 MHGIVDEKTDVFAFGVLLLELVT-GRRALD 313
           +H I   ++DV+++GV + EL+T G +  D
Sbjct: 199 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 8/193 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + +V++G   + +     VAIK     T+D +   FL E   M   DHP+  KL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G   E  + I++EL   G L S L   K  L        A  ++  L YL     +R +H
Sbjct: 106 GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVH 162
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDI A N+L++ +   ++ DFGL++++ E  T++  SK +    ++APE +        +
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSAS 221
Query: 294 DVFAFGVLLLELV 306
           DV+ FGV + E++
Sbjct: 222 DVWMFGVCMWEIL 234

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV+E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IG G +  VYKG+      V I ++   T ++  A F +E+ ++    H N    +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQA-FRNEVAVLRKTRHVNILLFMGYMT 102
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
           +  + IV +     SL   L+  + K +      IA   A+G+ YLH    + IIHRD+K
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMK 159
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWT-HHTISKVEGTFGYLAPEFLM---HGIVDEKT 293
           + NI L E    +I DFGLA  +  +W+    + +  G+  ++APE +    +     ++
Sbjct: 160 SNNIFLHEGLTVKIGDFGLAT-VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 294 DVFAFGVLLLELVTGRRALDYSQ 316
           DV+++G++L EL+TG   L YS 
Sbjct: 219 DVYSYGIVLYELMTGE--LPYSH 239

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   + +     VAIK     T+D +   FL E 
Sbjct: 10  YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 68  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T++  SK +    +
Sbjct: 128 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 183
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 26/291 (8%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
            S D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 1   TSMDPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++ 
Sbjct: 57  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 114
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 115 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR 324
           T H  +K      + APE L +     K+DV+AFGVLL E+ T      Y          
Sbjct: 172 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY----- 218
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           P I  +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 219 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKIRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL + 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 62
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 177
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 64
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 123
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 179
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFS 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G+  E   DF+ E  +M  + HP  
Sbjct: 27  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE--DDFIEEAEVMMKLSHPKL 84
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 85  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 143
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 199
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 200 RYSSKSDVWSFGVLMWEVFS 219

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 67
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 68  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 124
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 125 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 182
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 183 FTIKSDVWSFGILLTELTTKGRV 205

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 127/285 (44%), Gaps = 35/285 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK----VEG 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S     + G
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSCHAPSSRRTTLSG 169
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQ 372
                R+L+   L      R M   +L        SS  +P  SQ
Sbjct: 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS--KPSNSQ 272

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 17/197 (8%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGI----- 288
           KA NIL T D + ++ DFG++           I + +   GT  ++APE +M        
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-----KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 289 VDEKTDVFAFGVLLLEL 305
            D K DV++ G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 99/193 (51%), Gaps = 8/193 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + +V++G   + +     VAIK     T+D +   FL E   M   DHP+  KL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G   E  + I++EL   G L S L   K  L        A  ++  L YL     +R +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 514
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDI A N+L++ +   ++ DFGL++++ E  T++  SK +    ++APE +        +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 294 DVFAFGVLLLELV 306
           DV+ FGV + E++
Sbjct: 574 DVWMFGVCMWEIL 586

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 65
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 66  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 122
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 123 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 180
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 181 FTIKSDVWSFGILLTELTTKGRV 203

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 103/197 (52%), Gaps = 17/197 (8%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYG 176
           +G G + +VYK + +   ++A  ++    ++E + D++ E+ I+A  DHPN  KLL  + 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            E  + I++E    G++ +++  ++  L       +     + L YLH+    +IIHRD+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE---GTFGYLAPEFLMHGI----- 288
           KA NIL T D + ++ DFG++           I + +   GT  ++APE +M        
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA-----KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 289 VDEKTDVFAFGVLLLEL 305
            D K DV++ G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G +    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK----VEG 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S     + G
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLXG 173
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 233
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 234 VTEGARDLISRLLKHNPSQRPM 255

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 10  SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 67
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 68  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 126
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 182
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 183 RYSSKSDVWSFGVLMWEVFS 202

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 20  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 79
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 80  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 137
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 138 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 194
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 195 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I++E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 134/301 (44%), Gaps = 28/301 (9%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +++    + P +    +  +   +    E +IG G + EV  GRL+        VAIK L
Sbjct: 20  YIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL 79
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN   L G    G  + IV+E   NG+L + L    
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHD 139
Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL- 260
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ + 
Sbjct: 140 GQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE 196
Query: 261 --PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQ 316
             PE     T  K+     + APE + +      +DV+++G+++ E+++ G R   D S 
Sbjct: 197 DDPEAVYTTTGGKI--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 254
Query: 317 QSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
           Q +       IK  E    + A +       Q+ L       C Q+    RP+  Q+V +
Sbjct: 255 QDV-------IKAIEEGYRLPAPMDCPAGLHQLMLD------CWQKERAERPKFEQIVGI 301
Query: 377 L 377
           L
Sbjct: 302 L 302

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I++E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++     ++ DFGL++++ E  T++  SK +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 178
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 26/288 (9%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHH 267
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
             +K      + APE L +     K+DV+AFGVLL E+ T      Y          P I
Sbjct: 175 AGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGI 221
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 65
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E C 
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 124
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 180
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 26/288 (9%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHH 267
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 174
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
             +K      + APE L +     K+DV+AFGVLL E+ T      Y          P I
Sbjct: 175 AGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGI 221
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G G + EV+         VA+K +  G+    +  FL+E  +M  + H    
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLV 73
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           KL     +  ++I+ E    GSL   L    G K+ L   I +  +  +AEG+ ++    
Sbjct: 74  KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIE--- 128
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMH 286
           QR  IHRD++AANIL++     +I DFGLA+ + + ++T    +K      + APE +  
Sbjct: 129 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINF 186
Query: 287 GIVDEKTDVFAFGVLLLELVTGRR 310
           G    K+DV++FG+LL+E+VT  R
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 7/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV+E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
             +HRD++AANIL+ E+   ++ DFGLA+ L E          +    + APE  ++G  
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRF 192
Query: 290 DEKTDVFAFGVLLLELVTGRRA 311
             K+DV++FG+LL EL T  R 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRV 214

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +V+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  YVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81
Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L   K
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RK 139
Query: 202 EKLKWGIRYKIAL--GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
              ++ +   + +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 260 L---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           L   PE    +T    +    + +PE + +      +DV+++G++L E+++
Sbjct: 197 LEDDPE--AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 134/287 (46%), Gaps = 24/287 (8%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEII 151
           +  P   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  +
Sbjct: 2   AMDPSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--V 57
Query: 152 ADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIR 209
            +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   + 
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHT 268
             +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H 
Sbjct: 118 LYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK 328
            +K      + APE L +     K+DV+AFGVLL E+ T      Y          P I 
Sbjct: 175 GAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGID 221
Query: 329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
            +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 194
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 254
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 255 VTEGARDLISRLLKHNPSQRPM 276

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV+E    G L   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    +L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    +   +HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 364
Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL EL T  R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    +L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    +   +HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 364
Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL EL T  R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 132/307 (42%), Gaps = 25/307 (8%)
Query: 80  IDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQ---- 135
           I    NL+        P +    +  +   +  + + +IG G + EVYKG L+       
Sbjct: 14  IPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 136 -LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSL 193
             VAIK L  G  ++   DFL E GIM    H N  +L G       M I+ E   NG+L
Sbjct: 74  VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD 253
              L     +        +  G+A G+ YL        +HRD+ A NIL+  +   ++ D
Sbjct: 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSD 190
Query: 254 FGLAKWL---PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           FGL++ L   PE    +T S  +    + APE + +      +DV++FG+++ E++T   
Sbjct: 191 FGLSRVLEDDPE--ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT--- 245
Query: 311 ALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQM 370
              Y ++    W    +  +E+ + ++            + +      C QQ   RRP+ 
Sbjct: 246 ---YGERP--YWE---LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 297
Query: 371 SQVVQLL 377
           + +V +L
Sbjct: 298 ADIVSIL 304

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 146 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDDLCG 194
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 254
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 255 VTEGARDLISRLLKHNPSQRPM 276

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G +    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 233
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 234 VTEGARDLISRLLKHNPSQRPM 255

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 26/291 (8%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTA 147
           N Y   SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T 
Sbjct: 9   NLYFQGSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 64
Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLK 205
           +  + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++ 
Sbjct: 65  E--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVN 122
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQW 264
             +   +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +
Sbjct: 123 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 179
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR 324
           T H  +K      + APE L +     K+DV+AFGVLL E+ T      Y          
Sbjct: 180 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY----- 226
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           P I  +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 227 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 277

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMT 251

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 69
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 70  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 126
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 127 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 184
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 185 FTIKSDVWSFGILLTELTTKGRV 207

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 128/280 (45%), Gaps = 38/280 (13%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV +GRL+        VAIK L  G  +    +FLSE  IM   +HPN 
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 170 AKLLGYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLY 222
            +L G  +   M +++  E   NG+L S L     +L  G    I L     G+A G+ Y
Sbjct: 78  IRLEGV-VTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRY 131
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           L E      +HRD+ A NIL+  +   ++ DFGL+++L E  +  T +   G      + 
Sbjct: 132 LAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT-GRRA-LDYSQQSLVLWARPMIKRNEIRELVD 337
           APE +        +D +++G+++ E+++ G R   D S Q ++         N I +   
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI---------NAIEQDYR 239
Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                +  T    L+L     C Q+    RP+  QVV  L
Sbjct: 240 LPPPPDCPTSLHQLML----DCWQKDRNARPRFPQVVSAL 275

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 136
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 137 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 185
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 245
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 246 VTEGARDLISRLLKHNPSQRPM 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 22/279 (7%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELG 159
           SL + +    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAA 59
Query: 160 IMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVA 217
           +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTF 276
             + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K     
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PI 174
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
            + APE L +     K+DV+AFGVLL E+ T      Y          P I  +++ EL+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDPSQVYELL 223
Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +     E        V      C Q +   RP  +++ Q
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           IG+G + +V++G   + +     VAIK     T+D +   FL E   M   DHP+  KL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G   E  + I++EL   G L S L   K  L        A  ++  L YL     +R +H
Sbjct: 458 GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVH 514
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDI A N+L++     ++ DFGL++++ E  T++  SK +    ++APE +        +
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 294 DVFAFGVLLLELV 306
           DV+ FGV + E++
Sbjct: 574 DVWMFGVCMWEIL 586

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMT 227

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
           +     K+DV+AFGVLL E+ T
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 22/279 (7%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELG 159
           SL + +    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAA 59
Query: 160 IMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVA 217
           +M  + HPN  +LLG    E   +I++E    G+L   L    ++++   +   +A  ++
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTF 276
             + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  +  T H  +K     
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PI 174
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
            + APE L +     K+DV+AFGVLL E+ T      Y          P I  +++ EL+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDPSQVYELL 223
Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +     E        V      C Q +   RP  +++ Q
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 133/284 (46%), Gaps = 24/284 (8%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADF 154
           P   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +F
Sbjct: 2   PSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEF 57
Query: 155 LSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKI 212
           L E  +M  + HPN  +LLG    E   +I++E    G+L   L    ++++   +   +
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISK 271
           A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  +  T H  +K
Sbjct: 118 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 174
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE 331
                 + APE L +     K+DV+AFGVLL E+ T      Y          P I  ++
Sbjct: 175 F--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQ 221
Query: 332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           + EL++     E        V      C Q +   RP  +++ Q
Sbjct: 222 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 265

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 236
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 236
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 28/275 (10%)
Query: 114 FENLIGKGGYAEVYKGRLR-NGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV  G L+  G+    VAIK L  G  ++   DFLSE  IM   DHPN 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L G   +   + I+ E   NGSL S L     +        +  G+A G+ YL +   
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD--- 127
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYLAPEFLM 285
              +HR + A NIL+  +   ++ DFGL+++L +  +  T +   G      + APE + 
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 286 HGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           +      +DV+++G+++ E+++ G R   D + Q ++         N I +  D  L   
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI---------NAIEQ--DYRLPPP 236
Query: 344 YD-TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
            D    ++ ++L    C Q+    RP+  Q+V  L
Sbjct: 237 MDCPSALHQLMLD---CWQKDRNHRPKFGQIVNTL 268

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 170
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 230
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 231 VTEGARDLISRLLKHNPSQRPM 252

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    +L     
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    +   +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 447
Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL EL T  R
Sbjct: 448 WSFGILLTELTTKGR 462

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLM 285
            ++  IHRD+ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
           +     K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERP 234
Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                 V      C Q +   RP  +++ Q
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD+ AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              K+DV++FG+LL EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 10/208 (4%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 5   YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 63  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ E  T    SK +    +
Sbjct: 123 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKW 178
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +APE +        +DV+ FGV + E++
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 120/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS----KVEG 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S    ++ G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTELCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDTLCG 169
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 230 VTEGARDLISRLLKHNPSQRPM 251

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 169
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 230 VTEGARDLISRLLKHNPSQRPM 251

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E ++ H  +  +    ++A E L 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMT 229

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 233
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 234 VTEGARDLISRLLKHNPSQRPM 255

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    +L     
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 178 EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+    +   +HRD+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G    K+DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 364
Query: 296 FAFGVLLLELVTGRR 310
           ++FG+LL EL T  R
Sbjct: 365 WSFGILLTELTTKGR 379

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 26/218 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++   E +   T+
Sbjct: 135 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM 190
Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++     ++A E L + +    +DV+++GVLL E+V+
Sbjct: 191 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/239 (31%), Positives = 116/239 (48%), Gaps = 29/239 (12%)
Query: 90  SYDSQSPQKIFS---LYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TR 144
           S  S SP +      L  L+     F    L+G G Y +VYKGR ++ GQL AIK +   
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLL 197
           G  +E I   ++ L   +H  H N A   G        G++  + +V+E    GS+  L+
Sbjct: 61  GDEEEEIKQEINMLKKYSH--HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 198 YGMKE---KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
              K    K +W I Y I   +  GL +LH   Q ++IHRDIK  N+LLTE+ E ++ DF
Sbjct: 119 KNTKGNTLKEEW-IAY-ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTG 308
           G++  L    T    +   GT  ++APE +          D K+D+++ G+  +E+  G
Sbjct: 174 GVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 26/218 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++   E +   T+
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM 200
Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++     ++A E L + +    +DV+++GVLL E+V+
Sbjct: 201 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 173
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 233
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 234 VTEGARDLISRLLKHNPSQRPM 255

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 76
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    G L   L G M + L+      +A  +A G+ Y+    + 
Sbjct: 77  QLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RM 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 134 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 191
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 192 FTIKSDVWSFGILLTELTTKGRV 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 119/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +N + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +++IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 128/280 (45%), Gaps = 38/280 (13%)
Query: 114 FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV +GRL+        VAIK L  G  +    +FLSE  IM   +HPN 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 170 AKLLGYGIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIAL-----GVAEGLLY 222
            +L G  +   M +++  E   NG+L S L     +L  G    I L     G+A G+ Y
Sbjct: 80  IRLEGV-VTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRY 133
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           L E      +HRD+ A NIL+  +   ++ DFGL+++L E  +  T +   G      + 
Sbjct: 134 LAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVD 337
           APE +        +D +++G+++ E+++ G R   D S Q ++         N I +   
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI---------NAIEQDYR 241
Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                +  T    L+L     C Q+    RP+  QVV  L
Sbjct: 242 LPPPPDCPTSLHQLML----DCWQKDRNARPRFPQVVSAL 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTDLCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 139/295 (47%), Gaps = 21/295 (7%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLT--RGTADEIIA 152
           PQK        +   NF  E  IG+G ++EVY+   L +G  VA+K++        +  A
Sbjct: 18  PQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA 77
Query: 153 DFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK---LKWGI 208
           D + E+ ++  ++HPN  K     IE   ++IVLEL+  G L+ ++   K++   +    
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
            +K  + +   L ++H    RR++HRDIK AN+ +T     ++ D GL ++   + T   
Sbjct: 138 VWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--A 192
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK 328
              + GT  Y++PE +     + K+D+++ G LL E+   +      + +L    +  I+
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIE 251
Query: 329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC 383
           + +   L     +D Y      LV    ++CI     +RP ++ V  + +    C
Sbjct: 252 QCDYPPLP----SDHYSEELRQLV----NMCINPDPEKRPDVTYVYDVAKRMHAC 298

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 26/288 (9%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +   L VA+K L   T +  
Sbjct: 4   DPSSPN--YDKWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 57
Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGI 208
           + +FL E  +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHH 267
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  +  T H
Sbjct: 118 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 174
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
             +K      + APE L +     K+DV+AFGVLL E+ T      Y          P I
Sbjct: 175 AGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGI 221
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             +++ EL++     E        V      C Q +   RP  +++ Q
Sbjct: 222 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 33/205 (16%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 132
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFGYLAPEFLM 285
           D+ A N+L++ED   ++ DFGL K          LP +WT              APE L 
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEALR 178
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRR 310
                 K+DV++FG+LL E+ +  R
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 118
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 119 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 167
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 227
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 228 VTEGARDLISRLLKHNPSQRPM 249

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 136
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +     F + APE L      
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 196
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 197 HASDTWMFGVTLWEMFT 213

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMT 231

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRAALCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTXLCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 9/203 (4%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 73
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  ++IV E    GSL   L G   K L+      ++  +A G+ Y+    + 
Sbjct: 74  QLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RM 130
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGI 288
             +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G 
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGR 188
Query: 289 VDEKTDVFAFGVLLLELVTGRRA 311
              K+DV++FG+LL EL T  R 
Sbjct: 189 FTIKSDVWSFGILLTELTTKGRV 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRXXLCG 168
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 228
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 229 VTEGARDLISRLLKHNPSQRPM 250

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 33/205 (16%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 313
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFGYLAPEFLM 285
           D+ A N+L++ED   ++ DFGL K          LP +WT              APE L 
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEALR 359
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRR 310
                 K+DV++FG+LL E+ +  R
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 71
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            ++  IHRD+ A N L+ E+   ++ DFGL++ +    T+   +  +    + APE L +
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAY 187
Query: 287 GIVDEKTDVFAFGVLLLELVT 307
                K+DV+AFGVLL E+ T
Sbjct: 188 NKFSIKSDVWAFGVLLWEIAT 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRDDLCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +     F + APE L      
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 193 HASDTWMFGVTLWEMFT 209

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 172
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 232
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 233 VTEGARDLISRLLKHNPSQRPM 254

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 125/269 (46%), Gaps = 20/269 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 72
Query: 169 TAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            ++  IHRD+ A N L+ E+   ++ DFGL++ +    T+   +  +    + APE L +
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIKWTAPESLAY 188
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
                K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E   
Sbjct: 189 NKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERPE 237
Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                V      C Q +   RP  +++ Q
Sbjct: 238 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 266

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 80  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 136
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +     F + APE L      
Sbjct: 137 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 196
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 197 HASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +     F + APE L      
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 193 HASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H+ + +     F + APE L      
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 202
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 203 HASDTWMFGVTLWEMFT 219

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
            N S + ++G G + EV  GRL+        VAIK L  G  ++   DFL E  IM   D
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLY 222
           HPN  +L G   +   + IV E   NGSL S L   K   ++ +   + +  G+A G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYL 279
           L +      +HRD+ A NIL+  +   ++ DFGL++ L   PE    +T    +    + 
Sbjct: 134 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWT 188
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +PE + +      +DV+++G++L E+++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
            N S + ++G G + EV  GRL+        VAIK L  G  ++   DFL E  IM   D
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLY 222
           HPN  +L G   +   + IV E   NGSL S L   K   ++ +   + +  G+A G+ Y
Sbjct: 76  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYL 279
           L +      +HRD+ A NIL+  +   ++ DFGL++ L   PE    +T    +    + 
Sbjct: 134 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWT 188
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +PE + +      +DV+++G++L E+++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 65
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 125
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHR++   NIL+  +   +I DFGL K LP+   ++ + +  E   
Sbjct: 126 KGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI 182
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 183 FWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 63
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 123
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 124 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 180
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 181 FWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I +FG        W+ H  S       G
Sbjct: 122 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG--------WSVHAPSSRRTTLCG 170
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 230
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 231 VTEGARDLISRLLKHNPSQRPM 252

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G+G + EV+ G       VAIK L  G        FL E  +M  + H    +L     
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP--EAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 178 EGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L G M + L+      +A  +A G+ Y+    +   +HRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 307
Query: 237 KAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           +AANIL+ E+   ++ DFGL + + + ++T    +K      + APE  ++G    K+DV
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSDV 365
Query: 296 FAFGVLLLELVTGRRA 311
           ++FG+LL EL T  R 
Sbjct: 366 WSFGILLTELTTKGRV 381

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 33/205 (16%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 141
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFGYLAPEFLM 285
           D+ A N+L++ED   ++ DFGL K          LP +WT              APE L 
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEALR 187
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRR 310
                 K+DV++FG+LL E+ +  R
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 98/206 (47%), Gaps = 33/206 (16%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N  +LLG  +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 178 E--GGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQRRIIHR 234
           E  GG++IV E    GSL   L      +  G    K +L V E + YL EG     +HR
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG--NNFVHR 126
Query: 235 DIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFGYLAPEFLM 285
           D+ A N+L++ED   ++ DFGL K          LP +WT              APE L 
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT--------------APEALR 172
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRA 311
                 K+DV++FG+LL E+ +  R 
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRV 198

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 68
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 128
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 129 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 185
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 186 FWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
            N S + ++G G + EV  GRL+        VAIK L  G  ++   DFL E  IM   D
Sbjct: 33  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 92
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLY 222
           HPN  +L G   +   + IV E   NGSL S L   K   ++ +   + +  G+A G+ Y
Sbjct: 93  HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYL 279
           L +      +HRD+ A NIL+  +   ++ DFGL++ L   PE    +T    +    + 
Sbjct: 151 LSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWT 205
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +PE + +      +DV+++G++L E+++
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 114 FENLIGKGGYAEVYKGRLR-NGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV  GRL+  G+    VAIK L  G  D+   DFLSE  IM   DHPN 
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 170 AKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L G   +   + I+ E   NGSL + L     +        +  G+  G+ YL +   
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD--- 134
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAPEFLM 285
              +HRD+ A NIL+  +   ++ DFG+++ L   PE    +T    +    + APE + 
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEAIA 192
Query: 286 HGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           +      +DV+++G+++ E+++ G R   D S Q ++   + + +   +   +D  +A  
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---KAIEEGYRLPPPMDCPIA-- 247
Query: 344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                ++ ++L    C Q+    RP+  Q+V +L
Sbjct: 248 -----LHQLMLD---CWQKERSDRPKFGQIVNML 273

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 131/274 (47%), Gaps = 28/274 (10%)
Query: 114 FENLIGKGGYAEVYKGRLR-NGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            E +IG G + EV  GRL+  G+    VAIK L  G  D+   DFLSE  IM   DHPN 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 170 AKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L G   +   + I+ E   NGSL + L     +        +  G+  G+ YL +   
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD--- 128
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAPEFLM 285
              +HRD+ A NIL+  +   ++ DFG+++ L   PE    +T    +    + APE + 
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEAIA 186
Query: 286 HGIVDEKTDVFAFGVLLLELVT-GRRAL-DYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           +      +DV+++G+++ E+++ G R   D S Q ++   + + +   +   +D  +A  
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---KAIEEGYRLPPPMDCPIA-- 241
Query: 344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                ++ ++L    C Q+    RP+  Q+V +L
Sbjct: 242 -----LHQLMLD---CWQKERSDRPKFGQIVNML 267

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 62
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 122
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 123 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 179
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 180 FWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 181
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 111/218 (50%), Gaps = 26/218 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L   +                 L     
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  VA G+ YL    Q++ IHR++ A NIL+ E++  +I DFGL++   E +   T+
Sbjct: 142 LHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRG-QEVYVKKTM 197
Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++     ++A E L + +    +DV+++GVLL E+V+
Sbjct: 198 GRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 7/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H    
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 66
Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L     E  + IV E    GSL   L G   K L+      +A  +A G+ Y+    + 
Sbjct: 67  QLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RM 123
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
             +HRD++AANIL+ E+   ++ DFGLA+ L E          +    + APE  ++G  
Sbjct: 124 NYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRF 182
Query: 290 DEKTDVFAFGVLLLELVTGRRA 311
             K+DV++FG+LL EL T  R 
Sbjct: 183 TIKSDVWSFGILLTELTTKGRV 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 76
Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHRD++AAN+L++E    +I DFGLA+ + + ++T    +K      + APE +  G   
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGCFT 189
Query: 291 EKTDVFAFGVLLLELVT 307
            K+DV++FG+LL E+VT
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 71
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 132 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 188
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 189 FWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 22/269 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN 
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 278
Query: 170 AKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMH 286
           ++  IHR++ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAY 393
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
                K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E   
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERPE 442
Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                V      C Q +   RP  +++ Q
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 471

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 69
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 129
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 130 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 186
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 187 FWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 22/279 (7%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELG 159
           SL + +    + + ++ +G G + EVY+G  +   L VA+K L   T +  + +FL E  
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAA 59
Query: 160 IMAHVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVA 217
           +M  + HPN  +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTF 276
             + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +  +  T H  +K     
Sbjct: 120 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PI 174
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
            + APE L +     K+DV+AFGVLL E+ T      Y          P I  +++ EL+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDPSQVYELL 223
Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +     E        V      C Q +   RP  +++ Q
Sbjct: 224 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 262

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 64
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 95
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 156 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 212
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 7   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 64
Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E   
Sbjct: 65  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 122
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             +IHRD+ A N L+ E+   ++ DFG+ ++ L +Q+T  T +K      + +PE     
Sbjct: 123 -SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVKWASPEVFSFS 179
Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FGVL+ E+ +
Sbjct: 180 RYSSKSDVWSFGVLMWEVFS 199

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 116
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 165
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 225
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 226 VTEGARDLISRLLKHNPSQRPM 247

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 70
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 130
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 131 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 187
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 188 FWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I DFG        W+ H  S       G
Sbjct: 125 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG--------WSVHAPSSRRTTLCG 173
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           T  YL PE +     DEK D+++ GVL  E + G+
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 118 IGKGGYAEVYKG--RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G +  V +G  R+R  Q+ VAIK L +GT      + + E  IM  +D+P   +L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
                 + +V+E++  G L   L G +E++      ++   V+ G+ YL E   +  +HR
Sbjct: 78  VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHR 134
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVEGTFGYLAPEFLMHGIVDEKT 293
           D+ A N+LL      +I DFGL+K L    +++T  S  +    + APE +       ++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 294 DVFAFGVLLLELVTGRRALDYSQQ 317
           DV+++GV + E      AL Y Q+
Sbjct: 195 DVWSYGVTMWE------ALSYGQK 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 22/271 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           + + ++ +G G Y EVY+G  +   L VA+K L   T +  + +FL E  +M  + HPN 
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 317
Query: 170 AKLLGYGI-EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGC 227
            +LLG    E   +I+ E    G+L   L    ++++   +   +A  ++  + YL    
Sbjct: 318 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 374
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMH 286
           ++  IHR++ A N L+ E+   ++ DFGL++ +  + +T H  +K      + APE L +
Sbjct: 375 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAY 432
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
                K+DV+AFGVLL E+ T      Y          P I  +++ EL++     E   
Sbjct: 433 NKFSIKSDVWAFGVLLWEIAT------YGMSPY-----PGIDLSQVYELLEKDYRMERPE 481
Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                V      C Q +   RP  +++ Q  
Sbjct: 482 GCPEKVYELMRACWQWNPSDRPSFAEIHQAF 512

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q    +F     +GKG +  VY  R R  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL  + E +I DFG        W+ H  S       G
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG--------WSVHAPSSRRDTLCG 172
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T  YL PE +   + DEK D+++ GVL  E + G
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 76  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 132
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H  + +     F + APE L      
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 193 HASDTWMFGVTLWEMFT 209

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q    +F     +GKG +  VY  R R  + + A+K L +   ++  +      E+ I +
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELAN 123
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL  + E +I DFG        W+ H  S       G
Sbjct: 124 ALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFG--------WSVHAPSSRRTTLCG 172
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T  YL PE +   + DEK D+++ GVL  E + G
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 118 IGKGGYAEVYKGRLR--NGQLV--AIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAK 171
           +G G +  V +G     +G+ V  A+K L     +  E + DF+ E+  M  +DH N  +
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL     +R 
Sbjct: 86  LYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRF 142
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT-FGYLAPEFLMHGIVD 290
           IHRD+ A N+LL      +I DFGL + LP+   H  + +     F + APE L      
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFS 202
Query: 291 EKTDVFAFGVLLLELVT 307
             +D + FGV L E+ T
Sbjct: 203 HASDTWMFGVTLWEMFT 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE--IIADFLSELGIMA 162
           Q A  +F     +GKG +  VY  R +  + + A+K L +   ++  +      E+ I +
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 163 HVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE--- 218
           H+ HPN  +L GY  +   ++++LE +P G++    Y   +KL      + A  + E   
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----G 274
            L Y H    +R+IHRDIK  N+LL    E +I +FG        W+ H  S       G
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFG--------WSVHAPSSRRTTLCG 171
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-------YSQQSLVLWARPMI 327
           T  YL PE +   + DEK D+++ GVL  E + G+   +       Y + S V +  P  
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 231
Query: 328 KRNEIRELVDASLADEYDTRQM 349
                R+L+   L      R M
Sbjct: 232 VTEGARDLISRLLKHNPSQRPM 253

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 82
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 92/195 (47%), Gaps = 7/195 (3%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G       VAIK L  GT       FL E  IM  + H    +L     
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP--ESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 178 EGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
           E  ++IV E    GSL   L  G    LK      +A  VA G+ Y+    +   IHRD+
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 131
Query: 237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVF 296
           ++ANIL+      +I DFGLA+ L E          +    + APE  ++G    K+DV+
Sbjct: 132 RSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 297 AFGVLLLELVTGRRA 311
           +FG+LL ELVT  R 
Sbjct: 191 SFGILLTELVTKGRV 205

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 82
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L   KE++      +    + 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 199
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 200 FWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E    G+ +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N+L+  + + +I DFGL K +       T+    +    + APE LM   
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 289 VDEKTDVFAFGVLLLELVT 307
               +DV++FGV L EL+T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++ H N  K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 173 LGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G   E    G+ +++E  P+GSL   L   K K+    + K A+ + +G+ YL     R
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N+L+  + + +I DFGL K +       T+    +    + APE LM   
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 289 VDEKTDVFAFGVLLLELVT 307
               +DV++FGV L EL+T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G + EV+ G   N   VA+K L  GT    +  FL E  +M  + H    +L  Y +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRL--YAV 75
Query: 178 ---EGGMHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              E  ++I+ E    GSL   L    G K  L   I +  +  +AEG+ Y+    ++  
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDF--SAQIAEGMAYIE---RKNY 130
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           IHRD++AAN+L++E    +I DFGLA+ + + ++T    +K      + APE +  G   
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGCFT 188
Query: 291 EKTDVFAFGVLLLELVT 307
            K++V++FG+LL E+VT
Sbjct: 189 IKSNVWSFGILLYEIVT 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGI 160
           Q    +  F   +GKG +  V   R        G++VA+K+L   T +E + DF  E+ I
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEI 67
Query: 161 MAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
           +  + H N  K  G     G   + +++E  P GSL   L    E++      +    + 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQIC 127
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTF 276
           +G+ YL     +R IHRD+   NIL+  +   +I DFGL K LP+      + +  E   
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI 184
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + APE L        +DV++FGV+L EL T
Sbjct: 185 FWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 118 IGKGGYAEVYKG--RLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G +  V +G  R+R  Q+ VAIK L +GT      + + E  IM  +D+P   +L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
                 + +V+E++  G L   L G +E++      ++   V+ G+ YL E   +  +HR
Sbjct: 404 VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHR 460
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVEGTFGYLAPEFLMHGIVDEKT 293
           ++ A N+LL      +I DFGL+K L    +++T  S  +    + APE +       ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 294 DVFAFGVLLLELVTGRRALDYSQQ 317
           DV+++GV + E      AL Y Q+
Sbjct: 521 DVWSYGVTMWE------ALSYGQK 538

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+  +  E  + H  +  +    ++A E L 
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMT 232

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP 167
           +F   NL+GKG +A VY+   +  G  VAIK + +    +  ++    +E+ I   + HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           +  +L  Y  +   +++VLE+  NG +   L    +             +  G+LYLH  
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH-- 129
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTFGYLAPEFL 284
               I+HRD+  +N+LLT +   +I DFGLA  L  P +  H+T+    GT  Y++PE  
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYTLC---GTPNYISPEIA 184
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALD 313
                  ++DV++ G +   L+ GR   D
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/259 (30%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           IGKG + EV+KG   R  Q+VAIK +    A++ I D   E+ +++  D     K  G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 177 IEGG-MHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           ++G  + I++E    GS   LL  G  ++ +     K  L   +GL YLH     + IHR
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIHR 144
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  + ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 202
Query: 295 VFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN----------EIRELVDASLADEY 344
           +++ G+  +EL  G           VL+  P  K N            +E +DA L  + 
Sbjct: 203 IWSLGITAIELAKGEPPNSDMHPMRVLFLIP--KNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 345 DTRQMNLVLLAASLCIQQS 363
             R     LL     ++ S
Sbjct: 261 SFRPTAKELLKHKFIVKNS 279

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 114 FENLIGKGGYAEVYKGRL--RNGQLV--AIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L   +G+ +  A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+ +L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW--THHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+ + ++   + H  +  +    ++A E L 
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 K+DV++FGVLL EL+T
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMT 233

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 118/235 (50%), Gaps = 27/235 (11%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQL 136
           G+D+   NL+  S D   P+++F+  E             IGKG + EV+KG   R  ++
Sbjct: 10  GVDLGTENLYFQSMD---PEELFTKLEK------------IGKGSFGEVFKGIDNRTQKV 54
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLAS 195
           VAIK +    A++ I D   E+ +++  D P   K  G Y  +  + I++E    GS   
Sbjct: 55  VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 114
Query: 196 LLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
           LL  G  ++ +      I   + +GL YLH     + IHRDIKAAN+LL+E  E ++ DF
Sbjct: 115 LLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADF 168
Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           G+A  L +  T    +   GT  ++APE +     D K D+++ G+  +EL  G 
Sbjct: 169 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 102 LYELQSAT----NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIA 152
           LY  Q  T     +  + + +GKG +  V   R        G LVA+K+L     D+   
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-R 69
Query: 153 DFLSELGIMA--HVDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIR 209
           DF  E+ I+   H D     + + YG     + +V+E  P+G L   L   + +L     
Sbjct: 70  DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              +  + +G+ YL     RR +HRD+ A NIL+  +   +I DFGLAK LP    ++ +
Sbjct: 130 LLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 270 SKV-EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            +  +    + APE L   I   ++DV++FGV+L EL T
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 112/235 (47%), Gaps = 31/235 (13%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTA 147
           N+  ++ P++ F++       ++F     +GKG +  VY  R +  + + A+K L +   
Sbjct: 1   NTALAEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL 53
Query: 148 DE--IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKE 202
           ++  +      E+ I +H+ HPN  ++  Y  +   ++++LE +P G L   L  +G  +
Sbjct: 54  EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           + +          +A+ L Y HE   R++IHRDIK  N+L+    E +I DFG       
Sbjct: 114 EQRSAT---FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG------- 160
Query: 263 QWTHHTIS----KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            W+ H  S     + GT  YL PE +     DEK D++  GVL  E + G    D
Sbjct: 161 -WSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 257
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 308

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 169 -TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALG-----VAEGL 220
             +    + ++  + +V++L   GS+  ++  +  K + K G+  +  +      V EGL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE--QWTHHTISKV-EGTFG 277
            YLH+  Q   IHRD+KA NILL ED   QI DFG++ +L      T + + K   GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 278 YLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS------LVLWARPMIKR 329
           ++APE +  + G  D K D+++FG+  +EL TG  A  Y +        L L   P    
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             ++   D  +  +Y      ++    SLC+Q+   +RP  +++++
Sbjct: 249 TGVQ---DKEMLKKYGKSFRKMI----SLCLQKDPEKRPTAAELLR 287

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 115 ENLIGKGGYAEVYKG----RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +IGKG +  VY G    + +N    AIK L+R T  + +  FL E  +M  ++HPN  
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 171 KLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            L+G  +  EG  H++L    +G L   +   +            L VA G+ YL E   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAK------WLPEQWTHHTISKVEGTFGYLAPE 282
           ++ +HRD+ A N +L E F  ++ DFGLA+      +   Q   H    V+ T    A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT 307
            L       K+DV++FGVLL EL+T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADE-- 149
           ++ P++ F++       ++F     +GKG +  VY  R +  + + A+K L +   ++  
Sbjct: 4   AEMPKRKFTI-------DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--YGMKEKLKW 206
           +      E+ I +H+ HPN  ++  Y  +   ++++LE +P G L   L  +G  ++ + 
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 116
Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
                    +A+ L Y HE   R++IHRDIK  N+L+    E +I DFG        W+ 
Sbjct: 117 AT---FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG--------WSV 162
Query: 267 HTIS----KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
           H  S     + GT  YL PE +     DEK D++  GVL  E + G    D
Sbjct: 163 HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 62
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 119
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+  
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLMYSK 177
Query: 289 VDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELVDA 338
              K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++ +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYS 236
Query: 339 SLADEYDTRQMNLVLLAASL 358
              ++ D R    +LL+  L
Sbjct: 237 CWHEKADERPTFKILLSNIL 256

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 169 -TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALG-----VAEGL 220
             +    + ++  + +V++L   GS+  ++  +  K + K G+  +  +      V EGL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE--QWTHHTISKV-EGTFG 277
            YLH+  Q   IHRD+KA NILL ED   QI DFG++ +L      T + + K   GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 278 YLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS------LVLWARPMIKR 329
           ++APE +  + G  D K D+++FG+  +EL TG  A  Y +        L L   P    
Sbjct: 187 WMAPEVMEQVRG-YDFKADIWSFGITAIELATG--AAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             ++   D  +  +Y      ++    SLC+Q+   +RP  +++++
Sbjct: 244 TGVQ---DKEMLKKYGKSFRKMI----SLCLQKDPEKRPTAAELLR 282

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 134/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 188
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 189 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 294
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 345

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 248
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 299

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 248
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 299

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 66
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 123
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+  
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLMYSK 181
Query: 289 VDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELVDA 338
              K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++ +
Sbjct: 182 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYS 240
Query: 339 SLADEYDTRQMNLVLLAASL 358
              ++ D R    +LL+  L
Sbjct: 241 CWHEKADERPTFKILLSNIL 260

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +        
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 257
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 308

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +        
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 248
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 299

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 67
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 124
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLMYSK 182
Query: 289 VDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELVDA 338
              K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++ +
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYS 241
Query: 339 SLADEYDTRQMNLVLLAASLCIQQSSI 365
              ++ D R    +LL+  L +   ++
Sbjct: 242 CWHEKADERPTFKILLSNILDVMDENL 268

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 22/219 (10%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEII 151
           ++ P+++F + E             +G+G Y  VYK      GQ+VAIK++     +  +
Sbjct: 24  TKQPEEVFDVLEK------------LGEGSYGSVYKAIHKETGQIVAIKQVP---VESDL 68
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
            + + E+ IM   D P+  K  G Y     + IV+E    GS++ ++    + L      
Sbjct: 69  QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
            I     +GL YLH     R IHRDIKA NILL  +   ++ DFG+A  L +       +
Sbjct: 129 TILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--N 183
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            V GT  ++APE +     +   D+++ G+  +E+  G+
Sbjct: 184 XVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMA--HVDHPNTA 170
           +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+   H D     
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKY 76
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           + + YG     + +V+E  P+G L   L   + +L        +  + +G+ YL     R
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---R 133
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFLMHGI 288
           R +HRD+ A NIL+  +   +I DFGLAK LP    ++ + +  +    + APE L   I
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 289 VDEKTDVFAFGVLLLELVT 307
              ++DV++FGV+L EL T
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 11/194 (5%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 143
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  E ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 295 VFAFGVLLLELVTG 308
           +++ G+  +EL  G
Sbjct: 202 IWSLGITAIELARG 215

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMA--HVDHPNTA 170
           +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+   H D     
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKY 77
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           + + YG     + +V+E  P+G L   L   + +L        +  + +G+ YL     R
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---R 134
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFLMHGI 288
           R +HRD+ A NIL+  +   +I DFGLAK LP    ++ + +  +    + APE L   I
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 289 VDEKTDVFAFGVLLLELVT 307
              ++DV++FGV+L EL T
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 11/194 (5%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  E ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 295 VFAFGVLLLELVTG 308
           +++ G+  +EL  G
Sbjct: 187 IWSLGITAIELARG 200

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 24/262 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 82
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 83  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMH 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLMY 195
Query: 287 GIVDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
                K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIM 254
Query: 337 DASLADEYDTRQMNLVLLAASL 358
            +   ++ D R    +LL+  L
Sbjct: 255 YSCWHEKADERPTFKILLSNIL 276

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 102/194 (52%), Gaps = 11/194 (5%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           IGKG + EV+KG   R  ++VAIK +    A++ I D   E+ +++  D P   K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 176 GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
             +  + I++E    GS   LL  G  ++ +      I   + +GL YLH     + IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLDYLH---SEKKIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
           DIKAAN+LL+E  E ++ DFG+A  L +  T    +   GT  ++APE +     D K D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 295 VFAFGVLLLELVTG 308
           +++ G+  +EL  G
Sbjct: 187 IWSLGITAIELARG 200

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 17/202 (8%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPNT +  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH      +IH
Sbjct: 83  CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVD 290
           RD+KA NILL+E    ++ DFG A  +         +   GT  ++APE ++    G  D
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 291 EKTDVFAFGVLLLELVTGRRAL 312
            K DV++ G+  +EL   +  L
Sbjct: 193 GKVDVWSLGITCIELAERKPPL 214

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK+A               
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 151
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +        
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 257
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 308

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 42/288 (14%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK----------IALGVA 217
            LLG   + G  + +++E    G+L++ L   + E + +   YK           +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +           
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IREL 335
           ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R L
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCRRL 260
Query: 336 VDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 304

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 13/222 (5%)
Query: 94  QSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQL---VAIKRLTRGTADE 149
           + P +    +  +   +  + E +IG G + EV  GRL+  G+    VAIK L  G  ++
Sbjct: 6   EDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEK 65
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              DFL E  IM   DHPN   L G   +   + IV E   NGSL + L     +     
Sbjct: 66  QRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQ 125
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWT 265
              +  G++ G+ YL +      +HRD+ A NIL+  +   ++ DFGL++ L   PE   
Sbjct: 126 LVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--A 180
Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            +T    +    + APE +        +DV+++G+++ E+V+
Sbjct: 181 AYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + ++ E    G+L++ L   + +    + YK+A               
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDFLTLEHLI 142
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +        
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 248
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 249 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 299

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 67
Query: 171 KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
           +L G    +  + I+ E   NG L + L  M+ + +     ++   V E + YL     +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SK 124
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+  
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS--PPEVLMYSK 182
Query: 289 VDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELVDA 338
              K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++ +
Sbjct: 183 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMYS 241
Query: 339 SLADEYDTRQMNLVLLAASL 358
              ++ D R    +LL+  L
Sbjct: 242 CWHEKADERPTFKILLSNIL 261

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 125/262 (47%), Gaps = 24/262 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 73
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 74  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 128
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMH 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L +++T    SK    +    PE LM+
Sbjct: 129 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS--PPEVLMY 186
Query: 287 GIVDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
                K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIM 245
Query: 337 DASLADEYDTRQMNLVLLAASL 358
            +   ++ D R    +LL+  L
Sbjct: 246 YSCWHEKADERPTFKILLSNIL 267

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+++     ++E   D + E+  +  + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           T +  G Y  E    +V+E    GS + LL   K+ L+      +  G  +GL YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-- 285
              +IHRD+KA NILL+E    ++ DFG A  +         +   GT  ++APE ++  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMAPEVILAM 225
Query: 286 -HGIVDEKTDVFAFGVLLLELVTGRRAL 312
             G  D K DV++ G+  +EL   +  L
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 21/224 (9%)
Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRG 145
           F N +    P+++F+              + IGKG + EVYKG      ++VAIK +   
Sbjct: 8   FANQHSRVDPEELFTKL------------DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLE 55
Query: 146 TADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKL 204
            A++ I D   E+ +++  D P   +  G Y     + I++E    GS   LL      L
Sbjct: 56  EAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPL 113
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
           +      I   + +GL YLH     R IHRDIKAAN+LL+E  + ++ DFG+A  L +  
Sbjct: 114 EETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-- 168
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T    +   GT  ++APE +     D K D+++ G+  +EL  G
Sbjct: 169 TQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 212

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 110 NNFSFENLIGKGGYAEVYKGR------LRNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF  E  +MA 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 164 VDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYK----------- 211
            D+PN  KLLG    G  M ++ E    G L   L  M       + +            
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 212 ------------IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                       IA  VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +     +           ++ PE + +     ++DV+A+GV+L E+ +
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDXXK 207
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 151/327 (46%), Gaps = 36/327 (11%)
Query: 68  LSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATN-NFSF--ENL-----IG 119
           +S  +      G+ +P+  F     S +P +        S  N NF    ++L     +G
Sbjct: 1   MSQSKGKKRNPGLKIPKEAFEQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELG 60
Query: 120 KGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGYGI 177
           +G Y  V K R + +GQ++A+KR+      +     L +L I M  VD P T    G   
Sbjct: 61  RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 120
Query: 178 -EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            EG + I +EL  + SL      + +K   +   I  KIA+ + + L +LH   +  +IH
Sbjct: 121 REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIH 177
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE-- 291
           RD+K +N+L+    + ++CDFG++ +L +     TI    G   Y+APE +   +  +  
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDS-VAKTIDA--GCKPYMAPERINPELNQKGY 234
Query: 292 --KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-ADEYDTRQ 348
             K+D+++ G+ ++EL   R   D        W  P  +  ++ E     L AD++    
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYDS-------WGTPFQQLKQVVEEPSPQLPADKFSAEF 287
Query: 349 MNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           ++      S C++++S  RP   +++Q
Sbjct: 288 VDF----TSQCLKKNSKERPTYPELMQ 310

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 133/295 (45%), Gaps = 52/295 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA--------------- 213
            LLG   + G  + +++E    G+L++ L   + +    + YK A               
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKEAPEDLYKDFLTLEHLI 153
Query: 214 ---LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
                VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN 330
                  ++APE +   +   ++DV++FGVLL E+            SL     P +K +
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKID 259
Query: 331 E--IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           E   R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 260 EEFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 310

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 51/294 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI---------------- 212
            LLG   + G  + +++E    G+L++ L   + +    + YK                 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKTPEDLYKDFLTLEHLIC 152
Query: 213 -ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
            +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +         
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE 331
                 ++APE +   +   ++DV++FGVLL E+            SL     P +K +E
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDE 258
Query: 332 --IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
              R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 308

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 126
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 127 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 220

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 127
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 128 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 221

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 192
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEKLKWGIRYK----------------I 212
            LLG   + G  + +++E    G+L++ L   + +    + YK                 
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKPEDLYKDFLTLEHLIXY 153
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +          
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE- 331
                ++APE +   +   ++DV++FGVLL E+            SL     P +K +E 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEE 259
Query: 332 -IRELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
             R L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 308

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 243

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 196
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 117 LIGKGGYAEVYKG-RLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G G +  VYKG  + +G+     VAIK L   T+ +   + L E  +MA V  P  ++
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 172 LLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           LLG  +   + +V +L P G L   +       G ++ L W       + +A+G+ YL +
Sbjct: 84  LLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKGMSYLED 137
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
               R++HRD+ A N+L+      +I DFGLA+ L    T +     +    ++A E ++
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
                 ++DV+++GV + EL+T
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIALG-----VAEGLLYLHEGC 227
             E G + I +E  P GSL++LL     + KWG     +  +G     + EGL YLH+  
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             +I+HRDIK  N+L+ T     +I DFG +K L     +       GT  Y+APE +  
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDK 197
Query: 287 GI--VDEKTDVFAFGVLLLELVTGR 309
           G     +  D+++ G  ++E+ TG+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 118 IGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +GKG +  V   R        G LVA+K+L     D+   DF  E+ I+  +      K 
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-RDFQREIQILKALHSDFIVKY 73
Query: 173 LGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            G     G   + +V+E  P+G L   L   + +L        +  + +G+ YL     R
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---R 130
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV-EGTFGYLAPEFLMHGI 288
           R +HRD+ A NIL+  +   +I DFGLAK LP       + +  +    + APE L   I
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 289 VDEKTDVFAFGVLLLELVT 307
              ++DV++FGV+L EL T
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 125
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
               + +D++A G ++ +LV G
Sbjct: 185 KSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 124
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 125 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
               + +D++A G ++ +LV G
Sbjct: 184 KSACKSSDLWALGCIIYQLVAG 205

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 149
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFG 277
              + +I+HRD+K  N+LL   ++D   +I DFGL+       TH   SK      GT  
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAY 199
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE L HG  DEK DV++ GV+L  L++G
Sbjct: 200 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLG 174
           ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+ ++  +DHPN  KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 175 Y-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
                   +IV EL   G L   +   K +       +I   V  G+ Y+H   +  I+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 234 RDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           RD+K  NILL    +D + +I DFGL+    +   +  +    GT  Y+APE L  G  D
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 291 EKTDVFAFGVLLLELVTG 308
           EK DV++ GV+L  L++G
Sbjct: 201 EKCDVWSAGVILYILLSG 218

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 200
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 24/262 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H    
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 82
Query: 171 KLLGYGI---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +L  YG+   +  + I+ E   NG L + L  M+ + +     ++   V E + YL    
Sbjct: 83  QL--YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMH 286
            ++ +HRD+ A N L+ +    ++ DFGL+++ L ++ T    SK      +  PE LM+
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMY 195
Query: 287 GIVDEKTDVFAFGVLLLEL----------VTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
                K+D++AFGVL+ E+           T     ++  Q L L+ RP +   ++  ++
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIM 254
Query: 337 DASLADEYDTRQMNLVLLAASL 358
            +   ++ D R    +LL+  L
Sbjct: 255 YSCWHEKADERPTFKILLSNIL 276

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 143
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFG 277
              + +I+HRD+K  N+LL   ++D   +I DFGL+       TH   SK      GT  
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAY 193
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE L HG  DEK DV++ GV+L  L++G
Sbjct: 194 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 199
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K +      VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L               +  +E+L        
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +     HH     
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-----HHIDYYK 207
Query: 273 EGTFG-----YLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           + T G     ++APE L   I   ++DV++FGVLL E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
                   +HRDI   NIL+      ++ DFGL++++ ++  ++  S       +++PE 
Sbjct: 126 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPES 181
Query: 284 LMHGIVDEKTDVFAFGVLLLELVT 307
           +        +DV+ F V + E+++
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILS 205

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 131
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 132 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
               + +D++A G ++ +LV G
Sbjct: 191 KSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 146
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
               + +D++A G ++ +LV G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAG 227

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y H
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYXH 143
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFG 277
              + +I+HRD+K  N+LL   ++D   +I DFGL+       TH   SK      GT  
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKXKDKIGTAY 193
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE ++HG  DEK DV++ GV+L  L++G
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 146
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 287 GIVDEKTDVFAFGVLLLELVTG 308
               + +D++A G ++ +LV G
Sbjct: 206 KSACKSSDLWALGCIIYQLVAG 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 147
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
                   +HRDI   NIL+      ++ DFGL++++ ++  ++  S       +++PE 
Sbjct: 142 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPES 197
Query: 284 LMHGIVDEKTDVFAFGVLLLELVT 307
           +        +DV+ F V + E+++
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILS 221

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 147
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 139/302 (46%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E   +    K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 234 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPKMRPTFLEIVNLLKD 288
Query: 380 NL 381
           +L
Sbjct: 289 DL 290

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF 243

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 147
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 150
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 244

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 243

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQ----LVAIKRLTRGTADEIIADFLSELGIMAH 163
           A  +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM +
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DHP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
                   +HRDI   NIL+      ++ DFGL++++ ++  ++  S       +++PE 
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPES 185
Query: 284 LMHGIVDEKTDVFAFGVLLLELVT 307
           +        +DV+ F V + E+++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 243

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSEL 158
           +LY   +    ++   ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 159 GIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  +DHPN  KL     +    +IV EL   G L   +   K +       +I   V 
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVF 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G+ Y+H   +  I+HRD+K  NILL    +D + +I DFGL+    +   +  +    G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIG 185
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T  Y+APE ++ G  DEK DV++ GV+L  L++G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+H
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 166
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFG 277
              + +I+HRD+K  N+LL   ++D   +I DFGL+       TH   SK      GT  
Sbjct: 167 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAY 216
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE L HG  DEK DV++ GV+L  L++G
Sbjct: 217 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSEL 158
           +LY   +    ++   ++GKG + EV K + R   Q  A+K + + +A ++  +  L E+
Sbjct: 13  NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 159 GIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  +DHPN  KL     +    +IV EL   G L   +   K +       +I   V 
Sbjct: 73  ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVF 131
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G+ Y+H   +  I+HRD+K  NILL    +D + +I DFGL+    +   +  +    G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIG 185
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T  Y+APE ++ G  DEK DV++ GV+L  L++G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 150
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 244

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 149
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 243

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 154
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 155 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 248

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 97/193 (50%), Gaps = 30/193 (15%)
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLA 194
           VA+K L     ++ ++D +SE+ +M  +  H N   LLG   + G +++++E +  G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 195 SLL---------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
             L               +  +E+L        A  VA G+ YL     ++ IHRD+ A 
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 220
Query: 240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG-----YLAPEFLMHGIVDEKTD 294
           N+L+TED   +I DFGLA+ +     HH     + T G     ++APE L   I   ++D
Sbjct: 221 NVLVTEDNVMKIADFGLARDI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 295 VFAFGVLLLELVT 307
           V++FGVLL E+ T
Sbjct: 276 VWSFGVLLWEIFT 288

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 138/302 (45%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E        K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 234 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPKMRPTFLEIVNLLKD 288
Query: 380 NL 381
           +L
Sbjct: 289 DL 290

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 23/211 (10%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII--ADFLSELGIMAHVD 165
           ++ +  + ++GKG + EV   + +  GQ  A+K +++    +       L E+ ++  +D
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  KL  +  + G  ++V E+   G L   +   K +       +I   V  G+ Y+H
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH 167
Query: 225 EGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFG 277
              + +I+HRD+K  N+LL   ++D   +I DFGL+       TH   SK      GT  
Sbjct: 168 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAY 217
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE L HG  DEK DV++ GV+L  L++G
Sbjct: 218 YIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 120/258 (46%), Gaps = 45/258 (17%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LLYGMKEKLKWGIRY--------------------------KIALGVAEGLLYLHEGCQR 229
            L   +E  K G  Y                            A  +++G+ YL E    
Sbjct: 116 FL---RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---M 169
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           +++HRD+ A NIL+ E  + +I DFGL++ + E+ ++   S+      ++A E L   I 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY 229
Query: 290 DEKTDVFAFGVLLLELVT 307
             ++DV++FGVLL E+VT
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 139/302 (46%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  +F   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E   +    K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 234 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPKMRPTFLEIVNLLKD 288
Query: 380 NL 381
           +L
Sbjct: 289 DL 290

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 152
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 153 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 246

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGI--RYKIALG-----VAEGLLYLHEGC 227
             E G + I +E  P GSL++LL     + KWG     +  +G     + EGL YLH+  
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 126
Query: 228 QRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             +I+HRDIK  N+L+ T     +I DFG +K L     +       GT  Y+APE +  
Sbjct: 127 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEIIDK 183
Query: 287 GI--VDEKTDVFAFGVLLLELVTGR 309
           G     +  D+++ G  ++E+ TG+
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   +F   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 60
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 61  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 17/222 (7%)
Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLS 156
           I S  + Q    N+  +  IGKG +A+V   R +  G+ VA+K + +   +   +     
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR 63
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKI 212
           E+ IM  ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              V     Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +   
Sbjct: 124 VSAVQ----YCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSN---EFTVGNKLDTF 173
Query: 273 EGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
            G+  Y APE       D  + DV++ GV+L  LV+G    D
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +G G +  V  G+ +    VA+K +  G+  E   +F  E   M  + HP   K   YG+
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKLVKF--YGV 71
Query: 178 ---EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              E  ++IV E   NG L + L    + L+     ++   V EG+ +L      + IHR
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 235 DIKAANILLTEDFEPQICDFGLAKW-LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           D+ A N L+  D   ++ DFG+ ++ L +Q+     +K    +   APE   +     K+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS--APEVFHYFKYSSKS 186
Query: 294 DVFAFGVLLLELVT-GRRALD-YSQQSLVL 321
           DV+AFG+L+ E+ + G+   D Y+   +VL
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VAIK + +   +   +     E+ IM  
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 67
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++++E +  G +   L     MKEK       +I   V   
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ-- 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+RI+HRD+KA N+LL  D   +I DFG +    E      +    G+  Y 
Sbjct: 126 --YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDTFCGSPPYA 177
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLS 156
           I S  + Q    N+     IGKG +A+V   R +  G+ VAIK + +   +   +     
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR 63
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKI 212
           E+ IM  ++HPN  KL      E  +++++E +  G +   L     MKEK       +I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              V     Y H   Q+RI+HRD+KA N+LL  D   +I DFG +    E      +   
Sbjct: 124 VSAVQ----YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAF 173
Query: 273 EGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
            G   Y APE       D  + DV++ GV+L  LV+G    D
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 8/215 (3%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLS-ELGIMAHVDHP 167
           +F F  ++G+G ++     R L   +  AIK L  R    E    +++ E  +M+ +DHP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L YLH  
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLH-- 147
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
               + +D++A G ++ +LV G        + L+ 
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 241

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 119/258 (46%), Gaps = 45/258 (17%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LLYGMKEKLKWGIRY--------------------------KIALGVAEGLLYLHEGCQR 229
            L   +E  K G  Y                            A  +++G+ YL E    
Sbjct: 116 FL---RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---M 169
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           +++HRD+ A NIL+ E  + +I DFGL++ + E+ +    S+      ++A E L   I 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIY 229
Query: 290 DEKTDVFAFGVLLLELVT 307
             ++DV++FGVLL E+VT
Sbjct: 230 TTQSDVWSFGVLLWEIVT 247

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHPNTAKLLGY 175
           +G+G Y  V K R + +GQ++A+KR+      +     L +L I M  VD P T    G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 176 GI-EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALGVAEGLLYLHEGCQRRI 231
              EG + I +EL  + SL      + +K   +   I  KIA+ + + L +LH   +  +
Sbjct: 75  LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           IHRD+K +N+L+    + ++CDFG++ +L +       +   G   Y+APE +   +  +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERINPELNQK 188
Query: 292 ----KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-ADEYDT 346
               K+D+++ G+ ++EL   R   D        W  P  +  ++ E     L AD++  
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDS-------WGTPFQQLKQVVEEPSPQLPADKFSA 241
Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             ++      S C++++S  RP   +++Q
Sbjct: 242 EFVDF----TSQCLKKNSKERPTYPELMQ 266

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 138/302 (45%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HRD+ A N ++  DF  +I DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E        K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 234 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPNMRPTFLEIVNLLKD 288
Query: 380 NL 381
           +L
Sbjct: 289 DL 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGT 146
           S S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK 205
           +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 206 ---------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                         ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 179 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 92/174 (52%), Gaps = 20/174 (11%)
Query: 157 ELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL-------ASLLYGMKEKLKWGI 208
           E+ ++A++ HPN  +    +   G ++IV++    G L         +L+   + L W +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
           +  +AL       ++H+   R+I+HRDIK+ NI LT+D   Q+ DFG+A+ L    T   
Sbjct: 133 QICLALK------HVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVEL 181
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY-SQQSLVL 321
                GT  YL+PE   +   + K+D++A G +L EL T + A +  S ++LVL
Sbjct: 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGT 146
           S S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK 205
           +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 206 ---------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                         ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + + E        K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 179 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGTADE--IIADFLSELGIMAHVDH 166
           ++F     +GKG +  VY  R +    +VA+K L +   ++  +      E+ I AH+ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLY 222
           PN  +L  Y  +   ++++LE +P G L   L       E+    I  ++A    + L+Y
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELA----DALMY 138
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS----KVEGTFGY 278
            H    +++IHRDIK  N+LL    E +I DFG        W+ H  S     + GT  Y
Sbjct: 139 CH---GKKVIHRDIKPENLLLGLKGELKIADFG--------WSVHAPSLRRKTMCGTLDY 187
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L PE +   + +EK D++  GVL  EL+ G
Sbjct: 188 LPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 63  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 104 ELQSAT-NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF--LSELG 159
           E Q  T N F    ++GKGG+ EV   ++R  G++ A K+L +    +   +   L+E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 160 IMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVA 217
           I+  V+      L   Y  +  + +VL L   G L   +Y M +      R    A  + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL  LH   + RI++RD+K  NILL +    +I D GLA  +PE     TI    GT G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVG 350
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD 337
           Y+APE + +       D +A G LL E++ G        QS     +  IKR E+  LV 
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAG--------QSPFQQRKKKIKREEVERLV- 401
Query: 338 ASLADEYDTRQMNLVLLAASLCIQ 361
             + +EY  R       A SLC Q
Sbjct: 402 KEVPEEYSER---FSPQARSLCSQ 422

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 129
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 63  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 122
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 123 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 180 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 19/220 (8%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 158 LGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ + + E     
Sbjct: 124 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 118 IGKGGYAEVYKG------RLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP-NTA 170
           +G+G + +V +       +    + VA+K L  G         +SEL I+ H+ H  N  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 171 KLLGYGIEGG--MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK----------IALGVA 217
            LLG   + G  + +++E    G+L++ L   + E + +   YK           +  VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +G+ +L     R+ IHRD+ A NILL+E    +I DFGLA+ + +   +           
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IREL 335
           ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R L
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFXRRL 260
Query: 336 VDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 304

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 19/220 (8%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 158 LGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ + + E   + 
Sbjct: 126 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 120/264 (45%), Gaps = 24/264 (9%)
Query: 104 ELQSAT-NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF--LSELG 159
           E Q  T N F    ++GKGG+ EV   ++R  G++ A K+L +    +   +   L+E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 160 IMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVA 217
           I+  V+      L   Y  +  + +VL L   G L   +Y M +      R    A  + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            GL  LH   + RI++RD+K  NILL +    +I D GLA  +PE     TI    GT G
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVG 350
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD 337
           Y+APE + +       D +A G LL E++ G        QS     +  IKR E+  LV 
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAG--------QSPFQQRKKKIKREEVERLV- 401
Query: 338 ASLADEYDTRQMNLVLLAASLCIQ 361
             + +EY  R       A SLC Q
Sbjct: 402 KEVPEEYSER---FSPQARSLCSQ 422

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++ ++H N  + +G  ++     I+L
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILL 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVF 296
           N LLT        +I DFG+A+ +     +           ++ PE  M GI   KTD +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 297 AFGVLLLELVT 307
           +FGVLL E+ +
Sbjct: 245 SFGVLLWEIFS 255

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 32  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 91
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK-- 205
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++  
Sbjct: 92  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 151
Query: 206 -------WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 152 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 209 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 39/255 (15%)
Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-----RLRNG-QL 136
           P +L V+++      KI    + +    N      +G+G + +V K      + R G   
Sbjct: 2   PLSLSVDAF------KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 137 VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLAS 195
           VA+K L    +   + D LSE  ++  V+HP+  KL G    +G + +++E +  GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 196 LL-----------------------YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            L                       +  +  L  G     A  +++G+ YL E     ++
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLV 172
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           HRD+ A NIL+ E  + +I DFGL++ + E+ +    S+      ++A E L   I   +
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 293 TDVFAFGVLLLELVT 307
           +DV++FGVLL E+VT
Sbjct: 233 SDVWSFGVLLWEIVT 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 177
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 178 CGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 234
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++ +
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 152 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 167
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 168 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 224
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTG 308
            L  G+  D   D F+ G +L +L+ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTG 308
            L  G+  D   D F+ G +L +L+ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 306
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE
Sbjct: 307 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 359
Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTG 308
            L  G+  D   D F+ G +L +L+ G
Sbjct: 360 VLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK-----RLTRGTADEIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R  + G++ A+K     R+     + +  +    L +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 164 VDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +   +     +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 307
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTG 308
            L  G+  D   D F+ G +L +L+ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 131/280 (46%), Gaps = 30/280 (10%)
Query: 118 IGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  R+   G+    VA+K +    +     +FL+E  +M      +  +
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 172 LLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI---------RYKIALGVAEGLL 221
           LLG   +G    +V+EL  +G L S L  ++ + +              ++A  +A+G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL+    ++ +HRD+ A N ++  DF  +I DFG+ + + E        K      ++AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           E L  G+    +D+++FGV+L E+ +       ++Q      + +     ++ ++D    
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY----QGLSNEQVLKFVMDGGYL 248
Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           D+ D     +  L   +C Q +   RP   ++V LL+ +L
Sbjct: 249 DQPDNCPERVTDL-MRMCWQFNPKMRPTFLEIVNLLKDDL 287

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 157
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 158 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 214
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 192 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 168
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 169 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 225
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 226 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 152 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 208
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 29/281 (10%)
Query: 111 NFSFENL-----IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGI-MA 162
           +F+ E+L     IG+G Y  V K   + +GQ++A+KR+ R T DE      L +L + M 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMR 76
Query: 163 HVDHPNTAKLLGYGI-EGGMHIVLELSPNG--SLASLLYG-MKEKLKWGIRYKIALGVAE 218
             D P   +  G    EG   I +EL           +Y  + + +   I  KI L   +
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L +L E    +IIHRDIK +NILL      ++CDFG++  L +       ++  G   Y
Sbjct: 137 ALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPY 191
Query: 279 LAPEFLMHGI----VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE 334
           +APE +         D ++DV++ G+ L EL TGR    Y + + V      + + +  +
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 335 LVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           L + S   E+    +N V    +LC+ +   +RP+  ++++
Sbjct: 250 LSN-SEEREFSPSFINFV----NLCLTKDESKRPKYKELLK 285

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     +E ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 95  SPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTAD 148
           S   ++   E + A    +    +G+G +  VY+G  +          VAIK +    + 
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 149 EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKL--- 204
               +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L  ++  +   
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 205 ------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                       ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + E   +    K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 118 IGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G +  VY+G  R+   G+    VA+K +    +     +FL+E  +M      +  +
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 172 LLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI---------RYKIALGVAEGLL 221
           LLG   +G    +V+EL  +G L S L  ++ + +              ++A  +A+G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL+    ++ +HRD+ A N ++  DF  +I DFG+ + + E   +    K      ++AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           E L  G+    +D+++FGV+L E+ +       ++Q      + +     ++ ++D    
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY----QGLSNEQVLKFVMDGGYL 250
Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           D+ D     +  L   +C Q +   RP   ++V LL+ +L
Sbjct: 251 DQPDNCPERVTDL-MRMCWQFNPKMRPTFLEIVNLLKDDL 289

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNTAKLLG- 174
           IG+G Y  V+K R R+ GQ+VAIK+      D +I    L E+ ++  + HPN   LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR-IIH 233
           +  +  +H+V E   +  L  L     ++ + G+   +   +    L     C +   IH
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL-----DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTFGYLAPEFLMHGI-VD 290
           RD+K  NIL+T+    ++CDFG A+ L  P  +    ++    T  Y +PE L+      
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA----TRWYRSPELLVGDTQYG 181
Query: 291 EKTDVFAFGVLLLELVTG 308
              DV+A G +  EL++G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 158 LGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKL---------KWG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++  +            
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
              ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DFG+ + + E   + 
Sbjct: 129 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              K      +++PE L  G+    +DV++FGV+L E+ T
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 152 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML 208
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I+LEL   G L S L   + +      L       +A  +A
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 142
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 143 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 199
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSE 157
           E + A    +    +G+G +  VY+G  +          VAIK +    +     +FL+E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 158 LGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLK---------WG 207
             +M   +  +  +LLG   +G    +++EL   G L S L  ++ +++           
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
              ++A  +A+G+ YL+     + +HRD+ A N  + EDF  +I DFG+ + + E   + 
Sbjct: 126 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
              K      +++PE L  G+    +DV++FGV+L E+ T       ++Q      + + 
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY----QGLS 232
Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
               +R +++  L D+ D    +++L    +C Q +   RP   +++  ++
Sbjct: 233 NEQVLRFVMEGGLLDKPDNCP-DMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 112/226 (49%), Gaps = 11/226 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V K + R   L+  ++L        I +  + EL ++   + P 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L   K ++   I  K+++ V  GL YL E  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLRE-- 132
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y+APE L   
Sbjct: 133 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMAPERLQGT 188
Query: 288 IVDEKTDVFAFGVLLLELVTGRRALDY--SQQSLVLWARPMIKRNE 331
               ++D+++ G+ L+EL  GR  +    +++   ++ RP++   E
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEE 234

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 111/251 (44%), Gaps = 28/251 (11%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++  +H N  + +G  ++     I++
Sbjct: 68  GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILM 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVF 296
           N LLT        +I DFG+A+ +     +           ++ PE  M GI   KTD +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 297 AFGVLLLELVT 307
           +FGVLL E+ +
Sbjct: 245 SFGVLLWEIFS 255

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 28/251 (11%)
Query: 79  GIDMPRNLFVNSYDSQSPQKIF-----SLYELQSAT-NNFSFENLIGKGGYAEVYKGRLR 132
           GI    NL+   +   +P   F     S+ +L+     N +    +G G + EVY+G++ 
Sbjct: 11  GIPTTENLY---FQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVS 67
Query: 133 ------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL 185
                 +   VA+K L    +++   DFL E  I++  +H N  + +G  ++     I+L
Sbjct: 68  GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 127
Query: 186 ELSPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA 239
           EL   G L S L   + +      L       +A  +A G  YL E      IHRDI A 
Sbjct: 128 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAAR 184
Query: 240 NILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVF 296
           N LLT        +I DFG+A+ +     +           ++ PE  M GI   KTD +
Sbjct: 185 NCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244
Query: 297 AFGVLLLELVT 307
           +FGVLL E+ +
Sbjct: 245 SFGVLLWEIFS 255

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 139/302 (46%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 3   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 62
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 63  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 122
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HR++ A N ++  DF  +I DFG+ + 
Sbjct: 123 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E   +    K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 234 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPNMRPTFLEIVNLLKD 288
Query: 380 NL 381
           +L
Sbjct: 289 DL 290

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G+  Y 
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFCGSPPYA 179
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G+  Y 
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFCGSPPYA 179
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N +    +G G + EVY+G++       +   VA+K L    +++   DFL E  I++  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 165 DHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEK------LKWGIRYKIALGVA 217
           +H N  + +G  ++     I++EL   G L S L   + +      L       +A  +A
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            G  YL E      IHRDI A N LLT        +I DFG+A+ +     +        
Sbjct: 151 CGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML 207
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE  M GI   KTD ++FGVLL E+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 139/302 (46%), Gaps = 30/302 (9%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN---GQL---VAIKRLTRGTADE 149
           P  ++   E + +    +    +G+G +  VY+G  R+   G+    VA+K +    +  
Sbjct: 4   PSSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR 63
Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGI 208
              +FL+E  +M      +  +LLG   +G    +V+EL  +G L S L  ++ + +   
Sbjct: 64  ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP 123
Query: 209 ---------RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                      ++A  +A+G+ YL+    ++ +HR++ A N ++  DF  +I DFG+ + 
Sbjct: 124 GRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRD 180
Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           + E   +    K      ++APE L  G+    +D+++FGV+L E+ +       ++Q  
Sbjct: 181 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 234
Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
               + +     ++ ++D    D+ D     +  L   +C Q +   RP   ++V LL+ 
Sbjct: 235 ----QGLSNEQVLKFVMDGGYLDQPDNCPERVTDL-MRMCWQFNPNMRPTFLEIVNLLKD 289
Query: 380 NL 381
           +L
Sbjct: 290 DL 291

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQ----------RRIIHRDIKAANILLTEDFEP 249
               L+    + IA   A     LH   Q          +  IHRD+ A N+LLT     
Sbjct: 144 KSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +I DFGLA+ +     +           ++APE +   +   ++DV+++G+LL E+ +
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA++ + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + + +  G+  Y 
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDEFCGSPPYA 179
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 26/241 (10%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEKLKWGIRYKIALG-------------VAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
               L+    + IA               VA+G+ +L     +  IHRD+ A N+LLT  
Sbjct: 144 KSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 200
Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
              +I DFGLA+ +     +           ++APE +   +   ++DV+++G+LL E+ 
Sbjct: 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
Query: 307 T 307
           +
Sbjct: 261 S 261

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G   Y 
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDAFCGAPPYA 179
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 107 SATNNFSFENL---------IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLS 156
           S   N  F+ L         +G+G Y  VYK +   G++VA+KR+     DE I +  + 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL- 214
           E+ ++  + HPN   L+     E  + +V E      L  +L   K  L+   + KI L 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLY 126
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISK 271
            +  G+ + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+   +P   +TH  +  
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-- 181
Query: 272 VEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGR 309
              T  Y AP+ LM         D+++ G +  E++TG+
Sbjct: 182 ---TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 107 SATNNFSFENL---------IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLS 156
           S   N  F+ L         +G+G Y  VYK +   G++VA+KR+     DE I +  + 
Sbjct: 9   SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 157 ELGIMAHVDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL- 214
           E+ ++  + HPN   L+     E  + +V E      L  +L   K  L+   + KI L 
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ-DSQIKIYLY 126
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISK 271
            +  G+ + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+   +P   +TH  +  
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-- 181
Query: 272 VEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGR 309
              T  Y AP+ LM         D+++ G +  E++TG+
Sbjct: 182 ---TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 17/215 (7%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA++ + +   +   +     E+ IM  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEG 219
           ++HPN  KL      E  +++V+E +  G +   L     MKEK       +I   V   
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
             Y H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G+  Y 
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFCGSPPYA 179
Query: 280 APEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
           APE       D  + DV++ GV+L  LV+G    D
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 171
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 170
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 171
Query: 281 PEFLM-HGIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 170
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 123
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 124 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 175
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +         +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 32/245 (13%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGM 200
            +   ADE  A  +SEL IM+H+  H N   LLG    GG   VL ++       LL  +
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFL 141
Query: 201 KEKLKWGIRYK------------------IALGVAEGLLYLHEGCQRRIIHRDIKAANIL 242
           + K   G+ Y                    +  VA+G+ +L     +  IHRD+ A N+L
Sbjct: 142 RRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 198
Query: 243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
           LT     +I DFGLA+ +     +           ++APE +   +   ++DV+++G+LL
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 258
Query: 303 LELVT 307
            E+ +
Sbjct: 259 WEIFS 263

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHPN 168
           N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ IM  ++HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLH 224
             KL      E  +++V+E +  G +   L     MKEK       +I   V     Y H
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YCH 123
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G+  Y APE  
Sbjct: 124 ---QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFCGSPPYAAPELF 177
Query: 285 MHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
                D  + DV++ GV+L  LV+G    D
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 172
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +         +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 171
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 126
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 178
Query: 281 PEFLM-HGIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLSFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 171
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 126
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 127 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 178
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSP----NGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSP----NGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L      GM+          E++ +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR--NGQLV--AIKRLTRGT-ADEIIADFLSELGIMAHV 164
             F+   ++GKG +  V + +L+  +G  V  A+K L     A   I +FL E   M   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 165 DHPNTAKLLGYGI----EGGMHIVLELSP---NGSLASLLYGMK-----EKLKWGIRYKI 212
           DHP+ AKL+G  +    +G + I + + P   +G L + L   +       L      + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTIS 270
            + +A G+ YL     R  IHRD+ A N +L ED    + DFGL++  +  + +     S
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           K+     +LA E L   +    +DV+AFGV + E++T
Sbjct: 200 KL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT--IS 270
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L     H T    
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAK 174
Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              GT  Y++PE +     +EK+D+++ G LL EL
Sbjct: 175 TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELS----PNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E       +   AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 117 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L  G   ++ + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 190 NGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            GSL   L     G+ + L +      A  + EG+ YLH    +  IHR + A N+LL  
Sbjct: 97  LGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLH---AQHYIHRALAARNVLLDN 147
Query: 246 DFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE 304
           D   +I DFGLAK +PE   ++ + +  +    + APE L        +DV++FGV L E
Sbjct: 148 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYE 207
Query: 305 LVT 307
           L+T
Sbjct: 208 LLT 210

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 26/214 (12%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
             KLL     E  +++V E   +  L     AS L G+   L     +++     +GL +
Sbjct: 63  IVKLLDVIHTENKLYLVFE-HVHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAF 117
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYL 279
            H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y 
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYR 169
Query: 280 APEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L     +H  S  
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----NHDTSFA 173
Query: 273 E---GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
           +   GT  Y++PE +     +EK+D+++ G LL EL
Sbjct: 174 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 127/276 (46%), Gaps = 24/276 (8%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ ++  + +  +  LQ    ++    +IG+G + EV   R +  Q 
Sbjct: 42  LDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQK 101
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 102 VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 158
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L       +IHRD+K  N+LL +    
Sbjct: 159 GGDLVNLMSNYDVPEKWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 213
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + E    H  + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 214 KLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 272
Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           + G     Y+   +  +++ M  +N +    DA ++
Sbjct: 273 LVGDTPF-YADSLVGTYSKIMDHKNSLCFPEDAEIS 307

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGYLAP 281
           H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 171
Query: 282 EFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           E L+         D+++ G +  E+VT RRAL
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 114 FENL--IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTA 170
           FE +  +G G    V+K   +   LV  ++L        I +  + EL ++   + P   
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  + 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLRE--KH 143
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L     
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHY 199
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW 322
             ++D+++ G+ L+E+  GR  +     S+ ++
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIF 232

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 116
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 169
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L  G   ++ + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 190 NGSLASLL----YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            GSL   L     G+ + L +      A  + EG+ YLH    +  IHR + A N+LL  
Sbjct: 96  LGSLRDYLPRHCVGLAQLLLF------AQQICEGMAYLH---AQHYIHRALAARNVLLDN 146
Query: 246 DFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE 304
           D   +I DFGLAK +PE   ++ + +  +    + APE L        +DV++FGV L E
Sbjct: 147 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYE 206
Query: 305 LVT 307
           L+T
Sbjct: 207 LLT 209

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSEL 158
           +++S    +   + +G+G +A VYK R +N  Q+VAIK++  G      D I    L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 159 GIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  + HPN   LL  +G +  + +V +      L  ++      L         L   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGT 275
           +GL YLH   Q  I+HRD+K  N+LL E+   ++ DFGLAK    P +   H +     T
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV----T 175
Query: 276 FGYLAPEFL----MHGIVDEKTDVFAFGVLLLELV 306
             Y APE L    M+G+     D++A G +L EL+
Sbjct: 176 RWYRAPELLFGARMYGV---GVDMWAVGCILAELL 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 38/225 (16%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHP 167
           +N     LIG+G Y  VYKG L + + VA+K  +         +F++E  I  +  ++H 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHD 67
Query: 168 NTAKLL----GYGIEGGMH--IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           N A+ +        +G M   +V+E  PNGSL    Y       W    ++A  V  GL 
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 222 YLHEGCQR------RIIHRDIKAANILLTEDFEPQICDFGLAKWL-------PEQWTHHT 268
           YLH    R       I HRD+ + N+L+  D    I DFGL+  L       P +  +  
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 269 ISKVEGTFGYLAPEFLMHGIVD--------EKTDVFAFGVLLLEL 305
           IS+V GT  Y+APE L  G V+        ++ D++A G++  E+
Sbjct: 186 ISEV-GTIRYMAPEVL-EGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGYLAP 281
           H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y AP
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 171
Query: 282 EFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           E L+         D+++ G +  E+VT RRAL
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFL-SELGIMA 162
           + S   ++     IG G Y    K R + +G+++  K L  G+  E     L SE+ ++ 
Sbjct: 1   MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAE 218
            + HPN  +     I+     ++IV+E    G LAS++  G KE+    +  +  L V  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMT 118
Query: 219 GLLYLHEGCQRR------IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
            L    + C RR      ++HRD+K AN+ L      ++ DFGLA+ L          + 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEF 176
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
            GT  Y++PE +     +EK+D+++ G LL EL
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 22/237 (9%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 84
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 85  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 143
Query: 200 MKEK---------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
             E          L+       +  VA+G+ +L     +  IHRD+ A N+LLT     +
Sbjct: 144 KAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 200
Query: 251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           I DFGLA+ +     +           ++APE +   +   ++DV+++G+LL E+ +
Sbjct: 201 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 120
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 173
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 118
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 119 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 171
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLE-LSPNGSL---ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E LS +      AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 120 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 109/215 (50%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLE-LSPNGSL---ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E LS +      AS L G+   L     +++     +GL
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 117
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 170
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTR-----GTADEIIADFLSELGIMAHVDHPNTAK 171
           ++G+G +  V +G L+     ++K   +      ++   I +FLSE   M    HPN  +
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 172 LLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRY-------KIALGVAE 218
           LLG  IE          ++L     G L +  Y +  +L+ G ++       K  + +A 
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTF 276
           G+ YL     R  +HRD+ A N +L +D    + DFGL+K  +  + +    I+K+    
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PV 213
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++A E L   +   K+DV+AFGV + E+ T
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 120
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTISKVEGTFGYLAP 281
           H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y AP
Sbjct: 121 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 173
Query: 282 EFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           E L+         D+++ G +  E+VT RRAL
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 184
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 185 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 240
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 241 HYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFC 122
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAP 281
           H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y AP
Sbjct: 123 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAP 175
Query: 282 EFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           E L+         D+++ G +  E+VT RRAL
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 22/237 (9%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 17  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 76
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG 199
            +   ADE  A  +SEL IM+H+  H N   LLG    GG + ++ E    G L + L  
Sbjct: 77  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRR 135
Query: 200 MKEK---------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
             E          L+       +  VA+G+ +L     +  IHRD+ A N+LLT     +
Sbjct: 136 KAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAK 192
Query: 251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           I DFGLA+ +     +           ++APE +   +   ++DV+++G+LL E+ +
Sbjct: 193 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T+    GT  ++APE +       K D+++ G++ +E++ G
Sbjct: 174 STMV---GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 125
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L ++  +  +    GT  Y++PE L   
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV----GTRSYMSPERLQGT 181
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++  +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           +  NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HPN  KLL     E  +++V E           AS L G+   L     +++     +GL
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL----QGL 119
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEGTFGY 278
            + H     R++HRD+K  N+L+  +   ++ DFGLA+   +P +   H +     T  Y
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWY 172
Query: 279 LAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
            APE L+         D+++ G +  E+VT RRAL
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 18/214 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM--A 162
           Q+  N+      +G G   +V+K R R  G ++A+K++ R    E     L +L ++  +
Sbjct: 21  QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKS 80
Query: 163 HVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGL 220
           H D P   +  G  I    + I +EL   G+ A  L   M+  +   I  K+ + + + L
Sbjct: 81  H-DCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            YL E  +  +IHRD+K +NILL E  + ++CDFG++  L +        +  G   Y+A
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMA 192
Query: 281 PEFL-----MHGIVDEKTDVFAFGVLLLELVTGR 309
           PE +          D + DV++ G+ L+EL TG+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 149
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 205
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+ ++   T  E + +  + E+ ++  ++HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 120 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 171
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+ ++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 169 TAKLLGY-GIEGGMHIVLELSPNG----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
             KLL     E  +++V E           AS L G+   L     +++     +GL + 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFC 118
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLA 280
           H     R++HRD+K  N+L+  +   ++ DFGLA+        +TH  +     T  Y A
Sbjct: 119 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-----TLWYRA 170
Query: 281 PEFLMH-GIVDEKTDVFAFGVLLLELVTGRRAL 312
           PE L+         D+++ G +  E+VT RRAL
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 33  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 89
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 90  GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLH---NN 145
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L +D + +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + D+++ G +L  L+ G+   + S
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLH---NN 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L +D + +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + D+++ G +L  L+ G+   + S
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 178
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 178
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 178
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  ++F    ++G+G + +V+      R  +G L A+K L + T    D +      E 
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM--ER 81
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+A V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 82  DILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 140
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS-KVEGTF 276
            GL +LH      II+RD+K  NILL E+   ++ DFGL+K   E   H   +    GT 
Sbjct: 141 LGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTV 194
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            Y+APE +         D +++GVL+ E++TG
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLH---NN 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L +D + +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + D+++ G +L  L+ G+   + S
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 130/289 (44%), Gaps = 35/289 (12%)
Query: 105 LQSATNNFSF--ENL-----IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS 156
            Q A  NF    ++L     +G+G Y  V K R + +GQ+ A+KR+      +     L 
Sbjct: 22  FQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLX 81
Query: 157 ELGIMAH-VDHPNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYK 211
           +L I    VD P T    G    EG + I  EL  + SL      + +K   +   I  K
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREGDVWICXELX-DTSLDKFYKQVIDKGQTIPEDILGK 140
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           IA+ + + L +LH   +  +IHRD+K +N+L+    + + CDFG++ +L +       + 
Sbjct: 141 IAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA- 197
Query: 272 VEGTFGYLAPEFLMHGIVDE----KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI 327
             G   Y APE +   +  +    K+D+++ G+  +EL   R   D        W  P  
Sbjct: 198 --GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS-------WGTPFQ 248
Query: 328 KRNEIRELVDASL-ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +  ++ E     L AD++    ++      S C++++S  RP   ++ Q
Sbjct: 249 QLKQVVEEPSPQLPADKFSAEFVDF----TSQCLKKNSKERPTYPELXQ 293

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              S++ GT  ++APE +       K D+++ G++ +E++ G
Sbjct: 174 ---SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ Y+        +  G++V    L +    E ++   +E+ I   +D+P+  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS---TEIAIHKSLDNPHVV 105
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   +++VLE+    SL  L    K   +   RY +   + +G+ YLH     
Sbjct: 106 GFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLH---NN 161
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L +D + +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + D+++ G +L  L+ G+   + S
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 178
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 9/202 (4%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   +   LV  ++L        I +  + EL ++   + P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
                G +  +G + I +E    GSL  +L     ++   I  K+++ V +GL YL E  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLRE-- 122
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE L   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGT 178
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
               ++D+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I A ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 28/215 (13%)
Query: 118 IGKGGYAEVY--------KGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V         K + +    VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY-----GMK----------EKLKWGIRYKI 212
              LLG   + G +++++  +  G+L   L      GM+          E++ +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+ +     +   +  
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                ++APE L   +   ++DV++FGVL+ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 106/243 (43%), Gaps = 22/243 (9%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDY---SQQSLVLWARPMIKRNEIRELVDA 338
               H    E  DV++ G++L  ++ G    D    S Q    W       N  +++  A
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSA 236
Query: 339 SLA 341
            LA
Sbjct: 237 PLA 239

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 62  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 116
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 117 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              S + GT  ++APE +       K D+++ G++ +E++ G
Sbjct: 174 ---SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTAD 148
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI++  L +    
Sbjct: 3   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 62
Query: 149 EIIADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           E+I   ++E+ +M    +PN    L  Y +   + +V+E    GSL  ++   +  +  G
Sbjct: 63  ELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG 117
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL-AKWLPEQWTH 266
               +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG  A+  PEQ   
Sbjct: 118 QIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 174
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
              S + GT  ++APE +       K D+++ G++ +E++ G
Sbjct: 175 ---SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 213

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           +K  N+L+  + E +I DFGLA+   +P  ++TH  +     T  Y AP+ LM       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKYST 180
Query: 293 T-DVFAFGVLLLELVTG 308
           T D+++ G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 38/314 (12%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK----GRLRN--GQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +    G +++     VA+K L
Sbjct: 25  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 84
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 85  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 144
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           T     +ICDFGLA+ +     +           ++APE + + +   ++DV+++G+ L 
Sbjct: 202 THGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 261
Query: 304 ELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQS 363
           EL +   +  Y    +      MIK        + + A+ YD  +          C    
Sbjct: 262 ELFSLGSS-PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT---------CWDAD 311
Query: 364 SIRRPQMSQVVQLL 377
            ++RP   Q+VQL+
Sbjct: 312 PLKRPTFKQIVQLI 325

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           +K  N+L+  + E +I DFGLA+   +P  ++TH  +     T  Y AP+ LM       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDVLMGSKKYST 180
Query: 293 T-DVFAFGVLLLELVTG 308
           T D+++ G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H N   LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 174 ---GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGC 227
                 +       L +    +    + G+K   EK+++     +   + +GL Y+H   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHSAG 146
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              ++HRD+K  N+ + ED E +I DFGLA+    + T + +++      Y APE ++  
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSW 198
Query: 288 I-VDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
           +  ++  D+++ G ++ E++TG+   +  DY  Q
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH G    I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH-GIG--IT 127
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 186
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
             E  DV++ G++L  ++ G    D    S
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGYG 176
           IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N  KL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV- 68
Query: 177 IEGGMHIVLELSP-NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
           I     +VL     +  L  LL   +  L+        L +  G+ Y H+   RR++HRD
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           +K  N+L+  + E +I DFGLA+   +P  ++TH  +     T  Y AP+ LM       
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPDVLMGSKKYST 180
Query: 293 T-DVFAFGVLLLELVTG 308
           T D+++ G +  E+V G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH G    I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH-GIG--IT 126
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA- 185
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
             E  DV++ G++L  ++ G    D    S
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-- 173
           +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H N   LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 174 ---GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGC 227
                 +       L +    +    + GM+   EK+++     +   + +GL Y+H   
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHSAG 164
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              ++HRD+K  N+ + ED E +I DFGLA+    + T + +++      Y APE ++  
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSW 216
Query: 288 I-VDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
           +  ++  D+++ G ++ E++TG+   +  DY  Q
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHSAG- 143
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +       T  Y APE +++ +
Sbjct: 144 --IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV-----ATRWYRAPEIMLNWM 196
Query: 289 -VDEKTDVFAFGVLLLELVTGR 309
             ++  D+++ G ++ EL+ G+
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK 218

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 38/314 (12%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK----GRLRN--GQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +    G +++     VA+K L
Sbjct: 25  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 84
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 85  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 144
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           T     +ICDFGLA+ +     +           ++APE + + +   ++DV+++G+ L 
Sbjct: 202 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 261
Query: 304 ELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQS 363
           EL +   +  Y    +      MIK        + + A+ YD  +          C    
Sbjct: 262 ELFSLGSS-PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT---------CWDAD 311
Query: 364 SIRRPQMSQVVQLL 377
            ++RP   Q+VQL+
Sbjct: 312 PLKRPTFKQIVQLI 325

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 38/314 (12%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK----GRLRN--GQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +    G +++     VA+K L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 178
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           T     +ICDFGLA+ +     +           ++APE + + +   ++DV+++G+ L 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 304 ELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQS 363
           EL +   +  Y    +      MIK        + + A+ YD  +          C    
Sbjct: 239 ELFSLGSS-PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT---------CWDAD 288
Query: 364 SIRRPQMSQVVQLL 377
            ++RP   Q+VQL+
Sbjct: 289 PLKRPTFKQIVQLI 302

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                R++HRD+K  NIL+T   + ++ DFGLA+    Q     ++ V  T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVL 191
Query: 285 MHGIVDEKTDVFAFGVLLLEL 305
           +        D+++ G +  E+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEM 212

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 38/314 (12%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK----GRLRN--GQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +    G +++     VA+K L
Sbjct: 20  NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 79
Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG  +V+ E    G L + L   
Sbjct: 80  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 139
Query: 201 KEKL-----------------KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                           +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 140 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 196
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           T     +ICDFGLA+ +     +           ++APE + + +   ++DV+++G+ L 
Sbjct: 197 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 256
Query: 304 ELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQS 363
           EL +   +  Y    +      MIK        + + A+ YD  +          C    
Sbjct: 257 ELFSLGSS-PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT---------CWDAD 306
Query: 364 SIRRPQMSQVVQLL 377
            ++RP   Q+VQL+
Sbjct: 307 PLKRPTFKQIVQLI 320

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 111 NFSFENLIGKGGYAEVYK----GRLRNGQ--LVAIKRLTRGTADEIIADFLSELGIMAHV 164
           N  F  ++G G + +V      G  + G    VA+K L            +SEL +M  +
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 165 -DHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYK---------- 211
             H N   LLG   + G ++++ E    G L + L   +EK     I Y+          
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 212 -----------IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL 260
                       A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                +           ++APE L  GI   K+DV+++G+LL E+ +
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---GIGIT 126
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
             E  DV++ G++L  ++ G    D    S
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---GIGIT 126
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
             E  DV++ G++L  ++ G    D    S
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 120
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 121 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 179 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 212

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 87/179 (48%), Gaps = 9/179 (5%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHRD+ A N+LL  D   
Sbjct: 119 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLV 173
Query: 250 QICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +I DFGLAK +PE    + + +  +    + APE L        +DV++FGV L EL+T
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---GIGIT 127
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 186
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDY---SQQSLVLWARPMIKRNEIRELVDASLA 341
             E  DV++ G++L  ++ G    D    S Q    W       N  +++  A LA
Sbjct: 187 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 9/179 (5%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHR++ A N+LL  D   
Sbjct: 102 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLV 156
Query: 250 QICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +I DFGLAK +PE   ++ + +  +    + APE L        +DV++FGV L EL+T
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
           G    I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 103/236 (43%), Gaps = 22/236 (9%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N  K  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 177 IEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
            EG + ++ LE    G L   +    GM E       +++  GV    +YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---GIGIT 126
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----MHGI 288
           HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L     H  
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA- 185
Query: 289 VDEKTDVFAFGVLLLELVTGRRALDY---SQQSLVLWARPMIKRNEIRELVDASLA 341
             E  DV++ G++L  ++ G    D    S Q    W       N  +++  A LA
Sbjct: 186 --EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT GY+APE L
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++ GV+   L+ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIHSAG- 151
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +       T  Y APE +++ +
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-----ATRWYRAPEIMLNWM 204
Query: 289 -VDEKTDVFAFGVLLLELVTGR 309
             ++  D+++ G ++ EL+ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT GY+APE L
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++ GV+   L+ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT GY+APE L
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++ GV+   L+ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 103
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +   R    LG A 
Sbjct: 104 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE--DRALYYLGQAL 160
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWL-PEQWTHHTISK--VE 273
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A  L P+      ++   + 
Sbjct: 161 EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           GT  ++APE +M    D K D+++   ++L ++ G
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 181 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 118 IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
           +G G Y  V   Y  RLR  Q VA+K+L+R     I A     EL ++ H+ H N   LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 174 -----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                   IE    + L  +  G+  + +   +      +++ +   +  GL Y+H    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIHSAG- 151
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             IIHRD+K +N+ + ED E +I DFGLA+   E+ T +       T  Y APE +++ +
Sbjct: 152 --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV-----ATRWYRAPEIMLNWM 204
Query: 289 -VDEKTDVFAFGVLLLELVTGR 309
             ++  D+++ G ++ EL+ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 139/308 (45%), Gaps = 30/308 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 36  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 96  VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 152
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 153 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 207
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + ++      + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSI 365
           + G     Y+   +  +++ M  +N +      +  D+ D  +    L+ A L  ++  +
Sbjct: 267 LVGDTPF-YADSLVGTYSKIMNHKNSL------TFPDDNDISKEAKNLICAFLTDREVRL 319
Query: 366 RRPQMSQV 373
            R  + ++
Sbjct: 320 GRNGVEEI 327

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 9/179 (5%)
Query: 133 NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSP 189
            G++VA+K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            GSL   L   +  +        A  + EG+ YLH    +  IHR++ A N+LL  D   
Sbjct: 102 LGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLV 156
Query: 250 QICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +I DFGLAK +PE   ++ + +  +    + APE L        +DV++FGV L EL+T
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 67  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 119
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +    Y +   + E
Sbjct: 120 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-E 177
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWL-PEQWTHHTISK--VEG 274
           GL YLH    RRI+H D+KA N+LL+ D     +CDFG A  L P+      ++   + G
Sbjct: 178 GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T  ++APE +M    D K D+++   ++L ++ G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAH 163
           Q    N+     IGKG +A+V   R +  G+ VA+K + +   +   +     E+ I   
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV 69
Query: 164 VDHPNTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           ++HPN  KL      E  +++V E +  G +   L       +   R K    +   + Y
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQY 128
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
            H   Q+ I+HRD+KA N+LL  D   +I DFG +    E    + +    G   Y APE
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFSN---EFTFGNKLDAFCGAPPYAAPE 182
Query: 283 FLMHGIVD-EKTDVFAFGVLLLELVTGRRALD 313
                  D  + DV++ GV+L  LV+G    D
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 139/308 (45%), Gaps = 30/308 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 41  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 100
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 101 VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 157
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 158 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 212
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + ++      + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 213 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271
Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSI 365
           + G     Y+   +  +++ M  +N +      +  D+ D  +    L+ A L  ++  +
Sbjct: 272 LVGDTPF-YADSLVGTYSKIMNHKNSL------TFPDDNDISKEAKNLICAFLTDREVRL 324
Query: 366 RRPQMSQV 373
            R  + ++
Sbjct: 325 GRNGVEEI 332

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HPN  
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHEGC 227
            L   Y   G ++++++L   G L   +    EK  +  R   ++   V + + YLH+  
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 228 QRRIIHRDIKAANIL---LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              I+HRD+K  N+L   L ED +  I DFGL+K    +     +S   GT GY+APE L
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++ GV+   L+ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    VY    +  GQ VAI++  L +    E+I   ++E+ +M    +PN    L 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLD 85
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    GSL  ++   +  +  G    +     + L +LH     ++IH
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 140
Query: 234 RDIKAANILLTEDFEPQICDFGL-AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           R+IK+ NILL  D   ++ DFG  A+  PEQ    T+    GT  ++APE +       K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPK 197
Query: 293 TDVFAFGVLLLELVTG 308
            D+++ G++ +E++ G
Sbjct: 198 VDIWSLGIMAIEMIEG 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                R++HRD+K  NIL+T   + ++ DFGLA+    Q     ++ V  T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVL 191
Query: 285 MHGIVDEKTDVFAFGVLLLEL 305
           +        D+++ G +  E+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEM 212

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/308 (23%), Positives = 139/308 (45%), Gaps = 30/308 (9%)
Query: 80  IDMP---RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL 136
           +D P   +N  ++++ S+    I  + +L+    ++    +IG+G + EV   R ++ + 
Sbjct: 41  LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 100
Query: 137 V-AIKRLTRGTADEII-----ADFLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           V A+K L++    E+I     A F  E  IMA  + P   +L   +  +  +++V+E  P
Sbjct: 101 VYAMKLLSKF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMP 157
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G L +L+       KW   Y      AE +L L        IHRD+K  N+LL +    
Sbjct: 158 GGDLVNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 212
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    + ++      + V GT  Y++PE L      G    + D ++ GV L E+
Sbjct: 213 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 271
Query: 306 VTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSI 365
           + G     Y+   +  +++ M  +N +      +  D+ D  +    L+ A L  ++  +
Sbjct: 272 LVGDTPF-YADSLVGTYSKIMNHKNSL------TFPDDNDISKEAKNLICAFLTDREVRL 324
Query: 366 RRPQMSQV 373
            R  + ++
Sbjct: 325 GRNGVEEI 332

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 39/252 (15%)
Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK------GRLRNGQLVAIKRL 142
           NSY    P ++    + +   NN  F   +G G + +V +      G+      VA+K L
Sbjct: 10  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML 69
Query: 143 -TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGM 200
            +   ADE  A  +SEL IM+H+  H N   LLG    GG   VL ++       LL  +
Sbjct: 70  KSTAHADEKEA-LMSELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFL 126
Query: 201 KEKLKWGIRYKIALG-------------------------VAEGLLYLHEGCQRRIIHRD 235
           + K +  +   +A G                         VA+G+ +L     +  IHRD
Sbjct: 127 RRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRD 183
Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
           + A N+LLT     +I DFGLA+ +     +           ++APE +   +   ++DV
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 243
Query: 296 FAFGVLLLELVT 307
           +++G+LL E+ +
Sbjct: 244 WSYGILLWEIFS 255

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 118 IGKGGYAEVYKGR-LRNG-QLVAIKRLTRGTADE-IIADFLSELGIMAHVD---HPNTAK 171
           IG+G Y +V+K R L+NG + VA+KR+   T +E +    + E+ ++ H++   HPN  +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 172 LLGYGI------EGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLH 224
           L           E  + +V E   +  L + L  + E  +       +   +  GL +LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                R++HRD+K  NIL+T   + ++ DFGLA+    Q     ++ V  T  Y APE L
Sbjct: 138 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVL 191
Query: 285 MHGIVDEKTDVFAFGVLLLEL 305
           +        D+++ G +  E+
Sbjct: 192 LQSSYATPVDLWSVGCIFAEM 212

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++ + +  G   A+K  RL     +E++A       
Sbjct: 65  YEYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------- 117
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+  M    +   R    LG A 
Sbjct: 118 -CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE--DRALYYLGQAL 174
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWL-PEQWTHHTISK--VE 273
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A  L P+      ++   + 
Sbjct: 175 EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           GT  ++APE +M    D K D+++   ++L ++ G
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           ++ F  E+ +G+G  + VY+ + +  Q     ++ + T D+ I    +E+G++  + HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPN 109
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR--YKIALGVAEGLLYLHE 225
             KL   +     + +VLEL   G L   +    EK  +  R        + E + YLHE
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHE 166
Query: 226 GCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
                I+HRD+K  N+L      D   +I DFGL+K +  Q    T+    GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCAPE 220
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            L       + D+++ G++   L+ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGIMAHVD 165
           + +     IG G Y  V   R R  GQ VAIK++    A +++ +    L EL I+ H  
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRTLRELKILKHFK 112
Query: 166 HPNTAKL-------LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           H N   +       + YG    +++VL+L     L  +++  +      +RY +   +  
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFL-YQLLR 170
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTF 276
           GL Y+H     ++IHRD+K +N+L+ E+ E +I DFG+A+ L      H     E   T 
Sbjct: 171 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 277 GYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRR 310
            Y APE +  +H    +  D+++ G +  E++  R+
Sbjct: 228 WYRAPELMLSLHEYT-QAIDLWSVGCIFGEMLARRQ 262

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVDHP 167
            ++G G +  V+KG  +  G+ + I    +   D       + + D +  +G    +DH 
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 93
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLL 221
           +  +LLG      + +V +  P GSL   +       G +  L WG++      +A+G+ 
Sbjct: 94  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL E     ++HR++ A N+LL    + Q+ DFG+A  LP        S+ +    ++A 
Sbjct: 148 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT 307
           E +  G    ++DV+++GV + EL+T
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR+ + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISKVEGTFGY 278
              L+   Q  IIHRD+K ANIL++     ++ DFG+A+ + +        + V GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGT---ADEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 77
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 136
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS-KVEGTF 276
             L +LH      II+RD+K  NILL E+   ++ DFGL+K   E   H   +    GT 
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTV 190
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            Y+APE +      +  D ++FGVL+ E++TG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 114 FENL--IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHPNT 169
           +ENL  +G+G Y  V K R ++ G++VAIK+      D+++    + E+ ++  + H N 
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 170 AKLLGYG---------IEGGMHIVL---ELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
             LL             E   H +L   EL PNG            L + +  K    + 
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG------------LDYQVVQKYLFQII 134
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGT 275
            G+ + H      IIHRDIK  NIL+++    ++CDFG A+ L  P +     ++    T
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----T 187
Query: 276 FGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTG 308
             Y APE L+  +   +  DV+A G L+ E+  G
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 34  YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 94  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 151 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 202
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 116/249 (46%), Gaps = 33/249 (13%)
Query: 79  GIDM-PRNLFVNSYDSQSPQKIF------SLYELQSATNNFSFENLIGKGGYAEVYKG-R 130
           G+D+   NL+  S  SQ     +      +++E+     N S    +G G Y  V     
Sbjct: 10  GVDLGTENLYFQSNASQERPTFYRQELNKTIWEVPERYQNLS---PVGSGAYGSVCAAFD 66
Query: 131 LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL-----GYGIEGGMHIV 184
            + G  VA+K+L+R     I A     EL ++ H+ H N   LL        +E    + 
Sbjct: 67  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 126
Query: 185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
           L     G+  + +   ++     +++ I   +  GL Y+H      IIHRD+K +N+ + 
Sbjct: 127 LVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIHSA---DIIHRDLKPSNLAVN 182
Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYLAPEFLMHGI-VDEKTDVFAFGV 300
           ED E +I DFGLA+        HT  ++ G   T  Y APE +++ +  ++  D+++ G 
Sbjct: 183 EDCELKILDFGLAR--------HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 234
Query: 301 LLLELVTGR 309
           ++ EL+TGR
Sbjct: 235 IMAELLTGR 243

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 112 FSFENLIGKGGYAEVYKGR----LRNGQLVAIKRL-----TRGTADEIIADFLSELGIMA 162
           F    ++GKGGY +V++ R       G++ A+K L      R   D   A   +E  I+ 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNILE 76
Query: 163 HVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            V HP    L+  +   G ++++LE    G L   L    E+    +       +AE  +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISM 132
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLA 280
            L    Q+ II+RD+K  NI+L      ++ DFGL K  + +    HT     GT  Y+A
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMA 189
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE LM    +   D ++ G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 198
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 188
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-- 168
           +  +  +G GG+  V +   ++ G+ VAIK+  +  + +    +  E+ IM  ++HPN  
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 169 TAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLL 221
           +A+ +  G++         + +E    G L   L   +    LK G    +   ++  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEGTF 276
           YLHE    RIIHRD+K  NI+L     PQ     I D G AK L +       ++  GT 
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPG--PQRLIHKIIDLGYAKELDQ---GELCTEFVGTL 187
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE 331
            YLAPE L         D ++FG L  E +TG R    + Q +    +   K NE
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-- 168
           +  +  +G GG+  V +   ++ G+ VAIK+  +  + +    +  E+ IM  ++HPN  
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 169 TAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLL 221
           +A+ +  G++         + +E    G L   L   +    LK G    +   ++  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEGTF 276
           YLHE    RIIHRD+K  NI+L     PQ     I D G AK L +       ++  GT 
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPG--PQRLIHKIIDLGYAKELDQ---GELCTEFVGTL 188
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE 331
            YLAPE L         D ++FG L  E +TG R    + Q +    +   K NE
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 243

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  IG G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 197
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVDHP 167
            ++G G +  V+KG  +  G+ + I    +   D       + + D +  +G    +DH 
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG---SLDHA 75
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGVAEGLL 221
           +  +LLG      + +V +  P GSL   +       G +  L WG++      +A+G+ 
Sbjct: 76  HIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL E     ++HR++ A N+LL    + Q+ DFG+A  LP        S+ +    ++A 
Sbjct: 130 YLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVT 307
           E +  G    ++DV+++GV + EL+T
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 110 NNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDH 166
           ++F     IGKG + +V    +    ++ A+K + +    E   + +   EL IM  ++H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 167 PNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK---IALGVAEGLLY 222
           P    L   +  E  M +V++L   G L       +  L+  + +K   + L + E ++ 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDL-------RYHLQQNVHFKEETVKLFICELVMA 127
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           L     +RIIHRD+K  NILL E     I DF +A  LP +     I+ + GT  Y+APE
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPE 184
Query: 283 FLMH---GIVDEKTDVFAFGVLLLELVTGRR 310
                         D ++ GV   EL+ GRR
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLL-- 173
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 174 ------GYG-IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                  Y   +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------PEQWTHHTISKVEGTFGYL 279
            + +I+HRD+KAAN+L+T D   ++ DFGLA+         P ++ +  +     T  Y 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-----TLWYR 196
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVT 307
            PE L+ G  D     D++  G ++ E+ T
Sbjct: 197 PPELLL-GERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           +H      IIHRD+K +N+ + ED E +I DFGLA+        HT  ++ G   T  Y 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYR 189
Query: 280 APEFLMHGI-VDEKTDVFAFGVLLLELVTGR 309
           APE +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           +H      IIHRD+K +N+ + ED E +I DFGLA+        HT  ++ G   T  Y 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYR 189
Query: 280 APEFLMHGI-VDEKTDVFAFGVLLLELVTGR 309
           APE +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGIMAHVD 165
           + +     IG G Y  V   R R  GQ VAIK++    A +++ +    L EL I+ H  
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP--NAFDVVTNAKRTLRELKILKHFK 111
Query: 166 HPNTAKL-------LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           H N   +       + YG    +++VL+L     L  +++  +      +RY +   +  
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYFL-YQLLR 169
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTF 276
           GL Y+H     ++IHRD+K +N+L+ E+ E +I DFG+A+ L      H     E   T 
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 277 GYLAPEFL--MHGIVDEKTDVFAFGVLLLELVTGRR 310
            Y APE +  +H    +  D+++ G +  E++  R+
Sbjct: 227 WYRAPELMLSLHEYT-QAIDLWSVGCIFGEMLARRQ 261

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD--FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y EV   R +   +    ++ R T+    ++   L E+ ++  +DHPN  KL  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 176 GIEG-GMHIVLELSPNGSL-ASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
             +    ++V+E    G L   +++ MK  ++   +  K  L    G+ YLH   +  I+
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLH---KHNIV 158
Query: 233 HRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           HRD+K  N+LL    +D   +I DFGL+     Q     + +  GT  Y+APE L     
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLRKK-Y 214
Query: 290 DEKTDVFAFGVLLLELVTG 308
           DEK DV++ GV+L  L+ G
Sbjct: 215 DEKCDVWSIGVILFILLAG 233

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 38/293 (12%)
Query: 110 NNFSFENLIGKGGYAEVYK----GRLRN--GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           N  SF   +G G + +V +    G +++     VA+K L            +SEL ++++
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 164 V-DHPNTAKLLGYGIEGGMHIVL-ELSPNGSLASLLYGMKEKL----------------- 204
           + +H N   LLG    GG  +V+ E    G L + L   ++                   
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
                   +  VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA+ +    
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR 324
            +           ++APE + + +   ++DV+++G+ L EL +   +  Y    +     
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-PYPGMPVDSKFY 274
Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
            MIK        + + A+ YD  +          C     ++RP   Q+VQL+
Sbjct: 275 KMIKEGFRMLSPEHAPAEMYDIMKT---------CWDADPLKRPTFKQIVQLI 318

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 212
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 149
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIM 201
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 103 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 211
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTA---DEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 78
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 79  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 137
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS-KVEGTF 276
             L +LH      II+RD+K  NILL E+   ++ DFGL+K   E   H   +    GT 
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTV 191
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            Y+APE +      +  D ++FGVL+ E++TG
Sbjct: 192 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTA---DEIIADFLSEL 158
           ++  + F    ++G+G + +V+  +  +G    QL A+K L + T    D +      E 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ER 77
Query: 159 GIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            I+  V+HP   KL   +  EG ++++L+    G L + L       +  +++ +A  +A
Sbjct: 78  DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELA 136
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS-KVEGTF 276
             L +LH      II+RD+K  NILL E+   ++ DFGL+K   E   H   +    GT 
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTV 190
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            Y+APE +      +  D ++FGVL+ E++TG
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 194
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           +H      IIHRD+K +N+ + ED E +I DFGLA+        HT  ++ G   T  Y 
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYR 185
Query: 280 APEFLMHGI-VDEKTDVFAFGVLLLELVTGR 309
           APE +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 110 NNFSFENLIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F+F  ++GKG + +V    R    +L AIK L +     D+ +   + E  ++A +D 
Sbjct: 19  TDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLY 222
           P     L   +     ++ V+E    G L   +Y +++  K K       A  ++ GL +
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISIGLFF 135
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH   +R II+RD+K  N++L  +   +I DFG+ K         T  +  GT  Y+APE
Sbjct: 136 LH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPE 190
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            + +    +  D +A+GVLL E++ G+   D
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 197
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPE 199
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 149
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIM 201
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 197
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 83  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 140 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 191
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 194
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 176 G---------IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 141
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------PEQWTHHTISKVEGTFGYL 279
            + +I+HRD+KAAN+L+T D   ++ DFGLA+         P ++ +  +     T  Y 
Sbjct: 142 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-----TLWYR 195
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVT 307
            PE L+ G  D     D++  G ++ E+ T
Sbjct: 196 PPELLL-GERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           +H      IIHRD+K +N+ + ED E +I DFGLA+        HT  ++ G   T  Y 
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVATRWYR 209
Query: 280 APEFLMHGI-VDEKTDVFAFGVLLLELVTGR 309
           APE +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 91  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 199
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 194
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 194
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 95  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 203
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 194
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 86  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 143 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 194
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 154
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 206
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 112 FSFENLIGKGGYAEVYKGR----LRNGQLVAIKRL-----TRGTADEIIADFLSELGIMA 162
           F    ++GKGGY +V++ R       G++ A+K L      R   D   A   +E  I+ 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD--TAHTKAERNILE 76
Query: 163 HVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            V HP    L+  +   G ++++LE    G L   L    E+    +       +AE  +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL----EREGIFMEDTACFYLAEISM 132
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-GTFGYLA 280
            L    Q+ II+RD+K  NI+L      ++ DFGL K   E     T++    GT  Y+A
Sbjct: 133 ALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHXFCGTIEYMA 189
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE LM    +   D ++ G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 154
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 206
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 198
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 89  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 146 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 197
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 194
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 95  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 152 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 203
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +    +     +++ I   +  GL Y+H
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-YQILRGLKYIH 138
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 190
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 198
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 81  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 189
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 90  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 147 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 198
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 102
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 103 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 160 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 211
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELG 159
           +++    +F    ++GKG + +V+    +   Q  AIK L +      D++    + +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 160 IMAHVDHPN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGV 216
           +    +HP  T     +  +  +  V+E    G L   +Y ++   K+ +      A  +
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 128
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
             GL +LH    + I++RD+K  NILL +D   +I DFG+ K           ++  GT 
Sbjct: 129 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTP 183
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            Y+APE L+    +   D ++FGVLL E++ G+
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 176 G---------IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +G +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------PEQWTHHTISKVEGTFGYL 279
            + +I+HRD+KAAN+L+T D   ++ DFGLA+         P ++ +  +     T  Y 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-----TLWYR 196
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVT 307
            PE L+ G  D     D++  G ++ E+ T
Sbjct: 197 PPELLL-GERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 80  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 188
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 81  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 138 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 189
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELG 159
           Y LQ    +F     +G G +  V+  R R NG+  A+K L +     +  +     E  
Sbjct: 3   YSLQ----DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           +++ V HP   ++ G +     + ++++    G L SLL    ++    +    A  V  
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCL 117
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YLH    + II+RD+K  NILL ++   +I DFG AK++P+         + GT  Y
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           +APE +     ++  D ++FG+L+ E++ G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 82  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 139 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 190
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG---TFGYL 279
           +H      IIHRD+K +N+ + ED E +I DFGLA+        HT  ++ G   T  Y 
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGXVATRWYR 189
Query: 280 APEFLMHGI-VDEKTDVFAFGVLLLELVTGR 309
           APE +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 103
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 104 IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 161 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 212
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           QR II+RD+K  N+LL +D   +I D GLA  L    T        GT G++APE L+  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
             D   D FA GV L E++  R
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 107 IGLLDVFTPAR---SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE
Sbjct: 164 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 215
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/258 (30%), Positives = 116/258 (44%), Gaps = 38/258 (14%)
Query: 58  KSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL 117
           +S+  L P ++S R  +S  E +  P       YD   P+  F          +F   + 
Sbjct: 21  QSMHQLQPRRVSFRGEAS--ETLQSP------GYDPSRPESFFQ--------QSFQRLSR 64
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLT---RGTADEIIADFLSELGIMAHV-DHPNTAKL 172
           +G G Y EV+K R + +G+L A+KR     RG  D   A  L+E+G    V  HP   +L
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR--ARKLAEVGSHEKVGQHPCCVRL 122
Query: 173 LGYGIEGG-MHIVLEL-SPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                EGG +++  EL  P+       +G  + E   WG      L +A    +LH    
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA----HLHS--- 175
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           + ++H D+K ANI L      ++ DFGL   L E  T       EG   Y+APE L+ G 
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGL---LVELGTAGAGEVQEGDPRYMAPE-LLQGS 231
Query: 289 VDEKTDVFAFGVLLLELV 306
                DVF+ G+ +LE+ 
Sbjct: 232 YGTAADVFSLGLTILEVA 249

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V     +++G  +A+K+L+R     I A     EL ++ H+ H N   LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 176 GIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
                    LE   +  L + L G         +KL       +   +  GL Y+H    
Sbjct: 119 FTPA---TSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA-- 173
Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +++ +
Sbjct: 174 -DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIMLNWM 227
Query: 289 -VDEKTDVFAFGVLLLELVTGR 309
             +   D+++ G ++ EL+TGR
Sbjct: 228 HYNMTVDIWSVGCIMAELLTGR 249

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 125
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V GT  Y
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G   EV     R   + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 170 AKLLGYGIEGGM-HIVLELSPNGSLASLL---YGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            K  G+  EG + ++ LE    G L   +    GM E       +++  GV    +YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH- 121
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
                I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L 
Sbjct: 122 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 ---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
               H    E  DV++ G++L  ++ G    D    S
Sbjct: 180 RREFHA---EPVDVWSCGIVLTAMLAGELPWDQPSDS 213

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           QR II+RD+K  N+LL +D   +I D GLA  L    T        GT G++APE L+  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
             D   D FA GV L E++  R
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           QR II+RD+K  N+LL +D   +I D GLA  L    T        GT G++APE L+  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
             D   D FA GV L E++  R
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 117 LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA--DFLSELGIMAHVDHPNTAKLL 173
           ++G+GG+ EV+  +++  G+L A K+L +    +       + E  I+A V H      L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSL 250
Query: 174 GYGIEG--GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
            Y  E    + +V+ +   G +   +Y + E    G +   A+     +  GL +LH   
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH--- 306
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           QR II+RD+K  N+LL +D   +I D GLA  L    T        GT G++APE L+  
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364
Query: 288 IVDEKTDVFAFGVLLLELVTGR 309
             D   D FA GV L E++  R
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 125
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEF 283
               R +++RDIK  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE 
Sbjct: 126 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEV 179
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           L         D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 226

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEF 283
               R +++RDIK  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE 
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEV 176
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           L         D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I D+GLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEF 283
               R +++RDIK  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE 
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAPEV 176
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           L         D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 11/216 (5%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV 164
             +NF F  ++GKG + +V   R++  G L A+K L +     D+ +   ++E  I++  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 165 -DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            +HP   +L   +     +  V+E    G L   +   +   +   R+  A  +   L++
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH+   + II+RD+K  N+LL  +   ++ DFG+ K         T +   GT  Y+APE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPE 194
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
            L   +     D +A GVLL E++ G    +   + 
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L++     I A     EL ++ H+ H N 
Sbjct: 36  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 154
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I DFGLA+   ++ T +       T  Y APE +
Sbjct: 155 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPEIM 206
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
               R +++RDIK  N++L +D   +I DFGL K         T+    GT  YLAPE L
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEYLAPEVL 177
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A +      F  E    A ++
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 166 HPNTAKLLGYG---IEGGM--HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV-AEG 219
           HP    +   G      G   +IV+E     +L  +++      +  +  K A+ V A+ 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADA 142
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEGTFGY 278
              L+   Q  IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V GT  Y
Sbjct: 143 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           L+PE      VD ++DV++ G +L E++TG
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 15/213 (7%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELG 159
           +++    +F    ++GKG + +V+    +   Q  AIK L +      D++    + +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 160 IMAHVDHPN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGV 216
           +    +HP  T     +  +  +  V+E    G L   +Y ++   K+ +      A  +
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEI 127
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
             GL +LH    + I++RD+K  NILL +D   +I DFG+ K           +   GT 
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTP 182
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            Y+APE L+    +   D ++FGVLL E++ G+
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEIIADFLSELG 159
           +LY   +  + F F+  +G G + +V+    R+  L   IK + +  +   +    +E+ 
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72
Query: 160 IMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEK---LKWGIRYKIALG 215
           ++  +DHPN  K+   +     M+IV+E    G L   +   + +   L  G   ++   
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHTISK 271
           +   L Y H    + ++H+D+K  NIL  +D  P    +I DFGLA+    +   H+ + 
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELF--KSDEHS-TN 185
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             GT  Y+APE     +   K D+++ GV++  L+TG
Sbjct: 186 AAGTALYMAPEVFKRDVTF-KCDIWSAGVVMYFLLTG 221

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
               R +++RDIK  N++L +D   +I DFGL K         T+    GT  YLAPE L
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEYLAPEVL 177
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++   +  G   A+K  RL    A+E++A       
Sbjct: 86  YEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------- 138
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+   ++      R    LG A 
Sbjct: 139 -CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQAL 195
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWL-PEQWTHHTISK--VE 273
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A  L P+      ++   + 
Sbjct: 196 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           GT  ++APE ++    D K DV++   ++L ++ G
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 84
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 140
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 118 IGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADE------------IIADFLSELGIMAHV 164
           +G G Y EV   + +NG    AIK + +   D+               +  +E+ ++  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 165 DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           DHPN  KL   +  +   ++V E    G L   +   + K        I   +  G+ YL
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYL 162
Query: 224 HEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           H   +  I+HRDIK  NILL         +I DFGL+ +  + +    +    GT  Y+A
Sbjct: 163 H---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIA 216
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE L     +EK DV++ GV++  L+ G
Sbjct: 217 PEVLKKK-YNEKCDVWSCGVIMYILLCG 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
               R +++RDIK  N++L +D   +I DFGL K         T+    GT  YLAPE L
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEYLAPEVL 177
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 223

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DF LA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 88/174 (50%), Gaps = 24/174 (13%)
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
           +  VA G+ +L     R+ IHRD+ A NILL+E+   +ICDFGLA+ + +   +      
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE- 331
                ++APE +   I   K+DV+++GVLL E+            SL     P ++ +E 
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF-----------SLGGSPYPGVQMDED 310
Query: 332 ----IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
               +RE +    A EY T ++  ++L    C  +    RP+ +++V+ L G+L
Sbjct: 311 FCSRLREGMRMR-APEYSTPEIYQIMLD---CWHRDPKERPRFAELVEKL-GDL 359

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGM-------KEKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I DFGL +   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           + +G+ + H+    RI+HRDIK  NIL+  +   +I DFG+AK L E     T + V GT
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGT 175
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
             Y +PE       DE TD+++ G++L E++ G 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 15/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R +  G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH 127
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
               R +++RDIK  N++L +D   +I DFGL K         T+    GT  YLAPE L
Sbjct: 128 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEYLAPEVL 182
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFE--LILMEEIR 228

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIADFLSELG 159
           YE +   +  + +  +G+G + EV++   +  G   A+K  RL    A+E++A       
Sbjct: 67  YEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------- 119
Query: 160 IMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA- 217
             A +  P    L G   EG  ++I +EL   GSL  L+   ++      R    LG A 
Sbjct: 120 -CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV--KEQGCLPEDRALYYLGQAL 176
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWL-PEQWTHHTISK--VE 273
           EGL YLH    RRI+H D+KA N+LL+ D     +CDFG A  L P+      ++   + 
Sbjct: 177 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           GT  ++APE ++    D K DV++   ++L ++ G
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 126/286 (44%), Gaps = 47/286 (16%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F    LIG GG+ +V+K + R +G+   IKR+              E+  +A +DH N 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVNI 66
Query: 170 AKLLG------YGIEGG-----------MHIVLELSPNGSLASLLYGMK-EKLKWGIRYK 211
               G      Y  E             + I +E    G+L   +   + EKL   +  +
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +   + +G+ Y+H    +++I+RD+K +NI L +  + +I DFGL   L          +
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---XR 180
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE 331
            +GT  Y++PE +      ++ D++A G++L EL+      D + ++   +         
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSKFFT-------- 229
Query: 332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
             +L D  ++D +D ++  L+       + +    RP  S++++ L
Sbjct: 230 --DLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILRTL 269

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 80
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 136
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +         
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCR 307
Query: 334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 353

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +         
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCR 314
Query: 334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 315 RLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +         
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCR 312
Query: 334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 313 RLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 358

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 22/170 (12%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +         
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE--IR 333
             ++APE +   +   ++DV++FGVLL E+            SL     P +K +E   R
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----------SLGASPYPGVKIDEEFCR 305
Query: 334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
            L + +   A +Y T +M   +L    C      +RP  S++V+ L GNL
Sbjct: 306 RLKEGTRMRAPDYTTPEMYQTMLD---CWHGEPSQRPTFSELVEHL-GNL 351

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 80
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 136
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKR-LTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G + EV+K R R  GQ VA+K+ L     +      L E+ I+  + H N   L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 176 G---------IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
                      +  +++V +   +  LA LL  +  K       ++   +  GL Y+H  
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH-- 142
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-------PEQWTHHTISKVEGTFGYL 279
            + +I+HRD+KAAN+L+T D   ++ DFGLA+         P ++ +  +     T  Y 
Sbjct: 143 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-----TLWYR 196
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVT 307
            PE L+ G  D     D++  G ++ E+ T
Sbjct: 197 PPELLL-GERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 102
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 158
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I +E   NG+L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW------------THHTI 269
           Y+H    + IIHRD+K  NI + E    +I DFGLAK +                +   +
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 270 SKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELV 306
           +   GT  Y+A E L   G  +EK D+++ G++  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 105 LQSATNNFSFENLIGKGGYAEVY--KGRLRNGQ-LVAIKRLTRGTADEIIADFLSELGIM 161
            Q  ++ +     +G G Y EV   K +L   +  + I + +  T        L E+ ++
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 162 AHVDHPNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
             +DHPN  KL  +  +    ++V+E+   G L   +  +++K        I   V  G 
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGT 134
Query: 221 LYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            YLH   +  I+HRD+K  N+LL   + D   +I DFGL+           + +  GT  
Sbjct: 135 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAY 188
Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE L     DEK DV++ GV+L  L+ G
Sbjct: 189 YIAPEVLRKK-YDEKCDVWSCGVILYILLCG 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 24/216 (11%)
Query: 107 SATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           S+++ F     +G G YA VYKG  +  G  VA+K +   + +   +  + E+ +M  + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 166 HPNTAKLLGY-GIEGGMHIVLELSPNG--------SLASLLYGMKEKLKWGIRYKIALGV 216
           H N  +L      E  + +V E   N         ++ +   G++  L   ++Y     +
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL---VKY-FQWQL 117
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WLPEQWTHHTISKVEG 274
            +GL + HE    +I+HRD+K  N+L+ +  + ++ DFGLA+   +P     +T S    
Sbjct: 118 LQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV----NTFSSEVV 170
Query: 275 TFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGR 309
           T  Y AP+ LM         D+++ G +L E++TG+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 104
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 160
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/299 (21%), Positives = 127/299 (42%), Gaps = 60/299 (20%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +F    LIG GG+ +V+K + R +G+   I+R+              E+  +A +DH N 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA-----EREVKALAKLDHVNI 67
Query: 170 AKLLG--------------------YGIEGG----------MHIVLELSPNGSLASLLYG 199
               G                    Y  E            + I +E    G+L   +  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 200 MK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + EKL   +  ++   + +G+ Y+H    +++IHRD+K +NI L +  + +I DFGL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS 318
            L         ++ +GT  Y++PE +      ++ D++A G++L EL+      D + ++
Sbjct: 185 SLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFET 238
Query: 319 LVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
              +           +L D  ++D +D ++  L+       + +    RP  S++++ L
Sbjct: 239 SKFFT----------DLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILRTL 283

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 118 IGKGGYAEVY--KGRLRNGQ-LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           +G G Y EV   K +L   +  + I + +  T        L E+ ++  +DHPN  KL  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 175 YGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           +  +    ++V+E+   G L   +  +++K        I   V  G  YLH   +  I+H
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLSGTTYLH---KHNIVH 127
Query: 234 RDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD 290
           RD+K  N+LL   + D   +I DFGL+           + +  GT  Y+APE L     D
Sbjct: 128 RDLKPENLLLESKSRDALIKIVDFGLSAHFE---VGGKMKERLGTAYYIAPEVLRKK-YD 183
Query: 291 EKTDVFAFGVLLLELVTG 308
           EK DV++ GV+L  L+ G
Sbjct: 184 EKCDVWSCGVILYILLCG 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 117 LIGKGGYAEVYK------GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
            +GKGG+A+ ++        +  G++V    L +    E ++    E+ I   + H +  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 78
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
              G+  +   + +VLEL    SL  L    K   +   RY +   +  G  YLH   + 
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLH---RN 134
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           R+IHRD+K  N+ L ED E +I DFGLA  +  ++       + GT  Y+APE L     
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 290 DEKTDVFAFGVLLLELVTGRRALDYS 315
             + DV++ G ++  L+ G+   + S
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I  FGLA+   ++ T +       T  Y APE +
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV-----ATRWYRAPEIM 194
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 42/294 (14%)
Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A + HP
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 168 NTAKLLG-------------YGIEGGMHIVLEL-SPNGSLASLL--YGMKEKLKWGIRYK 211
           N   LLG             Y   G +H  L + SP+  + S      +K  L+      
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +   +A G+ YL       ++H+D+   N+L+ +    +I D GL + +     +  +  
Sbjct: 150 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 206
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG--RRALDYSQQSLVLWARPMIKR 329
                 ++APE +M+G     +D++++GV+L E+ +   +    YS Q +V     MI+ 
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----EMIRN 262
Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR--GNL 381
            ++    D   A  Y        L+    C  +   RRP+   +   LR  GNL
Sbjct: 263 RQVLPCPDDCPAWVY-------ALMIE--CWNEFPSRRPRFKDIHSRLRAWGNL 307

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLL-----GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
             LL        +E    + L     G+  + +   ++     +++ I   +  GL Y+H
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH 142
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 IIHRD+K +N+ + ED E +I D GLA+   ++ T +       T  Y APE +
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYV-----ATRWYRAPEIM 194
Query: 285 MHGI-VDEKTDVFAFGVLLLELVTGR 309
           ++ +  ++  D+++ G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 93  SQSPQKIFSLYEL---------QSATNNFSFENLIGKGGYAEVYKGRLRNG------QLV 137
           S S  K+F  ++L         ++  + +     +G G   EV     R        +++
Sbjct: 123 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 182
Query: 138 AIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           + ++   G+A E     +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 183 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 242
Query: 196 LLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            + G   +KE       Y++ L V     YLHE     IIHRD+K  N+LL+   ED   
Sbjct: 243 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHEN---GIIHRDLKPENVLLSSQEEDCLI 295
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELV 306
           +I DFG +K L E     T+    GT  YLAPE L+       +   D ++ GV+L   +
Sbjct: 296 KITDFGHSKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 352
Query: 307 TG 308
           +G
Sbjct: 353 SG 354

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I D GLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 108/242 (44%), Gaps = 36/242 (14%)
Query: 93  SQSPQKIFSLYEL---------QSATNNFSFENLIGKGGYAEVYKGRLRNG------QLV 137
           S S  K+F  ++L         ++  + +     +G G   EV     R        +++
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 138 AIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           + ++   G+A E     +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228
Query: 196 LLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            + G   +KE       Y++ L V     YLHE     IIHRD+K  N+LL+   ED   
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELV 306
           +I DFG +K L E     T+    GT  YLAPE L+       +   D ++ GV+L   +
Sbjct: 282 KITDFGHSKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 307 TG 308
           +G
Sbjct: 339 SG 340

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+    GT
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 276 FGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTG 308
             YLAPE L+       +   D ++ GV+L   ++G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+    GT
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 276 FGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTG 308
             YLAPE L+       +   D ++ GV+L   ++G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 128
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+    GT
Sbjct: 129 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 179
Query: 276 FGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTG 308
             YLAPE L+       +   D ++ GV+L   ++G
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 125
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              ++ +++RD+K  N++L +D   +I DFGL K   +     T+    GT  YLAPE L
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEYLAPEVL 181
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE--LILMEEIR 227

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 127
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+    GT
Sbjct: 128 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 178
Query: 276 FGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTG 308
             YLAPE L+       +   D ++ GV+L   ++G
Sbjct: 179 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 127
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              ++ +++RD+K  N++L +D   +I DFGL K   +     T+    GT  YLAPE L
Sbjct: 128 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEYLAPEVL 183
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE--LILMEEIR 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 114 FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNT 169
           ++NL  +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H N 
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-------EKLKWGIRYKIALGVAEGLLY 222
             LL           LE   +  L + L G         +KL       +   +  GL Y
Sbjct: 84  IGLLDVFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H      IIHRD+K +N+ + ED E +I D GLA+   ++ T +       T  Y APE
Sbjct: 141 IHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYV-----ATRWYRAPE 192
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGR 309
            +++ +  ++  D+++ G ++ EL+TGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 111 NFSFENLIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F+F  ++GKG + +V    R    +L A+K L +     D+ +   + E  ++A    P
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 168 NTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLYL 223
                L   +     ++ V+E    G L   +Y +++  ++   + +  A  +A GL +L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
                + II+RD+K  N++L  +   +I DFG+ K     W   T     GT  Y+APE 
Sbjct: 459 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI 513
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
           + +    +  D +AFGVLL E++ G+   +
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 126
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              ++ +++RD+K  N++L +D   +I DFGL K   +     T+    GT  YLAPE L
Sbjct: 127 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEYLAPEVL 182
Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
                    D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE--LILMEEIR 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGY 175
           +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H N   LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 176 -----GIEGGMHIVLELSPNGS-LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
                 ++      L +   G+ L  L+    EKL       +   + +GL Y+H     
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAG-- 148
Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
            IIHRD+K  N+ + ED E +I DFGLA+    +     +++      Y APE +++ + 
Sbjct: 149 -IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMR 202
Query: 290 DEKT-DVFAFGVLLLELVTGR 309
             +T D+++ G ++ E++TG+
Sbjct: 203 YTQTVDIWSVGCIMAEMITGK 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +G A +       EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-----RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   R+ +      DE I    +E  +     +H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              R II+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L 
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALD 313
                   D +A GVL+ E++ GR   D
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTR-----GTADEI--IADFLSELGIM 161
           + +     +G G   EV     R   + VAIK +++     G+A E     +  +E+ I+
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 162 AHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
             ++HP   K+  +      +IVLEL   G L   + G   +KE       Y++ L V  
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ- 134
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
              YLHE     IIHRD+K  N+LL+   ED   +I DFG +K L E     T+    GT
Sbjct: 135 ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC---GT 185
Query: 276 FGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTG 308
             YLAPE L+       +   D ++ GV+L   ++G
Sbjct: 186 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 16/230 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 268
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEF 283
              ++ +++RD+K  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE 
Sbjct: 269 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEV 323
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           L         D +  GV++ E++ GR    Y+Q    L+   +I   EIR
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFE--LILMEEIR 370

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
           N F +  L+GKG + +V   + +  G+  A+K L +    A + +A  L+E  ++ +  H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 167 PN-TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI-ALGVAEGLLYLH 224
           P  TA    +     +  V+E +  G L    +  +E++    R +     +   L YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPEF 283
              ++ +++RD+K  N++L +D   +I DFGL K  + +  T  T     GT  YLAPE 
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---GTPEYLAPEV 320
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGR 309
           L         D +  GV++ E++ GR
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 52/238 (21%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEI-IADFLSELGIMAHVD 165
             +N+  ++LIG+G Y  VY    +N +  VAIK++ R   D I     L E+ I+  + 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 166 HPNTAKLLGYGIEGGM------HIVLELSPNGSLASL----LYGMKEKLKWGIRYKIALG 215
                +L    I   +      +IVLE++ +  L  L    ++  +E +K  I Y + LG
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIK-TILYNLLLG 141
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA------------------ 257
                 ++HE     IIHRD+K AN LL +D   ++CDFGLA                  
Sbjct: 142 EN----FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 258 -------KWLPEQWTHHTISKVEGTFGYLAPEF-LMHGIVDEKTDVFAFGVLLLELVT 307
                  K L +Q T H +++      Y APE  L+     +  D+++ G +  EL+ 
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G+GG+  V++ + +      AIKR+     +      + E+  +A ++HP   +     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 177 IEGGMHIVLELSPNGSLASLLYGM----KEKLK-W------------GIRYKIALGVAEG 219
           +E   +   +L P+     L   M    KE LK W             +   I L +AE 
Sbjct: 73  LEK--NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-------SKV 272
           + +LH    + ++HRD+K +NI  T D   ++ DFGL   + +     T+       ++ 
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 273 EGTFG---YLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            G  G   Y++PE +       K D+F+ G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 119/290 (41%), Gaps = 40/290 (13%)
Query: 114 FENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A + HP
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 168 NTAKLLG-------------YGIEGGMHIVLEL-SPNGSLASLL--YGMKEKLKWGIRYK 211
           N   LLG             Y   G +H  L + SP+  + S      +K  L+      
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           +   +A G+ YL       ++H+D+   N+L+ +    +I D GL + +     +  +  
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG--RRALDYSQQSLVLWARPMIKR 329
                 ++APE +M+G     +D++++GV+L E+ +   +    YS Q +V     MI+ 
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----EMIRN 245
Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
            ++    D   A  Y        L+    C  +   RRP+   +   LR 
Sbjct: 246 RQVLPCPDDCPAWVY-------ALMIE--CWNEFPSRRPRFKDIHSRLRA 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 93
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 148
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 206
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 207 DIWSLGIMVIEMVDG 221

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 209
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 210 KSDVWSFGVLMWE------AFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 95  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 209
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 210 KSDVWSFGVLMWE------AFSYGQK 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 215
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIH 270
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 328
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 329 DIWSLGIMVIEMVDG 343

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 110 NNFSFENLIGKGGYAEVY-KGRLRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F+F  ++GKG + +V    R    +L A+K L +     D+ +   + E  ++A    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI--ALGVAEGLLY 222
           P     L   +     ++ V+E    G L   +Y +++  ++   + +  A  +A GL +
Sbjct: 80  PPFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           L     + II+RD+K  N++L  +   +I DFG+ K     W   T     GT  Y+APE
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPE 191
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALD 313
            + +    +  D +AFGVLL E++ G+   +
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL----- 173
            +G +  V+K +L N   VA+K       D+       E+     + H N  + +     
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFP--LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE-------- 225
           G  +E  + ++      GSL   L G    + W     +A  ++ GL YLHE        
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYLKG--NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWTHHTISKVEGTFGYLAPEFL 284
           G +  I HRD K+ N+LL  D    + DFGLA ++ P +    T  +V GT  Y+APE L
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV-GTRRYMAPEVL 197
Query: 285 MHGIVDE-----KTDVFAFGVLLLELVTGRRALD 313
              I  +     + D++A G++L ELV+  +A D
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 95
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 208
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 209 DIWSLGIMVIEMVDG 223

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 13/165 (7%)
Query: 151 IADFLSELGIMAHVDHPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
           I     E+ I+  +DHPN  KL   L    E  +++V EL   G +  +   +K   +  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQ 138
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            R+     + +G+ YLH    ++IIHRDIK +N+L+ ED   +I DFG++     + +  
Sbjct: 139 ARFYFQ-DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDA 192
Query: 268 TISKVEGTFGYLAPEFL--MHGIVDEKT-DVFAFGVLLLELVTGR 309
            +S   GT  ++APE L     I   K  DV+A GV L   V G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+    Q  
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM- 166
Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              ++ V  T  Y APE L+        D+++ G +  E+
Sbjct: 167 --ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 84
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIH 139
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 197
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 198 DIWSLGIMVIEMVDG 212

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 93  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 148
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 149 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 207
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 208 KSDVWSFGVLMWE------AFSYGQK 227

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 139
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              R II+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L 
Sbjct: 140 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALD 313
                   D +A GVL+ E++ GR   D
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 85  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 140
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 199
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 200 KSDVWSFGVLMWE------AFSYGQK 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 111 NFSFENLIGKGGYAEVYKGR----LRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAH 163
           NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ H
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 164 VDHPNTAKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           +        L Y    E  +H++L+    G L + L   +E+      +++ + V E +L
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERF---TEHEVQIYVGEIVL 170
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            L    +  II+RDIK  NILL  +    + DFGL+K      T        GT  Y+AP
Sbjct: 171 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAP 229
Query: 282 EFLMHGIV--DEKTDVFAFGVLLLELVTG 308
           + +  G    D+  D ++ GVL+ EL+TG
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 75  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 130
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 189
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 190 KSDVWSFGVLMWE------AFSYGQK 209

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 134
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 193
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 194 KSDVWSFGVLMWE------AFSYGQK 213

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 73  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 128
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 129 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 187
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 188 KSDVWSFGVLMWE------AFSYGQK 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 88
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIH 143
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 201
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 202 DIWSLGIMVIEMVDG 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I +E   N +L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW------------THHTI 269
           Y+H    + IIHRD+K  NI + E    +I DFGLAK +                +   +
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 270 SKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELV 306
           +   GT  Y+A E L   G  +EK D+++ G++  E++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 41/234 (17%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----EIIAD------ 153
           EL +  + ++ +  I  G Y  V  G    G  VAIKR+    +D     I++D      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 154 FLSELGIMAHVDHPNTAKLLGYGI---EGGMH---IVLELSPNGSLASLLYGMK-----E 202
            L E+ ++ H  HPN   L    +   E  MH   +V EL     LA +++  +     +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WL 260
            +++ + Y I LG    L  LHE     ++HRD+   NILL ++ +  ICDF LA+    
Sbjct: 135 HIQYFM-YHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRAL 312
               TH+   +      Y APE +M   G   +  D+++ G ++ E+   R+AL
Sbjct: 187 DANKTHYVTHR-----WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMF-NRKAL 233

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+    Q  
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM- 166
Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              +  V  T  Y APE L+        D+++ G +  E+
Sbjct: 167 --ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 124
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              R II+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L 
Sbjct: 125 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALD 313
                   D +A GVL+ E++ GR   D
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 79  GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 134
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+ A N+LL      +I DFGL+K L  ++  +   +  +    + APE + +     K
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSK 194
Query: 293 TDVFAFGVLLLELVTGRRALDYSQQ 317
           +DV++FGVL+ E      A  Y Q+
Sbjct: 195 SDVWSFGVLMWE------AFSYGQK 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 19/172 (11%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGTADEI-IADFLSELGIMAHVDHP 167
           +N+  ++LIG+G Y  VY    +N  + VAIK++ R   D I     L E+ I+  +   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 168 NTAKLLGYGIEGGM------HIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
              +L    I   +      +IVLE++ +  L  L      + E+    I Y + LG   
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEQHVKTILYNLLLGEK- 145
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
              ++HE     IIHRD+K AN LL +D   +ICDFGLA+ +      H ++
Sbjct: 146 ---FIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVN 191

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 97/195 (49%), Gaps = 14/195 (7%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG 174
           IG+G    V    +R+ G+LVA+K+  L +    E++    +E+ IM    H N  ++  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL---FNEVVIMRDYQHENVVEMYN 138
Query: 175 -YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +V+E    G+L  ++     ++       + L V + L  LH    + +IH
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHA---QGVIH 193
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           RDIK+ +ILLT D   ++ DFG    + ++        + GT  ++APE +       + 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMAPELISRLPYGPEV 251
Query: 294 DVFAFGVLLLELVTG 308
           D+++ G++++E+V G
Sbjct: 252 DIWSLGIMVIEMVDG 266

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            F F  ++G G ++EV+  + R  G+L A+K + +  A    +   +E+ ++  + H N 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-SSLENEIAVLKKIKHENI 68
Query: 170 AKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK-----IALGVAEGLLYL 223
             L   Y      ++V++L   G L   +      L+ G+  +     +   V   + YL
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYL 122
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           HE     I+HRD+K  N+L     E+ +  I DFGL+K   EQ  +  +S   GT GY+A
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQ--NGIMSTACGTPGYVA 175
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE L      +  D ++ GV+   L+ G
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 11/208 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG---TADEIIADFLSELGIMAHV-DH 166
           +F    +IG+G YA+V   RL+    +   ++ +      DE I    +E  +     +H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L   +  E  +  V+E    G L   +   ++  +   R+  A  ++  L YLHE
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 128
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              R II+RD+K  N+LL  +   ++ D+G+ K         T S   GT  Y+APE L 
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALD 313
                   D +A GVL+ E++ GR   D
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 41/234 (17%)
Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----EIIAD------ 153
           EL +  + ++ +  I  G Y  V  G    G  VAIKR+    +D     I++D      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 154 FLSELGIMAHVDHPNTAKLLGYGI---EGGMH---IVLELSPNGSLASLLYGMK-----E 202
            L E+ ++ H  HPN   L    +   E  MH   +V EL     LA +++  +     +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--WL 260
            +++ + Y I LG    L  LHE     ++HRD+   NILL ++ +  ICDF LA+    
Sbjct: 135 HIQYFM-YHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRAL 312
               TH+   +      Y APE +M   G   +  D+++ G ++ E+   R+AL
Sbjct: 187 DANKTHYVTHR-----WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMF-NRKAL 233

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 437 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 492
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 551
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 552 KSDVWSFGVLMWE------AFSYGQK 571

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVD 165
           AT+ +     IG G Y  VYK R   +G  VA+K +     +E +    + E+ ++  ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 166 ---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              HPN  +L+                    ++  +   L+ +P   L +    +K+ ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKDLMR 119
Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
             +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+    Q  
Sbjct: 120 QFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM- 166
Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              +  V  T  Y APE L+        D+++ G +  E+
Sbjct: 167 --ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 118 IGKGGYAEVYKG--RLRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +++        ++ +  A++  +  + L+E  +M  +D+P   +++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L   +      I  ++   V+ G+ YL E      +H
Sbjct: 438 GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-IELVHQVSMGMKYLEES---NFVH 493
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 552
Query: 292 KTDVFAFGVLLLELVTGRRALDYSQQ 317
           K+DV++FGVL+ E      A  Y Q+
Sbjct: 553 KSDVWSFGVLMWE------AFSYGQK 572

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 109
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSXICSRY-YR 223
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 83
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 144 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 197
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 198 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 94
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 155 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 208
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 209 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 109
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 223
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 76
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 137 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 190
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 191 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 87
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 201
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 202 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 108 ATNNFSFENLI-------GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI 160
            T N  F+++         +G +  V+K +L N + VA+K            ++  E+  
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYS 71
Query: 161 MAHVDHPNTAKLLG-----YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           +  + H N  + +G       ++  + ++      GSL+  L      + W     IA  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 216 VAEGLLYLHE-------GCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWTHH 267
           +A GL YLHE       G +  I HRDIK+ N+LL  +    I DFGLA K+   +    
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 268 TISKVEGTFGYLAPEFLMHGIVDE-----KTDVFAFGVLLLELVTGRRALD 313
           T  +V GT  Y+APE L   I  +     + D++A G++L EL +   A D
Sbjct: 190 THGQV-GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 189
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 87
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 148 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 201
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 202 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 103
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 164 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 217
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 218 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           F F+  +G G ++EV     +  G+L A+K + +       +   +E+ ++  + H N  
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL--GVAEGLLYLHEGC 227
            L   Y     +++V++L   G L   +    EK  +  +    L   V + + YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIV---EKGFYTEKDASTLIRQVLDAVYYLH--- 137
Query: 228 QRRIIHRDIKAANILL-TEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
           +  I+HRD+K  N+L  ++D E +I   DFGL+K    +     +S   GT GY+APE L
Sbjct: 138 RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVL 194
Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                 +  D ++ GV+   L+ G
Sbjct: 195 AQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 88
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 149 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 202
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 203 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 115 ENLIGKGGYAEVYKGRLR-NGQLVAIK-------RLTRGTADEIIADFLSELGIMAHV-D 165
           +++IG+G  + V +   R  G   A+K       RL+    +E+      E  I+  V  
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 166 HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HP+   L+  Y     M +V +L   G L   L   K  L       I   + E + +LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLH 217
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                 I+HRD+K  NILL ++ + ++ DFG +  L        + ++ GT GYLAPE L
Sbjct: 218 AN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPGYLAPEIL 271
Query: 285 ------MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
                  H    ++ D++A GV+L  L+ G     + +Q L+L
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 111
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 172 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YR 225
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 226 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 79
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 140 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSXICSRY-YR 193
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 194 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHPN 168
           ++ EN IG+G + EV K  ++ G    I+R  +      + D   F  E+ IM  +DHPN
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L   +     +++V+EL   G L   +   K   +     +I   V   + Y H   
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 140
Query: 228 QRRIIHRDIKAANILL---TEDFEPQICDFGL-AKWLPEQWTHHTISKVEGTFGYLAPEF 283
           +  + HRD+K  N L    + D   ++ DFGL A++ P +     +    GT  Y++P+ 
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQV 196
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTG 308
           L  G+   + D ++ GV++  L+ G
Sbjct: 197 L-EGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)
Query: 105 LQSATNNFSFENL------IGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIA--D 153
           L  A ++  FE++      IGKG ++ V +   R  GQ  A+K   + + T+   ++  D
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 154 FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E  I   + HP+  +LL  Y  +G +++V E       A L + + ++   G  Y  
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSE 129
Query: 213 ALG------VAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEP-QICDFGLAKWLPEQ 263
           A+       + E L Y H+     IIHRD+K  N+LL   E+  P ++ DFG+A  L E 
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES 186
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                     GT  ++APE +      +  DV+  GV+L  L++G
Sbjct: 187 GL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD---FLSELGIMAHVDHPN 168
           ++ EN IG+G + EV K  ++ G    I+R  +      + D   F  E+ IM  +DHPN
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKG--TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 169 TAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L   +     +++V+EL   G L   +   K   +     +I   V   + Y H   
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 228 QRRIIHRDIKAANILL---TEDFEPQICDFGL-AKWLPEQWTHHTISKVEGTFGYLAPEF 283
           +  + HRD+K  N L    + D   ++ DFGL A++ P +     +    GT  Y++P+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSPQV 179
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTG 308
           L  G+   + D ++ GV++  L+ G
Sbjct: 180 L-EGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 75
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRY-YR 189
Query: 280 APEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
           APE L+ G  D  +  DV++ G +L EL+ G+
Sbjct: 190 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGT--ADEIIADFLSELGIM- 161
            +  ++F F  +IGKG + +V   R +  ++  A+K L +      +     +SE  ++ 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 162 AHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
            +V HP    L   +     ++ VL+    G L   L   +  L+   R+  A  +A  L
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASAL 152
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TISKVEGTFGYL 279
            YLH      I++RD+K  NILL       + DFGL K   E   H+ T S   GT  YL
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYL 206
Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           APE L     D   D +  G +L E++ G
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 113
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 174 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YR 227
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 228 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 25/212 (11%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 80
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L        +S +   + Y 
Sbjct: 141 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRY-YR 194
Query: 280 APEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 195 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 111 NFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +   D+   +   EL IM  +DH N 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKN--RELQIMRKLDHCNI 154
Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRY-KIAL-GVAEGL 220
            +L  +    G       +++VL+  P        +  + K    + Y K+ +  +   L
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL--PEQWTHHTISKVEGTFG 277
            Y+H      I HRDIK  N+LL  D    ++CDFG AK L   E    +  S+      
Sbjct: 215 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 266
Query: 278 YLAPEFLMHGIVD--EKTDVFAFGVLLLELVTGR 309
           Y APE L+ G  D     DV++ G +L EL+ G+
Sbjct: 267 YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 43/234 (18%)
Query: 109 TNNFSFENLIGKGG--YAEVYKGRLRNGQLVAIKR-LTRGTADEIIADFLSELGIMAHVD 165
             ++ F   +G+GG  Y ++ +G L +G   A+KR L     D   A    E  +    +
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQ--READMHRLFN 84
Query: 166 HPNTAKLLGYGIE--GGMH---IVLELSPNGSLASLLYGMKEKLKWGIRYKIA---LGVA 217
           HPN  +L+ Y +   G  H   ++L     G+L + +  +K+K  +    +I    LG+ 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG--- 274
            GL  +H    +   HRD+K  NILL ++ +P + D G          +     VEG   
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGS--------MNQACIHVEGSRQ 193
Query: 275 ------------TFGYLAPEFL---MHGIVDEKTDVFAFGVLLLELVTGRRALD 313
                       T  Y APE      H ++DE+TDV++ G +L  ++ G    D
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 104/240 (43%), Gaps = 55/240 (22%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHVDHP 167
           + +   +LIG G Y  V +   +   ++VAIK++ R   D I     L E+ I+  ++H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 168 NTAKLLGYGIEGG------MHIVLELSPNGS---LASLLYGMKEKLKWGIRYKIALGVAE 218
           +  K+L   I         +++VLE++ +       + +Y  +  +K  + Y + +GV  
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLLYNLLVGVK- 170
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA--------------------- 257
              Y+H      I+HRD+K AN L+ +D   ++CDFGLA                     
Sbjct: 171 ---YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 258 ---------KWLPEQWTHHTISKVEGTFGYLAPEF-LMHGIVDEKTDVFAFGVLLLELVT 307
                    K L  Q T H +++      Y APE  L+     E  DV++ G +  EL+ 
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTR-----WYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 22/199 (11%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLL- 173
           IG+G    V   R ++ G+ VA+K   L +    E++    +E+ IM    H N  ++  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL---FNEVVIMRDYQHFNVVEMYK 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            Y +   + +++E    G+L  ++  ++  L       +   V + L YLH    + +IH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 234 RDIKAANILLTEDFEPQICDFG----LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV 289
           RDIK+ +ILLT D   ++ DFG    ++K +P++        + GT  ++APE +   + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR------KXLVGTPYWMAPEVISRSLY 218
Query: 290 DEKTDVFAFGVLLLELVTG 308
             + D+++ G++++E+V G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +GKG Y EV++G L +G+ VA+K  +  + DE      +E+     + H N    +   +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS--SRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 178 EG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---GCQR 229
                   + ++     +GSL   L   ++ L+  +  ++A+  A GL +LH    G Q 
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 230 R--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFLM 285
           +  I HRD K+ N+L+  + +  I D GLA    +   +  I      GT  Y+APE L 
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 286 HGIVDE------KTDVFAFGVLLLELVTGRRAL 312
             I  +       TD++AFG++L E+   RR +
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 106 QSATNNF---SFENLIGKGGYAEVYK-GRLRNGQLVAIKRL-TRGTADEIIADFLSELGI 160
           Q A N+F   S   ++G G + +V+K      G  +A K + TRG  D+   +  +E+ +
Sbjct: 82  QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK--EEVKNEISV 139
Query: 161 MAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           M  +DH N  +L   +  +  + +V+E    G L   +      L           + EG
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK-WLPEQWTHHTISKVEGTF 276
           + ++H   Q  I+H D+K  NIL       QI   DFGLA+ + P +       K++  F
Sbjct: 200 IRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-------KLKVNF 249
Query: 277 G---YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           G   +LAPE + +  V   TD+++ GV+   L++G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 31/237 (13%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL        +   M   + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT--------IS 270
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E    ++        ++
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 271 KVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRAL---DYSQQSLVLWA 323
           +   T  Y APE ++         DV++ G +L EL   R      DY  Q L+++ 
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 31/237 (13%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL        +   M   + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT--------IS 270
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E    ++        ++
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 271 KVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRAL---DYSQQSLVLWA 323
           +   T  Y APE ++         DV++ G +L EL   R      DY  Q L+++ 
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 115/242 (47%), Gaps = 30/242 (12%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +G GG   V+     +  + VAIK++   T  + +   L E+ I+  +DH N  K+    
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVFEIL 77
Query: 177 IEGGMHIVLELSPNGSLASL--LYGMKEKLKWGIRYKIALG-------------VAEGLL 221
              G  +  ++   GSL  L  +Y ++E ++  +   +  G             +  GL 
Sbjct: 78  GPSGSQLTDDV---GSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLK 134
Query: 222 YLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHH-TISKVEGTFGYL 279
           Y+H      ++HRD+K AN+ + TED   +I DFGLA+ +   ++H   +S+   T  Y 
Sbjct: 135 YIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 280 APEFLMH-GIVDEKTDVFAFGVLLLELVTGRR----ALDYSQQSLVLWARPMIKRNEIRE 334
           +P  L+      +  D++A G +  E++TG+     A +  Q  L+L + P++   + +E
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251
Query: 335 LV 336
           L+
Sbjct: 252 LL 253

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 108 ATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRL----TRGTADEIIADFLSELGIMA 162
           AT+ +     IG G Y  VYK R   +G  VA+K +      G    +    + E+ ++ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 163 HVD---HPNTAKLLGY-----------------GIEGGMHIVLELSPNGSLASLLYGMKE 202
            ++   HPN  +L+                    ++  +   L+ +P   L +    +K+
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA--ETIKD 124
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
            ++  +R         GL +LH  C   I+HRD+K  NIL+T     ++ DFGLA+    
Sbjct: 125 LMRQFLR---------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
           Q     ++ V  T  Y APE L+        D+++ G +  E+
Sbjct: 173 QM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 150
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    WT      + GT  YLAPE ++    ++ 
Sbjct: 151 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSKGYNKA 204
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 205 VDWWALGVLIYEMAAG 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H    +    
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVXLLASLNHQYVVRYYAA 70
Query: 176 GIE--------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            +E                + I  E   N +L  L++      +    +++   + E L 
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW------------THHTI 269
           Y+H    + IIHR++K  NI + E    +I DFGLAK +                +   +
Sbjct: 131 YIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 270 SKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELV 306
           +   GT  Y+A E L   G  +EK D ++ G++  E +
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 115 ENLIGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
           E   GK   AE Y     ++  LVA+K L +  +D    DF  E  ++ ++ H +  K  
Sbjct: 23  EGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQHEHIVKFY 81
Query: 174 GYGIEGG-MHIVLELSPNGSLASLLYG-------MKE-----KLKWGIRYKIALGVAEGL 220
           G  +EG  + +V E   +G L   L         M E     +L       IA  +A G+
Sbjct: 82  GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGM 141
Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           +YL     +  +HRD+   N L+ E+   +I DFG+++ +     +           ++ 
Sbjct: 142 VYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 198
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVT 307
           PE +M+     ++DV++ GV+L E+ T
Sbjct: 199 PESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 32/207 (15%)
Query: 118 IGKGGYAEVYKGRLRN-GQLVAIKRLT-RGTADEIIADFLSELGIMA-----------HV 164
           +G+G +A V +   ++ GQ  A K L  R    +  A+ L E+ ++            H 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASL-LYGMKEKLKWGIRYKIALGVAEGLLYL 223
            + NT++++         ++LE +  G + SL L  + E +      ++   + EG+ YL
Sbjct: 97  VYENTSEII---------LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 224 HEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           H   Q  I+H D+K  NILL+  +   + +I DFG+++ +        + ++ GT  YLA
Sbjct: 148 H---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLA 201
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVT 307
           PE L +  +   TD++  G++   L+T
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 133 NGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            G+ VA+K+  L +    E++    +E+ IM    H N   +   Y +   + +V+E   
Sbjct: 69  TGKQVAVKKMDLRKQQRRELL---FNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLE 125
Query: 190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP 249
            G+L  ++     ++       + L V   L YLH    + +IHRDIK+ +ILLT D   
Sbjct: 126 GGALTDIV--THTRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRI 180
Query: 250 QICDFG----LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
           ++ DFG    ++K +P++        + GT  ++APE +       + D+++ G++++E+
Sbjct: 181 KLSDFGFCAQVSKEVPKR------KXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 234
Query: 306 VTG 308
           + G
Sbjct: 235 IDG 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    WT      + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 109 TNNFSFENLIGKG--GYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
           ++ + F   IG G  G A + + +L   +LVA+K + RG A  I  +   E+     + H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAA--IDENVQREIINHRSLRH 75
Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +     +    + I++E +  G L   +       +   R+     +  G+ Y H 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLSGVSYCH- 133
Query: 226 GCQRRIIHRDIKAANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
               +I HRD+K  N LL     P  +ICDFG +K       H       GT  Y+APE 
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEV 188
Query: 284 LMHGIVDEK-TDVFAFGVLLLELVTG 308
           L+    D K  DV++ GV L  ++ G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           +++F  ++L+G+G Y  V     +  G++VAIK++            L E+ I+ H  H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 168 NTAKLLG------YGIEGGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKI-ALGVAE 218
           N   +        +     ++I+ EL        +   M   + +++ I   + A+ V  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT--------IS 270
           G           +IHRD+K +N+L+  + + ++CDFGLA+ + E    ++        + 
Sbjct: 130 G---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 271 KVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRAL---DYSQQSLVLWA 323
           +   T  Y APE ++         DV++ G +L EL   R      DY  Q L+++ 
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 35/257 (13%)
Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAI-------KRLTRGTADEIIADFLSELGIMAHVDH 166
           F+  IG+G +  VYKG L     V +       ++LT+         F  E   +  + H
Sbjct: 30  FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQR----FKEEAEXLKGLQH 84
Query: 167 PNTAKLLGY---GIEGGMHIVL--ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           PN  +        ++G   IVL  EL  +G+L + L   K   K  +       + +GL 
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQ 143
Query: 222 YLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           +LH      IIHRD+K  NI +T      +I D GLA      +    I    GT  + A
Sbjct: 144 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFXA 198
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR----------PMIKRN 330
           PE       DE  DV+AFG   LE  T        Q +  ++ R            +   
Sbjct: 199 PEXYEEK-YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 331 EIRELVDASLADEYDTR 347
           E++E+++  +    D R
Sbjct: 258 EVKEIIEGCIRQNKDER 274

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    Q+ DFGLAK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++ +G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ GV++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++ +G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ GV++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 83
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLP-- 261
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L   
Sbjct: 143 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVT-GRRAL--DYS 315
           +      ++   GT G+ APE L       +    D+F+ G +   +++ G+      YS
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 316 QQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           ++S ++  R +   +E++ L D SL  E      +L+    S  I    ++RP   +V++
Sbjct: 260 RESNII--RGIFSLDEMKCLHDRSLIAE----ATDLI----SQMIDHDPLKRPTAMKVLR 309

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 136/300 (45%), Gaps = 49/300 (16%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 83
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 84  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 142
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLP-- 261
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L   
Sbjct: 143 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVT-GRRAL--DYS 315
           +      ++   GT G+ APE L       +    D+F+ G +   +++ G+      YS
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 316 QQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           ++S ++  R +   +E++ L D SL  E      +L+    S  I    ++RP   +V++
Sbjct: 260 RESNII--RGIFSLDEMKCLHDRSLIAE----ATDLI----SQMIDHDPLKRPTAMKVLR 309

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 176 -GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  + +V E   +  L          L   I       + +GL + H    R ++HR
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKT 293
           D+K  N+L+  + E ++ DFGLA+        ++   V  T  Y  P+ L    +     
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSI 183
Query: 294 DVFAFGVLLLELVTGRRAL 312
           D+++ G +  EL    R L
Sbjct: 184 DMWSAGCIFAELANAARPL 202

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIK----RLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +G+G ++   K    ++ Q  A+K    R+   T  EI A  L E        HPN  KL
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCE-------GHPNIVKL 71
Query: 173 LGYGIEGGMH--IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
                   +H  +V+EL   G L   +   K   +    Y I   +   + ++H+     
Sbjct: 72  HEV-FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-IMRKLVSAVSHMHD---VG 126
Query: 231 IIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
           ++HRD+K  N+L T+   + E +I DFG A+  P    +  +     T  Y APE L   
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184
Query: 288 IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV 320
             DE  D+++ GV+L  +++G+       +SL 
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT 217

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPAFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-Y 175
           +G+G YA VYKG+ +    LVA+K +     +      + E+ ++  + H N   L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 176 GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
             E  + +V E   +  L   L      +           +  GL Y H   +++++HRD
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRD 125
Query: 236 IKAANILLTEDFEPQICDFGL--AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           +K  N+L+ E  E ++ DFGL  AK +P +    T      T  Y  P+ L+ G  D  T
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTK----TYDNEVVTLWYRPPDILL-GSTDYST 180
Query: 294 --DVFAFGVLLLELVTGR 309
             D++  G +  E+ TGR
Sbjct: 181 QIDMWGVGCIFYEMATGR 198

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 8/152 (5%)
Query: 157 ELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           E+ I++ V+H N  K+L  +  +G   +V+E   +G           +L   +   I   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           +   + YL     + IIHRDIK  NI++ EDF  ++ DFG A +L      +T     GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GT 192
Query: 276 FGYLAPEFLM-HGIVDEKTDVFAFGVLLLELV 306
             Y APE LM +     + ++++ GV L  LV
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 78
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +     +    +     
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++ PE +++     ++DV++FGV+L E+ T
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L +  ++    DF  E  ++  + H +  +
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVR 84
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +     +    +     
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++ PE +++     ++DV++FGV+L E+ T
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEII 151
           S +  +   +++     +G G +A V K R +        + +  +RL+   RG + E I
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
                E+ I+  + HPN   L   +  +  + ++LEL   G L   L   KE L      
Sbjct: 63  E---REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEAT 118
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTH 266
           +    + +G+ YLH    +RI H D+K  NI+L +   P    ++ DFG+A  +      
Sbjct: 119 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AG 172
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           +    + GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 173 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++   + +    +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLR 60
Query: 166 HPNTAKLLG-----------------YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI 208
           H N    +                  Y   G ++  L+L+   +++ L            
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL------------ 108
Query: 209 RYKIALGVAEGLLYLH---EGCQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
             +I L +A GL +LH    G Q +  I HRD+K+ NIL+ ++ +  I D GLA    + 
Sbjct: 109 --RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 264 WTHHTISKVE--GTFGYLAPEFLMHGI-VD-----EKTDVFAFGVLLLEL 305
                +      GT  Y+APE L   I VD     ++ D++AFG++L E+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 106 QSATNN-FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           QS +N+ +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 164 VDHPNTAKLLGYGIEGGMH---IVLELSPNGSLASLL------YGMKEKLKWGIRYKIAL 214
           ++H N  KL     E       +++E  P GSL ++L      YG+ E       + I L
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-----EFLIVL 118
Query: 215 -GVAEGLLYLHEGCQRRIIHRDIKAANIL--LTEDFEP--QICDFGLAKWLPEQWTHHTI 269
             V  G+ +L E     I+HR+IK  NI+  + ED +   ++ DFG A+ L +       
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQF 172
Query: 270 SKVEGTFGYLAPEFLMHGIVDE--------KTDVFAFGVLLLELVTG 308
             + GT  YL P+     ++ +          D+++ GV      TG
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 27/243 (11%)
Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR 130
           SS ++E +   +  F+  ++S +          Q+  +   FE +  +G G +  V   +
Sbjct: 5   SSDVKEFLAKAKEDFLKKWESPA----------QNTAHLDQFERIKTLGTGSFGRVMLVK 54
Query: 131 LR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLE 186
            +  G   A+K L +    ++  I   L+E  I+  V+ P   KL   +     +++V+E
Sbjct: 55  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 114
Query: 187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
             P G + S L  +    +   R+  A  +     YLH      +I+RD+K  N+L+ + 
Sbjct: 115 YVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 170
Query: 247 FEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              Q+ DFG AK +    W       + GT  YLAPE ++    ++  D +A GVL+ E+
Sbjct: 171 GYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224
Query: 306 VTG 308
             G
Sbjct: 225 AAG 227

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 18/250 (7%)
Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRG 145
           L   S+  ++ Q    L E            LIGKG + +VY GR      + +  + R 
Sbjct: 9   LSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD 68
Query: 146 TADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGMKEKL 204
             D++ A F  E+       H N    +G  +    + I+  L    +L S++   K  L
Sbjct: 69  NEDQLKA-FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL---AKWLP 261
                 +IA  + +G+ YLH    + I+H+D+K+ N+   ++ +  I DFGL   +  L 
Sbjct: 128 DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQ 183
Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGIVD---------EKTDVFAFGVLLLELVTGRRAL 312
                  +    G   +LAPE +     D         + +DVFA G +  EL       
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
Query: 313 DYSQQSLVLW 322
                  ++W
Sbjct: 244 KTQPAEAIIW 253

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFGLAK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           ++  +  +    +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + 
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLR 60
Query: 166 HPNTAKLLGYGIEG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           H N    +   +        + ++      GSL    Y     L      +I L +A GL
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGL 118
Query: 221 LYLH---EGCQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE-- 273
            +LH    G Q +  I HRD+K+ NIL+ ++ +  I D GLA    +      +      
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 274 GTFGYLAPEFLMHGI-VD-----EKTDVFAFGVLLLEL 305
           GT  Y+APE L   I VD     ++ D++AFG++L E+
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +G+G + +V+     N        LVA+K L   + +    DF  E  ++  + H +  +
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVR 107
Query: 172 LLGYGIEG-GMHIVLELSPNGSL----------ASLLYGMKE----KLKWGIRYKIALGV 216
             G   EG  + +V E   +G L          A LL G ++     L  G    +A  V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           A G++YL        +HRD+   N L+ +    +I DFG+++ +     +    +     
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            ++ PE +++     ++DV++FGV+L E+ T
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           IG G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 155 LSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           L E+ I+  V  HPN  +L   Y       +V +L   G L   L   K  L      KI
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKI 116
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              + E +  LH   +  I+HRD+K  NILL +D   ++ DFG +  L        + +V
Sbjct: 117 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREV 170
Query: 273 EGTFGYLAPEFLMHGIVD------EKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
            GT  YLAPE +   + D      ++ D+++ GV++  L+ G     + +Q L+L
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 20/279 (7%)
Query: 52  FRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNN 111
           +RN+S  S+ TL  + + +    S      + R+ +V  +   +      + E+Q    +
Sbjct: 19  WRNESALSVETLLDVLVCLYTECSHSA---LRRDKYVAEFLEWAKPFTQLVKEMQLHRED 75
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HP 167
           F    +IG+G + EV   +++N + + A+K L +         A F  E  ++ + D   
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEG 226
            TA    +  E  +++V++    G L +LL   ++KL   + R+ I     E +L +   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG----EMVLAIDSI 191
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            Q   +HRDIK  N+LL  +   ++ DFG    + +  T  +   V GT  Y++PE L  
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQA 250
Query: 287 -----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV 320
                G    + D ++ GV + E++ G     +  +SLV
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETP--FYAESLV 287

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 109/243 (44%), Gaps = 27/243 (11%)
Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR 130
           SS ++E +   +  F+  ++S +          Q+  +   FE +  +G G +  V   +
Sbjct: 5   SSDVKEFLAKAKEDFLKKWESPA----------QNTAHLDQFERIKTLGTGSFGRVMLVK 54
Query: 131 LR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLE 186
            +  G   A+K L +    ++  I   L+E  I+  V+ P   KL   +     +++V+E
Sbjct: 55  HKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 114
Query: 187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
             P G + S L  +    +   R+  A  +     YLH      +I+RD+K  N+L+ + 
Sbjct: 115 YVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQ 170
Query: 247 FEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
              Q+ DFG AK +    W       + GT  YLAPE ++    ++  D +A GVL+ E+
Sbjct: 171 GYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224
Query: 306 VTG 308
             G
Sbjct: 225 AAG 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI 177
           +GKG Y EV++G  + G+ VA+K  +  + DE      +EL     + H N    +   +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 178 EG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---GCQR 229
                   + ++      GSL    Y     L      +I L +A GL +LH    G Q 
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 230 R--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFLM 285
           +  I HRD+K+ NIL+ ++ +  I D GLA    +      +      GT  Y+APE L 
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 219
Query: 286 HGI-VD-----EKTDVFAFGVLLLEL 305
             I VD     ++ D++AFG++L E+
Sbjct: 220 ETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           IG G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++ +G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 20/279 (7%)
Query: 52  FRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNN 111
           +RN+S  S+ TL  + + +    S      + R+ +V  +   +      + E+Q    +
Sbjct: 35  WRNESALSVETLLDVLVCLYTECSHSA---LRRDKYVAEFLEWAKPFTQLVKEMQLHRED 91
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQ-LVAIKRLTRGT--ADEIIADFLSELGIMAHVD-HP 167
           F    +IG+G + EV   +++N + + A+K L +         A F  E  ++ + D   
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEG 226
            TA    +  E  +++V++    G L +LL   ++KL   + R+ I     E +L +   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG----EMVLAIDSI 207
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            Q   +HRDIK  N+LL  +   ++ DFG    + +  T  +   V GT  Y++PE L  
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQA 266
Query: 287 -----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV 320
                G    + D ++ GV + E++ G     +  +SLV
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETP--FYAESLV 303

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           IG G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 106 QSATNN-FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           QS +N+ +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  
Sbjct: 4   QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 164 VDHPNTAKLLGYGIEGGMH---IVLELSPNGSLASLL------YGMKEKLKWGIRYKIAL 214
           ++H N  KL     E       +++E  P GSL ++L      YG+ E       + I L
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-----EFLIVL 118
Query: 215 -GVAEGLLYLHEGCQRRIIHRDIKAANIL--LTEDFEP--QICDFGLAKWLPEQWTHHTI 269
             V  G+ +L E     I+HR+IK  NI+  + ED +   ++ DFG A+ L +       
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQF 172
Query: 270 SKVEGTFGYLAPEFLMHGIVDEK--------TDVFAFGVLLLELVTG 308
             + GT  YL P+     ++ +          D+++ GV      TG
Sbjct: 173 VXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 155 LSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           L E+ I+  V  HPN  +L   Y       +V +L   G L   L   K  L      KI
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKI 129
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              + E +  LH   +  I+HRD+K  NILL +D   ++ DFG +  L        + +V
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREV 183
Query: 273 EGTFGYLAPEFLMHGIVD------EKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
            GT  YLAPE +   + D      ++ D+++ GV++  L+ G     + +Q L+L
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 16/197 (8%)
Query: 118 IGKG--GYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG G  G A + + +  N +LVA+K + RG  ++I A+   E+     + HPN  +    
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERG--EKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
            +    + IV+E +  G L   +       +   R+     ++ G+ Y H     ++ HR
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYCH---AMQVCHR 139
Query: 235 DIKAANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           D+K  N LL     P  +ICDFG +K       H       GT  Y+APE L+    D K
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 293 T-DVFAFGVLLLELVTG 308
             DV++ GV L  ++ G
Sbjct: 197 VADVWSCGVTLYVMLVG 213

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 53/304 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 65
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLPE- 262
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L   
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 263 QWTHHT-ISKVEGTFGYLAPEFLMHGI-------VDEKTDVFAFGVLLLELVT-GRRAL- 312
           Q +  T ++   GT G+ APE L           +    D+F+ G +   +++ G+    
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 313 -DYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMS 371
             YS++S ++  R +   +E++ L D SL  E      +L+    S  I    ++RP   
Sbjct: 242 DKYSRESNII--RGIFSLDEMKCLHDRSLIAE----ATDLI----SQMIDHDPLKRPTAM 291
Query: 372 QVVQ 375
           +V++
Sbjct: 292 KVLR 295

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E  P G + S L  +    +   R+  A
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E  P G + S L  +    +   R+  A
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV--DHPNTAKLLGY 175
           IGKG Y EV+ G+ R G+ VA+K     T +E  A +  E  I   V   H N    +  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFF--TTEE--ASWFRETEIYQTVLMRHENILGFIAA 99
Query: 176 GIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC--- 227
            I+G      ++++ +   NGSL   L       K  +  K+A     GL +LH      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML--KLAYSSVSGLCHLHTEIFST 157
Query: 228 --QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI--SKVEGTFGYLAPEF 283
             +  I HRD+K+ NIL+ ++    I D GLA           I  +   GT  Y+ PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 284 LMHGIVDEK------TDVFAFGVLLLEL 305
           L   +           D+++FG++L E+
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E  P G + S L  +    +   R+  A
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 20/230 (8%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQL-----VAIKRLTRGTADEIIADFLS- 156
           ++ Q   + +     +G G +A V K R ++  L        KR +R +   +  + +  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 157 ELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           E+ I+  V HPN   L   Y     + ++LEL   G L   L   KE L           
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQ 123
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHTISK 271
           + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      I  
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
             GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 180 --GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 24/205 (11%)
Query: 118 IGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R +        + +  +RL+   RG + E I     E+ I+  + HPN
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIE---REVNILREIRHPN 69
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   +  +  + ++LEL   G L   L   KE L      +    + +G+ YLH   
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 228 QRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
            +RI H D+K  NI+L +   P    ++ DFG+A  +      +    + GT  ++APE 
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEI 182
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTG 308
           + +  +  + D+++ GV+   L++G
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 155 LSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           L E+ I+  V  HPN  +L   Y       +V +L   G L   L   K  L      KI
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKI 129
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              + E +  LH   +  I+HRD+K  NILL +D   ++ DFG +  L        +  V
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLRSV 183
Query: 273 EGTFGYLAPEFLMHGIVD------EKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
            GT  YLAPE +   + D      ++ D+++ GV++  L+ G     + +Q L+L
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 136/304 (44%), Gaps = 53/304 (17%)
Query: 106 QSATNNFSFENLIGKGGYAEV-YKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           QS  N    E ++G G    V ++G  + G+ VA+KR+     D  IA  L E+ ++   
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCD--IA--LMEIKLLTES 65
Query: 165 D-HPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYK-IAL--GV 216
           D HPN  +       +  ++I LEL  N +L  L+       E LK    Y  I+L   +
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLP-- 261
           A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L   
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGI-------VDEKTDVFAFGVLLLELVT-GRRAL- 312
           +      ++   GT G+ APE L           +    D+F+ G +   +++ G+    
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 313 -DYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMS 371
             YS++S ++  R +   +E++ L D SL  E      +L+    S  I    ++RP   
Sbjct: 242 DKYSRESNII--RGIFSLDEMKCLHDRSLIAE----ATDLI----SQMIDHDPLKRPTAM 291
Query: 372 QVVQ 375
           +V++
Sbjct: 292 KVLR 295

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I   V+ P   KL   +     +++VLE +P G + S L  +    +   R+  A
Sbjct: 90  LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    ++ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 109 TNNFSFENLIGKGGYAE----VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           ++ +  +  IG G Y+E    V+K       +  I +  R  ++EI  + L   G     
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI--EILLRYG----- 78
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL-GVAEGLLY 222
            HPN   L     +G  +++V EL   G L   +  +++K          L  + + + Y
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVLHTIGKTVEY 136
Query: 223 LHEGCQRRIIHRDIKAANIL-LTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           LH    + ++HRD+K +NIL + E   P+   ICDFG AK L  +  +  +     T  +
Sbjct: 137 LHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NGLLMTPCYTANF 191
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           +APE L     DE  D+++ G+LL  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 109 TNNFSFENLIGKGGYAE----VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           ++ +  +  IG G Y+E    V+K       +  I +  R  ++EI      E+ ++ + 
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEI------EI-LLRYG 78
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL-GVAEGLLY 222
            HPN   L     +G  +++V EL   G L   +  +++K          L  + + + Y
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI--LRQKFFSEREASFVLHTIGKTVEY 136
Query: 223 LHEGCQRRIIHRDIKAANIL-LTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           LH    + ++HRD+K +NIL + E   P+   ICDFG AK L  +  +  +     T  +
Sbjct: 137 LHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE--NGLLMTPCYTANF 191
Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           +APE L     DE  D+++ G+LL  ++ G
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E  P G + S L  +    +   R+  A
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YA 168
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 169 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 165
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 166 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 219
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 10/199 (5%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H N  +L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 176 -GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
              +  + +V E   +  L          L   I       + +GL + H    R ++HR
Sbjct: 70  LHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 235 DIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKT 293
           D+K  N+L+  + E ++ +FGLA+        ++   V  T  Y  P+ L    +     
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTSI 183
Query: 294 DVFAFGVLLLELVTGRRAL 312
           D+++ G +  EL    R L
Sbjct: 184 DMWSAGCIFAELANAGRPL 202

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 74
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 130
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 187
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 10  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 67
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 68  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 128 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 177
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E +P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+++ +    ++ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLT---RGTADEII 151
           +LY      +++     +G G +A V K R +        + +  +RL    RG + E I
Sbjct: 17  NLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEI 76
Query: 152 ADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
                E+ I+  + HPN   L   +  +  + ++LEL   G L   L   KE L      
Sbjct: 77  E---REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEAT 132
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTH 266
           +    + +G+ YLH    +RI H D+K  NI+L +   P    ++ DFG+A  +      
Sbjct: 133 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AG 186
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           +    + GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLEL-SPNGSLASLLYGMKE 202
           A     EL +M  V+H N   LL              ++IV+EL   N S    +    E
Sbjct: 67  AKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE 126
Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
           ++ + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+    
Sbjct: 127 RMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---T 175
Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 74
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 130
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 187
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 225

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E  P G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T   ++    T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 177 GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 111 NFSFENLIGKGGYAEVYKGRLRNG-QLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
           +F    +IG+G + EV   +L+N  ++ A+K L +         A F  E  ++ + D  
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 168 NTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
               L   +  +  +++V++    G L +LL   +++L   +       +AE ++ +   
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIAIDSV 191
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM- 285
            Q   +HRDIK  NIL+  +   ++ DFG    L E  T  +   V GT  Y++PE L  
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
Query: 286 ----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV 320
                G    + D ++ GV + E++ G     +  +SLV
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP--FYAESLV 287

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL      A+L   ++ +
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQME 122
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 107 SATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHV 164
           S T+ +     IGKG ++ V +  +L  G   A K + T+  +         E  I   +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 165 DHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            H N  +L     E G H +V +L   G L   +   +   +    + I   + E +L+ 
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHC 119
Query: 224 HEGCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           H   Q  ++HRD+K  N+LL    +    ++ DFGLA  +  Q          GT GYL+
Sbjct: 120 H---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE L      +  D++A GV+L  L+ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEG 274
           +  GL Y+H      ++HRD+K +N+L+    + +ICDFGLA+   PE      +++   
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E +P G + S L  +    +   R+  A
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+++ +    ++ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 11  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 68
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 69  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 128
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 129 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 178
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            T   +     T  Y APE ++     E  D+++ G ++ E++ G
Sbjct: 179 GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 141 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 135 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 139 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 130 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 153 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   +++   
Sbjct: 131 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++LEL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSLV 320
           + +  +  + D+++ GV+   L++G      D  Q++L 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +   L    ++  T+  +         E  I   + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L     E   H +V +L   G L   +   +   +    + I   + E + Y H 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHS 123
Query: 226 GCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
                I+HR++K  N+LL    +    ++ DFGLA  + +    H  +   GT GYL+PE
Sbjct: 124 N---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 177
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            L      +  D++A GV+L  L+ G
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 64
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 122
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 281 PEFL------MHGIVDEKTDVFAFGVLLLELV 306
           PE L       H    ++ D++A G++  E+ 
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 109 TNNFSFENLIGKGGYAE----VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           T+ +  +  IG G Y+     ++K       +  I +  R   +EI  + L   G     
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEI--EILLRYG----- 73
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGL 220
            HPN   L     +G  +++V EL   G L   +   K   E+    + + I   V    
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE--- 130
Query: 221 LYLHEGCQRRIIHRDIKAANIL-LTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEGTF 276
            YLH    + ++HRD+K +NIL + E   P+   ICDFG AK L  +  +  +     T 
Sbjct: 131 -YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTA 184
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            ++APE L     D   D+++ GVLL  ++TG
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 104
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 165 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 214
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 65
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 123
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 281 PEFL------MHGIVDEKTDVFAFGVLLLELV 306
           PE L       H    ++ D++A G++  E+ 
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL      A+L   ++ +
Sbjct: 67  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQME 122
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + + +G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E    G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 151
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ E    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 152 RDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 205
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 206 VDWWALGVLIYEMAAG 221

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 168
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    WT      +
Sbjct: 169 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT------L 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 103
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 161
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 281 PEFLMHGI------VDEKTDVFAFGVLLLELV 306
           PE L   I        ++ D++A G++  E+ 
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 59
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL      A+L   ++ +
Sbjct: 60  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLXQVIQME 115
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
           L       +   +  G+ +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TA 169
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 29/225 (12%)
Query: 105 LQSATNNFSFENL------IGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIA--D 153
           L  A ++  FE++      IGKG ++ V +   R  GQ  A+K   + + T+   ++  D
Sbjct: 13  LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 154 FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E  I   + HP+  +LL  Y  +G +++V E       A L + + ++   G  Y  
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSE 129
Query: 213 ALG------VAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEP-QICDFGLAKWLPEQ 263
           A+       + E L Y H+     IIHRD+K   +LL   E+  P ++  FG+A  L E 
Sbjct: 130 AVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                     GT  ++APE +      +  DV+  GV+L  L++G
Sbjct: 187 GL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 90
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 148
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 281 PEFLMHGI------VDEKTDVFAFGVLLLELV 306
           PE L   I        ++ D++A G++  E+ 
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 9   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 65
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 66  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 125
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 126 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 175
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 176 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +   L    ++  T+  +         E  I   + H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L     E   H +V +L   G L   +   +   +    + I   + E + Y H 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHS 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
                I+HR++K  N+LL    +    ++ DFGLA  + +    H  +   GT GYL+PE
Sbjct: 123 N---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 176
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            L      +  D++A GV+L  L+ G
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 10  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 109 TNNFSFENLIGKGGYAE----VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
           T+ +  +  IG G Y+     ++K       +  I +  R   +EI  + L   G     
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEI--EILLRYG----- 73
Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGL 220
            HPN   L     +G  +++V EL   G L   +   K   E+    + + I   V    
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVE--- 130
Query: 221 LYLHEGCQRRIIHRDIKAANIL-LTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEGTF 276
            YLH    + ++HRD+K +NIL + E   P+   ICDFG AK L  +  +  +     T 
Sbjct: 131 -YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLXTPCYTA 184
Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            ++APE L     D   D+++ GVLL   +TG
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 11  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 67
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 68  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 127
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 128 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 177
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 115 ENLIGKGGYAEVYK-GRLRNGQLVAIKRLTRGTADEIIA---DFLSELGIMAHVDHPNTA 170
           E   GK   AE Y     ++  LVA+K L     D  +A   DF  E  ++ ++ H +  
Sbjct: 25  EGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNLQHEHIV 80
Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYG---------------MKEKLKWGIRYKIAL 214
           K  G   +G  + +V E   +G L   L                  K +L       IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            +A G++YL     +  +HRD+   N L+  +   +I DFG+++ +     +        
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              ++ PE +M+     ++DV++FGV+L E+ T
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 70
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 128
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 281 PEFL------MHGIVDEKTDVFAFGVLLLELV 306
           PE L       H    ++ D++A G++  E+ 
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD- 153
            Y +Q A + F+    ++ L  IG G    V        G  VA+K+L+R   ++  A  
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 67
Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGM--KEKL 204
              EL ++  V+H N   LL              +++V+EL  + +L  +++     E++
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERM 126
Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
            + + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+      
Sbjct: 127 SY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAS 175
Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           T+  ++    T  Y APE ++     E  D+++ G ++ ELV G
Sbjct: 176 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 11  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 67
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 68  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 127
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 128 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 177
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 48  FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 104
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 165 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 214
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +   L    ++  T+  +         E  I   + H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L     E   H +V +L   G L   +   +   +    + I   + E + Y H 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCHS 146
Query: 226 GCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
                I+HR++K  N+LL    +    ++ DFGLA  + +    H  +   GT GYL+PE
Sbjct: 147 NG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 200
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            L      +  D++A GV+L  L+ G
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 4   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 60
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 120
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 121 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 3   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 60
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 61  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 120
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 121 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            T   ++    T  Y APE ++     E  D+++ G ++ E+V  +
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 29/226 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 14  NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 71
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 72  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 131
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 132 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 181
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            T   ++    T  Y APE ++     E  D+++ G ++ E+V  +
Sbjct: 182 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 3   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 59
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 60  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 119
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 120 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 169
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 31/223 (13%)
Query: 102 LYELQSATNNFS----FENL--IGKGGYAEV---YKGRL-RNGQLVAIKRLTRGTADEII 151
            Y ++   + F+    ++NL  IG G    V   Y   L RN   VAIK+L+R   ++  
Sbjct: 4   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTH 60
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              +++V+EL        +   +  +
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 120
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 121 RMSYLLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 170
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T   ++    T  Y APE ++     E  D+++ G ++ E+V
Sbjct: 171 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 118 IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY-- 175
           IGKG + EV++G+ R G+ VA+K  +         +  +E+     + H N   +LG+  
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHEN---ILGFIA 67
Query: 176 ------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE---G 226
                 G    + +V +   +GSL   L      ++  I  K+AL  A GL +LH    G
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVG 125
Query: 227 CQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----GTFGYLA 280
            Q +  I HRD+K+ NIL+ ++    I D GLA  +       TI        GT  Y+A
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 281 PEFL------MHGIVDEKTDVFAFGVLLLELV 306
           PE L       H    ++ D++A G++  E+ 
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   + +   
Sbjct: 137 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +   L    ++  T+  +         E  I   + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 167 PNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L     E   H +V +L   G L   +   +   +    + I   + E + Y H 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QILESIAYCH- 122
Query: 226 GCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
                I+HR++K  N+LL    +    ++ DFGLA  + +    H  +   GT GYL+PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLSPE 177
Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTG 308
            L      +  D++A GV+L  L+ G
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +ICDFGLA+       H   + +   
Sbjct: 138 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 10/147 (6%)
Query: 166 HPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HPN  +L     E G H +V +L   G L   +   +   +    + I   + E + ++H
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIH-QILESVNHIH 147
Query: 225 EGCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
              Q  I+HRD+K  N+LL    +    ++ DFGLA  +  Q          GT GYL+P
Sbjct: 148 ---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSP 202
Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTG 308
           E L      +  D++A GV+L  L+ G
Sbjct: 203 EVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 13/110 (11%)
Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
           G+   I + +AE + +LH    + ++HRD+K +NI  T D   ++ DFGL   + +    
Sbjct: 164 GVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220
Query: 267 HTI----------SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
            T+              GT  Y++PE +       K D+F+ G++L EL+
Sbjct: 221 QTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YA 142
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 143 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 193
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            T   +     T  Y APE ++     E  D+++ G ++ E+V  +
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 108 ATNNFSFENL------IGKGGYAEVYKG-RLRNGQLVAIKRL-TRGTADEIIADFLSELG 159
            T N  F+++      +GKG ++ V +  ++  GQ  A K + T+  +         E  
Sbjct: 14  GTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREAR 73
Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           I   + HPN  +L     E G H ++ +L   G L   +   +   +    + I   + E
Sbjct: 74  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILE 132
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGT 275
            +L+ H   Q  ++HRD+K  N+LL    +    ++ DFGLA  +  +          GT
Sbjct: 133 AVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGT 187
Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GYL+PE L      +  D++A GV+L  L+ G
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 118 IGKG--GYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG G  G A + + +  N +LVA+K + RG  ++I  +   E+     + HPN  +    
Sbjct: 26  IGSGNFGVARLMRDKQSN-ELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
            +    + IV+E +  G L   +       +   R+     ++ G+ Y H     ++ HR
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYCH---AMQVCHR 138
Query: 235 DIKAANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           D+K  N LL     P  +ICDFG +K       H       GT  Y+APE L+    D K
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 293 T-DVFAFGVLLLELVTG 308
             DV++ GV L  ++ G
Sbjct: 196 VADVWSCGVTLYVMLVG 212

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 108 ATNNFSFENL------IGKGGYAEVYKGRLR-NGQLVAIK--RLTRGTADEIIA--DFLS 156
           A ++  FE++      IGKG ++ V +   R  GQ  A+K   + + T+   ++  D   
Sbjct: 18  ADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR 77
Query: 157 ELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG 215
           E  I   + HP+  +LL  Y  +G +++V E       A L + + ++   G  Y  A+ 
Sbjct: 78  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG---ADLCFEIVKRADAGFVYSEAVA 134
Query: 216 ------VAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEP-QICDFGLAKWLPEQWTH 266
                 + E L Y H+     IIHRD+K   +LL   E+  P ++  FG+A  L E    
Sbjct: 135 SHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 190
Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                  GT  ++APE +      +  DV+  GV+L  L++G
Sbjct: 191 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKL-L 173
           +G G +  V   + +  G   A+K L +    ++  I   L+E  I+  V+ P   KL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
            +     +++V+E    G + S L  +    +   R+  A  +     YLH      +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH---SLDLIY 164
Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           RD+K  N+L+ +    Q+ DFG AK +    W       + GT  YLAPE ++    ++ 
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------LCGTPEYLAPEIILSKGYNKA 218
Query: 293 TDVFAFGVLLLELVTG 308
            D +A GVL+ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 107 SATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHV 164
           S T+ +     +GKG ++ V +  ++  GQ  A K + T+  +         E  I   +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 165 DHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HPN  +L     E G H +V +L   G L   +   +   +    + I   + E + + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILESVNHC 119
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           H      I+HRD+K  N+LL   ++    ++ DFGLA  +  Q          GT GYL+
Sbjct: 120 H---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE L      +  D++A GV+L  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YA 168
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 169 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 219
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 106/259 (40%), Gaps = 57/259 (22%)
Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLV-AIKRLTRGTADEI----IADFL 155
           SL ELQ     +  +  IG+G Y  V        + + AIK + +    +I    +    
Sbjct: 20  SLLELQKK---YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 156 SELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL----------------- 197
           +E+ +M  + HPN A+L   Y  E  + +V+EL   G L   L                 
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 198 ------------------YGMKEKLKWGIRYK----IALGVAEGLLYLHEGCQRRIIHRD 235
                             +G +E L +  R K    I   +   L YLH    + I HRD
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRD 193
Query: 236 IKAANILLTED--FEPQICDFGLAK--WLPEQWTHHTISKVEGTFGYLAPEFL--MHGIV 289
           IK  N L + +  FE ++ DFGL+K  +      ++ ++   GT  ++APE L   +   
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253
Query: 290 DEKTDVFAFGVLLLELVTG 308
             K D ++ GVLL  L+ G
Sbjct: 254 GPKCDAWSAGVLLHLLLMG 272

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 148
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 149 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 199
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 101 SLYELQSATNNFS----FENL--IGKGGYAEV---YKGRLRNGQLVAIKRLTRGTADEII 151
           + Y ++   + F+    ++NL  IG G    V   Y   L     VAIK+L+R   ++  
Sbjct: 9   NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH 66
Query: 152 AD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVLELSPNGSLASLLYGMKEK 203
           A     EL +M  V+H N   LL              ++IV+EL        +   +  +
Sbjct: 67  AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126
Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
               + Y++  G+     +LH      IIHRD+K +NI++  D   +I DFGLA+     
Sbjct: 127 RMSYLLYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 176
Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            T   +     T  Y APE ++     E  D+++ G ++ E+V  +
Sbjct: 177 GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 12/208 (5%)
Query: 107 SATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHV 164
           S T+ +     +GKG ++ V +  ++  GQ  A K + T+  +         E  I   +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 165 DHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            HPN  +L     E G H +V +L   G L   +   +   +    + I   + E + + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ-QILESVNHC 119
Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           H      I+HRD+K  N+LL   ++    ++ DFGLA  +  Q          GT GYL+
Sbjct: 120 H---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLS 174
Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           PE L      +  D++A GV+L  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 118 IGKGGYAEVYKGRLRNGQL-----VAIKRLT----RGTADEIIADFLSELGIMAHVDHPN 168
           +G G +A V K R ++  L        KR T    RG + E   D   E+ I+  + HPN
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE---DIEREVSILKEIQHPN 75
Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L   Y  +  + ++ EL   G L   L   KE L      +    +  G+ YLH   
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH--- 131
Query: 228 QRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
             +I H D+K  NI+L +   P+    I DFGLA  +      +    + GT  ++APE 
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEI 188
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 226

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 112/245 (45%), Gaps = 25/245 (10%)
Query: 81  DMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAI 139
           ++ ++ +V  +   +   +  L E++   ++F    +IG+G ++EV   +++  GQ+ A+
Sbjct: 32  ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 140 K------RLTRGTADEIIADFLSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGS 192
           K       L RG     ++ F  E  ++ + D     +L   +  E  +++V+E    G 
Sbjct: 92  KIMNKWDMLKRGE----VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGD 147
Query: 193 LASLLYGMKEKLKWGI-RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI 251
           L +LL    E++   + R+ +A    E ++ +    +   +HRDIK  NILL      ++
Sbjct: 148 LLTLLSKFGERIPAEMARFYLA----EIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203
Query: 252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-------HGIVDEKTDVFAFGVLLLE 304
            DFG    L    T  ++  V GT  YL+PE L         G    + D +A GV   E
Sbjct: 204 ADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 305 LVTGR 309
           +  G+
Sbjct: 263 MFYGQ 267

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 91/185 (49%), Gaps = 22/185 (11%)
Query: 134 GQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGYGIEG-------GMHIVL 185
           G  VA+K+L+R   ++  A     EL ++  V+H N   LL              +++V+
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 186 ELSPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           EL  + +L  +++     E++ + + Y++  G+     +LH      IIHRD+K +NI++
Sbjct: 109 ELM-DANLCQVIHMELDHERMSY-LLYQMLCGIK----HLHSA---GIIHRDLKPSNIVV 159
Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
             D   +I DFGLA+      T+  ++    T  Y APE ++        D+++ G ++ 
Sbjct: 160 KSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMG 216
Query: 304 ELVTG 308
           ELV G
Sbjct: 217 ELVKG 221

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+++ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 117 LIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG 176
           +IG G +  V++ +L     VAIK++ +   D+   +   EL IM  V HPN   L  + 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKRFKN--RELQIMRIVKHPNVVDLKAFF 101
Query: 177 IEGG-------MHIVLELSPNGSL-ASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              G       +++VLE  P     AS  Y  +K+ +   +       +   L Y+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 228 QRRIIHRDIKAANILLTEDFEP-----QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
              I HRDIK  N+LL    +P     ++ DFG AK L        +S +   + Y APE
Sbjct: 162 ---ICHRDIKPQNLLL----DPPSGVLKLIDFGSAKIL--IAGEPNVSXICSRY-YRAPE 211
Query: 283 FLMHGIVDEKT--DVFAFGVLLLELVTGR 309
            L+ G  +  T  D+++ G ++ EL+ G+
Sbjct: 212 -LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAPE ++    ++  D +A GVL+ ++  G
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           ++++   T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 271

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT---------RGTADEIIAD 153
           ++ Q   + +     +G G +A V K R ++  L    +           RG + E I  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 154 FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E+ I+  V H N   L   Y     + ++LEL   G L   L   KE L        
Sbjct: 64  --REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF 120
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHT 268
              + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           I    GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 178 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT---------RGTADEIIAD 153
           ++ Q   + +     +G G +A V K R ++  L    +           RG + E I  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 154 FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E+ I+  V H N   L   Y     + ++LEL   G L   L   KE L        
Sbjct: 64  --REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF 120
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHT 268
              + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           I    GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 178 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 224
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 277

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 227

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 188
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 241

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 225

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 179
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 232

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 180
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 233

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 178
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 231

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 173
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 226

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT---------RGTADEIIAD 153
           ++ Q   + +     +G G +A V K R ++  L    +           RG + E I  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 154 FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E+ I+  V H N   L   Y     + ++LEL   G L   L   KE L        
Sbjct: 64  --REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF 120
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHT 268
              + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           I    GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 178 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D+++ GV++  L+ G     YS   L +
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAI 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT---------RGTADEIIAD 153
           ++ Q   + +     +G G +A V K R ++  L    +           RG + E I  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 154 FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E+ I+  V H N   L   Y     + ++LEL   G L   L   KE L        
Sbjct: 64  --REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF 120
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHT 268
              + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           I    GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 178 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT  YLAP  ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 12/208 (5%)
Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
           ++   + +G G + +V  G+    G  VA+K L R    + +++     E+  +    HP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 168 NTAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           +  KL         + +V+E    G L   +     +L      ++   +  G+ Y H  
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH-- 133
Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
            +  ++HRD+K  N+LL      +I DFGL+  + +      +    G+  Y APE +  
Sbjct: 134 -RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRXSCGSPNYAAPEVISG 189
Query: 287 GI-VDEKTDVFAFGVLLLELVTGRRALD 313
            +    + D+++ GV+L  L+ G    D
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT-ISKVEG 274
           +  GL Y+H      ++HRD+K +N+LL    + +I DFGLA+       H   +++   
Sbjct: 133 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 275 TFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           T  Y APE +++     K+ D+++ G +L E+++ R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 109/247 (44%), Gaps = 28/247 (11%)
Query: 75  SMREGIDMPRNL-FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN 133
           SM++ +    NL ++N Y  +   K  + Y +    N   F  +I      + Y  +   
Sbjct: 5   SMKDILSNYSNLIYLNKY-VKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYE 63
Query: 134 GQLVAIKR-LTRGTADEI-----IADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIV 184
             L+  KR  T+   D+I       DF +EL I+   D  N   L   GI      ++I+
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT--DIKNEYCLTCEGIITNYDEVYII 121
Query: 185 LELSPNGSLASL---LYGMKEKLKWGIRYKIALGVAEGLL----YLHEGCQRRIIHRDIK 237
            E   N S+       + + +     I  ++   + + +L    Y+H   ++ I HRD+K
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVK 179
Query: 238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH--GIVDEKTDV 295
            +NIL+ ++   ++ DFG ++++ ++     I    GT+ ++ PEF  +       K D+
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 296 FAFGVLL 302
           ++ G+ L
Sbjct: 236 WSLGICL 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 118 IGKG--GYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG G  G A + + +  N +LVA+K + RG  ++I  +   E+     + HPN  +    
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 176 GI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
            +    + IV+E +  G L   +       +   R+     ++ G+ Y H     ++ HR
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYCH---AMQVCHR 139
Query: 235 DIKAANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           D+K  N LL     P  +IC FG +K       H       GT  Y+APE L+    D K
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 293 T-DVFAFGVLLLELVTG 308
             DV++ GV L  ++ G
Sbjct: 197 VADVWSCGVTLYVMLVG 213

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 24/195 (12%)
Query: 131 LRNGQLVAIKRLT-RGTADEIIADFL------------SELGIMAHVDHPNTAKLL-GYG 176
           L  G    + R+T R T +   A F+             E+  M+ + HP    L   + 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +  M ++ E    G L   +     K+      +    V +GL ++HE      +H D+
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDL 175
Query: 237 KAANILLT--EDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           K  NI+ T     E ++ DFGL   L P+Q    ++    GT  + APE      V   T
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYT 231
Query: 294 DVFAFGVLLLELVTG 308
           D+++ GVL   L++G
Sbjct: 232 DMWSVGVLSYILLSG 246

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 16/197 (8%)
Query: 118 IGKG--GYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           IG G  G A + + +  N +LVA+K + RG  ++I  +   E+     + HPN  +    
Sbjct: 27  IGSGNFGVARLMRDKQSN-ELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
            +    + IV+E +  G L   +       +   R+     ++ G+ Y H     ++ HR
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYCH---AMQVCHR 139
Query: 235 DIKAANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           D+K  N LL     P  +IC FG +K       H       GT  Y+APE L+    D K
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 293 T-DVFAFGVLLLELVTG 308
             DV++ GV L  ++ G
Sbjct: 197 VADVWSCGVTLYVMLVG 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 26/233 (11%)
Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLT---------RGTADEIIAD 153
           ++ Q   + +     +G G +A V K R ++  L    +           RG + E I  
Sbjct: 5   FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE- 63
Query: 154 FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
              E+ I+  V H N   L   Y     + ++LEL   G L   L   KE L        
Sbjct: 64  --REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF 120
Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP----QICDFGLAKWLPEQWTHHT 268
              + +G+ YLH    ++I H D+K  NI+L +   P    ++ DFGLA  + +      
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL--DYSQQSL 319
           I    GT  ++APE + +  +  + D+++ GV+   L++G      D  Q++L
Sbjct: 178 IF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 11/157 (7%)
Query: 156 SELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           +E+ IM  + HP    L   +  +  M ++LE    G L   +     K+          
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANIL--LTEDFEPQICDFGLAKWL-PEQWTHHTISK 271
              EGL ++HE     I+H DIK  NI+    +    +I DFGLA  L P++    T + 
Sbjct: 157 QACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 213
Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            E    + APE +    V   TD++A GVL   L++G
Sbjct: 214 AE----FAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 5/91 (5%)
Query: 225 EGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           E C R +I+HRD+K  N+LL ++   +I DFGL+  + +    + +    G+  Y APE 
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEV 178
Query: 284 LMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
           +   +    + DV++ G++L  ++ GR   D
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 24/195 (12%)
Query: 131 LRNGQLVAIKRLT-RGTADEIIADFL------------SELGIMAHVDHPNTAKLL-GYG 176
           L  G    + R+T R T +   A F+             E+  M+ + HP    L   + 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 177 IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI 236
            +  M ++ E    G L   +     K+      +    V +GL ++HE      +H D+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDL 281
Query: 237 KAANILLT--EDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT 293
           K  NI+ T     E ++ DFGL   L P+Q    ++    GT  + APE      V   T
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 294 DVFAFGVLLLELVTG 308
           D+++ GVL   L++G
Sbjct: 338 DMWSVGVLSYILLSG 352

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 114 FENLIGKGGYA------EVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           FE L GKG ++      +V  G+     ++  K+L+     ++      E  I   + HP
Sbjct: 16  FEEL-GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL----EREARICRLLKHP 70
Query: 168 NTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N  +L     E G H ++ +L   G L   +   +   +    + I   + E +L+ H  
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QILEAVLHCH-- 127
Query: 227 CQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
            Q  ++HR++K  N+LL    +    ++ DFGLA  +  +          GT GYL+PE 
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 284 LMHGIVDEKTDVFAFGVLLLELVTG 308
           L      +  D++A GV+L  L+ G
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVG 209

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 10/114 (8%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI---CDFGLAKWLPEQWTHH 267
           +I   + E + YLH      I HRD+K  N+L T      I    DFG AK   E  +H+
Sbjct: 165 EIXKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL 321
           +++    T  Y+APE L     D+  D ++ GV+   L+ G     YS   L +
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF-YSNHGLAI 271

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 155 LSELGIMAHVDHPNTAKL-LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
           L+E  I+  V+ P   KL   +     +++V+E    G + S L  +    +   R+  A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YA 147
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP-EQWTHHTISKV 272
             +     YLH      +I+RD+K  N+L+ +    Q+ DFG AK +    W       +
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX------L 198
Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            GT   LAPE ++    ++  D +A GVL+ E+  G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 44/224 (19%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVD-HPNTAKLLG 174
           +GKG Y  V+K    R G++VA+K++     +   A     E+ I+  +  H N   LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---------YLHE 225
                    VL    +  +  +   M+  L   IR  I   V +  +         YLH 
Sbjct: 77  ---------VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----------LPEQWTHHT------- 268
           G    ++HRD+K +NILL  +   ++ DFGL++           +P     +T       
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 269 --ISKVEGTFGYLAPEFLMHGIVDEK-TDVFAFGVLLLELVTGR 309
             ++    T  Y APE L+      K  D+++ G +L E++ G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 14/194 (7%)
Query: 119 GKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE 178
           G  G A + + +  N +LVA+K + RG  ++I  +   E+     + HPN  +     + 
Sbjct: 30  GNFGVARLMRDKQAN-ELVAVKYIERG--EKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 179 GG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK 237
              + IV+E +  G L   +       +   R+     ++ G+ Y H     ++ HRD+K
Sbjct: 87  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-GVSYAH---AMQVAHRDLK 142
Query: 238 AANILLTEDFEP--QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT-D 294
             N LL     P  +I DFG +K       H       GT  Y+APE L+    D K  D
Sbjct: 143 LENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVAD 199
Query: 295 VFAFGVLLLELVTG 308
           V++ GV L  ++ G
Sbjct: 200 VWSCGVTLYVMLVG 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 27/228 (11%)
Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADEIIADF 154
           P K   +Y+L S         L+G+G YA+V     L+NG+  A+K + +         F
Sbjct: 7   PGKFEDMYKLTS--------ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVF 58
Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
                +     + N  +L+ +  +    ++V E    GS+ + +   K         ++ 
Sbjct: 59  REVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVV 117
Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILL--TEDFEP-QICDFGLAKWLPEQWTHHTIS 270
             VA  L +LH    + I HRD+K  NIL    E   P +ICDF L   +    +   I+
Sbjct: 118 RDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 271 KVE-----GTFGYLAPEFL-----MHGIVDEKTDVFAFGVLLLELVTG 308
             E     G+  Y+APE +          D++ D+++ GV+L  +++G
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 116/282 (41%), Gaps = 54/282 (19%)
Query: 97  QKIFSLYE-LQSATNNFSFENLIGKGGYAEVY--KGRLRNG--QLVAIKRLTRGTADEII 151
           + I  LYE +   +N F  E+ IG+G ++ VY    +L+ G  + +A+K L   +    I
Sbjct: 7   KDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRI 66
Query: 152 ADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           A  L  L +    D+    K   Y      H+V+ + P     S L  +   L +    +
Sbjct: 67  AAELQCLTVAGGQDNVMGVK---YCFRKNDHVVIAM-PYLEHESFL-DILNSLSFQEVRE 121
Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWLPEQWTHHT-- 268
             L + + L  +H   Q  I+HRD+K +N L     +   + DFGLA     Q TH T  
Sbjct: 122 YMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA-----QGTHDTKI 173
Query: 269 -----------------------------ISKVEGTFGYLAPEFLMHGIVDEKT--DVFA 297
                                        ++   GT G+ APE L     ++ T  D+++
Sbjct: 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-CPNQTTAIDMWS 232
Query: 298 FGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS 339
            GV+ L L++GR     +   L   A+ M  R   RE + A+
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS-RETIQAA 273

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 16/106 (15%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILL--TEDFEP-QICDFGLAKWLPEQWTHHTISKV 272
           VA  L +LH    + I HRD+K  NIL        P +ICDFGL   +        IS  
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 273 E-----GTFGYLAPEFL-----MHGIVDEKTDVFAFGVLLLELVTG 308
           E     G+  Y+APE +        I D++ D+++ GV+L  L++G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLG 174
           ++ +GG+A VY+ + + +G+  A+KRL     ++  A  + E+  M  +  HPN  +   
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA-IIQEVCFMKKLSGHPNIVQFCS 93
Query: 175 YGIEG------GMHIVLELSP--NGSLASLLYGMKEK--LKWGIRYKIALGVAEGLLYLH 224
               G      G    L L+    G L   L  M+ +  L      KI       + ++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE----QWTHHTISKVE------G 274
              +  IIHRD+K  N+LL+     ++CDFG A  +       W+    + VE       
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 275 TFGYLAPEFL---MHGIVDEKTDVFAFGVLL 302
           T  Y  PE +    +  + EK D++A G +L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 139 IKRLTR-GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLL 197
           IK L R   AD    D +    I+  +DH N           G+H+V+     G   +LL
Sbjct: 66  IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG------PNGVHVVMVFEVLGE--NLL 117
Query: 198 YGMKEKLKWGIRY----KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--- 250
             +K+    GI      +I+  +  GL Y+H  C   IIH DIK  N+L+     P+   
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 175
Query: 251 ---ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              I D G A W  E +T+ +I   E    Y +PE L+        D+++   L+ EL+T
Sbjct: 176 QIKIADLGNACWYDEHYTN-SIQTRE----YRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 308 G 308
           G
Sbjct: 231 G 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 80/181 (44%), Gaps = 26/181 (14%)
Query: 139 IKRLTR-GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLL 197
           IK L R   AD    D +    I+  +DH N           G+H+V+     G   +LL
Sbjct: 66  IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG------PNGVHVVMVFEVLGE--NLL 117
Query: 198 YGMKEKLKWGIRY----KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--- 250
             +K+    GI      +I+  +  GL Y+H  C   IIH DIK  N+L+     P+   
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 175
Query: 251 ---ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
              I D G A W  E +T+ +I   E    Y +PE L+        D+++   L+ EL+T
Sbjct: 176 QIKIADLGNACWYDEHYTN-SIQTRE----YRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 308 G 308
           G
Sbjct: 231 G 231

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 225 EGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           E C R +I+HRD+K  N+LL E    +I DFGL+  + +    + +    G+  Y APE 
Sbjct: 127 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEV 183
Query: 284 LMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
           +   +    + DV++ GV+L  ++  R   D
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 225 EGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           E C R +I+HRD+K  N+LL E    +I DFGL+  + +    + +    G+  Y APE 
Sbjct: 126 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEV 182
Query: 284 LMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
           +   +    + DV++ GV+L  ++  R   D
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 49/115 (42%), Gaps = 7/115 (6%)
Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           HRD+K  NIL++ D    + DFG+A    ++      + V GT  Y APE         +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 293 TDVFAFGVLLLELVTGRRALDYSQQSLV------LWARPMIKRNEIRELVDASLA 341
            D++A   +L E +TG       Q S+          RP   R  I    DA +A
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTVRPGIPVAFDAVIA 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 225 EGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           E C R +I+HRD+K  N+LL E    +I DFGL+  + +    + +    G+  Y APE 
Sbjct: 117 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEV 173
Query: 284 LMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
           +   +    + DV++ GV+L  ++  R   D
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            ++   + +G G + +V  G  +  G  VA+K L R    + +++     E+  +    H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 167 PNTAKLLGY-GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYL 223
           P+  KL           +V+E    G L   +  +G  E+++       A  + + +L  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLFQQILSA 123
Query: 224 HEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
            + C R  ++HRD+K  N+LL      +I DFGL+  + +     T     G+  Y APE
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
            +   +    + D+++ GV+L  L+ G    D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 225 EGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
           E C R +I+HRD+K  N+LL E    +I DFGL+  + +    + +    G+  Y APE 
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEV 177
Query: 284 LMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
           +   +    + DV++ GV+L  ++  R   D
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLT-----RGTADEIIADFLSELGIMAH 163
           + F  E + G+G +  V  G+ ++ G  VAIK++      R    +I+ D       +A 
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-------LAV 75
Query: 164 VDHPNTAKLLGYGIEGG--------MHIVLELSPNG-SLASLLYGMKEKLKWGIRYKI-- 212
           + HPN  +L  Y    G        +++V+E  P+        Y  ++     I  K+  
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 213 -ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQWTHHTIS 270
             L  + G L+L       + HRDIK  N+L+ E D   ++CDFG AK L    +   ++
Sbjct: 136 FQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVA 190
Query: 271 KVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTG 308
            +   + Y APE +  +       D+++ G +  E++ G
Sbjct: 191 YICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            ++   + +G G + +V  G  +  G  VA+K L R    + +++     E+  +    H
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 167 PNTAKLLGY-GIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYL 223
           P+  KL           +V+E    G L   +  +G  E+++       A  + + +L  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-------ARRLFQQILSA 123
Query: 224 HEGCQRR-IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
            + C R  ++HRD+K  N+LL      +I DFGL+  + +      +    G+  Y APE
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRDSCGSPNYAAPE 180
Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGRRALD 313
            +   +    + D+++ GV+L  L+ G    D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 30/238 (12%)
Query: 104 ELQSATNNFSFENL-IGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMA 162
           E +   + F +E   +G+G Y  VYK + ++G+      L +     I      E+ ++ 
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73
Query: 163 HVDHPNTAKL---------------LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG 207
            + HPN   L                 Y      HI+         AS       +L  G
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII-----KFHRASKANKKPVQLPRG 128
Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLAKWLPEQ 263
           +   +   + +G+ YLH      ++HRD+K ANIL+     E    +I D G A+     
Sbjct: 129 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 264 WTH-HTISKVEGTFGYLAPEFLMHGIVDEKT-DVFAFGVLLLELVTGRRALDYSQQSL 319
                 +  V  TF Y APE L+      K  D++A G +  EL+T        Q+ +
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 111 NFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRG-------TADEIIADFLSEL--GI 160
            +    L+GKGG+  V+ G RL +   VAIK + R         +D +       L   +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 161 MAHVDHPNTAKLLG-YGIEGGMHIVLELS-PNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            A   HP   +LL  +  + G  +VLE   P   L   +   K  L  G        V  
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCFFGQVVA 150
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLAKWLPEQWTHHTISKVEGT 275
            + + H    R ++HRDIK  NIL+  D      ++ DFG    L ++      +  +GT
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE----PYTDFDGT 201
Query: 276 FGYLAPEFL-MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
             Y  PE++  H        V++ G+LL ++V G    +  Q+ L
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL 246

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 116
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 117 -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 172
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 173 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +GL YLH    + I+H+DIK  N+LLT     +I   G+A+ L       T    +G+  
Sbjct: 120 DGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 278 YLAPEFL--MHGIVDEKTDVFAFGVLLLELVTG 308
           +  PE    +      K D+++ GV L  + TG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 72
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 73  -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 128
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 129 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 185
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 186 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 69
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 70  -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 125
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 126 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 88
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 89  -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 144
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 145 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 116
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 117 -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 172
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 173 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 229
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 117 LIGKG--GYAEVYKGRLR-NGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +IGKG      V   R +  G+ V ++R+     ++E++     EL +    +HPN    
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 173 LGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
               I +  + +V      GS   L+  + M    +  I Y I  GV + L Y+H     
Sbjct: 76  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIH---HM 131
Query: 230 RIIHRDIKAANILLTEDFEPQI----CDFGLAKWLPEQWTHHTISKVE-GTFGYLAPEFL 284
             +HR +KA++IL++ D +  +     +  +      Q   H   K       +L+PE L
Sbjct: 132 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 191
Query: 285 MHGI--VDEKTDVFAFGVLLLELVTGR 309
              +   D K+D+++ G+   EL  G 
Sbjct: 192 QQNLQGYDAKSDIYSVGITACELANGH 218

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 18/207 (8%)
Query: 117 LIGKG--GYAEVYKGRLR-NGQLVAIKRLT-RGTADEIIADFLSELGIMAHVDHPNTAKL 172
           +IGKG      V   R +  G+ V ++R+     ++E++     EL +    +HPN    
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 173 LGYGI-EGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
               I +  + +V      GS   L+  + M    +  I Y I  GV + L Y+H     
Sbjct: 92  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIH---HM 147
Query: 230 RIIHRDIKAANILLTEDFEPQI----CDFGLAKWLPEQWTHHTISKVE-GTFGYLAPEFL 284
             +HR +KA++IL++ D +  +     +  +      Q   H   K       +L+PE L
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 285 MHGI--VDEKTDVFAFGVLLLELVTGR 309
              +   D K+D+++ G+   EL  G 
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 16/100 (16%)
Query: 219 GLLYLHEGCQRRIIHRDIKAANILLT-----EDFEPQICDFGLAKWLPEQWTHHTISK-- 271
           GL +LH      I+HRD+K  NIL++        +  I DFGL K L      H+ S+  
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL--AVGRHSFSRRS 184
Query: 272 -VEGTFGYLAPEFLMHGIVDEKT---DVFAFGVLLLELVT 307
            V GT G++APE L     +  T   D+F+ G +   +++
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 51/106 (48%), Gaps = 16/106 (15%)
Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILL--TEDFEP-QICDFGLAKWLPEQWTHHTISKV 272
           VA  L +LH    + I HRD+K  NIL        P +ICDF L   +        IS  
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 273 E-----GTFGYLAPEFL-----MHGIVDEKTDVFAFGVLLLELVTG 308
           E     G+  Y+APE +        I D++ D+++ GV+L  L++G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 81/181 (44%), Gaps = 25/181 (13%)
Query: 118 IGKGGYAEVYKG-RLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKLLGY 175
           +G+G Y EVYK       + VAIKR+     +E +    + E+ ++  + H N  +L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHEGCQRRII 232
                 +H++ E + N     L   M +     +R        +  G+ + H    RR +
Sbjct: 102 IHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCL 154
Query: 233 HRDIKAANILL-----TEDFEPQICDFGLAK--WLP-EQWTHHTISKVEGTFGYLAPEFL 284
           HRD+K  N+LL     +E    +I DFGLA+   +P  Q+TH  I     T  Y  PE L
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-----TLWYRPPEIL 209
Query: 285 M 285
           +
Sbjct: 210 L 210

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-FLSELG----IMAHVDH 166
           +S    IG GG ++V++      Q+ AIK +    AD    D + +E+     +  H D 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD- 68
Query: 167 PNTAKLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K    W  R      + E +  +H 
Sbjct: 69  -KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH- 124
Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL- 284
             Q  I+H D+K AN L+  D   ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 125 --QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 181
Query: 285 ----------MHGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 182 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 33/212 (15%)
Query: 112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
            +F   + +    E++KGR +   +V      R  +     DF  E   +    HPN   
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 172 LLGY-GIEGGMH--IVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           +LG        H  ++    P GSL ++L+ G    +      K AL +A G+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130
Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF---------GY 278
           +  I    + + ++++ ED   +I                +++ V+ +F          +
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARI----------------SMADVKFSFQSPGRMYAPAW 174
Query: 279 LAPEFLMHGIVD---EKTDVFAFGVLLLELVT 307
           +APE L     D      D+++F VLL ELVT
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHH 267
           +I   +   + +LH      I HRD+K  N+L T   +D   ++ DFG AK    + T +
Sbjct: 132 EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQN 184
Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            +     T  Y+APE L     D+  D+++ GV++  L+ G
Sbjct: 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	408
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-133
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-116
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-112
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-72
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-62
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-44
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-42
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-41
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-40
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-39
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-39
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-37
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-37
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-35
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-35
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-26
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-26
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-21
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-13
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  384 bits (988), Expect = e-133
 Identities = 127/293 (43%), Positives = 181/293 (61%), Gaps = 11/293 (3%)

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSE 157
           K FSL ELQ A++NFS +N++G+GG+ +VYKGRL +G LVA+KRL           F +E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 158 LGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKE---KLKWGIRYKIA 213
           + +++   H N  +L G+ +     + V     NGS+AS L    E    L W  R +IA
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
           LG A GL YLH+ C  +IIHRD+KAANILL E+FE  + DFGLAK +  + TH T + V 
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVR 196

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ------QSLVLWARPMI 327
           GT G++APE+L  G   EKTDVF +GV+LLEL+TG+RA D ++        L+ W + ++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN 380
           K  ++  LVD  L   Y   ++  ++  A LC Q S + RP+MS+VV++L G+
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  339 bits (873), Expect = e-116
 Identities = 109/320 (34%), Positives = 164/320 (51%), Gaps = 18/320 (5%)

Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR 132
            S   +  +   +   +SY          L +L+ ATNNF  + LIG G + +VYKG LR
Sbjct: 2   GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 133 NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELS 188
           +G  VA+KR T  +    +E    F +E+  ++   HP+   L+G+  E    I + +  
Sbjct: 62  DGAKVALKRRTPESSQGIEE----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 189 PNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            NG+L   LYG       + W  R +I +G A GL YLH      IIHRD+K+ NILL E
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
           +F P+I DFG++K   E    H  + V+GT GY+ PE+ + G + EK+DV++FGV+L E+
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234

Query: 306 VTGRRALDYS----QQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQ 361
           +  R A+  S      +L  WA       ++ ++VD +LAD+     +      A  C+ 
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294

Query: 362 QSSIRRPQMSQVVQLLRGNL 381
            SS  RP M  V+  L   L
Sbjct: 295 LSSEDRPSMGDVLWKLEYAL 314

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  330 bits (848), Expect = e-112
 Identities = 104/295 (35%), Positives = 154/295 (52%), Gaps = 21/295 (7%)

Query: 98  KIFSLYELQSATNNFS------FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII 151
             FS YEL++ TNNF         N +G+GG+  VYKG + N   VA+K+L         
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 152 ---ADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI-VLELSPNGSLASLLYGMKEK--LK 205
                F  E+ +MA   H N  +LLG+  +G     V    PNGSL   L  +     L 
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           W +R KIA G A G+ +LHE      IHRDIK+ANILL E F  +I DFGLA+   +   
Sbjct: 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ--QSLVLWA 323
               S++ GT  Y+APE  + G +  K+D+++FGV+LLE++TG  A+D  +  Q L+   
Sbjct: 189 TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247

Query: 324 RPMIK-RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
             +      I + +D  + ++ D+  +  +   AS C+ +   +RP + +V QLL
Sbjct: 248 EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  227 bits (581), Expect = 6e-72
 Identities = 67/305 (21%), Positives = 106/305 (34%), Gaps = 32/305 (10%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
                L   +       +  +G +  V+K +L   + VA+K                E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS--WQNEYEVY 70

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
            +  + H N  + +G    G        ++      GSL+  L      + W     IA 
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAE 128

Query: 215 GVAEGLLYLHE-------GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
            +A GL YLHE       G +  I HRDIK+ N+LL  +    I DFGLA       +  
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 268 TISKVEGTFGYLAPEFLMHGI-----VDEKTDVFAFGVLLLELVTGRRALDYS----QQS 318
                 GT  Y+APE L   I        + D++A G++L EL +   A D         
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 319 LVLWARPMIKRNEIRELVDA-----SLADEYDTRQMNLVLLA-ASLCIQQSSIRRPQMSQ 372
                       +++E+V        L D +       +L      C    +  R     
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308

Query: 373 VVQLL 377
           V + +
Sbjct: 309 VGERI 313

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (516), Expect = 1e-62
 Identities = 79/286 (27%), Positives = 130/286 (45%), Gaps = 36/286 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD------EIIADFLSELGIMA 162
           N   +E  IGKGG+  V+KGRL  +  +VAIK L  G ++      E   +F  E+ IM+
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 163 HVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           +++HPN  KL G        +V+E  P G L   L      +KW ++ ++ L +A G+ Y
Sbjct: 79  NLNHPNIVKLYGLMHNP-PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEGTFG 277
           +       I+HRD+++ NI L    E       + DFGL++      + H++S + G F 
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191

Query: 278 YLAPEFLM--HGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWARPMIKRNEI 332
           ++APE +        EK D ++F ++L  ++TG        Y +   +   R    R  I
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251

Query: 333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            E     L +          ++    C      +RP  S +V+ L 
Sbjct: 252 PEDCPPRLRN----------VIEL--CWSGDPKKRPHFSYIVKELS 285

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  199 bits (507), Expect = 4e-61
 Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 37/282 (13%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPN 168
            + + +  IG G +  V++     G  VA+K L       E + +FL E+ IM  + HPN
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +G   +   + IV E    GSL  LL+  G +E+L    R  +A  VA+G+ YLH 
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
                I+HR++K+ N+L+ + +  ++CDFGL++     +         GT  ++APE L 
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVLR 212

Query: 286 HGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWA------RPMIKRNEIRELV 336
               +EK+DV++FGV+L EL T +     L+ +Q   V+ A      R      EI   +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGFKCKRL-----EIPRNL 264

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           +  +A           ++    C      +RP  + ++ LLR
Sbjct: 265 NPQVAA----------IIEG--CWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  198 bits (506), Expect = 6e-61
 Identities = 75/292 (25%), Positives = 133/292 (45%), Gaps = 47/292 (16%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI 160
           SL+ +         E ++G+G +  V K + R  + VAIK++    ++     F+ EL  
Sbjct: 1   SLHMIDY--KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE---SESERKAFIVELRQ 54

Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAE 218
           ++ V+HPN  KL G  +   + +V+E +  GSL ++L+G +              L  ++
Sbjct: 55  LSRVNHPNIVKLYGACLNP-VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWLPEQWTHHTISKVEGTFG 277
           G+ YLH    + +IHRD+K  N+LL       +ICDFG A  +    T++      G+  
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAA 168

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWA-----RPMIKR 329
           ++APE        EK DVF++G++L E++T R     +       ++WA     RP + +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHNGTRPPLIK 227

Query: 330 N---EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           N    I  L+                      C  +   +RP M ++V+++ 
Sbjct: 228 NLPKPIESLMTR--------------------CWSKDPSQRPSMEEIVKIMT 259

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  192 bits (490), Expect = 6e-59
 Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 48/286 (16%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI---IADFLSELGIMAHVDHPNTA 170
            E +IG GG+ +VY+     G  VA+K       ++I   I +   E  + A + HPN  
Sbjct: 11  LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            L G  ++   + +V+E +  G L  +L    +++   I    A+ +A G+ YLH+    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 230 RIIHRDIKAANILLTEDFEPQ--------ICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
            IIHRD+K++NIL+ +  E          I DFGLA+    +W   T     G + ++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWA------RPMIKRNEI 332
           E +   +  + +DV+++GVLL EL+TG    R +D      V +               I
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAYGVAMNKLAL-----PI 235

Query: 333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                   A           L+    C       RP  + ++  L 
Sbjct: 236 PSTCPEPFAK----------LMED--CWNPDPHSRPSFTNILDQLT 269

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (485), Expect = 8e-58
 Identities = 68/282 (24%), Positives = 114/282 (40%), Gaps = 34/282 (12%)

Query: 114 FENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKL 172
              ++GKG + +  K   R  G+++ +K L R   +E    FL E+ +M  ++HPN  K 
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +G   +   ++ + E    G+L  ++  M  +  W  R   A  +A G+ YLH      I
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK------------VEGTFGYL 279
           IHRD+ + N L+ E+    + DFGLA+ + ++ T     +            V G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY---SQQSLVLWARPMIKRNEIRELV 336
           APE +     DEK DVF+FG++L E++    A            L  R            
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR-GFLDRYCPPNC 248

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
             S              +    C      +RP   ++   L 
Sbjct: 249 PPSFFP-----------ITVR-CCDLDPEKRPSFVKLEHWLE 278

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  190 bits (483), Expect = 3e-57
 Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 49/319 (15%)

Query: 100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELG 159
            +  E     +N     LIG+G Y  VYKG L   + VA+K  +          F++E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQN----FINEKN 57

Query: 160 I--MAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           I  +  ++H N A+ +               +V+E  PNGSL   L        W    +
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCR 115

Query: 212 IALGVAEGLLYLHE------GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK------- 258
           +A  V  GL YLH         +  I HRD+ + N+L+  D    I DFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGI-------VDEKTDVFAFGVLLLELVTGRRA 311
             P +  +  IS+V GT  Y+APE L   +         ++ D++A G++  E+      
Sbjct: 176 VRPGEEDNAAISEV-GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 312 LDYS------QQSLVLWARPMIKRNEIRELVDA-----SLADEYDTRQMNLVLLA--ASL 358
           L         Q +            +++ LV          + +    + +  L      
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 359 CIQQSSIRRPQMSQVVQLL 377
           C  Q +  R       + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  188 bits (479), Expect = 4e-57
 Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 34/282 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
              +    IG G +  VYKG+      VA+K L         +  F +E+G++    H N
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               +GY     + IV +     SL   L+  + K +      IA   A G+ YLH    
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-- 286
           + IIHRD+K+ NI L ED   +I DFGLA         H   ++ G+  ++APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 287 -GIVDEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWA------RPMIKRNEIRELV 336
                 ++DV+AFG++L EL+TG+     ++   Q  ++         P +   ++R   
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSLSPDLS--KVRSNC 254

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
              +            L+A   C+++    RP   +++  + 
Sbjct: 255 PKRMKR----------LMAE--CLKKKRDERPSFPRILAEIE 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (458), Expect = 3e-54
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 30/278 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPN 168
              +F   + +    E++KGR + G  + +K L  R  +     DF  E   +    HPN
Sbjct: 10  KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 169 TAKLLGY---GIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLH 224
              +LG           ++    P GSL ++L+ G    +      K AL +A G+ +LH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
              +  I    + + ++++ ED   +I    +                     ++APE L
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEAL 180

Query: 285 MH---GIVDEKTDVFAFGVLLLELVTGRRA-LDYSQQSLVLWARPMIKRNEIRELVDASL 340
                       D+++F VLL ELVT      D S   + +       R  I   +   +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240

Query: 341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           +           L+    C+ +   +RP+   +V +L 
Sbjct: 241 SK----------LMKI--CMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (458), Expect = 9e-54
 Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 47/287 (16%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTAKL 172
              LIGKG + +VY GR   G+ VAI+ +     +E  +  F  E+       H N    
Sbjct: 37  IGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 173 LGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           +G  +    + I+  L    +L S++   K  L      +IA  + +G+ YLH    + I
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAK---WLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           +H+D+K+ N+   ++ +  I DFGL      L        +    G   +LAPE +    
Sbjct: 152 LHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 289 V---------DEKTDVFAFGVLLLELVTGR---RALDYSQQSLVLWA-----RPMIKRNE 331
                      + +DVFA G +  EL       +         ++W      +P +    
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---IIWQMGTGMKPNL---- 263

Query: 332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            +  +   ++D          +L    C       RP  ++++ +L 
Sbjct: 264 SQIGMGKEISD----------ILLF--CWAFEQEERPTFTKLMDMLE 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  161 bits (409), Expect = 1e-46
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 29/216 (13%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
               +GKG Y EV++G  + G+ VA+K  +          +  E  +     + H N   
Sbjct: 12  LLECVGKGRYGEVWRGSWQ-GENVAVKIFS----SRDEKSWFRETELYNTVMLRHENILG 66

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +   +        + ++      GSL   L      L      +I L +A GL +LH  
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 226 ----GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI---SKVEGTFGY 278
                 +  I HRD+K+ NIL+ ++ +  I D GLA    +      +    +V GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183

Query: 279 LAPEFLMHGIV------DEKTDVFAFGVLLLELVTG 308
           +APE L   I        ++ D++AFG++L E+   
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  161 bits (410), Expect = 4e-46
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +      IG+G + EV+ GRLR +  LVA+K        ++ A FL E  I+    HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             +L+G   +   ++IV+EL   G   + L     +L+     ++    A G+ YL    
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-- 231

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY--LAPEFLM 285
            +  IHRD+ A N L+TE    +I DFG+++   +    +  S           APE L 
Sbjct: 232 -KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD--GVYAASGGLRQVPVKWTAPEALN 288

Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
           +G    ++DV++FG+LL E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  160 bits (406), Expect = 6e-46
 Identities = 68/307 (22%), Positives = 110/307 (35%), Gaps = 62/307 (20%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
               IGKG Y EV+ G+ R G+ VA+K     T +E  A +  E  I     + H N   
Sbjct: 41  MVKQIGKGRYGEVWMGKWR-GEKVAVKVFF--TTEE--ASWFRETEIYQTVLMRHENILG 95

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +   I+G      ++++ +   NGSL   L      L      K+A     GL +LH  
Sbjct: 96  FIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 226 ----GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI---SKVEGTFGY 278
                 +  I HRD+K+ NIL+ ++    I D GLA           I   ++V GT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212

Query: 279 LAPEFL------MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--------- 323
           + PE L       H       D+++FG++L E+     +    ++  + +          
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 324 ------------RPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMS 371
                       RP        +     +            L+    C   +   R    
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGK----------LMTE--CWAHNPASRLTAL 320

Query: 372 QVVQLLR 378
           +V + L 
Sbjct: 321 RVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  158 bits (400), Expect = 5e-45
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGI--MAHVDHPNTAK 171
            +  IGKG + EV++G+ R G+ VA+K  +          +  E  I     + H N   
Sbjct: 46  LQESIGKGRFGEVWRGKWR-GEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILG 100

Query: 172 LLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE- 225
            +    +       + +V +   +GSL   L   +  +      K+AL  A GL +LH  
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158

Query: 226 ----GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI---SKVEGTFGY 278
                 +  I HRD+K+ NIL+ ++    I D GLA           I    +V GT  Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRY 217

Query: 279 LAPEFLM------HGIVDEKTDVFAFGVLLLELVTG 308
           +APE L       H    ++ D++A G++  E+   
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  154 bits (391), Expect = 9e-44
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 13/209 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG            VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPE 282
           +   RR++HRD+ A N+L+      +I DFGLAK L   E+  H    KV     ++A E
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALE 189

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
            ++H I   ++DV+++GV + EL+T G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (378), Expect = 6e-42
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 13/209 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
             F    ++G G +  VYKG       +    VAIK L   T+ +   + L E  +MA V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           D+P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL 
Sbjct: 75  DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPE 282
           +   RR++HRD+ A N+L+      +I DFGLAK L   E+  H    KV     ++A E
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALE 189

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
            ++H I   ++DV+++GV + EL+T G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  149 bits (377), Expect = 9e-42
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 13/209 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-----VAIKRLTRGTADEIIADFLSELGIMAHV 164
                  ++G G +  V+KG            V IK +   +  +        +  +  +
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           DH +  +LLG      + +V +  P GSL   +   +  L   +     + +A+G+ YL 
Sbjct: 73  DHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE 132

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPE 282
           E     ++HR++ A N+LL    + Q+ DFG+A  LP  ++   ++ +K      ++A E
Sbjct: 133 E---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--PIKWMALE 187

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
            +  G    ++DV+++GV + EL+T G  
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  147 bits (372), Expect = 3e-41
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 12/231 (5%)

Query: 85  NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIK 140
           ++ +++ + +  Q +     +  ++    F  +IG+G +  VY G L +        A+K
Sbjct: 1   HIDLSALNPELVQAV-QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59

Query: 141 RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLLY 198
            L R T    ++ FL+E  IM    HPN   LLG     EG   +VL    +G L + + 
Sbjct: 60  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 119

Query: 199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
                          L VA+G+ YL     ++ +HRD+ A N +L E F  ++ DFGLA+
Sbjct: 120 NETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 259 WLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            + ++  +   +K        ++A E L       K+DV++FGVLL EL+T
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  147 bits (372), Expect = 3e-41
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 15/227 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
                   +G+G + +V   R        G+ VA+K L   +    IAD   E+ I+ ++
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 165 DHPNTAKLLGYGIEGG---MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G   E G   + +++E  P+GSL   L   K K+    + K A+ + +G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYL 279
           YL     R+ +HRD+ A N+L+  + + +I DFGL K +     ++T  K +      + 
Sbjct: 141 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT-VKDDRDSPVFWY 196

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARP 325
           APE LM       +DV++FGV L EL+T            L +    
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (372), Expect = 3e-41
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 24/254 (9%)

Query: 89  NSYDSQSPQKIFSLYELQSAT-----NNFSFENLIGKGGYAEVYKGRLRN-----GQLVA 138
           + +       +  L++                  +G+G + +V            G++VA
Sbjct: 5   HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA 64

Query: 139 IKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG---MHIVLELSPNGSLAS 195
           +K L      +  + +  E+ I+  + H +  K  G   + G   + +V+E  P GSL  
Sbjct: 65  VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124

Query: 196 LLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
            L   +  +        A  + EG+ YLH    +  IHRD+ A N+LL  D   +I DFG
Sbjct: 125 YL--PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179

Query: 256 LAKWLPEQWTHHTISKVEGT---FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRA 311
           LAK +PE   ++ +   E       + APE L        +DV++FGV L EL+T    +
Sbjct: 180 LAKAVPEGHEYYRVR--EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237

Query: 312 LDYSQQSLVLWARP 325
                + L L    
Sbjct: 238 QSPPTKFLELIGIA 251

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  147 bits (374), Expect = 6e-41
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 13/265 (4%)

Query: 53  RNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSL--YELQSATN 110
            +     + ++  L  S+ + +          N       + +P+ + ++    +  ++ 
Sbjct: 30  GSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSL 89

Query: 111 NFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
              F  +IG+G +  VY G L +        A+K L R T    ++ FL+E  IM    H
Sbjct: 90  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149

Query: 167 PNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           PN   LLG     EG   +VL    +G L + +                L VA+G+ +L 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 209

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPE 282
               ++ +HRD+ A N +L E F  ++ DFGLA+ + ++      +K        ++A E
Sbjct: 210 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVT 307
            L       K+DV++FGVLL EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  145 bits (369), Expect = 8e-41
 Identities = 81/319 (25%), Positives = 140/319 (43%), Gaps = 42/319 (13%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADE 149
              PQK        +   NF  E  IG+G ++EVY+   L +G  VA+K  ++      +
Sbjct: 15  QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK--- 205
             AD + E+ ++  ++HPN  K     IE   ++IVLEL+  G L+ ++   K++ +   
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134

Query: 206 ----WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
               W    ++       L ++H    RR++HRDIK AN+ +T     ++ D GL ++  
Sbjct: 135 ERTVWKYFVQLCSA----LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187

Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR---ALDYSQQS 318
            + T    S V GT  Y++PE +     + K+D+++ G LL E+   +        +  S
Sbjct: 188 SK-TTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245

Query: 319 LVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           L       I++ +   L     +D Y      LV    ++CI     +RP ++ V     
Sbjct: 246 LCK----KIEQCDYPPL----PSDHYSEELRQLV----NMCINPDPEKRPDVTYV----- 288

Query: 379 GNLCCLKYMTKCRSPLLRK 397
                 K M  C +  L  
Sbjct: 289 --YDVAKRMHACTASSLEH 305

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  144 bits (366), Expect = 9e-41
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 34/216 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 65

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG+ YL E   
Sbjct: 66  VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-------------WTHHTISKVEGT 275
             +IHRD+ A N L+ E+   ++ DFG+ +++ +              W           
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------- 172

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
               +PE         K+DV++FGVL+ E+ + G+ 
Sbjct: 173 ----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  145 bits (367), Expect = 1e-40
 Identities = 66/227 (29%), Positives = 97/227 (42%), Gaps = 39/227 (17%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSEL 158
             +         + +IGKG +  VY G   +        AIK L+R T  + +  FL E 
Sbjct: 14  VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73

Query: 159 GIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGV 216
            +M  ++HPN   L+G     EG  H++L    +G L   +   +            L V
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----------------L 260
           A G+ YL E   ++ +HRD+ A N +L E F  ++ DFGLA+                 L
Sbjct: 134 ARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           P +WT              A E L       K+DV++FGVLL EL+T
Sbjct: 191 PVKWT--------------ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  149 bits (378), Expect = 2e-40
 Identities = 62/200 (31%), Positives = 98/200 (49%), Gaps = 9/200 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 324

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLY-GMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L     + L+      +A  +A G+ Y+     
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 381

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHG 287
              +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYG 439

Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FG+LL EL T
Sbjct: 440 RFTIKSDVWSFGILLTELTT 459

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  144 bits (365), Expect = 3e-40
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  F   +GKG +  V   R        G++VA+K+L   T + +  DF  E+ I+  +
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSL 68

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G         + +++E  P GSL   L   KE++      +    + +G+ 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGY 278
           YL     +R IHRD+   NIL+  +   +I DFGL K LP+      +   E       +
Sbjct: 129 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK--EPGESPIFW 183

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            APE L        +DV++FGV+L EL T
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  147 bits (374), Expect = 3e-40
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 9/200 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 241

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K L+      +A  +A G+ Y+     
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 298

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLMHG 287
              +HRD++AANIL+ E+   ++ DFGLA+ + + ++T    +K      + APE  ++G
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYG 356

Query: 288 IVDEKTDVFAFGVLLLELVT 307
               K+DV++FG+LL EL T
Sbjct: 357 RFTIKSDVWSFGILLTELTT 376

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  144 bits (365), Expect = 3e-40
 Identities = 57/287 (19%), Positives = 111/287 (38%), Gaps = 39/287 (13%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++ F   +G+GG++ V     L +G   A+KR+      +   +   E  +    +HPN 
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR-EEAQREADMHRLFNHPNI 88

Query: 170 AKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAE 218
            +L+ Y +          ++L     G+L +    ++     G          + LG+  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE---IERLKDKGNFLTEDQILWLLLGICR 145

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVE---- 273
           GL  +H    +   HRD+K  NILL ++ +P + D G                 ++    
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 274 --GTFGYLAPEFL---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK 328
              T  Y APE      H ++DE+TDV++ G +L  ++ G    D   Q     A  +  
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

Query: 329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           +  I +      +  + +    L+    +  +     +RP +  ++ 
Sbjct: 263 QLSIPQ------SPRHSSALWQLL----NSMMTVDPHQRPHIPLLLS 299

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  145 bits (367), Expect = 3e-40
 Identities = 69/276 (25%), Positives = 127/276 (46%), Gaps = 33/276 (11%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDH 166
             +     IG+G + +    +   +G+   IK   ++R ++ E   +   E+ ++A++ H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKH 82

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGL 220
           PN  +      E G ++IV++    G L   +   K     E        +I L     L
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA----L 138

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            ++H+   R+I+HRDIK+ NI LT+D   Q+ DFG+A+ L         + + GT  YL+
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLS 193

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-YSQQSLVLWARPMIKRNEIRELVDAS 339
           PE   +   + K+D++A G +L EL T + A +  S ++LVL     I            
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL----KIISGSF-----PP 244

Query: 340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           ++  Y     +LV    S   +++   RP ++ +++
Sbjct: 245 VSLHYSYDLRSLV----SQLFKRNPRDRPSVNSILE 276

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (363), Expect = 4e-40
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 35/219 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
                   IG+G + +V++G   +       VAIK     T+D +   FL E   M   D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           HP+  KL+G   E  + I++EL   G L S L   K  L        A  ++  L YL  
Sbjct: 75  HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------LPEQWTHHTISKV 272
              +R +HRDI A N+L++ +   ++ DFGL+++             LP +W        
Sbjct: 135 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------- 184

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
                  APE +        +DV+ FGV + E++  G +
Sbjct: 185 -------APESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (363), Expect = 4e-40
 Identities = 56/202 (27%), Positives = 104/202 (51%), Gaps = 10/202 (4%)

Query: 115 ENLIGKGGYAEVYKGRLRNGQ---LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK 171
           +  +G G +  V +G  R  +    VAIK L +GT      + + E  IM  +D+P   +
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 172 LLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRI 231
           L+G      + +V+E++  G L   L G +E++      ++   V+ G+ YL E   +  
Sbjct: 75  LIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNF 131

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIV 289
           +HRD+ A N+LL      +I DFGL+K L    +++T ++  G +   + APE +     
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKF 190

Query: 290 DEKTDVFAFGVLLLELVT-GRR 310
             ++DV+++GV + E ++ G++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  144 bits (364), Expect = 4e-40
 Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 24/257 (9%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSAT----NNFSFENLIGK 120
              + +   +   + +   +   V+     S       Y+          +F   + +G 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 121 GGYAEVYKGR-LRNGQLVAIKRLTRGTADEI-IADFLSELGIMAHV-DHPNTAKLLGYGI 177
           G Y EV+K R   +G+L A+KR           A  L+E+G    V  HP   +L     
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 178 EGG-MHIVLELSPNGSLASLL--YG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
           EGG +++  EL    SL      +G  + E   WG      L     L +LH    + ++
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHS---QGLV 179

Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
           H D+K ANI L      ++ DFGL   L            EG   Y+APE L        
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSY-GTA 235

Query: 293 TDVFAFGVLLLELVTGR 309
            DVF+ G+ +LE+    
Sbjct: 236 ADVFSLGLTILEVACNM 252

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  142 bits (361), Expect = 5e-40
 Identities = 52/216 (24%), Positives = 91/216 (42%), Gaps = 34/216 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
              +    +G G +  V  G+ +    VA+K +  G+  E   +F  E   M  + HP  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE--DEFFQEAQTMMKLSHPKL 65

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            K  G   +   ++IV E   NG L + L    + L+     ++   V EG+ +L     
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES--- 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-------------WTHHTISKVEGT 275
            + IHRD+ A N L+  D   ++ DFG+ +++ +              W+          
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------- 172

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
               APE   +     K+DV+AFG+L+ E+ + G+ 
Sbjct: 173 ----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (363), Expect = 9e-40
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  F   +GKG +  V   R        G++VA+K+L   T + +  DF  E+ I+  +
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-RDFEREIEILKSL 99

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            H N  K  G         + +++E  P GSL   L   KE++      +    + +G+ 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGY 278
           YL     +R IHRD+   NIL+  +   +I DFGL K LP+   ++ +   E       +
Sbjct: 160 YLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK--EPGESPIFW 214

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            APE L        +DV++FGV+L EL T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  141 bits (359), Expect = 1e-39
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 34/216 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H   
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 81

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G   +   + I+ E   NG L + L  M+ + +     ++   V E + YL     
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES--- 138

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------LPEQWTHHTISKVEGT 275
           ++ +HRD+ A N L+ +    ++ DFGL+++              P +W+          
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------- 188

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
                PE LM+     K+D++AFGVL+ E+ + G+ 
Sbjct: 189 ----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  142 bits (360), Expect = 1e-39
 Identities = 66/211 (31%), Positives = 96/211 (45%), Gaps = 15/211 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTAD--EIIADFLSELGIMAH 163
            +      +G G +  V +G           VA+K L        E + DF+ E+  M  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DH N  +L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT---FGYLA 280
                +R IHRD+ A N+LL      +I DFGL + LP+   H+ +   E     F + A
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAWCA 192

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
           PE L        +D + FGV L E+ T G+ 
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  143 bits (362), Expect = 1e-39
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 39/254 (15%)

Query: 79  GIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG---- 134
            I    NL+        P +    +  +   +  + + +IG G + EVYKG L+      
Sbjct: 13  DIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKK 72

Query: 135 -QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGS 192
              VAIK L  G  ++   DFL E GIM    H N  +L G   +   M I+ E   NG+
Sbjct: 73  EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 132

Query: 193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
           L   L     +        +  G+A G+ YL        +HRD+ A NIL+  +   ++ 
Sbjct: 133 LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVS 189

Query: 253 DFGLAKW---------------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFA 297
           DFGL++                +P +WT              APE + +      +DV++
Sbjct: 190 DFGLSRVLEDDPEATYTTSGGKIPIRWT--------------APEAISYRKFTSASDVWS 235

Query: 298 FGVLLLELVT-GRR 310
           FG+++ E++T G R
Sbjct: 236 FGIVMWEVMTYGER 249

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (358), Expect = 2e-39
 Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 34/232 (14%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEII 151
            S + Q  F                 IGKG + +V  G    G  VA+K +      +  
Sbjct: 3   GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-- 59

Query: 152 ADFLSELGIMAHVDHPNTAKLLG--YGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGI 208
             FL+E  +M  + H N  +LLG     +GG++IV E    GSL   L    +  L    
Sbjct: 60  -AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--------- 259
             K +L V E + YL        +HRD+ A N+L++ED   ++ DFGL K          
Sbjct: 119 LLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK 175

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
           LP +WT              APE L       K+DV++FG+LL E+ + GR 
Sbjct: 176 LPVKWT--------------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (358), Expect = 2e-39
 Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VA+K L +G+       FL+E  +M  + H   
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     +  ++I+ E   NGSL   L      KL       +A  +AEG+ ++ E   
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK--VEGTFGYLAPEFLM 285
           R  IHRD++AANIL+++    +I DFGLA+ + + ++T    +K  ++ T    APE + 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183

Query: 286 HGIVDEKTDVFAFGVLLLELVT-GRR 310
           +G    K+DV++FG+LL E+VT GR 
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI 209

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (360), Expect = 2e-39
 Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 44/254 (17%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            +  + + +GKG +  V   R        G LVA+K+L + +  +   DF  E+ I+  +
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-QHSGPDQQRDFQREIQILKAL 81

Query: 165 DHPNTAKLLG---YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
                 K  G         + +V+E  P+G L   L   + +L        +  + +G+ 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ---------------WTH 266
           YL     RR +HRD+ A NIL+  +   +I DFGLAK LP                 W  
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY- 197

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR--ALDYSQQSLVLWA 323
                        APE L   I   ++DV++FGV+L EL T   +  +       ++   
Sbjct: 198 -------------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 324 RPMIKRNEIRELVD 337
           R +   + + EL++
Sbjct: 245 RDVPALSRLLELLE 258

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (357), Expect = 2e-39
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL----VAIKRLTRGTADEIIADFLSELGIMAHVD 165
            +     ++G+G + EVY+G   N +     VA+K   +    +    F+SE  IM ++D
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           HP+  KL+G   E    I++EL P G L   L   K  LK       +L + + + YL  
Sbjct: 72  HPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------LPEQWTHHTISKV 272
                 +HRDI   NIL+      ++ DFGL+++             LP +W        
Sbjct: 132 ---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------- 181

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
                  +PE +        +DV+ F V + E+++ G++
Sbjct: 182 -------SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  144 bits (366), Expect = 4e-39
 Identities = 66/214 (30%), Positives = 95/214 (44%), Gaps = 34/214 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   IGKG + +V  G    G  VA+K +      +    FL+E  +M  + H N 
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 248

Query: 170 AKLLG--YGIEGGMHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            +LLG     +GG++IV E    GSL   L    +  L      K +L V E + YL   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG- 307

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKW---------LPEQWTHHTISKVEGTFG 277
                +HRD+ A N+L++ED   ++ DFGL K          LP +WT            
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------------ 353

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
             APE L       K+DV++FG+LL E+ + GR 
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  142 bits (359), Expect = 4e-39
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 26/251 (10%)

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
           S   +   R G +   N  V   +   P      YE +   +  + +  +G+G + EV++
Sbjct: 21  SSGSAKLQRLGPETEDNEGVLLTEKLKPVD----YEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 129 GR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE 186
            +  + G   A+K++       +    + EL   A +  P    L G   EG  ++I +E
Sbjct: 77  MKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130

Query: 187 LSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           L   GSL  L+   G + E       Y       EGL YLH    RRI+H D+KA N+LL
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDR---ALY-YLGQALEGLEYLHT---RRILHGDVKADNVLL 183

Query: 244 TED-FEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPEFLMHGIVDEKTDVFAFG 299
           + D     +CDFG A  L       ++     + GT  ++APE +M    D K D+++  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 300 VLLLELVTGRR 310
            ++L ++ G  
Sbjct: 244 CMMLHMLNGCH 254

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (365), Expect = 5e-39
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G G + EV+         VA+K +  G+       FL+E  +M  + H   
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV--EAFLAEANVMKTLQHDKL 245

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            KL     +  ++I+ E    GSL   L   +  K         +  +AEG+ ++ +   
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--- 302

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISK--VEGTFGYLAPEFLM 285
           R  IHRD++AANIL++     +I DFGLA+ + + ++T    +K  ++ T    APE + 
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAIN 358

Query: 286 HGIVDEKTDVFAFGVLLLELVT-GRR 310
            G    K+DV++FG+LL+E+VT GR 
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRI 384

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (371), Expect = 5e-39
 Identities = 71/308 (23%), Positives = 134/308 (43%), Gaps = 15/308 (4%)

Query: 14  LEDYFRSE-DSETCSSKEPCSETKPESKSNSRWHLF----YDLFRNKSKKSLVTLYPLKL 68
           L +Y + + D      KE C  +   + S +           L   + +   +       
Sbjct: 235 LVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTP 294

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
              R +S  +   MP +  V       P+++          N    +  +G G +  V +
Sbjct: 295 EPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQ 354

Query: 129 GRLR--NGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL 185
           G  R    Q+ VAIK L +GT      + + E  IM  +D+P   +L+G      + +V+
Sbjct: 355 GVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 414

Query: 186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
           E++  G L   L G +E++      ++   V+ G+ YL E   +  +HR++ A N+LL  
Sbjct: 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVN 471

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY--LAPEFLMHGIVDEKTDVFAFGVLLL 303
               +I DFGL+K L    +++T ++  G +     APE +       ++DV+++GV + 
Sbjct: 472 RHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530

Query: 304 ELVT-GRR 310
           E ++ G++
Sbjct: 531 EALSYGQK 538

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (354), Expect = 8e-39
 Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 55/289 (19%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F    LIG GG+ +V+K +   +G+   IKR+              E+  +A +DH N
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVN 65

Query: 169 -----------------TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-----EKLKW 206
                            ++K         + I +E    G+L   +   +     + L  
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 207 GIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
            +  +I  G    + Y+H    +++I+RD+K +NI L +  + +I DFGL   L      
Sbjct: 126 ELFEQITKG----VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM 326
                  GT  Y++PE +      ++ D++A G++L EL+                    
Sbjct: 179 TRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-------------TAF 222

Query: 327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                  +L D  ++D +D ++  L+       + +    RP  S++++
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILR 267

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (365), Expect = 8e-39
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +     VA+K L   T +    +FL E  +M  + HPN
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 277

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL-YGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG        +I+ E    G+L   L    ++++   +   +A  ++  + YL + 
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 336

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE-QWTHHTISKVEGTFGYLAPEFLM 285
             +  IHR++ A N L+ E+   ++ DFGL++ +    +T H  +K      + APE L 
Sbjct: 337 --KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 392

Query: 286 HGIVDEKTDVFAFGVLLLELVT 307
           +     K+DV+AFGVLL E+ T
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIAT 414

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (354), Expect = 2e-38
 Identities = 68/245 (27%), Positives = 101/245 (41%), Gaps = 38/245 (15%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRL 142
           +   +  + P +    +  +   +    E +IG G   EV  GRLR        VAIK L
Sbjct: 26  YAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85

Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  +    DFLSE  IM   DHPN  +L G    G    IV E   NGSL + L    
Sbjct: 86  KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP 261
            +        +  GV  G+ YL +      +HRD+ A N+L+  +   ++ DFGL++ L 
Sbjct: 146 GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202

Query: 262 EQ---------------WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
           +                WT              APE +        +DV++FGV++ E++
Sbjct: 203 DDPDAAYTTTGGKIPIRWT--------------APEAIAFRTFSSASDVWSFGVVMWEVL 248

Query: 307 T-GRR 310
             G R
Sbjct: 249 AYGER 253

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  139 bits (353), Expect = 2e-38
 Identities = 52/236 (22%), Positives = 98/236 (41%), Gaps = 23/236 (9%)

Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD 148
           +  D  +    F    ++     +S    IG GG ++V++      Q+ AIK +    AD
Sbjct: 9   SGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 66

Query: 149 E-IIADFLSELGIMAHVDHPNTA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKL 204
              +  + +E+  +  +   +    +L  Y I +  +++V+E   N  L S L   K+ +
Sbjct: 67  NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSI 124

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
               R      + E +  +H   Q  I+H D+K AN L+ +    ++ DFG+A  +    
Sbjct: 125 DPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT 180

Query: 265 THHTISKVEGTFGYLAPEFLM-----------HGIVDEKTDVFAFGVLLLELVTGR 309
           T        GT  Y+ PE +               +  K+DV++ G +L  +  G+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  145 bits (368), Expect = 2e-38
 Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 34/272 (12%)

Query: 53  RNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNF 112
           + + +++L ++  L  + ++            + +    D +    + S  + +      
Sbjct: 333 QKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERI 392

Query: 113 SFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
                IG+G + +V++G   +       VAIK     T+D +   FL E   M   DHP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL+G   E  + I++EL   G L S L   K  L        A  ++  L YL     
Sbjct: 453 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES--- 509

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------LPEQWTHHTISKVEGT 275
           +R +HRDI A N+L++ +   ++ DFGL+++             LP +W           
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM---------- 559

Query: 276 FGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
               APE +        +DV+ FGV + E++ 
Sbjct: 560 ----APESINFRRFTSASDVWMFGVCMWEILM 587

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  139 bits (353), Expect = 4e-38
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 21/215 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +S    IG GG ++V++      Q+ AIK +    AD   +  + +E+  +  +   +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 169 TA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K+ +    R      + E +  +H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH- 125

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
             Q  I+H D+K AN L+ +    ++ DFG+A  +    T        GT  Y+ PE + 
Sbjct: 126 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 286 -----------HGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  138 bits (349), Expect = 4e-38
 Identities = 58/292 (19%), Positives = 117/292 (40%), Gaps = 43/292 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F     +G+GG+  V++ +   +    AIKR+     +      + E+  +A ++HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 169 -------------TAKLLGYGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIA 213
                        T KL     +  ++I ++L    +L   +      E+ +  +   I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL----------PEQ 263
           L +AE + +LH    + ++HRD+K +NI  T D   ++ DFGL   +             
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA 323
             +   +   GT  Y++PE +       K D+F+ G++L EL+         ++   L  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTL-- 237

Query: 324 RPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                  ++R L    L  +    +  +V       +  S + RP+   +++
Sbjct: 238 ------TDVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAINIIE 279

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  138 bits (350), Expect = 7e-38
 Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 48/229 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
             F+   ++GKG +  V + +L+        VA+K L         I +FL E   M   
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 165 DHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKI 212
           DHP+ AKL+G        G      ++L    +G L + L           L      + 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW------------- 259
            + +A G+ YL     R  IHRD+ A N +L ED    + DFGL++              
Sbjct: 143 MVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 260 -LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            LP +W               A E L   +    +DV+AFGV + E++T
Sbjct: 200 KLPVKWL--------------ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  136 bits (346), Expect = 1e-37
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 36/218 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL-VAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            + + ++ +G G Y EVY+G  +   L VA+K L   T +    +FL E  +M  + HPN
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPN 70

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLAS-LLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
             +LLG        +I+ E    G+L   L    ++++   +   +A  ++  + YL + 
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK- 129

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------LPEQWTHHTISKVE 273
             +  IHRD+ A N L+ E+   ++ DFGL++               P +WT        
Sbjct: 130 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-------- 179

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRR 310
                 APE L +     K+DV+AFGVLL E+ T G  
Sbjct: 180 ------APESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  139 bits (352), Expect = 1e-37
 Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 38/245 (15%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRL 142
           FV+ +  + P +    +  +    N S + ++G G + EV  GRL+        VAIK L
Sbjct: 22  FVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL 81

Query: 143 TRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK 201
             G  ++   DFL E  IM   DHPN  +L G   +   + IV E   NGSL S L    
Sbjct: 82  KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD 141

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL- 260
            +        +  G+A G+ YL +      +HRD+ A NIL+  +   ++ DFGL + L 
Sbjct: 142 AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198

Query: 261 --------------PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
                         P +WT              +PE + +      +DV+++G++L E++
Sbjct: 199 DDPEAAYTTRGGKIPIRWT--------------SPEAIAYRKFTSASDVWSYGIVLWEVM 244

Query: 307 T-GRR 310
           + G R
Sbjct: 245 SYGER 249

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 2e-37
 Identities = 59/286 (20%), Positives = 113/286 (39%), Gaps = 36/286 (12%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAH 163
           S   ++     IG G Y    K R   +G+++  K       T  E     +SE+ ++  
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRE 61

Query: 164 VDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLK-------WGIRYKIA 213
           + HPN  +     I+     ++IV+E    G LAS++    ++ +         +  ++ 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121

Query: 214 LGVAEGLLYLHE--GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           L +       H        ++HRD+K AN+ L      ++ DFGLA+ L           
Sbjct: 122 LALK----ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKT 175

Query: 272 VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD-YSQQSLVLWARPMIKRN 330
             GT  Y++PE +     +EK+D+++ G LL EL         +SQ+ L       I+  
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREG 231

Query: 331 EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL 376
           +        +   Y      ++    +  +      RP + ++++ 
Sbjct: 232 KF-----RRIPYRYSDELNEII----TRMLNLKDYHRPSVEEILEN 268

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  138 bits (348), Expect = 2e-37
 Identities = 53/205 (25%), Positives = 104/205 (50%), Gaps = 15/205 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           ++F   + +G G    V+K   + +G ++A K +       I    + EL ++   + P 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHE 225
                G +  +G + I +E    GSL  +   +K+  +   +   K+++ V +GL YL E
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQV---LKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFL 284
             + +I+HRD+K +NIL+    E ++CDFG++  L +     +++    GT  Y++PE L
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERL 202

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGR 309
                  ++D+++ G+ L+E+  GR
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGR 227

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  136 bits (345), Expect = 3e-37
 Identities = 68/233 (29%), Positives = 101/233 (43%), Gaps = 21/233 (9%)

Query: 90  SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD 148
           S +S    KI           +      IG+G Y  V K     +GQ++A+KR+     +
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 149 EIIADFLSELGI-MAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW 206
           +     L +L + M   D P   +  G    EG   I +EL  + S       +   L  
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120

Query: 207 GIR----YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
            I      KI L   + L +L E    +IIHRDIK +NILL      ++CDFG++  L  
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL-- 176

Query: 263 QWTHHTISKVE--GTFGYLAPEFLMHGIV----DEKTDVFAFGVLLLELVTGR 309
                +I+K    G   Y+APE +         D ++DV++ G+ L EL TGR
Sbjct: 177 ---VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  135 bits (343), Expect = 4e-37
 Identities = 71/220 (32%), Positives = 107/220 (48%), Gaps = 31/220 (14%)

Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF 154
           P+++F+  E             IGKG + EV+KG   R  ++VAIK +    A++ I D 
Sbjct: 20  PEELFTKLEK------------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI 67

Query: 155 LSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYK 211
             E+ +++  D P   K  G Y  +  + I++E    GS   LL    + E     I   
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IAT- 123

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK 271
           I   + +GL YLH     + IHRDIKAAN+LL+E  E ++ DFG+A  L       T  K
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-----TDTQIK 175

Query: 272 ---VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                GT  ++APE +     D K D+++ G+  +EL  G
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  136 bits (345), Expect = 4e-37
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 48/229 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG---QLVAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++        AIKR+    + +   DF  EL ++  +  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L                     L     
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK----------- 258
              A  VA G+ YL +   ++ IHRD+ A NIL+ E++  +I DFGL++           
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201

Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            LP +W               A E L + +    +DV+++GVLL E+V+
Sbjct: 202 RLPVRWM--------------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (342), Expect = 8e-37
 Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 47/228 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG----QLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
           N      ++G+G +  V +G L+        VA+K +    + +  I +FLSE   M   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 165 DHPNTAKLLG------YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKIA 213
            HPN  +LLG              ++L     G L + L         + +      K  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW-------------- 259
           + +A G+ YL     R  +HRD+ A N +L +D    + DFGL+K               
Sbjct: 154 VDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           +P +W               A E L   +   K+DV+AFGV + E+ T
Sbjct: 211 MPVKWI--------------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  137 bits (346), Expect = 9e-37
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 21/215 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +S    IG GG ++V++      Q+ AIK +    AD   +  + +E+  +  +   +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 169 TA--KLLGYGI-EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
               +L  Y I +  +++V+E   N  L S L   K+ +    R      + E +  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
             Q  I+H D+K AN L+ +    ++ DFG+A  +    T        G   Y+ PE + 
Sbjct: 173 --QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 286 -----------HGIVDEKTDVFAFGVLLLELVTGR 309
                         +  K+DV++ G +L  +  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  134 bits (339), Expect = 1e-36
 Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 53/234 (22%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +   F   +G+  + +VYKG L         Q VAIK L       +  +F  E  + A 
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWG 207
           + HPN   LLG   +   + ++     +G L   L                 +K  L+  
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------- 258
               +   +A G+ YL       ++H+D+   N+L+ +    +I D GL +         
Sbjct: 129 DFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185

Query: 259 -----WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                 LP +W               APE +M+G     +D++++GV+L E+ +
Sbjct: 186 LLGNSLLPIRWM--------------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  134 bits (340), Expect = 1e-36
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 18/212 (8%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELG 159
           Y++            +G GG + VY          VAIK +     +  E +  F  E+ 
Sbjct: 13  YKIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH 63

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             + + H N   ++    E   + +V+E     +L+  +      L           + +
Sbjct: 64  NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILD 122

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           G+ + H     RI+HRDIK  NIL+  +   +I DFG+AK L E     T + V GT  Y
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQY 178

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
            +PE       DE TD+++ G++L E++ G  
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  134 bits (340), Expect = 2e-36
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 49/247 (19%)

Query: 91  YDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTR 144
           Y S +   +   +E+       +    +G+G +  VY+G  +          VAIK +  
Sbjct: 8   YFSAADVYVPDEWEVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65

Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------ 197
             +     +FL+E  +M   +  +  +LLG   +G    +++EL   G L S L      
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125

Query: 198 ---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
                +          ++A  +A+G+ YL+     + +HRD+ A N ++ EDF  +I DF
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182

Query: 255 GLAK--------------WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGV 300
           G+ +               LP +W               +PE L  G+    +DV++FGV
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWM--------------SPESLKDGVFTTYSDVWSFGV 228

Query: 301 LLLELVT 307
           +L E+ T
Sbjct: 229 VLWEIAT 235

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (336), Expect = 3e-36
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 21/207 (10%)

Query: 114 FENLIGKGGYAEVYKGR-LRNGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAK 171
           F+  IG+G +  VYKG        VA   L  R         F  E  ++  + HPN  +
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 172 LLGYGI-----EGGMHIVLELSPNGSLASLL--YG-MKEKLKWGIRYKIALGVAEGLLYL 223
                      +  + +V EL  +G+L + L  +  MK K+   +R      + +GL +L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV---LR-SWCRQILKGLQFL 145

Query: 224 HEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           H      IIHRD+K  NI +T      +I D GLA              V GT  ++APE
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPE 200

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGR 309
                  DE  DV+AFG+ +LE+ T  
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSE 226

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (336), Expect = 5e-36
 Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 13/202 (6%)

Query: 115 ENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAK 171
             L+G+GG  +VY+       ++VA+K ++   +           E      +  P+   
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 172 LLGYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRY--KIALGVAEGLLYLHEGCQ 228
           +  +G   G   + + L     LA++L   + +          I   +   L   H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---A 152

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
               HRD+K  NIL++ D    + DFG+A    ++          GT  Y+APE      
Sbjct: 153 AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYMAPERFSESH 211

Query: 289 VDEKTDVFAFGVLLLELVTGRR 310
              + D++A   +L E +TG  
Sbjct: 212 ATYRADIYALTCVLYECLTGSP 233

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (333), Expect = 7e-36
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 12/200 (6%)

Query: 118 IGKGGYAEVYKGRLRNGQL---VAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLL 173
           +G G +  V KG  +  ++   VA+K L     D  +  + L+E  +M  +D+P   +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 174 GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH 233
           G        +V+E++  G L   L      +K     ++   V+ G+ YL E      +H
Sbjct: 85  GICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVH 140

Query: 234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF--GYLAPEFLMHGIVDE 291
           RD+ A N+LL      +I DFGL+K L     ++  ++  G +   + APE + +     
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSS 199

Query: 292 KTDVFAFGVLLLELVT-GRR 310
           K+DV++FGVL+ E  + G++
Sbjct: 200 KSDVWSFGVLMWEAFSYGQK 219

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (332), Expect = 1e-35
 Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 54/234 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            +   +  +G+G + +V+     N        LVA+K L   T      DF  E  ++ +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-KDFQREAELLTN 73

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWG 207
           + H +  K  G   +G  + +V E   +G L   L                  K +L   
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------- 258
               IA  +A G++YL     +  +HRD+   N L+  +   +I DFG+++         
Sbjct: 134 QMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 259 -----WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                 LP +W                PE +M+     ++DV++FGV+L E+ T
Sbjct: 191 VGGHTMLPIRWM--------------PPESIMYRKFTTESDVWSFGVILWEIFT 230

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  132 bits (335), Expect = 1e-35
 Identities = 68/287 (23%), Positives = 113/287 (39%), Gaps = 63/287 (21%)

Query: 66  LKLSIRRSSSMREGIDMPRNLFVN-SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
           ++ +    +++   + + R L  N  Y          L  L+   NN  +   IG+G + 
Sbjct: 3   MESAAVTLTTLPSELLLDR-LHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61

Query: 125 EVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE 178
            V++ R           +VA+K L    + ++ ADF  E  +MA  D+PN  KLLG    
Sbjct: 62  RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121

Query: 179 GG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY-----------------------KIAL 214
           G  M ++ E    G L   L  M       + +                        IA 
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK--------------WL 260
            VA G+ YL E   R+ +HRD+   N L+ E+   +I DFGL++               +
Sbjct: 182 QVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAI 238

Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           P +W                PE + +     ++DV+A+GV+L E+ +
Sbjct: 239 PIRWM--------------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (334), Expect = 1e-35
 Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 53/233 (22%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            +   +  +G+G + +V+     N        LVA+K L   +      DF  E  ++  
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-DFQREAELLTM 99

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL--------------YGMKEKLKWGI 208
           + H +  +  G   EG  + +V E   +G L   L                    L  G 
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK---------- 258
              +A  VA G++YL        +HRD+   N L+ +    +I DFG+++          
Sbjct: 160 LLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 216

Query: 259 ----WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                LP +W                PE +++     ++DV++FGV+L E+ T
Sbjct: 217 GGRTMLPIRWM--------------PPESILYRKFTTESDVWSFGVVLWEIFT 255

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  131 bits (332), Expect = 2e-35
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 22/216 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++  + +IG G  A V         + VAIKR+        + + L E+  M+   HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----------VA 217
                  + ++  + +V++L   GS+  +   +K  +  G      L           V 
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDI---IKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK---VEG 274
           EGL YLH+      IHRD+KA NILL ED   QI DFG++ +L                G
Sbjct: 132 EGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 275 TFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
           T  ++APE +      D K D+++FG+  +EL TG 
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  130 bits (330), Expect = 2e-35
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGI-MAHVDHP 167
           ++      +G+G Y  V K R   +GQ++A+KR+      +     L +L I M  VD P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW---GIRYKIALGVAEGLLYL 223
            T    G    EG + I +EL  + SL      + +K +     I  KIA+ + + L +L
Sbjct: 67  FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK--VEGTFGYLAP 281
           H   +  +IHRD+K +N+L+    + ++CDFG++ +L        ++K    G   Y+AP
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-----VDDVAKDIDAGCKPYMAP 178

Query: 282 EFLMHGIV----DEKTDVFAFGVLLLELVTGR 309
           E +   +       K+D+++ G+ ++EL   R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (330), Expect = 3e-35
 Identities = 54/232 (23%), Positives = 100/232 (43%), Gaps = 41/232 (17%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            ++F    ++G+G + +V K R   + +  AIK++     +E ++  LSE+ ++A ++H 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQ 62

Query: 168 NTAKLLGYGIEGG--------------MHIVLELSPNGSLASLLYGMK----EKLKWGIR 209
              +     +E                + I +E   NG+L  L++           W + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
            +I   ++    Y+H    + IIHRD+K  NI + E    +I DFGLAK +        +
Sbjct: 123 RQILEALS----YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175

Query: 270 SKVE------------GTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTG 308
                           GT  Y+A E L   G  +EK D+++ G++  E++  
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (331), Expect = 3e-35
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 47/228 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N +    +G G + EVY+G++           VA+K L    +++   DFL E  I++ 
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
            +H N  + +G  ++     I++EL   G L S L            L       +A  +
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC---DFGLAK--------------W 259
           A G  YL E      IHRDI A N LLT     ++    DFG+A+               
Sbjct: 150 ACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           LP +W                PE  M GI   KTD ++FGVLL E+ +
Sbjct: 207 LPVKWM--------------PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  132 bits (333), Expect = 4e-35
 Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 63/289 (21%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIF-SLYELQSAT------NNFSFENL 117
            + +S   SSSM     + R     S  + +P     S YEL          +  +    
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP 88

Query: 118 IGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
           +G+G + +V                  VA+K L     ++ ++D +SE+ +M  +  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKLKWGIRYKI 212
              LLG   + G +++++E +  G+L   L                  +E++ +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW------------- 259
              +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+              
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265

Query: 260 -LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
            LP +W               APE L   +   ++DV++FGVL+ E+ T
Sbjct: 266 RLPVKWM--------------APEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  129 bits (327), Expect = 1e-34
 Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 55/236 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 164 VD-HPNTAKLLGYGIEGG--MHIVLELSPNGSLASLL---------------YGMKEKLK 205
           +  H N   LLG   + G  + +++E    G+L++ L                  K+ L 
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW------ 259
                  +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+       
Sbjct: 147 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 260 --------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                   LP +W               APE +   +   ++DV++FGVLL E+ +
Sbjct: 204 YVRKGDARLPLKWM--------------APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (326), Expect = 1e-34
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 61/242 (25%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N      +G+G + +V K    +         VA+K L    +   + D LSE  ++  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-----------------------YG 199
           V+HP+  KL G   + G + +++E +  GSL   L                       + 
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
            +  L  G     A  +++G+ YL E    +++HRD+ A NIL+ E  + +I DFGL++ 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 260 --------------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
                         +P +W               A E L   I   ++DV++FGVLL E+
Sbjct: 200 VYEEDSYVKRSQGRIPVKWM--------------AIESLFDHIYTTQSDVWSFGVLLWEI 245

Query: 306 VT 307
           VT
Sbjct: 246 VT 247

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  131 bits (330), Expect = 1e-34
 Identities = 49/234 (20%), Positives = 86/234 (36%), Gaps = 24/234 (10%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKG--GYAEVYKGR-LRNGQLVAIKRLT-RGTAD 148
                    +         +    +IGKG      V   R    G+ V ++R+     ++
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 149 EIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL-----YGMKE 202
           E++     EL +    +HPN       +  +  + +V      GS   L+      GM E
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127

Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE 262
                I Y I  GV + L Y+H       +HR +KA++IL++ D +  +        +  
Sbjct: 128 LA---IAY-ILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

Query: 263 QWT-----HHTISKVEGTFGYLAPEFLMHGIV--DEKTDVFAFGVLLLELVTGR 309
                   H           +L+PE L   +   D K+D+++ G+   EL  G 
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  129 bits (327), Expect = 1e-34
 Identities = 56/237 (23%), Positives = 101/237 (42%), Gaps = 56/237 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIM 161
           +  +    +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKL 204
             +  H N   LLG   + G +++++E +  G+L   L                  +E++
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----- 259
            +         +A G+ YL     ++ IHRD+ A N+L+TE+   +I DFGLA+      
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211

Query: 260 ---------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                    LP +W               APE L   +   ++DV++FGVL+ E+ T
Sbjct: 212 YYKKTTNGRLPVKWM--------------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (338), Expect = 2e-34
 Identities = 56/258 (21%), Positives = 94/258 (36%), Gaps = 40/258 (15%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LR-NGQLVAIKRLTRGTADEIIADFLSELGI 160
           YE++           I  GG   +Y       NG+ V +K L      E  A  ++E   
Sbjct: 82  YEVKG---------CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF 132

Query: 161 MAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           +A V HP+  ++  +      H      IV+E     SL        +KL         L
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLL 189

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
            +   L YLH      +++ D+K  NI+LTE+ + ++ D G    +           + G
Sbjct: 190 EILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSF--GYLYG 239

Query: 275 TFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR-----RALDYSQQSLVLWARPMIKR 329
           T G+ APE +  G     TD++  G  L  L         R +D   +   +        
Sbjct: 240 TPGFQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTY---- 294

Query: 330 NEIRELVDASLADEYDTR 347
           +    L+  ++  +   R
Sbjct: 295 DSYGRLLRRAIDPDPRQR 312

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  127 bits (322), Expect = 4e-34
 Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY 175
           ++GKG Y  VY GR L N   +AIK +    +         E+ +  H+ H N  + LG 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGS 87

Query: 176 GIEGG-MHIVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVAEGLLYLHEGCQRRI 231
             E G + I +E  P GSL++LL      LK     I       + EGL YLH+    +I
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLHD---NQI 143

Query: 232 IHRDIKAANILL-TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV- 289
           +HRDIK  N+L+ T     +I DFG +K L             GT  Y+APE +  G   
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRG 201

Query: 290 -DEKTDVFAFGVLLLELVTGRR 310
             +  D+++ G  ++E+ TG+ 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  127 bits (321), Expect = 4e-34
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F     +GKG +  VY  R  ++  ++A+K L +       +      E+ I +H+ H
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 167 PNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           PN  +L GY      H      ++LE +P G++   L  +  K            +A  L
Sbjct: 69  PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANAL 122

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            Y H    +R+IHRDIK  N+LL    E +I DFG +   P       +    GT  YL 
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLC---GTLDYLP 175

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           PE +   + DEK D+++ GVL  E + G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (322), Expect = 5e-34
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 22/217 (10%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--EIIADFLSELG 159
           YEL           ++G GG +EV+  R LR+ + VA+K L    A        F  E  
Sbjct: 14  YELGE---------ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64

Query: 160 IMAHVDHPNTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
             A ++HP    +   G           IV+E     +L  ++   +  +      ++  
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIA 123

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI-SKVE 273
              + L + H+     IIHRD+K ANI+++     ++ DFG+A+ + +     T  + V 
Sbjct: 124 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           GT  YL+PE      VD ++DV++ G +L E++TG  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (320), Expect = 7e-34
 Identities = 52/231 (22%), Positives = 78/231 (33%), Gaps = 42/231 (18%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHV-D 165
           T  F     IG G +  V+K     +G + AIKR  +  A      + L E+   A +  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAE 218
           H +  +      E   M I  E    GSLA  +    E  +    +       + L V  
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELKDLLLQVGR 126

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-------------------ICDFGLAKW 259
           GL Y+H      ++H DIK +NI ++    P                    I D G    
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
           +            EG   +LA E L        K D+FA  + ++      
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (320), Expect = 7e-34
 Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 21/208 (10%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G G + +VYK +    G L A K +   + +E+  D++ E+ I+A  DHP   
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIV 79

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEGCQ 228
           KLLG Y  +G + I++E  P G++ +++  +   L    I+  +   + E L +LH    
Sbjct: 80  KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH---S 135

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPEFLM 285
           +RIIHRD+KA N+L+T + + ++ DFG++          T+ K     GT  ++APE +M
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN-----LKTLQKRDSFIGTPYWMAPEVVM 190

Query: 286 HGIV-----DEKTDVFAFGVLLLELVTG 308
              +     D K D+++ G+ L+E+   
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQI 218

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  127 bits (321), Expect = 8e-34
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 28/224 (12%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            ++ + +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----VA 217
           +H N  KL             +++E  P GSL ++L   +    +G+     L     V 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVV 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVE 273
            G+ +L E     I+HR+IK  NI+     + Q    + DFG A+ L +     ++    
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 274 GTFGYLAPEFLMHGIV--------DEKTDVFAFGVLLLELVTGR 309
           GT  YL P+     ++            D+++ GV      TG 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  127 bits (321), Expect = 8e-34
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 18/216 (8%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGI-M 161
             Q+  N+      +G G   +V+K R  + G ++A+K++ R    E     L +L + +
Sbjct: 19  RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78

Query: 162 AHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
              D P   +  G +     + I +EL        L   M+  +   I  K+ + + + L
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGY 278
            YL E  +  +IHRD+K +NILL E  + ++CDFG++  L         +K    G   Y
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL-----VDDKAKDRSAGCAAY 190

Query: 279 LAPEFLMHGIV-----DEKTDVFAFGVLLLELVTGR 309
           +APE +          D + DV++ G+ L+EL TG+
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  126 bits (319), Expect = 9e-34
 Identities = 44/236 (18%), Positives = 91/236 (38%), Gaps = 47/236 (19%)

Query: 102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIAD 153
            +++++   +  F   +G+G + +++KG  R            V +K L +   +     
Sbjct: 2   FHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-S 58

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
           F     +M+ + H +     G  + G    +V E    GSL + L   K  +    + ++
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--------ICDFGLAKWL---- 260
           A  +A  + +L E     +IH ++ A NILL  + + +        + D G++  +    
Sbjct: 119 AKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

Query: 261 ----PEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVT-GRR 310
                  W                PE + +    +  TD ++FG  L E+ + G +
Sbjct: 176 ILQERIPWV--------------PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (321), Expect = 1e-33
 Identities = 58/233 (24%), Positives = 91/233 (39%), Gaps = 52/233 (22%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           NN  F   +G G + +V +              VA+K L      +     +SEL IM+H
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 164 VD-HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-------------YGMKEKLKWGI 208
           +  H N   LLG    GG + ++ E    G L + L                        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--------- 259
               +  VA+G+ +L     +  IHRD+ A N+LLT     +I DFGLA+          
Sbjct: 166 LLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 260 -----LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                LP +W               APE +   +   ++DV+++G+LL E+ +
Sbjct: 223 KGNARLPVKWM--------------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  128 bits (323), Expect = 1e-33
 Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 47/228 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N +    +G G + EVY+G++           VA+K L    +++   DFL E  I++ 
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
            +H N  + +G  ++     I+LEL   G L S L            L       +A  +
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC---DFGLAK--------------W 259
           A G  YL E      IHRDI A N LLT     ++    DFG+A+               
Sbjct: 191 ACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
           LP +W                PE  M GI   KTD ++FGVLL E+ +
Sbjct: 248 LPVKWM--------------PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (318), Expect = 2e-33
 Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 56/237 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           N  SF   +G G + +V +              VA+K L            +SEL ++++
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL-----------------YGMKEKL 204
           + +H N   LLG    GG   ++ E    G L + L                    +  L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----- 259
                   +  VA+G+ +L     +  IHRD+ A NILLT     +ICDFGLA+      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 260 ---------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                    LP +W               APE + + +   ++DV+++G+ L EL +
Sbjct: 200 NYVVKGNARLPVKWM--------------APESIFNCVYTFESDVWSYGIFLWELFS 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (318), Expect = 7e-33
 Identities = 51/224 (22%), Positives = 94/224 (41%), Gaps = 28/224 (12%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV 164
            ++ + +   +++G+G  A V++GR +  G L AIK     +    +   + E  ++  +
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 165 DHPNTAKLLGY---GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----VA 217
           +H N  KL             +++E  P GSL ++L   +    +G+     L     V 
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVV 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTISKVE 273
            G+ +L E     I+HR+IK  NI+     + Q    + DFG A+ L +     ++    
Sbjct: 123 GGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176

Query: 274 GTFGYLAPEFLMHGIV--------DEKTDVFAFGVLLLELVTGR 309
           GT  YL P+     ++            D+++ GV      TG 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  126 bits (318), Expect = 8e-33
 Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 56/237 (23%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIM 161
           +       +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLL---------------YGMKEKL 204
             +  H N   LLG   + G +++++E +  G+L   L               +  +E+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW----- 259
                   A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+      
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245

Query: 260 ---------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                    LP +W               APE L   I   ++DV++FGVLL E+ T
Sbjct: 246 YYKKTTNGRLPVKWM--------------APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (313), Expect = 1e-32
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 22/226 (9%)

Query: 93  SQSPQKIFSLYELQSATNN----FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA 147
              P++     +  S T      F     +G+G Y  VYK      GQ+VAIK++     
Sbjct: 8   RNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---V 64

Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKW 206
           +  + + + E+ IM   D P+  K  G Y     + IV+E    GS++ ++    + L  
Sbjct: 65  ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124

Query: 207 G-IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
             I   I     +GL YLH     R IHRDIKA NILL  +   ++ DFG+A  L +   
Sbjct: 125 DEIAT-ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177

Query: 266 HHTISK---VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
             T++K   V GT  ++APE +     +   D+++ G+  +E+  G
Sbjct: 178 --TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 3e-32
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 20/208 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
            +     +GKGG+A+ ++       ++ A K + +              E+ I   + H 
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 168 NTAKLLGYGIEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLY 222
           +     G+  E    +  VLEL    SL  L      + E      RY +   +  G  Y
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLR-QIVLGCQY 156

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAP 281
           LH   + R+IHRD+K  N+ L ED E +I DFGLA  +  +      +    GT  Y+AP
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 210

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           E L       + DV++ G ++  L+ G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 4e-32
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDH 166
            +F   NL+GKG +A VY+   +  G  VAIK + +       ++    +E+ I   + H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 167 PNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEKLK-WGIRYKIALGVAEG 219
           P+  +L  Y             +VLE+  NG +   L    +       R+ +   +  G
Sbjct: 71  PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITG 124

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA-KWLPEQWTHHTISKVEGTFGY 278
           +LYLH      I+HRD+  +N+LLT +   +I DFGLA +       H+T+    GT  Y
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNY 178

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           ++PE         ++DV++ G +   L+ GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  125 bits (315), Expect = 4e-32
 Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 23/211 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNT 169
           +F  ++++G G    +    + + + VA+KR+      E  +    E+ ++   D HPN 
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFADREVQLLRESDEHPNV 80

Query: 170 AKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
            +   +  E      +I +EL    +L   +              +      GL +LH  
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS- 136

Query: 227 CQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWL-PEQWTHHTISKVEGTFGYLA 280
               I+HRD+K  NIL++           I DFGL K L   + +    S V GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 281 PEFL---MHGIVDEKTDVFAFGVLLLELVTG 308
           PE L            D+F+ G +   +++ 
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  123 bits (311), Expect = 4e-32
 Identities = 60/242 (24%), Positives = 92/242 (38%), Gaps = 61/242 (25%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNG------QLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N  F  ++G G + +V                VA+K L            +SEL +M  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRY----------- 210
           +  H N   LLG     G ++++ E    G L + L   +EK                  
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 211 -----------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
                        A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA+ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221

Query: 260 --------------LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLEL 305
                         LP +W               APE L  GI   K+DV+++G+LL E+
Sbjct: 222 IMSDSNYVVRGNARLPVKWM--------------APESLFEGIYTIKSDVWSYGILLWEI 267

Query: 306 VT 307
            +
Sbjct: 268 FS 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (306), Expect = 7e-32
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 20/208 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHP 167
            +     +GKGG+A+ ++       ++ A K + +              E+ I   + H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 168 NTAKLLGYGIEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY 222
           +     G+  E    +  VLEL    SL  L      + E      RY +   +  G  Y
Sbjct: 76  HVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLR-QIVLGCQY 130

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAP 281
           LH   + R+IHRD+K  N+ L ED E +I DFGLA  +  +      +    GT  Y+AP
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 184

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           E L       + DV++ G ++  L+ G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (307), Expect = 9e-32
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 32/231 (13%)

Query: 98  KIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS 156
               L  L+     F    L+G G Y +VYKGR ++ GQL AIK +      +   +   
Sbjct: 12  DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEIKQ 69

Query: 157 ELGIMAHV-DHPNTAKLLG-------YGIEGGMHIVLELSPNGSLASLLYGMKEKL---K 205
           E+ ++     H N A   G        G++  + +V+E    GS+  L+   K      +
Sbjct: 70  EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
           W I Y I   +  GL +LH+    ++IHRDIK  N+LLTE+ E ++ DFG++  L     
Sbjct: 130 W-IAY-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----- 179

Query: 266 HHTISK---VEGTFGYLAPEFLMHGIV-----DEKTDVFAFGVLLLELVTG 308
             T+ +     GT  ++APE +          D K+D+++ G+  +E+  G
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (307), Expect = 1e-31
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 29/225 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN 168
                 ++ +GG+A VY+ + + +G+  A+KRL     ++     + E+  M  +  HPN
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-RAIIQEVCFMKKLSGHPN 87

Query: 169 TAKLLGYGIEGGMH--------IVLELSPNGSLASLLYGMKEKLKWG---IRYKIALGVA 217
             +       G           ++L     G L   L  M+ +       +  KI     
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTC 146

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL----PEQWTHHTISKVE 273
             + ++H   +  IIHRD+K  N+LL+     ++CDFG A  +       W+    + VE
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 274 ------GTFGYLAPE---FLMHGIVDEKTDVFAFGVLLLELVTGR 309
                  T  Y  PE      +  + EK D++A G +L  L   +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  119 bits (301), Expect = 3e-31
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 29/226 (12%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT--ADE 149
           ++ P++ F++       ++F     +GKG +  VY  R  +N  ++A+K L +     + 
Sbjct: 4   AEMPKRKFTI-------DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56

Query: 150 IIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH------IVLELSPNGSLASLLYGMKEK 203
           +      E+ I +H+ HPN  ++  Y      H      ++LE +P G L   L     +
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHG-R 110

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ 263
                       +A+ L Y H   +R++IHRDIK  N+L+    E +I DFG +      
Sbjct: 111 FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV-HAPS 166

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
               T+    GT  YL PE +     DEK D++  GVL  E + G 
Sbjct: 167 LRRRTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  119 bits (300), Expect = 4e-31
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           ++    IG+G    VY    +  GQ VAI+++      +     ++E+ +M    +PN  
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIV 80

Query: 171 KLLG-YGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             L  Y +   + +V+E    GSL  ++    M E     I   +     + L +LH   
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAA-VCRECLQALEFLH--- 133

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPEFL 284
             ++IHRDIK+ NILL  D   ++ DFG    +         SK   + GT  ++APE +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYWMAPEVV 188

Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
                  K D+++ G++ +E++ G
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEG 212

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (300), Expect = 1e-30
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKR--LTRGTADEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+   +   ++E   D + E+  +  + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAEGLLYLHEG 226
           T +  G Y  E    +V+E    GS + LL   K+ L+   I   +  G  +GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHS- 172

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPEF 283
               +IHRD+KA NILL+E    ++ DFG A           ++      GT  ++APE 
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA---------SIMAPANSFVGTPYWMAPEV 221

Query: 284 LMH---GIVDEKTDVFAFGVLLLELVTG 308
           ++    G  D K DV++ G+  +EL   
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAER 249

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (299), Expect = 1e-30
 Identities = 55/246 (22%), Positives = 106/246 (43%), Gaps = 36/246 (14%)

Query: 71  RRSSSMREGIDMPR-NLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKG 129
            +S  +          + V+  D   P+ +   Y              IG+G    V   
Sbjct: 20  FQSGVVTHEQFKAALRMVVDQGD---PRLLLDSYVK------------IGEGSTGIVCLA 64

Query: 130 R-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL 187
           R   +G+ VA+K +      +      +E+ IM    H N  ++   Y +   + +++E 
Sbjct: 65  REKHSGRQVAVKMMDL-RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123

Query: 188 SPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
              G+L  ++    + E+    I   +   V + L YLH    + +IHRDIK+ +ILLT 
Sbjct: 124 LQGGALTDIVSQVRLNEEQ---IAT-VCEAVLQALAYLH---AQGVIHRDIKSDSILLTL 176

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISK---VEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
           D   ++ DFG    + +      + K   + GT  ++APE +   +   + D+++ G+++
Sbjct: 177 DGRVKLSDFGFCAQISK-----DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231

Query: 303 LELVTG 308
           +E+V G
Sbjct: 232 IEMVDG 237

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (300), Expect = 1e-30
 Identities = 42/264 (15%), Positives = 98/264 (37%), Gaps = 44/264 (16%)

Query: 73  SSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR 132
             SM++ +    NL   +   +   K  + Y +            + +G + ++     +
Sbjct: 3   LGSMKDILSNYSNLIYLNKYVKEKDKYINDYRII---------RTLNQGKFNKIILCE-K 52

Query: 133 NGQLVAIKRLTRGTADEIIADFLS----------------ELGIMAHVDHPNTAKLLGYG 176
           + +  A+K+  +   ++      S                EL I+  + +       G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI- 111

Query: 177 IEGGMHI--VLELSPNGSLASLL---YGMKEKLKWGIRYKIAL----GVAEGLLYLHEGC 227
           I     +  + E   N S+       + + +     I  ++       V     Y+H   
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-- 169

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH- 286
           ++ I HRD+K +NIL+ ++   ++ DFG ++++ ++          GT+ ++ PEF  + 
Sbjct: 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----GSRGTYEFMPPEFFSNE 225

Query: 287 -GIVDEKTDVFAFGVLLLELVTGR 309
                 K D+++ G+ L  +    
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNV 249

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  120 bits (302), Expect = 4e-30
 Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 33/255 (12%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
               S R +   +  +     +F+ S        +  +Y+             +G G Y 
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITS----KKGHLSEMYQ---------RVKKLGSGAYG 51

Query: 125 EVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGM 181
           EV   R +      AIK +     +    +  L E+ ++  +DHPN  KL   +  +   
Sbjct: 52  EVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111

Query: 182 HIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA 238
           ++V+E    G L   +       E     I  ++  GV     YLH   +  I+HRD+K 
Sbjct: 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVT----YLH---KHNIVHRDLKP 164

Query: 239 ANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDV 295
            N+LL    +D   +I DFGL+     Q     + +  GT  Y+APE L     DEK DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVL-RKKYDEKCDV 220

Query: 296 FAFGVLLLELVTGRR 310
           ++ GV+L  L+ G  
Sbjct: 221 WSIGVILFILLAGYP 235

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (296), Expect = 6e-30
 Identities = 46/281 (16%), Positives = 94/281 (33%), Gaps = 28/281 (9%)

Query: 78  EGIDMPRNLFVNSYDSQSPQKIFSL-YELQSATNNFSFENLIGKGGYAEVYKGR------ 130
            G+  P + + N+++ Q          E Q  +      +L+G+G +A+VY+        
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91

Query: 131 LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            +N Q   +K        E        +  +         K    +  + G  +V EL  
Sbjct: 92  AKNKQKFVLKVQKPANPWEFYI-GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150

Query: 190 NGSLASLLYGMKE----KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE 245
            G+L + +   K      +  G+    A+ +   +  +H+     IIH DIK  N +L  
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGN 207

Query: 246 DFEP-----------QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
            F              + D G +  +         +    T G+   E L +   + + D
Sbjct: 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQID 267

Query: 295 VFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL 335
            F     +  ++ G   +    +        + +R    ++
Sbjct: 268 YFGVAATVYCMLFG-TYMKVKNEGGECKPEGLFRRLPHLDM 307

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (303), Expect = 6e-30
 Identities = 65/252 (25%), Positives = 97/252 (38%), Gaps = 28/252 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +  +  +G GG+  V +      G+ VAIK+  +  + +    +  E+ IM  ++HPN 
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 170 AKLL-------GYGIEGGMHIVLELSPNGSLASLL------YGMKEKLKWGIRYKIALGV 216
                               + +E    G L   L       G+KE     IR  +   +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP---IR-TLLSDI 130

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVE 273
           +  L YLHE    RIIHRD+K  NI+L    +     I D G AK L +           
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--- 184

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           GT  YLAPE L         D ++FG L  E +TG R         V W   + +++   
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF-LPNWQPVQWHGKVREKSNEH 243

Query: 334 ELVDASLADEYD 345
            +V   L     
Sbjct: 244 IVVYDDLTGAVK 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (295), Expect = 8e-30
 Identities = 23/276 (8%), Positives = 62/276 (22%), Gaps = 47/276 (17%)

Query: 71  RRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
            R  +++E   M   +    +   +   + S   L            +  G  + V+  R
Sbjct: 25  CREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVR 82

Query: 131 -LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL 187
            +   +  A+K   +    +   +          A +   +  +             + +
Sbjct: 83  DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142

Query: 188 S--------------------------PNGSLASLLYGMKEKLKWG------IRYKIALG 215
                                       +  L  L   +     +         + +   
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGT 275
           +      L     + ++H      N+ +  D    + D      +               
Sbjct: 203 LIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVP 254

Query: 276 FGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGR 309
             Y   EFL           + +  G+ +  +    
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  116 bits (293), Expect = 8e-29
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 34/246 (13%)

Query: 74  SSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR- 132
            SM + +     +FV      S       Y+          + ++GKG + EV   + + 
Sbjct: 3   GSMMDHLHATPGMFVQH----STAIFSDRYK---------GQRVLGKGSFGEVILCKDKI 49

Query: 133 NGQLVAIKRL--TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSP 189
            GQ  A+K +   +          L E+ ++  +DHPN  KL   +  +G  ++V E+  
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109

Query: 190 NGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-- 244
            G L   +   K   E     I  ++  G+     Y+H   + +I+HRD+K  N+LL   
Sbjct: 110 GGELFDEIISRKRFSEVDAARIIRQVLSGIT----YMH---KNKIVHRDLKPENLLLESK 162

Query: 245 -EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
            +D   +I DFGL+           +    GT  Y+APE L HG  DEK DV++ GV+L 
Sbjct: 163 SKDANIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILY 218

Query: 304 ELVTGR 309
            L++G 
Sbjct: 219 ILLSGC 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  116 bits (292), Expect = 9e-29
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 20/230 (8%)

Query: 90  SYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTA 147
            +         +LY   +    ++   ++GKG + EV K + R   Q  A+K +      
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61

Query: 148 DEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMK---EK 203
           ++  +  L E+ ++  +DHPN  KL          +IV EL   G L   +   K   E 
Sbjct: 62  NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH 121

Query: 204 LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWL 260
               I  ++  G+     Y+H   +  I+HRD+K  NILL    +D + +I DFGL+   
Sbjct: 122 DAARIIKQVFSGIT----YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
            +      +    GT  Y+APE L  G  DEK DV++ GV+L  L++G  
Sbjct: 175 QQN---TKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTP 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (287), Expect = 5e-28
 Identities = 63/259 (24%), Positives = 102/259 (39%), Gaps = 44/259 (16%)

Query: 72  RSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL 131
           R +   +GI +   ++V     +   KI   Y              +G G Y EV   + 
Sbjct: 11  RENLYFQGIAINPGMYVR----KKEGKIGESYF---------KVRKLGSGAYGEVLLCKE 57

Query: 132 R-NGQLVAIKRL------------TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGI 177
           +      AIK +                 ++   +  +E+ ++  +DHPN  KL   +  
Sbjct: 58  KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117

Query: 178 EGGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHR 234
           +   ++V E    G L   +       E     I  +I  G+     YLH   +  I+HR
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC----YLH---KHNIVHR 170

Query: 235 DIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDE 291
           DIK  NILL         +I DFGL+ +  + +         GT  Y+APE L     +E
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPEVL-KKKYNE 226

Query: 292 KTDVFAFGVLLLELVTGRR 310
           K DV++ GV++  L+ G  
Sbjct: 227 KCDVWSCGVIMYILLCGYP 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  109 bits (275), Expect = 1e-27
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + F F+  +G G + +V+    R +G    IK + +  +   +    +E+ ++  +DHP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEGL 220
           N  K+   +     M+IV+E    G    LL  +      G         ++   +   L
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGG---ELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 221 LYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            Y H    + ++H+D+K  NIL          +I DFGLA+           +   GT  
Sbjct: 138 AYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y+APE      V  K D+++ GV++  L+TG
Sbjct: 192 YMAPEVF-KRDVTFKCDIWSAGVVMYFLLTG 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  108 bits (271), Expect = 7e-27
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 44/214 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
              F F  ++G G ++EV+  + R  G+L A+K +       +  +   +E+ ++  + H
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKH 65

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
            N   L   Y      ++V++L   G L              ASL+  +++         
Sbjct: 66  ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV--IQQ--------- 114

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               V   + YLHE     I+HRD+K  N+L     E+ +  I DFGL+K          
Sbjct: 115 ----VLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----I 163

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
           +S   GT GY+APE L      +  D ++ GV+ 
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  109 bits (274), Expect = 1e-26
 Identities = 59/235 (25%), Positives = 92/235 (39%), Gaps = 42/235 (17%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           QS  N    E ++G G    V       G+ VA+KR+     D      L E+ ++   D
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA----LMEIKLLTESD 66

Query: 166 -HPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALG 215
            HPN  +   Y  E     ++I LEL  N +L  L+       +            +   
Sbjct: 67  DHPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLT-------------EDFEPQICDFGLAKWLP- 261
           +A G+ +LH     +IIHRD+K  NIL++             E+    I DFGL K L  
Sbjct: 124 IASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 262 -EQWTHHTISKVEGTFGYLAPEFLMHGIV-------DEKTDVFAFGVLLLELVTG 308
            +      ++   GT G+ APE L                D+F+ G +   +++ 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (269), Expect = 3e-26
 Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 28/247 (11%)

Query: 71  RRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR 130
           +R+S++   I  P   F +   +     + S Y +           ++G G + +V+K  
Sbjct: 57  KRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSK-------TEILGGGRFGQVHKCE 109

Query: 131 LRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLEL 187
               G  +A K + TRG  D    +  +E+ +M  +DH N  +L   +  +  + +V+E 
Sbjct: 110 ETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167

Query: 188 SPNGSL----ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
              G L        Y + E        +I     EG+ ++H   Q  I+H D+K  NIL 
Sbjct: 168 VDGGELFDRIIDESYNLTELDTILFMKQI----CEGIRHMH---QMYILHLDLKPENILC 220

Query: 244 TEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVL 301
                 QI   DFGLA+    +     +    GT  +LAPE + +  V   TD+++ GV+
Sbjct: 221 VNRDAKQIKIIDFGLARRYKPR---EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

Query: 302 LLELVTG 308
              L++G
Sbjct: 278 AYMLLSG 284

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  106 bits (267), Expect = 4e-26
 Identities = 58/252 (23%), Positives = 89/252 (35%), Gaps = 54/252 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK----RLTRGTADEIIADFLSELGIMAH 163
              +  +  IG+G Y  V          + AIK       R    + +    +E+ +M  
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSL----------------------------- 193
           + HPN A+L   Y  E  + +V+EL   G L                             
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 194 ----ASLLYGMKEKLKWGIRY------KIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
               A        +              I   +   L YLH    + I HRDIK  N L 
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLF 201

Query: 244 T--EDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFA 297
           +  + FE ++ DFGL+K         ++ ++   GT  ++APE L         K D ++
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 298 FGVLLLELVTGR 309
            GVLL  L+ G 
Sbjct: 262 AGVLLHLLLMGA 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (265), Expect = 4e-26
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
              ++   ++GKG + EV K + R   Q  A+K +      ++  +  L E+ ++  +DH
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGL 220
           PN  KL          +IV EL   G L         +   E     I  ++  G+    
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGIT--- 135

Query: 221 LYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFG 277
            Y+H   +  I+HRD+K  NILL    +D + +I DFGL+    +           GT  
Sbjct: 136 -YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLL 302
           Y+APE L  G  DEK DV++ GV+L
Sbjct: 189 YIAPEVL-RGTYDEKCDVWSAGVIL 212

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  105 bits (264), Expect = 4e-26
 Identities = 25/201 (12%), Positives = 54/201 (26%), Gaps = 39/201 (19%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
             G     + ++       + VA+          D+++ + LS    ++ +D P  A++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 174 GYGIEGGMH-IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRII 232
                     +V E    GSL  +              +    +A      H   +  + 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEK 292
                 + + ++ D        G                       +          + +
Sbjct: 152 LSIDHPSRVRVSID--------GDVVL--------------AYPATMPD-------ANPQ 182

Query: 293 TDVFAFGVLLLELVTGRRALD 313
            D+   G  L  L+  R  L 
Sbjct: 183 DDIRGIGASLYALLVNRWPLP 203

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (270), Expect = 4e-26
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 31/242 (12%)

Query: 84  RNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL 142
             +FV    +   Q ++     ++  + +     +G G   EV     R   + VAI+ +
Sbjct: 113 NKVFVFFDLTVDDQSVYP----KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168

Query: 143 TR-------GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLAS 195
           ++           +   +  +E+ I+  ++HP   K+  +      +IVLEL   G L  
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228

Query: 196 LLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-- 250
            + G K   E       Y++ L V     YLHE     IIHRD+K  N+LL+   E    
Sbjct: 229 KVVGNKRLKEATCKLYFYQMLLAVQ----YLHE---NGIIHRDLKPENVLLSSQEEDCLI 281

Query: 251 -ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV---DEKTDVFAFGVLLLELV 306
            I DFG +K L E     T+    GT  YLAPE L+       +   D ++ GV+L   +
Sbjct: 282 KITDFGHSKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338

Query: 307 TG 308
           +G
Sbjct: 339 SG 340

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 5e-26
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 46/225 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            +++     +G G +A V K R +  G+  A K     RL+         +   E+ I+ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            + HPN   L   +  +  + ++LEL   G L              A+    +K+     
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQ----- 116

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
                   + +G+ YLH    +RI H D+K  NI+L +   P     + DFG+A  +   
Sbjct: 117 --------ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                I    GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 166 NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  105 bits (264), Expect = 5e-26
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 41/214 (19%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +  G   A K + T+  +         E  I   + H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      E   ++V +L   G L              AS    +++         
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQ--------- 113

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E + Y H      I+HR++K  N+LL    +    ++ DFGLA  + +      
Sbjct: 114 ----ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 163

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
                GT GYL+PE L      +  D++A GV+L
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  106 bits (266), Expect = 7e-26
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 23/206 (11%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-GQLVAIK----RLTRGTADEIIADFLSELGIMAHVDH 166
           +    +IGKG ++ V +   R  GQ  A+K         +      D   E  I   + H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRY------KIALGVAEG 219
           P+  +LL  Y  +G +++V E         L + + ++   G  Y           + E 
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGA---DLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 220 LLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
           L Y H+     IIHRD+K   +LL         ++  FG+A  L E           GT 
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTP 197

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLL 302
            ++APE +      +  DV+  GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  105 bits (264), Expect = 8e-26
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     +           +   E+ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            V H N   L   Y     + ++LEL   G L              A+    +K+     
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQ----- 123

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
                   + +G+ YLH    ++I H D+K  NI+L +   P     + DFGLA  + + 
Sbjct: 124 --------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                I    GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 173 VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (264), Expect = 1e-25
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 43/213 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
           ++ F  E+ +G+G  + VY+ + +   +  A+K L + T D+      +E+G++  + HP
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDK--KIVRTEIGVLLRLSHP 108

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYKI 212
           N  KL   +     + +VLEL   G L              A+    +K+          
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA--VKQ---------- 156

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTI 269
              + E + YLHE     I+HRD+K  N+L      D   +I DFGL+K +  Q    T+
Sbjct: 157 ---ILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
               GT GY APE L       + D+++ G++ 
Sbjct: 211 C---GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (262), Expect = 1e-25
 Identities = 63/229 (27%), Positives = 94/229 (41%), Gaps = 40/229 (17%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTR------- 144
           S  P+ +   Y +            +G G   EV     R   + VAIK +++       
Sbjct: 2   SVYPKALRDEYIM---------SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS 52

Query: 145 GTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSL-----ASLLYG 199
               +   +  +E+ I+  ++HP   K+  +      +IVLEL   G L      +    
Sbjct: 53  AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL- 111

Query: 200 MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGL 256
            KE       Y++ L V     YLHE     IIHRD+K  N+LL+   E     I DFG 
Sbjct: 112 -KEATCKLYFYQMLLAVQ----YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV---DEKTDVFAFGVLL 302
           +K L E     T+    GT  YLAPE L+       +   D ++ GV+L
Sbjct: 164 SKILGETSLMRTLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (263), Expect = 2e-25
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 41/214 (19%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           ++N+  +  +GKG ++ V +   +  G   A K + T+  +         E  I   + H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      E   ++V +L   G L              AS    +++         
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQ--------- 136

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E + Y H      I+HR++K  N+LL    +    ++ DFGLA  + +      
Sbjct: 137 ----ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EA 186

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
                GT GYL+PE L      +  D++A GV+L
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  105 bits (263), Expect = 2e-25
 Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 46/225 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     +           +   E+ I+ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            V HPN   L   Y     + ++LEL   G L              A+    +K+     
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQ----- 123

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
                   + +G+ YLH    ++I H D+K  NI+L +   P     + DFGLA  + + 
Sbjct: 124 --------ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                I    GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 173 VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 8e-25
 Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 40/214 (18%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
           T  +     +GKG ++ V +      GQ  A   + T+  +         E  I   + H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWGIRYK 211
           PN  +L      EG  +++ +L   G L              AS    +++         
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--IQQ--------- 118

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHT 268
               + E +L+ H+     ++HR++K  N+LL    +    ++ DFGLA  +  +     
Sbjct: 119 ----ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQA 169

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
                GT GYL+PE L      +  D++A GV+L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 9e-25
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 46/225 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIK-----RLTRGTADEIIADFLSELGIMA 162
            + +     +G G +A V K R +  G   A K     R           D   E+ I+ 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
            + HPN   L   Y  +  + ++LEL   G L              A+    +K+     
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQ----- 122

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQ 263
                   +  G+ YLH     +I H D+K  NI+L +   P+    I DFGLA  +   
Sbjct: 123 --------ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                I    GT  ++APE + +  +  + D+++ GV+   L++G
Sbjct: 172 NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (255), Expect = 1e-24
 Identities = 51/334 (15%), Positives = 108/334 (32%), Gaps = 82/334 (24%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            +F     +G+GG+  V++ +   +    AIKR+     +      + E+  +A ++HP 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGM------------------KEKLKWGIRY 210
             +     +E       E      L                                   
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 211 KIALGVAEGLLYLH-EGCQRR--------------------------------------I 231
           ++     +  LY+  + C++                                       +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE----------GTFGYLAP 281
           +HRD+K +NI  T D   ++ DFGL   + +     T+              GT  Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
           E +       K D+F+ G++L EL+         ++  ++         ++R L    L 
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRII--------TDVRNLKFPLLF 295

Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
            +   ++  +V       +  S   RP+ + +++
Sbjct: 296 TQKYPQEHMMV----QDMLSPSPTERPEATDIIE 325

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (252), Expect = 2e-24
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 24/204 (11%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              ++ EN IG+G + EV     +      A K++ +   +++   F  E+ IM  +DHP
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHP 66

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLL 221
           N  +L   +     +++V+EL   G L        ++  +E     I   +   VA    
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF--RESDAARIMKDVLSAVA---- 120

Query: 222 YLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           Y H   +  + HRD+K  N L      D   ++ DFGLA           +    GT  Y
Sbjct: 121 YCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYY 174

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLL 302
           ++P+ L  G+   + D ++ GV++
Sbjct: 175 VSPQVL-EGLYGPECDEWSAGVMM 197

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (256), Expect = 2e-24
 Identities = 26/244 (10%), Positives = 59/244 (24%), Gaps = 55/244 (22%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIK--RLTRGTADEIIADFLSELGIMAH----- 163
                ++G+       +      G+   +     T       I     E+  +       
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 164 -----------------VDHPNTAKLLGYGIEGGMHIVLEL-----SPNGSLASLLYGMK 201
                            V  P   K++   ++     VL           +L +    + 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 202 EKLKWG------IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG 255
                        R ++ L V   L  LH      ++H  ++  +I+L +     +  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLM----------HGIVDEKTDVFAFGVLLLEL 305
                         +      G+  PE               ++    D +  G+ +  +
Sbjct: 257 HLVRDGAS------AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 306 VTGR 309
               
Sbjct: 311 WCAD 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  101 bits (253), Expect = 5e-24
 Identities = 33/306 (10%), Positives = 82/306 (26%), Gaps = 56/306 (18%)

Query: 51  LFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATN 110
           L+       ++     ++      +  E +    +  V++    + Q      EL     
Sbjct: 14  LYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 73

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----------------------RLTRGT 146
                 ++G+       +      G+   +                        RL RG 
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 147 ADEIIA----DFLSELGIMAHVDHPNTAKLLGYGIEGGMH--IVLELSPNGSLASLL--- 197
            ++  A     F+    ++         ++     +  +     L      +L +     
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 198 ---YGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
                  + L    R ++ L V   L  LH      ++H  ++  +I+L +     +  F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 250

Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-----------GIVDEKTDVFAFGVLLL 303
                   +           + G+  PE                ++    D +A G+++ 
Sbjct: 251 EHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 304 ELVTGR 309
            +    
Sbjct: 305 WIWCAD 310

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (255), Expect = 1e-23
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 11/204 (5%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            +++     +G G +  V++   R  G   A K +      +       E+  M+ + HP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHP 214

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
               L   +  +  M ++ E    G L   +     K+      +    V +GL ++HE 
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 273

Query: 227 CQRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
                +H D+K  NI+ T     ++   DFGL   L       ++    GT  + APE  
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVA 328

Query: 285 MHGIVDEKTDVFAFGVLLLELVTG 308
               V   TD+++ GVL   L++G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 61/242 (25%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIK--------RL 142
            S S    +  YE +          ++G+G  + V +   +   +  A+K          
Sbjct: 8   GSHSTHGFYENYEPK---------EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58

Query: 143 TRGTADEIIADFLSELGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSL------- 193
           +     E+    L E+ I+  V  HPN  +L   Y       +V +L   G L       
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK 118

Query: 194 -------ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
                     +  M+              + E +  LH+     I+HRD+K  NILL +D
Sbjct: 119 VTLSEKETRKI--MRA-------------LLEVICALHK---LNIVHRDLKPENILLDDD 160

Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV------DEKTDVFAFGV 300
              ++ DFG +  L        +    GT  YLAPE +   +        ++ D+++ GV
Sbjct: 161 MNIKLTDFGFSCQLDPGEKLREVC---GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

Query: 301 LL 302
           ++
Sbjct: 218 IM 219

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 64/313 (20%), Positives = 118/313 (37%), Gaps = 54/313 (17%)

Query: 23  SETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKKSLVTLY--PLKLSIRRSSSMREGI 80
               SS       K   ++        +L R + +  + +L   P + +   + + +   
Sbjct: 4   HHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLND 63

Query: 81  DMPRNLFVNSYDSQSPQKIFSLYELQSA-TNNFSFENLIGKGGYAEVYKGRLR-NGQLVA 138
             P+      + S  P+     +         +  +++IG+G  + V +   R  G   A
Sbjct: 64  AQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123

Query: 139 IK-------RLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHIVLELSP 189
           +K       RL+    +E+      E  I+  V  HP+   L+  Y     M +V +L  
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183

Query: 190 NGSL--------------ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD 235
            G L                 +  M+              + E + +LH      I+HRD
Sbjct: 184 KGELFDYLTEKVALSEKETRSI--MRS-------------LLEAVSFLHA---NNIVHRD 225

Query: 236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV------ 289
           +K  NILL ++ + ++ DFG +  L        + ++ GT GYLAPE L   +       
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELCGTPGYLAPEILKCSMDETHPGY 282

Query: 290 DEKTDVFAFGVLL 302
            ++ D++A GV+L
Sbjct: 283 GKEVDLWACGVIL 295

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 30/227 (13%)

Query: 94  QSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEII 151
           QS +   + Y L S          +G+G +A V +   +  GQ  A K L  R    +  
Sbjct: 21  QSMENFNNFYILTS--------KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR 72

Query: 152 ADFLSELGIMAHVDH-PNTAKLLG-YGIEGGMHIVLELSPNGSL-----ASLLYGMKEKL 204
           A+ L E+ ++      P    L   Y     + ++LE +  G +       L   + E  
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP 261
              +  +I     EG+ YLH+     I+H D+K  NILL       + +I DFG+++ + 
Sbjct: 133 VIRLIKQI----LEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
                  I    GT  YLAPE L +  +   TD++  G++   L+T 
Sbjct: 186 HACELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDH 166
            + +     +G G +  V++   +  G++   K + T    D       +E+ IM  + H
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHH 107

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSL----ASLLYGMKEKLKWGIRYKIALG---VAE 218
           P    L   +  +  M ++LE    G L    A+  Y M E        ++        E
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA-------EVINYMRQACE 160

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--ICDFGLAKWLPEQWTHHTISKVEGTF 276
           GL ++H   +  I+H DIK  NI+          I DFGLA  L        +     T 
Sbjct: 161 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATA 214

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            + APE +    V   TD++A GVL   L++G
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (251), Expect = 4e-23
 Identities = 70/302 (23%), Positives = 125/302 (41%), Gaps = 37/302 (12%)

Query: 34  ETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMREGIDMPRNLFVNSYDS 93
           +T  ++    +       +     +   +    +   R  +   +G+  P    V ++  
Sbjct: 96  DTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLG 155

Query: 94  QSPQKIF--SLY----------ELQSAT-NNFSFENLIGKGGYAEVYKGRLRN-GQLVAI 139
           Q+P + F  SLY          E Q    + F    ++G+GG+ EV+  +++  G+L A 
Sbjct: 156 QAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215

Query: 140 KRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSPNGSL 193
           K+L +     +         + E  I+A V       L   +  +  + +V+ +   G +
Sbjct: 216 KKLNK---KRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272

Query: 194 ASLLYGMKEKLKWGIRYKIALGV---AE---GLLYLHEGCQRRIIHRDIKAANILLTEDF 247
              +Y + E       ++    +   A+   GL +LH+   R II+RD+K  N+LL +D 
Sbjct: 273 RYHIYNVDEDNP---GFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDG 326

Query: 248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
             +I D GLA  L             GT G++APE L+    D   D FA GV L E++ 
Sbjct: 327 NVRISDLGLAVELKAG--QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

Query: 308 GR 309
            R
Sbjct: 385 AR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (251), Expect = 4e-23
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 38/303 (12%)

Query: 34  ETKPESKSNSRWHLFYDLFRNKSKKSLVTLYPLKLSIRRSSSMRE----GIDMPRNLFVN 89
           E  P+ K  +        F + +   L+   P +L    +  + +     +        +
Sbjct: 91  EVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTH 150

Query: 90  SYDSQSPQKIF--SLY----------ELQSAT-NNFSFENLIGKGGYAEVYKGRLRN-GQ 135
            Y S +P   +  S+Y          E Q  T N F    ++GKGG+ EV   ++R  G+
Sbjct: 151 EYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210

Query: 136 LVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLL-GYGIEGGMHIVLELSP 189
           + A K+L +     I         L+E  I+  V+      L   Y  +  + +VL L  
Sbjct: 211 MYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 267

Query: 190 NGSLASLLYGMKE---KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED 246
            G L   +Y M +        + Y  A  +  GL  LH     RI++RD+K  NILL + 
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLHR---ERIVYRDLKPENILLDDH 322

Query: 247 FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELV 306
              +I D GLA  +PE  T        GT GY+APE + +       D +A G LL E++
Sbjct: 323 GHIRISDLGLAVHVPEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

Query: 307 TGR 309
            G+
Sbjct: 380 AGQ 382

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           ++F     IGKG + +V   +     ++ A+K + +    + +          EL IM  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK---QKCVERNEVRNVFKELQIMQG 71

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA-LGVAEGLL 221
           ++HP    L   +  E  M +V++L   G L   L       +  ++  I  L +A  L 
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LD 129

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YL     +RIIHRD+K  NILL E     I DF +A  LP +    T++   GT  Y+AP
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAP 183

Query: 282 EFLMHGIV---DEKTDVFAFGVLLLELVTGRR 310
           E              D ++ GV   EL+ GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 41/211 (19%), Positives = 75/211 (35%), Gaps = 26/211 (12%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              +     +G+G +  V++     + +    K +     D        E+ I+    H 
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHR 61

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSL----ASLLYGMKEKLKWGIRYKIALG---VAEG 219
           N   L   +     + ++ E      +     +  + + E+       +I      V E 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER-------EIVSYVHQVCEA 114

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--ICDFGLAKWLPEQWTHHTISKVEGTFG 277
           L +LH      I H DI+  NI+          I +FG A+ L        +        
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPE 168

Query: 278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
           Y APE   H +V   TD+++ G L+  L++G
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 58/241 (24%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI 150
           DS S  +   +Y+LQ        E+++G+G +A V         Q  A+K + +     I
Sbjct: 4   DSFSG-RFEDVYQLQ--------EDVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHI 53

Query: 151 IADFLSELGIMAHV-DHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------A 194
            +    E+ ++     H N  +L+  +  E   ++V E    GS+              A
Sbjct: 54  RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113

Query: 195 SLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQI 251
           S++  +++             VA  L +LH    + I HRD+K  NIL     +    +I
Sbjct: 114 SVV--VQD-------------VASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKI 155

Query: 252 CDFGLAKWLPEQWTHHTISKVE-----GTFGYLAPEFLMHGIV-----DEKTDVFAFGVL 301
           CDF L   +        IS  E     G+  Y+APE +          D++ D+++ GV+
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

Query: 302 L 302
           L
Sbjct: 216 L 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 50/224 (22%)

Query: 99  IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSE 157
            +  Y+L         +  +G+G ++   K   + + Q  A+K +++     + A+   E
Sbjct: 6   FYQHYDLDLK------DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKE 55

Query: 158 LGIMAHVD-HPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMK 201
           +  +   + HPN  KL   +  +    +V+EL   G L              AS +  M+
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI--MR 113

Query: 202 EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAK 258
           +             +   + ++H+     ++HRD+K  N+L T   ++ E +I DFG A+
Sbjct: 114 K-------------LVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157

Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
             P    +  +     T  Y APE L     DE  D+++ GV+L
Sbjct: 158 LKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 47/243 (19%), Positives = 82/243 (33%), Gaps = 40/243 (16%)

Query: 75  SMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-N 133
           +            +          +   Y+L         + ++G G   +V +   R  
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLS--------KQVLGLGVNGKVLECFHRRT 53

Query: 134 GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLEL 187
           GQ  A+K L              E+         P+   +L      +  +  + I++E 
Sbjct: 54  GQKCALKLLYD------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107

Query: 188 SPNGSL-----ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL 242
              G L             E+    I   I   +     +LH      I HRD+K  N+L
Sbjct: 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ----FLHS---HNIAHRDVKPENLL 160

Query: 243 LT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFG 299
            T   +D   ++ DFG AK   +      +     T  Y+APE L     D+  D+++ G
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216

Query: 300 VLL 302
           V++
Sbjct: 217 VIM 219

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.3 bits (238), Expect = 5e-22
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 104 ELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF----LSEL 158
           +++S    +   + +G+G +A VYK R     Q+VAIK++  G   E         L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 159 GIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA 217
            ++  + HPN   LL  +G +  + +V +      L  ++      L         L   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 218 EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEG 274
           +GL YLH   Q  I+HRD+K  N+LL E+   ++ DFGLAK        +TH  +     
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----- 174

Query: 275 TFGYLAPEFLMH------GIVDEKTDVFAFGVLLLELVTGR 309
           T  Y APE L        G+     D++A G +L EL+   
Sbjct: 175 TRWYRAPELLFGARMYGVGV-----DMWAVGCILAELLLRV 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 6e-22
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 22/211 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R    G++ A+K L +     I         L+E  +++ 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSL 245

Query: 164 V---DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           V   D P    +   +     +  +L+L   G L   L       +  +R+  A  +  G
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILG 304

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           L ++H    R +++RD+K ANILL E    +I D GLA    ++  H   + V GT GY+
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-GTHGYM 357

Query: 280 APEFLMHGIVDEKT-DVFAFGVLLLELVTGR 309
           APE L  G+  + + D F+ G +L +L+ G 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.8 bits (234), Expect = 6e-22
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 21/209 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV         + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 170 AKLLGYG-IEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRY--KIALGVAEGLL 221
            K   YG    G      LE    G L   +    GM E      R+  ++  GV     
Sbjct: 68  VKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAGVV---- 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YLH      I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 282 EFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           E L       E  DV++ G++L  ++ G 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 56/220 (25%), Positives = 85/220 (38%), Gaps = 56/220 (25%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIA----DFLSELGIMAH 163
           T+ +  +  IG G Y+   +   +      A+K         II     D   E+ I+  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---------IIDKSKRDPTEEIEILLR 71

Query: 164 -VDHPNTAKLLG-YGIEGGMHIVLELSPNGSL--------------ASLLYGMKEKLKWG 207
              HPN   L   Y     +++V EL   G L              AS +  +       
Sbjct: 72  YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--LFT----- 124

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP-QICDFGLAKWL-PE 262
                   + + + YLH    + ++HRD+K +NIL      + E  +ICDFG AK L  E
Sbjct: 125 --------ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
                T      T  ++APE L     D   D+++ GVLL
Sbjct: 174 NGLLMTPC---YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 43/234 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGTADEIIADFLS------- 156
           N ++ ++ IGKG Y  V       +    A+K     +L R                   
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 157 -------------ELGIMAHVDHPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLY-- 198
                        E+ I+  +DHPN  KL   L    E  +++V EL   G +  +    
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 199 GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            + E         +  G+     YLH    ++IIHRDIK +N+L+ ED   +I DFG++ 
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 259 WLPEQWTHHTISKVEGTFGYLAPEFL--MHGIVD-EKTDVFAFGVLLLELVTGR 309
               + +   +S   GT  ++APE L     I   +  DV+A GV L   V G+
Sbjct: 186 EF--KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 21/209 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           ++     +G+G Y EV         + VA+K +    A +   +   E+ I   ++H N 
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 170 AKLLGYG-IEGGMHI--VLELSPNGSLASLLY---GMKEKLKWGIRY--KIALGVAEGLL 221
            K   YG    G      LE    G L   +    GM E      R+  ++  GV     
Sbjct: 68  VKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAGVV---- 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           YLH      I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+AP
Sbjct: 120 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 282 EFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           E L       E  DV++ G++L  ++ G 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 53/220 (24%), Positives = 84/220 (38%), Gaps = 26/220 (11%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF----LSELGIM 161
            AT+ +     IG G Y  VYK R   +G  VA+K +                + E+ ++
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 162 ---AHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYK 211
                 +HPN  +L+          E  + +V E      L + L       L       
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTHHTI 269
           +      GL +LH      I+HRD+K  NIL+T     ++ DFGLA+        T   +
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV 181

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
                T  Y APE L+        D+++ G +  E+   +
Sbjct: 182 -----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 34/235 (14%)

Query: 98  KIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---II 151
           K +   E         +E L  IG+G + EV+K R  + GQ VA+K++      E   I 
Sbjct: 3   KQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 152 ADFLSELGIMAHVDHPNTAKLLG---------YGIEGGMHIVLELSPNGSLASLLYGMKE 202
           A  L E+ I+  + H N   L+             +G +++V +   +  LA LL  +  
Sbjct: 63  A--LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV 119

Query: 203 KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA----- 257
           K       ++   +  GL Y+H   + +I+HRD+KAAN+L+T D   ++ DFGLA     
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 258 --KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
                P ++T+  +     T  Y  PE L+         D++  G ++ E+ T  
Sbjct: 177 AKNSQPNRYTNRVV-----TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 53/243 (21%), Positives = 94/243 (38%), Gaps = 28/243 (11%)

Query: 83  PRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKR 141
           PR   +   +     K+    E +   + +    L+G GG+  VY G  + +   VAIK 
Sbjct: 16  PRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH 75

Query: 142 LTRGTADEIIADFLS-----ELGIMAHVDH--PNTAKLLGYGIEGGMHIVLEL---SPNG 191
           + +    +            E+ ++  V        +LL +  E     VL L    P  
Sbjct: 76  VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQ 134

Query: 192 SLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDF 247
            L   +     ++E+L     +++   V     + H      ++HRDIK  NIL+     
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVR----HCH---NCGVLHRDIKDENILIDLNRG 187

Query: 248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELV 306
           E ++ DFG    L +          +GT  Y  PE++ +         V++ G+LL ++V
Sbjct: 188 ELKLIDFGSGALLKDTVYTDF----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

Query: 307 TGR 309
            G 
Sbjct: 244 CGD 246

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.2 bits (230), Expect = 3e-21
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE---IIADFLSELGIMA 162
           Q     +     +G+G Y  VYK +   G++VA+KR+     DE     A  + E+ ++ 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLK 74

Query: 163 HVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL 221
            + HPN   L+     E  + +V E      L  +L   K  L+          +  G+ 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGY 278
           + H   Q RI+HRD+K  N+L+  D   ++ DFGLA+        +TH  +     T  Y
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-----TLWY 185

Query: 279 LAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
            AP+ LM         D+++ G +  E++TG+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 26/212 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADF-LSELGIMAHVDHP 167
             +     IG+G Y  V+K R    GQ+VAIK+      D +I    L E+ ++  + HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 168 NTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   LL  +  +  +H+V E   + ++   L   +  +   +   I     + + + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAPEF 283
            +   IHRD+K  NIL+T+    ++CDFG A+ L    + +          T  Y +PE 
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-----TRWYRSPEL 173

Query: 284 LMH------GIVDEKTDVFAFGVLLLELVTGR 309
           L+        +     DV+A G +  EL++G 
Sbjct: 174 LVGDTQYGPPV-----DVWAIGCVFAELLSGV 200

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.0 bits (227), Expect = 7e-21
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVD 165
             +     IG+G Y  V+K +     ++VA+KR+     DE     A  L E+ ++  + 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELK 59

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N  +L      +  + +V E      L          L   I       + +GL + H
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTISKVEGTFGYLAP 281
               R ++HRD+K  N+L+  + E ++ +FGLA+   +P   ++   +     T  Y  P
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-----TLWYRPP 170

Query: 282 EFLMHGIV-DEKTDVFAFGVLLLELVTGRRAL 312
           + L    +     D+++ G +  EL    R L
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F F  ++G+G ++ V   R     +  AIK L +     II +        E  +M+ 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK---RHIIKENKVPYVTRERDVMSR 86

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           +DHP   KL   +  +  ++  L  + NG L   +  +    +   R+  A  +   L Y
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEY 145

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH    + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGR 309
            L      + +D++A G ++ +LV G 
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGL 229

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 30/214 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVD 165
             +    L+G+G Y  V K R    G++VAIK+      D+    IA  + E+ ++  + 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLR 82

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           H N   LL     +   ++V E   + ++   L      L + +  K    +  G+ + H
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAP 281
                 IIHRDIK  NIL+++    ++CDFG A+ L    E +          T  Y AP
Sbjct: 142 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-----TRWYRAP 193

Query: 282 EFLMH------GIVDEKTDVFAFGVLLLELVTGR 309
           E L+        +     DV+A G L+ E+  G 
Sbjct: 194 ELLVGDVKYGKAV-----DVWAIGCLVTEMFMGE 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 52/240 (21%), Positives = 104/240 (43%), Gaps = 33/240 (13%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG 145
           ++      + +    + +++    +F    +IG+G + EV   +L+   ++ A+K L + 
Sbjct: 55  YLEWAKPFTSK----VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK- 109

Query: 146 TADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYG 199
              E++       F  E  ++ + D      L   +  +  +++V++    G L +LL  
Sbjct: 110 --WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167

Query: 200 MKEKL--KWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
            +++L  +    Y     +AE    +  +H   Q   +HRDIK  NIL+  +   ++ DF
Sbjct: 168 FEDRLPEEMARFY-----LAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF 219

Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT-----DVFAFGVLLLELVTGR 309
           G    L E  T  +   V GT  Y++PE L      +       D ++ GV + E++ G 
Sbjct: 220 GSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 28/216 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS----ELGIMAHVD 165
            +   +L+G+G Y +V +          A+K L +     I  +  +    E+ ++  + 
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLR 64

Query: 166 HPNTAKL---LGYGIEGGMHIVLELSPNGSLASLLYGMKEKLK--WGIRY--KIALGVAE 218
           H N  +L   L    +  M++V+E    G    L    +++        Y  ++  G+  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE- 123

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
              YLH    + I+H+DIK  N+LLT     +I   G+A+ L       T    +G+  +
Sbjct: 124 ---YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 279 LAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGR 309
             PE         G    K D+++ GV L  + TG 
Sbjct: 178 QPPEIANGLDTFSG---FKVDIWSAGVTLYNITTGL 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 53/234 (22%), Positives = 90/234 (38%), Gaps = 37/234 (15%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK-----RLTRGT 146
            +  +   + Y L           L+GKGG+  V+ G  L +   VAIK     R+   +
Sbjct: 23  GKDREAFEAEYRL---------GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS 73

Query: 147 ADEIIADFLSELGIMAHVD----HPNTAKLLG-YGIEGGMHIVLEL-SPNGSLASLLYG- 199
                     E+ ++  V     HP   +LL  +  + G  +VLE   P   L   +   
Sbjct: 74  PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK 133

Query: 200 --MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGL 256
             + E        ++   +     + H    R ++HRDIK  NIL+       ++ DFG 
Sbjct: 134 GPLGEGPSRCFFGQVVAAIQ----HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGS 186

Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
              L ++         +GT  Y  PE++           V++ G+LL ++V G 
Sbjct: 187 GALLHDEPYTDF----DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.1 bits (222), Expect = 3e-20
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE---IIADFLSELGIMAHVDH 166
             +     IG+G Y  VYK +   G+  A+K++     DE        + E+ I+  + H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKH 59

Query: 167 PNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
            N  KL      +  + +V E      L  LL   +  L+        L +  G+ Y H 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LP-EQWTHHTISKVEGTFGYLAPE 282
              RR++HRD+K  N+L+  + E +I DFGLA+   +P  ++TH  +     T  Y AP+
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAPD 170

Query: 283 FLMHGIV-DEKTDVFAFGVLLLELVTGR 309
            LM         D+++ G +  E+V G 
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS-ELGIMAHVDHPN 168
           N+     IGKG +A+V   R +  G+ VAIK + +   +      L  E+ IM  ++HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 169 TAKLLGYGI---EGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY 222
             KL  + +   E  +++++E +  G +   L     MKEK       +I   V     Y
Sbjct: 76  IVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----Y 129

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
            H   Q+RI+HRD+KA N+LL  D   +I DFG +                G   Y APE
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE 183

Query: 283 FLMHGIVD-EKTDVFAFGVLLLELVTGR 309
                  D  + DV++ GV+L  LV+G 
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 26/214 (12%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTR-------GTADEIIADFLSELGIMA 162
            +S  + +G G +  V+        + V +K + +          D  +     E+ I++
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 163 HVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLL-Y-----GMKEKLKWGIRYKIALGV 216
            V+H N  K+L    E      L +  +GS   L  +      + E L   I  ++   V
Sbjct: 85  RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
                YL     + IIHRDIK  NI++ EDF  ++ DFG A +L      +T     GT 
Sbjct: 144 G----YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193

Query: 277 GYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
            Y APE LM       + ++++ GV L  LV   
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 48/233 (20%), Positives = 81/233 (34%), Gaps = 61/233 (26%)

Query: 96  PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF 154
              I   Y++           ++G G   +V +   +   +  A+K L            
Sbjct: 56  KNAIIDDYKV--------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKA 101

Query: 155 LSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLELSPNGSL--------------- 193
             E+ +       P+  +++      Y     + IV+E    G L               
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161

Query: 194 -ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEP 249
            AS +  MK              + E + YLH      I HRD+K  N+L T    +   
Sbjct: 162 EASEI--MKS-------------IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL 203

Query: 250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLL 302
           ++ DFG AK      +  T      T  Y+APE L     D+  D+++ GV++
Sbjct: 204 KLTDFGFAKETTSHNSLTTPC---YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.8 bits (223), Expect = 6e-20
 Identities = 57/251 (22%), Positives = 102/251 (40%), Gaps = 53/251 (21%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG 145
           F+   +    +    L E++   ++F    +IG+G ++EV   +++  GQ+ A+K + + 
Sbjct: 42  FLQWAEPIVVR----LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK- 96

Query: 146 TADEIIAD-----FLSELGIMAHVDHP----------NTAKLLGYGIEGGMHIVLELSPN 190
              +++       F  E  ++ + D            +   L         ++V+E    
Sbjct: 97  --WDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL---------YLVMEYYVG 145

Query: 191 GSLASLL--YGMKEKLKWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTE 245
           G L +LL  +G +   +    Y     +AE    +  +H   +   +HRDIK  NILL  
Sbjct: 146 GDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH---RLGYVHRDIKPDNILLDR 197

Query: 246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-HGIVDEKT------DVFAF 298
               ++ DFG    L    T  ++  V GT  YL+PE L   G            D +A 
Sbjct: 198 CGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256

Query: 299 GVLLLELVTGR 309
           GV   E+  G+
Sbjct: 257 GVFAYEMFYGQ 267

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 30/237 (12%)

Query: 87  FVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG 145
           F++ Y     +    + +L+    ++    +IG+G + EV   R +   ++ A+K L++ 
Sbjct: 50  FLSRYKDTINK----IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK- 104

Query: 146 TADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYG 199
              E+I       F  E  IMA  + P   +L   +  +  +++V+E  P G L +L+  
Sbjct: 105 --FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN 162

Query: 200 MKEKLKWGIRYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL 256
                KW   Y      AE    L  +H       IHRD+K  N+LL +    ++ DFG 
Sbjct: 163 YDVPEKWARFY-----TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 214

Query: 257 AKWLPEQWTHHTISKVEGTFGYLAPEFLM----HGIVDEKTDVFAFGVLLLELVTGR 309
              + ++      + V GT  Y++PE L      G    + D ++ GV L E++ G 
Sbjct: 215 CMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR--LRNGQLVAIKRLTRGTAD---------EIIADFL 155
            A   +     IG+G Y +V+K R     G+ VA+KR+   T +         E+     
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV----- 62

Query: 156 SELGIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEK-LKWGI 208
           + L  +   +HPN  +L           E  + +V E      L + L  + E  +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQWTH 266
              +   +  GL +LH     R++HRD+K  NIL+T   + ++ DFGLA+        T 
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
             +     T  Y APE L+        D+++ G +  E+   +
Sbjct: 179 VVV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 53/228 (23%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
             +++   +IG G +  VY+ +L  +G+LVAIK++ +    +       EL IM  +DH 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHC 107

Query: 168 NTAKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG----- 215
           N  +L  +    G       +++VL+             + E +    R+          
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDY------------VPETVYRVARHYSRAKQTLPV 155

Query: 216 ---------VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP-QICDFGLAKWL--PEQ 263
                    +   L Y+H      I HRDIK  N+LL  D    ++CDFG AK L   E 
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
              +  S+      Y APE L+ G  D  +  DV++ G +L EL+ G+
Sbjct: 213 NVSYICSRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 52/230 (22%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           +     ++   +IG G +  V++ +L     VAIK++ +    +       EL IM  V 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVK 90

Query: 166 HPNTAKLLGY-------GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG--- 215
           HPN   L  +         E  +++VLE             + E +    R+   L    
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEY------------VPETVYRASRHYAKLKQTM 138

Query: 216 -----------VAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWL--P 261
                      +   L Y+H      I HRDIK  N+LL       ++ DFG AK L   
Sbjct: 139 PMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195

Query: 262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
           E    +  S+      Y APE L+ G  +  T  D+++ G ++ EL+ G+
Sbjct: 196 EPNVSYICSRY-----YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 57/239 (23%), Positives = 87/239 (36%), Gaps = 35/239 (14%)

Query: 82  MPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK 140
           M R                  Y+             IG G +      R     +LVA+K
Sbjct: 1   MDRAPVTTGPLDMPIMHDSDRYDF---------VKDIGSGNFGVARLMRDKLTKELVAVK 51

Query: 141 RLTRGTADEIIADFLS-ELGIMAHVDHPNTAKLLGYG-IEGGMHI--VLELSPNGSLASL 196
            + RG     I + +  E+     + HPN  +      I    H+  ++E +  G L   
Sbjct: 52  YIERG---AAIDENVQREIINHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYER 106

Query: 197 LY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ--I 251
           +       E        ++  GV+    Y H     +I HRD+K  N LL     P+  I
Sbjct: 107 ICNAGRFSEDEARFFFQQLLSGVS----YCH---SMQICHRDLKLENTLLDGSPAPRLKI 159

Query: 252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           CDFG +K         +     GT  Y+APE L+    D +  DV++ GV L  ++ G 
Sbjct: 160 CDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 15/206 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
             +   + +G+G YA VYKG+ +    LVA+K +     +      + E+ ++  + H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 169 TAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L      E  + +V E      L   L      +           +  GL Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWL---PEQWTHHTISKVEGTFGYLAPEFL 284
           +++++HRD+K  N+L+ E  E ++ DFGLA+      + + +  +     T  Y  P+ L
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-----TLWYRPPDIL 172

Query: 285 MHGIV-DEKTDVFAFGVLLLELVTGR 309
           +       + D++  G +  E+ TGR
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 56/246 (22%), Positives = 105/246 (42%), Gaps = 29/246 (11%)

Query: 72  RSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRL 131
              S++E +   +  F+  +++ S              + F     +G G +  V   + 
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTA--------QLDQFDRIKTLGTGSFGRVMLVKH 62

Query: 132 R-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAHVDHPNTAKLLG-YGIEGGMHIV 184
           + +G   A+K L +    +++        L+E  I+  V+ P   KL   +     +++V
Sbjct: 63  KESGNHYAMKILDK---QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT 244
           +E    G + S L  +    +   R+  A  +     YLH      +I+RD+K  N+L+ 
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLHS---LDLIYRDLKPENLLID 175

Query: 245 EDFEPQICDFGLAKWLPEQ-WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           +    Q+ DFG AK +  + WT      + GT   LAPE ++    ++  D +A GVL+ 
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT------LCGTPEALAPEIILSKGYNKAVDWWALGVLIY 229

Query: 304 ELVTGR 309
           E+  G 
Sbjct: 230 EMAAGY 235

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 28/233 (12%)

Query: 93  SQSPQKIFSLYELQSATNNFSFENL--IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE 149
                   S+    SAT+   +  +  +G+G Y EVYK       + VAIKR+     +E
Sbjct: 15  QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE 74

Query: 150 ---IIADFLSELGIMAHVDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
                A  + E+ ++  + H N  +L         +H++ E + N  L   +    +   
Sbjct: 75  GVPGTA--IREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSM 131

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKW- 259
             I+      +  G+ + H    RR +HRD+K  N+LL+     +     I DFGLA+  
Sbjct: 132 RVIK-SFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187

Query: 260 -LPEQ-WTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
            +P + +TH  I     T  Y  PE L+         D+++   +  E++   
Sbjct: 188 GIPIRQFTHEII-----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 27/223 (12%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     +G G Y  V      R+G+ VAIK+L+R    EI A     EL ++ H+ H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYKIALGVAE 218
            N   LL               ++V+          L   M  K     I+Y +   + +
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGLKFSEEKIQY-LVYQMLK 137

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
           GL Y+H      ++HRD+K  N+ + ED E +I DFGLA+    + T + +     T  Y
Sbjct: 138 GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-----TRWY 189

Query: 279 LAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
            APE ++     ++  D+++ G ++ E++TG+   +  DY  Q
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 52/239 (21%), Positives = 92/239 (38%), Gaps = 52/239 (21%)

Query: 104 ELQSATNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELG 159
           E +   + F +E   +G+G Y  VYK + +   + +  A+K++       I      E+ 
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIA 70

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG----------SLASLLYGMKEKLKWGIR 209
           ++  + HPN   L          + L  +              L  ++   +        
Sbjct: 71  LLRELKHPNVISLQK--------VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKP 122

Query: 210 YKIALGVA--------EGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLA 257
            ++  G+         +G+ YLH      ++HRD+K ANIL+  +   +    I D G A
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

Query: 258 K--WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT-----DVFAFGVLLLELVTGR 309
           +    P +        V  TF Y APE L+ G    +      D++A G +  EL+T  
Sbjct: 180 RLFNSPLKPLADLDPVVV-TFWYRAPELLL-G---ARHYTKAIDIWAIGCIFAELLTSE 233

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 20/214 (9%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD 165
           S+++ F     +G G YA VYKG     G  VA+K +   + +   +  + E+ +M  + 
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 166 HPNTAKLLG-YGIEGGMHIVLELSPNGSLASLL-----YGMKEKLKWGIRYKIALGVAEG 219
           H N  +L      E  + +V E   N  L   +           L+  +       + +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW--LPEQ-WTHHTISKVEGTF 276
           L + H   + +I+HRD+K  N+L+ +  + ++ DFGLA+   +P   ++   +     T 
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-----TL 172

Query: 277 GYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
            Y AP+ LM         D+++ G +L E++TG+
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 36/207 (17%)

Query: 69  SIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYK 128
             + + S  +     R    +S  + S  +  S +++    + +   +LIG G Y  V +
Sbjct: 15  GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCE 71

Query: 129 GR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL------GYGIEGG 180
                  ++VAIK++ R   D I     L E+ I+  ++H +  K+L             
Sbjct: 72  AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131

Query: 181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVA----------EGLLYLHEGCQRR 230
           +++VLE+                 K   R  + L              G+ Y+H      
Sbjct: 132 LYVVLEI------------ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---G 176

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLA 257
           I+HRD+K AN L+ +D   ++CDFGLA
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 28/212 (13%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS-----ELGIMAHV 164
           ++   + +G G + +V  G     G  VA+K L R    +I +  +      E+  +   
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR---QKIRSLDVVGKIKREIQNLKLF 68

Query: 165 DHPNTAKLLGYGI---EGGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
            HP+  KL  Y +        +V+E    G L   +     ++E     +  +I   V  
Sbjct: 69  RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD- 125

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
              Y H   +  ++HRD+K  N+LL      +I DFGL+  + +     T     G+  Y
Sbjct: 126 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNY 176

Query: 279 LAPEFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
            APE +   +    + D+++ GV+L  L+ G 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 42/280 (15%)

Query: 64  YPLKLSIRRSSSMREGIDMPRNL-FVNSYDSQSPQKI---FSLYELQSAT----NNFSFE 115
           Y  + ++    +  +G D   ++ ++  + + S  K+   F   E+  +T      +   
Sbjct: 8   YCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNL 67

Query: 116 NLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLL 173
             IG G    V         + VAIK+L+R   ++  A     EL +M  V+H N   LL
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 174 -------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALGVAEGLLY 222
                         +++V+EL      A+L   ++ +L       + Y++  G    + +
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG----IKH 179

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ--WTHHTISKVEGTFGYLA 280
           LH      IIHRD+K +NI++  D   +I DFGLA+        T + +     T  Y A
Sbjct: 180 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----TRYYRA 231

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
           PE ++     E  D+++ G ++ E+V  +      DY  Q
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     IG G    V         + VAIK+L+R   ++  A     EL +M  V+H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG----IRYKIALG 215
            N   LL              ++IV+EL      A+L   ++ +L       + Y++   
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQML-- 137

Query: 216 VAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ--WTHHTISKVE 273
              G+ +LH      IIHRD+K +NI++  D   +I DFGLA+        T + +    
Sbjct: 138 --CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---- 188

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            T  Y APE ++     E  D+++ G ++ E++ G 
Sbjct: 189 -TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 59/237 (24%)

Query: 106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF------LSEL 158
           +   + F  E + G+G +  V  G+ +  G  VAIK+        +I D       L  +
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--------VIQDPRFRNRELQIM 70

Query: 159 GIMAHVDHPNTAKLLGYGIEGG--------MHIVLELSPNGSLASLLYGMKEKLKWGIRY 210
             +A + HPN  +L  Y    G        +++V+E             + + L    R 
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY------------VPDTLHRCCRN 118

Query: 211 KIALG--------------VAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFG 255
                              +   +  LH      + HRDIK  N+L+   D   ++CDFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 256 LAKWL-PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKT--DVFAFGVLLLELVTGR 309
            AK L P +     I     +  Y APE L+ G     T  D+++ G +  E++ G 
Sbjct: 178 SAKKLSPSEPNVAYIC----SRYYRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 56/232 (24%), Positives = 94/232 (40%), Gaps = 33/232 (14%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIAD-F---------LSEL 158
            + ++ +  I  G Y  V  G    G  VAIKR+    +D    +           L E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 159 GIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWG-IRYK 211
            ++ H  HPN   L              +++V EL     LA +++  +  +    I+Y 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY- 138

Query: 212 IALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE--QWTHHTI 269
               +  GL  LHE     ++HRD+   NILL ++ +  ICDF LA+        TH+  
Sbjct: 139 FMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195

Query: 270 SKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
                   Y APE +M      +  D+++ G ++ E+   +   R   +  Q
Sbjct: 196 -----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N F +  L+GKG + +V   + +  G+  A+K L +   + I+A       L+E  ++ +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK---EVIVAKDEVAHTLTENRVLQN 204

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
             HP    L   +     +  V+E +  G L   L   +   +   R+  A  +   L Y
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDY 263

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           LH   ++ +++RD+K  N++L +D   +I DFGL K         T+    GT  YLAPE
Sbjct: 264 LHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPE 319

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGR 309
            L         D +  GV++ E++ GR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 50/235 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +     +G G Y  V      R G  VAIK+L R    E+ A     EL ++ H+ H
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 167 PNTAKLL-------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR---------- 209
            N   LL               ++V+              M   L   ++          
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPF------------MGTDLGKLMKHEKLGEDRIQ 131

Query: 210 ---YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH 266
              Y++     +GL Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T 
Sbjct: 132 FLVYQML----KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184

Query: 267 HTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR---RALDYSQQ 317
           + +     T  Y APE ++      +  D+++ G ++ E++TG+   +  D+  Q
Sbjct: 185 YVV-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 41/218 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F     +G G +  V+  R R NG+  A+K L +   + ++          E  +++ 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK---EIVVRLKQVEHTNDERLMLSI 62

Query: 164 VDHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALG---VAE- 218
           V HP   ++ G +     + ++++    G L SLL   K +     R+   +     AE 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQ-----RFPNPVAKFYAAEV 115

Query: 219 --GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ-WTHHTISKVEGT 275
              L YLH    + II+RD+K  NILL ++   +I DFG AK++P+  +T      + GT
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------LCGT 166

Query: 276 FGYLAPEFLM---HGIVDEKT-DVFAFGVLLLELVTGR 309
             Y+APE +    +     K+ D ++FG+L+ E++ G 
Sbjct: 167 PDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGY 200

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 63/247 (25%), Positives = 108/247 (43%), Gaps = 34/247 (13%)

Query: 91  YDSQSPQKIFSLYELQSA----TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG 145
           +     +  F   EL          +   + +G G Y  V      + G  VA+K+L+R 
Sbjct: 6   HHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65

Query: 146 TADEIIAD-FLSELGIMAHVDHPNTAKLL-------GYGIEGGMHIVLELSPNGSLASLL 197
               I A     EL ++ H+ H N   LL              +++V  L     L +++
Sbjct: 66  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV 124

Query: 198 YGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF 254
              K   + +++ + Y+I      GL Y+H      IIHRD+K +N+ + ED E +I DF
Sbjct: 125 KCQKLTDDHVQF-LIYQIL----RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176

Query: 255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR---R 310
           GLA+   ++ T +       T  Y APE ++     ++  D+++ G ++ EL+TGR    
Sbjct: 177 GLARHTADEMTGYVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

Query: 311 ALDYSQQ 317
             D+  Q
Sbjct: 232 GTDHIDQ 238

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 47/167 (28%), Positives = 69/167 (41%), Gaps = 33/167 (19%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
            +N+  ++LIG+G Y  VY        + VAIK++ R   D I     L E+ I+  +  
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 167 PNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE-- 218
               +L              ++IVLE+                LK   +  I L      
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEI------------ADSDLKKLFKTPIFLTEEHIK 132

Query: 219 --------GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA 257
                   G  ++HE     IIHRD+K AN LL +D   ++CDFGLA
Sbjct: 133 TILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 3/97 (3%)

Query: 211 KIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTIS 270
             +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   +    
Sbjct: 197 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT 307
                  ++APE +   +   ++DV++FGVLL E+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 9/97 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 164 VD-HPNTAKLLGY--GIEGGMHIVLELSPNGSLASLL 197
           +  H N   LLG      G + +++E    G+L++ L
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 36/217 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           N+F +  L+GKG + +V   R +  G+  A+K L +   + IIA       ++E  ++ +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK---EVIIAKDEVAHTVTESRVLQN 61

Query: 164 VDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKI- 212
             HP             +L           V+E +  G L   L   +E++    R +  
Sbjct: 62  TRHPFLTALKYAFQTHDRL---------CFVMEYANGGELFFHLS--RERVFTEERARFY 110

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +   L YLH    R +++RDIK  N++L +D   +I DFGL K         T+   
Sbjct: 111 GAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            GT  YLAPE L         D +  GV++ E++ GR
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 67/255 (26%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADF---LSELGI 160
           L++++  +S    +G G +  V +     +G+  A+K+        ++ D      EL I
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDI 53

Query: 161 MAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG--------------------- 199
           M  +DH N  KL+ Y    G        P      L                        
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 200 ------MKEKLKWGIRYKIALG--------------VAEGLLYLHEGCQRRIIHRDIKAA 239
                 + + L   ++  I  G              +   + ++H      I HRDIK  
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQ 170

Query: 240 NILL-TEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPEFLMHGIVD--EKTD 294
           N+L+ ++D   ++CDFG AK L   E    +  S+      Y APE LM G  +     D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSID 224

Query: 295 VFAFGVLLLELVTGR 309
           +++ G +  EL+ G+
Sbjct: 225 LWSIGCVFGELILGK 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 46/232 (19%), Positives = 93/232 (40%), Gaps = 49/232 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DH 166
            +++     +G+G Y+EV++   + N + V +K L      +I      E+ I+ ++   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGG 90

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLL--YGMKEKLKWGIR-----------YKIA 213
           PN   L          IV    P     +L+  +      K   +           Y+I 
Sbjct: 91  PNIITLA--------DIVK--DPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL 140

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWL--PEQWTHHTIS 270
               + L Y H      I+HRD+K  N+++  E  + ++ D+GLA++    +++     S
Sbjct: 141 ----KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193

Query: 271 KVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRAL----DYSQQ 317
           +      +  PE L+   + D   D+++ G +L  ++  +       D   Q
Sbjct: 194 RY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 240

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLS----ELGIMAHVD 165
           ++   + +G G + +V  G+    G  VA+K L R        D +     E+  +    
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFR 74

Query: 166 HPNTAKLLGYGIEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGL 220
           HP+  KL    I     I  V+E    G L   +     + EK    +  +I  GV    
Sbjct: 75  HPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD--- 130

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            Y H   +  ++HRD+K  N+LL      +I DFGL+  + +     T     G+  Y A
Sbjct: 131 -YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAA 183

Query: 281 PEFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           PE +   +    + D+++ GV+L  L+ G 
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 37/188 (19%), Positives = 61/188 (32%), Gaps = 36/188 (19%)

Query: 86  LFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTR 144
             V S        I   Y++           ++G G   +V +   +   +  A+K L  
Sbjct: 2   PHVKSGLQIKKNAIIDDYKV--------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD 53

Query: 145 GTADEIIADFLSELGIMAHV-DHPNTAKLLG-----YGIEGGMHIVLELSPNGSL----- 193
                       E+ +       P+  +++      Y     + IV+E    G L     
Sbjct: 54  ------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 107

Query: 194 ASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQ 250
                   E+    I   I   +     YLH      I HRD+K  N+L T    +   +
Sbjct: 108 DRGDQAFTEREASEIMKSIGEAIQ----YLHS---INIAHRDVKPENLLYTSKRPNAILK 160

Query: 251 ICDFGLAK 258
           + DFG AK
Sbjct: 161 LTDFGFAK 168

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE--IIADFLSELGIMAHVDHP 167
            +     +G+G + +V      +  Q VA+K ++R    +  +      E+  +  + HP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 168 NTAKLLGYG-IEGGMHI--VLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLL 221
           +  KL  Y  I     I  V+E +  G L   +     M E        +I   +     
Sbjct: 70  HIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE---- 122

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP 281
           Y H   + +I+HRD+K  N+LL ++   +I DFGL+  + +     T     G+  Y AP
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAP 176

Query: 282 EFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           E +   +    + DV++ G++L  ++ GR
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 110 NNFSFENLIGKGGYAEVY----KGRLRNGQLVAIKRLTRGTADEIIAD----FLSELGIM 161
           + F    ++G+G + +V+           QL A+K L +     +          E  I+
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK---ATLKVRDRVRTKMERDIL 80

Query: 162 AHVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKL---KWGI 208
             V+HP             KL         +++L+    G L + L   KE +   +   
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKL---------YLILDFLRGGDLFTRLS--KEVMFTEEDVK 129

Query: 209 RYKIALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQW 264
            Y     +AE    L +LH      II+RD+K  NILL E+   ++ DFGL+K  +  + 
Sbjct: 130 FY-----LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181

Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
             ++     GT  Y+APE +      +  D ++FGVL+ E++TG 
Sbjct: 182 KAYSFC---GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 52/227 (22%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADF------LSELG 159
             F    ++GKGGY +V++ R       G++ A+K L +     I+ +        +E  
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK---AMIVRNAKDTAHTKAERN 73

Query: 160 IMAHVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR 209
           I+  V HP             KL         +++LE    G L   L   +E       
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKL---------YLILEYLSGGELFMQLE--REG-----I 117

Query: 210 YKIALG---VAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPE 262
           +        +AE    L +LH+   + II+RD+K  NI+L      ++ DFGL K  + +
Sbjct: 118 FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174

Query: 263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
               HT     GT  Y+APE LM    +   D ++ G L+ +++TG 
Sbjct: 175 GTVTHTFC---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 42/221 (19%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEI-IADFLSELGIMA--HVDH 166
            +G G ++ V+  + + N   VA+K        T    DEI +   +++        +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 167 PNTAKLLG---YGIEGGMH--IVLE-LSPNGSLASLLYGMKEKLKWG------IRYKIAL 214
            +  KLL    +    G+H  +V E L  N      L  + +K +        ++ +I+ 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGEN------LLALIKKYEHRGIPLIYVK-QISK 138

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ------ICDFGLAKWLPEQWTHHT 268
            +  GL Y+H  C   IIH DIK  N+L+     P+      I D G A      W    
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEH 191

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            +    T  Y +PE L+        D+++   L+ EL+TG 
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 19/209 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F+F  ++GKG + +V     +   +L A+K L +   D +I D      + E  ++A 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRVLAL 397

Query: 164 V-DHPNTAKLLG-YGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGL 220
               P   +L   +     ++ V+E    G L   +  +   K    + Y  A  +A GL
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGL 455

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            +L     + II+RD+K  N++L  +   +I DFG+ K     W   T     GT  Y+A
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           PE + +    +  D +AFGVLL E++ G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 55/242 (22%), Positives = 97/242 (40%), Gaps = 53/242 (21%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
           +++F  ++L+G+G Y  V        G++VAIK++       + A   L E+ I+ H  H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKH 68

Query: 167 PNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIR----------- 209
            N   +        +     ++I+ EL            M+  L   I            
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQEL------------MQTDLHRVISTQMLSDDHIQY 116

Query: 210 --YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH 267
             Y+        +  LH      +IHRD+K +N+L+  + + ++CDFGLA+ + E    +
Sbjct: 117 FIYQTL----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 268 TISKVEGTFG--------YLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR---RALDYS 315
           +    + +          Y APE ++         DV++ G +L EL   R      DY 
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

Query: 316 QQ 317
            Q
Sbjct: 230 HQ 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 54/250 (21%), Positives = 101/250 (40%), Gaps = 50/250 (20%)

Query: 95  SPQKIF-SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIA 152
            P+ +   ++++      ++  + IG+G Y  V       N   VAIK+++     +   
Sbjct: 14  GPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYC 69

Query: 153 D-FLSELGIMAHVDHPNTAKLL------GYGIEGGMHIVLELSPNGSLASLLYGMKEKLK 205
              L E+ I+    H N   +              ++IV +L            M+  L 
Sbjct: 70  QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL------------METDLY 117

Query: 206 WGIR-------------YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC 252
             ++             Y+I      GL Y+H      ++HRD+K +N+LL    + +IC
Sbjct: 118 KLLKTQHLSNDHICYFLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKIC 170

Query: 253 DFGLAKWL-PEQWTHHTISKVEGTFGYLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR- 309
           DFGLA+   P+      +++   T  Y APE ++      +  D+++ G +L E+++ R 
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

Query: 310 --RALDYSQQ 317
                 Y  Q
Sbjct: 231 IFPGKHYLDQ 240

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 46/226 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMA 162
            NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 163 HVDHP-----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYK 211
           H+                 KL         H++L+    G L + L   + +     R+ 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKL---------HLILDYINGGELFTHLS--QRE-----RFT 157

Query: 212 IALG---VAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                  V E    L +LH+     II+RDIK  NILL  +    + DFGL+K      T
Sbjct: 158 EHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 214

Query: 266 HHTISKVEGTFGYLAPEFLMHGIV--DEKTDVFAFGVLLLELVTGR 309
                   GT  Y+AP+ +  G    D+  D ++ GVL+ EL+TG 
Sbjct: 215 ERAYDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
           +NF F  ++GKG + +V   R++  G L A+K L +   D I+ D      ++E  I++ 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK---DVILQDDDVECTMTEKRILSL 79

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
             +HP             +L           V+E    G L   +   +         Y 
Sbjct: 80  ARNHPFLTQLFCCFQTPDRL---------FFVMEFVNGGDLMFHIQKSRRFDEARARFY- 129

Query: 212 IALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
                AE    L++LH+   + II+RD+K  N+LL  +   ++ DFG+ K         T
Sbjct: 130 ----AAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVT 180

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            +   GT  Y+APE L   +     D +A GVLL E++ G 
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 45/222 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F+F  ++GKG + +V     +   +L A+K L +   D +I D      + E  ++A 
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKK---DVVIQDDDVECTMVEKRVLAL 76

Query: 164 VD-HP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
               P             +L         + V+E    G L   +  +   K    + Y 
Sbjct: 77  PGKPPFLTQLHSCFQTMDRL---------YFVMEYVNGGDLMYHIQQVGRFKEPHAVFY- 126

Query: 212 IALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHH 267
                AE   GL +L     + II+RD+K  N++L  +   +I DFG+ K  + +  T  
Sbjct: 127 ----AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK 179

Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           T     GT  Y+APE + +    +  D +AFGVLL E++ G+
Sbjct: 180 TFC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 45/222 (20%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F    +IG+G YA+V   RL+   ++ A+K + +   + +  D       +E  +   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKK---ELVNDDEDIDWVQTEKHVFEQ 65

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYK 211
             +HP            ++L           V+E    G L   +   ++   +    Y 
Sbjct: 66  ASNHPFLVGLHSCFQTESRL---------FFVIEYVNGGDLMFHMQRQRKLPEEHARFY- 115

Query: 212 IALGVAE---GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHH 267
                AE    L YLHE   R II+RD+K  N+LL  +   ++ D+G+ K  L    T  
Sbjct: 116 ----SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 168

Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           T     GT  Y+APE L         D +A GVL+ E++ GR
Sbjct: 169 TFC---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 53/267 (19%)

Query: 65  PLKLSIRRSSSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYA 124
           P   ++    +M  GI+      +N+ +S        L        +F    +IG+G YA
Sbjct: 15  PTTENLYFQGAMGSGIE-EEKEAMNTRESGKASSSLGL-------QDFDLLRVIGRGSYA 66

Query: 125 EVYKGRLRN-GQLVAIKRLTRGTADEIIAD-----FLSELGIMAHV-DHP---------- 167
           +V   RL+   ++ A++ + +   + +  D       +E  +     +HP          
Sbjct: 67  KVLLVRLKKTDRIYAMRVVKK---ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123

Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAE---GLLYL 223
             ++L           V+E    G L   +   ++   +    Y      AE    L YL
Sbjct: 124 TESRL---------FFVIEYVNGGDLMFHMQRQRKLPEEHARFY-----SAEISLALNYL 169

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWTHHTISKVEGTFGYLAPE 282
           HE   R II+RD+K  N+LL  +   ++ D+G+ K  L    T  T     GT  Y+APE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPE 223

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGR 309
            L         D +A GVL+ E++ GR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 41/220 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMAH 163
            +F    ++GKG + +V+    +   Q  AIK L +   D ++ D      + E  +++ 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK---DVVLMDDDVECTMVEKRVLSL 73

Query: 164 V-DHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI---R 209
             +HP              L           V+E    G L   +Y ++   K+ +    
Sbjct: 74  AWEHPFLTHMFCTFQTKENL---------FFVMEYLNGGDL---MYHIQSCHKFDLSRAT 121

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           +  A  +  GL +LH    + I++RD+K  NILL +D   +I DFG+ K           
Sbjct: 122 FYAA-EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKT 175

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           +   GT  Y+APE L+    +   D ++FGVLL E++ G+
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 60/224 (26%), Positives = 87/224 (38%), Gaps = 49/224 (21%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-----FLSELGIMA- 162
           ++F F  +IGKG + +V   R +      A+K L +     I+        +SE  ++  
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKKEEKHIMSERNVLLK 94

Query: 163 HVDHP----------NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGI---- 208
           +V HP             KL         + VL+    G L   L       +       
Sbjct: 95  NVKHPFLVGLHFSFQTADKL---------YFVLDYINGGELFYHLQ------RERCFLEP 139

Query: 209 --RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK-WLPEQWT 265
             R+  A  +A  L YLH      I++RD+K  NILL       + DFGL K  +    T
Sbjct: 140 RARFYAA-EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195

Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
             T     GT  YLAPE L     D   D +  G +L E++ G 
Sbjct: 196 TSTFC---GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 58/240 (24%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAH-VD 165
              +     +GKG Y  V+K    R G++VA+K++     +   A     E+ I+     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 166 HPNTAKLLGYGIEGGMH---IVLELSPNGSLASLLYGMKEKLKWGIR------------- 209
           H N   LL            +V +             M+  L   IR             
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDY------------METDLHAVIRANILEPVHKQYVV 115

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
           Y++       + YLH G    ++HRD+K +NILL  +   ++ DFGL++           
Sbjct: 116 YQLIKV----IKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168

Query: 270 SKVEGTFG-------------------YLAPEFLM-HGIVDEKTDVFAFGVLLLELVTGR 309
             +                        Y APE L+      +  D+++ G +L E++ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 51/230 (22%), Positives = 89/230 (38%), Gaps = 46/230 (20%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
            + +     +G GG   V+        + VAIK++     D       L E+ I+  +DH
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDH 67

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYG-----------MKEKLKWGIR------ 209
            N  K+          I+       +                  M+  L   +       
Sbjct: 68  DNIVKVF--------EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119

Query: 210 -------YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL-TEDFEPQICDFGLAKWLP 261
                  Y++      GL Y+H      ++HRD+K AN+ + TED   +I DFGLA+ + 
Sbjct: 120 EHARLFMYQLL----RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 262 EQWTHHTI-SKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGR 309
             ++H    S+   T  Y +P  L+      +  D++A G +  E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 1e-11
 Identities = 31/200 (15%), Positives = 49/200 (24%), Gaps = 52/200 (26%)

Query: 108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI-------IADFLSELGI 160
            T        IG+G + EV++    +   VAIK +     D +         + L E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 161 M---------AHVDHPNTAKLLGYGIEGG------------------------------- 180
                               L       G                               
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN 240
           + IVLE    G    L     +         I   +   L       +    HRD+   N
Sbjct: 137 LFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192

Query: 241 ILLTEDFEPQICDFGLAKWL 260
           +LL +    ++      K  
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 64/261 (24%), Positives = 100/261 (38%), Gaps = 66/261 (25%)

Query: 91  YDSQSPQKIFSLYELQSATNNFSFEN---------------------LIGKGGYAEVYKG 129
           +   + +K   +       NN  +++                     +IGKG + +V K 
Sbjct: 60  FLGLNAKKRQGM---TGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKA 116

Query: 130 R-LRNGQLVAIK------RLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH 182
              +  Q VA+K      R  R  A+EI    L  L      +  N   +L        H
Sbjct: 117 YDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNVIHMLENFTFRN-H 173

Query: 183 --IVLE-LSPNGSLASLLYGMKEKLKWG---------IRYKIALGVAEGLLYLHEGCQRR 230
             +  E LS N      LY   E +K           +R K A  + + L  LH   + R
Sbjct: 174 ICMTFELLSMN------LY---ELIKKNKFQGFSLPLVR-KFAHSILQCLDALH---KNR 220

Query: 231 IIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           IIH D+K  NILL +     I   DFG + +  +    +T   ++  F Y APE ++   
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTY--IQSRF-YRAPEVILGAR 275

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
                D+++ G +L EL+TG 
Sbjct: 276 YGMPIDMWSLGCILAELLTGY 296

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 57/256 (22%), Positives = 89/256 (34%), Gaps = 72/256 (28%)

Query: 118 IGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-----DHPNTA- 170
           +G G ++ V+    ++  + VA+K +         A    E+ ++  V     + PN   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPNREM 102

Query: 171 --KLLGY-GIEG--GMHIVLELSPNG-SLASLLYGMKEK-LKWGIRYKIALGVAEGLLYL 223
             +LL    I G  G HI +     G  L   +     + L      KI   V +GL YL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162

Query: 224 HEGCQRRIIHRDIKAANILLT--------------------------------------- 244
           H  C+  IIH DIK  NILL+                                       
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 245 ----------EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTD 294
                     E  + +I D G A W+ + +T   I     T  Y + E L+    +   D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-IQ----TRQYRSLEVLIGSGYNTPAD 275

Query: 295 VFAFGVLLLELVTGRR 310
           +++   +  EL TG  
Sbjct: 276 IWSTACMAFELATGDY 291

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 55/222 (24%), Positives = 83/222 (37%), Gaps = 40/222 (18%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEIIADFLSELGIM 161
            + +  ++LIGKG + +V K       + VAIK              E+    L  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV--RLLELMNKH 110

Query: 162 AHVDHPNTAKLLGYGIEGGMH--IVLE-LSPNGSLASLLY---------GMKEKLKWGIR 209
                     L  + +    H  +V E LS N      LY         G+   L    R
Sbjct: 111 DTEMKYYIVHLKRHFMFRN-HLCLVFEMLSYN------LYDLLRNTNFRGVSLNL---TR 160

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHH 267
            K A  +   LL+L    +  IIH D+K  NILL       I   DFG +          
Sbjct: 161 -KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-----QLGQ 213

Query: 268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
            I +   +  Y +PE L+    D   D+++ G +L+E+ TG 
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.6 bits (137), Expect = 3e-09
 Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 25/178 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-P 167
            ++     IG+G +  +++G  L N Q VAIK   R +    + D   E      +    
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCT 66

Query: 168 NTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---- 221
               +  +G EG  ++ V++ L P  SL  LL     K       K     A+ +L    
Sbjct: 67  GIPNVYYFGQEGLHNVLVIDLLGP--SLEDLLDLCGRKFS----VKTVAMAAKQMLARVQ 120

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEG 274
            +HE   + +++RDIK  N L+            + DFG+ K+  +  T   I   E 
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 44/178 (24%), Positives = 64/178 (35%), Gaps = 25/178 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-P 167
            NF     IG G + E+  G+ L   + VAIK     +    +     E      +    
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQLGSGD 65

Query: 168 NTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL---- 221
              ++  +G  G  +  VLE L P  SL  L              K  L +A  L+    
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGP--SLEDLFDLCDRTFS----LKTVLMIAIQLISRME 119

Query: 222 YLHEGCQRRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTISKVEG 274
           Y+H    + +I+RD+K  N L+            I DF LAK   +  T   I   E 
Sbjct: 120 YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 32/209 (15%), Positives = 71/209 (33%), Gaps = 36/209 (17%)

Query: 78  EGIDMPRNLFVNSYDSQSPQKIFSLYELQSAT-NNFSFENLIGKGGYAEVYKGR------ 130
            G+D+          + S + + +   L   +   +  ++   +     +Y+        
Sbjct: 9   SGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLT 68

Query: 131 ---LRNGQLVAIKRLTRGTADEIIADF---------LSELGIMAHVDHPNTAKLLGYGIE 178
                  Q  ++K   +        +F         +++   +           +G+G+ 
Sbjct: 69  CDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128

Query: 179 GGMH--IVLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL----YLHEGCQRRI 231
              +  +VL  L    SL S L    + +   +  +  L VA  LL    +LHE      
Sbjct: 129 QDKYRFLVLPSLGR--SLQSALDVSPKHV---LSERSVLQVACRLLDALEFLHE---NEY 180

Query: 232 IHRDIKAANILLTEDFEPQI--CDFGLAK 258
           +H ++ A NI +  + + Q+    +G A 
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 44/174 (25%), Positives = 66/174 (37%), Gaps = 19/174 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEII---ADFLSELGIMAHVD 165
           N +     IG G + ++Y G  +  G+ VAIK     T    +   +     +       
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----G 63

Query: 166 HPNTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
                 +   G EG  ++ V+E L P  SL  L      K        +A  +   + Y+
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121

Query: 224 HEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQWTHHTISKVEG 274
           H    +  IHRD+K  N L+    +     I DFGLAK   +  TH  I   E 
Sbjct: 122 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 3e-07
 Identities = 76/471 (16%), Positives = 142/471 (30%), Gaps = 137/471 (29%)

Query: 3   KKEDSCSPVGVLEDYFRSEDSETCSSKEPCSETKPESKSNSRWHLFYDLFRNKSKK---- 58
                C  V   +D  +S       SKE          + S     +    +K ++    
Sbjct: 30  VDNFDCKDV---QDMPKS-----ILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQK 81

Query: 59  ----SLVTLY-----PLKLSIRRSSSMREGIDMPRNLFVNS------YDSQSPQKIF--- 100
                L   Y     P+K   R+ S M       R+   N       Y+    Q      
Sbjct: 82  FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR 141

Query: 101 -SLYELQSATNNFSFENLIGKGGY------AEVYKGRLRNGQLVAIKRLTRGTADEIIAD 153
            +L EL+ A N      + G  G        +V      +       ++      +I   
Sbjct: 142 QALLELRPAKNVL----IDGVLGSGKTWVALDV----CLS------YKVQCKMDFKI--- 184

Query: 154 F-LSELGIMAHVDHPNTA----KLLGYGIEGGMHIVLELSPNGSLA--SLLYGMKEKLKW 206
           F L+    + + + P T     + L Y I+       + S N  L   S+   ++  LK 
Sbjct: 185 FWLN----LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 207 GIRYKIALGV------AEGLLYLHEGCQRRIIHRDIKAANIL----------------LT 244
              Y+  L V      A+     +  C+  +  R  +  + L                LT
Sbjct: 241 K-PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE 304
            D    +    L K+L                  L  E L        T+     ++   
Sbjct: 300 PDEVKSL----LLKYL-----DCRPQD-------LPREVL-------TTNPRRLSIIAES 336

Query: 305 LVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA--DEYDTRQM--NLVLLAASLCI 360
           +  G    D  +          +  +++  ++++SL   +  + R+M   L +   S  I
Sbjct: 337 IRDGLATWDNWKH---------VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 361 QQSSIRRPQMSQVVQLLRGNL---CCLKYMTKC-RSPLLRKTLREELKSAP 407
                  P  + ++ L+  ++     +  + K  +  L+ K  +E   S P
Sbjct: 388 -------P--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 47/178 (26%), Positives = 71/178 (39%), Gaps = 27/178 (15%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEII---ADFLSELGIMAHVD 165
           N F     IG G + E+Y G  ++  + VAIK     T    +   +     L       
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----G 61

Query: 166 HPNTAKLLGYGIEGGMHI-VLE-LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL-- 221
                 +  +G+EG  ++ V++ L P  SL  L      KL      K  L +A+ ++  
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLLGP--SLEDLFNFCSRKLS----LKTVLMLADQMINR 115

Query: 222 --YLHEGCQRRIIHRDIKAANILLTEDFEPQ---ICDFGLAKWLPEQWTHHTISKVEG 274
             ++H    +  +HRDIK  N L+          I DFGLAK   +  TH  I   E 
Sbjct: 116 VEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 28/173 (16%), Positives = 60/173 (34%), Gaps = 29/173 (16%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEI----------------IAD 153
             +     IG+GG+  +Y   + + + V          +                    +
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGGMH-----IVLE-LSPNGSLASLLYGMKEKLKWG 207
            + +      + +    K  G G+          ++++       L  +     ++    
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKRFSRK 152

Query: 208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
              +++L + + L Y+HE      +H DIKA+N+LL      Q+   D+GLA 
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 34/173 (19%), Positives = 63/173 (36%), Gaps = 32/173 (18%)

Query: 110 NNFSFENLIGKGGYAEVYKG-RLRNGQLVAIKRLTRGTAD------EI-------IADFL 155
           N +     IG GG+  +Y        +  A   +     +      E+         D +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96

Query: 156 SELGIMAHVDHPNTAKLLGYGIE---GGMH--IVLE-LSPNGSLASLLYGMKEKLKWGIR 209
            +      +D+       G G+    G  +  +V+E L     L  +     +   +   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKIS---GQNGTFKKS 151

Query: 210 --YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI--CDFGLAK 258
              ++ + + + L Y+HE      +H DIKAAN+LL      Q+   D+GL+ 
Sbjct: 152 TVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 46/232 (19%), Positives = 78/232 (33%), Gaps = 62/232 (26%)

Query: 117 LIGKGGYAEVYKG--RLRNGQLVAIK------RLTRGTADEIIADFLSELGIMAHVDHPN 168
            +G+G + +V +     R    VA+K      +       EI  + L ++      +   
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI--NVLKKIKEKDKENKFL 83

Query: 169 TAKLLGYGIEGGMH--IVLE-LSPNGSLASLLYGMKEKLKWG---------IRYKIALGV 216
              +  +    G H  I  E L  N       +   E LK           +R  +A  +
Sbjct: 84  CVLMSDWFNFHG-HMCIAFELLGKN------TF---EFLKENNFQPYPLPHVR-HMAYQL 132

Query: 217 AEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ-------------------ICDFGLA 257
              L +LHE    ++ H D+K  NIL                           + DFG A
Sbjct: 133 CHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTG 308
                 + H   + +  T  Y  PE ++  +   +  DV++ G +L E   G
Sbjct: 190 -----TFDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRG 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 50/233 (21%), Positives = 88/233 (37%), Gaps = 60/233 (25%)

Query: 117 LIGKGGYAEVYKGR-LRNGQLVAIK------RLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +G G +  V   + + N +  A+K      + TR    E   D L ++     +++ N 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA--DILKKIQ-NDDINNNNI 98

Query: 170 AKLLGYGIEGGMH--IVLE-LSPNGSLASLLYG-MKEKLKWG-----IRYKIALGVAEGL 220
            K  G  +    H  ++ E L P+      LY  +      G     I+    + + + L
Sbjct: 99  VKYHGKFMYYD-HMCLIFEPLGPS------LYEIITRNNYNGFHIEDIK-LYCIEILKAL 150

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQ-------------------------ICDFG 255
            YL +     + H D+K  NILL + +  +                         + DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG 308
            A      +       +  T  Y APE +++   D  +D+++FG +L EL TG
Sbjct: 208 CA-----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	408
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.02
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.1
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.74
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.6
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.35
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.15
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.87
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.74
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.6
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.96
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.15
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.33
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.86
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.49
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.87

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-59  Score=442.69  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=211.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      +..+++.+.++||+|+||+||+|.+.+  .||||+++... ..+..+.|.+|+.++++++|||||++++++.++++++||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVm  110 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVT  110 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEE
Confidence            344788999999999999999998753  59999997543 345678899999999999999999999999988999999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.++|+.....+++..+..|+.||+.||+|||+   ++||||||||+||||++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999999998777889999999999999999999999   9999999999999999999999999999987755434


Q ss_pred             cceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc-
Q 015389          266 HHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA-  341 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  341 (408)
                      ........||+.|+|||++.+   +.|+.++|||||||+||||+||+.||.........           ...+..... 
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-----------~~~~~~~~~~  256 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-----------IFMVGRGYAS  256 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----------HHHHHTTCCC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-----------HHHHhcCCCC
Confidence            444556789999999999964   46899999999999999999999999764332111           111111110 


Q ss_pred             ---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          342 ---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       342 ---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                         ...+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence               112234566788999999999999999999999999776543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.4e-59  Score=441.64  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=215.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      .++++.+.||+|+||+||+|.+.      +++.||||+++........+.|.+|+.++++++|||||++++++.+. ..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677899999999999999863      47899999998665555567899999999999999999999988764 579


Q ss_pred             EEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          183 IVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      +||||+++|+|.++|...               ...+++..+..|+.||+.||+|||+   ++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence            999999999999999542               2458999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .+||+|||+|+.+.............||+.|+|||++.++.|+.++|||||||+||||+| |+.||......        
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--------  254 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--------  254 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--------
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            999999999987654433334456779999999999999999999999999999999998 89999864332        


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                          .+...+........+..++..+.+|+.+||+.||.+|||+.||++.|+...
T Consensus       255 ----~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          255 ----DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ----HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                122222233333344556778999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-58  Score=438.03  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=213.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|.+.+.||+|+||+||+|.+.      ++..||||+++... ....+.|.+|+.+|++++|||||++++++.++ ..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            57889999999999999999863      47899999998654 34568899999999999999999999988764 589


Q ss_pred             EEEEecCCCCHHHHHhcc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceE
Q 015389          183 IVLELSPNGSLASLLYGM------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ  250 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~k  250 (408)
                      +||||+++|+|.++|+..            ...+++..+..|+.||+.||.|||+   ++||||||||+||||+.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence            999999999999999653            2469999999999999999999999   9999999999999999999999


Q ss_pred             EeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccccc
Q 015389          251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      |+|||+|+...............||+.|+|||++.++.|+.++|||||||+||||+| |+.||.......          
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----------  238 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----------  238 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence            999999987655433333344669999999999999999999999999999999999 899998644321          


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                        +...+........+..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       239 --~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          239 --VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              12222222223344456678999999999999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.3e-58  Score=439.06  Aligned_cols=257  Identities=21%  Similarity=0.333  Sum_probs=207.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|.+.++||+|+||+||+|.+.      +++.||||+++... ....+.|.+|+.+|++++|||||++++++.+. ..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56788899999999999999864      47899999998654 34567899999999999999999999988765 589


Q ss_pred             EEEEecCCCCHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          183 IVLELSPNGSLASLLYGM--------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                      +||||+++|+|.++++..              ...+++..++.|+.||+.||.|||+   ++||||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence            999999999999999653              2458999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhcccc
Q 015389          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~  327 (408)
                      +||+|||+|+.+.............||+.|+|||++.+..|+.++|||||||+||||+| |+.||.......        
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--------  268 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------  268 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--------
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            99999999997755433344456779999999999999999999999999999999999 899998643321        


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                          +...+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       269 ----~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 ----AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             ----HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence                112222222333444566788999999999999999999999999988753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.6e-57  Score=433.13  Aligned_cols=249  Identities=22%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++|||||++++++.++ .+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            78999999999999999999876 69999999997654 344577899999999999999999999976664 5799999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |++||+|.+++... ...+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+...  
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            99999999999654 3457899999999999999999999   99999999999999999999999999999976432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......+||+.|+|||++.+..|+.++||||||||||||++|+.||.........           ..+..... ...+
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-----------~~i~~~~~-~~~~  246 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-----------LKIISGSF-PPVS  246 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----------HHHHHTCC-CCCC
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------HHHHcCCC-CCCC
Confidence            22234567999999999999999999999999999999999999999864432111           11111111 1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            334567888999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.2e-57  Score=435.69  Aligned_cols=269  Identities=25%  Similarity=0.372  Sum_probs=225.6

Q ss_pred             cCHHHHhhhcCCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC-CceeEE
Q 015389          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKL  172 (408)
Q Consensus       100 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l  172 (408)
                      +...++++..++|++.+.||+|+||+||+|.+..      ++.||||.+.........+.|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445566677899999999999999999998642      468999999887766667889999999999965 899999


Q ss_pred             EeEEEeC--CeEEEEEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeC
Q 015389          173 LGYGIEG--GMHIVLELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD  235 (408)
Q Consensus       173 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D  235 (408)
                      ++++.+.  .+++||||+++|+|.++|+..               ...+++..+..++.||+.||+|||+   ++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence            9988653  479999999999999999653               2348999999999999999999999   9999999


Q ss_pred             CCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 015389          236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDY  314 (408)
Q Consensus       236 ikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~  314 (408)
                      |||+|||+++++.+||+|||+|+.+.............||+.|+|||++.++.|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998765544445566789999999999999999999999999999999998 9999976


Q ss_pred             cccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          315 SQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .....           .+...+....+...+..++..+.+++.+||+.||.+|||+.||++.|+.+++
T Consensus       291 ~~~~~-----------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          291 VKIDE-----------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCCSH-----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHH-----------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            43221           1223333333344444556778899999999999999999999999987653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-56  Score=425.79  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=208.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...  ......+.+|+.++++++|||||++++++.+ +.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999876 699999999975432  2345778999999999999999999997665 4589999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||++||+|.+++.. .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999954 5679999999999999999999999   9999999999999999999999999999998765444


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .....+++||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.....           ..+....  ..++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----------~~i~~~~--~~~p  254 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF-----------AKIIKLE--YDFP  254 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTC--CCCC
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHcCC--CCCC
Confidence            44556788999999999999999999999999999999999999999864432111           1111111  1222


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVV  374 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl  374 (408)
                      ......+.+|+.+||+.||.+|||+.|++
T Consensus       255 ~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            33455678899999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.7e-56  Score=426.27  Aligned_cols=247  Identities=20%  Similarity=0.302  Sum_probs=204.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ..|++.+.||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+ +.+|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46899999999999999999986 6999999999754332 24567899999999999999999997665 458999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++|+|.+++.  ...+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+....  .
T Consensus       153 ~~gg~L~~~l~--~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~  225 (346)
T 4fih_A          153 LEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  225 (346)
T ss_dssp             CTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred             CCCCcHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence            99999999995  3569999999999999999999999   999999999999999999999999999998775432  2


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc-cCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-ADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~  346 (408)
                      ...+.+||+.|+|||++.+..|+.++||||||||||||++|+.||.........           ..+.+... ......
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----------~~i~~~~~~~~~~~~  294 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----------KMIRDNLPPRLKNLH  294 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------HHHHHSSCCCCSCGG
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------HHHHcCCCCCCCccc
Confidence            335678999999999999999999999999999999999999999764332111           11111100 111122


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+|+.+||+.||.+|||+.|+++
T Consensus       295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          295 KVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            34567888999999999999999999886

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-55  Score=413.42  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=197.3

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCeEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIV  184 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~~lv  184 (408)
                      |++.+.||+|+||+||+|.+. ++..||||++.... .....+.|.+|+.++++++|||||++++++.+     ..+++|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999876 58999999997543 33456789999999999999999999997653     237899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECC-CCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTE-DFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~  261 (408)
                      |||+++|+|.+++.. ...+++..+..++.||+.||+|||+   ++  ||||||||+||||+. +|.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            999999999999954 5679999999999999999999998   77  999999999999984 7899999999998654


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..    ...+.+||+.|+|||++.+ .|+.++|||||||+||||+||+.||.........+..          +......
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~----------i~~~~~~  248 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----------VTSGVKP  248 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----------HTTTCCC
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH----------HHcCCCC
Confidence            32    2345789999999998864 6999999999999999999999999754332111110          0110001


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..++......+.+|+.+||+.||.+|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112222345788999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.8e-55  Score=422.03  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .+.|.+.++||+|+||+||+|.+. +|+.||||+++.....      .+|+.+++.++|||||++++++.++ .+|+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            357888999999999999999976 5999999999765332      3699999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~  265 (408)
                      |++||+|.+++.. .+.+++..+..++.||+.||+|||+   ++||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus       131 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999954 4679999999999999999999999   9999999999999999988 699999999997754322


Q ss_pred             cc---eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc-c
Q 015389          266 HH---TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-A  341 (408)
Q Consensus       266 ~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~  341 (408)
                      ..   ....++||+.|+|||++.+..|+.++|||||||+||||++|+.||.........           ..+..... .
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----------~~i~~~~~~~  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-----------LKIASEPPPI  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-----------HHHHHSCCGG
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----------HHHHcCCCCc
Confidence            11   223467999999999999999999999999999999999999999764432111           11111000 0


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ...+...+..+.+++.+||+.||.+|||+.||++.|....
T Consensus       276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            1122344567888999999999999999999999886654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-55  Score=417.01  Aligned_cols=268  Identities=21%  Similarity=0.264  Sum_probs=204.0

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----~~~lv  184 (408)
                      ++|.+.+.||+|+||+||+|.+ +|+.||||++......  ...+..|+..+.+++|||||++++++.+.     .+++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4678889999999999999998 5899999999754322  22334577777889999999999987754     36899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC-----QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      |||+++|+|.++++  ...+++..+.+++.|++.||+|||+.+     ..+||||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~Ey~~~gsL~~~l~--~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999995  456899999999999999999999731     24999999999999999999999999999987


Q ss_pred             CCCCCccc--eecccccCCCccccccccCC------CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          260 LPEQWTHH--TISKVEGTFGYLAPEFLMHG------IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       260 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      ........  ......||+.|+|||++.+.      .++.++|||||||+||||+||+.||.........+.........
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            64432221  22345799999999998764      46789999999999999999999886543322221111111111


Q ss_pred             ---HHH-HhhhhccCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          332 ---IRE-LVDASLADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       332 ---~~~-~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                         +.. +....++...+     ......+.+|+.+||+.||.+||||.||++.|+.+.+
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence               111 22222332222     3466789999999999999999999999999987653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-54  Score=404.73  Aligned_cols=245  Identities=20%  Similarity=0.346  Sum_probs=189.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...  .+....+.+|+.+++.++|||||++++++.+ +.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999875 699999999976532  2345678999999999999999999997665 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+ +|+|.+++.. .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            998 7899999854 5679999999999999999999999   99999999999999999999999999999866432  


Q ss_pred             cceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       ....+.+||+.|+|||++.+..| +.++|||||||++|||++|+.||.........           ..+....  ..+
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~-----------~~i~~~~--~~~  231 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF-----------KNISNGV--YTL  231 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTC--CCC
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHcCC--CCC
Confidence             23345789999999999998876 57999999999999999999999764322110           1111111  112


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +...+..+.+++.+||+.||++|||+.|+++
T Consensus       232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2234556788999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=427.92  Aligned_cols=246  Identities=20%  Similarity=0.317  Sum_probs=205.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +.|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+ +.+|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56999999999999999999976 6999999999765432 24567899999999999999999996665 458999999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++||+|.+++.  ...+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+....  .
T Consensus       230 ~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~  302 (423)
T 4fie_A          230 LEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  302 (423)
T ss_dssp             CTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred             CCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence            99999999994  4569999999999999999999999   999999999999999999999999999998775432  2


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc--Cccc
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA--DEYD  345 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~  345 (408)
                      .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.........            ..+.....  ....
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------------~~i~~~~~~~~~~~  370 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM------------KMIRDNLPPRLKNL  370 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------------HHHHHSCCCCCSCT
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH------------HHHHcCCCCCCccc
Confidence            335678999999999999999999999999999999999999999764332111            11111111  1111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+|+.+||+.||.+|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            234567888999999999999999999887

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-53  Score=405.51  Aligned_cols=249  Identities=21%  Similarity=0.377  Sum_probs=189.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC--------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG--------  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~--------  180 (408)
                      ++|++++.||+|+||+||+|.+. +|+.||||++.....+...+.+.+|+.++++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999976 699999999987666666788999999999999999999999665422        


Q ss_pred             -----eEEEEEecCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          181 -----MHIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       181 -----~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                           +|+||||+++|+|.+++....  ...++..++.++.||+.||+|||+   ++||||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence                 689999999999999996532  235566788999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCcc----------ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh
Q 015389          254 FGLAKWLPEQWTH----------HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA  323 (408)
Q Consensus       254 fGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~  323 (408)
                      ||+|+.+......          ...+..+||+.|+|||++.+..|+.++|||||||+||||++   ||.........  
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~--  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT--  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH--
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH--
Confidence            9999877543221          12234679999999999999999999999999999999996   77643211110  


Q ss_pred             ccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          324 RPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       324 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                              +..+.... ...........+..++.+||+.||.+|||+.|+++
T Consensus       237 --------~~~~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 --------LTDVRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --------HHHHHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HHHHhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    00011100 01111223345677999999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.2e-55  Score=414.48  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=195.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      ++|++.+.||+|+||+||+|+..    .++.||||++.+.... .....+.+|+.++++++|||||++++++.+ +.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999862    4789999999764321 123457789999999999999999997665 45899


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||++||+|.+++.. .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            9999999999999954 5679999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        .....+.+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.....           ..+....  ..
T Consensus       180 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-----------~~i~~~~--~~  244 (304)
T 3ubd_A          180 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM-----------TMILKAK--LG  244 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCC--CC
T ss_pred             --CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH-----------HHHHcCC--CC
Confidence              22334578999999999999999999999999999999999999999864432111           1111111  12


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQM-----SQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~  375 (408)
                      ++...+..+.+|+.+||+.||.+|||+     +|+++
T Consensus       245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            223345678889999999999999984     56554

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-51  Score=400.75  Aligned_cols=266  Identities=22%  Similarity=0.308  Sum_probs=203.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-------CC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------GG  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-------~~  180 (408)
                      ++|++++.||+|+||+||+|.+. +|+.||||++..... ....+.+++|+.+|++++|||||++++++..       +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            67999999999999999999976 699999999976533 3456778899999999999999999997542       45


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      +|+||||+. |+|.+++. ..+.+++..+..++.||+.||.|||+   ++||||||||+|||++.+|.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 67999985 45679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCC--ccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--c----c------
Q 015389          261 PEQW--THHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--R----P------  325 (408)
Q Consensus       261 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~----~------  325 (408)
                      ....  ......+.+||+.|+|||++.+. .++.++||||+|||+|||++|+.||.+.........  .    +      
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4322  12234567899999999998875 569999999999999999999999986543211100  0    0      


Q ss_pred             ccccchHHHHhhhhcc-Cccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          326 MIKRNEIRELVDASLA-DEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       326 ~~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      ..........+...-. ...+     ......+.+|+.+||+.||.+|||+.|+++  .+.+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            0000001111110000 0000     112356788999999999999999999987  45443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.5e-50  Score=388.49  Aligned_cols=200  Identities=24%  Similarity=0.344  Sum_probs=168.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~  180 (408)
                      ...++|++.+.||+|+||+||+|..+    .++.||||.+.....   ..++.+|+.+++.+ +||||+++++++.+ +.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            45578999999999999999999753    478999999876543   24567899999988 69999999996665 55


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCccc
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKW  259 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla~~  259 (408)
                      +++||||+++|+|.+++.    .+++..+..++.||+.||.|||+   +||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            789999999999999983    58999999999999999999999   999999999999999877 7999999999986


Q ss_pred             CCCCCc--------------------------cceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCC
Q 015389          260 LPEQWT--------------------------HHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRAL  312 (408)
Q Consensus       260 ~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf  312 (408)
                      ......                          .......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                          1122345799999999999876 5899999999999999999999999


Q ss_pred             Cccc
Q 015389          313 DYSQ  316 (408)
Q Consensus       313 ~~~~  316 (408)
                      ....
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            6543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.1e-50  Score=383.75  Aligned_cols=288  Identities=43%  Similarity=0.717  Sum_probs=241.7

Q ss_pred             CccccCHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeE
Q 015389           96 PQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY  175 (408)
Q Consensus        96 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  175 (408)
                      ..+.|++.++..+.++|++.+.||+|+||.||+|...+|+.||||++...........+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            45678899999999999999999999999999999878999999999876544334468899999999999999999997


Q ss_pred             EEe-CCeEEEEEecCCCCHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEE
Q 015389          176 GIE-GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (408)
Q Consensus       176 ~~~-~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl  251 (408)
                      +.. ...++||||+.+|+|.+++....   ..+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            765 45789999999999999996532   34999999999999999999999933339999999999999999999999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcc------ccchhhhhcc
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYS------QQSLVLWARP  325 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~------~~~~~~~~~~  325 (408)
                      +|||++........ .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...      ......|...
T Consensus       176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            99999987654322 2334566999999999999999999999999999999999999999642      2223445555


Q ss_pred             ccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          326 MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       326 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ......+..+.+..+...+.......+.+++.+||+.||.+|||+.+|++.|++.....
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            55566666677777777888889999999999999999999999999999998765433

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.6e-50  Score=411.18  Aligned_cols=249  Identities=26%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  181 (408)
                      .++|++.++||+|+||+||+|... +|+.||||++.+..     ..........++.+++.++|||||++++++.+ +.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            468999999999999999999876 59999999997532     12223333455778888999999999996555 568


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |+||||++||+|.++|.. .+.+++..+..++.||+.||.|||+   ++||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            999999999999999954 5679999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ..    ...+.+||+.|+|||++.+ ..|+.++||||||||||||++|+.||.........        .........  
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--------~i~~~i~~~--  409 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------EIDRMTLTM--  409 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--------HHHHHHHHC--
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--------HHHHhhcCC--
Confidence            43    2345789999999999975 57999999999999999999999999754322110        000111111  


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ...++......+.+|+.+||+.||.+|++     +.||++
T Consensus       410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            11223344567888999999999999998     677765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.8e-49  Score=405.10  Aligned_cols=249  Identities=21%  Similarity=0.261  Sum_probs=207.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.++ +|+.||||++...... ....+.+|+.+|+.++|||||++++++.+ +.+++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            368999999999999999999876 6999999999765433 35678899999999999999999997665 45899999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC--CceEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED--FEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~~  264 (408)
                      |++||+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+... 
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            999999999997667789999999999999999999999   999999999999999854  89999999999987543 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh--ccC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS--LAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~~  342 (408)
                        ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.........           ..+....  +..
T Consensus       311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~-----------~~i~~~~~~~~~  377 (573)
T 3uto_A          311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-----------RNVKSCDWNMDD  377 (573)
T ss_dssp             --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHTTCCCCCS
T ss_pred             --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----------HHHHhCCCCCCc
Confidence              2334567999999999999999999999999999999999999999865432111           1111110  111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .........+.+|+.+||+.||.+|||+.|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111233456788999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.5e-49  Score=377.69  Aligned_cols=281  Identities=38%  Similarity=0.631  Sum_probs=230.7

Q ss_pred             ccCHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe
Q 015389           99 IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus        99 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      .+++.++..++++|++.+.||+|+||.||+|.+.+|+.||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3444556677899999999999999999999988899999999876543 346778899999999999999999998765


Q ss_pred             -CCeEEEEEecCCCCHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          179 -GGMHIVLELSPNGSLASLLYGMK---EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                       +..++||||+++|+|.+++....   ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence             45789999999999999986532   358999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc----hhhhhccccccc
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS----LVLWARPMIKRN  330 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~----~~~~~~~~~~~~  330 (408)
                      |++................||+.|+|||.+.++.++.++|||||||++|||++|+.||......    ...|........
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            9998754433333334556999999999999999999999999999999999999999764322    122222222222


Q ss_pred             hHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          331 EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       331 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      .+...+++.+...........+.+++.+||+.||.+|||+.||++.|+.+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            33344455555666778889999999999999999999999999999877643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.1e-48  Score=378.82  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=216.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ..++|.+.+.||+|+||.||+|.+.        ++..||||++...........+.+|+.+++.+ +||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3478999999999999999999852        35689999998776666778899999999999 89999999997765


Q ss_pred             -CCeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          179 -GGMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                       +..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence             45899999999999999996533               358899999999999999999999   99999999999999


Q ss_pred             ECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhh
Q 015389          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVL  321 (408)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~  321 (408)
                      ++.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---  312 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  312 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999987654333333344567889999999999999999999999999999999 99999754322   


Q ss_pred             hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          322 WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                               .+...+........+..+...+..++.+||+.||.+||++.||++.|+.+..
T Consensus       313 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          313 ---------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ---------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                     1222222222333344556678999999999999999999999999988753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-48  Score=374.39  Aligned_cols=258  Identities=27%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      ++|++.+.||+|+||+||+|.+. +|+    .||+|.+...........+.+|+.++++++||||+++++++.++..++|
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v   94 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   94 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            67999999999999999999864 344    4688888765544556788999999999999999999999999899999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +|++.+|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            99999999999998777889999999999999999999999   999999999999999999999999999998775544


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||......            .+...+.......
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~~~~~~~~~~~~~  239 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------EISSILEKGERLP  239 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------GHHHHHHTTCCCC
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------------HHHHHHHcCCCCC
Confidence            4333444567889999999999999999999999999999999 99999764332            2223333333333


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+......+..++.+||+.||.+||++.+|++.|+.+..
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            344456678899999999999999999999999977643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=368.99  Aligned_cols=262  Identities=28%  Similarity=0.406  Sum_probs=216.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|++.+.||+|+||.||+|.+.    .+..||||++...........+.+|+.+++.++||||+++++++.++ ..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            468999999999999999999874    35569999998776666778899999999999999999999987764 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+...
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999999997777789999999999999999999999   99999999999999999999999999999877543


Q ss_pred             Ccc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          264 WTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||......            .+...+.....
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------------~~~~~~~~~~~  272 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------------DVISSVEEGYR  272 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------------HHHHHHHTTCC
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------------HHHHHHHcCCC
Confidence            222 12233456788999999999999999999999999999999 99999754332            12222222223


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ...+...+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            33344556778899999999999999999999999998865444

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.9e-48  Score=379.15  Aligned_cols=260  Identities=27%  Similarity=0.398  Sum_probs=216.8

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||.+......+....+.+|+.++++++||||+++++++.+. ..++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34578999999999999999999986 69999999998765556667889999999999999999999987764 57999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999997766779999999999999999999999   999999999999999999999999999998654332


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........+++.|+|||.+.++.++.++|||||||++|||++ |..||......            .+...+....+..
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------------~~~~~~~~~~~~~  335 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------------QTREFVEKGGRLP  335 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------------HHHHHHHTTCCCC
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCCC
Confidence            2111122335778999999999999999999999999999998 99999764322            1222233322333


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+..++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            33445667889999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.1e-47  Score=364.70  Aligned_cols=269  Identities=28%  Similarity=0.434  Sum_probs=206.2

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G  180 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~  180 (408)
                      .++....++|++.+.||+|+||.||+|.+ .|+.||||++.... ..+....+.+|+.++++++||||+++++++.+. .
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            33445567899999999999999999987 58899999997654 344567889999999999999999999977664 5


Q ss_pred             eEEEEEecCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECCCCceEEeecCC
Q 015389          181 MHIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      .++||||+++|+|.+++....  ..+++..++.++.||+.||.|||+   ++  |+||||||+|||++.++.+||+|||+
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            799999999999999996533  238999999999999999999999   88  99999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      +.......  .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+.
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-----------~~~~  252 (309)
T 3p86_A          186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-----------AAVG  252 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----------HHHH
T ss_pred             Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHH
Confidence            98654321  1233467999999999999999999999999999999999999999864332111           1111


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccccc
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMT  388 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  388 (408)
                      ........+......+.+++.+||+.||.+|||+.+|++.|+........+.
T Consensus       253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            1111222233445678889999999999999999999999998876655443

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=361.43  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=213.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||+||+|.+. +|+.||+|.+.... .+....+.+|+.+++.++||||+++++++.++ ..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            67899999999999999999876 59999999986543 44578899999999999999999999977765 47899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            99999999997777889999999999999999999999   999999999999999999999999999998764432211


Q ss_pred             ------------eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          268 ------------TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       268 ------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                                  ......||+.|+|||.+.+..++.++|||||||++|||++|..||..........      .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------~~~~~~~  239 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVRGF  239 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS------SBCHHHH
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH------hhhhhcc
Confidence                        1114679999999999999999999999999999999999999987543321111      1112222


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      .+.....    ..+..+..++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       240 ~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          240 LDRYCPP----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             HHHTCCT----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ccccCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2222222    233467889999999999999999999999988764443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-47  Score=367.05  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=209.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-----eE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-----MH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-----~~  182 (408)
                      ..++|++.+.||+|+||.||+|.+. ++.||||++.....  .......|+.+++.++||||+++++++....     ++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            3478999999999999999999885 89999999975532  2345567999999999999999999776543     58


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeEeeCCCCCceEECCCCceEEe
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR----------RIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                      +||||+++|+|.+++..  ..+++..++.++.|++.||.|||+   .          +|+||||||+|||++.++.+||+
T Consensus        99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999954  459999999999999999999998   7          99999999999999999999999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCC-----CCCcchhHHHHHHHHHHHHhCCCCCCccccch-hhhhccc
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-----IVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPM  326 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvil~elltg~~pf~~~~~~~-~~~~~~~  326 (408)
                      |||+++.+.............||+.|+|||++.+.     .++.++|||||||++|||++|+.||....... ..+....
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876654333334456799999999999873     56678999999999999999999997643321 1111111


Q ss_pred             cccchHHHHhh----hhccCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          327 IKRNEIRELVD----ASLADE-----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       327 ~~~~~~~~~~d----~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ........+.+    ......     ........+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11111111111    111111     112456779999999999999999999999999987653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.5e-47  Score=372.34  Aligned_cols=268  Identities=25%  Similarity=0.384  Sum_probs=220.6

Q ss_pred             cCHHHHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEE
Q 015389          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKL  172 (408)
Q Consensus       100 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l  172 (408)
                      +....+....++|++.+.||+|+||.||+|.+.      +++.||||++...........+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            445566677899999999999999999999742      46899999998776666678899999999999 79999999


Q ss_pred             EeEEEeC-C-eEEEEEecCCCCHHHHHhcccC------------------------------------------------
Q 015389          173 LGYGIEG-G-MHIVLELSPNGSLASLLYGMKE------------------------------------------------  202 (408)
Q Consensus       173 ~~~~~~~-~-~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  202 (408)
                      ++++.+. . .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            9987763 3 7899999999999999965432                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          203 -----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       203 -----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                                       .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+.....
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             18899999999999999999999   9999999999999999999999999999987755444


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......           .+...+........
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------~~~~~~~~~~~~~~  317 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----------EFCRRLKEGTRMRA  317 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----------HHHHHHHHTCCCCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----------HHHHHHHcCCCCCC
Confidence            444455678999999999999999999999999999999998 999997643221           11222222222223


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      +......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            3334567888999999999999999999999998765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-47  Score=368.20  Aligned_cols=258  Identities=22%  Similarity=0.337  Sum_probs=211.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcE----EEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQL----VAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.    ||+|.+...........+.+|+.+++.++||||+++++++.+...++|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v   92 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV   92 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence            68999999999999999999865 3443    888887654433334556789999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+.+|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            99999999999997767789999999999999999999999   999999999999999999999999999999876554


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........||..|+|||.+.++.++.++|||||||++|+|++ |+.||......            .+...+.......
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~~~~  237 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------------EVPDLLEKGERLA  237 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------------HHHHHHHTTCBCC
T ss_pred             ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------------HHHHHHHcCCCCC
Confidence            4444455678899999999999999999999999999999999 99999864332            1222222222222


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+......+..++.+||+.||.+||++.+|++.|+.+..
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            222334457779999999999999999999999987653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.6e-47  Score=371.74  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=206.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|++.+.||+|+||.||+|.+.    ++..||||.+.....+.....+.+|+.++++++||||+++++++.+. ..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            368999999999999999999865    47789999998776666678899999999999999999999987764 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            999999999999997777789999999999999999999999   99999999999999999999999999999876543


Q ss_pred             Cccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          264 WTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       264 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      .... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......            .+...+.....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------------~~~~~i~~~~~  268 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------------DVIKAVDEGYR  268 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------------HHHHHHHTTEE
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCC
Confidence            2211 1122346788999999999999999999999999999998 99999754322            22223333333


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ...+..++..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            333445567789999999999999999999999999887543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-47  Score=358.39  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      ..++|++.+.||+|+||.||+|.+.    .+..||||.+...........+.+|+.++++++||||+++++++.++..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l   92 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI   92 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEE
Confidence            3478999999999999999999864    256799999987666667788999999999999999999999988888999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            999999999999997666679999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........            ...+......
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~------------~~~i~~~~~~  236 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIENGERL  236 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------------HHHHHTTCCC
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH------------HHHHHcCCCC
Confidence            21 12233457889999999999999999999999999999997 9999976433211            1111111112


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ..+...+..+..++.+||+.||.+|||+.+|++.|+.+..
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            2333455678889999999999999999999999987653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-46  Score=351.19  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=213.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ..++|++.+.||+|+||.||+|.+.++..||||++......  ...+.+|+.++.+++||||+++++++.+. ..++|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            34789999999999999999999988889999999876543  35678999999999999999999987664 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++........ 
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            999999999997766779999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.........            ..+........+
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~  227 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------------LKVSQGHRLYRP  227 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------------HHHHTTCCCCCC
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------------HHHHcCCCCCCC
Confidence            22233456788999999999899999999999999999999 99999754432111            111111111122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ......+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus       228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            22345688899999999999999999999999887643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=371.49  Aligned_cols=264  Identities=26%  Similarity=0.379  Sum_probs=219.7

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  177 (408)
                      ...++|.+.+.||+|+||.||+|.+.        .+..||||++...........+.+|+.+++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34578999999999999999999852        24689999998876666778899999999999 9999999999777


Q ss_pred             eC-CeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCce
Q 015389          178 EG-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (408)
Q Consensus       178 ~~-~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NI  241 (408)
                      .. ..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence            64 5799999999999999996543               358999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchh
Q 015389          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLV  320 (408)
Q Consensus       242 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~  320 (408)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......  
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--  300 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  300 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999987754433333445568899999999999999999999999999999999 99999754322  


Q ss_pred             hhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          321 LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                                .+...+........+......+.+++.+||+.||.+|||+.||++.|+.+.....
T Consensus       301 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 ----------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             ----------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             ----------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                      1222222222333334456678899999999999999999999999988864443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-47  Score=365.11  Aligned_cols=267  Identities=26%  Similarity=0.366  Sum_probs=216.9

Q ss_pred             HHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEE
Q 015389          104 ELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (408)
Q Consensus       104 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  177 (408)
                      .+....++|++.+.||+|+||.||+|.+.      +++.||||++......+....+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34455689999999999999999999874      348999999987766667788999999999999999999999876


Q ss_pred             e-CCeEEEEEecCCCCHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 015389          178 E-GGMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIH  233 (408)
Q Consensus       178 ~-~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH  233 (408)
                      + +..++||||+++|+|.+++....                       ..+++..++.++.||+.||.|||+   ++|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence            5 45799999999999999996532                       568999999999999999999999   99999


Q ss_pred             eCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 015389          234 RDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRAL  312 (408)
Q Consensus       234 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf  312 (408)
                      |||||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999987654322233344568999999999999999999999999999999999 99999


Q ss_pred             CccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          313 DYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ........            ...+........+...+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       278 ~~~~~~~~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          278 YGMAHEEV------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTSCHHHH------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCChHHH------------HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            75433211            11111111112233445678899999999999999999999999998875543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-45  Score=351.31  Aligned_cols=280  Identities=36%  Similarity=0.601  Sum_probs=227.8

Q ss_pred             CccccCHHHHhhhcCCCCcc------ceecccCcEEEEEEEEcCCcEEEEEEecCCC---chHHHHHHHHHHHHHhcCCC
Q 015389           96 PQKIFSLYELQSATNNFSFE------NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDH  166 (408)
Q Consensus        96 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~h  166 (408)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||||++....   .++....+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34678899999999998877      8999999999999987 58899999987532   23456788999999999999


Q ss_pred             CceeEEEeEEEe-CCeEEEEEecCCCCHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          167 PNTAKLLGYGIE-GGMHIVLELSPNGSLASLLYGM--KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       167 pniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      |||+++++++.+ +..++||||+++++|.+++...  ...+++..++.++.|++.||.|||+   ++|+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence            999999998766 4579999999999999999643  3468999999999999999999999   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh--h
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV--L  321 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~--~  321 (408)
                      +.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........  .
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            9999999999999987654433333445679999999998764 589999999999999999999999986443211  1


Q ss_pred             hhcc-ccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          322 WARP-MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       322 ~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      +... ......+...++..+ ..........+..++.+||+.+|.+|||+.+|++.|+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            1111 011223334444433 2345667888999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-46  Score=355.33  Aligned_cols=248  Identities=22%  Similarity=0.339  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++...... ....+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            368999999999999999999864 6999999998754332 245678999999999999999999976654 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+|+|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++........ 
T Consensus        98 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999999999953  468999999999999999999999   9999999999999999999999999999987654322 


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-hccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-SLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~  345 (408)
                       ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..........           .+... ......+
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----------~~~~~~~~~~~~~  239 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----------LIATNGTPELQNP  239 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----------HHHHHCSCCCSCG
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----------HHHhCCCCCCCCc
Confidence             2345679999999999999999999999999999999999999997644321111           00000 0011122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            334566888999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.5e-47  Score=352.52  Aligned_cols=255  Identities=25%  Similarity=0.402  Sum_probs=212.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      .++|++.+.||+|+||.||+|.+.+++.||||++......  ...+.+|+.++++++||||+++++++.+. ..++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3689999999999999999999988999999999876543  25688999999999999999999987764 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            99999999997777789999999999999999999999   999999999999999999999999999998764431 12


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......            +...+........+.
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------------~~~~~~~~~~~~~~~  230 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------VVEDISTGFRLYKPR  230 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------------HHHHHHTTCCCCCCT
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------------HHHHHhcCccCCCCC
Confidence            2233457888999999999999999999999999999999 999997643321            111111112222233


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .....+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            34567888999999999999999999999998765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.3e-47  Score=359.93  Aligned_cols=261  Identities=26%  Similarity=0.396  Sum_probs=216.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-C
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-G  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  179 (408)
                      ...++|.+.+.||+|+||.||+|.+      .++..||||++...........+.+|+.+++.++||||+++++++.+ +
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            3457899999999999999999986      24589999999876666667889999999999999999999997765 4


Q ss_pred             CeEEEEEecCCCCHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 015389          180 GMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  236 (408)
                      ..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||+   ++|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCccccc
Confidence            5799999999999999996532                       248899999999999999999999   99999999


Q ss_pred             CCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 015389          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYS  315 (408)
Q Consensus       237 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~  315 (408)
                      ||+||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654433333344567889999999999999999999999999999999 99999754


Q ss_pred             ccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          316 QQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ...            .+...+........+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       257 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          257 PPE------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CGG------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            332            1222222222223334455678899999999999999999999999987653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9e-47  Score=379.07  Aligned_cols=264  Identities=24%  Similarity=0.372  Sum_probs=220.0

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeE
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  182 (408)
                      ..+....++|.+.+.||+|+||.||+|.+.++..||||.++.....  .+.+.+|+.++++++||||+++++++.+...+
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc--HHHHHHHHHHHhhCCCCCEeeEEEEEeCCccE
Confidence            3445667889999999999999999999988899999999865432  56789999999999999999999998888899


Q ss_pred             EEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          183 IVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      +||||+.+|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            999999999999999653 3468899999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... .......+|+.|+|||.+.++.++.++|||||||+||||++ |+.||......            .+...+....
T Consensus       336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------------~~~~~i~~~~  402 (454)
T 1qcf_A          336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------------EVIRALERGY  402 (454)
T ss_dssp             CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------HHHHHHHHTC
T ss_pred             CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCC
Confidence            3211 11223446788999999999999999999999999999999 99999754322            1122222223


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      +...+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            33334455678899999999999999999999999998876443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=373.02  Aligned_cols=265  Identities=27%  Similarity=0.364  Sum_probs=215.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++...........+.+|+.++++++||||+++++++.+. ..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            468999999999999999999843      47789999998766666677889999999999999999999987764 57


Q ss_pred             EEEEEecCCCCHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEe
Q 015389          182 HIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQIC  252 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~  252 (408)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999996533      458999999999999999999999   9999999999999999555   59999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccch
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      |||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++ |..||......            .
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------------~  294 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------E  294 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------H
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------H
Confidence            9999976533222223344568999999999999999999999999999999998 99999764332            1


Q ss_pred             HHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccccc
Q 015389          332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMT  388 (408)
Q Consensus       332 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  388 (408)
                      +...+........+...+..+.+++.+||+.||.+||++.+|++.|+..........
T Consensus       295 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~  351 (367)
T 3l9p_A          295 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN  351 (367)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHT
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhcc
Confidence            222222222223333455678899999999999999999999999988765544333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-46  Score=356.57  Aligned_cols=270  Identities=25%  Similarity=0.360  Sum_probs=213.2

Q ss_pred             cCCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~  180 (408)
                      .++|++.+.||+|+||.||+|.+     .+|+.||||++.... .+....+.+|+.+++.++||||+++++++..   ..
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            47899999999999999999984     258999999998654 3456788999999999999999999998754   34


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~  164 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  164 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence            799999999999999997777779999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc----cchHHHH
Q 015389          261 PEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK----RNEIREL  335 (408)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~----~~~~~~~  335 (408)
                      ...... .......++..|+|||.+.+..++.++|||||||++|+|++|..|+................    ...+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (295)
T 3ugc_A          165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  244 (295)
T ss_dssp             -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence            543222 12233457788999999999999999999999999999999999987643322111111100    0112222


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      +........+..++..+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus       245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            22222333344566789999999999999999999999999987653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.6e-47  Score=362.30  Aligned_cols=254  Identities=24%  Similarity=0.308  Sum_probs=204.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......+....+.+|+.+++.++||||+++++++.+++ .++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999876 699999999976554445567889999999999999999999877755 689999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999984 34569999999999999999999999   99999999999999999999999999999876433333


Q ss_pred             ceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........+          .............
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~~  231 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----------SDWKEKKTYLNPW  231 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH----------HHHHTTCTTSTTG
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH----------HHHhcccccCCcc
Confidence            33445679999999999988776 779999999999999999999997644321111          1111111111111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ......+.+++.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          232 KKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            2344567789999999999999999999873

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-46  Score=356.43  Aligned_cols=263  Identities=24%  Similarity=0.378  Sum_probs=218.4

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ....++|++.+.||+|+||.||+|.+      .+++.||||++...........+.+|+.+++++ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34457899999999999999999985      247899999998776655678899999999999 99999999997765


Q ss_pred             -CCeEEEEEecCCCCHHHHHhcccC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCc
Q 015389          179 -GGMHIVLELSPNGSLASLLYGMKE-----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAAN  240 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~N  240 (408)
                       +..++||||+++|+|.+++.....                 .+++..++.++.||+.||.|||+   ++|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccce
Confidence             457899999999999999965432                 48999999999999999999999   999999999999


Q ss_pred             eEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccch
Q 015389          241 ILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSL  319 (408)
Q Consensus       241 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~  319 (408)
                      |+++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987765444333445568889999999999999999999999999999999 999997643221


Q ss_pred             hhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                                 .....+........+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       256 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          256 -----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             -----------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                       1222233333333333455678899999999999999999999999987653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-47  Score=363.22  Aligned_cols=260  Identities=27%  Similarity=0.413  Sum_probs=209.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      .++|++.+.||+|+||.||+|.+. +++    .||+|.+...........+.+|+.+++.++||||+++++++.....++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            378999999999999999999865 344    358887765544445678889999999999999999999999888999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |++++.+|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+...
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            999999999999998777889999999999999999999999   99999999999999999999999999999877544


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ..........||+.|+|||.+.+..++.++|||||||++|||++ |+.||......            .+...+......
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------------~~~~~~~~~~~~  238 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------EISSILEKGERL  238 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------------GHHHHHHTTCCC
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence            33333344557889999999999999999999999999999999 99999864332            222233333233


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ..+......+..++.+||+.||.+||++.|+++.|+.+...
T Consensus       239 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          239 PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            33344556788899999999999999999999999887643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=363.72  Aligned_cols=265  Identities=25%  Similarity=0.383  Sum_probs=213.5

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ....++|.+.+.||+|+||.||+|.+      .++..||||++...........+.+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34558899999999999999999986      246789999998655445567889999999999 89999999997765


Q ss_pred             -CCeEEEEEecCCCCHHHHHhcccC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeC
Q 015389          179 -GGMHIVLELSPNGSLASLLYGMKE----------------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRD  235 (408)
Q Consensus       179 -~~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D  235 (408)
                       +..++||||+++|+|.+++.....                      .+++..++.++.||+.||.|||+   ++|+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCC
Confidence             457999999999999999965432                      37899999999999999999999   9999999


Q ss_pred             CCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCc
Q 015389          236 IKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDY  314 (408)
Q Consensus       236 ikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~  314 (408)
                      |||+|||++.++.+||+|||++..+.............||+.|+|||.+.++.++.++|||||||++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987654433333445568899999999999999999999999999999998 9999976


Q ss_pred             cccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          315 SQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      .....           .+...+........+......+..++.+||+.||.+||++.+|++.|+.+....
T Consensus       278 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVDA-----------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCSH-----------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcHH-----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            43221           122222333333333445667889999999999999999999999998876443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.9e-46  Score=358.88  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=206.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++... ..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4578999999999999999999974 79999999997643 334567788999999999999999999977654 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            999999999999954 4679999999999999999999999   99999999999999999999999999999866433 


Q ss_pred             ccceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        ......+||+.|+|||.+.+..++ .++|||||||++|+|++|+.||.........           ..+.....  .
T Consensus       168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~~i~~~~~--~  232 (328)
T 3fe3_A          168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-----------ERVLRGKY--R  232 (328)
T ss_dssp             --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCCC--C
T ss_pred             --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCC--C
Confidence              223456799999999999988875 7999999999999999999999864322110           01111111  1


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+......+.+++.+||+.||.+|||+.|+++.
T Consensus       233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            122334567889999999999999999999873

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.5e-46  Score=360.10  Aligned_cols=274  Identities=25%  Similarity=0.375  Sum_probs=199.5

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEcC-C---cEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  179 (408)
                      +....++|++.+.||+|+||.||+|.+.. +   ..||||++.... .......+.+|+.++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            34556889999999999999999998653 3   279999997653 234567889999999999999999999987654


Q ss_pred             C-------eEEEEEecCCCCHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC
Q 015389          180 G-------MHIVLELSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF  247 (408)
Q Consensus       180 ~-------~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~  247 (408)
                      .       .++||||+.+|+|.+++....     ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCC
Confidence            3       289999999999999985422     258999999999999999999999   9999999999999999999


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~  326 (408)
                      .+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.......       
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------  247 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------  247 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH-------
Confidence            999999999987654433333334557889999999999999999999999999999999 999998643321       


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccccccccCCc
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSP  393 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~  393 (408)
                           +...+........+......+.+++.+||+.||.+|||+.++++.|+.+............|
T Consensus       248 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          248 -----IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             -----HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred             -----HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence                 11111111122223344567889999999999999999999999999988766665555544

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-46  Score=358.47  Aligned_cols=269  Identities=23%  Similarity=0.376  Sum_probs=218.5

Q ss_pred             cCHHHHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEE
Q 015389          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL  173 (408)
Q Consensus       100 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~  173 (408)
                      +...++....++|++.+.||+|+||.||+|.+.      +++.||||.+...........+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334455666789999999999999999999754      37889999998766656677889999999999999999999


Q ss_pred             eEEEeC-CeEEEEEecCCCCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          174 GYGIEG-GMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       174 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      +++.+. ..++||||+++|+|.+++....         ..+++..++.++.||+.||.|||+   ++|+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence            987664 5789999999999999996532         457899999999999999999999   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |+.||.......   
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence            9999999999999986644322223334557899999999999999999999999999999999 889987543221   


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                               +...+........+...+..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       249 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          249 ---------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             ---------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             ---------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                     1111111111122234456788899999999999999999999999887653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=351.09  Aligned_cols=262  Identities=25%  Similarity=0.387  Sum_probs=218.8

Q ss_pred             cCCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          109 TNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~-~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .++|.+.+ .||+|+||.||+|.+.   ++..||||++...........+.+|+.+++.++||||+++++++..+..++|
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv   87 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   87 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence            35677776 9999999999999853   5888999999887666677889999999999999999999999877889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            99999999999997767789999999999999999999999   999999999999999999999999999998775432


Q ss_pred             cc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 TH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......||+.|+|||.+.+..++.++|||||||++|+|++ |+.||......            .+...+......
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~~~~~i~~~~~~  232 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------EVMAFIEQGKRM  232 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------------HHHHHHHTTCCC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------------HHHHHHhcCCcC
Confidence            22 12233457899999999998899999999999999999998 99999754332            111222222222


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ..+...+..+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus       233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            3334556778899999999999999999999999988764444

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.2e-46  Score=350.97  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ..++|++.+.||+|+||.||+|.+.++..||||++......  ...+.+|+.++..++||||+++++++.+. ..++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            44789999999999999999999988889999999876543  25678999999999999999999987764 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++....... .
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  175 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y  175 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence            999999999997767789999999999999999999999   999999999999999999999999999998764421 1


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......            .....+........+
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------------~~~~~~~~~~~~~~~  243 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------------ETAEHIAQGLRLYRP  243 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------------HHHHHHHTTCCCCCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------------HHHHHHhcccCCCCC
Confidence            12233457788999999999999999999999999999998 99999754332            111122222222223


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ......+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            334567888999999999999999999999997764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.9e-46  Score=350.24  Aligned_cols=259  Identities=24%  Similarity=0.353  Sum_probs=212.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      ..++|.+.+.||+|+||.||+|.+.+    +..||||.+......+....+.+|+.+++.++||||+++++++.++..++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence            34789999999999999999998642    34699999987766666788999999999999999999999988888999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            999999999999997767779999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......            ....+......
T Consensus       167 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------------~~~~~~~~~~~  233 (281)
T 3cc6_A          167 DY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------------VIGVLEKGDRL  233 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------------HHHHHHHTCCC
T ss_pred             cc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------------HHHHHhcCCCC
Confidence            21 12234557889999999998999999999999999999998 999997543221            11111111112


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ..+...+..+..++.+||+.||.+||++.++++.|+.+..
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            2223345678889999999999999999999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-46  Score=352.42  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=201.7

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      ...++|++.+.||+|+||.||+|.+..  .||||++.... .......+.+|+.++++++||||++++++......++||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~   98 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   98 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEE
Confidence            345789999999999999999998643  59999997654 344567889999999999999999999998888899999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.+++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            9999999999997777789999999999999999999999   9999999999999999999999999999986654333


Q ss_pred             cceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh-cc
Q 015389          266 HHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS-LA  341 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~-l~  341 (408)
                      ........||+.|+|||.+.   +..++.++|||||||++|+|++|+.||........           +...+... ..
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~~~~~~~~~~~  244 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----------IIEMVGRGSLS  244 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-----------HHHHHHHTSCC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-----------HHHHhcccccC
Confidence            33344567999999999987   56789999999999999999999999976433211           11111111 11


Q ss_pred             C---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          342 D---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       342 ~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .   .....++..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            1   112234567889999999999999999999999998765

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-46  Score=350.21  Aligned_cols=260  Identities=26%  Similarity=0.401  Sum_probs=215.1

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      ....++|++.+.||+|+||.||+|...++..||||.+......  ...+.+|+.+++.++||||+++++++.++..++||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~   86 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIIT   86 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEE
Confidence            3445789999999999999999999888889999999765432  46788999999999999999999998888899999


Q ss_pred             EecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          186 ELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999996532 369999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      . .......++..|+|||.+.++.++.++||||||+++|+|++ |+.||.......            +...+.......
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------------~~~~~~~~~~~~  230 (279)
T 1qpc_A          164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------------VIQNLERGYRMV  230 (279)
T ss_dssp             E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------------HHHHHHTTCCCC
T ss_pred             c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------------HHHHHhcccCCC
Confidence            1 22233457889999999998899999999999999999999 899997543221            111111112222


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      .+...+..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            2334456788999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2e-45  Score=348.29  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=208.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCC--CchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||.+...  ...+....+.+|+.++++++||||+++++++.+.+ .++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            478999999999999999999875 6899999998643  23456788999999999999999999999877654 7899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++..+....
T Consensus        90 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999999999954 4579999999999999999999999   999999999999999999999999999998764332


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      . .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||....................        ....
T Consensus       166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~  236 (294)
T 4eqm_A          166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV--------TTDV  236 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH--------HHHS
T ss_pred             c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc--------chhc
Confidence            1 222345699999999999999999999999999999999999999986543211111000000000        0111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccCccc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRP-QMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~~~~  385 (408)
                      ....+..+..++.+||+.||.+|| ++.++.+.|+.......
T Consensus       237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            122346788899999999999998 99999999988765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-46  Score=354.71  Aligned_cols=269  Identities=24%  Similarity=0.340  Sum_probs=214.6

Q ss_pred             CCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---Ce
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~  181 (408)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++...........+.+|+.+++.++||||+++++++...   ..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5688999999999999999984     358999999998665444567888999999999999999999977653   47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            89999999999999997777789999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH---HHHhh
Q 015389          262 EQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI---RELVD  337 (408)
Q Consensus       262 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~d  337 (408)
                      ..... .......||..|+|||.+.+..++.++|||||||++|+|++|+.|+............+.......   ...+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            43322 223345688899999999999999999999999999999999998764332222222222222222   22222


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .......+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            22233344455678999999999999999999999999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.7e-46  Score=355.01  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=219.0

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEE
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLL  173 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~  173 (408)
                      ....+....++|++.+.||+|+||.||+|.+      .+++.||||++...........+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            4445556678999999999999999999974      247899999998776666677899999999999 799999999


Q ss_pred             eEEEeC--CeEEEEEecCCCCHHHHHhcccC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 015389          174 GYGIEG--GMHIVLELSPNGSLASLLYGMKE---------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (408)
Q Consensus       174 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  236 (408)
                      +++...  ..++||||+++++|.+++.....               .+++..++.++.||+.||.|||+   ++|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence            987653  37999999999999999965433               28899999999999999999999   99999999


Q ss_pred             CCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCcc
Q 015389          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYS  315 (408)
Q Consensus       237 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~  315 (408)
                      ||+||+++.++.+||+|||++..+.............||+.|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655433334445668999999999999999999999999999999998 99999764


Q ss_pred             ccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          316 QQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ....           .+...+........+......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       255 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDE-----------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSH-----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhH-----------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3221           111112222222222334556888999999999999999999999998775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-45  Score=346.84  Aligned_cols=254  Identities=30%  Similarity=0.532  Sum_probs=208.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch---HH---HHHHHHHHHHHhcCCCCceeEEEeEEEeCCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD---EI---IADFLSELGIMAHVDHPNTAKLLGYGIEGGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~---~~---~~~~~~E~~il~~l~hpniv~l~~~~~~~~~  181 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......   ..   ...+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            478999999999999999999875 6999999998754322   11   267889999999999999999999876554 


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECCCCc-----eEEeec
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFE-----PQICDF  254 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~~~~-----~kl~Df  254 (408)
                      ++||||+++|+|.+++......+++..++.++.|++.||.|||+   ++  |+||||||+|||++.++.     +||+||
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            79999999999999997777789999999999999999999999   88  999999999999988876     999999


Q ss_pred             CCcccCCCCCccceecccccCCCcccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLAPEFLM--HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      |++.....     ......||+.|+|||.+.  ...++.++|||||||++|+|++|+.||.........+         .
T Consensus       174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---------~  239 (287)
T 4f0f_A          174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF---------I  239 (287)
T ss_dssp             TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH---------H
T ss_pred             Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH---------H
Confidence            99985432     234467999999999984  4567899999999999999999999997643321111         1


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ............+...+..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            112222223333445566788999999999999999999999999753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.6e-46  Score=359.03  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++.+...  ......+.+|+.+++.++||||+++++++.. +..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999876 599999999975421  2235678899999999999999999997665 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++..... 
T Consensus        84 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            999999999999853 4678999999999999999999999   99999999999999999999999999999864322 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+....  ..+
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------~~i~~~~--~~~  224 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----------ELILMEE--IRF  224 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCC--CCC
T ss_pred             -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH-----------HHHHcCC--CCC
Confidence             12334567999999999999999999999999999999999999999754322110           1111111  112


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      +......+..++.+||+.||.+||     ++.||++
T Consensus       225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            233456788899999999999999     8999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.5e-46  Score=356.96  Aligned_cols=262  Identities=24%  Similarity=0.388  Sum_probs=215.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ..++|++.+.||+|+||.||+|.+.        ++..||||++...........+.+|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999863        47789999998776666678899999999999 89999999997765


Q ss_pred             C-CeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          179 G-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       179 ~-~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                      . ..++||||+++|+|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence            4 5799999999999999996533               248899999999999999999999   99999999999999


Q ss_pred             ECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhh
Q 015389          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVL  321 (408)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~  321 (408)
                      ++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||......   
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  266 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  266 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence            99999999999999987655433333344567889999999999999999999999999999999 99999754322   


Q ss_pred             hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          322 WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                               .+...+........+......+..++.+||+.+|.+||++.+|++.|+.+....
T Consensus       267 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          267 ---------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             ---------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                     111222222222333345567889999999999999999999999998876443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.9e-46  Score=356.33  Aligned_cols=269  Identities=24%  Similarity=0.314  Sum_probs=218.5

Q ss_pred             CCccceecccCcEEEEEEEEc-----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHI  183 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~l  183 (408)
                      |++.+.||+|+||.||++.+.     +|+.||||++...........+.+|+.+++.++||||+++++++.+.   ..++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999998643     58899999998776666678899999999999999999999988763   3689


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++..  ..+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            9999999999999943  458999999999999999999999   99999999999999999999999999999877553


Q ss_pred             Ccc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc---ccccchHHHHhhhh
Q 015389          264 WTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP---MIKRNEIRELVDAS  339 (408)
Q Consensus       264 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~d~~  339 (408)
                      ... .......||..|+|||.+.+..++.++|||||||++|+|++|+.||.........+...   ......+...+...
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG  267 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence            322 22334568889999999999999999999999999999999999997643322211111   11122233444444


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      .....+...+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            4444455567789999999999999999999999999988765444

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.2e-45  Score=352.33  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-------  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-------  180 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.....+...+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            367999999999999999999986 799999999986655556788999999999999999999999765432       


Q ss_pred             ---------------------------------------------------eEEEEEecCCCCHHHHHhccc--CCCCHH
Q 015389          181 ---------------------------------------------------MHIVLELSPNGSLASLLYGMK--EKLKWG  207 (408)
Q Consensus       181 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~--~~l~~~  207 (408)
                                                                         .++||||+++++|.+++....  ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               689999999999999996532  335666


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc----------ceecccccCCC
Q 015389          208 IRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH----------HTISKVEGTFG  277 (408)
Q Consensus       208 ~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  277 (408)
                      .++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            789999999999999999   99999999999999999999999999999877543211          12234569999


Q ss_pred             ccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHH
Q 015389          278 YLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAAS  357 (408)
Q Consensus       278 y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~  357 (408)
                      |+|||.+.+..++.++|||||||++|||++|..|+.....              ....................+..++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~li~  307 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--------------IITDVRNLKFPLLFTQKYPQEHMMVQ  307 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--------------HHHHHHTTCCCHHHHHHCHHHHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--------------HHHHhhccCCCcccccCChhHHHHHH
Confidence            9999999999999999999999999999998776432110              00001111111112334456788999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 015389          358 LCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       358 ~cl~~~P~~RPt~~evl~  375 (408)
                      +||+.||.+|||+.|+++
T Consensus       308 ~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          308 DMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHCSSGGGSCCHHHHHH
T ss_pred             HHccCCCCcCCCHHHHhh
Confidence            999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.9e-46  Score=363.05  Aligned_cols=270  Identities=16%  Similarity=0.218  Sum_probs=210.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchH----------HHHHHHHHHHHHhcCCCCceeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADE----------IIADFLSELGIMAHVDHPNTAK  171 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~----------~~~~~~~E~~il~~l~hpniv~  171 (408)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++.......          ....+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45789999999999999999998764      4789999987654211          0123445677788899999999


Q ss_pred             EEeEEEeC-----CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC--
Q 015389          172 LLGYGIEG-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--  244 (408)
Q Consensus       172 l~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~--  244 (408)
                      +++++...     ..++||||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence            99976652     268999999 999999997766789999999999999999999999   9999999999999998  


Q ss_pred             CCCceEEeecCCcccCCCCCccc-----eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccch
Q 015389          245 EDFEPQICDFGLAKWLPEQWTHH-----TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL  319 (408)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~  319 (408)
                      .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999998765432211     1134559999999999999999999999999999999999999998633221


Q ss_pred             hhh-hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          320 VLW-ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       320 ~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ... .........+..+++..+..   ...+..+..++..||+.+|.+||++.+|++.|+.+....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          269 KYVRDSKIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            110 11111122344455554421   123457888999999999999999999999998766433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.2e-46  Score=372.73  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=214.0

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++.....  .+.+.+|+.++++++||||+++++++.++..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEE
Confidence            34456789999999999999999999988888999999865432  3578899999999999999999999888889999


Q ss_pred             EEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            9999999999999653 3568999999999999999999999   99999999999999999999999999999876432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......+|..|+|||.+.++.++.++|||||||++|||++ |+.||......            .+...+....+.
T Consensus       334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------~~~~~i~~~~~~  400 (452)
T 1fmk_A          334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------EVLDQVERGYRM  400 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------HHHHHHHTTCCC
T ss_pred             ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence            11 12223457889999999999999999999999999999999 99999754322            111222222233


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ..+..++..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            3344556778899999999999999999999999998875544

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.5e-46  Score=356.40  Aligned_cols=263  Identities=24%  Similarity=0.352  Sum_probs=216.5

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  177 (408)
                      +....++|.+.+.||+|+||.||+|.+..      +..||+|.+......+....+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34556899999999999999999998642      2489999998776666678899999999999 8999999999776


Q ss_pred             e-CCeEEEEEecCCCCHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE
Q 015389          178 E-GGMHIVLELSPNGSLASLLYGM-------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       178 ~-~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      + +..++||||+++|+|.+++...             ...+++..++.++.||+.||.|||+   ++|+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence            5 4579999999999999999643             3457999999999999999999999   999999999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhh
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLW  322 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~  322 (408)
                      +.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |..||......    
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  273 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----  273 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----
Confidence            9999999999999987654433333344567889999999999999999999999999999998 99999754322    


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                             ..+...+........+...+..+..++.+||+.||.+|||+.+|++.|+...
T Consensus       274 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 -------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence                   1122223333332333334567888999999999999999999999998765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-45  Score=363.76  Aligned_cols=251  Identities=24%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|++.++||+|+||.||+|... +++.||||++++..  ..+....+..|..++.++ +||||+++++++.+. .+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            368999999999999999999976 58899999997643  223345677899999877 899999999976654 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|..++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.....
T Consensus       131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999854 4679999999999999999999999   99999999999999999999999999999853321


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH-HHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR-ELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~  342 (408)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........   .....+. .+...  ..
T Consensus       207 --~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~---~~~~~~~~~i~~~--~~  279 (396)
T 4dc2_A          207 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEK--QI  279 (396)
T ss_dssp             --TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------CCHHHHHHHHHHC--CC
T ss_pred             --CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch---hhHHHHHHHHhcc--cc
Confidence              2234567899999999999999999999999999999999999999975322110000   0000111 11111  11


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~  370 (408)
                      .++......+..++.+||+.||.+||++
T Consensus       280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            2233445678889999999999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=362.20  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++.+..  .......+..|..++..+ +||||+++++++.+. .+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999876 58999999997642  122356678899999988 799999999977654 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999999954 4679999999999999999999999   99999999999999999999999999999854322


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........           ...+....  ..
T Consensus       178 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----------~~~i~~~~--~~  242 (353)
T 3txo_A          178 --GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----------FEAILNDE--VV  242 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------HHHHHHCC--CC
T ss_pred             --CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-----------HHHHHcCC--CC
Confidence              2233457899999999999999999999999999999999999999986433211           11111111  11


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQM------SQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~------~evl~  375 (408)
                      ++......+..++.+||+.||.+||++      .++++
T Consensus       243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            223345568889999999999999998      67765

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-45  Score=350.47  Aligned_cols=263  Identities=21%  Similarity=0.295  Sum_probs=201.8

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ...++|++.+.||+|+||+||+|.+.+|+.||||++...... .....+.+|+.+++.++||||+++++++.+. ..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            345889999999999999999999988999999999755332 3457788999999999999999999977654 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+.+ +|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999975 8888887767779999999999999999999999   999999999999999999999999999998764322


Q ss_pred             ccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh-ccccc---c------chHH
Q 015389          265 THHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA-RPMIK---R------NEIR  333 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~---~------~~~~  333 (408)
                        .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .....   .      ....
T Consensus       174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence              22334568999999999876 5689999999999999999999999976443211100 00000   0      0000


Q ss_pred             HHhhhhcc---C----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVDASLA---D----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d~~l~---~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+....   .    .........+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000000   0    001112356788999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.6e-46  Score=368.50  Aligned_cols=282  Identities=20%  Similarity=0.264  Sum_probs=220.4

Q ss_pred             HHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEe
Q 015389          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus       102 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      +.++....++|.+.+.||+|+||+||+|.+. +|+.||+|++.+....  .....+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4456667789999999999999999999986 5899999999653211  112446789999999999999999997766


Q ss_pred             C-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          179 G-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       179 ~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                      . .+++||||+++|+|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||++
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence            5 47899999999999999953  468999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCC----CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGI----VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      +.+.... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||........           ..
T Consensus       216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----------~~  283 (410)
T 3v8s_A          216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----------YS  283 (410)
T ss_dssp             EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------HH
T ss_pred             EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-----------HH
Confidence            8765432 12234578999999999998765    88999999999999999999999986432211           11


Q ss_pred             HHhhhh--ccCcccHHHHHHHHHHHHhccccCCCC--CCCHHHHHH--HHhcccCccccccccCCchhhhhhh
Q 015389          334 ELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIR--RPQMSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTLR  400 (408)
Q Consensus       334 ~~~d~~--l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~--~L~~~~~~~~~~~~~~~~~~~~~~~  400 (408)
                      .+....  +...........+..++.+||+.+|.+  ||++.||++  .++++.+......+..+|+..+..+
T Consensus       284 ~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~  356 (410)
T 3v8s_A          284 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSS  356 (410)
T ss_dssp             HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSS
T ss_pred             HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCC
Confidence            121111  111111134566888999999999988  999999997  4566655555555566666555443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=349.96  Aligned_cols=248  Identities=18%  Similarity=0.174  Sum_probs=205.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|.+....  .....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            478999999999999999999876 58999999997553  2346678999999999999999999977664 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC--CCceEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~  264 (408)
                      |+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||++..+....
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999997666679999999999999999999999   99999999999999987  7899999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc-
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE-  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-  343 (408)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|..||........           +..+........ 
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----------~~~i~~~~~~~~~  224 (321)
T 1tki_A          159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----------IENIMNAEYTFDE  224 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------HHHHHHTCCCCCH
T ss_pred             ---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-----------HHHHHcCCCCCCh
Confidence               23445699999999999998899999999999999999999999976433211           111111111110 


Q ss_pred             -ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 -YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 -~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       .....+..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01123466888999999999999999999998

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.9e-45  Score=347.48  Aligned_cols=260  Identities=20%  Similarity=0.285  Sum_probs=210.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv  184 (408)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++...   ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999976 49999999998655444466778999999999999999999977653   46899


Q ss_pred             EEecCCCCHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE----CCCCceEEeecCCcc
Q 015389          185 LELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLAK  258 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla~  258 (408)
                      |||+++++|.+++.....  .+++..++.++.||+.||.|||+   ++|+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999965433  38999999999999999999999   999999999999999    778889999999998


Q ss_pred             cCCCCCccceecccccCCCcccccccc--------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLM--------HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      .+....   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.........       ..
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-------~~  234 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-------KE  234 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC-------HH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh-------HH
Confidence            765432   223456999999999986        578899999999999999999999999643221000       00


Q ss_pred             hHHHHhhh---------------------h--ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          331 EIRELVDA---------------------S--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       331 ~~~~~~d~---------------------~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+..+...                     .  ............+..++.+||+.||++|||+.|+++......
T Consensus       235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            00011100                     0  112344677888999999999999999999999999886543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.5e-45  Score=348.77  Aligned_cols=261  Identities=20%  Similarity=0.311  Sum_probs=209.1

Q ss_pred             cccCHHHHhhhcCC----------CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC
Q 015389           98 KIFSLYELQSATNN----------FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH  166 (408)
Q Consensus        98 ~~~~~~~~~~~~~~----------y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h  166 (408)
                      ..++..++..+++.          |...+.||+|+||.||+|... +|+.||||++...... ....+.+|+.+++.++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCC
Confidence            34666776666543          777789999999999999986 6999999999765432 35667899999999999


Q ss_pred             CceeEEEeEEEeC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC
Q 015389          167 PNTAKLLGYGIEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (408)
Q Consensus       167 pniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~  245 (408)
                      |||+++++++... ..++||||+++++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECT
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECC
Confidence            9999999977664 5789999999999999984  4569999999999999999999999   99999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc
Q 015389          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP  325 (408)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~  325 (408)
                      ++.+||+|||++..+.....  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........   
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~---  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---
T ss_pred             CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence            99999999999987654322  2234679999999999999999999999999999999999999997543221110   


Q ss_pred             ccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          326 MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       326 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                           .+.....+.+.  ........+.+++.+||+.||.+|||+.++++.
T Consensus       252 -----~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 -----RLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -----HHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -----HHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000001111  112234568889999999999999999999873

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-45  Score=356.30  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=203.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|.+.+.||+|+||.||+|... +|+.||||++......     .....+.+|+.++++++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            468999999999999999999876 5999999999765332     1246788999999999999999999977664 47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla  257 (408)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            899999999999999953 5679999999999999999999999   9999999999999998877    7999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ..+....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........           ..+..
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~-----------~~i~~  232 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----------ANITA  232 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHT
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHh
Confidence            8765432   234567999999999999999999999999999999999999999764332111           11111


Q ss_pred             hhcc--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASLA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....  ..........+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1000  0011123456888999999999999999999886

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.6e-46  Score=370.65  Aligned_cols=266  Identities=20%  Similarity=0.244  Sum_probs=211.8

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEE
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~  177 (408)
                      .+.++....++|++.++||+|+||+||+|.+. +++.||||++.+....  .....+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34566677889999999999999999999987 4899999999753211  12234778999999999999999999766


Q ss_pred             eC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          178 EG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       178 ~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      +. .+++||||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            64 5789999999999999997666789999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      ++.+..... ......+||+.|+|||++.     ++.++.++|||||||++|||++|+.||........           
T Consensus       222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-----------  289 (437)
T 4aw2_A          222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----------  289 (437)
T ss_dssp             CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------
T ss_pred             hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-----------
Confidence            987654322 2234467999999999997     56789999999999999999999999986433211           


Q ss_pred             HHHHhhhhccCccc---HHHHHHHHHHHHhccccCCCC--CCCHHHHHH--HHhccc
Q 015389          332 IRELVDASLADEYD---TRQMNLVLLAASLCIQQSSIR--RPQMSQVVQ--LLRGNL  381 (408)
Q Consensus       332 ~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~~P~~--RPt~~evl~--~L~~~~  381 (408)
                      ...++.......++   ......+.+++.+||+.+|.+  ||++.|+++  .++++.
T Consensus       290 ~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            11111111111111   123456788999999888888  999999987  455443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-45  Score=343.77  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=211.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      .++|++.+.||+|+||.||+|.+.+++.||||.+......  .+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            4688999999999999999999988899999999876543  2568899999999999999999997765 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            99999999997766779999999999999999999999   999999999999999999999999999998664321 11


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........            ...+........+.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------------~~~i~~~~~~~~~~  228 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------------VEDISTGFRLYKPR  228 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------HHHHHTTCCCCCCT
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------------HHHHhcCCcCCCCc
Confidence            2233457889999999998999999999999999999999 8999975432211            11111111222223


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .....+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            34567888999999999999999999999998764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=381.91  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=212.1

Q ss_pred             cCCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          109 TNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~-~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .+++.+.+ .||+|+||.||+|.+.   ++..||||+++........+.+.+|+.++++++||||+++++++..+..++|
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  413 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV  413 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEE
Confidence            34555555 7999999999999864   4678999999876544456789999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+.+|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus       414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            99999999999997777789999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ... ......+|+.|+|||++.++.++.++|||||||+||||++ |+.||......            .+...+....+.
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------------~~~~~i~~~~~~  558 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------EVMAFIEQGKRM  558 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH------------HHHHHHHTTCCC
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence            211 1223346789999999999999999999999999999998 99999864332            122233333333


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ..+..++..+.+++.+||+.+|.+||++.+|++.|+....
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            3444566789999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.3e-45  Score=346.63  Aligned_cols=260  Identities=27%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~  182 (408)
                      ..+|++.+.||+|+||.||+|.+.+    +..||+|.+...........+.+|+.++++++||||+++++++.+  +..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578899999999999999998642    346899999877666677889999999999999999999997653  3578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+.+|+|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            9999999999999997777789999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc--ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          263 QWTH--HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       263 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ....  .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......            ....+...
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------------~~~~~~~~  248 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------------ITVYLLQG  248 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------------HHHHHHTT
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------------HHHHHhcC
Confidence            3211  22234567889999999999999999999999999999999 555665432211            11111111


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      .....+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       249 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          249 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11122223445788899999999999999999999999887643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3e-45  Score=352.54  Aligned_cols=257  Identities=19%  Similarity=0.221  Sum_probs=206.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv~  185 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++......   ..+.+|+.+++.+ +||||+++++++..+. .++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            478999999999999999999874 6999999998754332   3467899999999 9999999999877755 68999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc-----eEEeecCCcccC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-----PQICDFGLAKWL  260 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DfGla~~~  260 (408)
                      ||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.     +||+|||++..+
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 999999997667789999999999999999999999   99999999999999999887     999999999876


Q ss_pred             CCCCccc-----eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          261 PEQWTHH-----TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       261 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      .......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........        +..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~--------~~~i  232 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER--------YQKI  232 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH--------HHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH--------HHHH
Confidence            4432211     12456799999999999999999999999999999999999999986433211100        0111


Q ss_pred             hhhhccCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          336 VDASLADEY---DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       336 ~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .........   ....+ .+..++.+||+.+|.+||++.+|++.|+...
T Consensus       233 ~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          233 GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            111110000   01123 7888999999999999999999999997654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=350.44  Aligned_cols=245  Identities=25%  Similarity=0.299  Sum_probs=194.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|++.++||+|+||+||+|.+. +|+.||||++..... ......+..|+..+..+ +||||+++++++.++. .++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            368999999999999999999986 699999999875432 23344555666665555 8999999999877654 7899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 779999987777789999999999999999999999   999999999999999999999999999998764322


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                         ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....              ...+.........
T Consensus       212 ---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------------~~~~~~~~~~~~~  273 (311)
T 3p1a_A          212 ---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------------WQQLRQGYLPPEF  273 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------------HHHHTTTCCCHHH
T ss_pred             ---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------------HHHHhccCCCccc
Confidence               2234569999999999875 799999999999999999999776653221              1111111111111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......+.+++.+||+.||.+|||+.|+++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            2233567888999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-45  Score=351.38  Aligned_cols=264  Identities=27%  Similarity=0.404  Sum_probs=209.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  182 (408)
                      ..+|.+.+.||+|+||.||+|.+..     +..||||.+...........+.+|+.+++.++||||+++++++.+ +..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4678889999999999999998642     346999999876666667789999999999999999999998766 4578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            9999999999999997766789999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......            .+...+....
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------------~~~~~~~~~~  267 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------------EVMKAINDGF  267 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------HHHHHHHTTC
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------------HHHHHHHCCC
Confidence            3221 11223346789999999999999999999999999999999 99999754322            1111222222


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccccc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYM  387 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~  387 (408)
                      ....+...+..+.+++.+||+.||.+||++.+|++.|+.+.......
T Consensus       268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence            22223345567889999999999999999999999998876554443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.8e-45  Score=367.81  Aligned_cols=251  Identities=28%  Similarity=0.399  Sum_probs=209.3

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC--CeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG--GMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--~~~lv  184 (408)
                      ...++|++.+.||+|+||.||+|.+. |+.||||+++...   ..+.+.+|+.++++++||||+++++++.+.  ..++|
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            45578999999999999999999985 7899999998654   346788999999999999999999987654  58999


Q ss_pred             EEecCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999976443 37999999999999999999999   99999999999999999999999999999854321


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                           .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......            .+...+....+.
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------~~~~~i~~~~~~  405 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------DVVPRVEKGYKM  405 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------------THHHHHHTTCCC
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence                 122357899999999999999999999999999999998 99999754322            112222222333


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+..++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            344456678899999999999999999999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=356.66  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=200.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCC--CceeEEEeEEEeCC-eEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDH--PNTAKLLGYGIEGG-MHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~h--pniv~l~~~~~~~~-~~l  183 (408)
                      ..++|++.+.||+|+||.||+|...+++.||||++.... .......+.+|+.++..++|  |||+++++++.... .++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            457899999999999999999998889999999997553 33456788999999999976  99999999877655 678


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||| +.+++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++ ++.+||+|||++..+...
T Consensus        87 v~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            888 678899999954 5678999999999999999999999   9999999999999997 578999999999877554


Q ss_pred             CccceecccccCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMH-----------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......          ..+
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------~~~  230 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----------SKL  230 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----------HHH
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----------HHH
Confidence            33333445679999999999865           678999999999999999999999997532211          122


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...+++.....++......+.+++.+||+.||.+|||+.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            23333333333333344568889999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.4e-45  Score=345.93  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCCceeEEEeEEEe-----CC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIE-----GG  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~-----~~  180 (408)
                      ..++|++.+.||+|+||+||+|.+ +|+.||||++....    ...+..|.+++..  ++||||+++++++..     ..
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            347899999999999999999988 68999999987543    2334456666555  799999999997543     23


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH--------EGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                      .++||||+++|+|.+++.  ...+++..++.++.||+.||.|||        +   ++|+||||||+|||++.++.+||+
T Consensus        81 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence            789999999999999993  457999999999999999999999        6   999999999999999999999999


Q ss_pred             ecCCcccCCCCCccc--eecccccCCCccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CCCCCc
Q 015389          253 DFGLAKWLPEQWTHH--TISKVEGTFGYLAPEFLMHG------IVDEKTDVFAFGVLLLELVTG----------RRALDY  314 (408)
Q Consensus       253 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvil~elltg----------~~pf~~  314 (408)
                      |||++..........  ......||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999997654432221  12334799999999999877      455799999999999999999          777754


Q ss_pred             cccchhhhhccccccchHHHHhh-hhccC-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          315 SQQSLVLWARPMIKRNEIRELVD-ASLAD-----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~d-~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .......       ...+..... .....     .........+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       236 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPS-------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCC-------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcc-------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            2211000       001111110 00111     12235678899999999999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-45  Score=344.46  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=211.0

Q ss_pred             CCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C-eEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G-MHIV  184 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~-~~lv  184 (408)
                      .|.+.+.||+|+||.||+|.+.+    +..||+|.+.........+.+.+|+.+++.++||||+++++++.+. . .++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667999999999999998532    3379999998766666778899999999999999999999987653 3 4899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+.+|+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++..+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            99999999999997777789999999999999999999999   999999999999999999999999999998664432


Q ss_pred             c--cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC-CccccchhhhhccccccchHHHHhhhhcc
Q 015389          265 T--HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRAL-DYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       265 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      .  ........+|+.|+|||.+.+..++.++|||||||++|+|++|..|+ ......            .+...+.....
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF------------DLTHFLAQGRR  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG------------GHHHHHHTTCC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH------------HHHHHhhcCCC
Confidence            1  12223456889999999999999999999999999999999966654 332211            12222222222


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ...+......+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            22333445678899999999999999999999999988765443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-45  Score=354.12  Aligned_cols=272  Identities=25%  Similarity=0.333  Sum_probs=217.5

Q ss_pred             CCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~  181 (408)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++..... .....+.+|+.++++++||||+++++++..   ...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            6899999999999999999984     3589999999987643 446778999999999999999999997653   337


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            89999999999999997766779999999999999999999999   999999999999999999999999999998775


Q ss_pred             CCCccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc---cchHHHHhh
Q 015389          262 EQWTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK---RNEIRELVD  337 (408)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~d  337 (408)
                      ...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||................   ...+...+.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            433221 2234568889999999999999999999999999999999999987644332211111111   122233333


Q ss_pred             hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       338 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      .......+...+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            333444455566789999999999999999999999999988865443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.6e-45  Score=343.79  Aligned_cols=263  Identities=18%  Similarity=0.203  Sum_probs=210.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++......   ..+.+|+.++..+ +|+|++++++++.++. .++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            347899999999999999999986 46999999998754322   3456899999999 7999999999877654 6899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc-----eEEeecCCccc
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-----PQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~-----~kl~DfGla~~  259 (408)
                      |||+ +++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.     +||+|||++..
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999 999999997766779999999999999999999999   99999999999999987776     99999999987


Q ss_pred             CCCCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH
Q 015389          260 LPEQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       260 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      .......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........        .+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--------~~~~  232 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--------KYER  232 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH--------HHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH--------HHHH
Confidence            6543221     12345679999999999999999999999999999999999999998643221110        0111


Q ss_pred             HhhhhccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          335 LVDASLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       335 ~~d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      +........   .....+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          233 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            111111110   111235678899999999999999999999999988765443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-45  Score=373.37  Aligned_cols=260  Identities=26%  Similarity=0.404  Sum_probs=216.9

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      .....+|++.+.||+|+||.||+|.+.. +..||||.+......  ...+.+|+.++++++||||+++++++.+. ..++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3445678999999999999999999874 889999999865433  46789999999999999999999987764 5899


Q ss_pred             EEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||||+++|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999999653 4568999999999999999999999   9999999999999999999999999999987643


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      .. ........+++.|+|||.+.++.++.++|||||||+||||++ |..||......            .+...+....+
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------------~~~~~~~~~~~  437 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYELLEKDYR  437 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------------GHHHHHHTTCC
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCC
Confidence            21 122233456789999999999999999999999999999999 99999764322            22233333333


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ...+..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            344445667889999999999999999999999999987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=347.26  Aligned_cols=249  Identities=24%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-------------------------HHHHHHHHHHHHHh
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------------------------EIIADFLSELGIMA  162 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-------------------------~~~~~~~~E~~il~  162 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++......                         .....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999875 5899999999754321                         12456889999999


Q ss_pred             cCCCCceeEEEeEEEe---CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCC
Q 015389          163 HVDHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAA  239 (408)
Q Consensus       163 ~l~hpniv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~  239 (408)
                      .++||||+++++++.+   ...++||||+++++|.+++  ....+++..+..++.||+.||.|||+   ++|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence            9999999999998775   3478999999999998865  34579999999999999999999999   99999999999


Q ss_pred             ceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccc
Q 015389          240 NILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVTGRRALDYSQ  316 (408)
Q Consensus       240 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltg~~pf~~~~  316 (408)
                      |||++.++.+||+|||++.......  .......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999998765432  2234567999999999998765   4788999999999999999999997543


Q ss_pred             cchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          317 QSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....           ..+................+.+++.+||+.||.+||++.|+++
T Consensus       245 ~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLH-----------SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHH-----------HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHH-----------HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21110           0111111111111234456888999999999999999999865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=347.14  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=201.7

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSP  189 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~  189 (408)
                      ++|++.+.||+|+||.||+|.+. ++.||||.+....   ....+.+|+.++++++||||+++++++. +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL-NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT-TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcEEEEEcCC
Confidence            67899999999999999999885 7889999987542   3567889999999999999999999766 45899999999


Q ss_pred             CCCHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc-eEEeecCCcccCCCCCcc
Q 015389          190 NGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE-PQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       190 ~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~-~kl~DfGla~~~~~~~~~  266 (408)
                      +|+|.+++.....  .+++..++.++.|++.||.|||+.+.++|+||||||+||+++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999965432  4788899999999999999999865578999999999999998886 799999999765432   


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                        .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........          +..............
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----------IMWAVHNGTRPPLIK  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----------HHHHHHTTCCCCCBT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----------HHHHHhcCCCCCccc
Confidence              22345999999999999999999999999999999999999999754322111          001111111222223


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ..+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            34567888999999999999999999999998776443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-45  Score=341.51  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=197.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch---HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD---EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      ..++|++.+.||+|+||.||+|.+. |+.||||++......   .....+.+|+.+++.++||||+++++++.+. ..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3478999999999999999999985 889999998764332   2356788999999999999999999977654 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eEeeCCCCCceEECC--------CCceEEe
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR---IIHRDIKAANILLTE--------DFEPQIC  252 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---iiH~Dikp~NIll~~--------~~~~kl~  252 (408)
                      ||||+++++|.+++.  ...+++..++.++.|++.||.|||+   ++   |+||||||+||+++.        ++.+||+
T Consensus        84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999999984  5679999999999999999999999   77   999999999999986        6789999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      |||++.......    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           
T Consensus       159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----------  223 (271)
T 3dtc_A          159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-----------  223 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-----------
T ss_pred             cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence            999998654321    22456999999999999999999999999999999999999999864432111           


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ............+...+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111112222223344556788999999999999999999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.9e-45  Score=352.57  Aligned_cols=250  Identities=24%  Similarity=0.288  Sum_probs=199.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++.+..  .......+.+|..++.++ +||||+++++++.+ ...++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            67999999999999999999976 58999999997643  334567788999999988 89999999997665 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        89 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-  163 (345)
T ss_dssp             ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred             EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence            999999999999954 4579999999999999999999999   99999999999999999999999999999864322 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH-HHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR-ELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~d~~l~~~  343 (408)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........   .....+. .+...  ...
T Consensus       164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~~~~~~i~~~--~~~  237 (345)
T 3a8x_A          164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---NTEDYLFQVILEK--QIR  237 (345)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------CHHHHHHHHHHC--CCC
T ss_pred             -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc---ccHHHHHHHHHcC--CCC
Confidence             1233456899999999999999999999999999999999999999975322100000   0000111 11111  112


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQM  370 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~  370 (408)
                      ++......+..++.+||+.||.+||++
T Consensus       238 ~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            233445678889999999999999995

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.2e-45  Score=338.81  Aligned_cols=251  Identities=21%  Similarity=0.289  Sum_probs=207.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|.+. |+.||||++.... .......+.+|+.++++++||||+++++++.+.   ..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            368999999999999999999985 8899999998654 334567899999999999999999999987764   47999


Q ss_pred             EEecCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||+   ++  |+||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999976443 58999999999999999999998   78  9999999999999999999999998876432


Q ss_pred             CCCccceecccccCCCccccccccCCCCCc---chhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDE---KTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      .       ....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||........           .......
T Consensus       165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----------~~~~~~~  226 (271)
T 3kmu_A          165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----------GMKVALE  226 (271)
T ss_dssp             C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----------HHHHHHS
T ss_pred             c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----------HHHHHhc
Confidence            2       2345899999999998765554   89999999999999999999975433211           1112222


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2223333445567889999999999999999999999998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.2e-45  Score=347.04  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=211.9

Q ss_pred             hcCCCCccc-eecccCcEEEEEEEEc---CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeE
Q 015389          108 ATNNFSFEN-LIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (408)
Q Consensus       108 ~~~~y~~~~-~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  182 (408)
                      ..++|.+.+ .||+|+||.||+|.+.   +++.||||++..... ......+.+|+.+++.++||||+++++++..+..+
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   93 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM   93 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcE
Confidence            346788888 9999999999999642   478999999986543 23467889999999999999999999998778899


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus        94 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             EEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999999954 4568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......            +...+....
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------~~~~~~~~~  237 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------VTAMLEKGE  237 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------------HHHHHHTTC
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------------HHHHHHcCC
Confidence            3222 12223456789999999998889999999999999999999 999998643321            122222222


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ....+...+..+..++.+||+.||.+||++.+|++.|+.+.....
T Consensus       238 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            223334456678899999999999999999999999988764443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-44  Score=346.76  Aligned_cols=257  Identities=22%  Similarity=0.338  Sum_probs=188.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++... ..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999875 58999999997655443456778999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          187 LSPNGSLASLLYGMK-----EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |+. |+|.+++....     ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999885432     458999999999999999999999   999999999999999999999999999998764


Q ss_pred             CCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-cc-------------
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PM-------------  326 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~-------------  326 (408)
                      ...  .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ ..             
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            321  223345689999999999764 6899999999999999999999999765432111000 00             


Q ss_pred             -----------cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 -----------IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 -----------~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                 .....+...+.+....    .....+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                       0001111111111111    23356889999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-45  Score=358.38  Aligned_cols=249  Identities=26%  Similarity=0.353  Sum_probs=202.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....  ......+.+|+.+++.++||||+++++++.+ ...++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            68999999999999999999876 589999999875431  1235678899999999999999999997665 4578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||++..+...  
T Consensus        95 e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--  168 (384)
T ss_dssp             CCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred             ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence            99999999999954 5679999999999999999999999   99999999999999999999999999999876543  


Q ss_pred             cceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          266 HHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                       .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........         .+...+.. ...
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---------~~~~~~~~-~~~  237 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---------EIVHTFET-TVV  237 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---------HHHHHHHH-CCC
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---------HHHHHHhh-ccc
Confidence             22345779999999999974   45899999999999999999999999753322110         11111111 111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQ-MSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~  375 (408)
                      .++......+..++.+||+.||.+||+ +.+|.+
T Consensus       238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            223344567888999999999999998 777765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.9e-45  Score=358.86  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCC--CCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|++.+.||+|+||.||+|...+++.||||++.... .......+.+|+.++..++  ||||+++++++.... .++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            35699999999999999999998889999999997653 3445788899999999996  599999999877654 6889


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      || +.+++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++ ++.+||+|||++..+....
T Consensus       135 ~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 678999999964 4578899999999999999999999   9999999999999996 5799999999998775443


Q ss_pred             ccceecccccCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH
Q 015389          265 THHTISKVEGTFGYLAPEFLMH-----------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR  333 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  333 (408)
                      .........||+.|+|||++.+           ..++.++||||||||||||++|+.||.......          ..+.
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------~~~~  278 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----------SKLH  278 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----------HHHH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----------HHHH
Confidence            3333345679999999999865           468999999999999999999999997532211          1122


Q ss_pred             HHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       334 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .++++.....++......+.+++.+||+.||.+||++.||++
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            333333332233333456888999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.1e-45  Score=344.93  Aligned_cols=259  Identities=26%  Similarity=0.404  Sum_probs=215.9

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      ....++|++.+.||+|+||.||+|.+.. +..||||.+.....  ....+.+|+.++++++||||+++++++.+. ..++
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3456789999999999999999999864 88999999986543  356788999999999999999999987664 5789


Q ss_pred             EEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||||+.+++|.+++.. ....+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999965 34569999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......            .+...+.....
T Consensus       164 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~------------~~~~~~~~~~~  230 (288)
T 3kfa_A          164 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------QVYELLEKDYR  230 (288)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------------GHHHHHHTTCC
T ss_pred             Ccc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHhccCC
Confidence            322 23334557889999999999999999999999999999999 99999754322            12222333333


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ...+...+..+.+++.+||+.||.+|||+.++++.|+....
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            33344456778899999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-45  Score=358.83  Aligned_cols=261  Identities=26%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc--C--CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--N--GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~l  183 (408)
                      ..|.+.+.||+|+||.||+|.+.  +  +..||||.+...........+.+|+.++++++||||+++++++.+  +..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            34778899999999999999864  2  246899999876555667889999999999999999999997653  45789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            999999999999997777789999999999999999999999   99999999999999999999999999999866432


Q ss_pred             Ccc--ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          264 WTH--HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       264 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ...  .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........            ...+....
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~------------~~~~~~~~  313 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------------TVYLLQGR  313 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH------------HHHHHTTC
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH------------HHHHHcCC
Confidence            211  11233457889999999999999999999999999999999 6777765432211            11111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ....+..++..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       314 ~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            112223345678899999999999999999999999988765443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-45  Score=357.42  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=201.7

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCe
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGM  181 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~  181 (408)
                      ...++|.+.+.||+|+||.||+|.++ +|+.||||++.+...  .+....+..|..++..+ +||||+++++++.+ +..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34589999999999999999999986 589999999975421  12345677899998876 99999999997665 457


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++...
T Consensus        94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            899999999999999954 4578999999999999999999999   999999999999999999999999999998643


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+...  .
T Consensus       170 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------~~i~~~--~  234 (345)
T 1xjd_A          170 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-----------HSIRMD--N  234 (345)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHC--C
T ss_pred             cC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH-----------HHHHhC--C
Confidence            22  12234578999999999999999999999999999999999999999864432111           011111  1


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMS-QVV  374 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl  374 (408)
                      ..++......+.+++.+||+.||.+||++. +|+
T Consensus       235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            112223456788899999999999999997 665

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-44  Score=340.97  Aligned_cols=260  Identities=20%  Similarity=0.290  Sum_probs=199.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.++ ..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999976 589999999975443 34567788999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+ +|.+.+......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9975 6666665667789999999999999999999999   99999999999999999999999999999876432  2


Q ss_pred             ceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc--c---cccch---HHHHhh
Q 015389          267 HTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP--M---IKRNE---IRELVD  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~--~---~~~~~---~~~~~d  337 (408)
                      .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.............  .   .....   .....+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2234456899999999998766 8999999999999999999988864322211100000  0   00000   000000


Q ss_pred             ---------hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ---------ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ---------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                               ..............+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                     00000111224456788999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=376.55  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=218.0

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      +....++|++.+.||+|+||.||+|.+.++..||||+++.....  .+.+.+|+.++++++||||+++++++.++..++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEe
Confidence            34455778999999999999999999988888999999865432  3578899999999999999999999888889999


Q ss_pred             EEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+.+|+|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus       340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999999653 3568999999999999999999999   99999999999999999999999999999876532


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      . ........++..|+|||.+.++.++.++|||||||+||||++ |+.||......            .+...+....+.
T Consensus       417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------------~~~~~i~~~~~~  483 (535)
T 2h8h_A          417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------EVLDQVERGYRM  483 (535)
T ss_dssp             H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------------HHHHHHHTTCCC
T ss_pred             c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence            1 111223447789999999999999999999999999999999 99999754322            112222222222


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ..+..+...+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            3334556778899999999999999999999999998865443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4e-45  Score=344.85  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||+|...+|+.||||++...... .....+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            579999999999999999999888999999999765432 234667899999999999999999997765 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.+ +|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 8999987766789999999999999999999999   999999999999999999999999999998654321  1


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-cccc---cc---hHH--HHhh
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PMIK---RN---EIR--ELVD  337 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~~---~~---~~~--~~~d  337 (408)
                      ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ ....   ..   ...  ...+
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            22345689999999999764 5899999999999999999999999764332111000 0000   00   000  0000


Q ss_pred             hhcc-------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASLA-------DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l~-------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +...       ..........+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000       0011123456788999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-44  Score=345.93  Aligned_cols=273  Identities=24%  Similarity=0.335  Sum_probs=203.2

Q ss_pred             HHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCCceeEEEeEEEeC
Q 015389          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIEG  179 (408)
Q Consensus       102 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~~  179 (408)
                      ........++|++.+.||+|+||.||+|.+. |+.||||++.....    ..+..|.+++..  ++||||+++++++...
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            3334455678999999999999999999985 89999999865432    233445555544  4999999999977664


Q ss_pred             -----CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeEeeCCCCCceEECCC
Q 015389          180 -----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR--------RIIHRDIKAANILLTED  246 (408)
Q Consensus       180 -----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~iiH~Dikp~NIll~~~  246 (408)
                           ..++||||+++|+|.+++.  ...+++..++.++.|++.||.|||+   +        +|+||||||+|||++.+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHH--HCCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCceEEEEeccCCCcHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCC
Confidence                 4789999999999999994  3468999999999999999999998   6        99999999999999999


Q ss_pred             CceEEeecCCcccCCCCCccc--eecccccCCCccccccccCCCCCcc------hhHHHHHHHHHHHHhCCCCCCccccc
Q 015389          247 FEPQICDFGLAKWLPEQWTHH--TISKVEGTFGYLAPEFLMHGIVDEK------TDVFAFGVLLLELVTGRRALDYSQQS  318 (408)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------~DvwSlGvil~elltg~~pf~~~~~~  318 (408)
                      +.+||+|||++..+.......  ......||+.|+|||.+.+..++.+      +|||||||++|||++|..|+......
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999998765432221  1224579999999999988776665      99999999999999995444322211


Q ss_pred             hhhhhcccccc---chHHHHh-hhhccCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          319 LVLWARPMIKR---NEIRELV-DASLADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       319 ~~~~~~~~~~~---~~~~~~~-d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ...|.......   ..+...+ ...+....+     ..+...+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            11111111111   1111111 111122222     267788999999999999999999999999998876544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=346.71  Aligned_cols=248  Identities=24%  Similarity=0.321  Sum_probs=202.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|.+.+.||+|+||.||+|... +|+.||||++......     .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            57899999999999999999976 5899999999764322     1356788999999999999999999977764 478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCcc
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla~  258 (408)
                      +||||+++++|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||++.
T Consensus        91 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           91 LILELVAGGELFDFLA-EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             EEEECCCSCBHHHHHT-TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCCCHHHHHH-hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            9999999999999995 35679999999999999999999999   9999999999999999887    79999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      .+....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+...
T Consensus       167 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------~~~~~~  232 (326)
T 2y0a_A          167 KIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----------ANVSAV  232 (326)
T ss_dssp             ECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHHT
T ss_pred             ECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----------HHHHhc
Confidence            765322   223456999999999999999999999999999999999999999754322111           001000


Q ss_pred             h--ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 S--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .  ............+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0  000111123456788999999999999999999987

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.3e-45  Score=347.84  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  180 (408)
                      ....++|.+.+.||+|+||.||+|.+.    .+..||||.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            345578999999999999999999764    35589999997653 3445678899999999999999999999876532


Q ss_pred             ------eEEEEEecCCCCHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          181 ------MHIVLELSPNGSLASLLYG-----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       181 ------~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                            .++||||+++++|.+++..     ....+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcE
Confidence                  4899999999999999843     33569999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  328 (408)
                      ||+|||++..+.............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......         
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---------  257 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---------  257 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---------
Confidence            9999999987654332233344567889999999999999999999999999999999 888987543321         


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                         +...+........+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       258 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          258 ---MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ---HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence               1111111112223334556788999999999999999999999999887543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.1e-45  Score=339.47  Aligned_cols=253  Identities=24%  Similarity=0.316  Sum_probs=205.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++.+++ .++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            367999999999999999999976 689999999976544455678889999999999999999999877654 689999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++. ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.........
T Consensus        86 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999884 34568999999999999999999999   99999999999999999999999999999866433222


Q ss_pred             ceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.........+.          .+..........
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~~  231 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----------DWKEKKTYLNPW  231 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH----------HHHTTCTTSTTG
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH----------HhhhcccccCch
Confidence            33345679999999999988775 7899999999999999999999986543221111          111111011111


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          232 KKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            233456788999999999999999999876

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=362.27  Aligned_cols=265  Identities=22%  Similarity=0.244  Sum_probs=210.0

Q ss_pred             cCHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEE
Q 015389          100 FSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYG  176 (408)
Q Consensus       100 ~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~  176 (408)
                      +.+.+.....++|++.+.||+|+||+||+|..+ +|+.||||++.+...  ......+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345566667789999999999999999999986 699999999975321  12234578899999999999999999976


Q ss_pred             EeC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          177 IEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       177 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      .+. .+++||||+++|+|.+++...+..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeech
Confidence            654 5789999999999999997666689999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCcccccccc-------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLM-------HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  328 (408)
                      +++.+..... ......+||+.|+|||++.       ++.++.++|||||||++|||++|+.||........        
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------  278 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--------  278 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--------
Confidence            9987654322 1223467999999999997       45789999999999999999999999976433211        


Q ss_pred             cchHHHHhhhh--cc-CcccHHHHHHHHHHHHhccccCCCCC---CCHHHHHH--HHhcc
Q 015389          329 RNEIRELVDAS--LA-DEYDTRQMNLVLLAASLCIQQSSIRR---PQMSQVVQ--LLRGN  380 (408)
Q Consensus       329 ~~~~~~~~d~~--l~-~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~~evl~--~L~~~  380 (408)
                         ...++...  +. .......+..+.+++.+||+ +|.+|   |++.||++  .++++
T Consensus       279 ---~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          279 ---YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ---HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ---HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence               11111110  11 11112345678889999999 99998   58999876  34444

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=360.09  Aligned_cols=251  Identities=20%  Similarity=0.239  Sum_probs=203.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3468999999999999999999875 699999999986543 33467788999999999999999999977665 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC---CCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~~  261 (408)
                      |||+.+|+|.+.+.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||++....
T Consensus        89 ~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999999999854 4679999999999999999999999   9999999999999998   46789999999998765


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........           ..+......
T Consensus       165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~-----------~~i~~~~~~  231 (444)
T 3soa_A          165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY-----------QQIKAGAYD  231 (444)
T ss_dssp             TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----------HHHHHTCCC
T ss_pred             CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH-----------HHHHhCCCC
Confidence            432  2224467999999999999999999999999999999999999999764332111           111111110


Q ss_pred             --CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 --DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 --~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        ..........+.+++.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              1111233566888999999999999999999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-44  Score=351.81  Aligned_cols=251  Identities=21%  Similarity=0.278  Sum_probs=204.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3468999999999999999999876 58999999997654 234567788999999999999999999977765 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~~  261 (408)
                      |||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||++....
T Consensus       107 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999853 4678999999999999999999999   9999999999999998654   59999999998765


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........           ..+......
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------~~i~~~~~~  248 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----------AQIKAGAYD  248 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTCCC
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHhCCCC
Confidence            322   223467999999999999999999999999999999999999999764332111           011111110


Q ss_pred             --CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          342 --DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       342 --~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        ..........+.+++.+||+.||.+||++.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              11112234568889999999999999999998863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-45  Score=351.27  Aligned_cols=263  Identities=27%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             cCCCCccceecccCcEEEEEEEE------cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL------RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|++.+.||+|+||.||+|.+      .+++.||||.+...........+.+|+.+++.++||||+++++++.+. ..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            47899999999999999999983      247899999998766666677889999999999999999999987764 57


Q ss_pred             EEEEEecCCCCHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEe
Q 015389          182 HIVLELSPNGSLASLLYGMK------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQIC  252 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~  252 (408)
                      ++||||+++++|.+++....      ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999996543      458899999999999999999999   99999999999999984   4469999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccch
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      |||++................||+.|+|||.+.+..++.++|||||||++|+|++ |+.||......            .
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~  253 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------E  253 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------H
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------------H
Confidence            9999976533322223334568999999999999999999999999999999998 99999754322            1


Q ss_pred             HHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccc
Q 015389          332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKY  386 (408)
Q Consensus       332 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~  386 (408)
                      +...+........+......+.+++.+||+.||.+||++.+|++.|+........
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          254 VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            1112222222223334456788999999999999999999999999877654443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-44  Score=351.30  Aligned_cols=249  Identities=20%  Similarity=0.246  Sum_probs=200.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc----hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++.....    ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57999999999999999999875 699999999864321    11246788999999999999999999977664 5789


Q ss_pred             EEEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc---eEEeecCCc
Q 015389          184 VLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLA  257 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla  257 (408)
                      ||||+++++|.+++...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999887542   3358999999999999999999999   99999999999999987654   999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........            ..+..
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------------~~i~~  246 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF------------EGIIK  246 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHH------------HHHHH
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHH------------HHHHc
Confidence            8765432  123345799999999999999999999999999999999999999986432111            11111


Q ss_pred             hhccCc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASLADE--YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......  ........+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111100  00123467888999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=353.32  Aligned_cols=250  Identities=21%  Similarity=0.237  Sum_probs=205.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            368999999999999999999876 6899999999765433 345788999999999999999999977664 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC--CCceEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~  264 (408)
                      |+.+|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.  ++.+||+|||++..+....
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999997666689999999999999999999999   99999999999999974  4679999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh--ccC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS--LAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~~  342 (408)
                         ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........           ..+....  ...
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----------~~i~~~~~~~~~  271 (387)
T 1kob_A          206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-----------QNVKRCDWEFDE  271 (387)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHHCCCCCCS
T ss_pred             ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCCCc
Confidence               223456999999999999999999999999999999999999999864332110           1111110  111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .........+.+++.+||+.||.+|||+.|+++.
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1112345678889999999999999999999973

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.2e-45  Score=353.11  Aligned_cols=244  Identities=22%  Similarity=0.266  Sum_probs=202.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++.....  ......+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999976 699999999975432  12356788999999999999999999977654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            99999999999954 4568999999999999999999999   99999999999999999999999999999876432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........           ...+....  ..++
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----------~~~i~~~~--~~~p  258 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----------YEKIVSGK--VRFP  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------HHHHHHCC--CCCC
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-----------HHHHHcCC--CCCC
Confidence               2346799999999999999999999999999999999999999975432211           11111111  1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      ......+..++.+||+.||.+||+     +.+|++
T Consensus       259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            334567888999999999999998     788775

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-44  Score=347.42  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=193.7

Q ss_pred             cCCCCccceecccCcEEEEEEEE----cCCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  180 (408)
                      .++|++.+.||+|+||.||+|..    .+|+.||||++.....   ......+.+|+.+++.++||||+++++++.. +.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36899999999999999999987    4689999999986532   2235667889999999999999999997665 56


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        96 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            8999999999999999954 4568999999999999999999999   99999999999999999999999999999754


Q ss_pred             CCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ...  ........||+.|+|||.+.+..++.++|||||||++|+|++|+.||........           +..+.... 
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~~~i~~~~-  237 (327)
T 3a62_A          172 IHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-----------IDKILKCK-  237 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------HHHHHHTC-
T ss_pred             ccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-----------HHHHHhCC-
Confidence            322  1223456799999999999999999999999999999999999999986433211           11111111 


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                       ...+......+.+++.+||+.||.+||     ++.++++
T Consensus       238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence             112223456788899999999999999     7778876

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.5e-44  Score=352.32  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=192.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++......  ...+.+|+.+++.++||||+++++++... ..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            478999999999999999999986 6999999999765432  24567999999999999999999977664 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc--eEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGla~~~~~~~  264 (408)
                      |+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.  +||+|||+++..... 
T Consensus        97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            9999999999854 4579999999999999999999999   99999999999999987765  999999999743321 


Q ss_pred             ccceecccccCCCccccccccCCCCCcc-hhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEK-TDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........       ...+..+........
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~~~~~~~~~~~~~~  242 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-------RKTIQRILSVKYSIP  242 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-------HHHHHHHHTTCCCCC
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-------HHHHHHHhcCCCCCC
Confidence              22234569999999999998888765 89999999999999999999864321100       011111222111111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ........+..++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 DDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            11123456788999999999999999999987

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.7e-45  Score=346.44  Aligned_cols=258  Identities=21%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C----
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G----  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~----  180 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....  .......+.+|+.+++.++||||+++++++... .    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            478999999999999999999974 69999999998653  334567889999999999999999999976543 2    


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            3899999999999999954 4578999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          261 PEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........+.........        
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------  238 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--------  238 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC--------
Confidence            543222 22234569999999999999999999999999999999999999998654332211110000000        


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHHhc
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVV-QLLRG  379 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl-~~L~~  379 (408)
                       ........+..+..++.+||+.||.+||++.+++ ..|..
T Consensus       239 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          239 -PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             -HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence             0000112345688899999999999999765544 44543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-44  Score=346.97  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEE--EEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLV--AIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~v--avK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|.+. +|..+  |||.+...........+.+|+.+++++ +||||+++++++.+. ..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999865 56644  999988655555567788999999999 899999999977765 47899


Q ss_pred             EEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          185 LELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      |||+++++|.+++....               ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            99999999999996543               469999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~  328 (408)
                      ||+|||++......   .......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.......         
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---------  249 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  249 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---------
Confidence            99999999744321   11233457889999999998899999999999999999998 999997643221         


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                         +...+........+......+.+++.+||+.||.+|||+.++++.|+.+....+
T Consensus       250 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          250 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ---HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ---HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence               111111112222233445678899999999999999999999999987765443

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=344.46  Aligned_cols=244  Identities=26%  Similarity=0.368  Sum_probs=202.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||.||+|... +|+.||||++.+....  .....+.+|..+++.++||||+++++++.+. ..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67999999999999999999876 6999999999754221  2356678899999999999999999977664 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.....  
T Consensus        86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            99999999999954 4578999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........           ...+....+  .++
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----------~~~i~~~~~--~~p  223 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----------YEKILNAEL--RFP  223 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------HHHHHHCCC--CCC
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhCCC--CCC
Confidence               2346799999999999999999999999999999999999999975432211           111122111  122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ......+.+++.+||+.||.+||     ++.+|++
T Consensus       224 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            33446788899999999999999     8888885

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-45  Score=341.74  Aligned_cols=255  Identities=20%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC-C-------cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN-G-------QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  179 (408)
                      .++|.+.+.||+|+||.||+|.+.. +       ..||+|.+..... .....+.+|+.++++++||||+++++++.+. 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4689999999999999999998653 3       5799999976543 3457788999999999999999999987764 


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc--------eEE
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--------PQI  251 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~--------~kl  251 (408)
                      ..++||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            5789999999999999997766669999999999999999999999   99999999999999998887        999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCC-CCCccccchhhhhcccccc
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRR-ALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~~  329 (408)
                      +|||++......      ....||+.|+|||.+.+ ..++.++|||||||++|||++|.. ||.........        
T Consensus       163 ~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--------  228 (289)
T 4fvq_A          163 SDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--------  228 (289)
T ss_dssp             CCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--------
T ss_pred             ccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--------
Confidence            999999754321      23458999999999987 679999999999999999999655 44432221110        


Q ss_pred             chHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccccc
Q 015389          330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYM  387 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~  387 (408)
                          .....  ....+......+.+++.+||+.||.+|||+.++++.|+.+..+....
T Consensus       229 ----~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          229 ----QFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             ----HHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             ----HHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence                11110  11111112345778999999999999999999999999887655433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-45  Score=340.85  Aligned_cols=251  Identities=28%  Similarity=0.409  Sum_probs=201.2

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv  184 (408)
                      ...++|++.+.||+|+||.||+|.+. |+.||||.+....   ..+.+.+|+.+++.++||||+++++++.+  +..++|
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            34578999999999999999999885 8899999997653   34678899999999999999999997654  357999


Q ss_pred             EEecCCCCHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMKE-KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+++++|.+++..... .+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999965432 38899999999999999999999   99999999999999999999999999999865432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......            .+...+......
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------------~~~~~~~~~~~~  233 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------DVVPRVEKGYKM  233 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------------GHHHHHTTTCCC
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHhcCCCC
Confidence                 123457899999999999999999999999999999998 99999754322            111112222222


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+...+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            333345567889999999999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.7e-44  Score=351.42  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=205.1

Q ss_pred             cCCCCccceeccc--CcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          109 TNNFSFENLIGKG--GYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G--~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      .++|++.+.||+|  +||.||+|.+. +|+.||||++.... ..+....+.+|+.+++.++||||+++++++.+. ..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4789999999999  99999999986 69999999997643 334567788999999999999999999977665 4789


Q ss_pred             EEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||||+++|+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999653 3569999999999999999999999   9999999999999999999999999998865422


Q ss_pred             CCc-----cceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          263 QWT-----HHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       263 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      ...     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.............   ......+
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~  257 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL---NGTVPCL  257 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---cCCCCcc
Confidence            111     111223468999999999987  579999999999999999999999997643322111100   0000000


Q ss_pred             hhhh------------------------------------ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--H
Q 015389          336 VDAS------------------------------------LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--L  377 (408)
Q Consensus       336 ~d~~------------------------------------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L  377 (408)
                      .+..                                    ............+.+|+.+||+.||.+|||+.|+++.  +
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence            0000                                    0001122334668899999999999999999999863  4


Q ss_pred             hcc
Q 015389          378 RGN  380 (408)
Q Consensus       378 ~~~  380 (408)
                      +..
T Consensus       338 ~~~  340 (389)
T 3gni_B          338 KQI  340 (389)
T ss_dssp             GGC
T ss_pred             HHH
Confidence            443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=349.34  Aligned_cols=268  Identities=20%  Similarity=0.274  Sum_probs=198.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.+++.++||||+++++++.. +..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            67999999999999999999976 6899999999765443333345679999999999999999997765 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +. |+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++......  ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            97 58999987777789999999999999999999999   99999999999999999999999999999865432  12


Q ss_pred             eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhccc------------cccchHH
Q 015389          268 TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPM------------IKRNEIR  333 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~------------~~~~~~~  333 (408)
                      ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .....            .......
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            2334568999999999876 56899999999999999999999999865432111 00000            0000000


Q ss_pred             HHhhhhccC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccCc
Q 015389          334 ELVDASLAD----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCC  383 (408)
Q Consensus       334 ~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~~  383 (408)
                      ....+....    .........+.+++.+||+.||.+|||+.|+++  .+.+..+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            000000000    001123456788999999999999999999988  45554433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.2e-44  Score=354.37  Aligned_cols=263  Identities=20%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC---Ce
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG---GM  181 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~---~~  181 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++..+. ||||+++++++...   ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4579999999999999999999875 69999999987543 3345677889999999997 99999999987643   47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++||||+. ++|..++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 589998843  578999999999999999999999   999999999999999999999999999998653


Q ss_pred             CCC-------------------ccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh
Q 015389          262 EQW-------------------THHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL  321 (408)
Q Consensus       262 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~  321 (408)
                      ...                   .....+...||+.|+|||++.+ ..++.++||||||||+|||++|+.||.........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            210                   1122344679999999999987 67899999999999999999999999865432110


Q ss_pred             hh-ccccc-----------cchHHHHhhh----------hccCcc------------cHHHHHHHHHHHHhccccCCCCC
Q 015389          322 WA-RPMIK-----------RNEIRELVDA----------SLADEY------------DTRQMNLVLLAASLCIQQSSIRR  367 (408)
Q Consensus       322 ~~-~~~~~-----------~~~~~~~~d~----------~l~~~~------------~~~~~~~l~~li~~cl~~~P~~R  367 (408)
                      .. .....           .......+..          .....+            .......+.+|+.+||+.||.+|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            00 00000           0000000000          000000            00224568899999999999999


Q ss_pred             CCHHHHHHH
Q 015389          368 PQMSQVVQL  376 (408)
Q Consensus       368 Pt~~evl~~  376 (408)
                      ||+.|+++.
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8e-45  Score=364.05  Aligned_cols=272  Identities=22%  Similarity=0.301  Sum_probs=203.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~l  183 (408)
                      ..++|++.+.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++... ..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            3468999999999999999999875 69999999997532  233456778999999999999999999977665 5789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.  ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       226 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            9999999999999854 45789999999999999999999952  78999999999999999999999999999864332


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+....  ..
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-----------~~i~~~~--~~  367 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-----------ELILMEE--IR  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCC--CC
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-----------HHHHhCC--CC
Confidence              22334577999999999999999999999999999999999999999764332111           1111111  11


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH--HHhcccCccccccccCCchhhh
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ--LLRGNLCCLKYMTKCRSPLLRK  397 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~--~L~~~~~~~~~~~~~~~~~~~~  397 (408)
                      ++......+.+++.+||+.||.+||     ++.|+++  .+.++.+..-...+..+||...
T Consensus       368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~  428 (446)
T 4ejn_A          368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ  428 (446)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred             CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence            2223446688899999999999999     9999987  4444433222233344444433

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-44  Score=340.73  Aligned_cols=266  Identities=24%  Similarity=0.397  Sum_probs=200.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++....  .......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            468999999999999999999874 69999999997532  344567889999999999999999999977664 57899


Q ss_pred             EEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |||+.+++|.+++..   ....+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.++|+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999854   35668999999999999999999999   999999999999999999999999999998664


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........         ..+......
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---------~~~~~~~~~  256 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC---------KKIEQCDYP  256 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH---------HHHHTTCSC
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH---------HHhhcccCC
Confidence            321  122345689999999999999999999999999999999999999975432211111         011111111


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcccccc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMT  388 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  388 (408)
                      ..........+..++.+||+.||.+||++.+|++.|+.+....+.+.
T Consensus       257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence            11112345678889999999999999999999999988876555443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=8.4e-45  Score=342.31  Aligned_cols=259  Identities=27%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc--CCc--EEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR--NGQ--LVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~--~g~--~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~  182 (408)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||||++....  ..+....+.+|+.++++++||||+++++++.....+
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            368999999999999999999853  233  68999987643  234577889999999999999999999999888899


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +|+||+++++|.+++......+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence            9999999999999997766779999999999999999999999   9999999999999999999999999999987754


Q ss_pred             CCccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          263 QWTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       263 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ..... ......+|..|+|||.+.+..++.++||||||+++|+|++ |+.||........           +..+.....
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------~~~~~~~~~  242 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----------LHKIDKEGE  242 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------HHHHHTSCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----------HHHHHccCC
Confidence            43222 2233457889999999998889999999999999999999 9999976433211           111111111


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ....+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence            11222344567889999999999999999999999998765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.4e-44  Score=348.25  Aligned_cols=267  Identities=21%  Similarity=0.228  Sum_probs=206.1

Q ss_pred             cccCHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-----CCceeE
Q 015389           98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----HPNTAK  171 (408)
Q Consensus        98 ~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----hpniv~  171 (408)
                      ..+++.+.....++|.+.+.||+|+||.||+|.+. +++.||||++....  .....+..|+.+++.+.     ||||++
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34556666677899999999999999999999875 68999999997532  34566678999999886     999999


Q ss_pred             EEeEEEeC-CeEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC----
Q 015389          172 LLGYGIEG-GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE----  245 (408)
Q Consensus       172 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~----  245 (408)
                      +++++... ..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            99977664 578999999 999999996533 458999999999999999999999   99999999999999975    


Q ss_pred             ---------------------CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHH
Q 015389          246 ---------------------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLE  304 (408)
Q Consensus       246 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~e  304 (408)
                                           ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999865432     234569999999999999999999999999999999


Q ss_pred             HHhCCCCCCccccchhhhh----ccccccchHHHHhhh---------h--------------------ccCcccHHHHHH
Q 015389          305 LVTGRRALDYSQQSLVLWA----RPMIKRNEIRELVDA---------S--------------------LADEYDTRQMNL  351 (408)
Q Consensus       305 lltg~~pf~~~~~~~~~~~----~~~~~~~~~~~~~d~---------~--------------------l~~~~~~~~~~~  351 (408)
                      |++|+.||...........    ...............         .                    ............
T Consensus       252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999999976443211100    000000000000000         0                    000001111256


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 015389          352 VLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       352 l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +.+|+.+||+.||.+|||+.|+++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            789999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=339.37  Aligned_cols=260  Identities=24%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++.+. ..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            68999999999999999999986 5999999998765443 4467788999999999999999999977765 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++++|.+++. ....+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.......  
T Consensus        83 ~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  156 (311)
T 4agu_A           83 YCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--  156 (311)
T ss_dssp             CCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence            999999998874 35668999999999999999999999   999999999999999999999999999998765321  


Q ss_pred             ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc-ccc--cchHHHHhh-hhc-
Q 015389          267 HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP-MIK--RNEIRELVD-ASL-  340 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~-~~~--~~~~~~~~d-~~l-  340 (408)
                      .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............. ...  ......... ... 
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            22234568999999999976 568999999999999999999999997654321111000 000  000000000 000 


Q ss_pred             -----cC-----c---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 -----AD-----E---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 -----~~-----~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                           ..     .   ........+.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                 00     0   00123456888999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-44  Score=354.84  Aligned_cols=252  Identities=25%  Similarity=0.296  Sum_probs=194.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHH-HhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGI-MAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~i-l~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ++|++.+.||+|+||.||+|..+ +++.||||++.+...  ......+..|..+ ++.++||||+++++++.+ +..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            68999999999999999999986 588999999976532  2334566778777 577899999999997665 457999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++..... 
T Consensus       118 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-  192 (373)
T 2r5t_A          118 LDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  192 (373)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred             EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence            999999999999954 4578899999999999999999999   99999999999999999999999999999864321 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........           ...+....+  .+
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----------~~~i~~~~~--~~  258 (373)
T 2r5t_A          193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----------YDNILNKPL--QL  258 (373)
T ss_dssp             -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-----------HHHHHHSCC--CC
T ss_pred             -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHhccc--CC
Confidence             1233457899999999999999999999999999999999999999975432211           111122111  12


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      +......+..++.+||+.||.+||++.+.++.+...
T Consensus       259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            223445688899999999999999986555444443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=343.55  Aligned_cols=263  Identities=21%  Similarity=0.303  Sum_probs=206.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGM  181 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~  181 (408)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++..     ...
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4478999999999999999999974 69999999987644 3456778899999999999999999997752     247


Q ss_pred             EEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          182 HIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ++|+||+.+|+|.+++..   ....+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            899999999999999865   35679999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCccc-------eecccccCCCccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc
Q 015389          259 WLPEQWTHH-------TISKVEGTFGYLAPEFLMHGI---VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       259 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  328 (408)
                      .........       ......||+.|+|||.+.+..   ++.++|||||||++|+|++|+.||......          
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------  252 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----------  252 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----------
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----------
Confidence            654211110       112345799999999987554   789999999999999999999999642111          


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ...+...................+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            00111111111111222334567889999999999999999999999998876433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-44  Score=348.64  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC-CcEEEEEEecCCCc--hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~  182 (408)
                      ..++|++.+.||+|+||.||+|.... |+.||||++.+...  ......+..|..++..+ +||||+++++++.+ +..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34789999999999999999999864 88999999975421  12356678999999988 89999999997665 4578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999954 4579999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........           ...+....  .
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----------~~~i~~~~--~  238 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----------FQSIMEHN--V  238 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------HHHHHHCC--C
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHhCC--C
Confidence            2  1233457799999999999999999999999999999999999999976433211           11111111  1


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      .++......+..++.+||+.||.+||+     +.+|++
T Consensus       239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            122334567888999999999999995     566665

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-44  Score=348.70  Aligned_cols=246  Identities=19%  Similarity=0.318  Sum_probs=199.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......  +....+.+|+.+++.++||||+++++++... ..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            378999999999999999999974 6899999998753221  2245678999999999999999999977664 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+ +|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 7899998854 4679999999999999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                         .....+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||......... ..  ....          ...
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-~~--i~~~----------~~~  226 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-KK--VNSC----------VYV  226 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-CC--CCSS----------CCC
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-HH--HHcC----------CCC
Confidence               2244679999999999988876 78999999999999999999999764322110 00  0000          001


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+......+.+++.+||+.||.+|||+.|+++
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11223456778999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.8e-44  Score=337.17  Aligned_cols=263  Identities=21%  Similarity=0.256  Sum_probs=204.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEE-EeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.....   ...+..|+.+++.++|++++..+.++ .++ ..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            347899999999999999999987 4699999998765432   23467899999999988877777644 444 36899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~  261 (408)
                      |||+ +++|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 999999997667789999999999999999999999   999999999999999   788999999999998765


Q ss_pred             CCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          262 EQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       262 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........        ...+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~  231 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--------RQKYERIS  231 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--------SSHHHHHH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--------hhhhhhhh
Confidence            43221     122356799999999999999999999999999999999999999986432211        01111111


Q ss_pred             hhhccCccc---HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          337 DASLADEYD---TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       337 d~~l~~~~~---~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      .........   ...+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            111111111   1224678899999999999999999999999988764443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.3e-44  Score=346.79  Aligned_cols=246  Identities=28%  Similarity=0.394  Sum_probs=201.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      +.|++.+.||+|+||.||+|... +|+.||||++....  ..+....+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45889999999999999999874 69999999997543  234567889999999999999999999977765 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+. |+|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 68888886667789999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             cceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          266 HHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                          ....||+.|+|||++.   ++.++.++|||||||++|||++|+.||.........           ..+.......
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-----------~~~~~~~~~~  272 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------YHIAQNESPA  272 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------HHHHHSCCCC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----------HHHHhcCCCC
Confidence                2356999999999985   567899999999999999999999999754322111           1111111111


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .........+..++.+||+.||.+|||+.++++.
T Consensus       273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1122334567889999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=345.88  Aligned_cols=269  Identities=25%  Similarity=0.358  Sum_probs=214.9

Q ss_pred             cCCCCccceecccCcEEEEEEEE-----cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL-----RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---G  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~  180 (408)
                      .++|++.+.||+|+||.||+|.+     .+|+.||||++..... +....+.+|+.+++.++||||+++++++...   .
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            36789999999999999999984     3589999999986543 4567889999999999999999999976543   5


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++...
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            789999999999999997766779999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccc-eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc----cchHHHH
Q 015389          261 PEQWTHH-TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK----RNEIREL  335 (408)
Q Consensus       261 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~----~~~~~~~  335 (408)
                      ....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||................    ...+...
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            5543221 1233457888999999999899999999999999999999999986532221111100000    0112222


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      +........+...+..+..++.+||+.||.+||++.+|++.|+.+.
T Consensus       276 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            3322222333445678999999999999999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=355.64  Aligned_cols=269  Identities=20%  Similarity=0.262  Sum_probs=210.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC---CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG---GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---~~~lv  184 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++...   ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            468999999999999999999986 49999999998654444456778999999999999999999987653   46899


Q ss_pred             EEecCCCCHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE----CCCCceEEeecCCcc
Q 015389          185 LELSPNGSLASLLYGMKE--KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQICDFGLAK  258 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll----~~~~~~kl~DfGla~  258 (408)
                      |||+++|+|.+++.....  .+++..++.++.||+.||.|||+   ++|+||||||+|||+    +.++.+||+|||++.
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965332  38999999999999999999999   999999999999999    777889999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccC--------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchh--hhhccccc
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMH--------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV--LWARPMIK  328 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~--~~~~~~~~  328 (408)
                      .+....   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||........  ........
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            765432   2234669999999999875        5678899999999999999999999964321100  00000000


Q ss_pred             cch------HHHH------hhhh--ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          329 RNE------IREL------VDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       329 ~~~------~~~~------~d~~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ...      +...      ....  ............+..++.+||+.||++||++.|+++.++.+...
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000      0000      0000  01223466788899999999999999999999999999887654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=347.48  Aligned_cols=266  Identities=17%  Similarity=0.173  Sum_probs=199.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchH----------HHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADE----------IIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      .++|.+.+.||+|+||.||+|.+.    ++..||||++.......          ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            368999999999999999999875    57889999998654321          1133667889999999999999999


Q ss_pred             EEEe-----CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC--
Q 015389          175 YGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF--  247 (408)
Q Consensus       175 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~--  247 (408)
                      ++..     ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence            7665     3478999999 99999999543 389999999999999999999999   9999999999999998887  


Q ss_pred             ceEEeecCCcccCCCCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh
Q 015389          248 EPQICDFGLAKWLPEQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW  322 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~  322 (408)
                      .+||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211     11244579999999999999999999999999999999999999996432211110


Q ss_pred             hcc-ccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          323 ARP-MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       323 ~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ... ......+...+.....   ....+..+.+++.+||+.||.+||++.+|++.|+....
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhcccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            000 0000000111111000   01234578889999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.5e-43  Score=334.60  Aligned_cols=262  Identities=21%  Similarity=0.254  Sum_probs=207.4

Q ss_pred             cCCCCccceecccCcEEEEEEEE-cCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEE-EeC-CeEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRL-RNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYG-IEG-GMHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~-~~~lv~  185 (408)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++......   ..+.+|+.+++.++|++++..+.++ .++ ..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            47899999999999999999997 47999999998765432   3467899999999988877666644 443 368999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+ +++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999 999999997667789999999999999999999999   999999999999999   4788999999999987654


Q ss_pred             CCccc-----eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          263 QWTHH-----TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       263 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      .....     ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........        ...+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~  232 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--------RQKYERISE  232 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--------SSHHHHHHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh--------hhhhhhhcc
Confidence            32211     12456799999999999999999999999999999999999999986432110        011111111


Q ss_pred             hhccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          338 ASLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       338 ~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ......   .....+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            111111   011234568889999999999999999999999987754443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.4e-44  Score=334.37  Aligned_cols=248  Identities=26%  Similarity=0.433  Sum_probs=200.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~l  183 (408)
                      +.++|++.+.||+|+||.||+|.+. ++..||||++......  .....+.+|+.+++.++||||+++++++.+.. .++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999876 5789999998654322  22566889999999999999999999877654 789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999854 4568999999999999999999998   99999999999999999999999999998755432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                          ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           ..+..  ....
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~--~~~~  225 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-----------KRISR--VEFT  225 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHH--TCCC
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-----------HHHHh--CCCC
Confidence                223456999999999999999999999999999999999999999754322110           01111  1112


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .+......+.+++.+||+.||.+|||+.||++.
T Consensus       226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            223345567889999999999999999999973

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.7e-44  Score=338.21  Aligned_cols=248  Identities=28%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +.|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            57899999999999999999875 68999999998665545567889999999999999999999977664 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++++|.+++.  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++..+....  .
T Consensus       102 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  174 (303)
T 3a7i_A          102 LGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  174 (303)
T ss_dssp             CTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred             CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence            99999999994  4678999999999999999999999   999999999999999999999999999998664321  1


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........            ..+...........
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~~~~~  242 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL------------FLIPKNNPPTLEGN  242 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------------HHHHHSCCCCCCSS
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH------------HHhhcCCCCCCccc
Confidence            223456999999999999999999999999999999999999999754332111            11111111122223


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....+..++.+||+.||.+|||+.++++.
T Consensus       243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          243 YSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            44568889999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-44  Score=374.87  Aligned_cols=263  Identities=25%  Similarity=0.357  Sum_probs=216.1

Q ss_pred             HHhhhcCCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC
Q 015389          104 ELQSATNNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (408)
Q Consensus       104 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  179 (408)
                      +.....++|.+.+.||+|+||.||+|.+.    .+..||||.+...........+.+|+.++++++||||+++++++.++
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34445578999999999999999999874    25689999998766666678899999999999999999999998888


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            8999999999999999997666679999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........            ...+..
T Consensus       541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~------------~~~i~~  607 (656)
T 2j0j_A          541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIEN  607 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------------HHHHHH
T ss_pred             cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH------------HHHHHc
Confidence            654322 22234557889999999999999999999999999999997 9999976433211            111111


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ......+...+..+..++.+||+.||.+||++.+|++.|+.+..
T Consensus       608 ~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            22222334455678899999999999999999999999987753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.1e-44  Score=348.62  Aligned_cols=259  Identities=23%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++...........+.+|+.+++.++||||+++++++.++ ..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            368999999999999999999876 68999999998776666678899999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   + +|+||||||+|||++.++.++|+|||++..+..   
T Consensus       112 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  184 (360)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---
Confidence            9999999999954 4578999999999999999999998   6 899999999999999999999999999975432   


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc-------------------
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-------------------  326 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-------------------  326 (408)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............                   
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence             122345799999999999999999999999999999999999999976443221111000                   


Q ss_pred             --------cccchHHHHhhhhcc----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 --------IKRNEIRELVDASLA----DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 --------~~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                              ..........+....    ..........+.+++.+||+.||.+|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                    000011111111111    1111223557889999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.8e-44  Score=340.45  Aligned_cols=261  Identities=23%  Similarity=0.296  Sum_probs=196.4

Q ss_pred             CCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~-~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      +.|.+. +.||+|+||.||+|... +|+.||||++..... .....+.+|+.++.++ +||||+++++++.+. ..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            678874 78999999999999865 699999999976543 2356788999999885 799999999977665 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc---eEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla~~~~~  262 (408)
                      ||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999954 4578999999999999999999999   99999999999999998776   99999999986542


Q ss_pred             CCc-----cceecccccCCCccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          263 QWT-----HHTISKVEGTFGYLAPEFLMH-----GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       263 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      ...     ........||+.|+|||.+.+     ..++.++|||||||++|+|++|+.||.........|..........
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     112234569999999999875     5689999999999999999999999986543322222111111111


Q ss_pred             HHHhhhhccC--cccH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLAD--EYDT----RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~--~~~~----~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+.......  .++.    .....+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1111111111  1111    23467889999999999999999999987

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=348.08  Aligned_cols=248  Identities=21%  Similarity=0.254  Sum_probs=198.1

Q ss_pred             cceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      .+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++.+. ..++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            578999999999999875 699999999987653 3457788999999999999999999987764 4789999999999


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE--CCCCceEEeecCCcccCCCCCccceec
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL--TEDFEPQICDFGLAKWLPEQWTHHTIS  270 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (408)
                      |.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||+  +.++.+||+|||++..+....   ...
T Consensus       173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~  246 (373)
T 2x4f_A          173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLK  246 (373)
T ss_dssp             EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccc
Confidence            999997766779999999999999999999999   999999999999999  567899999999998765432   223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc--CcccHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA--DEYDTRQ  348 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~  348 (408)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........           +..+....+.  .......
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----------~~~i~~~~~~~~~~~~~~~  315 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-----------LNNILACRWDLEDEEFQDI  315 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------HHHHHHTCCCSCSGGGTTS
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------HHHHHhccCCCChhhhccC
Confidence            45699999999999999999999999999999999999999976443211           1111111111  1111233


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          349 MNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       349 ~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      ...+.+++.+||+.||.+|||+.|+++  .+...
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            567888999999999999999999997  45443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.9e-44  Score=346.56  Aligned_cols=248  Identities=25%  Similarity=0.331  Sum_probs=188.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....   ..+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            4578999999999999999999986 58899999997653   235677899999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~  262 (408)
                      ||+++|+|.+++.. ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||++.....
T Consensus       128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999999954 4568999999999999999999999   99999999999999975   88999999999986543


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc--
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--  340 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--  340 (408)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+          ..+.....  
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------~~i~~~~~~~  270 (349)
T 2w4o_A          204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF----------RRILNCEYYF  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH----------HHHHTTCCCC
T ss_pred             c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH----------HHHHhCCCcc
Confidence            2   12234679999999999999999999999999999999999999997544321111          11111111  


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...........+.+++.+||+.||.+|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            01111234556888999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-44  Score=338.36  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=205.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~l  183 (408)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+.... .......+.+|+.++++++||||+++++++.+   ...++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999876 69999999998654 34456788999999999999999999997653   34789


Q ss_pred             EEEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEeeCCCCCceEECCCCceEEeecC
Q 015389          184 VLELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRR-----IIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+   .+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999653   3449999999999999999999999   77     9999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      ++........  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......            +...
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------~~~~  227 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------LAGK  227 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------HHHH
T ss_pred             hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------------HHHH
Confidence            9987643211  1233568999999999999999999999999999999999999998643221            1111


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      +........+......+.+++.+||+.||.+||++.||++.+..
T Consensus       228 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            11111122233445678899999999999999999999987643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.6e-44  Score=336.57  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=204.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--------  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--------  178 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||.+.....     .+.+|+.+++.++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3467999999999999999999986 699999999976542     34689999999999999999996643        


Q ss_pred             ---------CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc
Q 015389          179 ---------GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE  248 (408)
Q Consensus       179 ---------~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~  248 (408)
                               ...++||||+++++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence                     2368999999999999999653 4579999999999999999999999   99999999999999999999


Q ss_pred             eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc
Q 015389          249 PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~  328 (408)
                      +||+|||++..+....   ......||+.|+|||.+.+..++.++||||||+++|+|++|..|+.....           
T Consensus       161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----------  226 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----------  226 (284)
T ss_dssp             EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----------
T ss_pred             EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----------
Confidence            9999999998765432   22345699999999999999999999999999999999999988642211           


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                        ....+....+..    .....+..++.+||+.||.+||++.|+++.|.......+
T Consensus       227 --~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          227 --FFTDLRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             --HHHHHHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             --HHHHhhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence              011111111222    233457789999999999999999999999988765544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.8e-43  Score=355.86  Aligned_cols=259  Identities=22%  Similarity=0.224  Sum_probs=196.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------  179 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3578999999999999999999876 58999999997643 234567888999999999999999999977543      


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++||||+.++ |.+.+.   ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             CeEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence             358999999765 666663   348999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh-------------hcc
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW-------------ARP  325 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~-------------~~~  325 (408)
                      .....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+......             ...
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            66432   22345679999999999999999999999999999999999999998654221100             000


Q ss_pred             c-------------cccchHHHHhhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          326 M-------------IKRNEIRELVDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       326 ~-------------~~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .             .........+...+..   .........+.+|+.+||+.||.+|||+.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0             0000011111111100   0111235678999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-44  Score=373.58  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             ceecccCcEEEEEEEEc---CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  191 (408)
                      +.||+|+||.||+|.+.   .++.||||+++.... ......+.+|+.++++++||||+++++++..+..++||||+.+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            47999999999999653   468899999986533 23467889999999999999999999999888899999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc-ceec
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTIS  270 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  270 (408)
                      +|.+++. ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...... ....
T Consensus       455 ~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  530 (635)
T 4fl3_A          455 PLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  530 (635)
T ss_dssp             EHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred             CHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence            9999995 45678999999999999999999999   99999999999999999999999999999876543222 2223


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ...+|+.|+|||++.+..++.++|||||||+||||++ |+.||......            .+...+........+..++
T Consensus       531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------------~~~~~i~~~~~~~~p~~~~  598 (635)
T 4fl3_A          531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMGCPAGCP  598 (635)
T ss_dssp             ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------HHHHHHHTTCCCCCCTTCC
T ss_pred             CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCCCCCCCCC
Confidence            3457889999999999999999999999999999998 99999764332            2223333333333444566


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          350 NLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+.+++.+||+.||.+||++.+|++.|+...
T Consensus       599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          599 REMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            78899999999999999999999999997653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-43  Score=331.29  Aligned_cols=254  Identities=21%  Similarity=0.285  Sum_probs=205.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~  185 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.. .++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999876 58999999997543 3345677889999999999999999999877654 68999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc---eEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla~~~~~  262 (408)
                      ||+.+++|.+.+.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999999998854 4678999999999999999999999   99999999999999987655   99999999986654


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc-
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA-  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  341 (408)
                      ..   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           ..+...... 
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----------~~~~~~~~~~  226 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----------AQIKAGAYDY  226 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTCCCC
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHH-----------HHHHhccccC
Confidence            32   223466999999999999999999999999999999999999999754332111           011111110 


Q ss_pred             -CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          342 -DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       342 -~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                       ..........+.+++.+||+.||.+|||+.|+++  .+...
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          227 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence             0011123456888999999999999999999987  44443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=345.02  Aligned_cols=272  Identities=24%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe----C--CeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE----G--GMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----~--~~~  182 (408)
                      .++|++.+.||+|+||.||+|.. +++.||||++.......  .....|+..+..++||||+++++++..    +  ..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN--FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh--HHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            47899999999999999999987 58999999997543322  111234444556899999999974432    1  357


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeEeeCCCCCceEECCCCceEEee
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR---------RIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                      +||||+++|+|.+++..  ...++..++.++.||+.||.|||+   .         +|+||||||+|||++.++.+||+|
T Consensus        89 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEee
Confidence            99999999999999943  445889999999999999999998   6         999999999999999999999999


Q ss_pred             cCCcccCCCCCc------cceecccccCCCccccccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCccccch-
Q 015389          254 FGLAKWLPEQWT------HHTISKVEGTFGYLAPEFLMH-------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-  319 (408)
Q Consensus       254 fGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~-  319 (408)
                      ||++..+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||....... 
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987653211      112234569999999999987       456789999999999999999987764322110 


Q ss_pred             --hhhhcccc---ccchHHHHhh-hhccCcc------cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccccc
Q 015389          320 --VLWARPMI---KRNEIRELVD-ASLADEY------DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYM  387 (408)
Q Consensus       320 --~~~~~~~~---~~~~~~~~~d-~~l~~~~------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~  387 (408)
                        ..+.....   ....+...+. ......+      .......+.+++.+||+.||.+|||+.||++.|+.+...++--
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence              00000000   0111111111 1111111      1235667999999999999999999999999999988666543


Q ss_pred             c
Q 015389          388 T  388 (408)
Q Consensus       388 ~  388 (408)
                      .
T Consensus       324 ~  324 (336)
T 3g2f_A          324 K  324 (336)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=338.27  Aligned_cols=262  Identities=22%  Similarity=0.291  Sum_probs=194.5

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc----hHHHHHHHHHHHHHhcC---CCCceeEEEeEEEe
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA----DEIIADFLSELGIMAHV---DHPNTAKLLGYGIE  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~il~~l---~hpniv~l~~~~~~  178 (408)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||++.....    ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34689999999999999999999964 699999999874321    11123445666666655   59999999997765


Q ss_pred             CC------eEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEE
Q 015389          179 GG------MHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQI  251 (408)
Q Consensus       179 ~~------~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl  251 (408)
                      ..      .++|||++. ++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEE
Confidence            43      689999997 59999986543 349999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-cc---c
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PM---I  327 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~---~  327 (408)
                      +|||++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||............ ..   .
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998764322   234567999999999999999999999999999999999999999764432111000 00   0


Q ss_pred             ccchHHH---HhhhhccC-------cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          328 KRNEIRE---LVDASLAD-------EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       328 ~~~~~~~---~~d~~l~~-------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......   +....+..       .........+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000   00000000       001123456888999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.1e-44  Score=354.39  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVDHPNTAKLLGYGIE  178 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  178 (408)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||++.....       ......+.+|+.++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34589999999999999999999876 589999999875321       1223457899999999999999999999888


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecC
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFG  255 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfG  255 (408)
                      +..++||||+++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence            88999999999999999884 35679999999999999999999999   9999999999999997554   59999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      +++.+...   .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||........           +
T Consensus       288 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-----------~  353 (419)
T 3i6u_A          288 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----------L  353 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-----------H
T ss_pred             cceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-----------H
Confidence            99876532   22345679999999999864   5788999999999999999999999975432211           1


Q ss_pred             HHHhhhhccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+.......   ........+.+++.+||+.||.+||++.|+++
T Consensus       354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11111111000   01123466888999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-44  Score=336.37  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|.+.+.||+|+||.||+|... +|..||+|++...........+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            67999999999999999999875 58999999998655444467788999999999999999999987764 47899999


Q ss_pred             cCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCC
Q 015389          188 SPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       188 ~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~  261 (408)
                      +++|+|.+++..   ....+++..++.++.||+.||.|||+   ++|+||||||+||++   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999854   24679999999999999999999999   999999999999999   456789999999998664


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..   .......||+.|+|||.+. +.++.++|||||||++|+|++|+.||.............         .......
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---------~~~~~~~  245 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---------YKEPNYA  245 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------HCCCCCC
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---------cCCcccc
Confidence            32   1223456999999999875 578999999999999999999999998643321110000         0000000


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .. .......+.+++.+||+.||.+|||+.||++
T Consensus       246 ~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 0012456778999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-43  Score=341.08  Aligned_cols=266  Identities=23%  Similarity=0.309  Sum_probs=208.0

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhc--CCCCceeEEEeEEEe
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAH--VDHPNTAKLLGYGIE  178 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~--l~hpniv~l~~~~~~  178 (408)
                      ++.......++|.+.+.||+|+||.||+|.+ +|+.||||++....    ...+..|.+++..  ++||||+++++++..
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            3444455668999999999999999999998 48999999996532    3456778888877  799999999998776


Q ss_pred             C-----CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEeeCCCCCceEECC
Q 015389          179 G-----GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH--------EGCQRRIIHRDIKAANILLTE  245 (408)
Q Consensus       179 ~-----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiH~Dikp~NIll~~  245 (408)
                      .     ..++||||+++|+|.+++..  ..+++..++.++.|++.||.|||        +   .+|+||||||+|||++.
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECC
Confidence            4     57899999999999999953  56899999999999999999999        6   89999999999999999


Q ss_pred             CCceEEeecCCcccCCCCCccc--eecccccCCCccccccccCCC------CCcchhHHHHHHHHHHHHhC---------
Q 015389          246 DFEPQICDFGLAKWLPEQWTHH--TISKVEGTFGYLAPEFLMHGI------VDEKTDVFAFGVLLLELVTG---------  308 (408)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvil~elltg---------  308 (408)
                      ++.+||+|||++..........  ......||+.|+|||.+.+..      ++.++|||||||++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999998664432211  223457999999999997763      34789999999999999999         


Q ss_pred             -CCCCCccccchhhhhccccccchHHH-HhhhhccCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          309 -RRALDYSQQSLVLWARPMIKRNEIRE-LVDASLADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       309 -~~pf~~~~~~~~~~~~~~~~~~~~~~-~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                       ..||........       ....+.. +....+....     .......+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       263 ~~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          263 YQLPYYDLVPSDP-------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCTTTTTSCSSC-------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCccccCcCcc-------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence             566654321100       0011111 1122222222     2356778999999999999999999999999998875


Q ss_pred             Cc
Q 015389          382 CC  383 (408)
Q Consensus       382 ~~  383 (408)
                      ..
T Consensus       336 ~~  337 (342)
T 1b6c_B          336 QQ  337 (342)
T ss_dssp             HT
T ss_pred             HH
Confidence            43

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=346.61  Aligned_cols=254  Identities=17%  Similarity=0.183  Sum_probs=202.7

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEE------EcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CCceeEEEeE
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGR------LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGY  175 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~------~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~  175 (408)
                      +....++|.+.+.||+|+||.||+|.      ..+++.||||++.....    ..+..|+.++..+.   |+||++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP----WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH----HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh----hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            34456889999999999999999994      34689999999986543    34556677666665   9999999997


Q ss_pred             EEe-CCeEEEEEecCCCCHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-----
Q 015389          176 GIE-GGMHIVLELSPNGSLASLLYG----MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-----  245 (408)
Q Consensus       176 ~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-----  245 (408)
                      +.. +..++||||+++|+|.+++..    ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCc
Confidence            665 568999999999999999964    35679999999999999999999999   99999999999999998     


Q ss_pred             ------CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccch
Q 015389          246 ------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL  319 (408)
Q Consensus       246 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~  319 (408)
                            ++.+||+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976543333344556789999999999999999999999999999999999999996433211


Q ss_pred             hhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcccC
Q 015389          320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRR-PQMSQVVQLLRGNLC  382 (408)
Q Consensus       320 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R-Pt~~evl~~L~~~~~  382 (408)
                      ..              ....+....   ..+.+..++..|++.+|.+| |++.++.+.|+....
T Consensus       293 ~~--------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 CK--------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EE--------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ee--------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence            00              000011111   13456678899999999998 688888888877653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-44  Score=345.09  Aligned_cols=256  Identities=23%  Similarity=0.292  Sum_probs=199.2

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC----chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT----ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  180 (408)
                      ....++|++.+.||+|+||.||+|... ++..||||++....    .......+.+|+.+++.++||||+++++++.+..
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            445688999999999999999999875 68899999987532    2234678899999999999999999999877654


Q ss_pred             -eEEEEEecCCCCHHHHHhcc---------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 015389          181 -MHIVLELSPNGSLASLLYGM---------------------------------------KEKLKWGIRYKIALGVAEGL  220 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~~L  220 (408)
                       .++||||+++|+|.+++...                                       ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence             78999999999999998421                                       11245677888999999999


Q ss_pred             HHHHhcCCCCeEeeCCCCCceEECCCC--ceEEeecCCcccCCCCCc--cceecccccCCCccccccccC--CCCCcchh
Q 015389          221 LYLHEGCQRRIIHRDIKAANILLTEDF--EPQICDFGLAKWLPEQWT--HHTISKVEGTFGYLAPEFLMH--GIVDEKTD  294 (408)
Q Consensus       221 ~~LH~~~~~~iiH~Dikp~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~k~D  294 (408)
                      .|||+   ++|+||||||+|||++.++  .+||+|||++..+.....  ........||+.|+|||.+.+  ..++.++|
T Consensus       182 ~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999   9999999999999998776  899999999986533211  112345679999999999975  67899999


Q ss_pred             HHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc--CcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015389          295 VFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       295 vwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e  372 (408)
                      ||||||++|||++|+.||........           +..+......  ..........+.+++.+||+.||.+||++.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  327 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADT-----------ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR  327 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHH-----------HHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHH-----------HHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence            99999999999999999976443211           1111111111  1111123456888999999999999999999


Q ss_pred             HHH
Q 015389          373 VVQ  375 (408)
Q Consensus       373 vl~  375 (408)
                      +++
T Consensus       328 ~l~  330 (345)
T 3hko_A          328 ALQ  330 (345)
T ss_dssp             HHH
T ss_pred             Hhc
Confidence            987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.6e-44  Score=335.61  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=187.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHH-HHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEII-ADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......... ..+..+...++.++||||+++++++.+ +..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            4578999999999999999999975 6999999999876444433 334445556888899999999997765 458899


Q ss_pred             EEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      |||++ |+|.+++..   ....+++..++.++.|++.||.|||+   + +|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 588777643   45679999999999999999999999   7 9999999999999999999999999999876


Q ss_pred             CCCCccceecccccCCCccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFL----MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      .....   .....||+.|+|||.+    .+..++.++|||||||++|+|++|+.||........          .+....
T Consensus       161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------~~~~~~  227 (290)
T 3fme_A          161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----------QLKQVV  227 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----------HHHHHH
T ss_pred             ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----------HHHHHh
Confidence            54322   2334699999999996    566789999999999999999999999975332211          111222


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...............+.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            222222222234567888999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3e-43  Score=332.04  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=198.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~~  182 (408)
                      ..|.+.+.||+|+||.||+|.+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..     ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45788899999999999999875 58899999987543 34457788999999999999999999997654     2368


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEEC-CCCceEEeecCCccc
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLT-EDFEPQICDFGLAKW  259 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~-~~~~~kl~DfGla~~  259 (408)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++  |+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999954 4678999999999999999999998   78  99999999999997 788999999999976


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ....    ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||.........+.          .+....
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----------~~~~~~  246 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR----------RVTSGV  246 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH----------HHTTTC
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH----------HHhccC
Confidence            5432    223456999999999876 5699999999999999999999999975433211110          111111


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+......+.+++.+||+.||.+|||+.+|++
T Consensus       247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111112222356888999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=333.03  Aligned_cols=249  Identities=26%  Similarity=0.405  Sum_probs=183.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||.+......  +....+.+|+.++++++||||+++++++.+.+ .++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            367999999999999999999874 6999999999654221  23467889999999999999999999877654 6899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.++|+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            99999999999997766789999999999999999999999   999999999999999999999999999998764321


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           .......  ...
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~--~~~  231 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLAD--YEM  231 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSC--CCC
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhcc--cCC
Confidence            1  223456999999999999999999999999999999999999999764322110           0000000  011


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......+.+++.+||+.||.+||++.++++
T Consensus       232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1223456788999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3e-43  Score=347.83  Aligned_cols=248  Identities=19%  Similarity=0.236  Sum_probs=189.3

Q ss_pred             CCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHH-hcCCCCceeEEEeEEEe-----CCe
Q 015389          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGYGIE-----GGM  181 (408)
Q Consensus       110 ~~y~~~-~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~-----~~~  181 (408)
                      ++|.+. +.||+|+||+||+|.+. +|+.||||++...      ..+.+|+.++ +..+||||+++++++..     ..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            567766 68999999999999876 5899999999643      2345788776 44589999999996653     347


Q ss_pred             EEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla  257 (408)
                      ++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            89999999999999996543 469999999999999999999999   99999999999999997   789999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      +.....   ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........       ......+..
T Consensus       212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~i~~  281 (400)
T 1nxk_A          212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTRIRM  281 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------CSHHHHHHH
T ss_pred             cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------HHHHHHHHc
Confidence            865432   2234567999999999999999999999999999999999999999764322100       000111111


Q ss_pred             hhcc--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          338 ASLA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       338 ~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ....  ..........+.+|+.+||+.||.+|||+.||++.
T Consensus       282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111  00112345678889999999999999999999973

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.7e-43  Score=345.14  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~  181 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||++...........+.+|+.++.+++||||+++++++...      ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999876 68899999998766666678899999999999999999999977543      47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      ++|+|++. |+|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++....
T Consensus       106 ~iv~e~~~-~~L~~~l~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            89999997 58999884  3569999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccc-eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh-ccccccc--------
Q 015389          262 EQWTHH-TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA-RPMIKRN--------  330 (408)
Q Consensus       262 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~--------  330 (408)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... .......        
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            432221 12445799999999987654 589999999999999999999999976543211100 0000000        


Q ss_pred             ---hHHHHhhhhc-cCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          331 ---EIRELVDASL-ADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       331 ---~~~~~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                         .......... ....     .......+.+++.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               0000000000 0000     0122456889999999999999999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-43  Score=339.62  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-Ce
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~  181 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||.+......     .....+.+|+.++++++||||+++++++.+. ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367999999999999999999976 5899999999764321     1356788999999999999999999977765 47


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla  257 (408)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            899999999999999954 5678999999999999999999999   9999999999999999888    7999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      .......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+..
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------~~i~~  232 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-----------ANITS  232 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHT
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHh
Confidence            8765432   223456999999999999999999999999999999999999999754322111           01111


Q ss_pred             hhc--cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...  ...........+.+++.+||+.||.+|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000  00011123456888999999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-43  Score=357.06  Aligned_cols=251  Identities=20%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++......  +....+.+|+.+++.++||||+++++++.. +..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            478999999999999999999986 6999999999754321  235678899999999999999999997765 457899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++...... 
T Consensus        95 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           95 MEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            99999999999995 35679999999999999999999999   99999999999999999999999999999876542 


Q ss_pred             ccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                        ......+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........           ...+.+...  .
T Consensus       170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-----------~~~i~~~~~--~  234 (476)
T 2y94_A          170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-----------FKKICDGIF--Y  234 (476)
T ss_dssp             --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-----------HHHHHTTCC--C
T ss_pred             --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-----------HHHHhcCCc--C
Confidence              22345679999999999988766 6899999999999999999999986432211           111111111  1


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRG  379 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~  379 (408)
                      .+......+.+++.+||+.||.+|||+.|+++  .+..
T Consensus       235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence            11223456788999999999999999999997  4544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.3e-44  Score=342.15  Aligned_cols=242  Identities=22%  Similarity=0.308  Sum_probs=176.3

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      +.||+|+||.||+|.+. +|+.||||++...    ....+.+|+.+++.+. ||||+++++++.+. ..++||||+++|+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            78999999999999986 5899999999653    2355678999999997 99999999987765 4789999999999


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceEEeecCCcccCCCCCcccee
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      |.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+||+|||++......  ....
T Consensus        93 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  166 (325)
T 3kn6_A           93 LFERIKK-KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL  166 (325)
T ss_dssp             HHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence            9999954 4679999999999999999999999   9999999999999997765   8999999999866442  2223


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc------
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE------  343 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~------  343 (408)
                      ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||........        .....++......+.      
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--------CTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--------cccHHHHHHHHHcCCCCCCcc
Confidence            445689999999999999999999999999999999999999986433210        001111111111111      


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ........+.+++.+||+.||.+|||+.|+++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            11234567889999999999999999999875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-43  Score=336.96  Aligned_cols=260  Identities=18%  Similarity=0.266  Sum_probs=200.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ......+.+|+.+++.++||||+++++++... ..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            378999999999999999999976 689999999976432  33467889999999999999999999977665 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +||+++++|.+++.. ...+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999999954 4578999999999999999999999   999999999999999999999999999998664321


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc--cC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--AD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~~  342 (408)
                      . .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........            ...+....  ..
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------------~~~~~~~~~~~~  255 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM------------GAHINQAIPRPS  255 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH------------HHHHHSCCCCGG
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH------------HHHhccCCCCcc
Confidence            1 122345699999999999999999999999999999999999999986443211            11111110  01


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcccCccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRP-QMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~~~~  385 (408)
                      ......+..+.+++.+||+.||.+|| ++.++++.|+.......
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            11223445688899999999999999 99999999988765443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-43  Score=328.53  Aligned_cols=247  Identities=22%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+...... ....+.+|+.++++++||||+++++++.+.. .++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            367999999999999999999876 4789999998764332 2567889999999999999999999877654 789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||++   +.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999998854 4668999999999999999999999   999999999999999   78889999999999876543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .   ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.........           ..+........
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~~~  227 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM-----------LKIREGTFTFP  227 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCCCCCC
T ss_pred             c---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHhCCCCCC
Confidence            2   2234569999999999865 4899999999999999999999999764332111           11111111000


Q ss_pred             c--cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 Y--DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .  .......+..++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0  0123467888999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=348.33  Aligned_cols=261  Identities=16%  Similarity=0.208  Sum_probs=204.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEcC---------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeE--------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAK--------  171 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~--------  171 (408)
                      .++|.+.+.||+|+||.||+|.+..         ++.||||.+...      ..+.+|+.++++++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            3789999999999999999998763         789999999754      34568999999999999987        


Q ss_pred             -------EEeEEEe--CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCce
Q 015389          172 -------LLGYGIE--GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (408)
Q Consensus       172 -------l~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NI  241 (408)
                             +++++..  ...++||||+ +++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence                   5666654  4578999999 99999999654 4679999999999999999999999   9999999999999


Q ss_pred             EECCCC--ceEEeecCCcccCCCCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          242 LLTEDF--EPQICDFGLAKWLPEQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       242 ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                      |++.++  .+||+|||++..+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876543221     112345799999999999999999999999999999999999999986


Q ss_pred             cccchhhhhccccccchHHHHhhhh--ccC--cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          315 SQQSLVLWARPMIKRNEIRELVDAS--LAD--EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~d~~--l~~--~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ...........      ........  +..  .........+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus       271 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          271 CLPNTEDIMKQ------KQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GTTCHHHHHHH------HHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CCcCHHHHHHH------HHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            53221110000      00000000  000  0001234678889999999999999999999999988765444

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.8e-44  Score=344.76  Aligned_cols=247  Identities=23%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv~  185 (408)
                      .++|++.+.||+|+||.||+|.++ +|+.||||++......     ..+|+.++.++ +||||+++++++.++. .++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999876 5899999999765432     23678888777 7999999999777654 78999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC----CceEEeecCCcccCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED----FEPQICDFGLAKWLP  261 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~~~  261 (408)
                      ||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+..+    +.+||+|||++..+.
T Consensus        96 E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999854 4579999999999999999999999   999999999999998543    359999999998764


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh-hhh-
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV-DAS-  339 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-d~~-  339 (408)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|..||........         ..+...+ ... 
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---------~~~~~~i~~~~~  240 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---------EEILARIGSGKF  240 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---------HHHHHHHHHCCC
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---------HHHHHHHccCCc
Confidence            322  223456799999999999888899999999999999999999999975322100         0111111 111 


Q ss_pred             -ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 -LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 -l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       +...........+.+++.+||+.||.+||++.++++
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             111122334567888999999999999999999886

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.8e-44  Score=343.79  Aligned_cols=243  Identities=24%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-------HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-------EIIADFLSELGIMAHVDHPNTAKLLGYGIEG  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~il~~l~hpniv~l~~~~~~~  179 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......       .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3468999999999999999999865 6899999999765321       1234567899999999999999999987765


Q ss_pred             C-eEEEEEecCCC-CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          180 G-MHIVLELSPNG-SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       180 ~-~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                      + .++||||+.+| +|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH-TCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            4 68999998777 9999985 34569999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      ..+....   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........                
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----------------  238 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE----------------  238 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT----------------
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh----------------
Confidence            8765432   2234569999999999988877 7899999999999999999999975322110                


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ....  .+......+..++.+||+.||.+|||+.++++.
T Consensus       239 -~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 -AAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -hccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000  011134567889999999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.1e-43  Score=330.36  Aligned_cols=243  Identities=24%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++..+ +||||+++++++.+. ..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            467999999999999999999986 699999999986432 33467788999999999 999999999977765 47899


Q ss_pred             EEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---------------
Q 015389          185 LELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---------------  246 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---------------  246 (408)
                      |||+++++|.+++...   ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999653   2568999999999999999999999   999999999999999844               


Q ss_pred             ----CceEEeecCCcccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh
Q 015389          247 ----FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL  321 (408)
Q Consensus       247 ----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~  321 (408)
                          ..+||+|||++......      ....||+.|+|||.+.+. .++.++|||||||++|+|++|..++......   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred             cCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence                47999999999876432      223599999999999876 5678999999999999999998876532211   


Q ss_pred             hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          322 WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                 ..+... .....+......+.+++.+||+.||.+|||+.++++
T Consensus       238 -----------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 -----------HEIRQG-RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----------HHHHTT-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------HHHHcC-CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                       111111 111222234467888999999999999999999976

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6e-43  Score=351.56  Aligned_cols=195  Identities=27%  Similarity=0.419  Sum_probs=154.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe------CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~  180 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++..... ....+++.+|+.+++.++||||+++++++..      ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            378999999999999999999876 689999999976432 3456788999999999999999999997743      34


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      +++|||++ +++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            79999987 578999884 35679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc-------------------------ceecccccCCCccccccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 015389          261 PEQWTH-------------------------HTISKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELVTG  308 (408)
Q Consensus       261 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~elltg  308 (408)
                      ......                         ...+...||+.|+|||++ .+..++.++||||||||||||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            432111                         123445789999999986 456799999999999999999993

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=8.2e-44  Score=339.72  Aligned_cols=262  Identities=19%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             cccCHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCC--CCceeEEEe
Q 015389           98 KIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVD--HPNTAKLLG  174 (408)
Q Consensus        98 ~~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~--hpniv~l~~  174 (408)
                      +.+.+..+....++|++.+.||+|+||.||+|.+.+|+.||||++.... .......+.+|+.++..++  ||||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            3444455556668899999999999999999998889999999997543 3445678899999999997  599999999


Q ss_pred             EEEeCC-eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          175 YGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       175 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                      ++.... .++||| +.+++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+++ +.+||+|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEee
Confidence            877655 678888 678999999954 4578999999999999999999999   99999999999999965 7999999


Q ss_pred             cCCcccCCCCCccceecccccCCCccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh
Q 015389          254 FGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-----------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW  322 (408)
Q Consensus       254 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~  322 (408)
                      ||++..+.............||+.|+|||.+.+           ..++.++|||||||++|+|++|+.||.......   
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence            999987654433323344569999999999875           478899999999999999999999997543221   


Q ss_pred             hccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       323 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                             ..+....++.....++......+.+++.+||+.||.+||++.|+++
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                   1122333333333333333567888999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=340.29  Aligned_cols=264  Identities=25%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch----HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG  180 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  180 (408)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++......    .....+.+|+.+++.++||||+++++++.+ +.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999875 5899999999754322    123467899999999999999999997765 45


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+.+ +|.+++......+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            8999999986 8999887766779999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--ccc--cccchHH--
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RPM--IKRNEIR--  333 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~~--~~~~~~~--  333 (408)
                      ....  .......||+.|+|||.+.+. .++.++|||||||++|+|++|..||...........  ...  .......  
T Consensus       163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            4322  223446799999999999764 589999999999999999999999976443211000  000  0000000  


Q ss_pred             -HHhhhh---ccCc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          334 -ELVDAS---LADE-----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       334 -~~~d~~---l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ...+..   ....     ........+.+++.+||+.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             000000   0000     001234678899999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-43  Score=343.43  Aligned_cols=262  Identities=23%  Similarity=0.312  Sum_probs=199.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.++++++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            478999999999999999999875 69999999996543 334567889999999999999999999987653       


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++||||+ +++|.+++..  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            358999999 8899999854  578999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--cc----------c
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RP----------M  326 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~----------~  326 (408)
                      ....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........  ..          .
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            5432     234568999999999987 6799999999999999999999999986543211000  00          0


Q ss_pred             cccchHHHHhhhh--c-cC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhccc
Q 015389          327 IKRNEIRELVDAS--L-AD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNL  381 (408)
Q Consensus       327 ~~~~~~~~~~d~~--l-~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~  381 (408)
                      +........+...  . ..   .........+.+++.+||+.||.+|||+.|+++  .++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            0000111111100  0 00   011123456888999999999999999999998  455443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.8e-44  Score=349.24  Aligned_cols=251  Identities=12%  Similarity=0.094  Sum_probs=184.2

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHH---HHHhcCCCCceeEEE-------eEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSEL---GIMAHVDHPNTAKLL-------GYG  176 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~---~il~~l~hpniv~l~-------~~~  176 (408)
                      .+|.+.+.||+|+||.||+|.+. +|+.||||++.....  ......+.+|+   .+++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            46899999999999999999976 699999999987653  33456677774   55555 799988865       322


Q ss_pred             Ee------------------CCeEEEEEecCCCCHHHHHhcccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeE
Q 015389          177 IE------------------GGMHIVLELSPNGSLASLLYGMKEKLKWGIR------YKIALGVAEGLLYLHEGCQRRII  232 (408)
Q Consensus       177 ~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ii  232 (408)
                      ..                  ...++||||+. |+|.+++...+..+.+..+      ..++.||+.||.|||+   ++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence            21                  22689999998 8999999765556677777      7888999999999999   9999


Q ss_pred             eeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCC
Q 015389          233 HRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRR  310 (408)
Q Consensus       233 H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~  310 (408)
                      ||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999866432     113457799999999987  679999999999999999999999


Q ss_pred             CCCccccchh-hhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          311 ALDYSQQSLV-LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       311 pf~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ||........ .+.......     ..............+..+.+++.+||+.||.+|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRV-----PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTS-----CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhhhhhh-----ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9987533211 111100000     00001111111233567888999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.5e-43  Score=348.82  Aligned_cols=200  Identities=28%  Similarity=0.384  Sum_probs=167.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC------C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG------G  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~  180 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... .....++.+|+.++++++||||+++++++...      .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999876 589999999976432 34567889999999999999999999977653      4


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+. ++|.+++. ....+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~-~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            799999886 69999984 35669999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCcc--------------------ceecccccCCCccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015389          261 PEQWTH--------------------HTISKVEGTFGYLAPEFL-MHGIVDEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       261 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvil~elltg~~pf~  313 (408)
                      ......                    ...+...||+.|+|||++ .+..++.++||||||||+|||++|..||.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            543211                    123556799999999986 45679999999999999999998666654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-44  Score=340.73  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=184.5

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ...++|.+.+.||+|+||.||+|.+. +++.||||.+...........+.+|+.+++.++||||+++++++.. +..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            44589999999999999999999864 6899999998765544556778899999999999999999997665 568899


Q ss_pred             EEecCCCCHHHHHhc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCc
Q 015389          185 LELSPNGSLASLLYG-------MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLA  257 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla  257 (408)
                      |||+++++|.+++..       ....+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999863       24568999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCc---cceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH-
Q 015389          258 KWLPEQWT---HHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI-  332 (408)
Q Consensus       258 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-  332 (408)
                      ..+.....   ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.................... 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            86643221   112234569999999999876 5689999999999999999999999986443211110000000000 


Q ss_pred             HHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ....+....    ......+.+++.+||+.||.+||++.++++
T Consensus       249 ~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          249 TGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             C-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000111111    123356788999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-43  Score=342.73  Aligned_cols=262  Identities=23%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC--------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG--------  179 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~--------  179 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            68999999999999999999985 6999999998654332 2345677999999999999999999976642        


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..++||||+.+ +|.+.+......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             36899999975 7888886766789999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCc--cceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-c---ccccch
Q 015389          259 WLPEQWT--HHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-P---MIKRNE  331 (408)
Q Consensus       259 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~---~~~~~~  331 (408)
                      .+.....  ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............ .   ......
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            7643221  222345678999999999876 45899999999999999999999999865432111000 0   000000


Q ss_pred             HHH-----Hhhhh--c---cCcccHH-----HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 IRE-----LVDAS--L---ADEYDTR-----QMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ~~~-----~~d~~--l---~~~~~~~-----~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...     ..+..  .   .......     ....+.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000     00000  0   0000000     1345788999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=332.36  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=199.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||.+.....   ...+.+|+.++..++||||+++++++... ..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3478999999999999999999876 599999999976542   35678899999999999999999977654 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.+++|.+++......+++..++.++.||+.||.|||+   .+|+|+||||+||+++.++.++|+|||++........
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            9999999999997667789999999999999999999999   9999999999999999999999999999986643221


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........+...        ....+  ....+
T Consensus       181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------~~~~~--~~~~~  248 (314)
T 3com_A          181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP--------TNPPP--TFRKP  248 (314)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------HSCCC--CCSSG
T ss_pred             --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh--------cCCCc--ccCCc
Confidence              2234569999999999999999999999999999999999999997643321111000        00000  00112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            223456888999999999999999999987

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-43  Score=361.71  Aligned_cols=253  Identities=29%  Similarity=0.401  Sum_probs=205.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l  183 (408)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.+...  ......+.+|+.+++.++||||+++++++.+ +..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            4567999999999999999999876 699999999975421  1234667899999999999999999997665 45799


Q ss_pred             EEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||++..+..
T Consensus       262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999986543 349999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......        ....+...+.. ...
T Consensus       339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--------~~~~i~~~i~~-~~~  406 (576)
T 2acx_A          339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--------KREEVERLVKE-VPE  406 (576)
T ss_dssp             TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--------CHHHHHHHHHH-CCC
T ss_pred             Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--------hHHHHHHHhhc-ccc
Confidence            32   2234579999999999999999999999999999999999999998643210        01111111111 122


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      .++......+..++.+||+.||.+||     ++.||++
T Consensus       407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            23334456788899999999999999     7888876

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.1e-43  Score=329.60  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=199.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|++.+.||+|+||.||+|... +|+.||||.+......     .....+.+|+.++++++||||+++++++.+. ..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57899999999999999999986 6999999998754321     1356788999999999999999999977765 478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCcc
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla~  258 (408)
                      +||||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++    .++|+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999953 5678999999999999999999999   9999999999999998877    79999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           ..+...
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~  226 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-----------TNISAV  226 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHTT
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-----------HHhHhc
Confidence            764322   223456999999999999999999999999999999999999999764332111           000000


Q ss_pred             hc--cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..  ...........+.+++.+||+.||.+||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            00  00011123456888999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.9e-43  Score=334.80  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=198.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~  180 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.....       ......+.+|+.+++.++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            367999999999999999999876 589999999875431       123455789999999999999999999988888


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc---eEEeecCCc
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGLA  257 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGla  257 (408)
                      .++||||+++++|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.   +||+|||++
T Consensus        89 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            999999999999999985 35678999999999999999999999   99999999999999987664   999999999


Q ss_pred             ccCCCCCccceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHH
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRE  334 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  334 (408)
                      ......   .......||+.|+|||++.   +..++.++|||||||++|+|++|+.||........           +..
T Consensus       165 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~  230 (322)
T 2ycf_A          165 KILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-----------LKD  230 (322)
T ss_dssp             EECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-----------HHH
T ss_pred             eecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-----------HHH
Confidence            876432   1223456999999999974   56789999999999999999999999975433211           111


Q ss_pred             HhhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 LVDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ~~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+......   .........+.+++.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11111000   001123467888999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=8e-43  Score=329.77  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=204.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|.+.+.||+|+||.||+|.+. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367999999999999999999986 58899999987542  3345677889999999999999999999877655 6899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+.+++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999999998843 4678999999999999999999999   999999999999999999999999999998764322


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........           ..+....  ...
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~--~~~  234 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----------LRIKKNE--YSI  234 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHTTC--CCC
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHhhcc--CCC
Confidence            2  223456999999999999999999999999999999999999999764322110           1111111  111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......+..++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            2233456788999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.1e-43  Score=339.80  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=198.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++.+.. .++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            68999999999999999999986 499999999875543 345667889999999999999999999877655 689999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+++|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++..+....  
T Consensus       105 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  178 (331)
T 4aaa_A          105 FVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  178 (331)
T ss_dssp             CCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc--
Confidence            999999988764 45569999999999999999999999   999999999999999999999999999998654321  


Q ss_pred             ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc---cchHHHHhh-----
Q 015389          267 HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK---RNEIRELVD-----  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~---~~~~~~~~d-----  337 (408)
                      .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||................   .......+.     
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            223345699999999999875 78999999999999999999999998654321111000000   000000000     


Q ss_pred             -----hhccCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 -----ASLADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 -----~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                           +.+....     .......+.+++.+||+.||.+|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 0000000     1123567889999999999999999999886

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-43  Score=340.81  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=201.9

Q ss_pred             CHHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc----------hHHHHHHHHHHHHHhcCCCCcee
Q 015389          101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA----------DEIIADFLSELGIMAHVDHPNTA  170 (408)
Q Consensus       101 ~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~----------~~~~~~~~~E~~il~~l~hpniv  170 (408)
                      ...++....++|++.+.||+|+||.||+|...+|+.||||++.....          ......+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35677888899999999999999999999988899999999864321          22457889999999999999999


Q ss_pred             EEEeEEEeC------CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC
Q 015389          171 KLLGYGIEG------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT  244 (408)
Q Consensus       171 ~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~  244 (408)
                      ++++++...      ..++||||+. |+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEc
Confidence            999976432      3689999997 68888887777789999999999999999999999   9999999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh-
Q 015389          245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW-  322 (408)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~-  322 (408)
                      .++.+||+|||++......   .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......... 
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             CCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999754332   22234568999999999887 678999999999999999999999998644221100 


Q ss_pred             hccccc-----------cchHHHHhhhhccCc-------ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          323 ARPMIK-----------RNEIRELVDASLADE-------YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       323 ~~~~~~-----------~~~~~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......           .......+...+...       ........+.+++.+||+.||.+|||+.|+++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            000000           001111111111100       01122456888999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.9e-43  Score=343.42  Aligned_cols=256  Identities=20%  Similarity=0.246  Sum_probs=199.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC--------CCceeEEEeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--------HPNTAKLLGYGI  177 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--------hpniv~l~~~~~  177 (408)
                      ...++|++.+.||+|+||.||+|.+. +|+.||||++...  ......+.+|+.+++.+.        ||||+++++++.
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            34588999999999999999999875 5899999999754  334567889999998885        788999999665


Q ss_pred             -----eCCeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCC---
Q 015389          178 -----EGGMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDF---  247 (408)
Q Consensus       178 -----~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~---  247 (408)
                           ....++||||+ +++|.+.+.. ....+++..+..++.||+.||.|||+   + +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhh
Confidence                 23478999999 5566666544 34679999999999999999999999   8 999999999999999775   


Q ss_pred             ----------------------------------------------ceEEeecCCcccCCCCCccceecccccCCCcccc
Q 015389          248 ----------------------------------------------EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAP  281 (408)
Q Consensus       248 ----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP  281 (408)
                                                                    .+||+|||++......     .....||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCC
Confidence                                                          7999999999876432     2345699999999


Q ss_pred             ccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-----h--hccccccc------------------------
Q 015389          282 EFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-----W--ARPMIKRN------------------------  330 (408)
Q Consensus       282 E~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-----~--~~~~~~~~------------------------  330 (408)
                      |++.+..++.++|||||||+||||++|+.||.........     .  ........                        
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            9999999999999999999999999999999754321100     0  00000000                        


Q ss_pred             ------hHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          331 ------EIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       331 ------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                            .....+..  ....+......+.+|+.+||+.||.+|||+.|+++
T Consensus       343 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          343 TKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                  00000000  11234566788999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-42  Score=339.31  Aligned_cols=257  Identities=23%  Similarity=0.238  Sum_probs=193.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++...       
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999875 68999999997643 334567788999999999999999999977643       


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++||||+.+ +|.+++.   ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            46899999975 7888773   458999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--ccc-----------
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RPM-----------  326 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~~-----------  326 (408)
                      ....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........  ...           
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            5432   123346799999999999999999999999999999999999999986543211000  000           


Q ss_pred             -------------cccchHHHHhhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 -------------IKRNEIRELVDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 -------------~~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                   ................   .........+.+|+.+||+.||.+|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                         0000001111110000   111234677899999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-42  Score=351.27  Aligned_cols=259  Identities=22%  Similarity=0.278  Sum_probs=204.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC-CceeEEEeEEEeCC-eEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~-~~lv~  185 (408)
                      .++|++.++||+|+||.||+|.+. +|+.||||++......   ..+..|+.+++.++| +++..+..++.+.. .++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            478999999999999999999874 6999999988754432   246789999999987 45555555655554 57899


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~  262 (408)
                      ||+ +++|.+++......+++..++.|+.||+.||.|||+   ++|+||||||+||||   +.++.+||+|||+++.+..
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            999 999999997667789999999999999999999999   999999999999999   6888999999999987654


Q ss_pred             CCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          263 QWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       263 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ....     .......||+.|+|||.+.+..++.++||||||||||||++|+.||..........        .+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~--------~~~~i~~  230 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--------KYEKISE  230 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH--------HHHHHHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH--------HHHHHhh
Confidence            3222     12235679999999999999999999999999999999999999998644321111        1111111


Q ss_pred             hhccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          338 ASLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       338 ~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      ..+...   ....++..+..++..||+.+|.+||++.+|++.|+.+..
T Consensus       231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          231 KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            111111   011234678899999999999999999999999987643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=337.81  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe--
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE--  178 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~--  178 (408)
                      .++....++|++.+.||+|+||.||+|.+. +|+.||||++......  ...+.+|+.+++.+ +||||+++++++..  
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            344456689999999999999999999975 6899999999765432  35678899999998 79999999997764  


Q ss_pred             -----CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEe
Q 015389          179 -----GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQIC  252 (408)
Q Consensus       179 -----~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~  252 (408)
                           ...++||||+.+++|.+++... ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEe
Confidence                 3478999999999999999653 3578999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCCCccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  327 (408)
                      |||++..+.....  ......||+.|+|||.+.     +..++.++|||||||++|+|++|+.||.........+.    
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----  245 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  245 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----
Confidence            9999986643211  223456999999999987     56789999999999999999999999975433211110    


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                             +................+..++.+||+.||.+||++.++++
T Consensus       246 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 -------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   11100111111223456888999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-44  Score=351.42  Aligned_cols=240  Identities=12%  Similarity=0.088  Sum_probs=187.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHH---HHHhcCCCCceeEEE-------eE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSEL---GIMAHVDHPNTAKLL-------GY  175 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~---~il~~l~hpniv~l~-------~~  175 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  .....+.+.+|+   .+++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999864 69999999997432  233567788999   555666899999998       54


Q ss_pred             EEeC------------------CeEEEEEecCCCCHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015389          176 GIEG------------------GMHIVLELSPNGSLASLLYGMKE------KLKWGIRYKIALGVAEGLLYLHEGCQRRI  231 (408)
Q Consensus       176 ~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  231 (408)
                      +...                  ..++||||+ +|+|.+++.....      .+++..++.++.||+.||.|||+   ++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence            4433                  278999999 6899999965322      23358888999999999999999   999


Q ss_pred             EeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCC-----------CCCcchhHHHHHH
Q 015389          232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-----------IVDEKTDVFAFGV  300 (408)
Q Consensus       232 iH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGv  300 (408)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985432     2344568 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          301 LLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       301 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ++|||++|+.||..........           .+.. . ..    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~-----------~~~~-~-~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSE-----------WIFR-S-CK----NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSG-----------GGGS-S-CC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchh-----------hhhh-h-cc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999997543221100           0000 0 01    22356788999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-44  Score=346.15  Aligned_cols=254  Identities=25%  Similarity=0.321  Sum_probs=200.1

Q ss_pred             CCCCccceecccCcEEEEEEEE----cCCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-C
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-G  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~  180 (408)
                      ++|++.+.||+|+||.||+|..    .+|+.||||++.....   ......+.+|+.++.++ +||||+++++++... .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6899999999999999999987    3689999999875321   12234556799999999 699999999976664 5


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            7899999999999999954 4578999999999999999999999   99999999999999999999999999999866


Q ss_pred             CCCCccceecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ..... .......||+.|+|||++.++  .++.++|||||||++|||++|+.||.........        ..+...+..
T Consensus       210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~~~~  280 (355)
T 1vzo_A          210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--------AEISRRILK  280 (355)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--------HHHHHHHHH
T ss_pred             ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--------HHHHHHHhc
Confidence            43322 223346799999999999863  4789999999999999999999999754321100        001111100


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQLL  377 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~L  377 (408)
                       ....++......+.+++.+||+.||.+||     ++.++++..
T Consensus       281 -~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 -SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence             11223334456788899999999999999     999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.9e-43  Score=336.94  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=204.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv  184 (408)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+ .++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            367999999999999999999876 58899999987542  3345677889999999999999999999877654 7899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+.+++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            999999999998843 4678999999999999999999999   999999999999999999999999999998764322


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                      .  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+....  ...
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------~~~~~~~--~~~  260 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-----------LRIKKNE--YSI  260 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHHTC--CCC
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-----------HHHhcCC--CCC
Confidence            2  223466999999999999999999999999999999999999999764322110           0111111  111


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      +......+..++.+||+.||.+||++.|+++
T Consensus       261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 PKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2223456788999999999999999999987

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.4e-43  Score=338.27  Aligned_cols=261  Identities=18%  Similarity=0.275  Sum_probs=190.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++.++ ..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            3478999999999999999999865 6999999999765433 3456678999999999999999999977665 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-----CCCceEEeecCCccc
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-----EDFEPQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-----~~~~~kl~DfGla~~  259 (408)
                      |||+. |+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++     .++.+||+|||++..
T Consensus       112 ~e~~~-~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCS-EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCC-CCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            99997 599999854 4568999999999999999999999   9999999999999994     455699999999986


Q ss_pred             CCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc----ccccchHHH
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP----MIKRNEIRE  334 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~----~~~~~~~~~  334 (408)
                      +....  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.............    .........
T Consensus       187 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          187 FGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            64321  223345689999999999875 48999999999999999999999997644321110000    000000000


Q ss_pred             H-------------hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          335 L-------------VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       335 ~-------------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .             ....+...........+.+|+.+||+.||.+|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0             0000000000113356788999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.9e-43  Score=328.21  Aligned_cols=245  Identities=27%  Similarity=0.420  Sum_probs=202.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|.+.+.||+|+||.||+|... +++.||||++......  .....+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            68999999999999999999876 5889999998654221  2246788999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++......  
T Consensus        94 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           94 EFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             CCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            99999999999954 4568999999999999999999999   99999999999999999999999999999765432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........           ...+....  ..++
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~~~~~~--~~~~  232 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----------HRRIVNVD--LKFP  232 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----------HHHHHTTC--CCCC
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----------HHHHhccc--cCCC
Confidence              12345699999999999999999999999999999999999999976432211           11111111  1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            234456788999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.5e-43  Score=368.60  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=203.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-CCeE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~  182 (408)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++.+..  .......+..|..++..+ +||||+++++++.+ +.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999876 58899999997532  122356678899999987 79999999997665 4578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            99999999999999954 4579999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .  ........||+.|+|||++.+..|+.++|||||||+||||++|+.||...+....           ...+....  .
T Consensus       495 ~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-----------~~~i~~~~--~  559 (674)
T 3pfq_A          495 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----------FQSIMEHN--V  559 (674)
T ss_dssp             T--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----------HHHHHSSC--C
T ss_pred             C--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-----------HHHHHhCC--C
Confidence            2  2234567899999999999999999999999999999999999999986433211           11111111  1


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQM-----SQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~  375 (408)
                      .++......+.+|+.+||+.||.+||++     .||++
T Consensus       560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            2233455678889999999999999997     66654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-42  Score=336.65  Aligned_cols=252  Identities=26%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-------hHHHHHHHHHHHHHhcC-CCCceeEEEeEE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHV-DHPNTAKLLGYG  176 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l-~hpniv~l~~~~  176 (408)
                      ....++|.+.+.||+|+||.||+|.+. +|+.||||++.....       .+....+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            445578999999999999999999986 699999999875431       22356788999999999 899999999977


Q ss_pred             EeC-CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          177 IEG-GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       177 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      ... ..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+   .||+||||||+|||++.++.++|+|||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence            654 47899999999999999953 4679999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccccc
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMH------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKR  329 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~  329 (408)
                      ++..+....   ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||.........        
T Consensus       246 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--------  314 (365)
T 2y7j_A          246 FSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML--------  314 (365)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------
T ss_pred             cccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH--------
Confidence            998765432   2244679999999999863      35889999999999999999999999754322110        


Q ss_pred             chHHHHhhhhccCccc--HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          330 NEIRELVDASLADEYD--TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       330 ~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                         ..+.........+  ......+..++.+||+.||.+|||+.++++
T Consensus       315 ---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 ---RMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0111111110000  122456888999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=326.83  Aligned_cols=250  Identities=25%  Similarity=0.345  Sum_probs=197.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      +.|.....||+|+||.||+|.+. +++.||||.+..... .....+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            44555569999999999999875 688999999976543 3457788999999999999999999977765 47899999


Q ss_pred             cCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-CCceEEeecCCcccCCCCC
Q 015389          188 SPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-DFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       188 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~  264 (408)
                      +++++|.+++....  ..+++..+..++.|++.||.|||+   ++|+||||||+||+++. ++.+||+|||++.......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999996543  346688899999999999999999   99999999999999987 8899999999998764321


Q ss_pred             ccceecccccCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                        .......||+.|+|||.+.++.  ++.++||||||+++|+|++|+.||.........          ...........
T Consensus       178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~~~~~  245 (295)
T 2clq_A          178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----------MFKVGMFKVHP  245 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----------HHHHHHHCCCC
T ss_pred             --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----------HHhhccccccc
Confidence              1223456999999999997654  889999999999999999999999753322111          00000111122


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+......+..++.+||+.||.+||++.++++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            233344567888999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-42  Score=352.15  Aligned_cols=249  Identities=23%  Similarity=0.364  Sum_probs=198.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch------------HHHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD------------EIIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      ..++|.+.+.||+|+||+||+|... +++.||||++......            .....+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3478999999999999999999976 5889999999764321            23567889999999999999999999


Q ss_pred             EEEeCC-eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC---ceE
Q 015389          175 YGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF---EPQ  250 (408)
Q Consensus       175 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~---~~k  250 (408)
                      ++.+.. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence            877654 7899999999999999854 4679999999999999999999999   9999999999999998776   699


Q ss_pred             EeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc
Q 015389          251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      |+|||++.......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||.........         
T Consensus       190 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------  256 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII---------  256 (504)
T ss_dssp             ECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------
T ss_pred             EEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---------
Confidence            99999998765432   233456999999999986 56999999999999999999999999864432111         


Q ss_pred             hHHHHhhhhccCcc--cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          331 EIRELVDASLADEY--DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       331 ~~~~~~d~~l~~~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        ..+.........  ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       257 --~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          257 --KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --HHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              111111111000  0123466888999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-42  Score=331.78  Aligned_cols=253  Identities=17%  Similarity=0.261  Sum_probs=198.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe---CCeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE---GGMHI  183 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~~~l  183 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++....    ...+.+|+.+++.+. ||||+++++++.+   ...++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            368999999999999999999874 68999999997543    356789999999997 9999999998775   34789


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPE  262 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~  262 (408)
                      ||||+.+++|.+++.    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||++.....
T Consensus       111 v~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999999999883    48899999999999999999999   9999999999999999776 899999999987654


Q ss_pred             CCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc--cccccchHHHHhhhh
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR--PMIKRNEIRELVDAS  339 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~d~~  339 (408)
                      ..   ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||............  ...........++..
T Consensus       184 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            32   2234568999999999987 67899999999999999999999999543322111100  001111111111110


Q ss_pred             -----------------------ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 -----------------------LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 -----------------------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                             ............+.+++.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                                   001111123567889999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-43  Score=342.88  Aligned_cols=258  Identities=19%  Similarity=0.266  Sum_probs=194.7

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----  179 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----  179 (408)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......     ..+|+.+++.++||||+++++++...     
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            455689999999999999999999874 6999999998755322     13799999999999999999976432     


Q ss_pred             ----------------------------------CeEEEEEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHH
Q 015389          180 ----------------------------------GMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLY  222 (408)
Q Consensus       180 ----------------------------------~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~  222 (408)
                                                        ..++||||++ |+|.+.+..   ....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                              1679999998 587777643   45679999999999999999999


Q ss_pred             HHhcCCCCeEeeCCCCCceEEC-CCCceEEeecCCcccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHH
Q 015389          223 LHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGV  300 (408)
Q Consensus       223 LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGv  300 (408)
                      ||+   ++|+||||||+|||++ .++.+||+|||++..+....   ......||+.|+|||.+.+. .++.++|||||||
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            999   9999999999999997 68899999999998764432   22345689999999998875 4899999999999


Q ss_pred             HHHHHHhCCCCCCccccchhhhhc-cccccchHHHHh--hh-------------hccCcccHHHHHHHHHHHHhccccCC
Q 015389          301 LLLELVTGRRALDYSQQSLVLWAR-PMIKRNEIRELV--DA-------------SLADEYDTRQMNLVLLAASLCIQQSS  364 (408)
Q Consensus       301 il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~--d~-------------~l~~~~~~~~~~~l~~li~~cl~~~P  364 (408)
                      ++|||++|+.||............ ..........+.  ++             .+...++...+..+.+++.+||+.||
T Consensus       231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999999865432111000 000000000000  00             00111122245568899999999999


Q ss_pred             CCCCCHHHHHH
Q 015389          365 IRRPQMSQVVQ  375 (408)
Q Consensus       365 ~~RPt~~evl~  375 (408)
                      .+|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-43  Score=357.74  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=203.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++.+....  .....+.+|+.+++.++||||+++++++.. ..+++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999986 5999999999754321  234678899999999999999999996665 458999


Q ss_pred             EEecCCCCHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGM---KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~  261 (408)
                      |||+++|+|.+++...   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999998653   3469999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHH-HHhhhhc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR-ELVDASL  340 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~d~~l  340 (408)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........        ...+. .+...  
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--------~~~~~~~i~~~--  408 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--------NKELKQRVLEQ--  408 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--------HHHHHHHHHHC--
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--------HHHHHHHHhhc--
Confidence            4322  22346799999999999999999999999999999999999999986432100        00111 11111  


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQM-----SQVVQ  375 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~  375 (408)
                      ...++......+..++.+||+.||.+||++     .+|++
T Consensus       409 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            112233445678889999999999999975     55554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-42  Score=336.35  Aligned_cols=268  Identities=21%  Similarity=0.307  Sum_probs=205.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe------CC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~  180 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++..      ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3478999999999999999999976 6999999999876656667788899999999999999999997654      35


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++|+||+. ++|.+++..  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++..+
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            789999997 689998843  579999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccc--------eecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--c-----
Q 015389          261 PEQWTHH--------TISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--R-----  324 (408)
Q Consensus       261 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~-----  324 (408)
                      .......        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........  .     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            5322111        1233578999999998765 6789999999999999999999999986542211000  0     


Q ss_pred             ------cccccchHHHHhhhhcc-C-----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhccc
Q 015389          325 ------PMIKRNEIRELVDASLA-D-----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNL  381 (408)
Q Consensus       325 ------~~~~~~~~~~~~d~~l~-~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~  381 (408)
                            ...........+..... .     .........+.+++.+||+.||.+|||+.|+++  .+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                  00001111111111000 0     001123456888999999999999999999997  455444

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=339.29  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=189.5

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe-----
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE-----  178 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-----  178 (408)
                      .....+|++.+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+.++.++. ||||+++++++..     
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            344568999999999999999999975 689999999865543 44677889999999995 9999999997742     


Q ss_pred             ----CCeEEEEEecCCCCHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEECCCCceE
Q 015389          179 ----GGMHIVLELSPNGSLASLLYG--MKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLTEDFEPQ  250 (408)
Q Consensus       179 ----~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~~~~~~k  250 (408)
                          ...++|+||+. |+|.+++..  ....+++..++.++.||+.||.|||+   .+  |+||||||+|||++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence                12678999985 789998854  45569999999999999999999998   88  99999999999999999999


Q ss_pred             EeecCCcccCCCCCccc----------eecccccCCCccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 015389          251 ICDFGLAKWLPEQWTHH----------TISKVEGTFGYLAPEFL---MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQ  317 (408)
Q Consensus       251 l~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~  317 (408)
                      |+|||++..........          ......||+.|+|||.+   .+..++.++|||||||++|+|++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432211          11245589999999998   567789999999999999999999999975332


Q ss_pred             chhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          318 SLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      ...               ................+..++.+||+.||.+||++.|+++.|+.+.....
T Consensus       259 ~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          259 LRI---------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHh---------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            111               11111111111122346779999999999999999999999988765443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=327.65  Aligned_cols=256  Identities=20%  Similarity=0.232  Sum_probs=203.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc---hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCe
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---DEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGM  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~  181 (408)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....   ......+.+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999875 689999999975432   2345778999999999999999999997642   357


Q ss_pred             EEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          182 HIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ++||||+.++ |.+++.. ....+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.++|+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999887 7676644 35679999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCCccceecccccCCCccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHGI--VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      .............||+.|+|||.+.+..  ++.++|||||||++|+|++|+.||........           ...+...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------~~~i~~~  228 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-----------FENIGKG  228 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----------HHHHHHC
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-----------HHHHhcC
Confidence            5433333444567999999999987644  47899999999999999999999985432111           0011111


Q ss_pred             hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhccc
Q 015389          339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNL  381 (408)
Q Consensus       339 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~  381 (408)
                      .  ...+......+.+++.+||+.||.+|||+.|+++  .+.+..
T Consensus       229 ~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          229 S--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             C--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             C--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            0  1112234456788999999999999999999997  454443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.9e-43  Score=326.47  Aligned_cols=249  Identities=19%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++.....  .+....+.+|+.+++.++||||+++++++... ..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            34578999999999999999999986 699999999875422  12356788999999999999999999977664 478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++++|.+++.. ...+++..+..++.||+.||.|||+   ++|+|+||||+||+++.++.++|+|||++.....
T Consensus        88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999999954 4568999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..   ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........            ...+.... 
T Consensus       164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------~~~~~~~~-  227 (276)
T 2h6d_A          164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------------FKKIRGGV-  227 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------------HHHHHHCC-
T ss_pred             Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------------HHHhhcCc-
Confidence            21   2234568999999999988765 6899999999999999999999975432211            11111110 


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+......+..++.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1112223456888999999999999999999997

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.7e-43  Score=333.05  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  185 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++++.. +..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            3478999999999999999999986 589999999876533 235678899999999999999999997665 4688999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++++|.+++......+++..+..++.||+.||.|||+   ++++||||||+||+++.++.+||+|||++......  
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--  170 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999987667789999999999999999999999   99999999999999999999999999987543211  


Q ss_pred             cceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          266 HHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ........||+.|+|||.+.     +..++.++|||||||++|+|++|+.||.........           ..+.....
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~  239 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----------LKIAKSDP  239 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------HHHHHSCC
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-----------HHHhccCC
Confidence            11123456999999999983     667899999999999999999999999864332111           00111000


Q ss_pred             -cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          341 -ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       341 -~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ....+......+..++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00112233456888999999999999999999876

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-42  Score=329.09  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=202.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+...... ....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            367899999999999999999976 6999999999865432 345678999999999999999999977765 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~~~  263 (408)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+   ++|+||||||+||++   +.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999999854 4578999999999999999999999   999999999999999   78889999999999765432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc--c
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--A  341 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~  341 (408)
                          ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........           ...+.....  .
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~~i~~~~~~~~  227 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-----------FEKIKEGYYEFE  227 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----------HHHHHHCCCCCC
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-----------HHHHHcCCCCCC
Confidence                22345699999999999999999999999999999999999999975432211           011111100  1


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      .......+..+.+++.+||+.||.+||++.|+++  .+.+.
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            1111234567888999999999999999999987  45443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.7e-42  Score=327.83  Aligned_cols=249  Identities=24%  Similarity=0.440  Sum_probs=194.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---------  178 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||.+...  ......+.+|+.+++.++||||+++++++.+         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            467999999999999999999975 6999999999643  3456788899999999999999999997643         


Q ss_pred             -----CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          179 -----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       179 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                           ...++||||+++++|.+++......+++..++.++.|++.||.|||+   ++|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence                 34689999999999999997766778899999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCc------------cceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchh
Q 015389          254 FGLAKWLPEQWT------------HHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV  320 (408)
Q Consensus       254 fGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~  320 (408)
                      ||++........            ........||+.|+|||.+.+. .++.++|||||||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            999987643211            1122345699999999999864 68999999999999999998   5543211100


Q ss_pred             hhhccccccchHHHHh--hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          321 LWARPMIKRNEIRELV--DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~--d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .          ...+.  ...+...........+.+++.+||+.||.+|||+.++++
T Consensus       237 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 I----------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H----------HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----------HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0          01111  111222333444566888999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7e-43  Score=341.30  Aligned_cols=257  Identities=24%  Similarity=0.328  Sum_probs=184.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-------C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------G  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-------~  179 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++..       .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999865 69999999997643 33456788899999999999999999997754       3


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++|+|++ +++|.+++..  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            468999998 7899998843  579999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh--hc----------cc
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW--AR----------PM  326 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~--~~----------~~  326 (408)
                      ....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........  ..          ..
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5432     234569999999999987 678999999999999999999999998654321100  00          00


Q ss_pred             cccchHHHHhhhhcc-Cccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          327 IKRNEIRELVDASLA-DEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~-~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      .........+..... ....     ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            001111111111100 0000     1123567889999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=339.52  Aligned_cols=266  Identities=22%  Similarity=0.324  Sum_probs=203.3

Q ss_pred             HHHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-
Q 015389          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-  179 (408)
Q Consensus       102 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-  179 (408)
                      ..+.....++|++.+.||+|+||.||+|.+.+  .||+|++..... ......+.+|+.++++++||||+++++++.+. 
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34445566899999999999999999998854  399999875432 22335567899999999999999999977764 


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      ..++|+||+++++|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++ ++.++|+|||++..
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            5789999999999999997766679999999999999999999999   9999999999999998 67999999999876


Q ss_pred             CCCCC---ccceecccccCCCccccccccC---------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc
Q 015389          260 LPEQW---THHTISKVEGTFGYLAPEFLMH---------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI  327 (408)
Q Consensus       260 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~  327 (408)
                      .....   .........||+.|+|||.+.+         ..++.++|||||||++|+|++|+.||.........+.    
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----  254 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ----  254 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH----
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence            53211   1122234568999999999875         4578999999999999999999999986543322111    


Q ss_pred             ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          328 KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       328 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                             +.............+..+..++.+||+.||.+|||+.+|++.|+.+....
T Consensus       255 -------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          255 -------MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -------HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -------hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                   00100001111123345788999999999999999999999999887554

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6e-43  Score=336.26  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             HHHHhhhcCCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcC-CCCceeEEEeEEE
Q 015389          102 LYELQSATNNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHV-DHPNTAKLLGYGI  177 (408)
Q Consensus       102 ~~~~~~~~~~y~~~-~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~~~~~  177 (408)
                      +.......+.|.+. +.||+|+||.||+|... +|+.||||++..... ......+.+|+.++..+ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445556778887 89999999999999876 599999999976432 22356788999999999 5699999999777


Q ss_pred             eC-CeEEEEEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEe
Q 015389          178 EG-GMHIVLELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQIC  252 (408)
Q Consensus       178 ~~-~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~  252 (408)
                      +. ..++||||+.+|+|.+++.. ....+++..++.++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence            65 47899999999999999854 34679999999999999999999999   99999999999999988   7899999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      |||++.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..........          
T Consensus       177 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------  243 (327)
T 3lm5_A          177 DFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL----------  243 (327)
T ss_dssp             CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------
T ss_pred             eCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH----------
Confidence            999998765322   2234579999999999999999999999999999999999999997644321110          


Q ss_pred             HHHhhh--hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          333 RELVDA--SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       333 ~~~~d~--~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       .+...  .............+.+++.+||+.||.+|||+.++++.
T Consensus       244 -~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 -NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -HHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             01110  01111112345668889999999999999999999873

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.3e-42  Score=351.67  Aligned_cols=249  Identities=27%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.+. ..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999976 699999999864321 12356788999999999999999999987765 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC---CCCceEEeecCCcccCCC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~~~  262 (408)
                      ||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||++.....
T Consensus       101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999998854 4679999999999999999999999   9999999999999995   456799999999986643


Q ss_pred             CCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc-
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA-  341 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  341 (408)
                      .   .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.........           ..+...... 
T Consensus       177 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------~~i~~~~~~~  241 (486)
T 3mwu_A          177 N---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYAF  241 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTCCCS
T ss_pred             C---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCC
Confidence            2   22344579999999999875 5999999999999999999999999764332111           111111111 


Q ss_pred             -CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          342 -DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       342 -~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ..........+.+++.+||+.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11112345668889999999999999999999983

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-42  Score=348.97  Aligned_cols=247  Identities=27%  Similarity=0.349  Sum_probs=195.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++.+.||+|+||+||+|.+. ++..||||++..... ......+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            57999999999999999999986 689999999976532 22356778999999999999999999987765 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~~~  263 (408)
                      |+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++..   +.+||+|||++......
T Consensus       117 ~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999999998854 4678999999999999999999999   999999999999999764   45999999999876432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc--
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA--  341 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--  341 (408)
                         .......||+.|+|||++. +.++.++|||||||++|+|++|..||.........           ..+......  
T Consensus       193 ---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------~~i~~~~~~~~  257 (494)
T 3lij_A          193 ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-----------RKVEKGKYTFD  257 (494)
T ss_dssp             ---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTCCCCC
T ss_pred             ---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCCC
Confidence               2234467999999999875 57999999999999999999999999864432111           111111111  


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1111233456888999999999999999999886

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7e-42  Score=328.66  Aligned_cols=257  Identities=18%  Similarity=0.260  Sum_probs=199.5

Q ss_pred             hcCCCCccceecccCcEEEEEEEE-c-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC------ceeEEEeEEEeC
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRL-R-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP------NTAKLLGYGIEG  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~-~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp------niv~l~~~~~~~  179 (408)
                      ..++|++.+.||+|+||.||+|.+ . +|+.||||++....  .....+.+|+.+++.++|+      +++++++++...
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            347899999999999999999987 3 68999999997542  3456778899988888655      599999977654


Q ss_pred             -CeEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC------------
Q 015389          180 -GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE------------  245 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~------------  245 (408)
                       ..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.            
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence             578999999 899999986543 368899999999999999999999   99999999999999987            


Q ss_pred             -------CCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 015389          246 -------DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS  318 (408)
Q Consensus       246 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~  318 (408)
                             ++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   668999999999865432     23456999999999999999999999999999999999999999865432


Q ss_pred             hhhhhccc----ccc----------------------chHHHHhhhhc-----cCcccHHHHHHHHHHHHhccccCCCCC
Q 015389          319 LVLWARPM----IKR----------------------NEIRELVDASL-----ADEYDTRQMNLVLLAASLCIQQSSIRR  367 (408)
Q Consensus       319 ~~~~~~~~----~~~----------------------~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~~P~~R  367 (408)
                      ........    ...                      ......+....     ...........+.+++.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            11100000    000                      00000000000     011123456789999999999999999


Q ss_pred             CCHHHHHH
Q 015389          368 PQMSQVVQ  375 (408)
Q Consensus       368 Pt~~evl~  375 (408)
                      ||+.||++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.5e-43  Score=352.83  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=202.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....  ......+.+|+.++++++||||+++++++.+. ..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999986 699999999875432  23457788999999999999999999987765 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE---CCCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL---TEDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll---~~~~~~kl~DfGla~~~~  261 (408)
                      |||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||++..+.
T Consensus       105 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999999999854 4678999999999999999999999   999999999999999   567899999999998765


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ...   ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.........           ..+......
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----------~~i~~~~~~  245 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL-----------KKVEKGKYT  245 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCCCC
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHcCCCC
Confidence            432   2234569999999999865 6999999999999999999999999865432111           111111111


Q ss_pred             --CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 --DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 --~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        .......+..+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence              1111234566888999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.9e-42  Score=343.73  Aligned_cols=199  Identities=25%  Similarity=0.329  Sum_probs=169.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC------CCCceeEEEeEEEe-C
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHV------DHPNTAKLLGYGIE-G  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l------~hpniv~l~~~~~~-~  179 (408)
                      ...+|++.+.||+|+||.||+|.+. +++.||||++....  .....+..|+.++..+      +|+||+++++++.. .
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            4478999999999999999999876 58999999997643  3345666777777666      67899999997665 4


Q ss_pred             CeEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc--eEEeecCC
Q 015389          180 GMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE--PQICDFGL  256 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~--~kl~DfGl  256 (408)
                      ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.  +||+|||+
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            5789999995 68999886543 459999999999999999999999   89999999999999999987  99999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCcccc
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQ  317 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~  317 (408)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            9765432     2345799999999999999999999999999999999999999986543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.9e-42  Score=323.26  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=202.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCC-CCceeEEEeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVD-HPNTAKLLGYGI  177 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~-hpniv~l~~~~~  177 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++.....        ......+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3478999999999999999999986 589999999975431        234567889999999995 999999999877


Q ss_pred             eCC-eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCC
Q 015389          178 EGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGL  256 (408)
Q Consensus       178 ~~~-~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGl  256 (408)
                      ... .++||||+++++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccc
Confidence            654 7899999999999999954 4678999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccceecccccCCCcccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccc
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLM------HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN  330 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~  330 (408)
                      +.......   ......||+.|+|||.+.      ...++.++||||||+++|+|++|+.||.........         
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---------  238 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML---------  238 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH---------
Confidence            98765322   223456999999999985      456889999999999999999999999754322110         


Q ss_pred             hHHHHhhhhcc--CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          331 EIRELVDASLA--DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       331 ~~~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        ..+......  .......+..+.+++.+||+.||.+|||+.++++
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 --RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              111111111  1111234567889999999999999999999876

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-42  Score=344.45  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------Ce
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------GM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------~~  181 (408)
                      .+|++.+.||+|+||.||+|.+. +|+.||||++......     ..+|+.+++.++||||+++++++...       .+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            46899999999999999999986 5999999998754321     23699999999999999999976431       15


Q ss_pred             EEEEEecCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla  257 (408)
                      ++||||+++ +|.+.+.   .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            689999976 5665553   245679999999999999999999999   999999999999999965 57899999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--hhccc--cccchH
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--WARPM--IKRNEI  332 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--~~~~~--~~~~~~  332 (408)
                      +.+.....   .....||+.|+|||++.+. .++.++||||||||||||++|+.||.........  .....  .....+
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            87644322   2345689999999999765 7999999999999999999999999865432111  00000  000111


Q ss_pred             HHHhhhhc--------c-----CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDASL--------A-----DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~l--------~-----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+ ++..        .     ..+.......+.+|+.+||+.||.+||++.|+++
T Consensus       282 ~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            111 1000        0     0011223467889999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.9e-42  Score=335.13  Aligned_cols=267  Identities=21%  Similarity=0.270  Sum_probs=189.5

Q ss_pred             HhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CC--
Q 015389          105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GG--  180 (408)
Q Consensus       105 ~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~--  180 (408)
                      .....++|++.+.||+|+||.||+|.+. +|+.||||++......  ...+..++..+..++||||+++++++.. +.  
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4456689999999999999999999985 6899999998654321  2344677888888999999999997654 22  


Q ss_pred             -----eEEEEEecCCCCHHHHHh---cccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEeeCCCCCceEECC-CCce
Q 015389          181 -----MHIVLELSPNGSLASLLY---GMKEKLKWGIRYKIALGVAEGLLYLH--EGCQRRIIHRDIKAANILLTE-DFEP  249 (408)
Q Consensus       181 -----~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~iiH~Dikp~NIll~~-~~~~  249 (408)
                           .++||||+.++ |...+.   .....+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++.+
T Consensus        96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcE
Confidence                 67999999864 444432   24567899999999999999999999  7   99999999999999996 8999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--ccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--RPM  326 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~~~  326 (408)
                      ||+|||++..+....   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........  ...
T Consensus       172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            999999998765432   223456899999999987654 89999999999999999999999987543211100  000


Q ss_pred             -cccchHHHHhhhh----------------ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          327 -IKRNEIRELVDAS----------------LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       327 -~~~~~~~~~~d~~----------------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                       .........+++.                ............+.+|+.+||+.||.+|||+.|+++  .+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence             0000111111100                001111224567899999999999999999999997  34444

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-42  Score=340.96  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=196.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C------e
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G------M  181 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~------~  181 (408)
                      ..+|++.+.||+|+||.||+|.+..+..||+|++......     ..+|+.+++.++||||+++++++... .      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3579999999999999999999877777999988654321     13699999999999999999976532 2      6


Q ss_pred             EEEEEecCCCCHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-CCCceEEeecCCcc
Q 015389          182 HIVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAK  258 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~DfGla~  258 (408)
                      ++||||+.++.+.....  .....+++..+..++.||+.||.|||+   ++|+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            79999998765444332  245679999999999999999999999   9999999999999998 78999999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh--hccc--cccchHH
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW--ARPM--IKRNEIR  333 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~--~~~~--~~~~~~~  333 (408)
                      .+.....   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||..........  ....  .....+.
T Consensus       191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            7643322   2345689999999998765 58999999999999999999999998654321110  0000  0000011


Q ss_pred             HHhhhhc-c------------CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhccc
Q 015389          334 ELVDASL-A------------DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNL  381 (408)
Q Consensus       334 ~~~d~~l-~------------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~  381 (408)
                      .+ ++.. .            ..+.......+.+++.+||+.||.+|||+.|+++.  ++++.
T Consensus       268 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          268 TM-NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HH-CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hh-ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            10 0000 0            00111234578899999999999999999999873  54443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-42  Score=335.33  Aligned_cols=256  Identities=20%  Similarity=0.300  Sum_probs=197.3

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------  180 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... +.....+.+|+.+++.++||||+++++++....      
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            478999999999999999999876 699999999986533 345678889999999999999999999876543      


Q ss_pred             -eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                       .++||||+. ++|.+++   ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence             289999997 6888877   3459999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc------------cc
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR------------PM  326 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~------------~~  326 (408)
                      ....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||............            ..
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            5432     234568999999999987 67899999999999999999999999865422111000            00


Q ss_pred             cccchHHHHhhhhcc---Cc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          327 IKRNEIRELVDASLA---DE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~---~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ...............   ..   ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000111111111000   00   011235678899999999999999999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-42  Score=333.06  Aligned_cols=254  Identities=25%  Similarity=0.409  Sum_probs=179.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHH-HHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELG-IMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|.+.+.||+|+||.||+|.+. +|+.||||++...........+..|+. +++.++||||+++++++... ..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3478999999999999999999985 699999999987655555566667766 67788999999999977664 47899


Q ss_pred             EEecCCCCHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          185 LELSPNGSLASLLYG----MKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      |||+.+ +|.+++..    ....+++..+..++.|++.||.|||+   + +|+||||||+||+++.++.+||+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999975 78777742    35678999999999999999999999   7 999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFL----MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      +....   ......||+.|+|||.+    .+..++.++|||||||++|+|++|+.||............. . ...    
T Consensus       176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~----  246 (327)
T 3aln_A          176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-V-KGD----  246 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-C-CSC----
T ss_pred             ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-h-cCC----
Confidence            64332   12334699999999998    45678999999999999999999999997533211110000 0 000    


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       .+.+...........+.+++.+||+.||.+||++.+|++
T Consensus       247 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          247 -PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence             001111111223456888999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=328.29  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=193.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---------  178 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+.+++.++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            478999999999999999999986 49999999987654 3456788999999999999999999987632         


Q ss_pred             ------CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-CCCceEE
Q 015389          179 ------GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQI  251 (408)
Q Consensus       179 ------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl  251 (408)
                            ...++||||+. |+|.+++.  ...+++..+..++.||+.||.|||+   ++|+||||||+||+++ .++.+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence                  34689999997 69999984  4678999999999999999999999   9999999999999997 5679999


Q ss_pred             eecCCcccCCCCCcc-ceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh----hcc
Q 015389          252 CDFGLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW----ARP  325 (408)
Q Consensus       252 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~----~~~  325 (408)
                      +|||++......... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||..........    ..+
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999876432221 12234557999999998876 678999999999999999999999998654321110    000


Q ss_pred             ccccchHHHHhh-------hhcc-Cc-----ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 MIKRNEIRELVD-------ASLA-DE-----YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 ~~~~~~~~~~~d-------~~l~-~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ........++..       .... ..     ........+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            011111111110       0000 00     01123567889999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-42  Score=330.58  Aligned_cols=271  Identities=23%  Similarity=0.356  Sum_probs=201.2

Q ss_pred             hhcCCCCccceecccCcEEEEEEEE--cCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcC---CCCceeEEEeEEE---
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRL--RNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGI---  177 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~--~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l---~hpniv~l~~~~~---  177 (408)
                      .+.++|++.+.||+|+||.||+|.+  .+|+.||||++...... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3457899999999999999999997  36899999998753321 1122345666666555   8999999999765   


Q ss_pred             ---eCCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEee
Q 015389          178 ---EGGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICD  253 (408)
Q Consensus       178 ---~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~D  253 (408)
                         ....++||||+. |+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence               234789999997 6999998654 3458999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh--hcc--cccc
Q 015389          254 FGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW--ARP--MIKR  329 (408)
Q Consensus       254 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~--~~~--~~~~  329 (408)
                      ||++......   .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||..........  ...  ....
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            9999866432   12334679999999999999999999999999999999999999998654321100  000  0000


Q ss_pred             chHH-------HHhhh---hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccCcc
Q 015389          330 NEIR-------ELVDA---SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCCL  384 (408)
Q Consensus       330 ~~~~-------~~~d~---~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~~~  384 (408)
                      ....       .....   .............+.+++.+||+.||.+|||+.++++  .+.....+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            0000       00000   0000111223456788999999999999999999995  455554443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-41  Score=334.24  Aligned_cols=205  Identities=25%  Similarity=0.339  Sum_probs=171.1

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CC-----ceeEEEeE
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HP-----NTAKLLGY  175 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hp-----niv~l~~~  175 (408)
                      .......++|++.+.||+|+||+||+|.+. +|+.||||++....  .....+..|+.++..++ |+     +|++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            334455689999999999999999999876 68899999997542  34566677888887774 44     59999997


Q ss_pred             EEe-CCeEEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC--CCCceEE
Q 015389          176 GIE-GGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEPQI  251 (408)
Q Consensus       176 ~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl  251 (408)
                      +.. +..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||. +..+|+||||||+|||++  .++.+||
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEE
Confidence            665 55789999996 59999986543 568999999999999999999994 127999999999999995  4778999


Q ss_pred             eecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccc
Q 015389          252 CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQ  316 (408)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~  316 (408)
                      +|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999876432     234569999999999999999999999999999999999999998654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-42  Score=339.70  Aligned_cols=258  Identities=22%  Similarity=0.380  Sum_probs=179.6

Q ss_pred             CCCCc-cceecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeE
Q 015389          110 NNFSF-ENLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMH  182 (408)
Q Consensus       110 ~~y~~-~~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~  182 (408)
                      +.|.+ .++||+|+||.||+|.+.   +++.||||++......   ..+.+|+.+++.++||||+++++++..   ...+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            44665 458999999999999865   4789999999765433   356789999999999999999997754   3478


Q ss_pred             EEEEecCCCCHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE----CCCCceE
Q 015389          183 IVLELSPNGSLASLLYGM--------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL----TEDFEPQ  250 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll----~~~~~~k  250 (408)
                      +||||+. ++|.+++...        ...+++..++.++.||+.||.|||+   ++|+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999986 5788777421        1248999999999999999999999   999999999999999    6778999


Q ss_pred             EeecCCcccCCCCCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-------
Q 015389          251 ICDFGLAKWLPEQWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-------  321 (408)
Q Consensus       251 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-------  321 (408)
                      |+|||++..+...... .......||+.|+|||++.+. .++.++||||||||+|+|++|+.||.........       
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            9999999876542221 223456799999999999874 5899999999999999999999999754332100       


Q ss_pred             ----------------hhccccccchHHHHhhhhccCcc---c-H--------HHHHHHHHHHHhccccCCCCCCCHHHH
Q 015389          322 ----------------WARPMIKRNEIRELVDASLADEY---D-T--------RQMNLVLLAASLCIQQSSIRRPQMSQV  373 (408)
Q Consensus       322 ----------------~~~~~~~~~~~~~~~d~~l~~~~---~-~--------~~~~~l~~li~~cl~~~P~~RPt~~ev  373 (408)
                                      |.... .-..............+   . .        .....+.+|+.+||+.||.+|||+.|+
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIK-KMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGG-GSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhh-cCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence                            00000 00000000000000000   0 0        013467889999999999999999999


Q ss_pred             HH
Q 015389          374 VQ  375 (408)
Q Consensus       374 l~  375 (408)
                      ++
T Consensus       332 L~  333 (405)
T 3rgf_A          332 MQ  333 (405)
T ss_dssp             HT
T ss_pred             hc
Confidence            98

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-42  Score=334.29  Aligned_cols=260  Identities=18%  Similarity=0.291  Sum_probs=201.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch----------------HHHHHHHHHHHHHhcCCCCceeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD----------------EIIADFLSELGIMAHVDHPNTAKL  172 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~----------------~~~~~~~~E~~il~~l~hpniv~l  172 (408)
                      .++|.+.+.||+|+||.||+|.+ +|+.||||.+......                .....+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47999999999999999999999 8999999998643211                112778899999999999999999


Q ss_pred             EeEEEeC-CeEEEEEecCCCCHHHH------Hhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC
Q 015389          173 LGYGIEG-GMHIVLELSPNGSLASL------LYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT  244 (408)
Q Consensus       173 ~~~~~~~-~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~  244 (408)
                      ++++.+. ..++||||+++++|.++      +... ...+++..++.++.||+.||.|||+  .++|+||||||+||+++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence            9977765 47899999999999998      5332 5679999999999999999999996  37999999999999999


Q ss_pred             CCCceEEeecCCcccCCCCCccceecccccCCCccccccccCC-CCCc-chhHHHHHHHHHHHHhCCCCCCccccchhhh
Q 015389          245 EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDE-KTDVFAFGVLLLELVTGRRALDYSQQSLVLW  322 (408)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwSlGvil~elltg~~pf~~~~~~~~~~  322 (408)
                      .++.++|+|||++......    ......||+.|+|||.+.+. .++. ++|||||||++|+|++|+.||.........+
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999999999999876432    33456799999999999887 6766 9999999999999999999998654311111


Q ss_pred             hccccccchHH----HHhhhhcc---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          323 ARPMIKRNEIR----ELVDASLA---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       323 ~~~~~~~~~~~----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...........    ....+...   ..........+.+++.+||+.||.+||++.|+++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000000000    00000000   0001234567888999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=331.05  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG------  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~------  180 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+++.++||||+++++++....      
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999999875 699999999976533 345678889999999999999999999876543      


Q ss_pred             -eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                       .++||||+. ++|.+++   ...+++..+..++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             489999997 5887776   3458999999999999999999999   9999999999999999999999999999986


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--c----------cc
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--R----------PM  326 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~----------~~  326 (408)
                      ....     .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........  .          ..
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            5432     234568999999999887 6789999999999999999999999986443211000  0          00


Q ss_pred             cccchHHHHhhhhc---cC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 IKRNEIRELVDASL---AD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 ~~~~~~~~~~d~~l---~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .........+...-   ..   .........+.+++.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00011111111000   00   111234567889999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-41  Score=330.17  Aligned_cols=254  Identities=20%  Similarity=0.277  Sum_probs=197.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-----------CCceeEEEeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----------HPNTAKLLGYG  176 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l~~~~  176 (408)
                      .++|.+.+.||+|+||.||+|.+. +|+.||||++....  .....+.+|+.++++++           ||||+++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            368999999999999999999874 69999999997543  23466778999888876           89999999976


Q ss_pred             EeC-----CeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEEC-----
Q 015389          177 IEG-----GMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLT-----  244 (408)
Q Consensus       177 ~~~-----~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~-----  244 (408)
                      ...     ..++|||++ +++|.+++... ...+++..+..++.||+.||.|||+   + +|+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence            643     467899999 99999998653 4569999999999999999999999   8 999999999999994     


Q ss_pred             -CCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh---
Q 015389          245 -EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV---  320 (408)
Q Consensus       245 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~---  320 (408)
                       ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999876432     2335699999999999999999999999999999999999999985432100   


Q ss_pred             -----hhhccc--c---------------------------ccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCC
Q 015389          321 -----LWARPM--I---------------------------KRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIR  366 (408)
Q Consensus       321 -----~~~~~~--~---------------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~  366 (408)
                           ......  .                           ....+......  ...++......+.+|+.+||+.||.+
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccc
Confidence                 000000  0                           00000111111  12244667888999999999999999


Q ss_pred             CCCHHHHHH
Q 015389          367 RPQMSQVVQ  375 (408)
Q Consensus       367 RPt~~evl~  375 (408)
                      |||+.||++
T Consensus       325 Rpt~~ell~  333 (373)
T 1q8y_A          325 RADAGGLVN  333 (373)
T ss_dssp             CBCHHHHHT
T ss_pred             cCCHHHHhh
Confidence            999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3e-41  Score=326.54  Aligned_cols=257  Identities=17%  Similarity=0.220  Sum_probs=196.1

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-C-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc------eeEEEeEEEe-
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-N-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN------TAKLLGYGIE-  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn------iv~l~~~~~~-  178 (408)
                      ..++|++.+.||+|+||.||+|... + ++.||||++....  .....+.+|+.+++.++|++      ++.+++++.. 
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            4579999999999999999999875 3 4789999997542  34566778999998887655      8899886665 


Q ss_pred             CCeEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEE--------------
Q 015389          179 GGMHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL--------------  243 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll--------------  243 (408)
                      +..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||+              
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccc
Confidence            5578999999 66677766543 3569999999999999999999999   999999999999999              


Q ss_pred             -----CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccc
Q 015389          244 -----TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQS  318 (408)
Q Consensus       244 -----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~  318 (408)
                           +.++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 56789999999999865432     23456999999999999999999999999999999999999999864432


Q ss_pred             hhhhh-cccc---ccc----------------------hHHHHhhhhcc-----CcccHHHHHHHHHHHHhccccCCCCC
Q 015389          319 LVLWA-RPMI---KRN----------------------EIRELVDASLA-----DEYDTRQMNLVLLAASLCIQQSSIRR  367 (408)
Q Consensus       319 ~~~~~-~~~~---~~~----------------------~~~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~~P~~R  367 (408)
                      ..... ....   ...                      ...........     ..........+.+++.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            11100 0000   000                      00000000000     01122345678899999999999999


Q ss_pred             CCHHHHHH
Q 015389          368 PQMSQVVQ  375 (408)
Q Consensus       368 Pt~~evl~  375 (408)
                      ||+.|+++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2e-41  Score=319.21  Aligned_cols=249  Identities=26%  Similarity=0.367  Sum_probs=199.6

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.+. ..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3478999999999999999999986 689999999875432 22356788999999999999999999977765 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC---CceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED---FEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~---~~~kl~DfGla~~~~  261 (408)
                      +|++.+++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++.+   +.+||+|||++....
T Consensus       100 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999999998854 4578999999999999999999999   999999999999999764   469999999998664


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ....   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.........           ..+......
T Consensus       176 ~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----------~~~~~~~~~  240 (287)
T 2wei_A          176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL-----------KRVETGKYA  240 (287)
T ss_dssp             CCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCCCC
T ss_pred             CCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHcCCCC
Confidence            4321   223458999999998865 5899999999999999999999999764322110           111111111


Q ss_pred             Cc--ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DE--YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..  .....+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11  11223456888999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.7e-42  Score=330.65  Aligned_cols=250  Identities=20%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             ccCHHHHhhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCC--CCcee
Q 015389           99 IFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVD--HPNTA  170 (408)
Q Consensus        99 ~~~~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~--hpniv  170 (408)
                      ..+..+.....++|++.+.||+|+||.||+|.+. +|+.||||.+......     .....+.+|+.+++.+.  ||||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            3344455556789999999999999999999865 6899999999754321     12244567899999986  59999


Q ss_pred             EEEeEEEeC-CeEEEEEecCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-CCC
Q 015389          171 KLLGYGIEG-GMHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDF  247 (408)
Q Consensus       171 ~l~~~~~~~-~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~~~  247 (408)
                      ++++++... ..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+|||++ .++
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTT
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCC
Confidence            999987765 47899999976 899999854 5678999999999999999999999   9999999999999999 778


Q ss_pred             ceEEeecCCcccCCCCCccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc
Q 015389          248 EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM  326 (408)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~  326 (408)
                      .+||+|||++......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......       
T Consensus       188 ~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-------  256 (320)
T 3a99_A          188 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------  256 (320)
T ss_dssp             EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-------
T ss_pred             CEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh-------
Confidence            9999999999876542    2234569999999999987766 688999999999999999999997532110       


Q ss_pred             cccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          327 IKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       327 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                ...  ..........+.+++.+||+.||.+|||+.+|++
T Consensus       257 ----------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 ----------RGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ----------HCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----------ccc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      000  0011123456788999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=321.94  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=181.4

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHH-HHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++......+.... +..+..+++.++||||+++++++.+. ..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3478999999999999999999986 699999999987655443334 44455567888999999999977765 47899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR-RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+ ++.+..+.......+++..+..++.|++.||.|||+   + +|+||||||+||+++.++.+||+|||++..+...
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 566666665556789999999999999999999998   6 9999999999999999999999999999765432


Q ss_pred             CccceecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          264 WTHHTISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      .   ......||+.|+|||.+.     +..++.++|||||||++|+|++|+.||.........          +..+...
T Consensus       179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------~~~~~~~  245 (318)
T 2dyl_A          179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV----------LTKVLQE  245 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------HHHHHHS
T ss_pred             c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH----------HHHHhcc
Confidence            1   223456999999999984     557889999999999999999999999753322111          1111111


Q ss_pred             hcc-CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SLA-DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ... ..........+..++.+||+.||.+||++.+|++
T Consensus       246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            000 0001123456888999999999999999999886

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-41  Score=325.81  Aligned_cols=252  Identities=20%  Similarity=0.234  Sum_probs=172.8

Q ss_pred             cCCCCccc-eecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCe
Q 015389          109 TNNFSFEN-LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGM  181 (408)
Q Consensus       109 ~~~y~~~~-~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~  181 (408)
                      .++|.+.+ .||+|+||.||+|.+. +|+.||||++....  ....   .....++.++||||+++++++..     ...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            47888855 6999999999999986 69999999997542  1112   22233566789999999997654     237


Q ss_pred             EEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla  257 (408)
                      ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            89999999999999996543 469999999999999999999999   99999999999999976   445999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVD  337 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d  337 (408)
                      ......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........       ....+..
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~  247 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-------MKRRIRL  247 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-------HHHhhhc
Confidence            865432    22345689999999999888999999999999999999999999975433211000       0000000


Q ss_pred             h--hccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 015389          338 A--SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRG  379 (408)
Q Consensus       338 ~--~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~  379 (408)
                      .  .............+.+++.+||+.||.+|||+.|+++  .+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            0  0111111234567888999999999999999999998  4444

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=323.91  Aligned_cols=243  Identities=24%  Similarity=0.377  Sum_probs=192.0

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcC----CCCceeEEEeE
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHV----DHPNTAKLLGY  175 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l----~hpniv~l~~~  175 (408)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++......     .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            345588999999999999999999874 6899999999765321     1233455788888888    89999999997


Q ss_pred             EEe-CCeEEEEEe-cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC-CCCceEEe
Q 015389          176 GIE-GGMHIVLEL-SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQIC  252 (408)
Q Consensus       176 ~~~-~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~-~~~~~kl~  252 (408)
                      +.. +..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||.|||+   ++|+||||||+||+++ .++.+||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~  182 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLI  182 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEE
Confidence            654 557899999 789999999954 4569999999999999999999999   8999999999999999 88999999


Q ss_pred             ecCCcccCCCCCccceecccccCCCccccccccCCCCC-cchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          253 DFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVD-EKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      |||++......    ......||..|+|||++.+..+. .++|||||||++|+|++|+.||......             
T Consensus       183 dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------  245 (312)
T 2iwi_A          183 DFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------  245 (312)
T ss_dssp             CCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------
T ss_pred             EcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------------
Confidence            99999876543    22345699999999999877764 5899999999999999999999753211             


Q ss_pred             HHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          332 IRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       332 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                          ....  ...+......+.+++.+||+.||.+||++.|+++
T Consensus       246 ----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 ----LEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----hhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1110  1112223456788999999999999999999998

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-40  Score=333.06  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=184.2

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv~e~  187 (408)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....    ...+.+|+.++.++ +||||+++++++.+.. .++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            4455678899999999987766679999999986542    34567899999876 8999999999777654 7899999


Q ss_pred             cCCCCHHHHHhcccCC------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-------------Cc
Q 015389          188 SPNGSLASLLYGMKEK------LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-------------FE  248 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~------l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-------------~~  248 (408)
                      +. |+|.+++......      .++..++.++.||+.||.|||+   ++|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999999653221      1333457899999999999999   999999999999999754             48


Q ss_pred             eEEeecCCcccCCCCCccc--eecccccCCCccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCccccc
Q 015389          249 PQICDFGLAKWLPEQWTHH--TISKVEGTFGYLAPEFLMH-------GIVDEKTDVFAFGVLLLELVT-GRRALDYSQQS  318 (408)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~  318 (408)
                      +||+|||++..+.......  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998775432211  1234579999999999976       678999999999999999999 99999754322


Q ss_pred             hhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          319 LVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...........        +.+...........+.+++.+||+.||.+|||+.+|++
T Consensus       247 ~~~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 ESNIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11111000000        00111123456678899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=333.07  Aligned_cols=250  Identities=21%  Similarity=0.256  Sum_probs=186.9

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv~  185 (408)
                      ...+|.+.++||+|+||+||.....+|+.||||++......    .+.+|+.+++++ +||||+++++++.+.. .++||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            34578999999999999976655567999999999765432    235799999999 7999999999777655 68999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-----CCceEEeecCCcccC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAKWL  260 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~  260 (408)
                      |++. |+|.+++........+..+..++.||+.||.|||+   ++|+||||||+|||++.     ...+||+|||+++.+
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            9996 69999997766666666778999999999999999   99999999999999953     235889999999876


Q ss_pred             CCCCcc-ceecccccCCCcccccccc---CCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHH
Q 015389          261 PEQWTH-HTISKVEGTFGYLAPEFLM---HGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      ...... .......||+.|+|||++.   +..++.++|||||||++|||++ |..||................       
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-------  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS-------  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC-------
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC-------
Confidence            543211 2234567999999999997   4567889999999999999999 899986433221111000000       


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ..  ...........+.+++.+||+.||.+|||+.+|++
T Consensus       247 -~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 -LD--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -CT--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cc--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             00  00111234455778999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-40  Score=347.67  Aligned_cols=240  Identities=23%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc--CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C----
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G----  180 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~----  180 (408)
                      ..++|++.+.||+|+||.||+|.+.  +|+.||||++......+....+.+|+.++.+++||||+++++++... .    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3479999999999999999999975  58999999998765556677889999999999999999999977653 3    


Q ss_pred             -eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          181 -MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       181 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                       .++||||+++++|.+++..   .+++..++.++.||+.||.|||+   ++|+||||||+|||++.+ .+||+|||+++.
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence             5899999999999988733   79999999999999999999999   999999999999999986 899999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ....      ....||+.|+|||++.++. +.++|||||||++|+|++|..||.......      . .           
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------~-~-----------  285 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------L-P-----------  285 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------C-C-----------
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------c-c-----------
Confidence            6432      3456999999999987654 899999999999999999998876422110      0 0           


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhcc
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQ-MSQVVQLLRGN  380 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~~L~~~  380 (408)
                       ...........+..++.+||+.||.+||+ +.++.+.|.+.
T Consensus       286 -~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 -EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             00111123356788999999999999995 66666666554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1e-40  Score=344.99  Aligned_cols=256  Identities=25%  Similarity=0.326  Sum_probs=198.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-------CCe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------GGM  181 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-------~~~  181 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.+++.++||||+++++++..       +..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            78999999999999999999875 6899999999876666667889999999999999999999986533       346


Q ss_pred             EEEEEecCCCCHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc---eEEeecCC
Q 015389          182 HIVLELSPNGSLASLLYGMK--EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE---PQICDFGL  256 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~---~kl~DfGl  256 (408)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            89999999999999996533  368999999999999999999999   99999999999999997765   99999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      +.......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..|..............
T Consensus       171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------CCS
T ss_pred             cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchhhhh
Confidence            98765432   224467999999999999999999999999999999999999999754221 11211111110000000


Q ss_pred             hhh------------ccCcccHHHHHHHHHHHHhccccCCCCCCCHHH
Q 015389          337 DAS------------LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQ  372 (408)
Q Consensus       337 d~~------------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e  372 (408)
                      ...            ............+..++.+||+.||.+|||+.+
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000            011233446778999999999999999999876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.5e-39  Score=305.42  Aligned_cols=232  Identities=14%  Similarity=0.081  Sum_probs=183.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++.....  .+....+.+|+.++..++||||+++++++.+. ..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            378999999999999999999986 489999999986543  45568889999999999999999999977765 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++..  + .....+..++.|++.||.|||+   ++|+||||||+|||++.+|.+||+++|         
T Consensus       110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999999943  2 3556788899999999999999   999999999999999999999998443         


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh-hhcccccc-chHHHHhhhhccC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL-WARPMIKR-NEIRELVDASLAD  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~-~~~~~~~~-~~~~~~~d~~l~~  342 (408)
                                   |++|       ++.++|||||||++|||++|+.||......... ........ .....        
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------  226 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA--------  226 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH--------
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh--------
Confidence                         3333       688999999999999999999999875432111 00000000 00000        


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      ......+..+..++.+||+.||.+| |+.|+++.|+......
T Consensus       227 ~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          227 DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0111234568889999999999999 9999999998876443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.8e-40  Score=324.68  Aligned_cols=241  Identities=11%  Similarity=0.062  Sum_probs=179.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch--HHHHHHHHHHHHHhcCCC-Cce--------------
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD--EIIADFLSELGIMAHVDH-PNT--------------  169 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~h-pni--------------  169 (408)
                      ...+|...+.||+|+||.||+|.+. +|+.||||++......  ...+.+.+|+.++..+.| +|.              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            3456888899999999999999965 6999999998844332  235778899999999977 211              


Q ss_pred             -eE------EEeEEEe------CCeEEEEEecCCCCHHHHHh------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 015389          170 -AK------LLGYGIE------GGMHIVLELSPNGSLASLLY------GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR  230 (408)
Q Consensus       170 -v~------l~~~~~~------~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  230 (408)
                       +.      ++.+...      ...+++|+ ..+++|.+++.      .....+++..++.++.||+.||.|||+   ++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEE-CCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hcccCCCCccccccCCCccccccceEEEee-hhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence             11      1111111      12344544 55789999884      234557888999999999999999999   99


Q ss_pred             eEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccc----------cCCCCCcchhHHHHHH
Q 015389          231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL----------MHGIVDEKTDVFAFGV  300 (408)
Q Consensus       231 iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwSlGv  300 (408)
                      |+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999999865432     345668 999999999          5566889999999999


Q ss_pred             HHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          301 LLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       301 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ++|||++|+.||.........               ...+...  ...+..+.+++.+||+.||.+||++.++++
T Consensus       306 il~elltg~~Pf~~~~~~~~~---------------~~~~~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGS---------------EWIFRSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCS---------------GGGGSSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhhhH---------------HHHHhhc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            999999999999764322110               0111100  012356888999999999999999776643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.6e-38  Score=298.94  Aligned_cols=227  Identities=18%  Similarity=0.247  Sum_probs=174.6

Q ss_pred             CCCCcc-ceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHH-hcCCCCceeEEEeEEEe-----CCe
Q 015389          110 NNFSFE-NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIM-AHVDHPNTAKLLGYGIE-----GGM  181 (408)
Q Consensus       110 ~~y~~~-~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il-~~l~hpniv~l~~~~~~-----~~~  181 (408)
                      ++|.+. +.||+|+||.||+|.+. +|+.||||++...      ..+.+|+.++ +.++||||+++++++..     ...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            567776 78999999999999875 6899999999643      2345788877 66699999999997654     347


Q ss_pred             EEEEEecCCCCHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCCc
Q 015389          182 HIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLA  257 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla  257 (408)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            89999999999999996543 469999999999999999999999   99999999999999998   788999999998


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh-ccccccchHHHHh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA-RPMIKRNEIRELV  336 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~  336 (408)
                      ....                        +..++.++|||||||++|+|++|+.||........... ........     
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-----  218 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----  218 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC-----
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc-----
Confidence            6432                        24567899999999999999999999975432211000 00000000     


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                       ..............+..++.+||+.||.+|||+.|+++
T Consensus       219 -~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          219 -YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             00000000123456888999999999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-39  Score=309.64  Aligned_cols=237  Identities=16%  Similarity=0.139  Sum_probs=184.1

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-------hHHHHHHHHHHHHHhcCC---------CCceeEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-------DEIIADFLSELGIMAHVD---------HPNTAKL  172 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~---------hpniv~l  172 (408)
                      .++|++.+.||+|+||+||+|.+ +|+.||||++.....       ......+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46789999999999999999998 689999999976532       223466778888887775         8888888


Q ss_pred             EeEEE-------------------------------eCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Q 015389          173 LGYGI-------------------------------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL  221 (408)
Q Consensus       173 ~~~~~-------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~  221 (408)
                      .+.+.                               .+..++||||+++|++.+.+.  +..+++..+..++.||+.||.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHHH
Confidence            77432                               456899999999998777663  367899999999999999999


Q ss_pred             HHH-hcCCCCeEeeCCCCCceEECCCC--------------------ceEEeecCCcccCCCCCccceecccccCCCccc
Q 015389          222 YLH-EGCQRRIIHRDIKAANILLTEDF--------------------EPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA  280 (408)
Q Consensus       222 ~LH-~~~~~~iiH~Dikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  280 (408)
                      ||| +   ++|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|
T Consensus       176 ~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~a  245 (336)
T 2vuw_A          176 VAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMD  245 (336)
T ss_dssp             HHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTC
T ss_pred             HHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccC
Confidence            999 8   9999999999999999887                    8999999999865432       3469999999


Q ss_pred             cccccCCCCCcchhHHHHHHH-HHHHHhCCCCCCccccchhhhhccccccchHHHHhhh-----hccCcccHHHHHHHHH
Q 015389          281 PEFLMHGIVDEKTDVFAFGVL-LLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA-----SLADEYDTRQMNLVLL  354 (408)
Q Consensus       281 PE~~~~~~~~~k~DvwSlGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~-----~l~~~~~~~~~~~l~~  354 (408)
                      ||++.+.. +.++||||||++ .+++++|..||...     .|...     ....+...     .............+.+
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHY-----LTDKMLKQMTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHH-----HHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhH-----HHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence            99998766 899999998777 77888899998531     01000     01111110     0111223456778999


Q ss_pred             HHHhccccCCCCCCCHHHHH
Q 015389          355 AASLCIQQSSIRRPQMSQVV  374 (408)
Q Consensus       355 li~~cl~~~P~~RPt~~evl  374 (408)
                      |+.+||+.|     |+.|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.3e-32  Score=280.88  Aligned_cols=185  Identities=15%  Similarity=0.124  Sum_probs=128.6

Q ss_pred             eecccCcEEEEEEE-EcCCcEEEEEEecCCC---------chHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC-CeEEE
Q 015389          117 LIGKGGYAEVYKGR-LRNGQLVAIKRLTRGT---------ADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       117 ~lg~G~fg~V~~~~-~~~g~~vavK~~~~~~---------~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ..+.|++|.+..++ .--|+.||+|++....         .+...++|.+|+++|+++ .|+||+++++++.++ ..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35566666666553 2248889999997542         122456799999999999 799999999988765 58999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||++|++|.++|.. .+.++..   +|+.||+.||.|||+   +|||||||||+|||++.+|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999954 4556654   588999999999999   999999999999999999999999999998765432


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRA  311 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~p  311 (408)
                        ....+.+||++|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              23345779999999999865 567789999999999888766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2e-28  Score=250.28  Aligned_cols=186  Identities=19%  Similarity=0.138  Sum_probs=144.5

Q ss_pred             CccceecccCcEEEEEEEEcCCcEEEEEEecCCCc--h-----HHHHHHHHHHHHHhcCCCCceeEEEeEE-EeCCeEEE
Q 015389          113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA--D-----EIIADFLSELGIMAHVDHPNTAKLLGYG-IEGGMHIV  184 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~--~-----~~~~~~~~E~~il~~l~hpniv~l~~~~-~~~~~~lv  184 (408)
                      ...+.||+|+||.||+|.. .+..+|+|.......  .     ...+++.+|+.++++++||||+++..++ .....++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3457899999999999955 478889998654321  1     1246689999999999999999444333 34567999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++++|.+++..         +..++.|++.||.|||+   ++|+||||||+|||++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999854         56799999999999999   99999999999999998  99999999999875432


Q ss_pred             ccc-----eecccccCCCccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015389          265 THH-----TISKVEGTFGYLAPEFLMH--GIVDEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       265 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvil~elltg~~pf~  313 (408)
                      ...     ....+.||+.|+|||++.+  ..|+..+|+||..+-..+.+.++.+|.
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            211     1235679999999999987  568889999999999999998887764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.1e-26  Score=214.42  Aligned_cols=153  Identities=16%  Similarity=0.095  Sum_probs=124.2

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch-----------------HHHHHHHHHHHHHhcCC
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-----------------EIIADFLSELGIMAHVD  165 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~E~~il~~l~  165 (408)
                      ..+......|.+.+.||+|+||.||+|.+.+|+.||||.+......                 .....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444455677888999999999999999877999999999753321                 13567889999999998


Q ss_pred             CCceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC
Q 015389          166 HPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE  245 (408)
Q Consensus       166 hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~  245 (408)
                        | +++++++..+..++||||+++++|.+ +.       ......++.|++.||.|||+   .+|+||||||+|||++ 
T Consensus       163 --~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          163 --G-LAVPKVYAWEGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             --T-SSSCCEEEEETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred             --C-CCcCeEEeccceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence              4 56666556677899999999999988 41       12345799999999999999   9999999999999999 


Q ss_pred             CCceEEeecCCcccCCCCCccceecccccCCCcccccccc
Q 015389          246 DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM  285 (408)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  285 (408)
                      ++.+||+|||+|.               .+..|.|||++.
T Consensus       228 ~~~vkl~DFG~a~---------------~~~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSV---------------EVGEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred             CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence            9999999999986               334578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=1.6e-21  Score=180.73  Aligned_cols=139  Identities=20%  Similarity=0.182  Sum_probs=108.6

Q ss_pred             CCCCccceecccCcEEEEEEEE-cCCcE--EEEEEecCCCch-----------------------HHHHHHHHHHHHHhc
Q 015389          110 NNFSFENLIGKGGYAEVYKGRL-RNGQL--VAIKRLTRGTAD-----------------------EIIADFLSELGIMAH  163 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~-~~g~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~il~~  163 (408)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                       .....+.+|+.++..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999987 67989  999987543211                       122467889999999


Q ss_pred             CCCCce--eEEEeEEEeCCeEEEEEecCC-C----CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeeC
Q 015389          164 VDHPNT--AKLLGYGIEGGMHIVLELSPN-G----SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH-EGCQRRIIHRD  235 (408)
Q Consensus       164 l~hpni--v~l~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiH~D  235 (408)
                      +.|+++  ..++++   ...++||||+.+ |    +|.++...    .++..+..++.|++.||.||| +   .+|+|||
T Consensus       127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD  196 (258)
T 1zth_A          127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHAD  196 (258)
T ss_dssp             HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred             HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence            987754  334432   467899999942 3    67766522    234567889999999999999 8   9999999


Q ss_pred             CCCCceEECCCCceEEeecCCcccC
Q 015389          236 IKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       236 ikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=3.3e-18  Score=165.77  Aligned_cols=145  Identities=17%  Similarity=0.138  Sum_probs=103.2

Q ss_pred             HHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc----------------h-H----HHHHHHHHHHHHh
Q 015389          104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA----------------D-E----IIADFLSELGIMA  162 (408)
Q Consensus       104 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~----------------~-~----~~~~~~~E~~il~  162 (408)
                      .+.....-|++.+.||.|+||.||+|...+|+.||||+++....                . .    ......+|...|.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            33333445999999999999999999988999999998753211                0 0    0111234666666


Q ss_pred             cCCCCceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          163 HVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       163 ~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                      ++.+.++.-..-+.. ...++||||++|++|..+..       ......++.||+.+|.|||+   .|||||||||.|||
T Consensus       169 rL~~~gv~vp~p~~~-~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQ-SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHHTTCSCCCEEEE-ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEE
T ss_pred             HHHhcCCCCCeeeec-cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEE
Confidence            664443321111222 23479999999988865431       22345688999999999999   99999999999999


Q ss_pred             ECCCCc----------eEEeecCCccc
Q 015389          243 LTEDFE----------PQICDFGLAKW  259 (408)
Q Consensus       243 l~~~~~----------~kl~DfGla~~  259 (408)
                      +++++.          +.|+||+-+..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EeCCCCcccccccccceEEEEeCCccc
Confidence            988773          89999997653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.30  E-value=9.6e-12  Score=114.57  Aligned_cols=143  Identities=15%  Similarity=0.061  Sum_probs=109.0

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-CeEEEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ....|.+...++.|+.+.||++... |+.+++|+....... ....+.+|+.+++.+. +..+.++++++... ..++||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            3467888889999999999999764 678999998752111 1234678899888884 67788888877665 468999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG---------------------------------------  226 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  226 (408)
                      |+++|.+|.+.+.      +......++.+++.+|..||+.                                       
T Consensus        90 e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999987631      1223446788999999999981                                       


Q ss_pred             -----------------CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          227 -----------------CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       227 -----------------~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                                       ....++|+|++|.||++++++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             11458999999999999876666799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=1.9e-11  Score=111.94  Aligned_cols=136  Identities=16%  Similarity=0.144  Sum_probs=96.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc--eeEEEeEEEe-CCeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN--TAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn--iv~l~~~~~~-~~~~lv~e  186 (408)
                      .+|.+....+.|..+.||++...+|..++||......    ...+..|+.+++.+.+.+  +.+++++... +..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            4455443334566699999987778889999976542    134567888888875434  5567776655 45789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC---------------------------------------  227 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------  227 (408)
                      +++|.+|.  ...    .+   ...++.+++..|..||...                                       
T Consensus        96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            99998884  211    11   2356777888888888621                                       


Q ss_pred             ----------------CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          228 ----------------QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       228 ----------------~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                                      ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                            1239999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=2.1e-10  Score=110.71  Aligned_cols=143  Identities=13%  Similarity=0.070  Sum_probs=104.8

Q ss_pred             ccceecccCcEEEEEEEEcCCcEEEEEEec--CCCchHHHHHHHHHHHHHhcCC--CCceeEEEeEEEeC----CeEEEE
Q 015389          114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLT--RGTADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEG----GMHIVL  185 (408)
Q Consensus       114 ~~~~lg~G~fg~V~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~----~~~lv~  185 (408)
                      -.+.|+.|.++.||+....+ ..+++|+..  ..........+.+|+.+++.+.  +..+.+++.++.+.    ..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35789999999999998754 578888876  4332222346678999998886  45678888877654    368999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC--------------------------------------  227 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  227 (408)
                      |+++|..+.+..   -..++...+..++.+++.+|..||...                                      
T Consensus       121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999998775421   234677788889999999999999721                                      


Q ss_pred             -----------------CCCeEeeCCCCCceEECCCCc--eEEeecCCcccC
Q 015389          228 -----------------QRRIIHRDIKAANILLTEDFE--PQICDFGLAKWL  260 (408)
Q Consensus       228 -----------------~~~iiH~Dikp~NIll~~~~~--~kl~DfGla~~~  260 (408)
                                       ...++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             257999999999999987753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.02  E-value=1.7e-10  Score=108.71  Aligned_cols=183  Identities=17%  Similarity=0.142  Sum_probs=121.0

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCc--eeEEEeEEEeCC----eEEEEEe
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPN--TAKLLGYGIEGG----MHIVLEL  187 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpn--iv~l~~~~~~~~----~~lv~e~  187 (408)
                      .+.++.|....||+..    ..++||+....   .....+.+|..+++.+ .+..  +.+++.+.....    .++||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3568999999999863    45888886532   3456778899998877 3322  344454433322    4789999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-----------------------------------------  226 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  226 (408)
                      ++|.+|.....   ..++...+..++.+++..|..||+.                                         
T Consensus        98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99998875432   3466777778888888888888861                                         


Q ss_pred             --------------CCCCeEeeCCCCCceEECC--CCceEEeecCCcccCCCCCccceecccccCCCc---cccccccC-
Q 015389          227 --------------CQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY---LAPEFLMH-  286 (408)
Q Consensus       227 --------------~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  286 (408)
                                    ....++|+|++|.||+++.  ++.+.|+||+.+........      +.....+   ..|+.... 
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHHH
Confidence                          1135899999999999998  45688999998875422110      0011111   22322110 


Q ss_pred             ----CCC---------CcchhHHHHHHHHHHHHhCCCCCC
Q 015389          287 ----GIV---------DEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       287 ----~~~---------~~k~DvwSlGvil~elltg~~pf~  313 (408)
                          +..         ....+.|++|.++|.+.+|+.+|-
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                111         123689999999999999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=1.5e-06  Score=81.82  Aligned_cols=136  Identities=17%  Similarity=0.098  Sum_probs=92.1

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCC---ceeEEEeEEE--eCCeEEEEEecC
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP---NTAKLLGYGI--EGGMHIVLELSP  189 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hp---niv~l~~~~~--~~~~~lv~e~~~  189 (408)
                      .+.++.|....||+.    |..++||+...   ......+..|..++..+.+.   .+.+.+.++.  .+..++||++++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888888999988    45688887532   23456788999999998642   3555666553  344789999999


Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-------------------------------------------  226 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------  226 (408)
                      |.++.....   ..++......++.+++..|..||+.                                           
T Consensus        97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            988876321   1233444444455555555555431                                           


Q ss_pred             --------------CCCCeEeeCCCCCceEECC---CCc-eEEeecCCcccC
Q 015389          227 --------------CQRRIIHRDIKAANILLTE---DFE-PQICDFGLAKWL  260 (408)
Q Consensus       227 --------------~~~~iiH~Dikp~NIll~~---~~~-~kl~DfGla~~~  260 (408)
                                    ....++|+|++|.||+++.   ++. +.|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          2346799999999999987   355 589999988653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=2.4e-06  Score=78.49  Aligned_cols=133  Identities=14%  Similarity=0.061  Sum_probs=92.7

Q ss_pred             eecccCcE-EEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          117 LIGKGGYA-EVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       117 ~lg~G~fg-~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      .+..|..| .||+.... ++..++||+-...    ....+..|..+|+.+. +--+.++++++.++ ..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            44455554 78988754 4677899986543    2345667888887773 33466777776654 4689999999998


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG----------------------------------------------  226 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------------  226 (408)
                      +.+....     .......+..+++..|.-||..                                              
T Consensus       107 ~~~~~~~-----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          107 AFQVLEE-----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHH-----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             ccccccC-----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            8876532     1123344666777777777751                                              


Q ss_pred             ---------CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          227 ---------CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       227 ---------~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                               ....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     11238999999999999988777899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=2.2e-06  Score=83.52  Aligned_cols=76  Identities=14%  Similarity=0.045  Sum_probs=48.5

Q ss_pred             cceecccCcEEEEEEEEc-CCcEEEEEEecCCCc---h---HHHHHHHHHHHHHhcCCC--C-ceeEEEeEEEeCCeEEE
Q 015389          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA---D---EIIADFLSELGIMAHVDH--P-NTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~---~---~~~~~~~~E~~il~~l~h--p-niv~l~~~~~~~~~~lv  184 (408)
                      .+.||.|.++.||++... +++.|+||.......   +   ....++..|..+++.+..  | .+.+++.+ .....++|
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv  113 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV  113 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence            467999999999999754 468899998653211   0   112345678888876632  3 34456554 34456899


Q ss_pred             EEecCCC
Q 015389          185 LELSPNG  191 (408)
Q Consensus       185 ~e~~~~g  191 (408)
                      ||++.+.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=1.5e-05  Score=75.39  Aligned_cols=31  Identities=23%  Similarity=0.312  Sum_probs=28.2

Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      +..++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4789999999999999888899999999775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.10  E-value=9.6e-06  Score=77.62  Aligned_cols=80  Identities=9%  Similarity=-0.026  Sum_probs=51.9

Q ss_pred             ccee-cccCcEEEEEEEEc-------CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCC-C--CceeEEEeEEEeC--
Q 015389          115 ENLI-GKGGYAEVYKGRLR-------NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD-H--PNTAKLLGYGIEG--  179 (408)
Q Consensus       115 ~~~l-g~G~fg~V~~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~-h--pniv~l~~~~~~~--  179 (408)
                      .+.| +.|....+|+....       ++..+++|.......  ......+..|+.+++.+. +  ..+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999998754       267789998754320  000123456777777663 2  3566777766554  


Q ss_pred             --CeEEEEEecCCCCHH
Q 015389          180 --GMHIVLELSPNGSLA  194 (408)
Q Consensus       180 --~~~lv~e~~~~g~L~  194 (408)
                        ..++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence              358999999886653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.02  E-value=1.6e-05  Score=73.91  Aligned_cols=79  Identities=13%  Similarity=0.160  Sum_probs=54.7

Q ss_pred             CCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC---CceeEEEeEEEeCCeEEEEEe
Q 015389          111 NFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH---PNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h---pniv~l~~~~~~~~~~lv~e~  187 (408)
                      ...-++.+|.|..+.||+....+|+.|+||+....... ....+..|...|+.|..   -.+.+++++   +..++|||+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEEEEe
Confidence            34446789999999999999999999999987644321 12335678888777632   234444443   345789999


Q ss_pred             cCCCCH
Q 015389          188 SPNGSL  193 (408)
Q Consensus       188 ~~~g~L  193 (408)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            887653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.74  E-value=0.00014  Score=71.27  Aligned_cols=77  Identities=14%  Similarity=0.148  Sum_probs=49.5

Q ss_pred             CCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccc--cCCCccccccccCCC---CCcchhHHHHHHHH
Q 015389          228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE--GTFGYLAPEFLMHGI---VDEKTDVFAFGVLL  302 (408)
Q Consensus       228 ~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~k~DvwSlGvil  302 (408)
                      ...++|+|++|.|||++.++ +.|+||+.+...+....-   ....  -...|++|+......   -....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            47899999999999998876 999999998754321110   0011  123466666553211   11235566888888


Q ss_pred             HHHHhC
Q 015389          303 LELVTG  308 (408)
Q Consensus       303 ~elltg  308 (408)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            888765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.61  E-value=0.00034  Score=61.55  Aligned_cols=163  Identities=12%  Similarity=0.020  Sum_probs=93.4

Q ss_pred             CCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcccee
Q 015389          190 NGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI  269 (408)
Q Consensus       190 ~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  269 (408)
                      .-+|.+.|...+.+++++++|.++.|.+.+|.-+-..  +.-..+=+.|..|++..+|.|.+.+ +.+.           
T Consensus        32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            3489999988999999999999999999998766210  1111233456899999999988874 2211           


Q ss_pred             cccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHH-
Q 015389          270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ-  348 (408)
Q Consensus       270 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-  348 (408)
                         .....+.|||... ...+.+.=|||||+++|.-+--..|=+.          +.....++..+++.+....-+... 
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e----------E~eLS~~LE~LL~~Mt~~~~d~~~~  163 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE----------ERELSPPLEQLIDHMANTVEADGSN  163 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE----------EECCCHHHHHHHHHHTTCCC-----
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc----------chhhCHHHHHHHHHHHhcccccccc
Confidence               1223466888763 4556889999999999999874433221          111223344444433322100000 


Q ss_pred             HHHHH------HHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          349 MNLVL------LAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       349 ~~~l~------~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      .+.+-      .--..  ...+..|++.++|++.-...+.
T Consensus       164 DeG~~~~~eg~~d~~~--~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          164 DEGYEAAEEGLGDEDE--KRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             ---------------C--CSCCCCCCSHHHHHHHHHTTSS
T ss_pred             cccccccccccccccc--cccccCcCCHHHHHHHHHhhcc
Confidence            00000      00000  1356789999999999887765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.60  E-value=0.00018  Score=68.06  Aligned_cols=141  Identities=11%  Similarity=0.075  Sum_probs=72.3

Q ss_pred             ceecccCcEE-EEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC--CCceeEEEeEEEeCCeEEEEEecCCCC
Q 015389          116 NLIGKGGYAE-VYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEGGMHIVLELSPNGS  192 (408)
Q Consensus       116 ~~lg~G~fg~-V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~~~~lv~e~~~~g~  192 (408)
                      +.|+.|+... +|+....+|..+++|.......    ..+..|+.++..+.  .-.+.+++.+..+.+ +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g-~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG-LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT-EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC-EEEEeeCCCcc
Confidence            4565555444 6677654466777886554321    11224555555542  123556666544444 68999997776


Q ss_pred             HHHHHhccc-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHHH---
Q 015389          193 LASLLYGMK-------------------------EKLKWGIRY-------KIA-------------LGVAEGLLYLH---  224 (408)
Q Consensus       193 L~~~l~~~~-------------------------~~l~~~~~~-------~i~-------------~~i~~~L~~LH---  224 (408)
                      +.+.+....                         ..++.....       .+.             ..+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            655442110                         011111100       000             01111222221   


Q ss_pred             hcCCCCeEeeCCCCCceEECCC----CceEEeecCCcccCC
Q 015389          225 EGCQRRIIHRDIKAANILLTED----FEPQICDFGLAKWLP  261 (408)
Q Consensus       225 ~~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~~~  261 (408)
                      ......++|||+.+.||+++.+    +.+.|+||+.+...+
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            1124689999999999999874    679999999887543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.59  E-value=0.00038  Score=65.40  Aligned_cols=135  Identities=19%  Similarity=0.204  Sum_probs=86.5

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC---CCceeEEEeEEEe-CCeEEEEEecCC
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD---HPNTAKLLGYGIE-GGMHIVLELSPN  190 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~---hpniv~l~~~~~~-~~~~lv~e~~~~  190 (408)
                      .+.|+.|....+|+... ++..++||+.....    ...+..|...|+.|.   ...+.+++.++.. +..++|||++++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            46789999999999876 46778889876432    455678888887773   3567788877654 457899999998


Q ss_pred             CCHH--------H---HHhcccC--C-------------------CCHHHHH---HHH----------------HHHHHH
Q 015389          191 GSLA--------S---LLYGMKE--K-------------------LKWGIRY---KIA----------------LGVAEG  219 (408)
Q Consensus       191 g~L~--------~---~l~~~~~--~-------------------l~~~~~~---~i~----------------~~i~~~  219 (408)
                      ..+.        .   .||....  .                   -+|...+   ++.                ..++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            8642        1   1222111  0                   1333221   011                112222


Q ss_pred             H-HHHHh-cCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          220 L-LYLHE-GCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       220 L-~~LH~-~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                      + ..|.. .....++|+|+.+.|++++.++ +.|+||+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            2 23321 1246799999999999999887 8899984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.35  E-value=0.0016  Score=60.91  Aligned_cols=153  Identities=17%  Similarity=0.197  Sum_probs=81.5

Q ss_pred             HHHHhhhcCCCCc-----cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-----CCceeE
Q 015389          102 LYELQSATNNFSF-----ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----HPNTAK  171 (408)
Q Consensus       102 ~~~~~~~~~~y~~-----~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----hpniv~  171 (408)
                      ..++......|.+     .+.|+.|....+|+....+| .+++|........   ..+..|+.++..+.     -|.++.
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccC
Confidence            3344444444544     24567788899999987656 5788988763111   22335666665552     233332


Q ss_pred             EE-e---EEEeCCeEEEEEecCCCCHHH--------------HHhcccCC--------C---CHHHHHH-----------
Q 015389          172 LL-G---YGIEGGMHIVLELSPNGSLAS--------------LLYGMKEK--------L---KWGIRYK-----------  211 (408)
Q Consensus       172 l~-~---~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~--------l---~~~~~~~-----------  211 (408)
                      .. +   ....+..++++++++|..+..              .+|.....        .   .|...+.           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            11 1   112345678999998865311              11211000        0   1111000           


Q ss_pred             -HHHHHHHHHHHHHhc----CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          212 -IALGVAEGLLYLHEG----CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       212 -i~~~i~~~L~~LH~~----~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       +...+...+..++..    .+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             001133445555532    23679999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.23  E-value=0.00067  Score=63.10  Aligned_cols=137  Identities=12%  Similarity=0.021  Sum_probs=72.3

Q ss_pred             cceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCce-eEEEeEEEeCCeEEEEEec-CCCC
Q 015389          115 ENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELS-PNGS  192 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~lv~e~~-~~g~  192 (408)
                      .+.|+.|....+|+.     ..+++|+.......  ......|+.+++.+...++ .+++++. ...-++|++|+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCCCcc
Confidence            578999999999998     45888887653211  1112356666655532122 3455442 33346899999 5544


Q ss_pred             HHH------------------HHhcccCCC----CH-HHHHHHHH--------------HHHHHHH----HHHh-cCCCC
Q 015389          193 LAS------------------LLYGMKEKL----KW-GIRYKIAL--------------GVAEGLL----YLHE-GCQRR  230 (408)
Q Consensus       193 L~~------------------~l~~~~~~l----~~-~~~~~i~~--------------~i~~~L~----~LH~-~~~~~  230 (408)
                      +..                  .+|.....+    +. .....+..              .+...+.    .|.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            421                  011111111    10 11111100              0111111    1111 12345


Q ss_pred             eEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          231 IIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       231 iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            899999999999 55667899999988643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.0013  Score=64.73  Aligned_cols=72  Identities=17%  Similarity=0.128  Sum_probs=46.7

Q ss_pred             cceecccCcEEEEEEEEcC--------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc-eeEEEeEEEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~lv~  185 (408)
                      .+.|+.|....||++...+        +..|++|+......   ...+..|..++..+...+ ..++++.+.+   .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CEEE
Confidence            3578888889999998653        57899998844222   123446888877774222 3556664432   3889


Q ss_pred             EecCCCC
Q 015389          186 ELSPNGS  192 (408)
Q Consensus       186 e~~~~g~  192 (408)
                      +|++|-+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9987633

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.16  E-value=0.0018  Score=60.84  Aligned_cols=139  Identities=15%  Similarity=0.108  Sum_probs=77.1

Q ss_pred             ceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC--CceeEEEeE------EEeCCeEEEEEe
Q 015389          116 NLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH--PNTAKLLGY------GIEGGMHIVLEL  187 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h--pniv~l~~~------~~~~~~~lv~e~  187 (408)
                      ..|+ |....||+....+|+.+++|........  ...+..|..++..+..  -.+.+++..      ..++..++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~--~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCC--HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4566 7788999987767778999998743221  2334456666666531  123333332      123345689999


Q ss_pred             cCCCCHH-----H------H---Hhcc--c------CCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 015389          188 SPNGSLA-----S------L---LYGM--K------EKLKWGIR----YKI---------------ALGVAEGLLYLHEG  226 (408)
Q Consensus       188 ~~~g~L~-----~------~---l~~~--~------~~l~~~~~----~~i---------------~~~i~~~L~~LH~~  226 (408)
                      ++|..+.     .      .   +|..  .      ...++...    ..+               ...+...+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     1      1   1110  0      11121110    001               00111122333221


Q ss_pred             ----CCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          227 ----CQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       227 ----~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                          .+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                246789999999999999 4 899999988764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.15  E-value=0.00058  Score=65.92  Aligned_cols=139  Identities=17%  Similarity=0.198  Sum_probs=78.8

Q ss_pred             ceecccCcEEEEEEEEc--------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeCCeEEEEE
Q 015389          116 NLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLE  186 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~lv~e  186 (408)
                      +.|..|-...+|+....        ++..|++|+.-...  .....+.+|..+++.+. +.-..++++++.+   .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE---GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---ccEEE
Confidence            56777778889998764        25789999863321  11334457888887763 2223556665443   28999


Q ss_pred             ecCCCCHHH--------------H---Hhccc----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 015389          187 LSPNGSLAS--------------L---LYGMK----EKLK--WGIRYKIALGVAE-------------------GLLYLH  224 (408)
Q Consensus       187 ~~~~g~L~~--------------~---l~~~~----~~l~--~~~~~~i~~~i~~-------------------~L~~LH  224 (408)
                      |++|.+|..              .   ||...    ....  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998765431              1   11111    1122  2344444433321                   123332


Q ss_pred             h-----cCCCCeEeeCCCCCceEECCC----CceEEeecCCccc
Q 015389          225 E-----GCQRRIIHRDIKAANILLTED----FEPQICDFGLAKW  259 (408)
Q Consensus       225 ~-----~~~~~iiH~Dikp~NIll~~~----~~~kl~DfGla~~  259 (408)
                      .     .....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2     123568999999999999876    6899999998763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.87  E-value=0.0036  Score=61.98  Aligned_cols=74  Identities=19%  Similarity=0.057  Sum_probs=46.0

Q ss_pred             cceecccCcEEEEEEEEcC-CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCce-eEEEeEEEeCCeEEEEEecCCCC
Q 015389          115 ENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT-AKLLGYGIEGGMHIVLELSPNGS  192 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpni-v~l~~~~~~~~~~lv~e~~~~g~  192 (408)
                      .+.|+.|-...+|+....+ +..+++|+...... ... ....|..++..|...++ .++++++. +  .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EII-NREREKKISCILYNKNIAKKIYVFFT-N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C--eEEEEeeCCcc
Confidence            3578888889999998765 57888998754321 111 11478888887754333 45666552 2  35999998754


Q ss_pred             H
Q 015389          193 L  193 (408)
Q Consensus       193 L  193 (408)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.74  E-value=0.002  Score=61.70  Aligned_cols=72  Identities=14%  Similarity=0.116  Sum_probs=41.3

Q ss_pred             ceecccCcEEEEEEEEcC---------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCc-eeEEEeEEEeCCeEEEE
Q 015389          116 NLIGKGGYAEVYKGRLRN---------GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN-TAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~~~~~lv~  185 (408)
                      +.|+.|....+|+....+         +..+++|+...... . ......|..++..+...+ +.++++..  . -++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~-~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-E-LYNTISEFEVYKTMSKYKIAPQLLNTF--N-GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T-TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-c-eecHHHHHHHHHHHHhcCCCCceEEec--C-CcEEE
Confidence            567788888999998653         26888998754321 1 112246777776663222 34555433  2 36899


Q ss_pred             EecCCCC
Q 015389          186 ELSPNGS  192 (408)
Q Consensus       186 e~~~~g~  192 (408)
                      +|++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.60  E-value=0.011  Score=56.02  Aligned_cols=32  Identities=25%  Similarity=0.299  Sum_probs=28.3

Q ss_pred             CCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       229 ~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            57999999999999998888999999887643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.15  E-value=0.03  Score=54.72  Aligned_cols=74  Identities=11%  Similarity=0.042  Sum_probs=45.2

Q ss_pred             cceecccCcEEEEEEEEcC--------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeCCeEEEE
Q 015389          115 ENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~lv~  185 (408)
                      .+.|..|-...+|+....+        +..|++++...... . .-...+|..+++.+. +.-..++++.+   .-++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~-~idR~~E~~~l~~L~~~gi~P~l~~~~---~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-K-FYDSKVELDVFRYLSNINIAPNIIADF---PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-h-hcCHHHHHHHHHHHHhcCCCCCEEEEc---CCCEEE
Confidence            3567778888999998653        57899998754321 1 111236777766663 22234455422   236899


Q ss_pred             EecCCCCH
Q 015389          186 ELSPNGSL  193 (408)
Q Consensus       186 e~~~~g~L  193 (408)
                      +|++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.33  E-value=0.022  Score=55.22  Aligned_cols=30  Identities=30%  Similarity=0.494  Sum_probs=25.0

Q ss_pred             CeEeeCCCCCceEE------CCCCceEEeecCCccc
Q 015389          230 RIIHRDIKAANILL------TEDFEPQICDFGLAKW  259 (408)
Q Consensus       230 ~iiH~Dikp~NIll------~~~~~~kl~DfGla~~  259 (408)
                      .++|+|+.+.||++      +++..+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4456799999998863

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.86  E-value=0.049  Score=53.84  Aligned_cols=62  Identities=8%  Similarity=0.187  Sum_probs=18.5

Q ss_pred             CccceecccCcEEEEEEEEcC-CcEEEE------EEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEE
Q 015389          113 SFENLIGKGGYAEVYKGRLRN-GQLVAI------KRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGI  177 (408)
Q Consensus       113 ~~~~~lg~G~fg~V~~~~~~~-g~~vav------K~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~  177 (408)
                      .+.+.||   ||.||+|.+.. ...|||      |..+... ..+....+.+|..++..++|||+++.++|..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4456776   99999998754 467888      7665433 2234567888999999999999999988754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.49  E-value=1.1  Score=39.09  Aligned_cols=115  Identities=16%  Similarity=0.133  Sum_probs=73.7

Q ss_pred             CCCceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEeeCCCCCceEE
Q 015389          165 DHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLL-YLHEGCQRRIIHRDIKAANILL  243 (408)
Q Consensus       165 ~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiH~Dikp~NIll  243 (408)
                      .||++ ..---..++.+.+.++.-+++.-...+    ..++...+++++.+|+.... ++     ..-+|--|.|+||++
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~-----~~r~tf~l~P~NL~f  117 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS-----ARRLIFIVCPENLMF  117 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC-----SSSEECCCCGGGEEE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh-----hCceeEEEeCceEEE
Confidence            57877 322223334455555554344333333    45678888988888877666 45     456888999999999


Q ss_pred             CCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 015389          244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALD  313 (408)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~  313 (408)
                      +.++.++|.-.|+-..+                   +|.-     .++.-=+-++=+++..++.++..|+
T Consensus       118 ~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          118 NRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             CTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999877764432                   2221     1122223467788888888887775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.87  E-value=0.98  Score=39.37  Aligned_cols=124  Identities=10%  Similarity=0.052  Sum_probs=79.3

Q ss_pred             HHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCC
Q 015389          157 ELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDI  236 (408)
Q Consensus       157 E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Di  236 (408)
                      |+.+|. ..||+++.. .+..+++ -+++.|-.......+-  .-..++...+++++.+|+....+++     .-+|--|
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD-~v~~~y~~~~~~~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L  105 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRD-SFQIHYDINDNHTPFD--NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVL  105 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSS-EEEEEECCCTTSEEGG--GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCC
T ss_pred             HHHHHh-ccCCcccce-EEEEccc-EEEEEEEcCcccCCHH--HHHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEE
Confidence            444443 258888866 3433333 3333343333222222  2345778889999999988876655     3578899


Q ss_pred             CCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCc
Q 015389          237 KAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDY  314 (408)
Q Consensus       237 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~  314 (408)
                      .|+||+++.++.+++.-.|+-..++                   |.     .++...=.-.+=+++..+++++..|..
T Consensus       106 ~P~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          106 APDELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             SGGGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             ecceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999999998777644322                   21     112223344677889999999988763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	408
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-69
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-59
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-57
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-54
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 3e-69
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 16/273 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPN 168
              +    IG G +  VYKG+      VA+K L       + +  F +E+G++    H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
               +GY     + IV +     SL   L+ ++ K +      IA   A+G+ YLH    
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH-- 286
           + IIHRD+K+ NI L ED   +I DFGLA         H   ++ G+  ++APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 287 -GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
                 ++DV+AFG++L EL+TG+    YS  +       M+ R  +   +   +     
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLP--YSNINNRDQIIFMVGRGYLSPDLS-KVRSNCP 239

Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                L+      C+++    RP   Q++  + 
Sbjct: 240 KAMKRLMA----ECLKKKRDERPLFPQILASIE 268

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 5e-63
 Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 11/304 (3%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           ++   ++F   + +G G    V+K   + +G ++A K +       I    + EL ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            + P      G     G + I +E    GSL  +L     ++   I  K+++ V +GL Y
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           L E  + +I+HRD+K +NIL+    E ++CDFG++  L +   +  +    GT  Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPE 173

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD 342
            L       ++D+++ G+ L+E+  GR  +       +          +  E        
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKC--RSPLLRKTLR 400
                   +         +       +    +     +L    ++ KC  ++P  R  L+
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 401 EELK 404
           + + 
Sbjct: 294 QLMV 297

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 1e-62
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 21/281 (7%)

Query: 104 ELQSATNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELG 159
           +L    +N    ++ +G G +  V +G  R       VAIK L +GT      + + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 160 IMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
           IM  +D+P   +L+G      + +V+E++  G L   L G +E++      ++   V+ G
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGY 278
           + YL    ++  +HRD+ A N+LL      +I DFGL+K L    +++T     +    +
Sbjct: 122 MKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVD 337
            APE +       ++DV+++GV + E ++ G++     +   V+      KR E      
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238

Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
             L                S C       RP    V Q +R
Sbjct: 239 PELYA------------LMSDCWIYKWEDRPDFLTVEQRMR 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 8e-62
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 18/269 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   +G G + EV+ G       VA+K L +G+       FL+E  +M  + H   
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRL 70

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMK-EKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L     +  ++I+ E   NGSL   L      KL       +A  +AEG+ ++ E   
Sbjct: 71  VRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           R  IHRD++AANIL+++    +I DFGLA+ + +   +      +    + APE + +G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGT 186

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ 348
              K+DV++FG+LL E+VT  R       +  +          +         D      
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------LERGYRMVRPDNCPEEL 239

Query: 349 MNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
             L+     LC ++    RP    +  +L
Sbjct: 240 YQLMR----LCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 7e-60
 Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 20/271 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +  +F   IG G +  V+ G   N   VAIK +  G   E   DF+ E  +M  + HP  
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKL 62

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G  +E   + +V E   +G L+  L   +          + L V EG   +    +
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG---MAYLEE 119

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
             +IHRD+ A N L+ E+   ++ DFG+ +++ +     +         + +PE      
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWASPEVFSFSR 178

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQ-QSLVLWARPMIKRNEIRELVDASLADEYDTR 347
              K+DV++FGVL+ E+ +  +    ++  S V+       R     L    +       
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ----- 233

Query: 348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                    + C ++    RP  S++++ L 
Sbjct: 234 -------IMNHCWKERPEDRPAFSRLLRQLA 257

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-59
 Identities = 58/271 (21%), Positives = 112/271 (41%), Gaps = 20/271 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            + +F   +G G +  V  G+ R    VAIK +  G+  E   +F+ E  +M ++ H   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKL 61

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
            +L G   +   + I+ E   NG L + L  M+ + +     ++   V E + YL     
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---S 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           ++ +HRD+ A N L+ +    ++ DFGL++++ +     ++        +  PE LM+  
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYSK 177

Query: 289 VDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR 347
              K+D++AFGVL+ E+ + G+   +    S          R     L    +       
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT----- 232

Query: 348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                      C  + +  RP    ++  + 
Sbjct: 233 -------IMYSCWHEKADERPTFKILLSNIL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 4e-59
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 31/296 (10%)

Query: 100 FSLYELQSATNNFS---------FENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT 146
           F+  +   A   F+          E +IG G + EV  G L+        VAIK L  G 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 147 ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLK 205
            ++   DFLSE  IM   DHPN   L G   +   + I+ E   NGSL S L     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                 +  G+A G+ YL        +HRD+ A NIL+  +   ++ DFGL+++L +  +
Sbjct: 127 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 266 HHTISKV---EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW 322
             T +     +    + APE + +      +DV+++G+++ E+++      +        
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------ 237

Query: 323 ARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                   ++   ++            + +      C Q+    RP+  Q+V  L 
Sbjct: 238 -----TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 7e-59
 Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 18/269 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +   E  +G+G + EV+ G       VAIK L  GT       FL E  +M  + H   
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKL 74

Query: 170 AKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLK-WGIRYKIALGVAEGLLYLHEGCQ 228
            +L     E  ++IV E    GSL   L G   K         +A  +A G+ Y+    +
Sbjct: 75  VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
              +HRD++AANIL+ E+   ++ DFGLA+ + +          +    + APE  ++G 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGR 190

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ 348
              K+DV++FG+LL EL T  R              P +   E+ + V+           
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPY-----------PGMVNREVLDQVERGYRMPCPPEC 239

Query: 349 MNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
              +      C ++    RP    +   L
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 30/299 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQ-----LVAIKRLTRGTADEIIADFLSELGIMAHV 164
           +  + + +IG G + EVYKG L+         VAIK L  G  ++   DFL E GIM   
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 165 DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
            H N  +L G   +   M I+ E   NG+L   L     +        +  G+A G+ YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH-HTISKVEGTFGYLAPE 282
                   +HRD+ A NIL+  +   ++ DFGL++ L +     +T S  +    + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD 342
            + +      +DV++FG+++ E++T                   +  +E+ + ++     
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGE-----------RPYWELSNHEVMKAINDGFRL 232

Query: 343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLRE 401
                  + +      C QQ   RRP+ + +V +L   +         R+P   KTL +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI---------RAPDSLKTLAD 282

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 7e-57
 Identities = 63/270 (23%), Positives = 111/270 (41%), Gaps = 22/270 (8%)

Query: 115 ENLIGKGGYAEVYKGRLRN---GQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPNTA 170
           +  +G G +  V KG  +     + VA+K L     D  +  + L+E  +M  +D+P   
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 171 KLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR 230
           +++G        +V+E++  G L   L      +K     ++   V+ G+ YL    +  
Sbjct: 72  RMIGICEAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE---ESN 127

Query: 231 IIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPEFLMHGIV 289
            +HRD+ A N+LL      +I DFGL+K L     ++      +    + APE + +   
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 290 DEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQ 348
             K+DV++FGVL+ E  + G++     + S V       +R          + D      
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD------ 241

Query: 349 MNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                   +LC       RP  + V   LR
Sbjct: 242 ------LMNLCWTYDVENRPGFAAVELRLR 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (472), Expect = 1e-56
 Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 44/308 (14%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADF 154
            L  L+   NN  +   IG+G +  V++ R           +VA+K L    + ++ ADF
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM------------- 200
             E  +MA  D+PN  KLLG    G  M ++ E    G L   L  M             
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 201 ----------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
                        L    +  IA  VA G+ YL E   R+ +HRD+   N L+ E+   +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180

Query: 251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           I DFGL++ +     +           ++ PE + +     ++DV+A+GV+L E+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 311 ALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQM 370
              Y      +     ++   I    +    + Y+            LC  +    RP  
Sbjct: 241 QPYYGMAHEEVIYY--VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSF 289

Query: 371 SQVVQLLR 378
             + ++L+
Sbjct: 290 CSIHRILQ 297

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 72/272 (26%), Positives = 109/272 (40%), Gaps = 26/272 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
                   IGKG + +V  G  R G  VA+K +     D     FL+E  +M  + H N 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62

Query: 170 AKLLGYGIE--GGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEG 226
            +LLG  +E  GG++IV E    GSL   L       L      K +L V E + YL   
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
                +HRD+ A N+L++ED   ++ DFGL K              +    + APE L  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174

Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
                K+DV++FG+LL E+ +  R          +  R  +++    +  D      Y+ 
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--VEKGYKMDAPDGCPPAVYEV 232

Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
                       C    +  RP   Q+ + L 
Sbjct: 233 ---------MKNCWHLDAAMRPSFLQLREQLE 255

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-56
 Identities = 71/273 (26%), Positives = 112/273 (41%), Gaps = 24/273 (8%)

Query: 114 FENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           F  +IG+G +  VY G L +        A+K L R T    ++ FL+E  IM    HPN 
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 170 AKLLGYGI--EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             LLG  +  EG   +VL    +G L + +                L VA+G+       
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLP--EQWTHHTISKVEGTFGYLAPEFLM 285
            ++ +HRD+ A N +L E F  ++ DFGLA+ +   E  + H  +  +    ++A E L 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL-VLWARPMIKRNEIRELVDASLADEY 344
                 K+DV++FGVLL EL+T          +  +       +R    E     L +  
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE-- 265

Query: 345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                         C    +  RP  S++V  +
Sbjct: 266 ----------VMLKCWHPKAEMRPSFSELVSRI 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-56
 Identities = 65/318 (20%), Positives = 122/318 (38%), Gaps = 38/318 (11%)

Query: 89  NSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRL 142
           N+Y    P ++   ++ +   N  SF   +G G + +V +              VA+K L
Sbjct: 2   NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61

Query: 143 TRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGM 200
                       +SEL +++++ +H N   LLG    GG   ++ E    G L + L   
Sbjct: 62  KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121

Query: 201 KE-----------------KLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILL 243
           ++                  L        +  VA+G+ +L     +  IHRD+ A NILL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178

Query: 244 TEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLL 303
           T     +ICDFGLA+ +     +           ++APE + + +   ++DV+++G+ L 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238

Query: 304 ELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQS 363
           EL +   +                  ++  +++               +      C    
Sbjct: 239 ELFSLGSSPYPGMPV----------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD 288

Query: 364 SIRRPQMSQVVQLLRGNL 381
            ++RP   Q+VQL+   +
Sbjct: 289 PLKRPTFKQIVQLIEKQI 306

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 9e-56
 Identities = 60/279 (21%), Positives = 112/279 (40%), Gaps = 24/279 (8%)

Query: 107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEI-IADFLSELGIMAHV 164
           S   ++     IG G Y    K R + +G+++  K L  G+  E      +SE+ ++  +
Sbjct: 1   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 165 DHPNTAKLLGYGIE---GGMHIVLELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAE 218
            HPN  +     I+     ++IV+E    G LAS++      ++ L      ++   +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 219 GLLYLHE--GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTF 276
            L   H        ++HRD+K AN+ L      ++ DFGLA+ L    +        GT 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTP 178

Query: 277 GYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV 336
            Y++PE +     +EK+D+++ G LL EL           Q  +       K   I    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238

Query: 337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
              L +          ++  +  +      RP + ++++
Sbjct: 239 SDELNE----------II--TRMLNLKDYHRPSVEEILE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (465), Expect = 1e-55
 Identities = 73/290 (25%), Positives = 131/290 (45%), Gaps = 24/290 (8%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGRLRN-GQLVAIKRLTRGTADEI 150
           D  SP   +  +E++    + + ++ +G G Y EVY+G  +     VA+K L   T +  
Sbjct: 3   DPSSPN--YDKWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-- 56

Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLY-GMKEKLKWGI 208
           + +FL E  +M  + HPN  +LLG        +I+ E    G+L   L    ++++   +
Sbjct: 57  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 116

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              +A  ++  + YL    ++  IHRD+ A N L+ E+   ++ DFGL++ +    T+  
Sbjct: 117 LLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTA 172

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK 328
            +  +    + APE L +     K+DV+AFGVLL E+ T   +             P I 
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----------PGID 221

Query: 329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            +++ EL++     E        V      C Q +   RP  +++ Q   
Sbjct: 222 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-55
 Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 43/302 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
            N  F  ++G G + +V                VA+K L            +SEL +M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 164 V-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEK------------------ 203
           +  H N   LLG     G ++++ E    G L + L   +EK                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 204 ----LKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW 259
               L +      A  VA+G+ +L     +  +HRD+ A N+L+T     +ICDFGLA+ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSL 319
           +     +           ++APE L  GI   K+DV+++G+LL E+ +            
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG---- 269

Query: 320 VLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG 379
                 +       +L+      +        + +    C    S +RP    +   L  
Sbjct: 270 ------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323

Query: 380 NL 381
            L
Sbjct: 324 QL 325

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-54
 Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 19/271 (7%)

Query: 112 FSFENLIGKGGYAEVYKGRLRN-----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDH 166
           F    ++G G +  VYKG            VAIK L   T+ +   + L E  +MA VD+
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           P+  +LLG  +   + ++ +L P G L   +   K+ +         + +A+G+ YL   
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--- 127

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             RR++HRD+ A N+L+      +I DFGLAK L  +   +     +    ++A E ++H
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187

Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
            I   ++DV+++GV + EL+T                   I  +EI  +++         
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGS-----------KPYDGIPASEISSILEKGERLPQPP 236

Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
                V +    C    +  RP+  +++   
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 62/269 (23%), Positives = 109/269 (40%), Gaps = 17/269 (6%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            ++     +G+G Y EV     R   + VA+K +    A +   +   E+ I   ++H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             K  G+  EG   ++ LE    G L   +      +      +    +  G++YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
              I HRDIK  N+LL E    +I DFGLA           ++K+ GT  Y+APE L   
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 288 -IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
               E  DV++ G++L  ++ G    D    S   ++    K+  +          + D+
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW------KKIDS 234

Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             + L+       + ++   R  +  + +
Sbjct: 235 APLALL----HKILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 68/270 (25%), Positives = 117/270 (43%), Gaps = 25/270 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F     +GKG +  VY  R + +  ++A+K L +       +      E+ I +H+ H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           PN  +L GY  +   ++++LE +P G++   L  +  K            +A  L Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 124

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              +R+IHRDIK  N+LL    E +I DFG +   P            GT  YL PE + 
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
             + DEK D+++ GVL  E + G+   + +      + R         + V     D   
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVEFTFPDFVTEGARD--- 233

Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
                L+    S  ++ +  +RP + +V++
Sbjct: 234 -----LI----SRLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-54
 Identities = 66/274 (24%), Positives = 122/274 (44%), Gaps = 23/274 (8%)

Query: 109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + +     +G G + +VYK + +    L A K +   + +E+  D++ E+ I+A  DHP
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL-EDYMVEIDILASCDHP 69

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N  KLL        + I++E    G++ +++  ++  L       +     + L YLH+ 
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD- 128

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM- 285
              +IIHRD+KA NIL T D + ++ DFG++                GT  ++APE +M 
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMC 184

Query: 286 ----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA 341
                   D K DV++ G+ L+E+              VL     I ++E   L   +  
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIAKSEPPTL---AQP 238

Query: 342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             + +   + +      C++++   R   SQ++Q
Sbjct: 239 SRWSSNFKDFL----KKCLEKNVDARWTTSQLLQ 268

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 7e-54
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 23/281 (8%)

Query: 103 YELQSATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSEL 158
           YE+Q           IG+G + +V++G   +       VAIK     T+D +   FL E 
Sbjct: 2   YEIQ--RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59

Query: 159 GIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
             M   DHP+  KL+G   E  + I++EL   G L S L   K  L        A  ++ 
Sbjct: 60  LTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGY 278
            L YL     +R +HRDI A N+L++ +   ++ DFGL++++ +   +   SK +    +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKW 175

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVD 337
           +APE +        +DV+ FGV + E++  G +     + + V+      +R  +     
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 338 ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            +L                + C      RRP+ +++   L 
Sbjct: 236 PTLYS------------LMTKCWAYDPSRRPRFTELKAQLS 264

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 8e-54
 Identities = 70/276 (25%), Positives = 108/276 (39%), Gaps = 20/276 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGTA--DEIIADFLSELGIMAH 163
            +      +G G +  V +G           VA+K L        E + DF+ E+  M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 164 VDHPNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYL 223
           +DH N  +L G  +   M +V EL+P GSL   L   +     G   + A+ VAEG+ YL
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 224 HEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYLAPE 282
                +R IHRD+ A N+LL      +I DFGL + LP+   H+ + +  +  F + APE
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD 342
            L        +D + FGV L E+ T  +          +  +  I +   R         
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--IDKEGERLPRPEDCPQ 242

Query: 343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           +        +      C       RP    +   L 
Sbjct: 243 D--------IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 8e-54
 Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 32/292 (10%)

Query: 114 FENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL 173
            +  IGKG + EV++G+ R G+ VA+K  +            +E+     + H N    +
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF--REAEIYQTVMLRHENILGFI 63

Query: 174 GYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC- 227
               +       + +V +   +GSL   L   +  +      K+AL  A GL +LH    
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 228 ----QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI--SKVEGTFGYLAP 281
               +  I HRD+K+ NIL+ ++    I D GLA           I  +   GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 282 EFL------MHGIVDEKTDVFAFGVLLLELVTGRRALD--------YSQQSLVLWARPMI 327
           E L       H    ++ D++A G++  E+                Y        +   +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 328 KRNEIRELVDASLADEYDTRQMNLVLLA-ASLCIQQSSIRRPQMSQVVQLLR 378
           ++    + +  ++ + + + +   V+      C   +   R    ++ + L 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (451), Expect = 2e-53
 Identities = 78/304 (25%), Positives = 132/304 (43%), Gaps = 36/304 (11%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPN 168
           FS    IG G +  VY  R +RN ++VAIK+++      +E   D + E+  +  + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           T +  G  +      +V+E     +   L    K+ L+      +  G  +GL YLH   
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS-- 133

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-- 285
              +IHRD+KA NILL+E    ++ DFG A  +    +        GT  ++APE ++  
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAM 186

Query: 286 -HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY 344
             G  D K DV++ G+  +EL   +  L        L+    I +NE   L     ++ +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNESPALQSGHWSEYF 243

Query: 345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMTKCRSPLLRKTLREELK 404
                N V      C+Q+    RP    +++         +++ + R P +   L +  K
Sbjct: 244 ----RNFV----DSCLQKIPQDRPTSEVLLK--------HRFVLRERPPTVIMDLIQRTK 287

Query: 405 SAPK 408
            A +
Sbjct: 288 DAVR 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-53
 Identities = 67/272 (24%), Positives = 111/272 (40%), Gaps = 25/272 (9%)

Query: 112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRL-TRGTADEIIADFLSELGIMAHVDHPNT 169
             F+  IG+G +  VYKG        VA   L  R         F  E  ++  + HPN 
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 170 AKLLGYGI-----EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
            +           +  + +V EL  +G+L + L   K  +K  +       + +GL +LH
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH 129

Query: 225 EGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
                 IIHRD+K  NI +T      +I D GLA      +    I    GT  ++APE 
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPE- 183

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           +     DE  DV+AFG+ +LE+ T        Q +  ++ R       +   V  +  D+
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDK 236

Query: 344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
               ++  ++     CI+Q+   R  +  ++ 
Sbjct: 237 VAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-52
 Identities = 79/319 (24%), Positives = 132/319 (41%), Gaps = 46/319 (14%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQL---VAIKRLTRGTADEIIADFLSELGIMAHV-D 165
           N+  F+++IG+G + +V K R++   L    AIKR+    + +   DF  EL ++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYG---------------MKEKLKWGIR 209
           HPN   LLG     G +++ +E +P+G+L   L                     L     
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
              A  VA G+ YL    Q++ IHRD+ A NIL+ E++  +I DFGL++           
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PMIK 328
                   ++A E L + +    +DV+++GVLL E+V+             L+ + P   
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLKYMT 388
           R E     D  + D                C ++    RP  +Q++         L  M 
Sbjct: 244 RLEKPLNCDDEVYD------------LMRQCWREKPYERPSFAQILV-------SLNRML 284

Query: 389 KCRSPLLRKTLREELKSAP 407
           + R   +  TL E+   A 
Sbjct: 285 EERKTYVNTTLYEKFTYAG 303

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 9e-51
 Identities = 61/286 (21%), Positives = 120/286 (41%), Gaps = 20/286 (6%)

Query: 92  DSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEI 150
           D +  +K+ S+  +      ++    IG+G    VY    +  GQ VAI+++      + 
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK 61

Query: 151 IADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIR 209
               ++E+ +M    +PN    L   + G  + +V+E    GSL  ++   +  +  G  
Sbjct: 62  -ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQI 118

Query: 210 YKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTI 269
             +     + L +LH     ++IHRDIK+ NILL  D   ++ DFG    +         
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKR 173

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKR 329
           S + GT  ++APE +       K D+++ G++ +E++ G            L+   +I  
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIAT 230

Query: 330 NEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           N   EL      ++      + +    + C+     +R    +++Q
Sbjct: 231 NGTPEL---QNPEKLSAIFRDFL----NRCLDMDVEKRGSAKELLQ 269

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 59/288 (20%), Positives = 118/288 (40%), Gaps = 30/288 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAH 163
              +    +G+G +  VY+G  +          VAIK +    +     +FL+E  +M  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKE---------KLKWGIRYKIA 213
            +  +  +LLG   +G    +++EL   G L S L  ++                  ++A
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVE 273
             +A+G+ YL      + +HRD+ A N ++ EDF  +I DFG+ + + E   +    K  
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
               +++PE L  G+    +DV++FGV+L E+ T          +  +     +    + 
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--VMEGGLL 254

Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL 381
           +  D      ++            +C Q +   RP   +++  ++  +
Sbjct: 255 DKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 8/204 (3%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHP 167
           +F F  ++G+G ++ V   R L   +  AIK L +     +  +     E  +M+ +DHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
              KL     +   ++  L  + NG L   +  +    +   R+  A    E +  L   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----EIVSALEYL 124

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + IIHRD+K  NILL ED   QI DFG AK L  +      +   GT  Y++PE L  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 287 GIVDEKTDVFAFGVLLLELVTGRR 310
               + +D++A G ++ +LV G  
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLP 208

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-48
 Identities = 68/293 (23%), Positives = 118/293 (40%), Gaps = 37/293 (12%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAH 163
           +       +G+G + +V +            + VA+K L  G         +SEL I+ H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 164 -VDHPNTAKLLGYGIEGG--MHIVLELSPNGSLASLLYGMKEK---------------LK 205
              H N   LLG   + G  + +++E    G+L++ L   + +               L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 206 WGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT 265
                  +  VA+G+ +L     R+ IHRD+ A NILL+E    +ICDFGLA+ + +   
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP 325
           +           ++APE +   +   ++DV++FGVLL E+ +      Y    +      
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPGVKIDEEFCR 248

Query: 326 MIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            +K        D +  + Y T            C      +RP  S++V+ L 
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLG 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  163 bits (413), Expect = 2e-47
 Identities = 52/270 (19%), Positives = 95/270 (35%), Gaps = 20/270 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           +++     +G G +  V++   R  G   A K +      +       E+  M+ + HP 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-ETVRKEIQTMSVLRHPT 84

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L     +   M ++ E    G L   +     K+      +    V +GL ++HE  
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-- 142

Query: 228 QRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
               +H D+K  NI+ T     ++   DFGL   L  + +        GT  + APE   
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAE 198

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
              V   TD+++ GVL   L++G            L     +K  +    +D S      
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR---NVKSCDWN--MDDSAFSGIS 253

Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
               + +       +      R  + Q ++
Sbjct: 254 EDGKDFI----RKLLLADPNTRMTIHQALE 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 1e-46
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 39/293 (13%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR--------NGQLVAIKRLTRGTADEIIADFLSELGIM 161
           +       +G+G + +V                  VA+K L     ++ ++D +SE+ +M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMK---------------EKL 204
             +  H N   LLG   + G +++++E +  G+L   L   +               E+L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 205 KWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW 264
                   A  VA G+ YL     ++ IHRD+ A N+L+TED   +I DFGLA+ +    
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR 324
            +   +       ++APE L   I   ++DV++FGVLL E+ T   +             
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----------- 238

Query: 325 PMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLL 377
           P +   E+ +L+      +  +   N + +    C      +RP   Q+V+ L
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  155 bits (393), Expect = 2e-44
 Identities = 61/306 (19%), Positives = 109/306 (35%), Gaps = 23/306 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           + +     +G G +  V++      G++   K +      +      +E+ IM  + HP 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPK 87

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
              L     +   M ++LE    G L   +     K+             EGL ++HE  
Sbjct: 88  LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-- 145

Query: 228 QRRIIHRDIKAANILLTEDFEPQI--CDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              I+H DIK  NI+        +   DFGLA  L         +    T  + APE + 
Sbjct: 146 -HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVD 201

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD 345
              V   TD++A GVL   L++G            L     +KR +     D        
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ---NVKRCDWE--FDEDAFSSVS 256

Query: 346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCCL-KYMTKCRSPLLRKTLREE 402
               + +       +Q+   +R  +   ++   L+G+   L   +   R   +R+ ++E+
Sbjct: 257 PEAKDFI----KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312

Query: 403 LKSAPK 408
               P 
Sbjct: 313 YADWPA 318

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 6e-44
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 11/204 (5%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDH 166
            +F     +G G +  V+  R R NG+  A+K L +      + +     E  +++ V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 167 PNTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           P   ++ G   +     ++     G     L    ++    +    A  V   L YLH  
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS- 122

Query: 227 CQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             + II+RD+K  NILL ++   +I DFG AK++P+           GT  Y+APE +  
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVST 175

Query: 287 GIVDEKTDVFAFGVLLLELVTGRR 310
              ++  D ++FG+L+ E++ G  
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (383), Expect = 8e-44
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 13/211 (6%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVD 165
           ++ +    ++G GG +EV+  R LR  + VA+K L    A        F  E    A ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 166 HPNTAKLLGYGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           HP    +   G          +IV+E     +L  +++     +      ++     + L
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISK-VEGTFGYL 279
            + H+     IIHRD+K ANI+++     ++ DFG+A+ + +     T +  V GT  YL
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           +PE      VD ++DV++ G +L E++TG  
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 18/243 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAH 163
           N+FS   +IG+GG+ EVY  R    G++ A+K L +          +  +    L +++ 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 164 VDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
            D P    +         +  +L+L   G L   L       +  +R+  A  +  GL +
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEH 122

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE 282
           +H    R +++RD+K ANILL E    +I D GLA    ++  H ++    GT GY+APE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 175

Query: 283 FLMHGI-VDEKTDVFAFGVLLLELVTGRRALDY--SQQSLVLWARPMIKRNEIRELVDAS 339
            L  G+  D   D F+ G +L +L+ G        ++    +    +    E+ +     
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 340 LAD 342
           L  
Sbjct: 236 LRS 238

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 68/306 (22%), Positives = 127/306 (41%), Gaps = 24/306 (7%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
            + + F +++G G ++EV      R  +LVAIK + +   +       +E+ ++  + HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 168 NTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG 226
           N   L      GG ++++++L   G L   +   K         ++   V + + YLH+ 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDL 126

Query: 227 CQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
               I+HRD+K  N+L     ED +  I DFGL+K         T     GT GY+APE 
Sbjct: 127 G---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC---GTPGYVAPEV 180

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE 343
           L      +  D ++ GV+   L+ G         + +      I + E     D+   D+
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE---QILKAEYE--FDSPYWDD 235

Query: 344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLCCLKYMTKCRSPLLRKTL-R 400
                 + +       +++   +R    Q +Q   + G+    K + +  S  ++K   +
Sbjct: 236 ISDSAKDFI----RHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK 291

Query: 401 EELKSA 406
            + K A
Sbjct: 292 SKWKQA 297

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 6e-43
 Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 18/250 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHV-D 165
            +F    ++GKG + +V+    +   Q  AIK L +     D+ +   + E  +++   +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 166 HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           HP    +         +  V+E    G L   +     K         A  +  GL +LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLH 120

Query: 225 EGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFL 284
               + I++RD+K  NILL +D   +I DFG+ K               GT  Y+APE L
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEIL 175

Query: 285 MHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW----ARPMIKRN---EIRELVD 337
           +    +   D ++FGVLL E++ G+       +  +        P   R    E ++L+ 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 235

Query: 338 ASLADEYDTR 347
                E + R
Sbjct: 236 KLFVREPEKR 245

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 4e-42
 Identities = 49/269 (18%), Positives = 89/269 (33%), Gaps = 21/269 (7%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
            +     +G+G +  V++     + +    K +     D+++     E+ I+    H N 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNI 63

Query: 170 AKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             L         + ++ E      +   +     +L           V E L +LH    
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 229 RRIIHRDIKAANILLTEDFEPQ--ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMH 286
             I H DI+  NI+          I +FG A+ L           +     Y APE   H
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQH 177

Query: 287 GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT 346
            +V   TD+++ G L+  L++G           ++     I   E     D     E   
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMNAEYT--FDEEAFKEISI 232

Query: 347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
             M+ V       + +    R   S+ +Q
Sbjct: 233 EAMDFV----DRLLVKERKSRMTASEALQ 257

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (371), Expect = 5e-42
 Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 33/282 (11%)

Query: 111 NFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD--------EIIADFLSELGIM 161
           N+  + ++G+G  + V +       +  A+K +              E+    L E+ I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 162 AHV-DHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEG 219
             V  HPN  +L           +V +L   G L   L   K  L      KI   + E 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEV 122

Query: 220 LLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
           +  LH+     I+HRD+K  NILL +D   ++ DFG +  L        + +V GT  YL
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYL 176

Query: 280 APEFLM------HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIR 333
           APE +       H    ++ D+++ GV++  L+ G     + +Q L+L    MI     +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR---MIMSGNYQ 233

Query: 334 ELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
               +   D+Y     +LV    S  +     +R    + + 
Sbjct: 234 --FGSPEWDDYSDTVKDLV----SRFLVVQPQKRYTAEEALA 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (363), Expect = 1e-40
 Identities = 57/279 (20%), Positives = 97/279 (34%), Gaps = 21/279 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
           N +     IG G + ++Y G  +  G+ VAIK     T          E  I   +    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGV 63

Query: 169 TAKLLGY-GIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
               + + G EG  ++++      SL  L      K        +A  +   + Y+H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-- 121

Query: 228 QRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQWTHHTI-----SKVEGTFGYL 279
            +  IHRD+K  N L+          I DFGLAK   +  TH  I       + GT  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS 339
           +    +      + D+ + G +L+    G       + +        I   ++   ++  
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-V 239

Query: 340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
           L   Y +     +    + C       +P  S + QL R
Sbjct: 240 LCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFR 274

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 1e-40
 Identities = 49/280 (17%), Positives = 96/280 (34%), Gaps = 21/280 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPN 168
            ++     IG+G +  +++G  L N Q VAIK   R +    + D      ++A      
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
              +  +G EG  ++++      SL  LL     K         A  +   +  +H   +
Sbjct: 65  --NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 229 RRIIHRDIKAANILLTEDFEPQ-----ICDFGLAKWLPEQWTHHTI-----SKVEGTFGY 278
           + +++RDIK  N L+            + DFG+ K+  +  T   I       + GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 279 LAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA 338
           ++    +      + D+ A G + +  + G       + +        I   +    +  
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR- 238

Query: 339 SLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR 378
            L   +       +  A +L         P    +  L  
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDA----TPDYDYLQGLFS 274

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-40
 Identities = 48/209 (22%), Positives = 87/209 (41%), Gaps = 13/209 (6%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHP 167
              ++  + IG+G Y  V       N   VAIK+++           L E+ I+    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 168 NTAKLLGYGIEGGMH-----IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLY 222
           N   +        +       ++       L  LL    + L           +  GL Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKY 124

Query: 223 LHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL-PEQWTHHTISKVEGTFGYLAP 281
           +H      ++HRD+K +N+LL    + +ICDFGLA+   P+      +++   T  Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 282 EFLMHGIVD-EKTDVFAFGVLLLELVTGR 309
           E +++     +  D+++ G +L E+++ R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 6e-39
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 18/218 (8%)

Query: 105 LQSATNNFSFENLIGKGGYAEVYKGRLR--NGQLVAIKRLTRGTADEIIA-DFLSELGIM 161
           L  A   +     IG+G Y +V+K R     G+ VA+KR+   T +E +    + E+ ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 162 AH---VDHPNTAKLLGYGIEGG------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKI 212
            H    +HPN  +L              + +V E         L    +  +       +
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 213 ALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKV 272
              +  GL +LH     R++HRD+K  NIL+T   + ++ DFGLA+    Q    +   V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---V 175

Query: 273 EGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
             T  Y APE L+        D+++ G +  E+   + 
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-38
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 10/205 (4%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRG--TADEIIADFLSELGIMAHVDH 166
           N+F +  L+GKG + +V   R    G+  A+K L +    A + +A  ++E  ++ +  H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 167 PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHE 225
           P    L         +  V+E +  G L   L   +   +   R+  A    E +  L  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSALEY 120

Query: 226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM 285
              R +++RDIK  N++L +D   +I DFGL K         T+    GT  YLAPE L 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLE 178

Query: 286 HGIVDEKTDVFAFGVLLLELVTGRR 310
                   D +  GV++ E++ GR 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 49/203 (24%), Positives = 90/203 (44%), Gaps = 7/203 (3%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
           NF     IG+G Y  VYK R +  G++VA+K++   T  E + +  + E+ ++  ++HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 169 TAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
             KLL        +++V E         +       +   +       + +GL + H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-- 120

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
             R++HRD+K  N+L+  +   ++ DFGLA+        +T  +V   +       L   
Sbjct: 121 -HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILLGCK 178

Query: 288 IVDEKTDVFAFGVLLLELVTGRR 310
                 D+++ G +  E+VT R 
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 2e-38
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 13/215 (6%)

Query: 116 NLIGKGGYAEVYKGRLRN-GQLVAIKRLTRG----TADEIIADFLSELGIMAHVDHPNTA 170
           + +G+G +A VYK R +N  Q+VAIK++  G      D I    L E+ ++  + HPN  
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 171 KLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQR 229
            LL        + +V +         ++      L         L   +GL YLH+    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 230 RIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLM-HGI 288
            I+HRD+K  N+LL E+   ++ DFGLAK        +T      T  Y APE L    +
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGARM 177

Query: 289 VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA 323
                D++A G +L EL+     L        L  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  136 bits (344), Expect = 5e-38
 Identities = 47/201 (23%), Positives = 85/201 (42%), Gaps = 5/201 (2%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHPN 168
             +     IG+G Y  VYK +   G+  A+K++     DE I +  + E+ I+  + H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 169 TAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQ 228
             KL          +++    +  L  LL   +  L+        L +  G+ Y H+   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--- 118

Query: 229 RRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGI 288
           RR++HRD+K  N+L+  + E +I DFGLA+            ++   +       +    
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 289 VDEKTDVFAFGVLLLELVTGR 309
                D+++ G +  E+V G 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGT 198

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-38
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 21/211 (9%)

Query: 111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNT 169
           +++   +IG G +  VY+ +L  +G+LVAIK++ +            EL IM  +DH N 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 75

Query: 170 AKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEK--LKWGIRYKIALGVAEGL 220
            +L  +    G       +++VL+  P        +  + K  L           +   L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQ-ICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            Y+H      I HRDIK  N+LL  D     +CDFG AK L     + +   +   +   
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRA 190

Query: 280 APEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
                         DV++ G +L EL+ G+ 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-37
 Identities = 51/252 (20%), Positives = 96/252 (38%), Gaps = 23/252 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTAD-----EIIADFLSELGIMAH 163
           + +    L+G GG+  VY G  + +   VAIK + +                 E+ ++  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 164 VD--HPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           V        +LL +        ++LE              +  L+  +       V E +
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 221 LYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLAKWLPEQWTHHTISKVEGTFGYL 279
            + H      ++HRDIK  NIL+  +  E ++ DFG    L +           GT  Y 
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYS 176

Query: 280 APEFLM-HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRN---EIREL 335
            PE++  H        V++ G+LL ++V G    ++ ++  ++  +   ++    E + L
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--IIRGQVFFRQRVSSECQHL 234

Query: 336 VDASLADEYDTR 347
           +   LA     R
Sbjct: 235 IRWCLALRPSDR 246

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 3e-37
 Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 19/240 (7%)

Query: 74  SSMREGIDMPRNLFVNSYDSQSPQKIFSLYELQSATNNFSFENLIGKGGYAEVYKGR-LR 132
            S++E +   +  F+  +++ S Q    L       + F     +G G +  V   +   
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPS-QNTAQL-------DQFDRIKTLGTGSFGRVMLVKHKE 64

Query: 133 NGQLVAIKRLTRGTADEI--IADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPN 190
           +G   A+K L +    ++  I   L+E  I+  V+ P   KL     +     ++     
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 191 GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ 250
           G           +         A  +     YLH      +I+RD+K  N+L+ +    Q
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQ 181

Query: 251 ICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR 310
           + DFG AK +  +        + GT   LAPE ++    ++  D +A GVL+ E+  G  
Sbjct: 182 VTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-36
 Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 18/220 (8%)

Query: 101 SLYELQSATNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-----IIADF 154
           +++  ++  + +     +G G +A V K R    G   A K + +             D 
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 60

Query: 155 LSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIA 213
             E+ I+  + HPN   L         + ++LEL   G L       KE L      +  
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFL 119

Query: 214 LGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQ----ICDFGLAKWLPEQWTHHTI 269
             +  G+   +     +I H D+K  NI+L +   P+    I DFGLA  +        I
Sbjct: 120 KQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176

Query: 270 SKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
               GT  ++APE + +  +  + D+++ GV+   L++G 
Sbjct: 177 F---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 8e-36
 Identities = 52/275 (18%), Positives = 101/275 (36%), Gaps = 34/275 (12%)

Query: 115 ENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKL 172
             ++G G   +V +    R  +  A+K L              E+ +       P+  ++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRI 70

Query: 173 LGYG-----IEGGMHIVLELSPNGSLASLLYGMKEK-LKWGIRYKIALGVAEGLLYLHEG 226
           +            + IV+E    G L S +    ++        +I   + E + YLH  
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS- 129

Query: 227 CQRRIIHRDIKAANILLTEDFEP---QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEF 283
               I HRD+K  N+L T        ++ DFG AK      +  T      T  Y+APE 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEV 184

Query: 284 LMHGIVDEKTDVFAFGVLLLELVTGRR---ALDYSQQSLVLWARPMIKRNEIRELVDASL 340
           L     D+  D+++ GV++  L+ G     +      S  +  R  + + E      + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ 375
           ++E       L+       ++    +R  +++ + 
Sbjct: 245 SEEV----KMLI----RNLLKTEPTQRMTITEFMN 271

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 18/215 (8%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
           + +     IG+G + EV+K R R  GQ VA+K++      E      L E+ I+  + H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 168 NTAKLLGYGI---------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
           N   L+             +G +++V +   +         +   L      +I   +  
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTLSEIKRVMQM 125

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL--PEQWTHHTISKVEGTF 276
            L  L+   + +I+HRD+KAAN+L+T D   ++ DFGLA+     +    +  +    T 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 277 GYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRR 310
            Y  PE L+         D++  G ++ E+ T   
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 3e-35
 Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 6/205 (2%)

Query: 110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
             +     IG+G Y  V+K + R   ++VA+KR+     DE + +  L E+ ++  + H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 168 NTAKLLGYGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGC 227
           N  +L           ++    +  L          L   I       + +GL + H   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--- 118

Query: 228 QRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHG 287
            R ++HRD+K  N+L+  + E ++ +FGLA+        ++  +V   +           
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-EVVTLWYRPPDVLFGAK 177

Query: 288 IVDEKTDVFAFGVLLLELVTGRRAL 312
           +     D+++ G +  EL    R L
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPL 202

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-33
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 16/212 (7%)

Query: 110 NNFSFENLIGKGGYAEVYKGRL----RNGQLVAIKRLTRGTA---DEIIADFLSELGIMA 162
            NF    ++G G Y +V+  R       G+L A+K L + T     +      +E  ++ 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 163 HVDH-PNTAKLLGYGIEGG-MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           H+   P    L         +H++L+    G L + L   +   +  ++  +     E +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIV 139

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
           L L    +  II+RDIK  NILL  +    + DFGL+K      T        GT  Y+A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY-DFCGTIEYMA 198

Query: 281 PEFLMHGI--VDEKTDVFAFGVLLLELVTGRR 310
           P+ +  G    D+  D ++ GVL+ EL+TG  
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 57/221 (25%), Positives = 88/221 (39%), Gaps = 19/221 (8%)

Query: 100 FSLYELQSAT----NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD- 153
           F   E+          +     +G G Y  V      R G  VAIK+L R    E+ A  
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 154 FLSELGIMAHVDHPNTAKLLGYGIEGG-----MHIVLELSPNGSLASLLYGMKEKLKWGI 208
              EL ++ H+ H N   LL                L +   G+    L    EKL    
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-KHEKLGEDR 122

Query: 209 RYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT 268
              +   + +GL Y+H      IIHRD+K  N+ + ED E +I DFGLA+    + T + 
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY- 178

Query: 269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
              V   +       L      +  D+++ G ++ E++TG+
Sbjct: 179 ---VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (286), Expect = 2e-29
 Identities = 39/210 (18%), Positives = 85/210 (40%), Gaps = 21/210 (10%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHP 167
           +++     +G+G Y+EV++   + N + V +K L      +       E+ I+ ++   P
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGP 90

Query: 168 NTAKLLGYG---IEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLH 224
           N   L       +     +V E   N     L     + L           + + L Y H
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 146

Query: 225 EGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPE- 282
                 I+HRD+K  N+++  E  + ++ D+GLA++      ++       +  +  PE 
Sbjct: 147 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPEL 200

Query: 283 FLMHGIVDEKTDVFAFGVLLLELVTGRRAL 312
            + + + D   D+++ G +L  ++  +   
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-29
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 19/209 (9%)

Query: 110 NNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADE-IIADFLSELGIMAHVDHP 167
             +     IG G    V         + VAIK+L+R   ++        EL +M  V+H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 168 NTAKLLGYGIEGG-------MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
           N   LL              +++V+EL        +   +  +        +   +  G+
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----YLLYQMLCGI 132

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            +LH       IHRD+K +NI++  D   +I DFGLA+      T   ++    T  Y A
Sbjct: 133 KHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRA 186

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
           PE ++     E  D+++ G ++ E+V  +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 7e-29
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)

Query: 109 TNNFSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIAD-FLSELGIMAHVDH 166
              +   + +G G Y  V      + G  VA+K+L+R     I A     EL ++ H+ H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 167 PNTAKLLGYGI------EGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGL 220
            N   LL          E     ++       L ++     +KL       +   +  GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILRGL 134

Query: 221 LYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLA 280
            Y+H      IIHRD+K +N+ + ED E +I DFGLA+   ++ T +  +     +    
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAP 187

Query: 281 PEFLMHGIVDEKTDVFAFGVLLLELVTGR 309
              L     ++  D+++ G ++ EL+TGR
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (273), Expect = 2e-27
 Identities = 43/236 (18%), Positives = 82/236 (34%), Gaps = 22/236 (9%)

Query: 112 FSFENLIGKGGYAEVYKGR-LRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTA 170
           +     +G G ++ V+  + + N   VA+K +              E+ ++  V+  +  
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNT 72

Query: 171 KLLGYGIEG----------------GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIAL 214
           K    G                    + +V E+     LA +       +      +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 215 GVAEGLLYLHEGCQRRIIHRDIKAANILLT-EDFEPQICDFGLAKWLPEQWTHHTISKVE 273
            +  GL Y+H   +  IIH DIK  N+L+   D    +    +A      W     +   
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 274 GTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKR 329
            T  Y +PE L+        D+++   L+ EL+TG    +  +          I +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 3e-19
 Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 26/160 (16%)

Query: 113 SFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA---------DEIIADFLSELGIMAH 163
           +   L+G+G  + V+           +K    G           D     F       A 
Sbjct: 3   AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 164 VDHPNTAKLLGYGIE-----GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAE 218
            +     KL G  +       G  +++EL               +++     ++   + E
Sbjct: 63  NEFRALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILE 114

Query: 219 GLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK 258
            +   +    R I+H D+   N+L++ +    I DF  + 
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	408
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.03
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.31
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=422.98  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=210.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~  185 (408)
                      ...++|++.+.||+|+||+||+|.+++  .||||+++... ..+..+.|.+|+.++++++|||||++++++.++..++||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~   82 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT   82 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEE
Confidence            345789999999999999999998753  59999997543 334578899999999999999999999999888899999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++...+..+++..+..++.||+.||+|||+   ++||||||||+||||+.++.+||+|||+|+.......
T Consensus        83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            9999999999998777789999999999999999999999   9999999999999999999999999999987765444


Q ss_pred             cceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc-
Q 015389          266 HHTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA-  341 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  341 (408)
                      ........||+.|+|||++.+   +.|+.++|||||||+||||+||+.||........           +...+..... 
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-----------~~~~~~~~~~~  228 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----------IIFMVGRGYLS  228 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----------HHHHHHHTSCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-----------HHHHHhcCCCC
Confidence            444556789999999999864   3589999999999999999999999986433211           1111111110 


Q ss_pred             ---CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          342 ---DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       342 ---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                         ...+..++..+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence               11223445678899999999999999999999999987653

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=417.04  Aligned_cols=253  Identities=24%  Similarity=0.316  Sum_probs=204.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......+..+.+.+|+.++++++||||+++++++.+++ .++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            368999999999999999999986 699999999987655555677899999999999999999999777654 789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+......
T Consensus        84 y~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999984 45679999999999999999999999   99999999999999999999999999999977544333


Q ss_pred             ceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      .......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.........+.          ............
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~----------~~~~~~~~~~~~  229 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----------DWKEKKTYLNPW  229 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH----------HHHTTCTTSTTG
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH----------HHhcCCCCCCcc
Confidence            44456789999999999988876 5789999999999999999999976543321111          111111111112


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         230 KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            233456778999999999999999999854

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=415.27  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=213.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLEL  187 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~  187 (408)
                      ..++|++.+.||+|+||+||+|.+++++.||||++......  .+.|.+|+.++++++|||||++++++.++..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEe
Confidence            44789999999999999999999988899999999865433  3578999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          188 SPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       188 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      +++|+|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+||||++++.+||+|||+|+.+.... .
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence            9999999988553 3469999999999999999999999   999999999999999999999999999999875432 2


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      .......||+.|+|||++.++.++.++|||||||++|||+||..|+......           ..+...+....+...+.
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----------~~~~~~i~~~~~~~~p~  233 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------PEVIQNLERGYRMVRPD  233 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCCT
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHhcCCCCCcc
Confidence            2334567999999999999999999999999999999999976654332211           11112222223333344


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+..+.+|+.+||+.||++||||.+|++.|+..
T Consensus       234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            4566788999999999999999999999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=416.37  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=218.4

Q ss_pred             cCCCCccce-ecccCcEEEEEEEEc---CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          109 TNNFSFENL-IGKGGYAEVYKGRLR---NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~-lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .++|.+.+. ||+|+||+||+|.+.   ++..||||+++........+.|.+|+.++++++|||||++++++..+..++|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lv   86 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   86 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEE
Confidence            356777774 999999999999764   3568999999877666677889999999999999999999999988889999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++...+..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            99999999999987777889999999999999999999999   999999999999999999999999999999876533


Q ss_pred             cc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          265 TH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       265 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      .. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......            ++...+....+.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------------~~~~~i~~~~~~  231 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------EVMAFIEQGKRM  231 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------------HHHHHHHTTCCC
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCCCC
Confidence            22 22334568999999999999999999999999999999998 89999864332            122223333333


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ..+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            44455667889999999999999999999999998754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-56  Score=412.03  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      ++|++.+.||+|+||+||+|.+.+++.||||++......  .+++.+|+.++++++||||+++++++.+ +..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            678999999999999999999988999999999865443  3578999999999999999999998775 5689999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...... .
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            9999999998777889999999999999999999999   99999999999999999999999999999876543222 2


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG-RRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....||+.|+|||++.++.++.++|||||||++|||+|+ ++||......            .+...+....+...+..
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------------~~~~~i~~~~~~~~p~~  226 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------------EVVEDISTGFRLYKPRL  226 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------------HHHHHHHHTCCCCCCTT
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH------------HHHHHHHhcCCCCCccc
Confidence            2345699999999999999999999999999999999995 5455432211            12222233333333444


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ++..+.+++.+||+.||++|||++||++.|+++.
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            5667889999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-55  Score=416.61  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=206.8

Q ss_pred             CCCCccceecccCcEEEEEEEEcC-C---cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRN-G---QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ++|++.++||+|+||+||+|.+.. |   ..||||.+.........+.|.+|+.++++++|||||++++++.+ +..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            568888999999999999998752 3   36999999877666677889999999999999999999998765 468999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            99999999999997777789999999999999999999999   999999999999999999999999999998775432


Q ss_pred             ccce---ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhc
Q 015389          265 THHT---ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASL  340 (408)
Q Consensus       265 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l  340 (408)
                      ....   .....||+.|+|||.+.++.++.++|||||||+||||+| |+.||......            .+...+....
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------------~~~~~i~~~~  250 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------------DVINAIEQDY  250 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------HHHHHHHTTC
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------------HHHHHHHcCC
Confidence            2221   122457999999999999999999999999999999998 89999754322            1222233333


Q ss_pred             cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 015389          341 ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLC  382 (408)
Q Consensus       341 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~  382 (408)
                      +...+..++..+.+++.+||+.||.+|||+.||++.|+.+..
T Consensus       251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            334445567788999999999999999999999999987754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=407.92  Aligned_cols=252  Identities=22%  Similarity=0.342  Sum_probs=196.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE---GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv  184 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||.+.... .+...+.+.+|+.++++++||||+++++++.+   +.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999875 69999999998654 34456778999999999999999999997754   347899


Q ss_pred             EEecCCCCHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          185 LELSPNGSLASLLYG---MKEKLKWGIRYKIALGVAEGLLYLHEGC--QRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      |||+++|+|.+++..   .+..+++..++.++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999854   3467999999999999999999999821  12499999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      +....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||........            ...+...
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~------------~~~i~~~  229 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------------AGKIREG  229 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------------HHHHHHT
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH------------HHHHHcC
Confidence            75432  223457799999999999999999999999999999999999999976433211            1111111


Q ss_pred             ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      -....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            111223345567889999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-55  Score=408.11  Aligned_cols=261  Identities=27%  Similarity=0.400  Sum_probs=210.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCC-----cEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNG-----QLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  182 (408)
                      .+.|++.++||+|+||+||+|.++++     ..||||++.....+.....|++|+.++++++|||||++++++.+ +..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            35688899999999999999987532     47999999877666667789999999999999999999998776 5578


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+.++++.+++......+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++.+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            9999999999999987777889999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      .... .......||+.|+|||++.++.++.++|||||||++|||++|..|+.....           ...+...+....+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----------~~~~~~~i~~~~~  231 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------NHEVMKAINDGFR  231 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------HHHHHHHHHTTCC
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----------HHHHHHHHhccCC
Confidence            3222 222345689999999999999999999999999999999997666543211           1122333444444


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ...+...+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            455555677899999999999999999999999999877643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-55  Score=412.68  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  184 (408)
                      ...++|++.+.||+|+||+||+|.+. +|+.||||+++....+  .+++.+|+.++++++|||||++++++.+ +..++|
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            34578999999999999999999986 5899999999765433  4678999999999999999999997776 468999


Q ss_pred             EEecCCCCHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYG-MKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      |||+++|+|.+++.. ....+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            999999999999864 45679999999999999999999999   99999999999999999999999999999977543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .. .......||+.|+|||++.++.|+.++|||||||++|||++|..|+.....           ...+...+....+..
T Consensus       169 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----------~~~~~~~i~~~~~~~  236 (287)
T d1opja_         169 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------LSQVYELLEKDYRME  236 (287)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------HHHHHHHHHTTCCCC
T ss_pred             Cc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----------HHHHHHHHhcCCCCC
Confidence            22 233445689999999999999999999999999999999998776643221           112233344444444


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      .+...+..+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus       237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            5555667899999999999999999999999999877543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=400.27  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=216.3

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      ++|++.++||+|+||+||+|++++++.||||+++.....  ...+++|+.++++++||||+++++++.+ +.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            689999999999999999999988999999999876543  3578999999999999999999998776 5689999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      ++|+|..++......+++..+++++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  157 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS  157 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence            9999999988888889999999999999999999999   9999999999999999999999999999987655322 23


Q ss_pred             ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          269 ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||........            ...+....+...+..
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------------~~~i~~~~~~~~p~~  225 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------------AEHIAQGLRLYRPHL  225 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------------HHHHHTTCCCCCCTT
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------------HHHHHhCCCCCCccc
Confidence            344669999999999999999999999999999999998 8999986543322            222222333334445


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      .+..+.+++.+||+.||++|||+.+|++.|..
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            56788999999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=405.18  Aligned_cols=247  Identities=22%  Similarity=0.338  Sum_probs=204.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.++++++||||+++++++.+. ..++||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            57999999999999999999875 6999999998754332 246788999999999999999999976664 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++|+|.+++.  ...+++..+..++.||+.||.|||+   +||+||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus        99 ~~gg~L~~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~  171 (293)
T d1yhwa1          99 LAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (293)
T ss_dssp             CTTCBHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             cCCCcHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence            99999999884  3569999999999999999999999   999999999999999999999999999998775432  2


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh-ccCcccH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS-LADEYDT  346 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~-l~~~~~~  346 (408)
                      ......||+.|+|||++.++.|+.++|||||||++|+|++|+.||.........+           ...... .....+.
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----------~~~~~~~~~~~~~~  240 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----------LIATNGTPELQNPE  240 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----------HHHHHCSCCCSSGG
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH-----------HHHhCCCCCCCCcc
Confidence            3345679999999999999999999999999999999999999997644321111           111110 0111223


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            34567888999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=412.81  Aligned_cols=256  Identities=27%  Similarity=0.427  Sum_probs=212.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc----EEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ----LVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv  184 (408)
                      .+|+++++||+|+||+||+|.+. +|+    .||||.+......+..+.+.+|+.++++++|||||++++++.++..+++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            56999999999999999999875 343    6899998765555557789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      +|++.+|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            99999999999998888889999999999999999999999   999999999999999999999999999999876544


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                      .........||+.|+|||.+.++.++.++|||||||+||||+| |..||......            .+...+....+..
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~------------~~~~~i~~~~~~~  233 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------------EISSILEKGERLP  233 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG------------GHHHHHHHTCCCC
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH------------HHHHHHHcCCCCC
Confidence            4444445679999999999999999999999999999999998 78898754322            2333333334444


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      .+..++..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus       234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            4455667889999999999999999999999988765

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=415.39  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=211.8

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC------CcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe-C
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE-G  179 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~  179 (408)
                      ..++|++.++||+|+||+||+|.+..      ...||||.+...........+.+|+.++.++ +|||||++++++.+ +
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44689999999999999999998642      2369999998765555567889999999998 89999999997765 5


Q ss_pred             CeEEEEEecCCCCHHHHHhccc----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCC
Q 015389          180 GMHIVLELSPNGSLASLLYGMK----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIK  237 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dik  237 (408)
                      ..++||||+++|+|.+++....                      ..+++..++.++.||+.||.|||+   ++|||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence            5899999999999999996543                      348899999999999999999999   999999999


Q ss_pred             CCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccc
Q 015389          238 AANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQ  316 (408)
Q Consensus       238 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~  316 (408)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+||||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987665444444556778999999999999999999999999999999998 899997543


Q ss_pred             cchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 015389          317 QSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLR  378 (408)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~  378 (408)
                      ..           ..+..++....+.+.+...+..+.+|+.+||+.||++|||+.||++.|.
T Consensus       272 ~~-----------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD-----------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS-----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH-----------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32           1223333444444455556678999999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=401.79  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|.++ +|+.||||++.+...  ......+.+|+.+++.++||||+++++++.++ ..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999986 689999999875432  22356788999999999999999999977765 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|......  
T Consensus        86 Ey~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999995 35679999999999999999999999   99999999999999999999999999999876543  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                        ......||+.|+|||++.+..++.++|||||||+||||++|+.||.........           ..+...  ...++
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----------~~i~~~--~~~~p  224 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-----------KRISRV--EFTFP  224 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHTT--CCCCC
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH-----------HHHHcC--CCCCC
Confidence              224467999999999999999999999999999999999999999764322111           111111  11122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+..+.+++.+||+.||.+|||+.|+++
T Consensus       225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            334567888999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-55  Score=415.86  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=206.6

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ...++|++.+.||+|+||+||+|.+. +|+.||+|+++..........+.+|+.++++++|||||++++++.+. .+++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34578999999999999999999975 69999999998765555667889999999999999999999977664 57999


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++.. .+.+++..+..++.||+.||.|||+.  ++|+||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        83 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            999999999999954 45799999999999999999999971  38999999999999999999999999999865322 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccc----------------
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIK----------------  328 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~----------------  328 (408)
                         ......||+.|+|||++.+..|+.++||||||||+|||++|+.||................                
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               2345679999999999999999999999999999999999999997644322111100000                


Q ss_pred             -----------cchHHHHhhhhccC----cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          329 -----------RNEIRELVDASLAD----EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       329 -----------~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                 .....+..+.....    .........+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                       00011111111100    001112356788999999999999999999987

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=402.86  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=205.3

Q ss_pred             ceecccCcEEEEEEEEc---CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEecCCC
Q 015389          116 NLIGKGGYAEVYKGRLR---NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELSPNG  191 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~~~g  191 (408)
                      ++||+|+||+||+|.+.   .++.||||+++.... ....+.+.+|+.++++++|||||++++++..+..++||||+++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            47999999999999864   257899999975433 34567899999999999999999999998888899999999999


Q ss_pred             CHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc-eec
Q 015389          192 SLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH-TIS  270 (408)
Q Consensus       192 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~  270 (408)
                      +|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus        93 ~L~~~l~-~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~  168 (277)
T d1xbba_          93 PLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT  168 (277)
T ss_dssp             EHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred             cHHHHHh-hccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence            9999985 45679999999999999999999999   999999999999999999999999999998775443332 233


Q ss_pred             ccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcccHHHH
Q 015389          271 KVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQM  349 (408)
Q Consensus       271 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  349 (408)
                      ...||+.|+|||.+.++.++.++|||||||++|||++ |+.||......            .+...+....+...+..++
T Consensus       169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------------~~~~~i~~~~~~~~p~~~~  236 (277)
T d1xbba_         169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------EVTAMLEKGERMGCPAGCP  236 (277)
T ss_dssp             --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------------HHHHHHHTTCCCCCCTTCC
T ss_pred             ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------------HHHHHHHcCCCCCCCcccC
Confidence            4579999999999999999999999999999999998 89999864322            2222333333344445566


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 015389          350 NLVLLAASLCIQQSSIRRPQMSQVVQLLRG  379 (408)
Q Consensus       350 ~~l~~li~~cl~~~P~~RPt~~evl~~L~~  379 (408)
                      ..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus       237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         237 REMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            788999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=404.60  Aligned_cols=258  Identities=26%  Similarity=0.368  Sum_probs=208.2

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      ..++|++.+.||+|+||+||+|.+..    +..||||.++....+.....+.+|+.++++++||||+++++++.++..++
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~i   84 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI   84 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEE
Confidence            34689999999999999999998642    45799999987766667788999999999999999999999998888999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..++.++.||+.||.|||+   ++|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            999999999999987777889999999999999999999999   99999999999999999999999999999876543


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccC
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD  342 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  342 (408)
                      . ........||+.|+|||.+.++.++.++|||||||++|||++ |..||........            ...+......
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------------~~~i~~~~~~  228 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRIENGERL  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------------HHHHHTTCCC
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------------HHHHHcCCCC
Confidence            2 223345668999999999999999999999999999999998 8999986543311            1112222222


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..+...+..+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus       229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            334455677899999999999999999999999998765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=404.60  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=205.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      +.|++.+.||+|+||+||+|.+. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            46899999999999999999976 6999999999765433 35678899999999999999999997665 457899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+...  ..
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence            99999999987667789999999999999999999999   99999999999999999999999999999765332  12


Q ss_pred             eecccccCCCcccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh-cc
Q 015389          268 TISKVEGTFGYLAPEFLM-----HGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS-LA  341 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~-l~  341 (408)
                      ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.........           ..+.... ..
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----------~~i~~~~~~~  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----------LKIAKSEPPT  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----------HHHHHSCCCC
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-----------HHHHcCCCCC
Confidence            234567999999999984     456899999999999999999999999865432211           1111110 01


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122334567888999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=404.16  Aligned_cols=260  Identities=26%  Similarity=0.377  Sum_probs=211.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEEEEEec
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHIVLELS  188 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~e~~  188 (408)
                      .++|++.+.||+|+||+||+|.+++++.||||+++.....  .+.|.+|+.++++++|||||++++++.+++.++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEec
Confidence            4689999999999999999999988889999999766543  36789999999999999999999999888899999999


Q ss_pred             CCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          189 PNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       189 ~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      ++|+|..++... ...+++..++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+..... .
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence            999999998653 4569999999999999999999999   9999999999999999999999999999987654322 2


Q ss_pred             eecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccHH
Q 015389          268 TISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTR  347 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  347 (408)
                      ......||+.|+|||++.++.++.++|||||||++|||++|..|+......           ..+...+....+...+..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----------~~~~~~i~~~~~~~~~~~  238 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------REVLDQVERGYRMPCPPE  238 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------HHHHHHHHTTCCCCCCTT
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----------HHHHHHHHhcCCCCCCcc
Confidence            233456999999999999999999999999999999999976665432211           112222333333344555


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCccc
Q 015389          348 QMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCLK  385 (408)
Q Consensus       348 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~  385 (408)
                      .++.+.+++.+||+.||++||++.+|++.|+.......
T Consensus       239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            66788999999999999999999999999988664443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=395.47  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=196.6

Q ss_pred             CCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-----CCeEEE
Q 015389          112 FSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-----GGMHIV  184 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~~~lv  184 (408)
                      |++.+.||+|+||+||+|.+. +++.||+|.+.... .....+.+.+|+.++++++|||||++++++.+     ..+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            367788999999999999976 58899999987543 34456788999999999999999999997653     236899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEeeCCCCCceEEC-CCCceEEeecCCcccCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRR--IIHRDIKAANILLT-EDFEPQICDFGLAKWLP  261 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dikp~NIll~-~~~~~kl~DfGla~~~~  261 (408)
                      |||+++|+|.+++.. ...+++..+..++.||+.||+|||+   ++  |+||||||+|||++ .++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            999999999999954 4679999999999999999999998   77  99999999999996 57899999999998654


Q ss_pred             CCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          262 EQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       262 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..    ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.........+..          +......
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~----------i~~~~~~  231 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----------VTSGVKP  231 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH----------HTTTCCC
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH----------HHcCCCC
Confidence            32    2235679999999999865 6999999999999999999999999754322111110          1110001


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..++......+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1112223345788999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-53  Score=404.43  Aligned_cols=265  Identities=26%  Similarity=0.369  Sum_probs=218.0

Q ss_pred             HHHHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeE
Q 015389          102 LYELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGY  175 (408)
Q Consensus       102 ~~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~  175 (408)
                      +.+++...++|++.+.||+|+||+||+|+++      +++.||||+++.....+...++.+|+.++++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3445556688999999999999999999864      3578999999877666677889999999999999999999997


Q ss_pred             EEe-CCeEEEEEecCCCCHHHHHhccc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 015389          176 GIE-GGMHIVLELSPNGSLASLLYGMK-----------------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRI  231 (408)
Q Consensus       176 ~~~-~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  231 (408)
                      +.. +..++||||+++|+|.+++....                       ..+++..++.|+.||+.||+|||+   ++|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence            765 46899999999999999996422                       248899999999999999999999   999


Q ss_pred             EeeCCCCCceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCC-C
Q 015389          232 IHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR-R  310 (408)
Q Consensus       232 iH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~-~  310 (408)
                      |||||||+|||++.++.+||+|||+|+.+.........+...||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998765544444455677999999999999999999999999999999999986 5


Q ss_pred             CCCccccchhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          311 ALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       311 pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ||........            ...+........+...+..+.+|+.+||+.+|.+||||.||+++|+++.
T Consensus       242 p~~~~~~~e~------------~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEEV------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHHH------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHHH------------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            6765433211            1111222222333445567889999999999999999999999998875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=404.37  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=202.5

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+...  +.....+.+|+.++++++||||+++++++.++ ..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 699999999975421  22356788999999999999999999977664 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+++|+|.+++. ..+.+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999885 45679999999999999999999999   9999999999999999999999999999998765444


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                      ........||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.....           ..+...  ...++
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-----------~~i~~~--~~~~p  230 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-----------QKIIKL--EYDFP  230 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHTT--CCCCC
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH-----------HHHHcC--CCCCC
Confidence            44445677999999999999999999999999999999999999999864332111           111111  11222


Q ss_pred             HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ......+.+|+.+||+.||.+|||+.|++.
T Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            334566888999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-53  Score=401.93  Aligned_cols=249  Identities=23%  Similarity=0.365  Sum_probs=189.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .+.|++.+.||+|+||+||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++.++ .+++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            367999999999999999999976 68999999998765555556788999999999999999999977665 4789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC---CCCceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT---EDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~---~~~~~kl~DfGla~~~~~~  263 (408)
                      |+++|+|.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999995 45679999999999999999999999   9999999999999994   5789999999999866432


Q ss_pred             CccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc--c
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--A  341 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~  341 (408)
                         .......||+.|+|||++.+..|+.++|||||||+||||++|+.||.........           ..+.....  .
T Consensus       164 ---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-----------~~i~~~~~~~~  229 (307)
T d1a06a_         164 ---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-----------EQILKAEYEFD  229 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----------HHHHTTCCCCC
T ss_pred             ---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-----------HHHhccCCCCC
Confidence               2234567999999999999999999999999999999999999999764332111           11111111  1


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1112234567888999999999999999999988

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-53  Score=400.25  Aligned_cols=244  Identities=27%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      .|+..+.||+|+||+||+|.+. +|+.||||++....  ..+..+.+.+|+.++++++|||||++++++.+. ..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4889999999999999999875 68999999997654  234567899999999999999999999977664 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.+|+|..++ ..+..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|......   
T Consensus        96 ~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---  168 (309)
T d1u5ra_          96 YCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (309)
T ss_dssp             CCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             ecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence            99999987665 345679999999999999999999999   99999999999999999999999999999865432   


Q ss_pred             ceecccccCCCccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCc
Q 015389          267 HTISKVEGTFGYLAPEFLMH---GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADE  343 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  343 (408)
                         ....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.........           ..+........
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~-----------~~i~~~~~~~~  234 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----------YHIAQNESPAL  234 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----------HHHHHSCCCCC
T ss_pred             ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH-----------HHHHhCCCCCC
Confidence               34579999999999864   46899999999999999999999999754332111           11111111111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            12234567888999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-53  Score=398.64  Aligned_cols=265  Identities=24%  Similarity=0.360  Sum_probs=207.5

Q ss_pred             HHHhhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeE
Q 015389          103 YELQSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGY  175 (408)
Q Consensus       103 ~~~~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~  175 (408)
                      ..++...++|++.+.||+|+||.||+|.+.      +++.||||+++..........+..|..++.++ +|+||+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344445578999999999999999999853      25689999998766666677888888888777 68999999997


Q ss_pred             EEeC--CeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCC
Q 015389          176 GIEG--GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKA  238 (408)
Q Consensus       176 ~~~~--~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp  238 (408)
                      +.+.  .+++||||+++|+|.+++....               ..+++..+..++.||+.||.|||+   ++|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCc
Confidence            7653  4789999999999999996432               358899999999999999999999   9999999999


Q ss_pred             CceEECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCcccc
Q 015389          239 ANILLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR-RALDYSQQ  317 (408)
Q Consensus       239 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~-~pf~~~~~  317 (408)
                      +||||+.++.+||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||++|. .||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998776544444445677999999999999999999999999999999999975 57764332


Q ss_pred             chhhhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          318 SLVLWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..           .+...+........+...+..+.+++.+||+.||.+|||+.||++.|+.++
T Consensus       243 ~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 DE-----------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             SH-----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HH-----------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21           122223333333334445567889999999999999999999999998765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-53  Score=395.59  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=205.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc--C--CcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCCeEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR--N--GQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEGGMHI  183 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~--~--g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~l  183 (408)
                      ++|++.+.||+|+||+||+|.+.  +  +..||||++....  ..+..+.|.+|+.++++++||||+++++++.+...++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l   87 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM   87 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence            67999999999999999999864  2  2478999987643  2345678999999999999999999999998888999


Q ss_pred             EEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCC
Q 015389          184 VLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       184 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  263 (408)
                      ||||+++|+|.+++......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+...
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            999999999999987777789999999999999999999999   99999999999999999999999999999987654


Q ss_pred             Cccce-ecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhcc
Q 015389          264 WTHHT-ISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLA  341 (408)
Q Consensus       264 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  341 (408)
                      ..... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||........           +..+.....+
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-----------~~~i~~~~~~  233 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----------LHKIDKEGER  233 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------HHHHHTSCCC
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----------HHHHHhCCCC
Confidence            33322 234568889999999999999999999999999999998 8999975443321           1122222223


Q ss_pred             CcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 015389          342 DEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGN  380 (408)
Q Consensus       342 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~  380 (408)
                      ...+...+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            333344556788999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-52  Score=401.16  Aligned_cols=249  Identities=21%  Similarity=0.250  Sum_probs=207.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.++++++|||||++++++.++ .+++||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            68999999999999999999975 6999999999766533 457788999999999999999999976664 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC--CCceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE--DFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~  265 (408)
                      +++|+|.+++....+.+++..+..++.||+.||.|||+   ++||||||||+|||++.  ++.+||+|||+|+.+.... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            99999999997777789999999999999999999999   99999999999999954  5789999999998775432 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc--cCc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL--ADE  343 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l--~~~  343 (408)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........           ..+.....  ...
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-----------~~i~~~~~~~~~~  247 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-----------RNVKSCDWNMDDS  247 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHTCCCSCCG
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCCCcc
Confidence              234567999999999999999999999999999999999999999764332111           11111111  111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                      ........+.+|+.+||+.||.+|||+.|+++.
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112344568889999999999999999999883

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=392.90  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.+....     ...+.+.+|+.++++++|||||++++++.+. ..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            67999999999999999999975 6999999999754321     2357789999999999999999999977665 478


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC----ceEEeecCCcc
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF----EPQICDFGLAK  258 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~----~~kl~DfGla~  258 (408)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++    .+||+|||+|.
T Consensus        90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence            99999999999999954 4579999999999999999999999   9999999999999998876    49999999998


Q ss_pred             cCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........           .+...
T Consensus       166 ~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~-----------~i~~~  231 (293)
T d1jksa_         166 KIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-----------NVSAV  231 (293)
T ss_dssp             ECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------HHHTT
T ss_pred             hcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH-----------HHHhc
Confidence            76543   22345679999999999999999999999999999999999999998644322111           01110


Q ss_pred             hc--cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          339 SL--ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       339 ~l--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..  ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  01111223456788999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.3e-52  Score=399.43  Aligned_cols=248  Identities=21%  Similarity=0.246  Sum_probs=207.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e~  187 (408)
                      ++|++++.||+|+||.||+|.+. +|+.||||++...... ....+.+|+.++++++|||||++++++.++ .+++||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            57999999999999999999975 6999999999876543 356788999999999999999999977654 57899999


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEEC--CCCceEEeecCCcccCCCCCc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLT--EDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~~~  265 (408)
                      +++|+|.+++......+++..+..|+.||+.||.|||+   +||+||||||+||||+  .++.+||+|||+|..+.... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            99999999887767789999999999999999999999   9999999999999997  57899999999999875432 


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh--ccCc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS--LADE  343 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~~~  343 (408)
                        ......||+.|+|||++.+..|+.++|||||||+||+|++|+.||.........           ..+....  ....
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----------~~i~~~~~~~~~~  250 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-----------QNVKRCDWEFDED  250 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----------HHHHHCCCCCCSS
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCCCcc
Confidence              234567999999999999999999999999999999999999999864432111           1111111  1111


Q ss_pred             ccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          344 YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       344 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22234567888999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=393.58  Aligned_cols=261  Identities=23%  Similarity=0.360  Sum_probs=220.4

Q ss_pred             hhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeC
Q 015389          107 SATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEG  179 (408)
Q Consensus       107 ~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~  179 (408)
                      ...++|++.++||+|+||.||+|.+.      +++.||||+++..........+.+|+.+++.+ +|||||++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34478999999999999999999752      46789999998776666677899999999999 699999999987765


Q ss_pred             -CeEEEEEecCCCCHHHHHhccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCce
Q 015389          180 -GMHIVLELSPNGSLASLLYGMK-----------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANI  241 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NI  241 (408)
                       ..++||||+++|+|.+++....                 ..+++..+..++.||+.||+|||+   ++|+||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence             5799999999999999996432                 258999999999999999999999   9999999999999


Q ss_pred             EECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCccccchh
Q 015389          242 LLTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTG-RRALDYSQQSLV  320 (408)
Q Consensus       242 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg-~~pf~~~~~~~~  320 (408)
                      +++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|+ .+||......  
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--  254 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--  254 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999999999987765555555567899999999999999999999999999999999995 5555443221  


Q ss_pred             hhhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          321 LWARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       321 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                               ..+..++....+...+...+..+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       255 ---------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 ---------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             ---------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                     2234445555555555556678999999999999999999999999998764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=387.77  Aligned_cols=249  Identities=29%  Similarity=0.420  Sum_probs=202.6

Q ss_pred             cCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~e  186 (408)
                      .++|++.+.||+|+||.||+|.++ |..||||+++...   ..+.+.+|+.++++++||||+++++++.+  +.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            467889999999999999999985 7889999997653   34678899999999999999999998764  45799999


Q ss_pred             ecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          187 LSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       187 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      |+++|+|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            99999999999653 3458999999999999999999999   99999999999999999999999999999865432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                         .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......            .+...+....+...
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------------~~~~~i~~~~~~~~  221 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------DVVPRVEKGYKMDA  221 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------------GHHHHHTTTCCCCC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH------------HHHHHHHcCCCCCC
Confidence               234568999999999999999999999999999999998 67777654332            12222233334444


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      +...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            5555678889999999999999999999999997653

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=390.86  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=208.6

Q ss_pred             cceecccCcEEEEEEEEcC----CcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe--CCeEEEEEec
Q 015389          115 ENLIGKGGYAEVYKGRLRN----GQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE--GGMHIVLELS  188 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~e~~  188 (408)
                      .++||+|+||+||+|.+.+    ...||||+++........++|.+|+.++++++||||+++++++.+  +..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4789999999999998753    236999999876666677899999999999999999999998765  3578999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc--
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH--  266 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~--  266 (408)
                      ++|+|.+++......+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++.+......  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999998877888999999999999999999999   99999999999999999999999999999877543222  


Q ss_pred             ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcccH
Q 015389          267 HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYDT  346 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  346 (408)
                      .......||+.|+|||.+.++.++.++|||||||++|||++|+.||.......           .+...+-...+...+.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----------~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----------DITVYLLQGRRLLQPE  257 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------------CHHHHHTTCCCCCCT
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----------HHHHHHHcCCCCCCcc
Confidence            22234568999999999999999999999999999999999888876432211           0111111111222233


Q ss_pred             HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          347 RQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       347 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                      ..+..+.+++.+||+.||++||+|.||++.|+.+...
T Consensus       258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            4456788999999999999999999999999888644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-52  Score=392.20  Aligned_cols=264  Identities=22%  Similarity=0.358  Sum_probs=217.4

Q ss_pred             hhhcCCCCccceecccCcEEEEEEEEc------CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-
Q 015389          106 QSATNNFSFENLIGKGGYAEVYKGRLR------NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-  178 (408)
Q Consensus       106 ~~~~~~y~~~~~lg~G~fg~V~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  178 (408)
                      +...++|++.+.||+|+||+||+|.+.      +++.||||+++..........+.+|+.++++++||||+++++++.. 
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            344578999999999999999999763      3678999999876666667789999999999999999999997765 


Q ss_pred             CCeEEEEEecCCCCHHHHHhccc---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          179 GGMHIVLELSPNGSLASLLYGMK---------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      +..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceE
Confidence            56899999999999999986422         347889999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGR-RALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~-~pf~~~~~~~~~~~~~~~~  328 (408)
                      ||+|||+|+.+.............||+.|+|||.+.++.++.++|||||||++|||+||. .||.......         
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---------  243 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------  243 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---------
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence            999999998776544444445567999999999999999999999999999999999985 6776433221         


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                         +...+........+...+..+.+++.+||+.+|.+|||+.+|++.|++..+..
T Consensus       244 ---~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         244 ---VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ---HHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence               11111112222233445567999999999999999999999999998876543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=391.19  Aligned_cols=259  Identities=26%  Similarity=0.392  Sum_probs=213.3

Q ss_pred             hcCCCCccceecccCcEEEEEEEEcC--------CcEEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEe
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIE  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~  178 (408)
                      ..++|.+.+.||+|+||.||+|+...        +..||||+++....+.....+.+|...+.++ +|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            34789999999999999999997532        3479999998877766678889999999888 79999999998776


Q ss_pred             C-CeEEEEEecCCCCHHHHHhccc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceE
Q 015389          179 G-GMHIVLELSPNGSLASLLYGMK---------------EKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANIL  242 (408)
Q Consensus       179 ~-~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIl  242 (408)
                      + ..++||||+++|+|.+++....               ..+++..++.++.||+.||+|||+   ++||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence            5 4899999999999999996433               358999999999999999999999   99999999999999


Q ss_pred             ECCCCceEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCccccchhh
Q 015389          243 LTEDFEPQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVT-GRRALDYSQQSLVL  321 (408)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~ellt-g~~pf~~~~~~~~~  321 (408)
                      ++.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||||+|||++ |..||......   
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---  244 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  244 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence            99999999999999997765544444556779999999999999999999999999999999998 68888754332   


Q ss_pred             hhccccccchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          322 WARPMIKRNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       322 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                               .+...+........+...+..+.+|+.+||+.||.+|||+.||++.|+++.
T Consensus       245 ---------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 ---------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ---------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                     122233333344444455677999999999999999999999999998764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=393.04  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      .++|++++.||+|+||.||+|..+ +|+.||||++.+...  .+....+.+|+.+++.++||||+++++++.+. .+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            368999999999999999999975 699999999975422  22357788999999999999999999976665 57899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||++.+|.+||+|||+|+..... 
T Consensus        84 ~ey~~gg~L~~~~~-~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-  158 (337)
T d1o6la_          84 MEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             EECCTTCBHHHHHH-HHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eeccCCCchhhhhh-cccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence            99999999999985 45678999999999999999999999   99999999999999999999999999999876432 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........           ..+...  ...+
T Consensus       159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----------~~i~~~--~~~~  224 (337)
T d1o6la_         159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-----------ELILME--EIRF  224 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHC--CCCC
T ss_pred             -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH-----------HHHhcC--CCCC
Confidence             22334578999999999999999999999999999999999999999865432111           111111  1122


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                      +......+.+|+.+||+.||.+||+     +.|+++
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            3334556788999999999999995     788776

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-52  Score=392.45  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=206.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCc--EEEEEEecCCCchHHHHHHHHHHHHHhcC-CCCceeEEEeEEEeCC-eEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQ--LVAIKRLTRGTADEIIADFLSELGIMAHV-DHPNTAKLLGYGIEGG-MHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~~~-~~lv  184 (408)
                      ++|++.++||+|+||+||+|.++ +|.  .||||.+......+..+.+.+|+.++.++ +||||+++++++.+++ +++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            68899999999999999999875 344  47888887655555667899999999998 7999999999877654 7899


Q ss_pred             EEecCCCCHHHHHhcc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCce
Q 015389          185 LELSPNGSLASLLYGM---------------KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEP  249 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~  249 (408)
                      |||+++|+|.++++..               ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            9999999999999643               3679999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCccccchhhhhccccc
Q 015389          250 QICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRR-ALDYSQQSLVLWARPMIK  328 (408)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~-pf~~~~~~~~~~~~~~~~  328 (408)
                      ||+|||+++.......   .....||..|+|||.+.++.++.++|||||||++|||++|.. ||.......         
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---------  234 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------  234 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---------
Confidence            9999999986543222   234569999999999999999999999999999999999765 665433221         


Q ss_pred             cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCc
Q 015389          329 RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCC  383 (408)
Q Consensus       329 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~  383 (408)
                         +...+....+...+...+..+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus       235 ---~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         235 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             ---HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence               1122222233344445567889999999999999999999999999887643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.2e-51  Score=382.93  Aligned_cols=257  Identities=21%  Similarity=0.284  Sum_probs=201.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC--chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-C----
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT--ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-G----  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~----  180 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++....  ..+....+.+|+.+++.++||||+++++++... .    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999875 69999999997653  344567899999999999999999999966542 2    


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .|+||||+++++|.+++. ..+.+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.++|+|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~-~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence            689999999999999884 45679999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCcc-ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhh
Q 015389          261 PEQWTH-HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDAS  339 (408)
Q Consensus       261 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~  339 (408)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+.           .+...
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-----------~~~~~  230 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ-----------HVRED  230 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-----------HHHCC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH-----------HHhcC
Confidence            433222 233456799999999999999999999999999999999999999986543221111           11100


Q ss_pred             --ccCcccHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 015389          340 --LADEYDTRQMNLVLLAASLCIQQSSIRRP-QMSQVVQLLRGN  380 (408)
Q Consensus       340 --l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~  380 (408)
                        .........+..+.+++.+||+.||.+|| |+.++++.|..+
T Consensus       231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence              00111122346788899999999999999 899999888654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.7e-51  Score=387.79  Aligned_cols=244  Identities=25%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++++.||+|+||+||+|.++ +|+.||||++.+...  ....+.+.+|+.+++.++||||+++++++.+. .+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 699999999975422  22357788999999999999999999977664 578999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.||+|..++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+|.+||+|||+|+.+...  
T Consensus        84 E~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            9999999999884 45678888999999999999999999   99999999999999999999999999999876542  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.........           ..+....  ..++
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----------~~i~~~~--~~~p  221 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-----------EKILNAE--LRFP  221 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHHCC--CCCC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH-----------HHHHcCC--CCCC
Confidence               23567999999999999999999999999999999999999999864332111           1111111  1222


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ...+..+.+++.+||+.||.+||     |+.++++
T Consensus       222 ~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            33445688899999999999996     8999886

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.7e-51  Score=393.63  Aligned_cols=244  Identities=22%  Similarity=0.267  Sum_probs=203.1

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVL  185 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~  185 (408)
                      ++|++++.||+|+||.||+|.++ +|+.||||++.+...  ......+.+|+.+++.++||||+++++++.+. ..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 699999999875322  12356788999999999999999999976664 478999


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCc
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWT  265 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  265 (408)
                      ||+.+|+|..++.. .+.+++..+..++.||+.||.|||+   ++||||||||+|||++.+|.+||+|||+|+.+...  
T Consensus       121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999999999854 4579999999999999999999999   99999999999999999999999999999876432  


Q ss_pred             cceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCccc
Q 015389          266 HHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEYD  345 (408)
Q Consensus       266 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  345 (408)
                         .....||+.|+|||++.+..++.++|||||||+||||++|+.||.........           ..+....  ...+
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----------~~i~~~~--~~~p  258 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-----------EKIVSGK--VRFP  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------HHHHHCC--CCCC
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-----------HHHhcCC--CCCC
Confidence               23467999999999999999999999999999999999999999764322111           1111111  1122


Q ss_pred             HHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 015389          346 TRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ  375 (408)
Q Consensus       346 ~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~  375 (408)
                      ......+.+++.+||+.||.+|+     |+.++++
T Consensus       259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            33456788899999999999994     8999886

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-51  Score=384.44  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=203.1

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----~~~lv  184 (408)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++......  ......|+..+.+++||||+++++++.+.     .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            5678889999999999999997 5899999999754322  22233566666788999999999987754     26899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-----CQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      |||+++|+|.+++..  ..+++..++.++.|++.||.|||+.     ..++|+||||||+||||+.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            999999999999954  4689999999999999999999962     136999999999999999999999999999987


Q ss_pred             CCCCCcc--ceecccccCCCccccccccCCC------CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccch
Q 015389          260 LPEQWTH--HTISKVEGTFGYLAPEFLMHGI------VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNE  331 (408)
Q Consensus       260 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~  331 (408)
                      .......  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||.........+.........
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            6543222  1234567999999999987643      6779999999999999999998886543322211111111111


Q ss_pred             HH----HHhhhhccCcc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          332 IR----ELVDASLADEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       332 ~~----~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      ..    ...+..++...     .......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            11    22222232222     2345677999999999999999999999999997664

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-50  Score=391.98  Aligned_cols=246  Identities=26%  Similarity=0.325  Sum_probs=197.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-----hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-----DEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMH  182 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~  182 (408)
                      ++|++.++||+|+||.||+|.+. +|+.||||++.+...     .........++.+++.++|||||++++++.+. .+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999976 699999999864321     11223334567888889999999999976654 589


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      +||||+++|+|.+++.. ...+++..+..++.||+.||.|||+   ++||||||||+|||++.+|.+||+|||+|+.+..
T Consensus        84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            99999999999999954 5678999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhc-
Q 015389          263 QWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASL-  340 (408)
Q Consensus       263 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l-  340 (408)
                      .    ......||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.........            .+..... 
T Consensus       160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------------~~~~~~~~  223 (364)
T d1omwa3         160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------------EIDRMTLT  223 (364)
T ss_dssp             S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH------------HHHHHSSS
T ss_pred             C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH------------HHHHhccc
Confidence            3    2244679999999999975 46899999999999999999999999764322111            1111111 


Q ss_pred             -cCcccHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 015389          341 -ADEYDTRQMNLVLLAASLCIQQSSIRRPQ-----MSQVVQ  375 (408)
Q Consensus       341 -~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~  375 (408)
                       ....+...+..+.+|+.+||+.||.+|||     +.|+++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             11122234556888999999999999999     678775

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=389.91  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--hHHHHHHHHHHHHHh-cCCCCceeEEEeEEEeC-CeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--DEIIADFLSELGIMA-HVDHPNTAKLLGYGIEG-GMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~~-~~~lv  184 (408)
                      ++|.+.+.||+|+||+||+|.+. +|+.||||++.+...  ++....+..|..++. .++||||+++++++.++ .+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999986 699999999975421  223456667777665 68999999999977765 48899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  264 (408)
                      |||+++|+|.+++. ....+++..+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++..... 
T Consensus        82 mEy~~~g~L~~~i~-~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999995 45678999999999999999999999   99999999999999999999999999999866543 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccCcc
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLADEY  344 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  344 (408)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+........           .+...  ...+
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~-----------~i~~~--~~~~  222 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH-----------SIRMD--NPFY  222 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------HHHHC--CCCC
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH-----------HHHcC--CCCC
Confidence             223345679999999999999999999999999999999999999998654332110           01100  1122


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 015389          345 DTRQMNLVLLAASLCIQQSSIRRPQMS-QVVQ  375 (408)
Q Consensus       345 ~~~~~~~l~~li~~cl~~~P~~RPt~~-evl~  375 (408)
                      +...+..+.+|+.+||+.||.+||++. +|++
T Consensus       223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            233456688999999999999999995 6754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=382.72  Aligned_cols=248  Identities=18%  Similarity=0.196  Sum_probs=204.8

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLE  186 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e  186 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||+++....+  ...+.+|+.+|+.++||||+++++++.+ +.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            378999999999999999999986 6899999999876533  3567899999999999999999997665 55899999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC--CceEEeecCCcccCCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED--FEPQICDFGLAKWLPEQW  264 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~~  264 (408)
                      |+++|+|.+++...+..+++..+..++.||+.||.|||+   ++|+||||||+|||++.+  +.+||+|||++...... 
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            999999999997666689999999999999999999999   999999999999999854  48999999999876442 


Q ss_pred             ccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhhhccC--
Q 015389          265 THHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDASLAD--  342 (408)
Q Consensus       265 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--  342 (408)
                        .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........           ..+.......  
T Consensus       158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~-----------~~i~~~~~~~~~  224 (321)
T d1tkia_         158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-----------ENIMNAEYTFDE  224 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-----------HHHHHTCCCCCH
T ss_pred             --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHhCCCCCCh
Confidence              2234456999999999999999999999999999999999999999865432111           1111111110  


Q ss_pred             cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          343 EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       343 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .........+.+|+.+||+.||.+|||+.|+++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000123456788999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-50  Score=374.88  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=204.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc--------hHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA--------DEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG  179 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~  179 (408)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....        +...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            78999999999999999999875 699999999876432        224567889999999997 99999999977765


Q ss_pred             -CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          180 -GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       180 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                       ..|+||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence             47999999999999999954 5679999999999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCccceecccccCCCccccccccC------CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchH
Q 015389          259 WLPEQWTHHTISKVEGTFGYLAPEFLMH------GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEI  332 (408)
Q Consensus       259 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~  332 (408)
                      .+.....   .....||+.|+|||++.+      ..++.++||||+||+||||++|+.||.........           
T Consensus       159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-----------  224 (277)
T d1phka_         159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----------  224 (277)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----------
T ss_pred             EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-----------
Confidence            8765322   244679999999999863      35788999999999999999999999865432211           


Q ss_pred             HHHhhhh--ccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          333 RELVDAS--LADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       333 ~~~~d~~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ..+....  .........+..+.+++.+||+.||.+|||+.||++
T Consensus       225 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111111  111122345567888999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=382.65  Aligned_cols=249  Identities=19%  Similarity=0.242  Sum_probs=196.2

Q ss_pred             cCCCCccc-eecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhc-CCCCceeEEEeEEEe-----CC
Q 015389          109 TNNFSFEN-LIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAH-VDHPNTAKLLGYGIE-----GG  180 (408)
Q Consensus       109 ~~~y~~~~-~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~-l~hpniv~l~~~~~~-----~~  180 (408)
                      .++|.+.. .||+|+||+||+|.+. +|+.||||++...      ..+.+|+.++.+ .+||||+++++++.+     ..
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            36888875 5999999999999874 6999999998643      234579988655 589999999997653     34


Q ss_pred             eEEEEEecCCCCHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCC
Q 015389          181 MHIVLELSPNGSLASLLYGM-KEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGL  256 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGl  256 (408)
                      +|+||||++||+|.+++... ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.   ++.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence            79999999999999999654 3569999999999999999999999   99999999999999985   45799999999


Q ss_pred             cccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhh-hccccccchHHHH
Q 015389          257 AKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLW-ARPMIKRNEIREL  335 (408)
Q Consensus       257 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~  335 (408)
                      |+......   ......||+.|+|||++.+..|+.++|||||||+||+|++|+.||.......... .........    
T Consensus       161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~----  233 (335)
T d2ozaa1         161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----  233 (335)
T ss_dssp             CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS----
T ss_pred             eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC----
Confidence            98765432   2345679999999999999999999999999999999999999997643321110 000000000    


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        ..+........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       234 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 --YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              00011111234567888999999999999999999988

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=376.31  Aligned_cols=262  Identities=22%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-CeEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIEG-GMHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~lv~e  186 (408)
                      ++|++++.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.++++++||||+++++++.++ ..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            68999999999999999999975 6999999999765432 2357788999999999999999999977665 5789999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      |+.++.+..........+++..+..++.||+.||+|||+   ++||||||||+|||++.++.+||+|||+|+.....  .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--S
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC--c
Confidence            997665555544556779999999999999999999999   99999999999999999999999999999876442  2


Q ss_pred             ceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc----cccc---hHHHHhh-
Q 015389          267 HTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM----IKRN---EIRELVD-  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~----~~~~---~~~~~~d-  337 (408)
                      .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.........+....    ..+.   ......+ 
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2334567999999999887765 57899999999999999999999986543221111000    0000   0000000 


Q ss_pred             -hh----ccCcc---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          338 -AS----LADEY---DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       338 -~~----l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                       ..    .....   .......+.+|+.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             00    00000   01223567889999999999999999999873

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-50  Score=378.13  Aligned_cols=255  Identities=25%  Similarity=0.285  Sum_probs=191.8

Q ss_pred             cceecccCcEEEEEEEEc-CCcEEEEEEecCCCch----HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEec
Q 015389          115 ENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD----EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLELS  188 (408)
Q Consensus       115 ~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~~  188 (408)
                      +++||+|+||+||+|.+. +|+.||||++......    .....+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999975 6999999999754332    224568899999999999999999997665 4589999999


Q ss_pred             CCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccce
Q 015389          189 PNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHHT  268 (408)
Q Consensus       189 ~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  268 (408)
                      .++++..+. .....+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|+.......  .
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            888776655 456779999999999999999999999   9999999999999999999999999999987654322  2


Q ss_pred             ecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc-ccc---ccchHH---HHhhh-h
Q 015389          269 ISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR-PMI---KRNEIR---ELVDA-S  339 (408)
Q Consensus       269 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~-~~~---~~~~~~---~~~d~-~  339 (408)
                      .....||+.|+|||++.++ .|+.++|||||||++|||++|+.||............ ...   ......   ..... .
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            3346799999999998755 5799999999999999999999999764332111000 000   000000   00000 0


Q ss_pred             c--cCccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          340 L--ADEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       340 l--~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      .  ....+     ......+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0  00000     122456888999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-50  Score=378.20  Aligned_cols=269  Identities=22%  Similarity=0.315  Sum_probs=200.7

Q ss_pred             hcCCCCccceecccCcEEEEEEEEc-C-CcEEEEEEecCCCch-HHHHHHHHHHHHHhcC---CCCceeEEEeEEEe---
Q 015389          108 ATNNFSFENLIGKGGYAEVYKGRLR-N-GQLVAIKRLTRGTAD-EIIADFLSELGIMAHV---DHPNTAKLLGYGIE---  178 (408)
Q Consensus       108 ~~~~y~~~~~lg~G~fg~V~~~~~~-~-g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l---~hpniv~l~~~~~~---  178 (408)
                      ..++|++++.||+|+||+||+|.+. + ++.||||++...... .....+.+|+.+++.+   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            4578999999999999999999874 3 678999998653322 1223345666666554   89999999997642   


Q ss_pred             ---CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecC
Q 015389          179 ---GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFG  255 (408)
Q Consensus       179 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfG  255 (408)
                         ...++++|++.++.+..........+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence               24689999999988877766677789999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc----cccccch
Q 015389          256 LAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR----PMIKRNE  331 (408)
Q Consensus       256 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~----~~~~~~~  331 (408)
                      ++......   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||............    .......
T Consensus       162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            99865432   2334567999999999999999999999999999999999999999865432111000    0000000


Q ss_pred             H------HH-Hhhhhc---cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcccC
Q 015389          332 I------RE-LVDASL---ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGNLC  382 (408)
Q Consensus       332 ~------~~-~~d~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~  382 (408)
                      .      .. ......   ...+.......+.+|+.+||+.||.+|||+.|+++  .|+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            0      00 000000   00111123456778999999999999999999987  3555443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=371.78  Aligned_cols=240  Identities=21%  Similarity=0.340  Sum_probs=194.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCch-----HHHHHHHHHHHHHhcCC--CCceeEEEeEEEeC-
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTAD-----EIIADFLSELGIMAHVD--HPNTAKLLGYGIEG-  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~-  179 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++......     ....++.+|+.++++++  ||||+++++++.+. 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            368999999999999999999875 6999999998753211     11234568999999986  89999999977664 


Q ss_pred             CeEEEEEecCC-CCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCC-CceEEeecCCc
Q 015389          180 GMHIVLELSPN-GSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTED-FEPQICDFGLA  257 (408)
Q Consensus       180 ~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~-~~~kl~DfGla  257 (408)
                      ..++||||+.+ +++.+++. ....+++..+..++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~-~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            57899999976 57777774 45679999999999999999999999   999999999999999854 79999999999


Q ss_pred             ccCCCCCccceecccccCCCccccccccCCCC-CcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHh
Q 015389          258 KWLPEQWTHHTISKVEGTFGYLAPEFLMHGIV-DEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELV  336 (408)
Q Consensus       258 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  336 (408)
                      +.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||......  .               
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~---------------  217 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I---------------  217 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H---------------
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--h---------------
Confidence            865432    2345679999999999987765 57799999999999999999999753211  0               


Q ss_pred             hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...  ..++...+..+.+++.+||+.||.+|||+.|+++
T Consensus       218 ~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            000  0111123456788999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=372.00  Aligned_cols=263  Identities=20%  Similarity=0.247  Sum_probs=200.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-----CeE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-----GMH  182 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-----~~~  182 (408)
                      +.+|++++.||+|+||+||+|.+. +|+.||||++.........+.+++|+.+|++++||||+++++++...     ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            467999999999999999999875 79999999998766666678899999999999999999999977653     245


Q ss_pred             EEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCC
Q 015389          183 IVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPE  262 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~  262 (408)
                      ++++++.+|+|.+++.  ...+++..+..++.||+.||+|||+   ++||||||||+|||++.++.+||+|||+|.....
T Consensus        87 ~l~~~~~~g~L~~~l~--~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            6777888999999994  3479999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCcc-ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc-cccc---------
Q 015389          263 QWTH-HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM-IKRN---------  330 (408)
Q Consensus       263 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~---------  330 (408)
                      .... .......||+.|+|||.+..+ .++.++||||+||++|+|++|+.||.........+.... ....         
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3222 223456799999999998554 578999999999999999999999976543211111000 0000         


Q ss_pred             --hHHHHhhhhcc-Cccc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 015389          331 --EIRELVDASLA-DEYD-----TRQMNLVLLAASLCIQQSSIRRPQMSQVVQL  376 (408)
Q Consensus       331 --~~~~~~d~~l~-~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~  376 (408)
                        ........... ...+     ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00000000000 0000     1122467889999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.4e-48  Score=366.50  Aligned_cols=260  Identities=23%  Similarity=0.300  Sum_probs=197.0

Q ss_pred             CCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCch-HHHHHHHHHHHHHhcCCCCceeEEEeEEEe-CCeEEEEEe
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTAD-EIIADFLSELGIMAHVDHPNTAKLLGYGIE-GGMHIVLEL  187 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~e~  187 (408)
                      ++|++.++||+|+||+||+|.+++|+.||||++...... .....+.+|+.++++++||||+++++++.+ +..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            689999999999999999999999999999999765432 335778899999999999999999996665 557888888


Q ss_pred             cCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCccc
Q 015389          188 SPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTHH  267 (408)
Q Consensus       188 ~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  267 (408)
                      +.++.+..+. .....+++..+..++.||+.||+|||+   .+||||||||+|||++.++.+||+|||++.......  .
T Consensus        82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            8776665555 556789999999999999999999999   999999999999999999999999999998764422  2


Q ss_pred             eecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc----ccccc---chHHHH--hh
Q 015389          268 TISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR----PMIKR---NEIREL--VD  337 (408)
Q Consensus       268 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~----~~~~~---~~~~~~--~d  337 (408)
                      ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||............    .....   ......  .+
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            22344689999999998764 5699999999999999999999999764332111000    00000   000000  00


Q ss_pred             hhc-------cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ASL-------ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                      ...       ...........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000       00111123456788999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=367.89  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=197.9

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCC-chHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGT-ADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------  179 (408)
                      .++|++++.||+|+||+||+|.+. +|+.||||++.... .+...+.+.+|+.+|++++|||||++++++...       
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            478999999999999999999975 69999999998643 334567889999999999999999999977653       


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      .+++||||+ +++|..++.  ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence            368999999 667777763  4579999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcccc-----------
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMI-----------  327 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~-----------  327 (408)
                      ....     .+...||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...............           
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            6443     2346699999999998764 5689999999999999999999999865432111000000           


Q ss_pred             ccchHHHHhhhhc---c-C---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HhcccCc
Q 015389          328 KRNEIRELVDASL---A-D---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQL--LRGNLCC  383 (408)
Q Consensus       328 ~~~~~~~~~d~~l---~-~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~  383 (408)
                      ............+   . .   .........+.+|+.+||+.||.+|||+.|+++.  |+.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            0000000000000   0 0   0111223467789999999999999999999984  6655433

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=364.02  Aligned_cols=262  Identities=22%  Similarity=0.315  Sum_probs=194.6

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe---------
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE---------  178 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---------  178 (408)
                      ++|++++.||+|+||+||+|.+. +|+.||||++..... +.....+.+|+.+|+.++||||+++++.+..         
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            78999999999999999999975 799999999865433 2345677899999999999999999986543         


Q ss_pred             CCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          179 GGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       179 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      +..++|||++.++.+.... .....+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence            3478999999877665444 556778999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCCcc--ceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhh--c---c-----
Q 015389          259 WLPEQWTH--HTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWA--R---P-----  325 (408)
Q Consensus       259 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~--~---~-----  325 (408)
                      ........  .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........  .   .     
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            76543221  222345799999999998765 689999999999999999999999976433211000  0   0     


Q ss_pred             --ccccchHHHHhhhhccCcccH-------HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 --MIKRNEIRELVDASLADEYDT-------RQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 --~~~~~~~~~~~d~~l~~~~~~-------~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                        .....................       .....+.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence              000000000010000000000       11235667999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=366.41  Aligned_cols=259  Identities=25%  Similarity=0.289  Sum_probs=194.3

Q ss_pred             CCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEEeEEEeC-------CeE
Q 015389          111 NFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLLGYGIEG-------GMH  182 (408)
Q Consensus       111 ~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-------~~~  182 (408)
                      +|+..++||+|+||+||+|++. +|+.||||++......     +.+|+.++++++||||+++++++...       .++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5888899999999999999986 6999999999765422     23799999999999999999976432       268


Q ss_pred             EEEEecCCCCHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCccc
Q 015389          183 IVLELSPNGSLASLLY--GMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKW  259 (408)
Q Consensus       183 lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~  259 (408)
                      +||||++++.+..+..  .....+++..+..++.||+.||+|||+   +||+||||||+|||++.++ .+||+|||++..
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999998765444432  245679999999999999999999999   9999999999999999775 899999999987


Q ss_pred             CCCCCccceecccccCCCccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccc----cccchHHH
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMH-GIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPM----IKRNEIRE  334 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~----~~~~~~~~  334 (408)
                      +....   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..............    .....+..
T Consensus       173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            65432   2234679999999998875 4689999999999999999999999976443211110000    00000111


Q ss_pred             Hhhhhc------------cCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          335 LVDASL------------ADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       335 ~~d~~l------------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      ......            ...........+.+|+.+||+.||.+|||+.|+++  .++.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            000000            00011223456888999999999999999999986  35444

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-46  Score=354.38  Aligned_cols=257  Identities=22%  Similarity=0.247  Sum_probs=197.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCCCceeEEE-eEEEeCC-eEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDHPNTAKLL-GYGIEGG-MHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~-~~~~~~~-~~lv~e  186 (408)
                      ++|++.+.||+|+||.||+|.+. +|+.||||++......   ..+..|+.+++.++|+|++..+ ++..++. .++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            57999999999999999999875 6899999998765432   3467899999999877655554 5555555 567888


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC---CCceEEeecCCcccCCCC
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE---DFEPQICDFGLAKWLPEQ  263 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~---~~~~kl~DfGla~~~~~~  263 (408)
                      |+ +++|...+......+++..+..++.|++.||+|||+   ++|+||||||+|||++.   +..++|+|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            87 667777776677889999999999999999999999   99999999999999864   457999999999977543


Q ss_pred             Ccc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          264 WTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       264 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............        .....
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~--------~~~~~  231 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE--------RISEK  231 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH--------HHHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHH--------Hhhcc
Confidence            222     12345679999999999999999999999999999999999999997644332211110        01111


Q ss_pred             hccCc---ccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 015389          339 SLADE---YDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNL  381 (408)
Q Consensus       339 ~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~  381 (408)
                      .+...   .....+..+.+++..|++.+|++||++.++.+.|+...
T Consensus       232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            11110   11123466888999999999999999999998887653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.1e-46  Score=352.83  Aligned_cols=264  Identities=19%  Similarity=0.193  Sum_probs=205.0

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC-CceeEEEeEEEeCC-eEEEE
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-PNTAKLLGYGIEGG-MHIVL  185 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~~~-~~lv~  185 (408)
                      .++|++.+.||+|+||+||+|++. +|+.||||++......   ..+.+|+++++.+.| +|++.+++++..+. .++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            478999999999999999999976 6899999998654332   234578888888865 89999999877765 57888


Q ss_pred             EecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECC-----CCceEEeecCCcccC
Q 015389          186 ELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTE-----DFEPQICDFGLAKWL  260 (408)
Q Consensus       186 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~-----~~~~kl~DfGla~~~  260 (408)
                      ||+ +++|.+++......+++..+..++.|++.||+|||+   +||+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            887 789999997777789999999999999999999999   99999999999999974     568999999999876


Q ss_pred             CCCCcc-----ceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHH
Q 015389          261 PEQWTH-----HTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIREL  335 (408)
Q Consensus       261 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  335 (408)
                      ......     .....+.||+.|+|||.+.+..++.++|||||||++|||++|+.||.................... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-ST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CC
Confidence            433221     123456799999999999999999999999999999999999999986443211111000000000 00


Q ss_pred             hhhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcccCcc
Q 015389          336 VDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQLLRGNLCCL  384 (408)
Q Consensus       336 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~  384 (408)
                      .-+.+..    ..+..+.+++..|+..+|++||++..+.+.|+.+....
T Consensus       236 ~~~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         236 PLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             CHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ChHHhcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0011111    23456888999999999999999999999887765433

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=352.75  Aligned_cols=260  Identities=20%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEeCC-eEEEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIEGG-MHIVLE  186 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~-~~lv~e  186 (408)
                      ++|++++.||+|+||+||+|++. +|+.||||+++.... +.....+.+|+.++++++||||+++++++.+.. .++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999975 689999999975443 345788899999999999999999999777654 688999


Q ss_pred             ecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccCCCCCcc
Q 015389          187 LSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWLPEQWTH  266 (408)
Q Consensus       187 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  266 (408)
                      ++.+++|..++ ...+.+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||.++....... 
T Consensus        82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            99998888877 456778999999999999999999999   9999999999999999999999999999987754322 


Q ss_pred             ceecccccCCCccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhc------c-cccc-chHHHHhh
Q 015389          267 HTISKVEGTFGYLAPEFLMHGI-VDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWAR------P-MIKR-NEIRELVD  337 (408)
Q Consensus       267 ~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~------~-~~~~-~~~~~~~d  337 (408)
                       ......+++.|+|||.+.+.. ++.++|||||||++|||++|+.||............      . .... .......+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             223345788999999987665 689999999999999999999997443221110000      0 0000 00000000


Q ss_pred             ---------hhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          338 ---------ASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       338 ---------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                               ..-...........+.+|+.+||+.||.+|||+.||++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     00000111223456788999999999999999999876

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=363.63  Aligned_cols=271  Identities=24%  Similarity=0.296  Sum_probs=208.4

Q ss_pred             CCCCccceecccCcEEEEEEEEc----CCcEEEEEEecCCC---chHHHHHHHHHHHHHhcCCC-CceeEEEeEEEe-CC
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR----NGQLVAIKRLTRGT---ADEIIADFLSELGIMAHVDH-PNTAKLLGYGIE-GG  180 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~----~g~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~  180 (408)
                      ++|++.+.||+|+||+||+|...    +|+.||||.++...   .....+.+.+|+.++++++| |||+++++++.+ ..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999752    48999999987542   12234567789999999976 899999997765 45


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            7899999999999999954 4567788899999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCccceecccccCCCccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhccccccchHHHHhhh
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHG--IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARPMIKRNEIRELVDA  338 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~d~  338 (408)
                      ...... ......|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||.........           ..+...
T Consensus       180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-----------~~i~~~  247 (322)
T d1vzoa_         180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-----------AEISRR  247 (322)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-----------HHHHHH
T ss_pred             cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----------HHHHHh
Confidence            543222 23456799999999999765  4688999999999999999999999765332111           111111


Q ss_pred             hc--cCcccHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH--HHhcccCccccccccCCchhh
Q 015389          339 SL--ADEYDTRQMNLVLLAASLCIQQSSIRRP-----QMSQVVQ--LLRGNLCCLKYMTKCRSPLLR  396 (408)
Q Consensus       339 ~l--~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~--~L~~~~~~~~~~~~~~~~~~~  396 (408)
                      ..  ....+......+.+++.+||+.||.+||     |++|+++  .++++.+..-...+..+|+..
T Consensus       248 ~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p  314 (322)
T d1vzoa_         248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP  314 (322)
T ss_dssp             HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred             cccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCC
Confidence            11  1222334567888899999999999999     4788886  455544333333344555543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.7e-46  Score=356.76  Aligned_cols=252  Identities=17%  Similarity=0.256  Sum_probs=195.3

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEe---CCeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIE---GGMHIV  184 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---~~~~lv  184 (408)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...    .+++.+|+.+|+++. ||||+++++++..   ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            57999999999999999999975 69999999997654    346778999999995 9999999997653   348899


Q ss_pred             EEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCC-ceEEeecCCcccCCCC
Q 015389          185 LELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDF-EPQICDFGLAKWLPEQ  263 (408)
Q Consensus       185 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~  263 (408)
                      |||+.+++|..+.    ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+|..+...
T Consensus       111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            9999999987653    468999999999999999999999   9999999999999998655 6999999999876543


Q ss_pred             CccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc--ccccchHHHHh----
Q 015389          264 WTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP--MIKRNEIRELV----  336 (408)
Q Consensus       264 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~----  336 (408)
                      .   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........+...  ...........    
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            2   23456799999999998875 47999999999999999999999997654322111100  00000000000    


Q ss_pred             -------------------hhhccCcccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          337 -------------------DASLADEYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       337 -------------------d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                         ...............+.+|+.+||+.||.+|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                               000001111123456788999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=356.95  Aligned_cols=257  Identities=22%  Similarity=0.218  Sum_probs=191.2

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe-------C
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE-------G  179 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-------~  179 (408)
                      .++|+++++||+|+||+||+|.+. +|+.||||++..... .....++.+|+.++++++||||+++++++..       .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            378999999999999999999976 699999999986543 3456778999999999999999999997643       3


Q ss_pred             CeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          180 GMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       180 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      .+|+||||+.++.+ +.+   ...+++..+..++.||+.||.|||+   +||+||||||+|||++.++.++++|||+++.
T Consensus        96 ~~~iv~Ey~~~~l~-~~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSEEHH-HHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccchHHH-Hhh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence            57899999976544 444   3468999999999999999999999   9999999999999999999999999999886


Q ss_pred             CCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchhh--------------hhcc
Q 015389          260 LPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVL--------------WARP  325 (408)
Q Consensus       260 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~--------------~~~~  325 (408)
                      ....   .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.....              |...
T Consensus       169 ~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            5432   2334567999999999999999999999999999999999999999754322110              0000


Q ss_pred             ------------ccccchHHHHhhhhccC---cccHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 015389          326 ------------MIKRNEIRELVDASLAD---EYDTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ  375 (408)
Q Consensus       326 ------------~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~  375 (408)
                                  .................   .........+.+|+.+||+.||++|||+.||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        00000111111111111   112335677899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-46  Score=357.55  Aligned_cols=262  Identities=23%  Similarity=0.270  Sum_probs=198.7

Q ss_pred             cCCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHhcCCCCceeEEEeEEEe------CC
Q 015389          109 TNNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTA-DEIIADFLSELGIMAHVDHPNTAKLLGYGIE------GG  180 (408)
Q Consensus       109 ~~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~  180 (408)
                      .++|++.+.||+|+||+||+|.+. +|+.||||++..... ....+++.+|+.++++++||||+++++++..      ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            478999999999999999999875 699999999986543 3346678899999999999999999997642      23


Q ss_pred             eEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeecCCcccC
Q 015389          181 MHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDFGLAKWL  260 (408)
Q Consensus       181 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~~~  260 (408)
                      .+++++++.+|+|.+++.  ...+++..+..++.||+.||.|||+   +||+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence            567888899999999994  4579999999999999999999999   99999999999999999999999999999765


Q ss_pred             CCCCccceecccccCCCccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCccccchhhhhcc------------cc
Q 015389          261 PEQWTHHTISKVEGTFGYLAPEFLMHG-IVDEKTDVFAFGVLLLELVTGRRALDYSQQSLVLWARP------------MI  327 (408)
Q Consensus       261 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~~~~~~------------~~  327 (408)
                      ..     ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.............            ..
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            33     22346699999999987765 46899999999999999999999997654321110000            00


Q ss_pred             ccchHHHHhhhhcc-Ccc-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 015389          328 KRNEIRELVDASLA-DEY-----DTRQMNLVLLAASLCIQQSSIRRPQMSQVVQ--LLRGN  380 (408)
Q Consensus       328 ~~~~~~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~  380 (408)
                      .............. ...     .......+.+|+.+||+.||.+|||+.|+++  .+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00000111110000 000     0112355788999999999999999999997  45544

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-40  Score=320.64  Aligned_cols=255  Identities=20%  Similarity=0.236  Sum_probs=187.9

Q ss_pred             CCCCccceecccCcEEEEEEEEc-CCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-----------CCceeEEEeEEE
Q 015389          110 NNFSFENLIGKGGYAEVYKGRLR-NGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-----------HPNTAKLLGYGI  177 (408)
Q Consensus       110 ~~y~~~~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----------hpniv~l~~~~~  177 (408)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...  .....+.+|+.+++.++           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            45999999999999999999975 69999999998653  23456678888887764           578999998654


Q ss_pred             e---CCeEEEEEecCCCCHHHH--HhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCc----
Q 015389          178 E---GGMHIVLELSPNGSLASL--LYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFE----  248 (408)
Q Consensus       178 ~---~~~~lv~e~~~~g~L~~~--l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~----  248 (408)
                      .   ...+++++++..+.....  .......+++..+..++.||+.||.|||+  ..||+||||||+|||++.++.    
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence            3   235566666655443332  23355678999999999999999999997  378999999999999986653    


Q ss_pred             --eEEeecCCcccCCCCCccceecccccCCCccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCccccchh------
Q 015389          249 --PQICDFGLAKWLPEQWTHHTISKVEGTFGYLAPEFLMHGIVDEKTDVFAFGVLLLELVTGRRALDYSQQSLV------  320 (408)
Q Consensus       249 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvil~elltg~~pf~~~~~~~~------  320 (408)
                        ++|+|||.+.....     ......||+.|+|||.+.+..++.++||||+||++++|++|+.||........      
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999986543     22346699999999999999999999999999999999999999975322100      


Q ss_pred             --hhhccc--cc---------------------------cchHHHHhhhhccCcccHHHHHHHHHHHHhccccCCCCCCC
Q 015389          321 --LWARPM--IK---------------------------RNEIRELVDASLADEYDTRQMNLVLLAASLCIQQSSIRRPQ  369 (408)
Q Consensus       321 --~~~~~~--~~---------------------------~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt  369 (408)
                        ......  ..                           .........  ............+.+|+.+||+.||.+|||
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence              000000  00                           000001111  112234566788999999999999999999


Q ss_pred             HHHHHH
Q 015389          370 MSQVVQ  375 (408)
Q Consensus       370 ~~evl~  375 (408)
                      +.|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=197.09  Aligned_cols=165  Identities=16%  Similarity=0.167  Sum_probs=123.0

Q ss_pred             CCccceecccCcEEEEEEEEcCCcEEEEEEecCCCc-----------------hHHHHHHHHHHHHHhcCCCCceeEEEe
Q 015389          112 FSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTA-----------------DEIIADFLSELGIMAHVDHPNTAKLLG  174 (408)
Q Consensus       112 y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~-----------------~~~~~~~~~E~~il~~l~hpniv~l~~  174 (408)
                      +.+.++||+|+||+||+|.+.+|+.||||+++....                 .........|...+.++.|++++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998753211                 112344567889999999999998886


Q ss_pred             EEEeCCeEEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeeCCCCCceEECCCCceEEeec
Q 015389          175 YGIEGGMHIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEGCQRRIIHRDIKAANILLTEDFEPQICDF  254 (408)
Q Consensus       175 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dikp~NIll~~~~~~kl~Df  254 (408)
                      +.   ..+++||++++..+.        .++......++.|++.+|.|||+   ++|+||||||+|||++++ .++|+||
T Consensus        82 ~~---~~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          82 WE---GNAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             EE---TTEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             ec---CCEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEEC
Confidence            53   347999999886543        24455667899999999999999   999999999999999966 5899999


Q ss_pred             CCcccCCCCCccceecccccCCCccc------cccccCCCCCcchhHHHHHHHH
Q 015389          255 GLAKWLPEQWTHHTISKVEGTFGYLA------PEFLMHGIVDEKTDVFAFGVLL  302 (408)
Q Consensus       255 Gla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~k~DvwSlGvil  302 (408)
                      |+|.........          .|..      .+++ .+.|+.++|+||+.--+
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            999765422111          1111      1222 46678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=1.8e-07  Score=83.38  Aligned_cols=147  Identities=16%  Similarity=0.081  Sum_probs=95.9

Q ss_pred             HHhhhcCCCCccceecccCcEEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeC-Ce
Q 015389          104 ELQSATNNFSFENLIGKGGYAEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEG-GM  181 (408)
Q Consensus       104 ~~~~~~~~y~~~~~lg~G~fg~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~-~~  181 (408)
                      ++......|++.+..+.++.+.||+... +++.++||+....... ....+.+|...+..+. +--+.+++.+..++ ..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            4455557787776655555679999875 4556778877644321 1223456777766653 43356677766554 46


Q ss_pred             EEEEEecCCCCHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 015389          182 HIVLELSPNGSLASLLYGMKEKLKWGIRYKIALGVAEGLLYLHEG-----------------------------------  226 (408)
Q Consensus       182 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------  226 (408)
                      ++||++++|.++.+....      ......++.+++..+..||+.                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            899999999888765421      112233455566666666641                                   


Q ss_pred             ---------------------CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          227 ---------------------CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       227 ---------------------~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                                           ....++|+|+.|.||++++++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                 02348899999999999987667799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.03  E-value=1e-05  Score=71.11  Aligned_cols=129  Identities=18%  Similarity=0.132  Sum_probs=79.8

Q ss_pred             eecccCc-EEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCC--CCceeEEEeEEEeC-CeEEEEEecCCCC
Q 015389          117 LIGKGGY-AEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVD--HPNTAKLLGYGIEG-GMHIVLELSPNGS  192 (408)
Q Consensus       117 ~lg~G~f-g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~--hpniv~l~~~~~~~-~~~lv~e~~~~g~  192 (408)
                      .+..|.. +.||+...+++..++||........    .+..|...++.+.  .-.+.+++.+..+. ..++||++++|.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444543 6899998888888999987655432    2345666665552  23356677765554 5689999998866


Q ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 015389          193 LASLLYGMKEKLKWGIRYKIALGVAEGLLYLH------------------------------------------------  224 (408)
Q Consensus       193 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH------------------------------------------------  224 (408)
                      +.+..      ...   ..++.++...|.-||                                                
T Consensus        93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            53210      000   111122222233333                                                


Q ss_pred             ---hc----CCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          225 ---EG----CQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       225 ---~~----~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                         ..    .+..++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               21    12348999999999999987667899998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.68  E-value=4.6e-05  Score=71.84  Aligned_cols=77  Identities=14%  Similarity=0.032  Sum_probs=47.1

Q ss_pred             ceecccCcEEEEEEEEc-CCcEEEEEEecCC------CchHHHHHHHHHHHHHhcCC-C--CceeEEEeEEEeCCeEEEE
Q 015389          116 NLIGKGGYAEVYKGRLR-NGQLVAIKRLTRG------TADEIIADFLSELGIMAHVD-H--PNTAKLLGYGIEGGMHIVL  185 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~-~g~~vavK~~~~~------~~~~~~~~~~~E~~il~~l~-h--pniv~l~~~~~~~~~~lv~  185 (408)
                      +.||.|....||+.... +++.|+||.-...      ...-...+...|...++.+. +  ..+.+++.+ ......+||
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lvm  110 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTVM  110 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEEE
Confidence            56899999999999865 4778999965321      11111233446777766552 2  345566655 344557899


Q ss_pred             EecCCCCH
Q 015389          186 ELSPNGSL  193 (408)
Q Consensus       186 e~~~~g~L  193 (408)
                      |++.+..+
T Consensus       111 E~L~~~~~  118 (392)
T d2pula1         111 EDLSHLKI  118 (392)
T ss_dssp             CCCTTSEE
T ss_pred             eccCCccc
Confidence            99977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.31  E-value=0.00051  Score=62.55  Aligned_cols=132  Identities=14%  Similarity=0.141  Sum_probs=72.9

Q ss_pred             EEEEEEEEcCCcEEEEEEecCCCchHHHHHHHHHHHHHhcCCC-----CceeEEEe---EEEeCCeEEEEEecCCCCHH-
Q 015389          124 AEVYKGRLRNGQLVAIKRLTRGTADEIIADFLSELGIMAHVDH-----PNTAKLLG---YGIEGGMHIVLELSPNGSLA-  194 (408)
Q Consensus       124 g~V~~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~h-----pniv~l~~---~~~~~~~~lv~e~~~~g~L~-  194 (408)
                      -.||++..++|+.|++|+...+...  ...+..|...+..|..     +..+..-+   +..++..+.+++++.|..+. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            4899999989999999998765432  2345567776666531     11112111   23334456788888764321 


Q ss_pred             ----HH---------Hhc--------ccCCCCHH-------------------H---HHHHHHHHHHHHHHH-HhcCCCC
Q 015389          195 ----SL---------LYG--------MKEKLKWG-------------------I---RYKIALGVAEGLLYL-HEGCQRR  230 (408)
Q Consensus       195 ----~~---------l~~--------~~~~l~~~-------------------~---~~~i~~~i~~~L~~L-H~~~~~~  230 (408)
                          .+         ++.        ....++..                   .   ....+..+...+.-+ ....+.+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                11         111        00111111                   1   112222232222211 1223467


Q ss_pred             eEeeCCCCCceEECCCCceEEeecCCccc
Q 015389          231 IIHRDIKAANILLTEDFEPQICDFGLAKW  259 (408)
Q Consensus       231 iiH~Dikp~NIll~~~~~~kl~DfGla~~  259 (408)
                      +||+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999743  56899998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.21  E-value=0.0017  Score=58.51  Aligned_cols=33  Identities=24%  Similarity=0.307  Sum_probs=28.9

Q ss_pred             cCCCCeEeeCCCCCceEECCCCceEEeecCCcc
Q 015389          226 GCQRRIIHRDIKAANILLTEDFEPQICDFGLAK  258 (408)
Q Consensus       226 ~~~~~iiH~Dikp~NIll~~~~~~kl~DfGla~  258 (408)
                      ..+.++||+|+.++||+++++...-|+||+.+.
T Consensus       180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCcchhhhhcccccceeEecccccc
Confidence            346789999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0068  Score=56.32  Aligned_cols=72  Identities=18%  Similarity=0.140  Sum_probs=46.5

Q ss_pred             ceecccCcEEEEEEEEcC--------CcEEEEEEecCCCchHHHHHHHHHHHHHhcCC-CCceeEEEeEEEeCCeEEEEE
Q 015389          116 NLIGKGGYAEVYKGRLRN--------GQLVAIKRLTRGTADEIIADFLSELGIMAHVD-HPNTAKLLGYGIEGGMHIVLE  186 (408)
Q Consensus       116 ~~lg~G~fg~V~~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~lv~e  186 (408)
                      +.|+.|-.-.+|++...+        +..|.+++.-....  . ....+|..+++.+. +.-..++++++.+   .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E-SHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC---ceEEE
Confidence            578888889999998653        35677776653222  1 23457888887774 4334567776532   57888


Q ss_pred             ecCCCCH
Q 015389          187 LSPNGSL  193 (408)
Q Consensus       187 ~~~~g~L  193 (408)
                      |++|..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9877543